(this.webpackJsonpdemo=this.webpackJsonpdemo||[]).push([[0],{1093:function(e,t,a){e.exports=a.p+"static/media/lightLoginBackground.d65ea7f1.jpg"},1094:function(e,t,a){e.exports=a.p+"static/media/Viv3211.3d27496c.png"},1096:function(e,t,a){e.exports=a.p+"static/media/download.32a62c80.svg"},1116:function(e,t,a){e.exports=a.p+"static/media/P.7eaa7b1f.svg"},1117:function(e,t,a){e.exports=a.p+"static/media/S.f52e91b9.svg"},1132:function(e,t,a){e.exports=a.p+"static/media/logoWhite.e3aeb3bb.svg"},1136:function(e,t){},1137:function(e,t,a){e.exports=a.p+"static/media/ria-brochure-steps.a4a318fe.png"},1138:function(e,t,a){e.exports=a.p+"static/media/ria-steppers.e4618c7d.png"},1139:function(e,t,a){e.exports=a.p+"static/media/ria-architecture.3f080725.png"},1140:function(e,t,a){e.exports=a.p+"static/media/ria-application-view.63b9573e.png"},1141:function(e,t,a){e.exports=a.p+"static/media/ria-filter.07678248.png"},1142:function(e,t,a){e.exports=a.p+"static/media/ria-analytic-view.41c5d64d.png"},1143:function(e,t,a){e.exports=a.p+"static/media/ria-list-view-new.7d748dda.png"},1144:function(e,t,a){e.exports=a.p+"static/media/ria-manage.290d9de1.png"},1145:function(e,t,a){e.exports=a.p+"static/media/ria-search-list.90d12a1b.png"},1146:function(e,t,a){e.exports=a.p+"static/media/ria-extended-card.4c38dfe1.png"},1147:function(e,t,a){e.exports=a.p+"static/media/ri-reg-new.94437e37.png"},1148:function(e,t,a){e.exports=a.p+"static/media/ria-clinic-new.e2a59596.png"},1149:function(e,t,a){e.exports=a.p+"static/media/ria-aria-new.d51303b6.png"},1156:function(e){e.exports=JSON.parse('[{"id":"y","color":"hsl(206\xb0, 88%, 46%)","data":[{"x":"Completed","y":150},{"x":"Active, not recruiting","y":228},{"x":"Terminated","y":156},{"x":"Unknown status","y":200},{"x":"Withdrawn","y":100},{"x":"Recruiting","y":245},{"x":"Not yet recruiting","y":167}]}]')},1157:function(e,t,a){e.exports=a.p+"static/media/undo-arrow.fb212e33.svg"},1158:function(e,t,a){e.exports=a.p+"static/media/filterPMR.71a1484f.svg"},1159:function(e,t,a){e.exports=a.p+"static/media/bot.3d4dee71.png"},1232:function(e,t,a){e.exports=a(1780)},1237:function(e,t,a){},1392:function(e,t){},1394:function(e,t){},1404:function(e,t){},1406:function(e,t){},1433:function(e,t){},1435:function(e,t){},1436:function(e,t){},1441:function(e,t){},1443:function(e,t){},1449:function(e,t){},1451:function(e,t){},1470:function(e,t){},1482:function(e,t){},1485:function(e,t){},1638:function(e,t,a){e.exports=a.p+"static/media/021505_s000_Keppra_Prntlbl.a7257dbe.pdf"},166:function(e,t,a){e.exports=a.p+"static/media/bot.3cc37c5c.svg"},1674:function(e){e.exports=JSON.parse("{}")},1675:function(e,t,a){e.exports=a.p+"static/media/Summary icon.fbbf3acc.svg"},1676:function(e,t,a){},170:function(e,t,a){e.exports=a.p+"static/media/aa.6ed57e4e.png"},171:function(e,t,a){e.exports=a.p+"static/media/bt.80c74045.png"},172:function(e,t,a){e.exports=a.p+"static/media/ft.6ee88615.png"},173:function(e,t,a){e.exports=a.p+"static/media/G.1e03c1bb.png"},1738:function(e,t){},1739:function(e,t,a){e.exports=a.p+"static/media/filter (1).204e1a93.svg"},1752:function(e,t){},1753:function(e,t){},1754:function(e,t){},1755:function(e,t){},1756:function(e,t){},1757:function(e,t,a){var n={"./amplify-amazon-button_5.entry.js":[1825,17],"./amplify-auth-fields_9.entry.js":[1826,18],"./amplify-authenticator.entry.js":[1827,6],"./amplify-button_3.entry.js":[1828,19],"./amplify-chatbot.entry.js":[1829,5],"./amplify-checkbox.entry.js":[1830,20],"./amplify-confirm-sign-in_7.entry.js":[1831,7],"./amplify-container.entry.js":[1832,21],"./amplify-federated-buttons_2.entry.js":[1833,22],"./amplify-federated-sign-in.entry.js":[1834,23],"./amplify-form-field_4.entry.js":[1835,24],"./amplify-greetings.entry.js":[1836,25],"./amplify-icon-button.entry.js":[1837,26],"./amplify-icon.entry.js":[1838,8],"./amplify-link.entry.js":[1839,27],"./amplify-nav_2.entry.js":[1840,28],"./amplify-photo-picker.entry.js":[1841,29],"./amplify-picker.entry.js":[1842,30],"./amplify-radio-button_2.entry.js":[1843,9],"./amplify-s3-album.entry.js":[1844,10],"./amplify-s3-image-picker.entry.js":[1845,11],"./amplify-s3-image.entry.js":[1846,12],"./amplify-s3-text-picker.entry.js":[1847,13],"./amplify-s3-text.entry.js":[1848,14],"./amplify-select-mfa-type.entry.js":[1849,31],"./amplify-sign-in-button.entry.js":[1850,15],"./amplify-toast.entry.js":[1851,32],"./amplify-tooltip.entry.js":[1852,33]};function r(e){if(!a.o(n,e))return Promise.resolve().then((function(){var t=new Error("Cannot find module '"+e+"'");throw t.code="MODULE_NOT_FOUND",t}));var t=n[e],r=t[0];return a.e(t[1]).then((function(){return a(r)}))}r.keys=function(){return Object.keys(n)},r.id=1757,e.exports=r},1780:function(e,t,a){"use strict";a.r(t);var n=a(0),r=a.n(n),i=a(48),o=a.n(i),l=(a(1237),a(5)),c=a.n(l),s=a(11),d=a(3),m=a(146),u=a(112),p=a(1912),g=a(4),h=a(574),T=a(476),f=(new h.a({UserPoolId:"us-east-1_tlbmVxyo8",ClientId:"6mhf74trqn5q9hj7g7m6cncn74"}),a(195)),A=a(1093),E=a.n(A),b=Object(f.a)((function(e){return{root:{height:"inherit",width:"inherit",backgroundImage:"url(".concat(E.a,")"),backgroundRepeat:"no-repeat",backgroundPosition:"center",backgroundSize:"cover",backgroundAttachment:"fixed"},loginForm:{margin:"1rem",justifyContent:"center",minWidth:"45vh",minHeight:"90vh"},button:{justifyContent:"center",background:"linear-gradient(180deg, ".concat(e.palette.gradient.primaryFrom," 10%, ").concat(e.palette.gradient.primaryTo," 90%)"),color:e.palette.white,borderRadius:"1.5rem",marginTop:"1rem",boxShadow:"2px 3px 5px 2px ".concat(e.palette.primary.shadow)},loginBackground:{justifyContent:"center",minHeight:"30vh",padding:"2rem",borderRadius:"0.6rem",width:"80vh"},titleBox:{justifyContent:"center"},logoBox:{justifyContent:"center"},logo:{minHeight:"10vh",minWidth:"15vh"},forgotPassword:{justifyContent:"center",padding:"1rem"},textField:{border:"2px solid #e3f1ff !important",borderRadius:"10px !important",backgroundColor:"#f7fbff !important",buttonBox:{justifyContent:"center"},"& .MuiInputBase-root":{margin:"0.5rem",fontSize:"1rem"}},fieldName:{padding:"5px",textAlign:"left",color:"#3B3B3B",opacity:"0.8",fontSize:"16px",fontWeight:"bold"},textFieldName:{border:"2px solid #e3f1ff !important",borderRadius:"10px !important",backgroundColor:"#f7fbff !important",buttonBox:{justifyContent:"center !important"},"& .MuiInputBase-root":{margin:"0.5rem",fontSize:"1rem"}},filterParent:{borderRadius:"10px",backgroundColor:e.palette.primary.lightBackground},filterLabel:{paddingLeft:"10px",textAlign:"left",width:"100%",color:e.palette.primary.main},filterSelect:{paddingLeft:"4px",textAlign:"left",fontSize:"2vh",width:"100%",color:e.palette.black}}})),N=a(280),C=a(1904),S=a(1949),y=a(117),D=a(585),_=a(353),O=a(1094),x=a.n(O),v=Object(f.a)((function(e){var t;return t={main:{height:"90vh",marginTop:e.spacing(8),padding:e.spacing(2),marginLeft:e.spacing(9)+1,width:"calc(100% - ".concat(e.spacing(9)+1,"px)")},airplaneIcon:{position:"fixed",zIndex:e.zIndex.drawer+2,bottom:e.spacing(2),left:e.spacing(2)},add:{fontSize:e.spacing(1.87),color:e.palette.navbar.button,cursor:"pointer",marginTop:e.spacing(1)},MainGrid:{marginTop:"0.5rem",height:"100%"},GridGraphBox:{height:"100%",backgroundColor:e.palette.white,boxShadow:"none",marginTop:e.spacing(4),borderRadius:0},GridGraph:{height:"100%",backgroundColor:e.palette.white,boxShadow:"none",borderRadius:0},GridNews:{height:"100%",width:"100%",boxShadow:"none",borderRadius:0},GridTitle:{fontSize:e.spacing(3),color:e.palette.home.heading,fontWeight:"bold",marginLeft:e.spacing(15)},newsHeading:{fontSize:e.spacing(3),color:e.palette.home.heading,fontWeight:"bold",marginLeft:e.spacing(15)},icon:{color:e.palette.home.heading},GridTitleBox:{},GridContentBox:{},graphInnerGrid:{height:"100%",width:"100%",boxShadow:"none",borderRadius:0},graphInnerTitleGrid:{width:"100%",boxShadow:"none",borderRadius:0},graphInnerChartGrid:{height:"90%",width:"100%",boxShadow:"none",borderRadius:0},graphInnerMessageGrid:{height:"5%",width:"100%",boxShadow:"none",borderRadius:0},graphInnerMessage:{fontSize:"1.5vh",fontWeight:"500",color:e.palette.black,padding:"5px"},graphInnerTitle:{fontSize:e.spacing(2),fontWeight:"700",color:e.palette.home.title,padding:"5px"},chart:{height:"60vh",width:"100%",boxShadow:"none",borderRadius:0}},Object(g.a)(t,"graphInnerChartGrid",{height:"90%"}),Object(g.a)(t,"paper",{borderRadius:e.spacing(2),height:"100%",overflowY:"auto",padding:e.spacing(1)}),Object(g.a)(t,"botIconFAB",{left:e.spacing(2),bottom:e.spacing(10),zIndex:e.zIndex.drawer+2,position:"fixed"}),Object(g.a)(t,"botIcon",{height:"100%",width:"100%"}),Object(g.a)(t,"botIntroPopup",{fontWeight:"900",fontSize:"2vh",padding:"4px",borderRadius:"10px",color:e.palette.primary.main,backgroundColor:e.palette.primary.lightBackground}),Object(g.a)(t,"botTextPopup",{fontSize:"1.5vh",padding:"4px",color:e.palette.white,opacity:1}),Object(g.a)(t,"ModalTitle",{padding:0}),Object(g.a)(t,"ModalCloseIconButton",{padding:0,marginBottom:"-20px",marginLeft:"-20px",color:e.palette.navbar.button}),Object(g.a)(t,"ModalCloseIcon",{color:e.palette.biologics.textPrimary}),Object(g.a)(t,"Dialog",{minHeight:"70vh",padding:0}),t})),R=a(677),P=a(9),I=a(155),w=a.n(I),L=a(916),j=a(418),B=a(1910),U=a(1808),k=a(1809),M=a(1914),F=a(166),z=a.n(F),Y=a(47),V=function(){return r.a.createElement("svg",{xmlns:"http://www.w3.org/2000/svg",width:"30.337",height:"30.337",viewBox:"0 0 12.473 12.473"},r.a.createElement("g",{id:"Group_330","data-name":"Group 330",transform:"translate(0.25 0.25)"},r.a.createElement("circle",{id:"Ellipse_51","data-name":"Ellipse 51",cx:"4.154",cy:"4.154",r:"4.154",fill:"none",stroke:"#b1bbe4","stroke-linecap":"round","stroke-linejoin":"round","stroke-width":"0.5"}),r.a.createElement("line",{id:"Line_17","data-name":"Line 17",x1:"4.778",y1:"4.778",transform:"translate(7.092 7.092)",fill:"none",stroke:"#b1bbe4","stroke-linecap":"round","stroke-linejoin":"round","stroke-width":"0.5"})))},G=a(122),H=a.n(G),W=a(749),Q=Object(f.a)((function(e){return{searchBar:{marginLeft:e.spacing(1),borderRadius:e.spacing(1.25),width:e.spacing(42),paddingLeft:e.spacing(1),border:"none",height:"100%",minHeight:"50px",fontSize:"2vh",background:e.palette.navbar.grayBackground,color:e.palette.black},searchBarLong:{borderRadius:e.spacing(1.25),borderBottomRightRadius:"0px",borderTopRightRadius:"0px",width:e.spacing(60),border:"none",height:"100%",minHeight:"50px",fontSize:"2vh",background:e.palette.navbar.grayBackground,color:e.palette.black,marginLeft:"10px"},searchBarPMR:{borderRadius:e.spacing(1.25),borderBottomRightRadius:"0px",borderTopRightRadius:"0px",width:e.spacing(60),border:"none",height:"100%",minHeight:"50px",fontSize:"14px",color:"#B1BBE4"}}})),J=function(e){var t=Q();return r.a.createElement(W.a,null,r.a.createElement("input",{className:t.searchBar,placeholder:e.placeholder,type:"search",onChange:function(t){e.handleChange(t)},required:!0,id:e.id,name:e.name,value:e.value,onKeyDown:e.onKeyDown,list:e.list}))},K=function(e){var t=Q();return r.a.createElement("input",{className:t.searchBarLong,placeholder:e.placeholder,type:"search",onChange:function(t){e.handleChange(t)},id:e.id,name:e.name,value:e.value,onKeyDown:e.onKeyDown,list:e.list})},Z=function(e){var t=Q();return r.a.createElement("input",{className:t.searchBarPMR,placeholder:e.placeholder,type:"search",onChange:function(t){e.handleChange(t)},id:e.id,name:e.name,value:e.value,onKeyDown:e.onKeyDown,list:e.list})},X=Object(f.a)((function(e){var t,a;return a={BotForm:{margin:"7px",width:"75%"},searchSpaceGridBot:{height:"100%",minHeight:"40px"},airplaneIcon:{position:"fixed",zIndex:e.zIndex.drawer+2,bottom:e.spacing(2),left:e.spacing(2)},BotButton:{width:"100%",borderRadius:"10px",fontSize:"2vh",fontWeight:"800",background:"linear-gradient(to bottom, ".concat(e.palette.gradient.primaryFrom," 10%, ").concat(e.palette.gradient.primaryTo," 90%)"),color:e.palette.white},BotDocumentIconButton:{margin:"1vh",padding:"7px",background:"linear-gradient(to bottom, ".concat(e.palette.gradient.primaryFrom," 10%, ").concat(e.palette.gradient.primaryTo," 90%)"),color:e.palette.white},Paper:{width:"100%",border:"none",boxShadow:"none"},FilterGrid:{height:"100%",width:"100%",borderTopRightRadius:"10px",borderBottomRightRadius:"10px",backgroundColor:e.palette.bot.filterBackground,padding:"7px",paddingTop:e.spacing(5),minHeight:"79vh"},TableGrid:{paddingLeft:"7px",paddingRight:"7px"},TopGrids:{padding:e.spacing(1),paddingBottom:e.spacing(0)},BotCardsGrid:{maxHeight:"68vh",overflowY:"scroll"},SuggestedAnswerGrid:{borderRadius:"5px",padding:e.spacing(1),margin:"10px",backgroundColor:e.palette.bot.darkBackground,marginBottom:"5px"},TopGridTypography:{paddingBottom:e.spacing(1),fontSize:"0.8rem",fontWeight:"400",color:e.palette.black,fontStyle:"normal",textTransform:"none"},TopGridTypographyTitle:{fontWeight:"700",color:e.palette.black,fontStyle:"normal",textTransform:"none"},Table:{width:"100%"},TableHead:{borderRadius:"10px"},TableBody:{borderRadius:"10px"},StyledHeaderTableRow:{borderRadius:"10px"},StyledHeaderTableCell:{padding:"7px",fontSize:"2vh",fontWeight:"800",color:e.palette.white,backgroundColor:e.palette.primary.main},StyledHeaderTableCellMapped:{padding:"7px",fontSize:"1.5vh",fontWeight:"700",color:e.palette.white,backgroundColor:e.palette.primary.main},StyledTableRow:{borderRadius:"10px",padding:"15px","&:nth-of-type(odd)":{backgroundColor:e.palette.primary.lightBackground},"&:nth-of-type(even)":{backgroundColor:e.palette.white}},StyledTableCell:{padding:"7px",fontSize:"1.5vh",fontWeight:"700",color:e.palette.black},StyledTableCellMapped:{padding:"7px",fontSize:"1.5vh",fontWeight:"500",color:e.palette.black},StyledTypography:{fontSize:"2vh",padding:"15px",color:e.palette.black,borderRadius:"10px",backgroundColor:e.palette.primary.lightBorder,boxShadow:"2px 2px 5px ".concat(e.palette.primary.lightBorder)},StyledErrorTypography:{fontSize:"2vh",padding:"15px",color:e.palette.black,borderRadius:"10px",backgroundColor:e.palette.primary.lightBorder,fontWeight:"700"},StyledErrorLine2Typography:{fontSize:"1.5vh",padding:"15px",color:e.palette.primary.main,fontWeight:"900"},StyledTypographyLink:{fontSize:"2vh",textAlign:"center",width:"100%",color:e.palette.white,fontWeight:"900"},StyledButton:{fontSize:"1.5vh",fontWeight:"500",margin:"15px",padding:"3px",borderRadius:"10px",width:"60%",background:"linear-gradient(to bottom, ".concat(e.palette.gradient.primaryFrom," 10%, ").concat(e.palette.gradient.primaryTo," 90%)"),color:e.palette.white},StyledTypographyCapsule:{padding:"7px",borderRadius:"10px",width:"60%",textAlign:"center",fontWeight:"900",fontSize:"1.5vh",color:e.palette.black,backgroundColor:e.palette.primary.lightBorder},ErrorGrid:{padding:e.spacing(3)},botIcon:{height:"12vh",width:"12vh",backgroundColor:e.palette.white},botResultsIcon:{height:"10vh",width:"10vh",paddingBottom:"10px",backgroundColor:e.palette.white},BotLogoBox:{height:"320px",width:"100%"},BotLogo:{marginRight:"-100px",height:"300px",width:"300px",padding:"10px"},Line1Typography:{fontSize:"1.8rem",fontWeight:"300",fontStyle:"italic",color:e.palette.black},Line1Title:{fontWeight:"900",color:e.palette.black,fontStyle:"normal",textTransform:"none"},Line2Typography:{fontSize:"1.2rem",fontWeight:"300",color:e.palette.black,paddingBottom:"20px"},Button:{marginTop:"-3px",fontSize:"0.8rem",textTransform:"none",fontWeight:"400",minHeight:"50px",padding:"10px",background:e.palette.navbar.grayBackground,borderRadius:"10px",borderBottomLeftRadius:"0px",borderTopLeftRadius:"0px"},StyledTypographyBlue:{textAlign:"left",width:"100%",fontSize:"0.8rem",fontWeight:"700",color:e.palette.black,padding:"10px"}},Object(g.a)(a,"BotDocumentIconButton",{fontSize:"0.7rem",textTransform:"none"}),Object(g.a)(a,"toggleButtonGroup",{paddingLeft:"10px"}),Object(g.a)(a,"toggleButtonIndivdual",(t={border:"none !important",marginRight:"20px !important",borderRadius:"10px !important",width:"70px !important",backgroundColor:"".concat(e.palette.white," !important")},Object(g.a)(t,"border","1px solid ".concat(e.palette.black," !important")),Object(g.a)(t,"padding","5px !important"),Object(g.a)(t,"paddingTop","3px !important"),Object(g.a)(t,"paddingBottom","3px !important"),Object(g.a)(t,"& .MuiToggleButton-label",{color:e.palette.black,fontWeight:"400",textTransform:"none"}),t)),Object(g.a)(a,"toggleButtonSelectedIndivdual",{border:"none !important",marginRight:"20px !important",borderRadius:"10px !important",width:"70px !important",backgroundColor:"".concat(e.palette.bot.buttonBackground," !important"),padding:"5px !important",paddingTop:"3px !important",paddingBottom:"3px !important","& .MuiToggleButton-label":{color:e.palette.white,fontWeight:"400",textTransform:"none"}}),Object(g.a)(a,"DisclaimerTypography",{paddingBottom:e.spacing(1),fontSize:"1rem",fontWeight:"600",color:e.palette.black,fontStyle:"normal",textTransform:"none"}),Object(g.a)(a,"BotLearnTypography",{fontSize:"0.9rem",fontWeight:"400",color:e.palette.black,fontStyle:"oblique"}),Object(g.a)(a,"BotLearnImg",{paddingLeft:"2px"}),a})),q=a(750),$=a.n(q),ee=a(1902),te=a(1903),ae=a(553),ne=a.n(ae),re=a(340),ie=a.n(re),oe=a(341),le=a.n(oe),ce=a(385),se=a.n(ce),de=a(386),me=a.n(de),ue=Object(f.a)((function(e){return{Card:{margin:"10px",borderRadius:"5px",boxShadow:"0px 0px 5px 2px ".concat(e.palette.navbar.grayBackground)},CardContent:{padding:"0","& .MuiCardContent-root:last-child":{paddingBottom:"5px"}},ResponseText:{backgroundColor:e.palette.bot.lightBackground,fontSize:"0.8rem",fontWeight:"500",borderRadius:"5px",color:e.palette.black,textAlign:"justify",padding:"10px",margin:0},BottomGrid:{paddingRight:"10px",paddingLeft:"10px"},StyledTypography:{textAlign:"left",width:"100%",fontSize:"0.8rem",fontWeight:"700",color:e.palette.black,padding:"5px",paddingTop:"10px",paddingBottom:"10px"},StyledTypographyCapsule:{borderRadius:"5px",backgroundColor:e.palette.bot.darkBackground,fontSize:"0.7rem",fontWeight:"700",color:e.palette.black,padding:"5px",margin:"2px",marginTop:"5px",marginBottom:"5px"},Divider:{color:e.palette.navbar.grayBackground,height:"0.5px"},BotDocumentIconButton:{fontSize:"0.7rem"},StyledTypographyCapsuleCircle:{color:e.palette.white,fontSize:e.spacing(1)},BotLikeButton:{fontSize:"0.7rem",padding:0,paddingLeft:"1px",paddingRight:"1px"},BotLikeButtonBox:{padding:"3px",width:"100%",backgroundColor:e.palette.white}}})),pe=a(1905),ge=a(84),he=a.n(ge),Te=H.a.create({baseURL:"https://ria-api-staging.vivpro.ai:8443/v2",headers:{"Content-type":"application/json"}}),fe=(a(86),"Basic "+a(86).Base64.encode("developers:>;JQwa[zL!EX+f{?3{fjnK"));function Ae(){return Te.get("/clignosis/health",{headers:{Authorization:fe}})}function Ee(e){return Te.get("/clignosis/generic_count/search?nda=".concat(e),{headers:{Authorization:fe}})}function be(e){return Te.get("/clignosis/ApplnContent/".concat(e),{headers:{Authorization:fe}})}function Ne(e){return Te.get("/PMR?nda=".concat(e),{headers:{Authorization:fe}})}function Ce(e){return Te.get("/RegulatoryPMR/".concat(e),{headers:{Authorization:fe}})}function Se(e){return Te.get("/clignosis/pmr/".concat(e),{headers:{Authorization:fe}})}function ye(e){return Te.get("/clignosis/drug/approvaljourney?applicationno=".concat(e),{headers:{Authorization:fe}})}function De(e){return Te.get("/clignosis/tradeNameSearch/".concat(e,"?module=others"),{headers:{Authorization:fe}})}function _e(e){return Te.get("/clignosis/activeIngredientsSearch/".concat(e,"?module=others"),{headers:{Authorization:fe}})}function Oe(e){return Te.get("/clignosis/formulationSearch/".concat(e,"?module=others"),{headers:{Authorization:fe}})}function xe(e){return Te.get("/clignosis/routeSearch/".concat(e,"?module=others"),{headers:{Authorization:fe}})}function ve(e){return Te.get("/clignosis/termSearch/".concat(e),{headers:{Authorization:fe}})}function Re(e){return Te.get("/clignosis/termSearch/".concat(e,"?module=default"),{headers:{Authorization:fe}})}function Pe(e){return Te.get("/clignosis/activeIngredientsSearch/bla/".concat(e),{headers:{Authorization:fe}})}function Ie(e){return Te.get("/clignosis/formulationSearch/bla/".concat(e),{headers:{Authorization:fe}})}function we(e){return Te.get("/clignosis/routeSearch/bla/".concat(e),{headers:{Authorization:fe}})}function Le(e){return Te.post("/comparison/viewer/pdf",e,{headers:{Authorization:fe}})}function je(e){return Te.get("/clignosis/fetch-stats/".concat(e),{headers:{Authorization:fe}})}function Be(e,t){return Te.get("/clignosis/ct_gov/".concat(e,"/").concat(t),{headers:{Authorization:fe}})}function Ue(){return Te.get("/clignosis/news-feed",{headers:{Authorization:fe}})}function ke(e){return Te.get("/clignosis/pdf_reader/".concat(e),{headers:{Authorization:fe}})}function Me(e){return Te.post("/clignosis/create-user",e,{headers:{Authorization:fe}})}function Fe(e){return Te.post("/clignosis/bot/submit_feedback",e,{headers:{Authorization:fe}})}function ze(){return Te.get("/clignosis/bla_stats",{headers:{Authorization:fe}})}function Ye(e){return Te.get("/clignosis/extended-card/".concat(e),{headers:{Authorization:fe}})}function Ve(e,t){return Te.post("/clignosis/bot/505b2/base_query?category=".concat(e),t,{headers:{Authorization:fe}})}function Ge(e,t){return Te.post("/clignosis/bot/bla/base_query?category=".concat(e),t,{headers:{Authorization:fe}})}function He(e,t){return Te.post("/clignosis/bot/base_query?category=".concat(e),t,{headers:{Authorization:fe}})}function We(e,t){return Te.post("/clignosis/bot/query?category=".concat(e),t,{headers:{Authorization:fe}})}function Qe(e){return Te.get("/clignosis/labelSearch/".concat(e.category,"/").concat(e.search,"/").concat(e.source).concat(e.query),{headers:{Authorization:fe}})}function Je(e){return Te.get("/clignosis/labelSearch/505b2/".concat(e.category,"/").concat(e.search,"/").concat(e.source).concat(e.query),{headers:{Authorization:fe}})}function Ke(e){return Te.post("/clignosis/advanceSearch/vivek.mishra/US".concat(e.query),e.data,{headers:{Authorization:fe}})}function Ze(){return Te.get("/clignosis/505b2_stats",{headers:{Authorization:fe}})}function Xe(e){return Te.post("/clignosis/advanceSearch/505b2",e.data,{headers:{Authorization:fe}})}function qe(e,t,a,n){return Te.get("/clignosis/admin/review/qc/".concat(e,"/").concat(t,"/").concat(a,"/").concat(n),{headers:{Authorization:fe}})}function $e(e){return Te.post("/clignosis/admin/review/qc",e,{headers:{Authorization:fe}})}function et(e){return Te.get("/clignosis/admin/pmr/review/".concat(e),{headers:{Authorization:fe}})}function tt(e){return Te.post("/clignosis/admin/pmr/review",e,{headers:{Authorization:fe}})}function at(e){var t=ue();Object(n.useEffect)((function(){try{window.scrollTo(0,0)}catch(e){}}),[e]);var i=Object(n.useState)([!1,!1]),o=Object(d.a)(i,2),l=o[0],m=o[1],u=function(){var e=Object(s.a)(c.a.mark((function e(t,n,r){var i,o,l,s,d;return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:if("RELEVANT"!==r){e.next=12;break}return m([!0,!1]),i=a(86).Base64,"developers:>;JQwa[zL!EX+f{?3{fjnK",o=i.encode("developers:>;JQwa[zL!EX+f{?3{fjnK"),"Basic "+o,l={"query-id":t,"result-id":n,"user-reaction":"RELEVANT"},console.log(l),e.next=10,Fe(l).then((function(e){e})).catch((function(e){console.log(e)}));case 10:e.next=20;break;case 12:return m([!1,!0]),i=a(86).Base64,"developers:>;JQwa[zL!EX+f{?3{fjnK",s=i.encode("developers:>;JQwa[zL!EX+f{?3{fjnK"),"Basic "+s,d={"query-id":t,"result-id":n,"user-reaction":"NOT_RELEVANT"},e.next=20,Fe(d).then((function(e){e})).catch((function(e){console.log(e)}));case 20:case"end":return e.stop()}}),e)})));return function(t,a,n){return e.apply(this,arguments)}}();return r.a.createElement(ee.a,{className:t.Card,id:"botCards"},r.a.createElement(te.a,{className:t.CardContent},r.a.createElement(y.a,{className:t.ResponseText},e.data.text),r.a.createElement(C.a,{container:!0,justify:"space-between",alignItems:"center",className:t.BottomGrid},r.a.createElement(C.a,{item:9,justify:"flex-start",alignItems:"center"},e.data.activeIngredient.length>20?r.a.createElement(L.a,{TransitionComponent:pe.a,title:e.data.activeIngredient},r.a.createElement(y.a,{className:t.StyledTypography},e.data.activeIngredient.substring(0,20),"...")):r.a.createElement(y.a,{className:t.StyledTypography},e.data.activeIngredient)),r.a.createElement(C.a,{item:3,justify:"flex-end",alignItems:"center"},r.a.createElement(j.a,{"aria-label":"show 0",color:"primary",className:t.BotDocumentIconButton,onClick:function(){return window.open(e.data.documentURL,"_blank")}},r.a.createElement("img",{src:ne.a})))),r.a.createElement(C.a,{container:!0,justify:"space-evenly",alignItems:"center",className:t.BottomGrid},r.a.createElement(C.a,{item:!0},r.a.createElement(y.a,{className:t.StyledTypographyCapsule},r.a.createElement("span",{className:t.StyledTypographyCapsuleCircles},r.a.createElement(he.a,{className:t.StyledTypographyCapsuleCircle})),e.data.application)),r.a.createElement(C.a,{item:!0,justify:"center",alignItems:"center"},r.a.createElement(y.a,{className:t.StyledTypographyCapsule},r.a.createElement("span",{className:t.StyledTypographyCapsuleCircles},r.a.createElement(he.a,{className:t.StyledTypographyCapsuleCircle})),e.data.submissionType)),r.a.createElement(C.a,{item:!0,justify:"center",alignItems:"center"},r.a.createElement(y.a,{className:t.StyledTypographyCapsule},r.a.createElement("span",{className:t.StyledTypographyCapsuleCircles},r.a.createElement(he.a,{className:t.StyledTypographyCapsuleCircle})),e.data.submissionDate)),r.a.createElement(C.a,{item:!0,justify:"center",alignItems:"center"},r.a.createElement(R.a,{display:"flex",justifyContent:"center",className:t.BotLikeButtonBox,id:"botLikeButtons"},r.a.createElement(j.a,{className:t.BotLikeButton,onClick:function(){return u(e.data.queryId,e.data.resultId,"RELEVANT")}},r.a.createElement("img",{src:l[0]?se.a:ie.a})),r.a.createElement(j.a,{className:t.BotLikeButton,onClick:function(){return u(e.data.queryId,e.data.resultId,"NOT_RELEVANT")}},r.a.createElement("img",{src:l[1]?me.a:le.a})))))))}var nt=a(1096),rt=a.n(nt),it=Object(f.a)((function(e){return{SuggestedAnswerGrid:{borderRadius:"5px",padding:e.spacing(1),margin:"10px",backgroundColor:e.palette.bot.darkBackground,marginBottom:"5px"},ResponseText:{fontSize:"0.9rem",fontWeight:"400",color:e.palette.black,fontStyle:"oblique",textAlign:"left",paddingLeft:"10px"},SuggestedIconButton:{margin:"1vh",padding:"7px",color:e.palette.white},BotLikeButton:{fontSize:"0.7rem",padding:0,paddingLeft:"2px",paddingRight:"2px"},BotLikeButtonBox:{padding:"5px",width:"100%"}}}));function ot(e){var t=it(),i=Object(n.useState)([!1,!1]),o=Object(d.a)(i,2),l=o[0],m=o[1];Object(n.useEffect)((function(){}),[e]);var u=function(){var e=Object(s.a)(c.a.mark((function e(t,n,r){var i,o,l,s,d;return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:if("RELEVANT"!==r){e.next=11;break}return m([!0,!1]),i=a(86).Base64,"developers:>;JQwa[zL!EX+f{?3{fjnK",o=i.encode("developers:>;JQwa[zL!EX+f{?3{fjnK"),"Basic "+o,l={"query-id":t,"result-id":n,"user-reaction":"RELEVANT"},e.next=9,Fe(l).then((function(e){e})).catch((function(e){console.log(e)}));case 9:e.next=19;break;case 11:return m([!1,!0]),i=a(86).Base64,"developers:>;JQwa[zL!EX+f{?3{fjnK",s=i.encode("developers:>;JQwa[zL!EX+f{?3{fjnK"),"Basic "+s,d={"query-id":t,"result-id":n,"user-reaction":"NOT_RELEVANT"},e.next=19,Fe(d).then((function(e){e})).catch((function(e){console.log(e)}));case 19:case"end":return e.stop()}}),e)})));return function(t,a,n){return e.apply(this,arguments)}}();return r.a.createElement(C.a,{item:!0,container:!0,xs:12,justify:"flex-start",alignItems:"center",className:t.SuggestedAnswerGrid},r.a.createElement(C.a,{item:!0,xs:10,justify:"flex-start",alignItems:"center"},r.a.createElement(y.a,{className:t.ResponseText},e.suggestedAns?e.ans.text:null)),r.a.createElement(C.a,{item:!0,xs:1,justify:"flex-end",alignItems:"center"},r.a.createElement(R.a,{display:"flex",justifyContent:"center",className:t.BotLikeButtonBox},r.a.createElement(j.a,{className:t.BotLikeButton,onClick:function(){return u(e.ans.queryId,e.ans.resultId,"RELEVANT")}},r.a.createElement("img",{src:l[0]?se.a:ie.a})),r.a.createElement(j.a,{className:t.BotLikeButton,onClick:function(){return u(e.ans.queryId,e.ans.resultId,"NOT_RELEVANT")}},r.a.createElement("img",{src:l[1]?me.a:le.a})))),r.a.createElement(C.a,{item:!0,xs:1,justify:"flex-end",alignItems:"center"},r.a.createElement(j.a,{"aria-label":"show 0",color:"primary",className:t.SuggestedIconButton,onClick:function(){return window.open(e.ans.documentURL,"_blank")}},r.a.createElement("img",{src:rt.a}))))}var lt=a(754),ct=a.n(lt),st=a(163),dt=a(1908),mt=a(1951),ut=Object(f.a)((function(e){return{root:{width:"100%",height:"100%"},FilterText:{color:e.palette.white,fontSize:"1rem",padding:"10px"},FilterSearch:{borderRadius:"10px",width:"100%",height:"100%",minHeight:"40px",fontSize:"2vh",backgroundColor:e.palette.bot.lightBackground,color:e.palette.black},ResetButton:{fontWeight:"400",borderRadius:"10px",textTransform:"none",border:"1px solid ".concat(e.palette.white),backgroundColor:"transparent",color:e.palette.white,fontSize:e.spacing(2),padding:0,marginRight:"10px"},Divider:{backgroundColor:e.palette.white,color:e.palette.white,height:"0.5px"}}})),pt=a(1946),gt=Object(f.a)((function(e){var t;return{AutoCompleteSearch:{border:"2px solid ".concat(e.palette.bot.filterBackground),borderRadius:"10px",width:"100%",height:"100%",minHeight:"40px",fontSize:"0.8rem",backgroundColor:e.palette.bot.lightBackground,color:e.palette.black,"& .MuiInputBase-input":{color:e.palette.black,fontSize:"0.8rem",opacity:1,"& .MuiAutocomplete-option":{backgroundColor:e.palette.bot.filterBackground,color:e.palette.black,fontSize:"0.8rem",textAlign:"left"}},"& .MuiChip-root":{backgroundColor:e.palette.bot.filterBackground,color:e.palette.black},"& .MuiAutocomplete-option":{backgroundColor:e.palette.bot.filterBackground,color:e.palette.black,fontSize:"0.8rem",textAlign:"left"}},AutoCompleteSearchTextfield:{border:"2px solid ".concat(e.palette.bot.filterBackground),borderRadius:"10px",width:"100%",height:"100%",minHeight:"40px",fontSize:"0.8rem",backgroundColor:e.palette.bot.lightBackground,color:e.palette.black,"& .MuiInputBase-input":{color:e.palette.black,fontSize:"0.8rem",opacity:1,"& .MuiAutocomplete-option":{backgroundColor:e.palette.bot.filterBackground,color:e.palette.black,fontSize:"0.8rem",textAlign:"left"}},"& .MuiChip-root":{backgroundColor:e.palette.bot.filterBackground,color:e.palette.black},"& .MuiAutocomplete-option":{backgroundColor:e.palette.bot.filterBackground,color:e.palette.black,fontSize:"0.8rem",textAlign:"left"}},FilterTitle:{fontSize:"0.8rem",margin:"5px",fontWeight:"500",padding:"10px",paddingRight:"0px",color:e.palette.white,borderRadius:"10px",textAlign:"left"},FilterTitleButton:(t={fontSize:"1.2rem",cursor:"pointer",margin:"5px",marginTop:"15px"},Object(g.a)(t,"marginTop","15px"),Object(g.a)(t,"color",e.palette.white),t),FilterOption:{textAlign:"left",fontSize:"0.6rem",fontWeight:"400",color:e.palette.black},FilterChecked:{padding:0,margin:0,paddingRight:"5px"}}})),ht=a(1787),Tt=a(124),ft=a.n(Tt),At=a(125),Et=a.n(At),bt=a(1087),Nt=a(91),Ct=a.n(Nt),St=r.a.createElement(ft.a,{fontSize:"small"}),yt=r.a.createElement(Et.a,{fontSize:"small"});function Dt(e){Object(n.useEffect)((function(){function e(){return(e=Object(s.a)(c.a.mark((function e(){return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:case"end":return e.stop()}}),e)})))).apply(this,arguments)}!function(){e.apply(this,arguments)}()}),[e]);var t=gt(),a=Object(n.useState)(!1),i=Object(d.a)(a,2),o=i[0],l=i[1];return r.a.createElement("div",{className:t.root},r.a.createElement(R.a,{display:"flex",justifyContent:"space-between",onClick:function(){l(!o)},style:{cursor:"pointer"}},r.a.createElement(y.a,{className:t.FilterTitle,"aria-expanded":o},e.title),r.a.createElement(Ct.a,{className:t.FilterTitleButton})),r.a.createElement(ht.a,{in:o,timeout:"auto",unmountOnExit:!0},r.a.createElement(pt.a,{multiple:!0,defaultValue:e.selected?e.selected:null,onChange:function(t,a){return function(t){e.handleChange(t)}(a)},id:"tags-outlined",options:e.options,disableCloseOnSelect:!0,renderOption:function(a,n){var i=n.selected;return r.a.createElement(r.a.Fragment,null,parseInt(e.filterCount[a])>0?r.a.createElement("div",null,r.a.createElement(R.a,{display:"flex"},r.a.createElement(bt.a,{icon:St,checkedIcon:yt,style:{marginRight:8},checked:i,className:t.FilterChecked}),r.a.createElement(y.a,{className:t.FilterOption},a+"  ("+e.filterCount[a]+")"))):r.a.createElement("div",null,r.a.createElement(R.a,{display:"flex"},r.a.createElement(bt.a,{icon:St,checkedIcon:yt,style:{marginRight:8},checked:i,className:t.FilterChecked}),r.a.createElement(y.a,{className:t.FilterOption},a))))},className:t.AutoCompleteSearch,renderInput:function(a){return r.a.createElement(D.a,Object.assign({},a,{className:t.AutoCompleteSearchTextField,variant:"outlined",placeholder:e.placeholder}))}})))}Object(f.a)((function(e){var t;return{FilterTitle:{fontSize:"0.8rem",margin:"5px",fontWeight:"500",padding:"10px",paddingRight:"0px",color:e.palette.white,borderRadius:"10px",textAlign:"left"},FilterTitleButton:(t={fontSize:"1.2rem",cursor:"pointer",margin:"5px",marginTop:"15px"},Object(g.a)(t,"marginTop","15px"),Object(g.a)(t,"color",e.palette.white),t),toggleButtonGroup:{borderRadius:"10px","& .MuiToggleButton-root.Mui-selected":{borderRadius:"10px !important",backgroundColor:e.palette.bot.filterBackground,color:e.palette.white}},toggleButtonIndivdual:{borderRadius:"10px !important",border:"2px solid ".concat(e.palette.bot.lightBackground," !important"),"& .MuiToggleButton-root.Mui-selected":{borderRadius:"10px !important",backgroundColor:e.palette.bot.filterBackground,color:e.palette.white},"& .MuiToggleButton-label":{borderRadius:"10px !important",color:e.palette.primary.main,fontWeight:"400"}}}}));var _t=Object(f.a)((function(e){var t;return{FilterTitle:{fontSize:"0.8rem",margin:"5px",fontWeight:"500",padding:"10px",paddingRight:"0px",color:e.palette.white,borderRadius:"10px",textAlign:"left"},FilterTitleButton:(t={fontSize:"1.2rem",cursor:"pointer",margin:"5px",marginTop:"15px"},Object(g.a)(t,"marginTop","15px"),Object(g.a)(t,"color",e.palette.white),t),RangeSlider:{paddingTop:"10px",paddingBottom:"10px",width:"80%"}}})),Ot=a(1952);function xt(e){var t=_t(),a=Object(n.useState)(!1),i=Object(d.a)(a,2),o=i[0],l=i[1];return r.a.createElement("div",{className:t.root},r.a.createElement(R.a,{display:"flex",justifyContent:"space-between",onClick:function(){l(!o)},style:{cursor:"pointer"}},r.a.createElement(y.a,{className:t.FilterTitle,"aria-expanded":o},e.title),r.a.createElement(Ct.a,{className:t.FilterTitleButton})),r.a.createElement(ht.a,{in:o,timeout:"auto",unmountOnExit:!0},r.a.createElement(Ot.a,{className:t.RangeSlider,value:e.selected,min:1930,max:parseInt((new Date).getFullYear()),onChange:function(t,a){!function(t){e.handleChange(t)}(a)},valueLabelDisplay:"auto","aria-labelledby":"range-slider"})))}Object(f.a)((function(e){return{CapsuleTypography:{borderRadius:"10px",fontSize:e.spacing(1.5),color:e.palette.navbar.breadcrumb,cursor:"pointer"},CapsuleLightTypography:{borderRadius:"10px",cursor:"pointer",fontSize:e.spacing(1.5),color:e.palette.navbar.breadcrumb},HeadingTypography:{textAlign:"center",fontWeight:"700",padding:"4px",color:e.palette.black}}}));var vt=a(1909);function Rt(e){for(var t=ut(),a=Object(n.useState)(!1),i=Object(d.a)(a,2),o=i[0],l=(i[1],{activeIngredient:{},submissions:{},applications:{},formulation:{},route:{},sponsor:{}}),m=0;m<e.dataRows.length;m++)e.dataRows[m].activeIngredient in l.activeIngredient?l.activeIngredient[e.dataRows[m].activeIngredient]=l.activeIngredient[e.dataRows[m].activeIngredient]+1:l.activeIngredient[e.dataRows[m].activeIngredient]=1,e.dataRows[m].submissions in l.submissions?l.submissions[e.dataRows[m].submissions]=l.submissions[e.dataRows[m].submissions]+1:l.submissions[e.dataRows[m].submissions]=1,e.dataRows[m].applications in l.applications?l.applications[e.dataRows[m].applications]=l.applications[e.dataRows[m].applications]+1:l.applications[e.dataRows[m].applications]=1,e.dataRows[m].formulation in l.formulation?l.formulation[e.dataRows[m].formulation]=l.formulation[e.dataRows[m].formulation]+1:l.formulation[e.dataRows[m].formulation]=1,e.dataRows[m].route in l.route?l.route[e.dataRows[m].route]=l.route[e.dataRows[m].route]+1:l.route[e.dataRows[m].route]=1,e.dataRows[m].sponsor in l.sponsor?l.sponsor[e.dataRows[m].sponsor]=l.sponsor[e.dataRows[m].sponsor]+1:l.sponsor[e.dataRows[m].sponsor]=1;var u=Object(n.useState)(l),p=Object(d.a)(u,2),g=p[0],h=p[1];return Object(n.useEffect)((function(){function t(){return(t=Object(s.a)(c.a.mark((function t(){var a,n;return c.a.wrap((function(t){for(;;)switch(t.prev=t.next){case 0:try{for(a={activeIngredient:{},submissions:{},applications:{},formulation:{},route:{},sponsor:{}},n=0;n<e.dataRows.length;n++)e.dataRows[n].activeIngredient in a.activeIngredient?a.activeIngredient[e.dataRows[n].activeIngredient]=a.activeIngredient[e.dataRows[n].activeIngredient]+1:a.activeIngredient[e.dataRows[n].activeIngredient]=1,e.dataRows[n].submissions in a.submissions?a.submissions[e.dataRows[n].submissions]=a.submissions[e.dataRows[n].submissions]+1:a.submissions[e.dataRows[n].submissions]=1,e.dataRows[n].applications in a.applications?a.applications[e.dataRows[n].applications]=a.applications[e.dataRows[n].applications]+1:a.applications[e.dataRows[n].applications]=1,e.dataRows[n].formulation in a.formulation?a.formulation[e.dataRows[n].formulation]=a.formulation[e.dataRows[n].formulation]+1:a.formulation[e.dataRows[n].formulation]=1,e.dataRows[n].route in a.route?a.route[e.dataRows[n].route]=a.route[e.dataRows[n].route]+1:a.route[e.dataRows[n].route]=1,e.dataRows[n].sponsor in a.sponsor?a.sponsor[e.dataRows[n].sponsor]=a.sponsor[e.dataRows[n].sponsor]+1:a.sponsor[e.dataRows[n].sponsor]=1;h(a)}catch(r){console.log(r)}case 1:case"end":return t.stop()}}),t)})))).apply(this,arguments)}!function(){t.apply(this,arguments)}()}),[e,o]),r.a.createElement("div",{className:t.root},r.a.createElement(R.a,{display:"flex",justifyContent:"space-between"},r.a.createElement(y.a,{className:t.FilterText},"Filters"),r.a.createElement(_.a,{onClick:e.handleResetFilters,className:t.ResetButton},"Reset")),r.a.createElement(Dt,{title:String(e.filters.activeIngredient.length)===String(e.baseFilters.activeIngredient.length)||0===e.filters.activeIngredient.length?"Active Ingredient ("+String(e.baseFilters.activeIngredient.length)+")":"Active Ingredient ("+String(e.filters.activeIngredient.length)+"/"+String(e.baseFilters.activeIngredient.length)+")",selected:e.filters.activeIngredient,handleChange:function(t){e.functionFilter("activeIngredient",t)},options:e.baseFilters.activeIngredient,placeholder:"Typer here ...",filterCount:g.activeIngredient}),r.a.createElement(vt.a,{className:t.Divider,variant:"middle"}),r.a.createElement(Dt,{title:String(e.filters.formulation.length)===String(e.baseFilters.formulation.length)||0===e.filters.formulation.length?"Formulation  ("+String(e.baseFilters.formulation.length)+")":"Formulation  ("+String(e.filters.formulation.length)+"/"+String(e.baseFilters.formulation.length)+")",selected:e.filters.formulation,handleChange:function(t){e.functionFilter("formulation",t)},options:e.baseFilters.formulation,placeholder:"Typer here ...",filterCount:g.formulation}),r.a.createElement(vt.a,{className:t.Divider,variant:"middle"}),r.a.createElement(Dt,{title:String(e.filters.route.length)===String(e.baseFilters.route.length)||0===e.filters.route.length?"Route  ("+String(e.baseFilters.route.length)+")":"Route  ("+String(e.filters.route.length)+"/"+String(e.baseFilters.route.length)+")",selected:e.filters.route,handleChange:function(t){e.functionFilter("route",t)},options:e.baseFilters.route,placeholder:"Typer here ...",filterCount:g.route}),r.a.createElement(vt.a,{className:t.Divider,variant:"middle"}),r.a.createElement(xt,{title:"Approval Date",selected:e.filters.submissionDate,handleChange:function(t){e.functionFilter("submissionDate",t)},options:e.baseFilters.submissionDate}),r.a.createElement(vt.a,{className:t.Divider,variant:"middle"}),r.a.createElement(Dt,{title:String(e.filters.sponsor.length)===String(e.baseFilters.sponsor.length)||0===e.filters.sponsor.length?"Sponsor Name ("+String(e.baseFilters.sponsor.length)+")":"Sponsor Name ("+String(e.filters.sponsor.length)+"/"+String(e.baseFilters.sponsor.length)+")",selected:e.filters.sponsor,handleChange:function(t){e.functionFilter("sponsor",t)},options:e.baseFilters.sponsor,placeholder:"Typer here ...",filterCount:g.sponsor}),r.a.createElement(vt.a,{className:t.Divider,variant:"middle"}),r.a.createElement(vt.a,{className:t.Divider,variant:"middle"}),r.a.createElement(Dt,{title:String(e.filters.applications.length)===String(e.baseFilters.applications.length)||0===e.filters.applications.length?"Application  ("+String(e.baseFilters.applications.length)+")":"Application  ("+String(e.filters.applications.length)+"/"+String(e.baseFilters.applications.length)+")",selected:e.filters.applications,handleChange:function(t){e.functionFilter("applications",t)},options:e.baseFilters.applications,placeholder:"Typer here ...",filterCount:g.applications}),r.a.createElement(vt.a,{className:t.Divider,variant:"middle"}),r.a.createElement(Dt,{title:String(e.filters.submissions.length)===String(e.baseFilters.submissions.length)||0===e.filters.submissions.length?"Submission  ("+String(e.baseFilters.submissions.length)+")":"Submission  ("+String(e.filters.submissions.length)+"/"+String(e.baseFilters.submissions.length)+")",selected:e.filters.submissions,handleChange:function(t){e.functionFilter("submissions",t)},options:e.baseFilters.submissions,placeholder:"Typer here ...",filterCount:g.submissions}),r.a.createElement(vt.a,{className:t.Divider,variant:"middle"}))}function Pt(e){var t=X(),a=Object(n.useState)(e.suggestedAns),i=Object(d.a)(a,2),o=i[0],l=i[1],c=Object(n.useState)(e.rows),s=Object(d.a)(c,2),m=s[0],u=s[1],p=Object(n.useState)(e.applicationNumber),g=Object(d.a)(p,2),h=g[0],T=g[1];return Object(n.useEffect)((function(){try{window.scrollTo(0,0),document.getElementById("HEADER").scrollIntoView(),l(e.suggestedAns),u(e.rows),T(e.applicationNumber)}catch(t){}}),[e]),r.a.createElement(r.a.Fragment,null,r.a.createElement(C.a,{container:!0,item:!0,xs:12,justify:"center",alignItems:"center",id:"HEADER"},r.a.createElement(C.a,{item:!0,container:!0,xs:12,justify:"flex-start",alignItems:"center"},o?r.a.createElement(r.a.Fragment,null,o.length>1?r.a.createElement(y.a,{className:t.StyledTypographyBlue},"Suggested Answers"):1===o.length?r.a.createElement(y.a,{className:t.StyledTypographyBlue},"Suggested Answer"):null):null,o?o.map((function(e){return r.a.createElement(ot,{suggestedAns:o,ans:e})})):null),m&&m.map((function(e,t){return r.a.createElement(C.a,{item:!0,xs:4,justify:"center",alignItems:"center"},r.a.createElement(at,{data:e}))})),r.a.createElement(C.a,{container:!0,item:!0,xs:12,justify:"center",alignItems:"center"},m.length<100?null:h&&h.length>150?r.a.createElement(y.a,{className:t.DisclaimerTypography},"Top 100 results for 150 Applications"):r.a.createElement(y.a,{className:t.DisclaimerTypography},"Top 100 results"))))}var It=a(78),wt={SET_LOADING:"SET_LOADING",SET_GRAPH_TYPE:"SET_GRAPH_TYPE",SET_CART_ITEMS:"SET_CART_ITEMS",SET_CARD_DETAILS:"SET_CARD_DETAILS",SET_USER_STUB:"SET_USER_STUB",SET_SEARCH_TERM:"SET_SEARCH_TERM",SET_PATENT_EXPANSION:"SET_PATENT_EXPANSION",SET_APPLICATION_CONTENT:"SET_APPLICATION_CONTENT",SET_MODULE:"SET_MODULE",SET_REPORT:"SET_REPORT",SET_PDF_MESSAGE:"SET_PDF_MESSAGE",SET_ADVANCE_SEARCH:"SET_ADVANCE_SEARCH",SET_ALERT:"SET_ALERT"},Lt=function(e,t){switch(t.type){case wt.SET_LOADING:return Object(Y.a)(Object(Y.a)({},e),{},{loading:t.value});case wt.SET_ADVANCE_SEARCH:return Object(Y.a)(Object(Y.a)({},e),{},{advanceSearch:t.value});case wt.SET_CART_ITEMS:return Object(Y.a)(Object(Y.a)({},e),{},{cartItems:t.value});case wt.SET_PDF_MESSAGE:return Object(Y.a)(Object(Y.a)({},e),{},{pdfMessage:t.value});case wt.SET_GRAPH_TYPE:return Object(Y.a)(Object(Y.a)({},e),{},{graphType:[].concat(Object(It.a)(e.graphType),[t.value])});case wt.SET_CARD_DETAILS:return Object(Y.a)(Object(Y.a)({},e),{},{cardDetails:[].concat(Object(It.a)(e.cardDetails),[t.value])});case wt.SET_USER_STUB:return Object(Y.a)(Object(Y.a)({},e),{},{userStub:t.value});case wt.SET_SEARCH_TERM:return Object(Y.a)(Object(Y.a)({},e),{},{searchTerm:t.value});case wt.SET_PATENT_EXPANSION:return Object(Y.a)(Object(Y.a)({},e),{},{patentExpansion:t.value});case wt.SET_APPLICATION_CONTENT:return Object(Y.a)(Object(Y.a)({},e),{},{applicationContent:[].concat(Object(It.a)(e.applicationContent),[t.value])});case wt.SET_MODULE:return Object(Y.a)(Object(Y.a)({},e),{},{module:t.value});case wt.SET_REPORT:return Object(Y.a)(Object(Y.a)({},e),{},{report:0===e.cartItems?t.value:[].concat(Object(It.a)(e.report),[t.value])});case wt.SET_ALERT:return Object(Y.a)(Object(Y.a)({},e),{},{alert:Object(Y.a)({},t.value)});default:return e}},jt={loading:!1,cartItems:0,advanceSearch:null,report:[],pdfMessage:"Nothing has been added to the report",graphType:[],searchTerm:null,cardDetails:[],applicationContent:[],patentExpansion:!1,userStub:null,module:"core",alert:{}},Bt=Object(n.createContext)(jt),Ut=Bt.Provider,kt=function(e){var t=e.children,a=Object(n.useReducer)(Lt,jt),i=Object(d.a)(a,2),o=i[0],l=i[1];return r.a.createElement(Ut,{value:{state:o,dispatch:l}},t)},Mt=Bt,Ft=a(126),zt=(a(261),function(){Object(n.useContext)(Mt).state;return r.a.createElement("svg",{xmlns:"http://www.w3.org/2000/svg",xlink:"http://www.w3.org/1999/xlink",width:"109",height:"102",viewBox:"0 0 68 68"},r.a.createElement("defs",null,r.a.createElement("style",null,"          .firstColor{            fill:url(#firstColor);          }          .secondColor{            fill:#dbdbdb;          }          .thirdColor{            fill:#fff;          }          "),r.a.createElement("linearGradient",{id:"firstColor",y1:"0.499",x2:"1",y2:"0.499",gradientUnits:"objectBoundingBox"},r.a.createElement("stop",{offset:"0",stopColor:"#47a7a9"}),r.a.createElement("stop",{offset:"1",stopColor:"#3bb44a"}))),r.a.createElement("circle",{class:"firstColor",cx:"34",cy:"34",r:"34",transform:"translate(0 0)"}),r.a.createElement("path",{class:"secondColor",d:"M133.839,157.054l-7.31-19.96,5.044-5.044c5.017-5.017,3.507-4.235,4.693-6.339a2.982,2.982,0,0,0,.526-1.065c.324-.8.324-1.295.108-1.511s-.715-.216-1.511.108a2.879,2.879,0,0,0-1.065.526c-2.1,1.187-1.322-.337-6.339,4.693l-5.044,5.044-19.96-7.31a.969.969,0,0,0-1.025.229l-1.484,1.484a.984.984,0,0,0-.283.755.951.951,0,0,0,.283.62l.094.094,15.321,11.612c-4.451,4.9-8.753,9.94-11.1,13.042l-4.478-1.146a.737.737,0,0,0-.715.189l-.391.391a.743.743,0,0,0-.216.593.732.732,0,0,0,.216.459c.027.027.067.054.094.081l3.345,2.347a.418.418,0,0,1,.445.445l2.347,3.345a.587.587,0,0,0,.081.094.733.733,0,0,0,.459.216.76.76,0,0,0,.593-.216l.391-.391a.737.737,0,0,0,.189-.715L106,155.247c3.1-2.347,8.146-6.662,13.042-11.1l11.612,15.321a.586.586,0,0,0,.081.094.951.951,0,0,0,.62.283.984.984,0,0,0,.755-.283l1.484-1.484A.949.949,0,0,0,133.839,157.054Z",transform:"translate(-85.637 -106.398)"}),r.a.createElement("path",{class:"thirdColor",d:"M266.3,157.054l-7.31-19.96,5.044-5.044c5.017-5.017,3.507-4.235,4.693-6.339a2.981,2.981,0,0,0,.526-1.065c.324-.8.324-1.295.108-1.511s-.715-.216-1.51.108a2.879,2.879,0,0,0-1.065.526c-2.1,1.187-1.322-.337-6.339,4.693l-5.044,5.044-3.3-1.214v12.6l11.046,14.566a.587.587,0,0,0,.081.094.951.951,0,0,0,.62.283.984.984,0,0,0,.755-.283l1.484-1.484A.962.962,0,0,0,266.3,157.054Z",transform:"translate(-218.1 -106.398)"}),r.a.createElement("g",{transform:"translate(10.122 28.706)"},r.a.createElement("path",{class:"secondColor",d:"M83.041,212.951a.358.358,0,0,1,0,.5l-7.391,7.391a.358.358,0,0,1-.5,0h0a.358.358,0,0,1,0-.5l7.391-7.391a.358.358,0,0,1,.5,0Z",transform:"translate(-75.05 -212.85)"}),r.a.createElement("path",{class:"secondColor",d:"M100.041,230.051a.358.358,0,0,1,0,.5l-7.391,7.391a.358.358,0,0,1-.5,0h0a.358.358,0,0,1,0-.5l7.391-7.391a.358.358,0,0,1,.5,0Z",transform:"translate(-89.757 -227.644)"}),r.a.createElement("path",{class:"secondColor",d:"M117.141,247.086a.358.358,0,0,1,0,.5l-7.391,7.391a.358.358,0,0,1-.5,0h0a.358.358,0,0,1,0-.5l7.391-7.391a.335.335,0,0,1,.5,0Z",transform:"translate(-104.551 -242.373)"}),r.a.createElement("path",{class:"secondColor",d:"M205.141,335.051a.358.358,0,0,1,0,.5l-7.391,7.391a.358.358,0,0,1-.5,0h0a.358.358,0,0,1,0-.5l7.391-7.391a.358.358,0,0,1,.5,0Z",transform:"translate(-180.683 -318.483)"}),r.a.createElement("path",{class:"secondColor",d:"M222.141,352.151a.358.358,0,0,1,0,.5l-7.391,7.391a.358.358,0,0,1-.5,0h0a.358.358,0,0,1,0-.5l7.391-7.391a.358.358,0,0,1,.5,0Z",transform:"translate(-195.39 -333.277)"}),r.a.createElement("path",{class:"secondColor",d:"M239.241,369.151a.358.358,0,0,1,0,.5l-7.391,7.391a.358.358,0,0,1-.5,0h0a.358.358,0,0,1,0-.5l7.391-7.391a.358.358,0,0,1,.5,0Z",transform:"translate(-210.184 -347.984)"})))});a(1267);function Yt(e){var t=X(),i=Object(n.useState)(e.data),o=Object(d.a)(i,2),l=o[0],m=(o[1],Object(n.useContext)(Mt)),u=m.state,p=(m.dispatch,Object(n.useState)()),g=Object(d.a)(p,2),h=(g[0],g[1]),T=Object(n.useState)(),f=Object(d.a)(T,2),A=f[0],E=f[1],b=Object(n.useState)(!1),S=Object(d.a)(b,2),D=S[0],_=S[1],O=Object(n.useState)(!1),x=Object(d.a)(O,2),v=x[0],P=x[1],I=Object(n.useState)([]),w=Object(d.a)(I,2),U=w[0],k=w[1],M=Object(n.useState)([]),F=Object(d.a)(M,2),G=F[0],H=F[1],W=Object(n.useState)("All"),Q=Object(d.a)(W,2),J=Q[0],Z=Q[1],q=Object(n.useState)([]),ee=Object(d.a)(q,2),te=ee[0],ae=ee[1],ne=Object(n.useState)(),re=Object(d.a)(ne,2),oe=re[0],ce=(re[1],Object(n.useState)({submissions:[],submissionDate:[1934,2020],applications:[],route:[],formulation:[],activeIngredient:[],sponsor:[]})),se=Object(d.a)(ce,2),de=se[0],me=se[1],ue=Object(n.useState)({submissions:[],submissionDate:[1934,2020],applications:[],route:[],formulation:[],activeIngredient:[],sponsor:[]}),pe=Object(d.a)(ue,2),ge=pe[0],he=pe[1],Te=Object(n.useState)(!1),fe=Object(d.a)(Te,2),Ae=fe[0],Ee=fe[1],be=Object(n.useState)(),Ne=Object(d.a)(be,2),Ce=Ne[0],Se=Ne[1],ye=Object(n.useState)([{element:"#botSearch",intro:"ARIA allows a query in natural language to search summary basis of approval documents",position:"bottom",tooltipClass:"myTooltipClass",highlightClass:"myHighlightClass"},{element:"#botCategories",intro:"ARIA search can be segregated based on type of document (Reviews, Labels, Letters)",position:"right",tooltipClass:"myTooltipClass",highlightClass:"myHighlightClass"},{element:"#botCards",intro:"ARIA search provides suggested answer and top 100 answers to question",position:"right",tooltipClass:"myTooltipClass",highlightClass:"myHighlightClass"},{element:"#botLikeButtons",intro:"ARIA is a machine learning assistant through incremental learning that will improve search results. Using feedback from queries, incremental learning improves the ranking algorithms and optimizes search results for greater accuracy",position:"right",tooltipClass:"myTooltipClass",highlightClass:"myHighlightClass"}]),De=Object(d.a)(ye,2),_e=De[0],Oe=(De[1],Object(n.useState)(!1)),xe=Object(d.a)(Oe,2),ve=xe[0],Re=xe[1];Object(n.useEffect)((function(){function t(){return(t=Object(s.a)(c.a.mark((function t(){var n,r,i,o,s,d,m,p,g,T;return c.a.wrap((function(t){for(;;)switch(t.prev=t.next){case 0:if(t.prev=0,!A){t.next=33;break}if(P(!1),n=a(86).Base64,"developers:>;JQwa[zL!EX+f{?3{fjnK",r=n.encode("developers:>;JQwa[zL!EX+f{?3{fjnK"),"Basic "+r,{},void 0!==l||"BLA"!==e.page){t.next=15;break}return i={email:u.userStub.attributes.email,userid:u.userStub.attributes.sub,organization:u.userStub.attributes["custom:organization"],tier:u.userStub.attributes["custom:license"],timestamp:new Date,query:A},o={query:A,searchLog:i},t.next=13,Ge(J,o).then((function(e){var t=e.data.success;if(_(!0),null===t||0===t.ResultItems.length)Ee(!0),P(!0),k([]);else{h(t);for(var a=0;a<t.ResultItems.length;a++){var n=t.ResultItems[a].DocumentExcerpt.Text;t.ResultItems[a].DocumentExcerpt.Highlights;if(t.ResultItems[a].DocumentExcerpt.Text=n,t.ResultItems[a].AdditionalAttributes)for(var r=0;r<t.ResultItems[a].AdditionalAttributes.length;r++){var i=t.ResultItems[a].AdditionalAttributes[r],o=i.Value.TextWithHighlightsValue.Text;i.Value.TextWithHighlightsValue.Highlights;t.ResultItems[a].AdditionalAttributes[r].Value.TextWithHighlightsValue.Text=o}}for(var l=[],c=[],s=[],d=[],m=[],u=[],p=[],g=[],T=[],f=0;f<t.ResultItems.length;f++){var A=t.ResultItems[f].DocumentExcerpt.Text,E=t.ResultItems[f].DocumentURI,b=t.ResultItems[f].DocumentId,N=t.QueryId,C=t.ResultItems[f].Id,S="",y="",D="",O="",x="",v="",R="",I="",w="";if("ANSWER"===t.ResultItems[f].Type){var L={text:t.ResultItems[f].DocumentExcerpt.Text,documentURL:t.ResultItems[f].DocumentURI,queryId:t.QueryId,resultId:t.ResultItems[f].Id};g.push(L)}else{for(var j=0;j<t.ResultItems[f].DocumentAttributes.length;j++)if("submission"===t.ResultItems[f].DocumentAttributes[j].Key&&(S=t.ResultItems[f].DocumentAttributes[j].Value.StringValue),"designation-type"===t.ResultItems[f].DocumentAttributes[j].Key&&(y=t.ResultItems[f].DocumentAttributes[j].Value.StringValue),"active-ingredient"===t.ResultItems[f].DocumentAttributes[j].Key&&(w=t.ResultItems[f].DocumentAttributes[j].Value.StringValue),"route"===t.ResultItems[f].DocumentAttributes[j].Key&&(R=t.ResultItems[f].DocumentAttributes[j].Value.StringValue),"formulation"===t.ResultItems[f].DocumentAttributes[j].Key&&(I=t.ResultItems[f].DocumentAttributes[j].Value.StringValue),"sponsor"===t.ResultItems[f].DocumentAttributes[j].Key&&(v=t.ResultItems[f].DocumentAttributes[j].Value.StringValue),"application-number"===t.ResultItems[f].DocumentAttributes[j].Key&&(D=t.ResultItems[f].DocumentAttributes[j].Value.StringListValue[0]),"approval-date"===t.ResultItems[f].DocumentAttributes[j].Key){x=t.ResultItems[f].DocumentAttributes[j].Value.StringValue;var B=new Date(x);x=B.getMonth()+"/"+B.getDate()+"/"+B.getFullYear()}if(O=y+D,!t.ResultItems[f].DocumentExcerpt)continue;u.push({queryId:N,resultId:C,text:A,documentName:b,documentURL:E,submissionType:S,applicationType:y,applicationNo:D,application:O,submissionDate:x,formulation:I,activeIngredient:w,route:R,sponsor:v}),c.includes(D)||c.push(D),s.includes(x)||s.push(x),l.includes(S)||l.push(S),d.includes(R)||d.push(R),T.includes(v)||T.push(v),m.includes(I)||m.push(I),p.includes(w)||p.push(w)}}me({applications:c,submissions:l,submissionDate:[1934,2020],formulation:m,route:d,sponsor:T,activeIngredient:p}),u===[]&&P(!0);var U=[];if(u.length<=49)H(u);else{for(var M=0;M<50;M++)U.push(u[M]);H(U)}k(u),ae(u),Se(g)}})).catch((function(e){console.log(e)}));case 13:t.next=33;break;case 15:if(void 0!==l||"Core"!==e.page){t.next=22;break}return s={email:u.userStub.attributes.email,userid:u.userStub.attributes.sub,organization:u.userStub.attributes["custom:organization"],tier:u.userStub.attributes["custom:license"],timestamp:new Date,query:A},d={query:A,searchLog:s},t.next=20,He(J,d).then((function(e){var t=e.data.success;if(_(!0),null===t||0===t.ResultItems.length)Ee(!0),P(!0),k([]);else{h(t);for(var a=0;a<t.ResultItems.length;a++){var n=t.ResultItems[a].DocumentExcerpt.Text;t.ResultItems[a].DocumentExcerpt.Highlights;if(t.ResultItems[a].DocumentExcerpt.Text=n,t.ResultItems[a].AdditionalAttributes)for(var r=0;r<t.ResultItems[a].AdditionalAttributes.length;r++){var i=t.ResultItems[a].AdditionalAttributes[r],o=i.Value.TextWithHighlightsValue.Text;i.Value.TextWithHighlightsValue.Highlights;t.ResultItems[a].AdditionalAttributes[r].Value.TextWithHighlightsValue.Text=o}}for(var l=[],c=[],s=[],d=[],m=[],u=[],p=[],g=[],T=[],f=0;f<t.ResultItems.length;f++){var A=t.ResultItems[f].DocumentExcerpt.Text,E=t.ResultItems[f].DocumentURI,b=t.ResultItems[f].DocumentId,N=t.QueryId,C=t.ResultItems[f].Id,S="",y="",D="",O="",x="",v="",R="",I="",w="";if("ANSWER"===t.ResultItems[f].Type){var L={text:t.ResultItems[f].DocumentExcerpt.Text,documentURL:t.ResultItems[f].DocumentURI,queryId:t.QueryId,resultId:t.ResultItems[f].Id};g.push(L)}else{for(var j=0;j<t.ResultItems[f].DocumentAttributes.length;j++)if("submission"===t.ResultItems[f].DocumentAttributes[j].Key&&(S=t.ResultItems[f].DocumentAttributes[j].Value.StringValue),"designation-type"===t.ResultItems[f].DocumentAttributes[j].Key&&(y=t.ResultItems[f].DocumentAttributes[j].Value.StringValue),"active-ingredient"===t.ResultItems[f].DocumentAttributes[j].Key&&(w=t.ResultItems[f].DocumentAttributes[j].Value.StringValue),"route"===t.ResultItems[f].DocumentAttributes[j].Key&&(R=t.ResultItems[f].DocumentAttributes[j].Value.StringValue),"formulation"===t.ResultItems[f].DocumentAttributes[j].Key&&(I=t.ResultItems[f].DocumentAttributes[j].Value.StringValue),"sponsor"===t.ResultItems[f].DocumentAttributes[j].Key&&(v=t.ResultItems[f].DocumentAttributes[j].Value.StringValue),"application-number"===t.ResultItems[f].DocumentAttributes[j].Key&&(D=t.ResultItems[f].DocumentAttributes[j].Value.StringListValue[0]),"approval-date"===t.ResultItems[f].DocumentAttributes[j].Key){x=t.ResultItems[f].DocumentAttributes[j].Value.StringValue;var B=new Date(x);x=B.getMonth()+"/"+B.getDate()+"/"+B.getFullYear()}if(O=y+D,!t.ResultItems[f].DocumentExcerpt)continue;u.push({queryId:N,resultId:C,text:A,documentName:b,documentURL:E,submissionType:S,applicationType:y,applicationNo:D,application:O,submissionDate:x,formulation:I,activeIngredient:w,route:R,sponsor:v}),c.includes(D)||c.push(D),s.includes(x)||s.push(x),l.includes(S)||l.push(S),d.includes(R)||d.push(R),T.includes(v)||T.push(v),m.includes(I)||m.push(I),p.includes(w)||p.push(w)}}me({applications:c,submissions:l,submissionDate:[1934,2020],formulation:m,route:d,sponsor:T,activeIngredient:p}),u===[]&&P(!0);var U=[];if(u.length<=49)H(u);else{for(var M=0;M<50;M++)U.push(u[M]);H(U)}k(u),ae(u),Se(g)}})).catch((function(e){console.log(e)}));case 20:t.next=33;break;case 22:if(void 0!==l||"505b2"!==e.page){t.next=29;break}return m={email:u.userStub.attributes.email,userid:u.userStub.attributes.sub,organization:u.userStub.attributes["custom:organization"],tier:u.userStub.attributes["custom:license"],timestamp:new Date,query:A},p={query:A,searchLog:m},t.next=27,Ve(J,p).then((function(e){var t=e.data.success;if(_(!0),null===t||0===t.ResultItems.length)Ee(!0),P(!0),k([]);else{h(t);for(var a=0;a<t.ResultItems.length;a++){var n=t.ResultItems[a].DocumentExcerpt.Text;t.ResultItems[a].DocumentExcerpt.Highlights;if(t.ResultItems[a].DocumentExcerpt.Text=n,t.ResultItems[a].AdditionalAttributes)for(var r=0;r<t.ResultItems[a].AdditionalAttributes.length;r++){var i=t.ResultItems[a].AdditionalAttributes[r],o=i.Value.TextWithHighlightsValue.Text;i.Value.TextWithHighlightsValue.Highlights;t.ResultItems[a].AdditionalAttributes[r].Value.TextWithHighlightsValue.Text=o}}for(var l=[],c=[],s=[],d=[],m=[],u=[],p=[],g=[],T=[],f=0;f<t.ResultItems.length;f++){var A=t.ResultItems[f].DocumentExcerpt.Text,E=t.ResultItems[f].DocumentURI,b=t.ResultItems[f].DocumentId,N=t.QueryId,C=t.ResultItems[f].Id,S="",y="",D="",O="",x="",v="",R="",I="",w="";if("ANSWER"===t.ResultItems[f].Type){var L={text:t.ResultItems[f].DocumentExcerpt.Text,documentURL:t.ResultItems[f].DocumentURI,queryId:t.QueryId,resultId:t.ResultItems[f].Id};g.push(L)}else{for(var j=0;j<t.ResultItems[f].DocumentAttributes.length;j++)if("submission"===t.ResultItems[f].DocumentAttributes[j].Key&&(S=t.ResultItems[f].DocumentAttributes[j].Value.StringValue),"designation-type"===t.ResultItems[f].DocumentAttributes[j].Key&&(y=t.ResultItems[f].DocumentAttributes[j].Value.StringValue),"active-ingredient"===t.ResultItems[f].DocumentAttributes[j].Key&&(w=t.ResultItems[f].DocumentAttributes[j].Value.StringValue),"route"===t.ResultItems[f].DocumentAttributes[j].Key&&(R=t.ResultItems[f].DocumentAttributes[j].Value.StringValue),"formulation"===t.ResultItems[f].DocumentAttributes[j].Key&&(I=t.ResultItems[f].DocumentAttributes[j].Value.StringValue),"sponsor"===t.ResultItems[f].DocumentAttributes[j].Key&&(v=t.ResultItems[f].DocumentAttributes[j].Value.StringValue),"application-number"===t.ResultItems[f].DocumentAttributes[j].Key&&(D=t.ResultItems[f].DocumentAttributes[j].Value.StringListValue[0]),"approval-date"===t.ResultItems[f].DocumentAttributes[j].Key){x=t.ResultItems[f].DocumentAttributes[j].Value.StringValue;var B=new Date(x);x=B.getMonth()+"/"+B.getDate()+"/"+B.getFullYear()}if(O=y+D,!t.ResultItems[f].DocumentExcerpt)continue;u.push({queryId:N,resultId:C,text:A,documentName:b,documentURL:E,submissionType:S,applicationType:y,applicationNo:D,application:O,submissionDate:x,formulation:I,activeIngredient:w,route:R,sponsor:v}),c.includes(D)||c.push(D),s.includes(x)||s.push(x),l.includes(S)||l.push(S),d.includes(R)||d.push(R),T.includes(v)||T.push(v),m.includes(I)||m.push(I),p.includes(w)||p.push(w)}}me({applications:c,submissions:l,submissionDate:[1934,2020],formulation:m,route:d,sponsor:T,activeIngredient:p}),u===[]&&P(!0);var U=[];if(u.length<=49)H(u);else{for(var M=0;M<50;M++)U.push(u[M]);for(var F=0;F<U.length;F++){var z="".concat(U[F].text);U[F].text=z}H(U)}k(u),ae(u),Se(g)}})).catch((function(e){console.log(e)}));case 27:t.next=33;break;case 29:return g={email:u.userStub.attributes.email,userid:u.userStub.attributes.sub,organization:u.userStub.attributes["custom:organization"],tier:u.userStub.attributes["custom:license"],timestamp:new Date,query:A},T={query:A,application_number:l,searchLog:g},t.next=33,We(J,T).then((function(e){var t=e.data.success;if(_(!0),null===t||0===t.ResultItems.length)Ee(!0),P(!0),k([]);else{h(t);for(var a=0;a<t.ResultItems.length;a++){var n=t.ResultItems[a].DocumentExcerpt.Text;t.ResultItems[a].DocumentExcerpt.Highlights;if(t.ResultItems[a].DocumentExcerpt.Text=n,t.ResultItems[a].AdditionalAttributes)for(var r=0;r<t.ResultItems[a].AdditionalAttributes.length;r++){var i=t.ResultItems[a].AdditionalAttributes[r],o=i.Value.TextWithHighlightsValue.Text;i.Value.TextWithHighlightsValue.Highlights;t.ResultItems[a].AdditionalAttributes[r].Value.TextWithHighlightsValue.Text=o}}for(var l=[],c=[],s=[],d=[],m=[],u=[],p=[],g=[],T=[],f=0;f<t.ResultItems.length;f++){var A=t.ResultItems[f].DocumentExcerpt.Text,E=t.ResultItems[f].DocumentURI,b=t.ResultItems[f].DocumentId,N=t.QueryId,C=t.ResultItems[f].Id,S="",y="",D="",O="",x="",v="",R="",I="",w="";if("ANSWER"===t.ResultItems[f].Type){var L={text:t.ResultItems[f].DocumentExcerpt.Text,documentURL:t.ResultItems[f].DocumentURI,queryId:t.QueryId,resultId:t.ResultItems[f].Id};g.push(L)}else{for(var j=0;j<t.ResultItems[f].DocumentAttributes.length;j++)if("submission"===t.ResultItems[f].DocumentAttributes[j].Key&&(S=t.ResultItems[f].DocumentAttributes[j].Value.StringValue),"designation-type"===t.ResultItems[f].DocumentAttributes[j].Key&&(y=t.ResultItems[f].DocumentAttributes[j].Value.StringValue),"active-ingredient"===t.ResultItems[f].DocumentAttributes[j].Key&&(w=t.ResultItems[f].DocumentAttributes[j].Value.StringValue),"route"===t.ResultItems[f].DocumentAttributes[j].Key&&(R=t.ResultItems[f].DocumentAttributes[j].Value.StringValue),"formulation"===t.ResultItems[f].DocumentAttributes[j].Key&&(I=t.ResultItems[f].DocumentAttributes[j].Value.StringValue),"sponsor"===t.ResultItems[f].DocumentAttributes[j].Key&&(v=t.ResultItems[f].DocumentAttributes[j].Value.StringValue),"application-number"===t.ResultItems[f].DocumentAttributes[j].Key&&(D=t.ResultItems[f].DocumentAttributes[j].Value.StringListValue[0]),"approval-date"===t.ResultItems[f].DocumentAttributes[j].Key){x=t.ResultItems[f].DocumentAttributes[j].Value.StringValue;var B=new Date(x);x=B.getMonth()+"/"+B.getDate()+"/"+B.getFullYear()}if(O=y+D,!t.ResultItems[f].DocumentExcerpt)continue;u.push({queryId:N,resultId:C,text:A,documentName:b,documentURL:E,submissionType:S,applicationType:y,applicationNo:D,application:O,submissionDate:x,formulation:I,activeIngredient:w,route:R,sponsor:v}),c.includes(D)||c.push(D),s.includes(x)||s.push(x),l.includes(S)||l.push(S),d.includes(R)||d.push(R),T.includes(v)||T.push(v),m.includes(I)||m.push(I),p.includes(w)||p.push(w)}}me({applications:c,submissions:l,submissionDate:[1934,2020],formulation:m,route:d,sponsor:T,activeIngredient:p}),u===[]&&P(!0);var U=[];if(u.length<=49)H(u);else{for(var M=0;M<50;M++)U.push(u[M]);H(U)}k(u),ae(u),Se(g)}})).catch((function(e){console.log(e)}));case 33:t.next=38;break;case 35:t.prev=35,t.t0=t.catch(0),console.log(t.t0);case 38:case"end":return t.stop()}}),t,null,[[0,35]])})))).apply(this,arguments)}!function(){t.apply(this,arguments)}()}),[J]);var Pe=function(){var t=Object(s.a)(c.a.mark((function t(n){var r,i,o,s,d,m,p,g,T,f,E;return c.a.wrap((function(t){for(;;)switch(t.prev=t.next){case 0:if(n.preventDefault(),Z("All"),window.scrollTo(0,0),P(!1),{},r=a(86).Base64,"developers:>;JQwa[zL!EX+f{?3{fjnK",i=r.encode("developers:>;JQwa[zL!EX+f{?3{fjnK"),"Basic "+i,void 0!==l||"BLA"!==e.page){t.next=16;break}return o={email:u.userStub.attributes.email,userid:u.userStub.attributes.sub,organization:u.userStub.attributes["custom:organization"],tier:u.userStub.attributes["custom:license"],timestamp:new Date,query:A},s={query:A,searchLog:o},t.next=14,Ge(J,s).then((function(e){var t=e.data.success;if(_(!0),null===t)Ee(!0),P(!0),k([]);else{h(t);for(var a=0;a<t.ResultItems.length;a++){var n=t.ResultItems[a].DocumentExcerpt.Text;t.ResultItems[a].DocumentExcerpt.Highlights;if(t.ResultItems[a].DocumentExcerpt.Text=n,t.ResultItems[a].AdditionalAttributes)for(var r=0;r<t.ResultItems[a].AdditionalAttributes.length;r++){var i=t.ResultItems[a].AdditionalAttributes[r],o=i.Value.TextWithHighlightsValue.Text;i.Value.TextWithHighlightsValue.Highlights;t.ResultItems[a].AdditionalAttributes[r].Value.TextWithHighlightsValue.Text=o}}for(var l=[],c=[],s=[],d=[],m=[],u=[],p=[],g=[],T=[],f=0;f<t.ResultItems.length;f++){var A=t.ResultItems[f].DocumentExcerpt.Text,E=t.ResultItems[f].DocumentURI,b=t.ResultItems[f].DocumentId,N=t.QueryId,C=t.ResultItems[f].Id,S="",y="",D="",O="",x="",v="",R="",I="",w="";if("ANSWER"===t.ResultItems[f].Type){var L={text:t.ResultItems[f].DocumentExcerpt.Text,documentURL:t.ResultItems[f].DocumentURI,queryId:t.QueryId,resultId:t.ResultItems[f].Id};g.push(L)}else{for(var j=0;j<t.ResultItems[f].DocumentAttributes.length;j++)if("submission"===t.ResultItems[f].DocumentAttributes[j].Key&&(S=t.ResultItems[f].DocumentAttributes[j].Value.StringValue),"designation-type"===t.ResultItems[f].DocumentAttributes[j].Key&&(y=t.ResultItems[f].DocumentAttributes[j].Value.StringValue),"active-ingredient"===t.ResultItems[f].DocumentAttributes[j].Key&&(w=t.ResultItems[f].DocumentAttributes[j].Value.StringValue),"route"===t.ResultItems[f].DocumentAttributes[j].Key&&(R=t.ResultItems[f].DocumentAttributes[j].Value.StringValue),"formulation"===t.ResultItems[f].DocumentAttributes[j].Key&&(I=t.ResultItems[f].DocumentAttributes[j].Value.StringValue),"sponsor"===t.ResultItems[f].DocumentAttributes[j].Key&&(v=t.ResultItems[f].DocumentAttributes[j].Value.StringValue),"application-number"===t.ResultItems[f].DocumentAttributes[j].Key&&(D=t.ResultItems[f].DocumentAttributes[j].Value.StringListValue[0]),"approval-date"===t.ResultItems[f].DocumentAttributes[j].Key){x=t.ResultItems[f].DocumentAttributes[j].Value.StringValue;var B=new Date(x);x=B.getMonth()+1+"/"+B.getDate()+"/"+B.getFullYear()}if(O=y+D,!t.ResultItems[f].DocumentExcerpt)continue;u.push({queryId:N,resultId:C,text:A,documentName:b,documentURL:E,submissionType:S,applicationType:y,applicationNo:D,application:O,submissionDate:x,formulation:I,activeIngredient:w,route:R,sponsor:v}),c.includes(D)||c.push(D),s.includes(x)||s.push(x),l.includes(S)||l.push(S),d.includes(R)||d.push(R),T.includes(v)||T.push(v),m.includes(I)||m.push(I),p.includes(w)||p.push(w)}}me({applications:c,submissions:l,submissionDate:[1934,2020],formulation:m,route:d,sponsor:T,activeIngredient:p}),u===[]&&P(!0);var U=[];if(u.length<=49)H(u);else{for(var M=0;M<50;M++)U.push(u[M]);H(U)}k(u),ae(u),Se(g)}})).catch((function(e){console.log(e)}));case 14:t.next=38;break;case 16:if(void 0!==l||"505b2"!==e.page){t.next=23;break}return d={email:u.userStub.attributes.email,userid:u.userStub.attributes.sub,organization:u.userStub.attributes["custom:organization"],tier:u.userStub.attributes["custom:license"],timestamp:new Date,query:A},m={query:A,searchLog:d},t.next=21,Ve(J,m).then((function(e){var t=e.data.success;if(_(!0),null===t||0===t.ResultItems.length)Ee(!0),P(!0),k([]);else{h(t);for(var a=0;a<t.ResultItems.length;a++){var n=t.ResultItems[a].DocumentExcerpt.Text;t.ResultItems[a].DocumentExcerpt.Highlights;if(t.ResultItems[a].DocumentExcerpt.Text=n,t.ResultItems[a].AdditionalAttributes)for(var r=0;r<t.ResultItems[a].AdditionalAttributes.length;r++){var i=t.ResultItems[a].AdditionalAttributes[r],o=i.Value.TextWithHighlightsValue.Text;i.Value.TextWithHighlightsValue.Highlights;t.ResultItems[a].AdditionalAttributes[r].Value.TextWithHighlightsValue.Text=o}}for(var l=[],c=[],s=[],d=[],m=[],u=[],p=[],g=[],T=[],f=0;f<t.ResultItems.length;f++){var A=t.ResultItems[f].DocumentExcerpt.Text,E=t.ResultItems[f].DocumentURI,b=t.ResultItems[f].DocumentId,N=t.QueryId,C=t.ResultItems[f].Id,S="",y="",D="",O="",x="",v="",R="",I="",w="";if("ANSWER"===t.ResultItems[f].Type){var L={text:t.ResultItems[f].DocumentExcerpt.Text,documentURL:t.ResultItems[f].DocumentURI,queryId:t.QueryId,resultId:t.ResultItems[f].Id};g.push(L)}else{for(var j=0;j<t.ResultItems[f].DocumentAttributes.length;j++)if("submission"===t.ResultItems[f].DocumentAttributes[j].Key&&(S=t.ResultItems[f].DocumentAttributes[j].Value.StringValue),"designation-type"===t.ResultItems[f].DocumentAttributes[j].Key&&(y=t.ResultItems[f].DocumentAttributes[j].Value.StringValue),"active-ingredient"===t.ResultItems[f].DocumentAttributes[j].Key&&(w=t.ResultItems[f].DocumentAttributes[j].Value.StringValue),"route"===t.ResultItems[f].DocumentAttributes[j].Key&&(R=t.ResultItems[f].DocumentAttributes[j].Value.StringValue),"formulation"===t.ResultItems[f].DocumentAttributes[j].Key&&(I=t.ResultItems[f].DocumentAttributes[j].Value.StringValue),"sponsor"===t.ResultItems[f].DocumentAttributes[j].Key&&(v=t.ResultItems[f].DocumentAttributes[j].Value.StringValue),"application-number"===t.ResultItems[f].DocumentAttributes[j].Key&&(D=t.ResultItems[f].DocumentAttributes[j].Value.StringListValue[0]),"approval-date"===t.ResultItems[f].DocumentAttributes[j].Key){x=t.ResultItems[f].DocumentAttributes[j].Value.StringValue;var B=new Date(x);x=B.getMonth()+"/"+B.getDate()+"/"+B.getFullYear()}if(O=y+D,!t.ResultItems[f].DocumentExcerpt)continue;u.push({queryId:N,resultId:C,text:A,documentName:b,documentURL:E,submissionType:S,applicationType:y,applicationNo:D,application:O,submissionDate:x,formulation:I,activeIngredient:w,route:R,sponsor:v}),c.includes(D)||c.push(D),s.includes(x)||s.push(x),l.includes(S)||l.push(S),d.includes(R)||d.push(R),T.includes(v)||T.push(v),m.includes(I)||m.push(I),p.includes(w)||p.push(w)}}me({applications:c,submissions:l,submissionDate:[1934,2020],formulation:m,route:d,sponsor:T,activeIngredient:p}),u===[]&&P(!0);var U=[];if(u.length<=49)H(u);else{for(var M=0;M<50;M++)U.push(u[M]);for(var F=0;F<U.length;F++){var z="".concat(U[F].text);U[F].text=z}H(U)}k(u),ae(u),Se(g)}})).catch((function(e){console.log(e)}));case 21:t.next=38;break;case 23:if(void 0!==l||"Core"!==e.page){t.next=30;break}return p={email:u.userStub.attributes.email,userid:u.userStub.attributes.sub,organization:u.userStub.attributes["custom:organization"],tier:u.userStub.attributes["custom:license"],timestamp:new Date,query:A},g={query:A,searchLog:p},t.next=28,He(J,g).then((function(e){var t=e.data.success;if(_(!0),null===t)Ee(!0),P(!0),k([]);else{h(t);for(var a=0;a<t.ResultItems.length;a++){var n=t.ResultItems[a].DocumentExcerpt.Text;t.ResultItems[a].DocumentExcerpt.Highlights;if(t.ResultItems[a].DocumentExcerpt.Text=n,t.ResultItems[a].AdditionalAttributes)for(var r=0;r<t.ResultItems[a].AdditionalAttributes.length;r++){var i=t.ResultItems[a].AdditionalAttributes[r],o=i.Value.TextWithHighlightsValue.Text;i.Value.TextWithHighlightsValue.Highlights;t.ResultItems[a].AdditionalAttributes[r].Value.TextWithHighlightsValue.Text=o}}for(var l=[],c=[],s=[],d=[],m=[],u=[],p=[],g=[],T=[],f=0;f<t.ResultItems.length;f++){var A=t.ResultItems[f].DocumentExcerpt.Text,E=t.ResultItems[f].DocumentURI,b=t.ResultItems[f].DocumentId,N=t.QueryId,C=t.ResultItems[f].Id,S="",y="",D="",O="",x="",v="",R="",I="",w="";if("ANSWER"===t.ResultItems[f].Type){var L={text:t.ResultItems[f].DocumentExcerpt.Text,documentURL:t.ResultItems[f].DocumentURI,queryId:t.QueryId,resultId:t.ResultItems[f].Id};g.push(L)}else{for(var j=0;j<t.ResultItems[f].DocumentAttributes.length;j++)if("submission"===t.ResultItems[f].DocumentAttributes[j].Key&&(S=t.ResultItems[f].DocumentAttributes[j].Value.StringValue),"designation-type"===t.ResultItems[f].DocumentAttributes[j].Key&&(y=t.ResultItems[f].DocumentAttributes[j].Value.StringValue),"active-ingredient"===t.ResultItems[f].DocumentAttributes[j].Key&&(w=t.ResultItems[f].DocumentAttributes[j].Value.StringValue),"route"===t.ResultItems[f].DocumentAttributes[j].Key&&(R=t.ResultItems[f].DocumentAttributes[j].Value.StringValue),"formulation"===t.ResultItems[f].DocumentAttributes[j].Key&&(I=t.ResultItems[f].DocumentAttributes[j].Value.StringValue),"sponsor"===t.ResultItems[f].DocumentAttributes[j].Key&&(v=t.ResultItems[f].DocumentAttributes[j].Value.StringValue),"application-number"===t.ResultItems[f].DocumentAttributes[j].Key&&(D=t.ResultItems[f].DocumentAttributes[j].Value.StringListValue[0]),"approval-date"===t.ResultItems[f].DocumentAttributes[j].Key){x=t.ResultItems[f].DocumentAttributes[j].Value.StringValue;var B=new Date(x);x=B.getMonth()+1+"/"+B.getDate()+"/"+B.getFullYear()}if(O=y+D,!t.ResultItems[f].DocumentExcerpt)continue;u.push({queryId:N,resultId:C,text:A,documentName:b,documentURL:E,submissionType:S,applicationType:y,applicationNo:D,application:O,submissionDate:x,formulation:I,activeIngredient:w,route:R,sponsor:v}),c.includes(D)||c.push(D),s.includes(x)||s.push(x),l.includes(S)||l.push(S),d.includes(R)||d.push(R),T.includes(v)||T.push(v),m.includes(I)||m.push(I),p.includes(w)||p.push(w)}}me({applications:c,submissions:l,submissionDate:[1934,2020],formulation:m,route:d,sponsor:T,activeIngredient:p}),u===[]&&P(!0);var U=[];if(u.length<=49)H(u);else{for(var M=0;M<50;M++)U.push(u[M]);for(var F=Object.keys(U[0]),z=0;z<U.length;z++)for(var Y=0;Y<F.length;Y++);H(U)}k(u),ae(u),Se(g)}})).catch((function(e){console.log(e)}));case 28:t.next=38;break;case 30:return T={email:u.userStub.attributes.email,userid:u.userStub.attributes.sub,organization:u.userStub.attributes["custom:organization"],tier:u.userStub.attributes["custom:license"],timestamp:new Date,query:A},f={query:A,application_number:l,searchLog:T},r=a(86).Base64,"developers:>;JQwa[zL!EX+f{?3{fjnK",E=r.encode("developers:>;JQwa[zL!EX+f{?3{fjnK"),"Basic "+E,t.next=38,We(J,f).then((function(e){var t=e.data.success;if(_(!0),null===t)Ee(!0),P(!0),k([]);else{h(t);for(var a=0;a<t.ResultItems.length;a++){var n=t.ResultItems[a].DocumentExcerpt.Text;t.ResultItems[a].DocumentExcerpt.Highlights;if(t.ResultItems[a].DocumentExcerpt.Text=n,t.ResultItems[a].AdditionalAttributes)for(var r=0;r<t.ResultItems[a].AdditionalAttributes.length;r++){var i=t.ResultItems[a].AdditionalAttributes[r],o=i.Value.TextWithHighlightsValue.Text;i.Value.TextWithHighlightsValue.Highlights;t.ResultItems[a].AdditionalAttributes[r].Value.TextWithHighlightsValue.Text=o}}for(var l=[],c=[],s=[],d=[],m=[],u=[],p=[],g=[],T=[],f=0;f<t.ResultItems.length;f++){var A=t.ResultItems[f].DocumentExcerpt.Text,E=t.ResultItems[f].DocumentURI,b=t.ResultItems[f].DocumentId,N=t.QueryId,C=t.ResultItems[f].Id,S="",y="",D="",O="",x="",v="",R="",I="",w="";if("ANSWER"===t.ResultItems[f].Type){var L={text:t.ResultItems[f].DocumentExcerpt.Text,documentURL:t.ResultItems[f].DocumentURI,queryId:t.QueryId,resultId:t.ResultItems[f].Id};g.push(L)}else{for(var j=0;j<t.ResultItems[f].DocumentAttributes.length;j++)if("submission"===t.ResultItems[f].DocumentAttributes[j].Key&&(S=t.ResultItems[f].DocumentAttributes[j].Value.StringValue),"designation-type"===t.ResultItems[f].DocumentAttributes[j].Key&&(y=t.ResultItems[f].DocumentAttributes[j].Value.StringValue),"active-ingredient"===t.ResultItems[f].DocumentAttributes[j].Key&&(w=t.ResultItems[f].DocumentAttributes[j].Value.StringValue),"route"===t.ResultItems[f].DocumentAttributes[j].Key&&(R=t.ResultItems[f].DocumentAttributes[j].Value.StringValue),"formulation"===t.ResultItems[f].DocumentAttributes[j].Key&&(I=t.ResultItems[f].DocumentAttributes[j].Value.StringValue),"sponsor"===t.ResultItems[f].DocumentAttributes[j].Key&&(v=t.ResultItems[f].DocumentAttributes[j].Value.StringValue),"application-number"===t.ResultItems[f].DocumentAttributes[j].Key&&(D=t.ResultItems[f].DocumentAttributes[j].Value.StringListValue[0]),"approval-date"===t.ResultItems[f].DocumentAttributes[j].Key){x=t.ResultItems[f].DocumentAttributes[j].Value.StringValue;var B=new Date(x);x=B.getMonth()+1+"/"+B.getDate()+"/"+B.getFullYear()}if(O=y+D,!t.ResultItems[f].DocumentExcerpt)continue;u.push({queryId:N,resultId:C,text:A,documentName:b,documentURL:E,submissionType:S,applicationType:y,applicationNo:D,application:O,submissionDate:x,formulation:I,activeIngredient:w,route:R,sponsor:v}),c.includes(D)||c.push(D),s.includes(x)||s.push(x),l.includes(S)||l.push(S),d.includes(R)||d.push(R),T.includes(v)||T.push(v),m.includes(I)||m.push(I),p.includes(w)||p.push(w)}}me({applications:c,submissions:l,submissionDate:[1934,2020],formulation:m,route:d,sponsor:T,activeIngredient:p}),u===[]&&P(!0);var U=[];if(u.length<=49)H(u);else{for(var M=0;M<50;M++)U.push(u[M]);H(U)}k(u),ae(u),Se(g)}})).catch((function(e){console.log(e)}));case 38:case"end":return t.stop()}}),t)})));return function(e){return t.apply(this,arguments)}}(),Ie=function(){var e=Object(s.a)(c.a.mark((function e(){var t;return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:he(t={submissions:[],submissionDate:[1934,2020],applications:[],route:[],formulation:[],sponsor:[],activeIngredient:[]}),we(Object(Y.a)({},t));case 3:case"end":return e.stop()}}),e)})));return function(){return e.apply(this,arguments)}}(),we=function(){var e=Object(s.a)(c.a.mark((function e(t){var a,n,r,i,o,l;return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:for(0===(a=Object(Y.a)({},t)).submissions.length&&(a.submissions=de.submissions),0===a.applications.length&&(a.applications=de.applications),0===a.activeIngredient.length&&(a.activeIngredient=de.activeIngredient),0===a.formulation.length&&(a.formulation=de.formulation),0===a.route.length&&(a.route=de.route),0===a.sponsor.length&&(a.sponsor=de.sponsor),n=te,r=[],i=0;i<n.length;i++)a.submissions.includes(n[i].submissionType)&&parseInt(n[i].submissionDate.substr(n[i].submissionDate.length-4))>=a.submissionDate[0]&&parseInt(n[i].submissionDate.substr(n[i].submissionDate.length-4))<=a.submissionDate[1]&&a.applications.includes(n[i].applicationNo)&&a.formulation.includes(n[i].formulation)&&a.route.includes(n[i].route)&&a.activeIngredient.includes(n[i].activeIngredient)&&a.sponsor.includes(n[i].sponsor)&&r.push(n[i]);if(o=[],r.length<=49)H(r);else{for(l=0;l<50;l++)o.push(r[l]);H(o)}k(r);case 13:case"end":return e.stop()}}),e)})));return function(t){return e.apply(this,arguments)}}(),Le=function(){var e=Object(s.a)(c.a.mark((function e(t,a){var n;return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:(n=ge)[t]=a,he(n),we(Object(Y.a)({},ge));case 4:case"end":return e.stop()}}),e)})));return function(t,a){return e.apply(this,arguments)}}();return r.a.createElement(R.a,{justifyContent:"center"},r.a.createElement(Ft.Steps,{enabled:ve,steps:_e,onBeforeChange:function(e){},initialStep:0,onExit:function(){Re(!1)}}),D?r.a.createElement(R.a,null,r.a.createElement(C.a,{item:!0,container:!0,xs:12,justify:"center",alignItems:"flex-start"},r.a.createElement(N.a,{variant:"outlined",className:t.Paper},r.a.createElement(C.a,{item:!0,container:!0,xs:12,justify:"center",alignItems:"flex-start"},r.a.createElement(C.a,{item:!0,container:!0,xs:2,justify:"center",alignItems:"flex-start",className:t.FilterGrid},r.a.createElement(C.a,{item:!0,className:t.FilterGrid},v&&0===U.length?null:r.a.createElement(Rt,{handleResetFilters:Ie,dataRows:U,baseFilters:de,filters:ge,functionFilter:Le}))),r.a.createElement(C.a,{item:!0,container:!0,xs:10,justify:"center",alignItems:"center",className:t.TableGrid},r.a.createElement(C.a,{item:!0,container:!0,xs:12,justify:"flex-start",alignItems:"center"},r.a.createElement(C.a,{item:!0,container:!0,xs:10,justify:"flex-start",alignItems:"center"},r.a.createElement(C.a,{id:"botSearch",item:!0,container:!0,xs:12,justify:"flex-start",alignItems:"center",className:t.TopGrids},r.a.createElement("form",{onSubmit:Pe},r.a.createElement(K,{placeholder:"Search here",handleChange:function(e){E(e.target.value)},value:A,id:"searchTerm",name:"searchTerm"}),r.a.createElement(j.a,{type:"submit",className:t.Button},r.a.createElement(V,null)))),r.a.createElement(C.a,{item:!0,container:!0,xs:6,justify:"flex-start",alignItems:"center",className:t.TopGrids},r.a.createElement(y.a,{className:t.TopGridTypography},"Showing search results from"," ",r.a.createElement("span",{className:t.TopGridTypographyTitle},"Summary Basis of Approval Documents"))),r.a.createElement(C.a,{item:!0,container:!0,xs:6,justify:"flex-start",alignItems:"center",className:t.TopGrids},r.a.createElement(L.a,{placement:"left-start",title:r.a.createElement(y.a,null,"50 Records available for download")},r.a.createElement("div",null,G?r.a.createElement(st.CSVLink,{data:G,filename:"Applicationdocs.csv",separator:oe},console.log("bot download",G),r.a.createElement("img",{src:ct.a})):r.a.createElement("div",null)))),r.a.createElement(C.a,{item:!0,container:!0,xs:12,justify:"flex-start",alignItems:"center"},r.a.createElement(mt.a,{id:"botCategories",exclusive:!0,name:J,onChange:function(e,t){null===t&&(t=J),Z(t)},"aria-label":"text alignment",value:J,className:t.toggleButtonGroup},r.a.createElement(dt.a,{value:"All","aria-label":"All",className:"All"!==J?t.toggleButtonIndivdual:t.toggleButtonSelectedIndivdual},"All"),r.a.createElement(dt.a,{value:"Reviews","aria-label":"Reviews",className:"Reviews"!==J?t.toggleButtonIndivdual:t.toggleButtonSelectedIndivdual},"Reviews"),r.a.createElement(dt.a,{value:"Labels","aria-label":"Labels",className:"Labels"!==J?t.toggleButtonIndivdual:t.toggleButtonSelectedIndivdual},"Labels"),r.a.createElement(dt.a,{value:"Letters","aria-label":"Letters",className:"Letters"!==J?t.toggleButtonIndivdual:t.toggleButtonSelectedIndivdual},"Letters"),r.a.createElement(dt.a,{value:"Others","aria-label":"Others",className:"Others"!==J?t.toggleButtonIndivdual:t.toggleButtonSelectedIndivdual},"Others")))),r.a.createElement(C.a,{item:!0,container:!0,xs:2,justify:"flex-start",alignItems:"center"},r.a.createElement(C.a,{container:!0,item:!0,xs:12,justify:"center",alignItems:"center"},r.a.createElement("img",{className:t.botResultsIcon,src:z.a})),r.a.createElement(C.a,{container:!0,item:!0,xs:12,justify:"center",alignItems:"center"},r.a.createElement(R.a,{display:"flex",justifyContent:"center",className:t.BotLikeButtonBox},r.a.createElement(y.a,{className:t.BotLearnTypography},"Click"),r.a.createElement("img",{className:t.BotLearnImg,src:ie.a}),r.a.createElement("img",{className:t.BotLearnImg,src:le.a}))),r.a.createElement(C.a,{container:!0,item:!0,xs:12,justify:"center",alignItems:"center"},r.a.createElement(y.a,{className:t.BotLearnTypography},'"I know I am Smart, but let me learn from you too!"')))),r.a.createElement(C.a,{className:t.BotCardsGrid},U.length>0?Ce?r.a.createElement(Pt,{suggestedAns:Ce,rows:U,applicationNumber:l}):null:v||0!==U.length?Ae||0===U.length?r.a.createElement(C.a,{container:!0,justify:"center",alignItems:"center"},r.a.createElement(C.a,{container:!0,item:!0,xs:12,justify:"center",alignItems:"center",className:t.ErrorGrid},r.a.createElement("img",{className:t.botIcon,src:z.a})),r.a.createElement(C.a,{container:!0,item:!0,xs:12,justify:"center",alignItems:"center",className:t.ErrorGrid},r.a.createElement(y.a,{className:t.StyledErrorTypography},"Sorry , we couldn't find any answers to your question '",A,"' in ",J,". Please try to ask a different question or try other document types.")),r.a.createElement(C.a,{container:!0,item:!0,xs:12,justify:"center",alignItems:"center",className:t.ErrorGrid},r.a.createElement(y.a,{className:t.StyledErrorLine2Typography},"You can always ping us using the contact button and we'll get back to you under 24 hours."))):null:r.a.createElement(C.a,{container:!0,justify:"center",alignItems:"center"},r.a.createElement(C.a,{container:!0,item:!0,xs:12,justify:"center",alignItems:"center",className:t.ErrorGrid},r.a.createElement("img",{className:t.botIcon,src:z.a})),r.a.createElement(C.a,{container:!0,item:!0,xs:12,justify:"center",alignItems:"center",className:t.ErrorGrid},r.a.createElement(y.a,{className:t.StyledErrorTypography},"Sorry , we couldn't find any answers to your question '",A,"' in ",J," with the applied filters . Please try to ask a different question or try other document types with these filters."))))))))):r.a.createElement(R.a,null,r.a.createElement(R.a,{className:t.BotLogoBox},r.a.createElement("img",{className:t.BotLogo,src:$.a})),r.a.createElement(y.a,{className:t.Line1Typography},"Hello, ",r.a.createElement("span",{className:t.Line1Title},"ARIA")," here!"),r.a.createElement(y.a,{className:t.Line2Typography},"Please ask me a question below to search Summary Basis of Approval Documents"),r.a.createElement("form",{onSubmit:Pe},r.a.createElement(K,{placeholder:"Search here",handleChange:function(e){E(e.target.value)},value:A,id:"searchTerm",name:"searchTerm"}),r.a.createElement(j.a,{type:"submit",className:t.Button},r.a.createElement(V,null)))),D?r.a.createElement(B.a,{"aria-label":"add",className:t.airplaneIcon,onClick:function(){window.scroll(0,0),Re(!0)}},r.a.createElement(zt,null)):null)}var Vt=a(1098),Gt=a(178),Ht=a(466),Wt=a(347),Qt=a(773),Jt=a.n(Qt);var Kt=function(e){var t=v(),i=Object(n.useState)(),o=Object(d.a)(i,2),l=o[0],m=o[1],u=Object(n.useState)(),p=Object(d.a)(u,2),g=p[0],h=p[1],T=Object(n.useState)(),f=Object(d.a)(T,2),A=f[0],E=f[1],b=Object(n.useState)(),S=Object(d.a)(b,2),D=S[0],_=S[1],O=Object(n.useState)(),x=Object(d.a)(O,2),R=x[0],P=x[1],I=Object(n.useState)(),w=Object(d.a)(I,2),L=w[0],j=w[1],B=Object(n.useState)(!0),U=Object(d.a)(B,2),k=U[0],M=U[1];return Object(n.useEffect)((function(){function t(){return(t=Object(s.a)(c.a.mark((function t(){var n,r,i,o,l;return c.a.wrap((function(t){for(;;)switch(t.prev=t.next){case 0:return t.prev=0,n=String(e.data),r=a(86).Base64,"developers:>;JQwa[zL!EX+f{?3{fjnK",i=r.encode("developers:>;JQwa[zL!EX+f{?3{fjnK"),"Basic "+i,t.next=8,je(n).then((function(e){o=e})).catch((function(e){console.log(e)}));case 8:l=o.data.success,h(l.graphType),m(l.Data),"Bar"===l.graphType&&m(l.Data[0].data),_("Title"),P(l.key),j(l.message),E(l.keyList),M(!1),t.next=22;break;case 19:t.prev=19,t.t0=t.catch(0),console.log(t.t0);case 22:case"end":return t.stop()}}),t,null,[[0,19]])})))).apply(this,arguments)}!function(){t.apply(this,arguments)}()}),[e.data]),!0===k?r.a.createElement("div",null):"Radar"===g?r.a.createElement(C.a,{container:!0,spacing:2,className:t.graphInnerGrid},r.a.createElement(C.a,{item:!0,xs:12,container:!0,justify:"center",alignItems:"center",className:t.graphInnerMessageGrid},r.a.createElement(y.a,{className:t.graphInnerMessage},L)),r.a.createElement(C.a,{item:!0,xs:12,container:!0,justify:"",alignItems:"center",className:t.graphInnerChartGrid},r.a.createElement(N.a,{className:t.chart},r.a.createElement(Vt.a,{data:l,keys:A,indexBy:D,maxValue:"auto",margin:{top:100,right:100,bottom:100,left:100},curve:"cardinalClosed",borderWidth:2,borderColor:{from:"color"},gridLevels:5,gridShape:"linear",gridLabelOffset:36,enableDots:!1,dotSize:10,dotColor:{theme:"background"},dotBorderWidth:2,dotBorderColor:{from:"color"},enableDotLabel:!0,dotLabel:"value",fontSize:20,dotLabelYOffset:-12,colors:["#1C2D59","#3AB09E","#20A1C7"],fillOpacity:1,blendMode:"multiply",animate:!0,motionStiffness:90,motionDamping:15,isInteractive:!0,theme:{axis:{ticks:{text:{fontSize:16}}},legends:{text:{fontSize:16}}},axisTop:{fontSize:30},axisBottom:{fontSize:30},legends:[{anchor:"top",direction:"row",translateX:-50,translateY:-90,itemWidth:200,itemHeight:20,itemTextColor:"#000000",symbolSize:15,symbolShape:"circle",effects:[{on:"hover",style:{fontSize:25,itemTextColor:"#000"}}]}]}))),r.a.createElement(C.a,{item:!0,xs:12,container:!0,justify:"center",alignItems:"center",className:t.graphInnerTitleGrid},r.a.createElement(y.a,{className:t.graphInnerTitle},R))):"Line"===g?r.a.createElement(C.a,{container:!0,spacing:2,className:t.graphInnerGrid},r.a.createElement(C.a,{item:!0,xs:12,container:!0,justify:"center",alignItems:"center",className:t.graphInnerMessageGrid},r.a.createElement(y.a,{className:t.graphInnerMessage},L)),r.a.createElement(C.a,{item:!0,xs:12,container:!0,justify:"",alignItems:"center",className:t.graphInnerChartGrid},r.a.createElement(N.a,{className:t.chart},r.a.createElement(Ht.a,{data:l,margin:{top:100,right:50,bottom:100,left:50},xScale:{type:"point"},yScale:{type:"linear",min:"auto",max:"auto",stacked:!0,reverse:!1},axisTop:null,axisRight:null,curve:"monotoneX",axisBottom:{orient:"bottom",tickSize:3,tickPadding:10,tickRotation:45},axisLeft:{orient:"left",tickSize:5,tickPadding:5,tickRotation:0,legend:"Number of Approvals",legendOffset:-40,legendPosition:"middle"},theme:{axis:{ticks:{text:{fontSize:13}}},legends:{text:{fontSize:16}}},enableArea:!0,areaOpacity:1,enableGridX:!1,enableGridY:!1,enablePoints:!1,colors:["#1C2D59","#008B8B","#48E0A6"],pointSize:10,pointColor:{theme:"background"},pointBorderWidth:1,pointBorderColor:{from:"serieColor"},pointLabel:"y",pointLabelYOffset:-12,useMesh:!0,legends:[{anchor:"top",direction:"row",justify:!1,fontSize:50,translateX:40,translateY:-60,itemsSpacing:0,itemDirection:"left-to-right",itemWidth:200,itemHeight:20,itemOpacity:.75,symbolSize:12,symbolShape:"circle",symbolBorderColor:"rgba(0, 0, 0, .5)",effects:[{on:"hover",style:{itemBackground:"rgba(0, 0, 0, .03)",itemOpacity:1}}]}]}))),r.a.createElement(C.a,{item:!0,xs:12,container:!0,justify:"center",alignItems:"center",className:t.graphInnerTitleGrid},r.a.createElement(y.a,{className:t.graphInnerTitle},R))):"Bar"===g?r.a.createElement(C.a,{container:!0,spacing:2,className:t.graphInnerGrid},r.a.createElement(C.a,{item:!0,xs:12,container:!0,justify:"center",alignItems:"center",className:t.graphInnerMessageGrid},r.a.createElement(y.a,{className:t.graphInnerMessage},L)),r.a.createElement(C.a,{item:!0,xs:12,container:!0,justify:"center",alignItems:"center",className:t.graphInnerChartGrid},r.a.createElement(N.a,{className:t.chart},r.a.createElement(Gt.a,{data:l,keys:["y"],indexBy:"x",margin:{top:100,right:20,bottom:50,left:60},padding:.3,borderRadius:2,colors:["#0E5A94","#318AC8","#008B8B","#3AB09E","#48E0A6","#1C2D59","#20A1C7"],colorBy:"index",axisTop:null,enableGridX:!1,enableGridY:!1,axisRight:null,axisBottom:{orient:"bottom",tickSize:1,tickPadding:5,tickRotation:90},axisLeft:{orient:"left",tickSize:3,tickPadding:5,tickRotation:0,legend:"Original PMA Approved (CDRH)",legendOffset:-40,legendPosition:"middle"},theme:{axis:{ticks:{text:{fontSize:10}}},legends:{text:{fontSize:16}}},labelSkipWidth:12,labelSkipHeight:12,labelTextColor:{from:"color",modifiers:[["darker",1.6]]},legends:[],animate:!0,motionStiffness:90,motionDamping:15}))),r.a.createElement(C.a,{item:!0,xs:12,container:!0,justify:"center",alignItems:"center",className:t.graphInnerTitleGrid},r.a.createElement(y.a,{className:t.graphInnerTitle},R))):"Pie"===g?r.a.createElement(C.a,{container:!0,spacing:2,className:t.graphInnerGrid},r.a.createElement(C.a,{item:!0,xs:12,container:!0,justify:"center",alignItems:"center",className:t.graphInnerMessageGrid},r.a.createElement(y.a,{className:t.graphInnerMessage},L)),r.a.createElement(C.a,{item:!0,xs:12,container:!0,justify:"",alignItems:"center",className:t.graphInnerChartGrid},r.a.createElement(N.a,{className:t.chart},r.a.createElement(Wt.a,{data:l,margin:{top:40,right:80,bottom:80,left:80},innerRadius:.1,padAngle:.7,cornerRadius:3,colors:["#48E0A6","#0A467C"],borderWidth:1,borderColor:{from:"color",modifiers:[["darker",.2]]},radialLabelsSkipAngle:10,radialLabelsTextXOffset:6,radialLabelsTextColor:"#1FBDCA",radialLabelsLinkOffset:0,radialLabelsLinkDiagonalLength:16,radialLabelsLinkHorizontalLength:24,radialLabelsLinkStrokeWidth:1,radialLabelsLinkColor:"#1D262D",sliceLabelsSkipAngle:10,sliceLabelsTextColor:"#fff",animate:!0,motionStiffness:90,motionDamping:15,theme:{axis:{ticks:{text:{fontSize:10}}},legends:{text:{fontSize:16}}},legends:[{anchor:"top",direction:"row",justify:!1,fontSize:50,translateX:40,translateY:-60,itemsSpacing:0,itemDirection:"left-to-right",itemWidth:200,itemHeight:20,itemOpacity:.75,symbolSize:12,symbolShape:"circle",symbolBorderColor:"rgba(0, 0, 0, .5)",effects:[{on:"hover",style:{itemBackground:"rgba(0, 0, 0, .03)",itemOpacity:1}}]}]}))),r.a.createElement(C.a,{item:!0,xs:12,container:!0,justify:"center",alignItems:"center",className:t.graphInnerTitleGrid},r.a.createElement(y.a,{className:t.graphInnerTitle},R))):void 0},Zt=Object(f.a)((function(e){return{NewsParent:{height:"100%"},paper:{width:"100%"},NewsDiv:{borderRadius:"10px",width:"100%",boxShadow:"none",margin:"2vh",padding:e.spacing(2),border:"1px solid ".concat(e.palette.home.border)},NewsLogo:{color:e.palette.white,background:e.palette.biologics.gradient},DateTypography:{paddingLeft:e.spacing(1),paddingRight:e.spacing(1),color:e.palette.home.subheading,fontWeight:"900",fontSize:"2vh",textAlign:"left"},DescriptionTypography:{paddingTop:e.spacing(1),paddingBottom:e.spacing(1),color:e.palette.black,fontWeight:"700",fontSize:"1.8vh",textAlign:"left"},LinkTypography:{paddingTop:e.spacing(1),paddingBottom:e.spacing(1),color:e.palette.black,opacity:.6,fontWeight:"500",fontSize:"1.5vh",textAlign:"left","&:hover":{color:e.palette.primary.main,opacity:1,cursor:"pointer"}},NewsImageDiv:{padding:e.spacing(2),backgroundColor:e.palette.white},NewsImage:{height:"5vh",width:"auto"}}})),Xt=a(1913),qt=a(642),$t=a.n(qt);function ea(){var e=Zt(),t=Object(n.useState)(),i=Object(d.a)(t,2),o=i[0],l=i[1];return Object(n.useEffect)((function(){function e(){return(e=Object(s.a)(c.a.mark((function e(){var t,n,r,i;return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:return e.prev=0,t=a(86).Base64,"developers:>;JQwa[zL!EX+f{?3{fjnK",n=t.encode("developers:>;JQwa[zL!EX+f{?3{fjnK"),"Basic "+n,e.next=7,Ue().then((function(e){r=e})).catch((function(e){console.log(e)}));case 7:i=r.data.success,l(i),e.next=14;break;case 11:e.prev=11,e.t0=e.catch(0),console.log(e.t0);case 14:case"end":return e.stop()}}),e,null,[[0,11]])})))).apply(this,arguments)}!function(){e.apply(this,arguments)}()}),[]),o?r.a.createElement(C.a,{item:!0,xs:12,container:!0,justify:"center",alignItems:"center",className:e.NewsParent},o[0].updates.map((function(t,a){return r.a.createElement(C.a,{key:a+String(t),item:!0,xs:12,container:!0,justify:"center",alignItems:"center",className:e.NewsDiv},r.a.createElement(C.a,{item:!0,xs:10,container:!0,justify:"center",alignItems:"center"},r.a.createElement(C.a,{item:!0,xs:1,container:!0,justify:"flex-start",alignItems:"center"},r.a.createElement(S.a,{"aria-label":"recipe",className:e.NewsLogo},r.a.createElement($t.a,{fontSize:"small"}))),r.a.createElement(C.a,{item:!0,xs:11,container:!0,justify:"flex-start",alignItems:"center"},r.a.createElement(y.a,{className:e.DateTypography},o[0].date)),r.a.createElement(C.a,{item:!0,xs:12,container:!0,justify:"flex-start",alignItems:"center"},r.a.createElement(y.a,{className:e.DescriptionTypography},t.text)),r.a.createElement(C.a,{item:!0,xs:12,container:!0,justify:"flex-start",alignItems:"center"},r.a.createElement(L.a,{TransitionComponent:pe.a,title:t.link},r.a.createElement(Xt.a,{target:"_blank",rel:"noopener",href:t.link,className:e.LinkTypography},t.link.substring(0,50),"...")))),r.a.createElement(C.a,{item:!0,xs:2,container:!0,justify:"center",alignItems:"center",className:e.NewsImageDiv},r.a.createElement("img",{src:"https://upload.wikimedia.org/wikipedia/commons/thumb/7/7d/Food_and_Drug_Administration_logo.svg/1280px-Food_and_Drug_Administration_logo.svg.png",alt:"fda-logo",className:e.NewsImage})))})),o[1].updates.map((function(t,a){return r.a.createElement(C.a,{item:!0,xs:12,key:a+String(t),container:!0,justify:"center",alignItems:"center",className:e.NewsDiv},r.a.createElement(C.a,{item:!0,xs:10,container:!0,justify:"center",alignItems:"center"},r.a.createElement(C.a,{item:!0,xs:1,container:!0,justify:"flex-start",alignItems:"center"},r.a.createElement(S.a,{"aria-label":"recipe",className:e.NewsLogo},r.a.createElement($t.a,{fontSize:"small"}))),r.a.createElement(C.a,{item:!0,xs:11,container:!0,justify:"flex-start",alignItems:"center"},r.a.createElement(y.a,{className:e.DateTypography},o[1].date)),r.a.createElement(C.a,{item:!0,xs:12,container:!0,justify:"flex-start",alignItems:"center"},r.a.createElement(y.a,{className:e.DescriptionTypography},t.text)),r.a.createElement(C.a,{item:!0,xs:12,container:!0,justify:"flex-start",alignItems:"center"},r.a.createElement(L.a,{TransitionComponent:pe.a,title:t.link},r.a.createElement(Xt.a,{target:"_blank",rel:"noopener",href:t.link,className:e.LinkTypography},t.link.substring(0,50),"...")))),r.a.createElement(C.a,{item:!0,xs:2,container:!0,justify:"center",alignItems:"center",className:e.NewsImageDiv},r.a.createElement("img",{src:"https://upload.wikimedia.org/wikipedia/commons/thumb/7/7d/Food_and_Drug_Administration_logo.svg/1280px-Food_and_Drug_Administration_logo.svg.png",alt:"fda=logo",className:e.NewsImage})))})),o[2].updates.map((function(t,a){return r.a.createElement(C.a,{item:!0,xs:12,key:a+String(t),container:!0,justify:"center",alignItems:"center",className:e.NewsDiv},r.a.createElement(C.a,{item:!0,xs:10,container:!0,justify:"center",alignItems:"center"},r.a.createElement(C.a,{item:!0,xs:1,container:!0,justify:"flex-start",alignItems:"center"},r.a.createElement(S.a,{"aria-label":"recipe",className:e.NewsLogo},r.a.createElement($t.a,{fontSize:"small"}))),r.a.createElement(C.a,{item:!0,xs:11,container:!0,justify:"flex-start",alignItems:"center"},r.a.createElement(y.a,{className:e.DateTypography},o[2].date)),r.a.createElement(C.a,{item:!0,xs:12,container:!0,justify:"flex-start",alignItems:"center"},r.a.createElement(y.a,{className:e.DescriptionTypography},t.text)),r.a.createElement(C.a,{item:!0,xs:12,container:!0,justify:"flex-start",alignItems:"center"},r.a.createElement(L.a,{TransitionComponent:pe.a,title:t.link},r.a.createElement(Xt.a,{target:"_blank",rel:"noopener",href:t.link,className:e.LinkTypography},t.link.substring(0,50),"...")))),r.a.createElement(C.a,{item:!0,xs:2,container:!0,justify:"center",alignItems:"center",className:e.NewsImageDiv},r.a.createElement("img",{src:"https://upload.wikimedia.org/wikipedia/commons/thumb/7/7d/Food_and_Drug_Administration_logo.svg/1280px-Food_and_Drug_Administration_logo.svg.png",alt:"fda-logo",className:e.NewsImage})))}))):r.a.createElement("div",null)}var ta=function(){return r.a.createElement("svg",{xmlns:"http://www.w3.org/2000/svg",width:"10.792",height:"10.792",viewBox:"0 0 14.792 14.792"},r.a.createElement("g",{id:"plus",opacity:"0.5"},r.a.createElement("g",{id:"Group_254","data-name":"Group 254"},r.a.createElement("path",{id:"Path_147",fill:"#3AB09E","data-name":"Path 147",d:"M14.214,6.818H7.974V.578a.578.578,0,1,0-1.156,0v6.24H.578a.578.578,0,1,0,0,1.156h6.24v6.24a.578.578,0,0,0,1.156,0V7.974h6.24a.578.578,0,1,0,0-1.156Z"}))))},aa=Object(P.a)((function(e){return{tooltip:{marginTop:"-11vh",marginLeft:"-1vh",width:"fit-content",padding:"10px",paddingLeft:"20px",paddingRight:"20px",borderRadius:"10px",color:e.palette.white,border:"2px solid ".concat(e.palette.primary.lightBorder)}}}))(L.a);function na(){var e=v(),t=Object(n.useContext)(Mt),a=t.state,i=t.dispatch,o=Math.floor(7*Math.random()+1),l=Object(n.useState)(o),m=Object(d.a)(l,2),u=m[0],p=m[1],g=Object(n.useState)(!1),h=Object(d.a)(g,2),T=h[0],f=h[1],A=Object(n.useState)(!0),E=Object(d.a)(A,2),b=E[0],S=E[1],D=Object(n.useState)([{element:"#coreIcon",intro:"Core Module: This is a core RIA module to search for all Drugs, Biologics and Devices for covered areas",position:"right",tooltipClass:"myTooltipClass",highlightClass:"myHighlightClass"},{element:"#tabletIcon",intro:"505b2 Module: This module includes applications approved under 505(b)(2) approval pathway",position:"right",tooltipClass:"myTooltipClass",highlightClass:"myHighlightClass"},{element:"#pediatricIcon",intro:"Pediatric Module: This module includes access pediatric written requests, waivers, and deferrals",position:"right",tooltipClass:"myTooltipClass",highlightClass:"myHighlightClass"},{element:"#blaIcon",intro:"BLA Module: This module includes Biologics Licensing Applications (BLAs)",position:"right",tooltipClass:"myTooltipClass",highlightClass:"myHighlightClass"},{element:"#pmrIcon",intro:"PMR Module: This module includes surveillance and impact for Post Marketing Requirements and Commitments",position:"right",tooltipClass:"myTooltipClass",highlightClass:"myHighlightClass"},{element:"#quickSearch",intro:"Quick Search: The user can search for a list of all drugs and brands by \u2018TA/Indication\u2019 or  \u2018Active Ingredient\u2019 or \u2018Trade Name\u2019 or \u2018formulation\u2019 or \u2018route\u2019 or \u2018Approval Date\u2019. The search process is as follows",position:"bottom",tooltipClass:"myTooltipClass",highlightClass:"myHighlightClass"},{element:"#filterTerm",intro:"select database (US FDA- Drugs and Biologics, EU EMA - Drugs and Biologics, US DA - Devices)",position:"bottom",tooltipClass:"myTooltipClass",highlightClass:"myHighlightClass"},{element:"#categoryTerm",intro:"select category (TA/Indication, Active Ingredient, Trade Name, Formulation, Route, Approval Date)",position:"bottom",tooltipClass:"myTooltipClass",highlightClass:"myHighlightClass"},{element:"#searchTerm",intro:"enter a search string and press enter or hit the search button.",position:"bottom",tooltipClass:"myTooltipClass",highlightClass:"myHighlightClass"},{element:"#advanceSearch",intro:"Advanced Search:  The user can search for different combinations the \u2018TA/Indication\u2019 or  \u2018Active Ingredient\u2019 or \u2018Trade Name\u2019 or \u2018formulation\u2019 or \u2018route\u2019 or \u2018Approval Date\u2019",position:"bottom",tooltipClass:"myTooltipClass",highlightClass:"myHighlightClass"},{element:"#homeInsights",intro:"Insights: Key business insights frequently asked questions from RIA database",position:"right",tooltipClass:"myTooltipClass",highlightClass:"myHighlightClass"},{element:"#homeNews",intro:"News: Recent FDA newsfeed for users to learn about the latest news",position:"left",tooltipClass:"myTooltipClass",highlightClass:"myHighlightClass"}]),_=Object(d.a)(D,2),O=_[0],x=(_[1],Object(n.useState)(!1)),P=Object(d.a)(x,2),I=P[0],L=P[1];Object(n.useEffect)((function(){function e(){return(e=Object(s.a)(c.a.mark((function e(){return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:return e.prev=0,e.next=3,i({type:wt.SET_MODULE,value:"core"});case 3:setTimeout((function(){S(!1)}),5e3),e.next=9;break;case 6:e.prev=6,e.t0=e.catch(0),console.log(e.t0);case 9:case"end":return e.stop()}}),e,null,[[0,6]])})))).apply(this,arguments)}!function(){e.apply(this,arguments)}()}),[i]);var F=function(){var e=Object(s.a)(c.a.mark((function e(){return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:return e.next=2,i({type:wt.SET_CART_ITEMS,value:a.cartItems+1});case 2:return e.next=4,i({type:wt.SET_REPORT,value:{id:"Home Report",data:{key:u}}});case 4:case"end":return e.stop()}}),e)})));return function(){return e.apply(this,arguments)}}();return r.a.createElement("div",{className:e.main},r.a.createElement(Ft.Steps,{enabled:I,steps:O,showProgress:!0,scrollToElement:!0,initialStep:0,onBeforeChange:function(e){},onExit:function(){L(!1)}}),r.a.createElement(C.a,{container:!0,spacing:2,className:e.GridGraphBox},r.a.createElement(C.a,{item:!0,xs:6,className:e.GridGraph},r.a.createElement(N.a,{elevation:1,className:e.paper},r.a.createElement(R.a,{display:"flex",justifyContent:"space-between",id:"homeInsights"},r.a.createElement(y.a,null," "),r.a.createElement(y.a,{variant:"h1",className:e.GridTitle},"Insights"),r.a.createElement(y.a,{onClick:F,className:e.add},r.a.createElement(ta,null)," Add to report")),r.a.createElement(C.a,{xs:12,item:!0,justify:"center",alignItems:"center",className:e.GridContentBox},r.a.createElement(Jt.a,{next:function(){p(u<7?u+1:1)},prev:function(){u<=7&&p(1===u?7:u-1)},autoPlay:!0,indicators:"true",interval:"20000",indicatorColor:"primary",className:e.GridContentBox},r.a.createElement(Kt,{data:u}))))),r.a.createElement(C.a,{item:!0,xs:6,container:!0,className:e.GridNews},r.a.createElement(N.a,{elevation:1,className:e.paper},r.a.createElement(R.a,{display:"flex",flexDirection:"column"},r.a.createElement(y.a,{variant:"h1",id:"homeNews",className:e.newsHeading,noWrap:!0},"Latest News"),r.a.createElement(ea,null))))),r.a.createElement(U.a,{fullWidth:!0,maxWidth:"lg",onClose:function(){f(!1)},"aria-labelledby":"customized-dialog-title",open:T},r.a.createElement(M.a,{className:e.ModalTitle},r.a.createElement(C.a,{container:!0},r.a.createElement(C.a,{container:!0,item:!0,xs:12,justify:"flex-end",alignItems:"center"},r.a.createElement(j.a,{"aria-label":"delete",className:e.ModalCloseIconButton,onClick:function(){f(!1)}},r.a.createElement(w.a,{className:e.ModalCloseIcon}))))),r.a.createElement(k.a,{className:e.Dialog},r.a.createElement(Yt,{page:"Core"}))),r.a.createElement(aa,{placement:"right-start",open:b,title:r.a.createElement(r.a.Fragment,null,r.a.createElement(y.a,{className:e.botIntroPopup},"Hi I'm ARIA"),r.a.createElement(y.a,{className:e.botTextPopup},"I can help you find information in Approval Documents."),r.a.createElement(y.a,{className:e.botTextPopup},"Ask me questions"))},r.a.createElement(B.a,{"aria-label":"add",className:e.botIconFAB,onClick:function(){return f(!0)}},r.a.createElement("img",{className:e.botIcon,src:z.a}))),r.a.createElement(B.a,{"aria-label":"add",className:e.airplaneIcon,onClick:function(){L(!0)}},r.a.createElement(zt,null)))}var ra=a(93),ia=Object(f.a)((function(e){return{filterParent:{borderRadius:e.spacing(1.25),paddingLeft:e.spacing(2),paddingRight:e.spacing(2),minHeight:"50px",minWidth:"150px",marginLeft:e.spacing(1),background:e.palette.navbar.grayBackground},filterParentPMR:{borderRadius:e.spacing(1.25),paddingRight:e.spacing(2),minHeight:"50px",minWidth:"150px",justifyContent:"center"},filterParentL:{borderRadius:e.spacing(1.25),background:e.palette.navbar.grayBackground},filterLabel:{padding:e.spacing(1),paddingLeft:e.spacing(3),textAlign:"left",width:"100%",color:e.palette.navbar.border},filterSelect:{paddingLeft:"4px",textAlign:"left",fontSize:"2vh",width:"100%",color:e.palette.black},filterSelectPMR:{textAlign:"left",fontSize:"0.8rem",width:"100%",color:e.palette.black},filterSelectL:{paddingLeft:"20px",textAlign:"left",fontSize:"2vh",width:"100%",color:e.palette.black},loginForm:{filterParent:{border:"2px solid ".concat(e.palette.primary.lightBorder),borderRadius:"15px",width:"60vh",minHeight:"50px",marginLeft:e.spacing(1),backgroundColor:e.palette.primary.lightBorder}},filterParentCompare:{borderRadius:"10px 10px 0px 0px",paddingLeft:e.spacing(2),paddingRight:e.spacing(2),minHeight:"50px",minWidth:"150px",marginLeft:e.spacing(1),background:"#33B187",color:"white"},filterSelectC:Object(g.a)({paddingLeft:"4px",textAlign:"left",fontSize:"2vh",width:"100%",color:e.palette.black,margin:"auto"},"color","white")}})),oa=a(755),la=a(964),ca=a(798),sa=function(e){var t=ia();return r.a.createElement("div",null,e.handleChange?r.a.createElement(W.a,{className:t.filterParent},r.a.createElement(oa.a,{className:t.filterLabel,id:"demo-simple-select-outlined-label"},e.title),r.a.createElement(ca.a,{className:t.filterSelect,labelId:"demo-simple-select-outlined-label",id:e.id,name:e.name,value:e.dropdownValue,disableUnderline:!0,onChange:e.handleChange},e.menuItems.map((function(e,t){return r.a.createElement(la.a,{key:String(e)+t,value:e},e)})))):r.a.createElement(W.a,{className:t.filterParent},r.a.createElement(oa.a,{className:t.filterLabel,id:"demo-simple-select-outlined-label"},e.title),r.a.createElement(ca.a,{className:t.filterSelect,labelId:"demo-simple-select-outlined-label",id:e.id,name:e.name,value:e.dropdownValue,disableUnderline:!0},e.menuItems.map((function(e,t){return r.a.createElement(la.a,{key:String(e)+t,value:e},e)})))))},da=function(e){var t=ia();return r.a.createElement("div",{style:{width:"100%"}},e.handleChange?r.a.createElement(W.a,{className:t.filterParentL,style:{width:"inherit",float:"right"}},r.a.createElement(oa.a,{className:t.filterLabel,id:"demo-simple-select-outlined-label",style:{color:"rgba(0, 0, 0, 0.87)",opacity:"0.5"}},e.title),r.a.createElement(ca.a,{className:t.filterSelectL,labelId:"demo-simple-select-outlined-label",id:e.id,name:e.name,value:e.dropdownValue,disableUnderline:!0,onChange:e.handleChange},e.menuItems.map((function(e,t){return r.a.createElement(la.a,{key:String(e)+t,value:e},e)})))):r.a.createElement(W.a,{className:t.filterParent,style:{width:"inherit",float:"right"}},r.a.createElement(oa.a,{className:t.filterLabel,id:"demo-simple-select-outlined-label"},e.title),r.a.createElement(ca.a,{className:t.filterSelect,labelId:"demo-simple-select-outlined-label",id:e.id,name:e.name,value:e.dropdownValue,disableUnderline:!0},e.menuItems.map((function(e,t){return r.a.createElement(la.a,{key:String(e)+t,value:e},e)})))))},ma=function(e){var t=ia();return r.a.createElement("div",null,e.handleChange?r.a.createElement(W.a,{className:t.filterParentPMR},r.a.createElement(ca.a,{className:t.filterSelectPMR,labelId:"demo-simple-select-outlined-label",id:e.id,name:e.name,value:e.dropdownValue,disableUnderline:!0,onChange:e.handleChange},e.menuItems.map((function(e,t){return r.a.createElement(la.a,{key:String(e)+t,value:e},e)})))):r.a.createElement(W.a,{className:t.filterParentPMR},r.a.createElement(ca.a,{className:t.filterSelectPMR,labelId:"demo-simple-select-outlined-label",id:e.id,name:e.name,value:e.dropdownValue,disableUnderline:!0},e.menuItems.map((function(e,t){return r.a.createElement(la.a,{key:String(e)+t,value:e},e)})))))},ua=function(e){var t,a=Object(u.f)(),i=b(),o=Object(n.useState)(""),l=Object(d.a)(o,2),m=l[0],p=l[1],h=Object(n.useState)(""),f=Object(d.a)(h,2),A=f[0],E=f[1],O=Object(n.useState)(""),v=Object(d.a)(O,2),R=(v[0],v[1],Object(n.useState)("")),P=Object(d.a)(R,2),I=(P[0],P[1],Object(n.useState)("Active")),w=Object(d.a)(I,2),L=w[0],j=w[1],B=Object(n.useState)(""),U=Object(d.a)(B,2),k=(U[0],U[1],Object(n.useState)("Admin")),M=Object(d.a)(k,2),F=M[0],z=M[1],Y=Object(n.useState)(""),V=Object(d.a)(Y,2),G=V[0],H=V[1],W=Object(n.useState)(""),Q=Object(d.a)(W,2),J=Q[0],K=Q[1],Z=Object(n.useState)(""),X=Object(d.a)(Z,2),q=X[0],$=X[1],ee=Object(n.useState)("Government"),te=Object(d.a)(ee,2),ae=te[0],ne=te[1],re=Object(n.useState)(""),ie=Object(d.a)(re,2),oe=(ie[0],ie[1]),le=function(){var e=Object(s.a)(c.a.mark((function e(t){var a,n;return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:return t.preventDefault(),a={first_name:G,last_name:J,user_email:m,password:A,license:ae,user_status:L,organization:q,user_role:F},e.next=4,Me(a).then((function(e){n=e})).catch((function(e){console.log(e)}));case 4:null!==n.data.success&&""!==n.data.success?ra.b.info(n.data.success):ra.b.error(n.data.error),H(""),K(""),p(""),E(""),ne(""),j(""),$(""),z("");case 13:case"end":return e.stop()}}),e)})));return function(t){return e.apply(this,arguments)}}();return Object(n.useEffect)((function(){function e(){return(e=Object(s.a)(c.a.mark((function e(){var t;return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:return e.next=2,T.a.currentAuthenticatedUser();case 2:t=e.sent,oe(t.attributes["custom:role"]),"Admin"!==t.attributes["custom:role"]&&a.push("/"),console.log("tier",t.attributes.email);case 6:case"end":return e.stop()}}),e)})))).apply(this,arguments)}!function(){e.apply(this,arguments)}()})),r.a.createElement(N.a,{className:i.root},r.a.createElement(C.a,{container:!0,spacing:0,justify:"center",direction:"row"},r.a.createElement(C.a,{item:!0},r.a.createElement(C.a,{container:!0,direction:"column",justify:"center",spacing:2,className:i.loginForm},r.a.createElement(N.a,{variant:"elevation",className:i.loginBackground},r.a.createElement(C.a,{container:!0,className:i.logoBox,alignItems:"center",justify:"center"},r.a.createElement(S.a,{alt:"Clignosis Logo",src:x.a,className:i.logo})),r.a.createElement(C.a,{item:!0,className:i.titleBox},r.a.createElement(y.a,{className:i.title,component:"h1",variant:"h1",align:"center"},"VivPro")),r.a.createElement(C.a,null,r.a.createElement(C.a,{item:!0},r.a.createElement("form",null,r.a.createElement(C.a,{container:!0,direction:"column",spacing:2},r.a.createElement(C.a,{item:!0,style:{display:"flex"}},r.a.createElement(C.a,{item:!0,xs:3},r.a.createElement("div",{className:i.fieldName}," ","User Name :")),r.a.createElement(C.a,{item:!0,xs:9,style:{display:"flex"},spacing:2},r.a.createElement(D.a,{type:"text",placeholder:"First Name",inputProps:{style:{fontSize:"1.5vh"}},fullWidth:!0,name:"username",id:"username",className:i.textFieldName,InputProps:{disableUnderline:!0},value:G,onChange:function(e){return H(e.target.value)},required:!0}),r.a.createElement(D.a,{type:"text",placeholder:"Last Name",fullWidth:!0,name:"username",id:"username",inputProps:{style:{fontSize:"1.5vh"}},className:i.textFieldName,InputProps:{disableUnderline:!0},value:J,onChange:function(e){return K(e.target.value)},required:!0}))),r.a.createElement(C.a,{item:!0,style:{display:"flex"}},r.a.createElement(C.a,{item:!0,xs:3},r.a.createElement("div",{className:i.fieldName},"Email :")),r.a.createElement(C.a,{item:!0,xs:9},r.a.createElement(D.a,{type:"email",placeholder:"Use email as username",fullWidth:!0,name:"username",id:"username",inputProps:{style:{fontSize:"1.5vh"}},className:i.textField,InputProps:{disableUnderline:!0},value:m,onChange:function(e){return p(e.target.value)},required:!0}))),r.a.createElement(C.a,{item:!0,style:{display:"flex"}},r.a.createElement(C.a,{item:!0,xs:3},r.a.createElement("div",{className:i.fieldName},"Organization :")),r.a.createElement(C.a,{item:!0,xs:9},r.a.createElement(D.a,{type:"text",placeholder:"Enter user Organization",fullWidth:!0,name:"username",id:"username",inputProps:{style:{fontSize:"1.5vh"}},className:i.textField,InputProps:{disableUnderline:!0},value:q,onChange:function(e){return $(e.target.value)},required:!0}))),r.a.createElement(C.a,{item:!0,style:{display:"flex"}},r.a.createElement(C.a,{item:!0,xs:3},r.a.createElement("div",{className:i.fieldName},"Status :")),r.a.createElement(C.a,{item:!0,xs:9},r.a.createElement(da,{id:"filterTerm",dropdownValue:L,menuItems:["Active","Inactive",""],title:"Select User Status",handleChange:function(e){return j(e.target.value)},className:i.textField,required:!0,style:{width:"60vh"}}))),r.a.createElement(C.a,{item:!0,style:{display:"flex"}},r.a.createElement(C.a,{item:!0,xs:3},r.a.createElement("div",{className:i.fieldName},"License :")),r.a.createElement(C.a,{item:!0,xs:9},r.a.createElement(da,{id:"filterTerm",dropdownValue:ae,menuItems:["Government","Educational","Enterprise","Individual","Free","Evaluation",""],title:"Select User License",handleChange:function(e){return ne(e.target.value)},className:i.textField,required:!0}))),r.a.createElement(C.a,{item:!0,style:{display:"flex"}},r.a.createElement(C.a,{item:!0,xs:3},r.a.createElement("div",{className:i.fieldName},"Role :")),r.a.createElement(C.a,{item:!0,xs:9},r.a.createElement(da,(t={className:i.dropdown,id:"filterTerm",dropdownValue:F,menuItems:["Admin","Developer","User","Data Curator",""],title:"Select User Role",handleChange:function(e){return z(e.target.value)}},Object(g.a)(t,"className",i.textField),Object(g.a)(t,"required",!0),t)))),r.a.createElement(C.a,{item:!0,style:{display:"flex"}},r.a.createElement(C.a,{item:!0,xs:3},r.a.createElement("div",{className:i.fieldName},"Password :")),r.a.createElement(C.a,{item:!0,xs:9},r.a.createElement(D.a,{type:"password",placeholder:"Password",fullWidth:!0,name:"password",id:"password",inputProps:{style:{fontSize:"1.5vh"}},autoComplete:"on",InputProps:{disableUnderline:!0},className:i.textField,value:A,onChange:function(e){return E(e.target.value)},required:!0}))),r.a.createElement(C.a,{item:!0,className:i.buttonBox,style:{display:"flex",margin:"0 auto"}},r.a.createElement(_.a,{variant:"contained",color:"primary",type:"submit",className:i.button,onClick:function(e){return le(e)}},"Submit")))))))))))},pa=Object(f.a)((function(e){var t;return t={root:{display:"flex"},appBar:{zIndex:e.zIndex.drawer+1,backgroundColor:e.palette.white,paddingTop:e.spacing(1),marginLeft:e.spacing(9)+1,width:"calc(100% - ".concat(e.spacing(9)+1,"px)"),transition:e.transitions.create(["width","margin"],{easing:e.transitions.easing.sharp,duration:e.transitions.duration.leavingScreen,backgroundColor:"#FFFFFF !important"})},navIcon:{color:"#ced6e0"},vivLogo:{width:e.spacing(20),height:e.spacing(9)},badgeBeta:{background:e.palette.navbar.button,color:e.palette.white},appBarShift:{marginLeft:240,width:"calc(100% - ".concat(240,"px)"),transition:e.transitions.create(["width","margin"],{easing:e.transitions.easing.sharp,duration:e.transitions.duration.enteringScreen})},menuButton:{marginRight:36},NavTitle:{fontSize:"3vh",color:e.palette.primary.main},logoLink:{cursor:"pointer"},mainLogo:{height:"4vh",width:"auto"},mainSidebarLogo:{"& .MuiAvatar-img":{height:"2.6vh",width:"3.75vh"}},hide:{display:"none"},pmrOption:{padding:e.spacing(1)},pmrStatus:{color:e.palette.successGreen,fontSize:e.spacing(1),marginRight:e.spacing(.5)},drawerOption:{color:e.palette.home.border,textAlign:"left",cursor:"pointer",textTransform:"capitalize",fontSize:e.spacing(2)},drawerOption1:{color:e.palette.home.border,textAlign:"left",textTransform:"capitalize",marginLeft:e.spacing(1.2),fontSize:e.spacing(2)},drawer:{width:240,flexShrink:0,whiteSpace:"nowrap"},drawerOpen:{backgroundColor:e.palette.white,width:240,transition:e.transitions.create("width",{easing:e.transitions.easing.sharp,duration:e.transitions.duration.enteringScreen})},drawerIcons:{color:e.palette.navbar.border,fontWeight:"bold",cursor:"pointer"},toggleDrawerIcon:{marginTop:e.spacing(8)},drawerClose:Object(g.a)({transition:e.transitions.create("width",{easing:e.transitions.easing.sharp,duration:e.transitions.duration.leavingScreen}),overflowX:"hidden",width:e.spacing(7)+1},e.breakpoints.up("sm"),{width:e.spacing(9)+1}),toggleDrawer:{marginTop:e.spacing(20)},toolbar:{marginTop:e.spacing(5)},sectionDesktop:Object(g.a)({display:"none",marginLeft:"auto"},e.breakpoints.up("md"),{display:"flex"}),content:{flexGrow:1,padding:e.spacing(3)},Icons:{color:"#FFFFFF"},main:{height:"95%",width:"100%"},MainGrid:{marginTop:"0.5rem",height:"100%"},GridSearchBox:{minHeight:"20%",boxShadow:"none",borderRadius:0},GridPage:{height:"90%",boxShadow:"none",borderRadius:0},DateTitle:{fontSize:"2vh"},searchSpaceGrid:{border:"2px solid ".concat(e.palette.primary.lightBorder),borderRadius:"10px"},searchSpace:{paddingLeft:"10px",width:"90%",height:"5vh",fontSize:"2vh","& .MuiInputBase-input":{fontSize:"2vh"}},searchFilter:{borderRadius:"10px",backgroundColor:e.palette.primary.lightBackground,border:"2px solid ".concat(e.palette.primary.lightBorder)},filterTabLeft:{width:"100%",height:"5vh",textAlign:"left","& .MuiSelect-icon":{color:e.palette.primary.main},"& .MuiSelect-root":{textAlign:"left",fontSize:"2vh",color:e.palette.primary.main,backgroundColor:"transparent"},"& .MuiFilledInput-input":{padding:8},"& .MuiInputBase-root":{backgroundColor:"transparent",color:e.palette.primary.main,fontSize:"2vh"}},searchIconButton:{width:"5%",height:"5vh",marginBottom:"-1vh"},searchIcon:{width:"5%",height:"5vh",marginBottom:"-1vh"},searchDialog:{padding:e.spacing(4)},buttonMain:{marginLeft:"10%",width:"auto",height:"5.4vh",marginBottom:"-2px",marginRight:"10px",fontSize:"3vh",borderRadius:"10px",background:"linear-gradient(to bottom, ".concat(e.palette.gradient.primaryFrom," 10%, ").concat(e.palette.gradient.primaryTo," 90%)"),color:e.palette.white},buttonSecondary:{width:"auto",borderRadius:"10px",height:"auto",paddingLeft:"1rem",paddingRight:"1rem",background:"linear-gradient(to bottom, ".concat(e.palette.gradient.primaryFrom," 10%, ").concat(e.palette.gradient.primaryTo," 90%)"),color:e.palette.white},advancedText:{fontSize:"1.1rem",color:e.palette.white},AdvancedDialog:{minHeight:"30%",maxHeight:"80%"},DialogTitle:{background:"linear-gradient(to bottom, ".concat(e.palette.gradient.primaryFrom," 10%, ").concat(e.palette.gradient.primaryTo," 90%)"),color:e.palette.white},chart:{height:"100%",width:"100%",backgroundColor:e.palette.white,boxShadow:"none",borderRadius:0},DialogContent:{padding:e.spacing(3),minHeight:"50vh"},AdvancedSearchDate:{},popoverTitle:{marginLeft:e.spacing(1)},popoverBox:{marginTop:e.spacing(1)},AdvancedSearchDatePicker:{width:e.spacing(20),marginLeft:e.spacing(1),borderRadius:"10px",border:"2px solid ".concat(e.palette.primary.lightBorder),"& .MuiInput":{border:"2px solid ".concat(e.palette.primary.lightBorder)},"& .MuiFormLabel-root":{marginLeft:e.spacing(1),color:e.palette.primary.main},"& .MuiInput-underline:before":{border:"none"},"& .MuiInput-underline:after":{border:"none"},"& .MuiInput-underline:hover":{border:"none"},"& .MuiInput-underline:focus":{border:"none"}},resize:{fontSize:e.spacing(1.85),marginLeft:e.spacing(1),width:"100%"},calendarIcon:{color:e.palette.variants.title,opacity:.7},box:{height:"100%"},btn:{marginLeft:e.spacing(1),fontSize:e.spacing(2),fontWeight:"500",borderRadius:"10px",background:e.palette.navbar.button,color:e.palette.white},logoutBtn:{fontSize:e.spacing(2),width:"100%",fontWeight:"500",borderRadius:"10px",background:e.palette.navbar.button,color:e.palette.white},search:{marginLeft:"10%",width:"60%",height:"70%"}},Object(g.a)(t,"searchDialog",{padding:e.spacing(4)}),Object(g.a)(t,"buttonMain",{marginLeft:"10%",width:"auto",height:"5.4vh",marginBottom:"-2px",marginRight:"10px",fontSize:"3vh",borderRadius:"10px",background:"linear-gradient(to bottom, ".concat(e.palette.gradient.primaryFrom," 10%, ").concat(e.palette.gradient.primaryTo," 90%)"),color:e.palette.white}),Object(g.a)(t,"buttonSecondary",{width:"auto",borderRadius:"10px",height:"auto",paddingLeft:"1rem",paddingRight:"1rem",background:"linear-gradient(to bottom, ".concat(e.palette.gradient.primaryFrom," 10%, ").concat(e.palette.gradient.primaryTo," 90%)"),color:e.palette.white}),Object(g.a)(t,"advancedText",{fontSize:"1.1rem",color:e.palette.white}),Object(g.a)(t,"AdvancedDialog",{minHeight:"30%",maxHeight:"80%"}),Object(g.a)(t,"DialogTitle",{background:"linear-gradient(to bottom, ".concat(e.palette.gradient.primaryFrom," 10%, ").concat(e.palette.gradient.primaryTo," 90%)"),color:e.palette.white}),Object(g.a)(t,"chart",{height:"100%",width:"100%",backgroundColor:e.palette.white,boxShadow:"none",borderRadius:0}),Object(g.a)(t,"DialogContent",{padding:e.spacing(3),minHeight:"50vh"}),Object(g.a)(t,"AdvancedSearchDate",{}),Object(g.a)(t,"AdvancedButtonBox",{width:"70%",borderRadius:"10px",paddingTop:e.spacing(2),paddingBottom:e.spacing(2)}),Object(g.a)(t,"expand",{transform:"rotate(0deg)",marginLeft:"auto",transition:e.transitions.create("transform",{duration:e.transitions.duration.shortest})}),Object(g.a)(t,"expandClose",{color:e.palette.white}),Object(g.a)(t,"expandOpen",{color:e.palette.white,transform:"rotate(180deg)"}),Object(g.a)(t,"botIcon",{marginLeft:"-1vh",height:"4vh",width:"4vh"}),Object(g.a)(t,"searchIconButton",{width:"auto",background:"linear-gradient(to bottom, ".concat(e.palette.gradient.primaryFrom," 10%, ").concat(e.palette.gradient.primaryTo," 90%)"),borderRadius:"10px",color:e.palette.white}),Object(g.a)(t,"searchIcon",{width:"auto",height:"3vh",color:e.palette.white}),Object(g.a)(t,"searchSpace",{border:"unset",outline:"unset",width:"85%",height:"100%",fontSize:"2vh"}),Object(g.a)(t,"avatar",{background:e.palette.navbar.avatar,fontSize:e.spacing(2),fontWeight:"bold",textTransform:"uppercase",opacity:.9}),Object(g.a)(t,"username",{color:e.palette.common.primaryBlack,fontWeight:"bold",fontSize:e.spacing(2.5)}),Object(g.a)(t,"emailText",{color:e.palette.common.primaryBlack,opacity:.8,fontWeight:"bold",fontSize:e.spacing(2)}),Object(g.a)(t,"statusIcon",{color:e.palette.successGreen}),Object(g.a)(t,"statusIcon",{color:e.palette.successGreen}),Object(g.a)(t,"modal",{display:"flex"}),Object(g.a)(t,"modalContainer",{margin:"auto",overflowX:"scroll",overflowY:"auto",height:"100%",width:"100vw"}),Object(g.a)(t,"badge",{color:e.palette.common.badge}),Object(g.a)(t,"dropdownAdv",{background:e.palette.navbar.grayBackground,paddingLeft:e.spacing(1),paddingRight:e.spacing(1),paddingTop:e.spacing(.5),paddingBottom:e.spacing(.5),borderRadius:e.spacing(1.5)}),Object(g.a)(t,"dropdownLabel",{margin:e.spacing(1),color:e.palette.navbar.border}),Object(g.a)(t,"textField",{background:e.palette.navbar.grayBackground,borderRadius:e.spacing(1.5),padding:e.spacing(1.5),marginLeft:e.spacing(1)}),t}),{index:1}),ga=a(6),ha=a(218),Ta=a(779),fa=a(1792),Aa=a(1921),Ea=a(555),ba=a(615),Na=a.n(ba),Ca=a(1810),Sa=a(1920),ya=a(1034),Da=a(1922),_a=a(350),Oa=a.n(_a),xa=a(616),va=a.n(xa),Ra=a(194),Pa=a(82),Ia=a(740),wa=a(233),La=a.n(wa),ja=a(1172),Ba=Object(f.a)((function(e){return{header:{width:"100%"},heading:{color:e.palette.home.heading},btn:{margin:e.spacing(1),fontSize:"3vh",textTransform:"capitalize",fontWeight:"500",borderRadius:"10px",background:e.palette.navbar.button,color:e.palette.white},logo:{height:e.spacing(3)},preview:{width:"100%",padding:e.spacing(5)},previewContainer:{width:"100%",border:"1px solid black"},graphs:{marginTop:e.spacing(10),paddingTop:e.spacing(10),width:"100%",height:"100%"},paper:{borderRadius:e.spacing(3),padding:e.spacing(3),width:"100%"},cardDetails:{marginTop:e.spacing(15),paddingTop:e.spacing(10),height:"100%",width:"100%"},highlightText:{opacity:.6,fontWeight:"bold",textTransform:"uppercase"},boxRoot:{marginTop:e.spacing(15),paddingTop:e.spacing(10),width:"100%"},progress:{color:e.palette.navbar.button}}})),Ua=a(1130),ka=a.n(Ua),Ma=a(1131),Fa=a.n(Ma),za=a(1061),Ya=a(1113),Va=a.n(Ya),Ga=Object(f.a)((function(e){return{graphs:{marginTop:e.spacing(10),paddingTop:e.spacing(10),width:"100%",height:"100%"},paper:{borderRadius:e.spacing(3),paddingTop:e.spacing(3)},highlightText:{opacity:.6,fontWeight:"bold",textTransform:"uppercase"}}})),Ha=function(e){var t=e.data,a=Ga();return r.a.createElement(n.Fragment,null,r.a.createElement(R.a,{display:"flex",flexDirection:"column",className:a.graphs},r.a.createElement(N.a,{elevation:0,className:a.paper},r.a.createElement(y.a,{variant:"h3"},"Insights"),r.a.createElement(Kt,{data:t.key}))))},Wa=Object(f.a)((function(e){return{paper:{borderRadius:e.spacing(3),padding:e.spacing(3)},cardDetails:{marginTop:e.spacing(15),paddingTop:e.spacing(10),height:"100%",width:"100%"},highlightText:{opacity:.6,fontWeight:"bold",textTransform:"uppercase"}}})),Qa=Object(f.a)((function(e){return{GridExtendedCardTabs:{backgroundColor:e.palette.white,margin:0,width:"100%"},ExtendedCardTabs:{backgroundColor:e.palette.white,margin:0,width:"100%"},airplaneIcon:{position:"fixed",bottom:e.spacing(2),left:e.spacing(2)},ExtendedCardTab:{backgroundColor:e.palette.white,margin:0,width:"100%",padding:e.spacing(3),height:"100%"},ExtendedCardIconTile:{marginTop:"-2vh",padding:"8px"},ExtendedCardTopLogosYes:{width:"3vh",height:"3vh",color:e.palette.primary.main,opacity:"1"},ExtendedCardTopLogosNo:{width:"3vh",height:"3vh",color:e.palette.primary.main,opacity:"0.2"},ExtendedCardLine1:{padding:"1vh"},ExtendedCardLine2:{padding:"1vh"},ExtendedCardLine3:{maxHeight:"18vh",overflow:"auto",padding:"1vh"},ExtendedCardTitle:{width:"100%",textAlign:"left",color:e.palette.black,fontWeight:"900",fontSize:"2vh"},ExtendedCardLabelingTitle:{width:"100%",textAlign:"left",color:e.palette.black,fontWeight:"900",fontSize:"2vh"},ExtendedCardFormulation:{borderRadius:"10px",width:"80%",height:"fit-content",textAlign:"center",fontWeight:"900",fontSize:"1.5vh",color:e.palette.black,backgroundColor:e.palette.primary.lightBorder},ExtendedCardApprovalPathway:{borderRadius:"10px",width:"60%",height:"2vh",textAlign:"center",color:e.palette.white,fontWeight:"900",fontSize:"1.5vh"},ExtendedCardGenericCount:{borderRadius:"10px",width:"60%",height:"2vh",textAlign:"center",color:e.palette.white,backgroundColor:e.palette.successGreen,fontWeight:"900",fontSize:"1.5vh"},ExtendedCardGenericCountClickable:{borderRadius:"10px",cursor:"pointer",width:"60%",height:"2vh",textAlign:"center",color:e.palette.white,backgroundColor:e.palette.successGreen,fontWeight:"900",fontSize:"1.5vh"},ExtendedCardBrandName:{width:"100%",color:e.palette.black,fontWeight:"900",opacity:"0.5",textAlign:"center",fontSize:"4vh",fontStyle:"oblique"},ExtendedCardProductsGrid:{marginTop:"2vh",marginBottom:"2vh"},ExtendedCardPatentsGrid:{marginBottom:"2vh"},ExtendedCardExclusivityGrid:{marginBottom:"2vh"},ExtendedCardCollapse:{},ExtendedCardLabeling:{paddingTop:"2vh",paddingBottom:"2vh",textAlign:"left",color:e.palette.black,fontWeight:"500",fontSize:"1.5vh"},ExtendedCardDropdown:{width:"100%"},ExtendedCardDropdownButton:{width:"100%",fontSize:"2vh",fontWeight:"500",backgroundColor:e.palette.primary.lightBackground,border:"2px solid ".concat(e.palette.primary.lightBorder),color:e.palette.primary.main},expand:{color:e.palette.primary.main,transform:"rotate(0deg)",transition:e.transitions.create("transform",{duration:e.transitions.duration.shortest})},expandClose:{color:e.palette.primary.main,transform:"rotate(180deg)"}}})),Ja=a(148),Ka=a.n(Ja),Za=a(604),Xa=a.n(Za),qa=Object(f.a)((function(e){return{Paper:{borderRadius:"5px",width:"100%",overflowX:"auto",boxShadow:"none"},Table:{},TableHead:{borderRadius:"10px"},TableBody:{borderRadius:"10px"},StyledHeaderTableRow:{borderRadius:"10px"},StyledHeaderTableCell:{padding:"7px",fontSize:"2vh",fontWeight:"800",color:e.palette.black,backgroundColor:e.palette.primary.lightBorder},StyledHeaderTableCellMapped:{padding:"7px",fontSize:"1.5vh",fontWeight:"700",color:e.palette.black,backgroundColor:e.palette.primary.lightBorder},StyledLogosCellDiv:{width:"10vh"},StyledTableRow:{borderRadius:"10px","&:nth-of-type(odd)":{backgroundColor:e.palette.primary.lightBackground},"&:nth-of-type(even)":{backgroundColor:e.palette.white}},StyledTableCell:{padding:"7px",fontSize:"1.5vh",fontWeight:"700",color:e.palette.black},StyledTableCellMapped:{padding:"7px",fontSize:"1.5vh",fontWeight:"500",color:e.palette.black},RefernceStatusLogosYes:{height:"120%",width:"120%",padding:"4px",marginLeft:"4px",marginRight:"4px"},RefernceStatusLogosNo:{height:"120%",width:"120%",padding:"4px",marginLeft:"4px",marginRight:"4px",opacity:"0.2"}}})),$a=a(1029),en=a(1033),tn=a(1032),an=a(1030),nn=a(1031),rn=a(812),on=a.n(rn),ln=a(813),cn=a.n(ln),sn=a(814),dn=a.n(sn);function mn(e){var t=qa(),a=Object(n.useState)(),i=Object(d.a)(a,2),o=i[0],l=i[1];return Object(n.useEffect)((function(){function t(){return(t=Object(s.a)(c.a.mark((function t(){return c.a.wrap((function(t){for(;;)switch(t.prev=t.next){case 0:try{l(e.products)}catch(a){console.log(a)}case 1:case"end":return t.stop()}}),t)})))).apply(this,arguments)}!function(){t.apply(this,arguments)}()}),[e.products]),o?r.a.createElement(N.a,{className:t.Paper},r.a.createElement($a.a,{className:t.Table,"aria-label":"customized table"},r.a.createElement(an.a,{className:t.TableHead},r.a.createElement(nn.a,{className:t.StyledHeaderTableRow},r.a.createElement(tn.a,{className:t.StyledHeaderTableCell},"Products"),Object.keys(o).map((function(e,a){return r.a.createElement(tn.a,{className:t.StyledHeaderTableCellMapped},"Product ",e)})))),r.a.createElement(en.a,{className:t.TableBody},r.a.createElement(nn.a,{className:t.StyledTableRow,key:"Strength"},r.a.createElement(tn.a,{className:t.StyledTableCell,component:"th",scope:"row"},"Reference Status"),Object.keys(o).map((function(e,a){return r.a.createElement(tn.a,{className:t.StyledTableCellMapped},r.a.createElement("div",{className:t.StyledLogosCellDiv},r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"center"},r.a.createElement(C.a,{container:!0,justify:"center",alignItems:"center",item:!0,xs:4},"YES"===o[e].rld?r.a.createElement(S.a,{alt:"Logo",src:on.a,className:t.RefernceStatusLogosYes}):r.a.createElement(S.a,{alt:"Logo",src:on.a,className:t.RefernceStatusLogosNo})),r.a.createElement(C.a,{container:!0,justify:"center",alignItems:"center",item:!0,xs:4},"YES"===o[e].rs?r.a.createElement(S.a,{alt:"Logo",src:cn.a,className:t.RefernceStatusLogosYes}):r.a.createElement(S.a,{alt:"Logo",src:cn.a,className:t.RefernceStatusLogosNo})),r.a.createElement(C.a,{container:!0,justify:"center",alignItems:"center",item:!0,xs:4},"None"!==o[e].teCode?r.a.createElement(S.a,{alt:"Logo",src:dn.a,className:t.RefernceStatusLogosYes}):r.a.createElement(S.a,{alt:"Logo",src:dn.a,className:t.RefernceStatusLogosNo})))))}))),r.a.createElement(nn.a,{className:t.StyledTableRow,key:"Strength"},r.a.createElement(tn.a,{className:t.StyledTableCell,component:"th",scope:"row"},"Strength"),Object.keys(o).map((function(e,a){return r.a.createElement(tn.a,{className:t.StyledTableCellMapped},o[e].Strength)}))),r.a.createElement(nn.a,{className:t.StyledTableRow,key:"Marketing"},r.a.createElement(tn.a,{className:t.StyledTableCell,component:"th",scope:"row"},"Marketing Status"),Object.keys(o).map((function(e,a){return r.a.createElement(tn.a,{className:t.StyledTableCellMapped},o[e].marketingstatus)})))))):r.a.createElement("div",null)}var un=Object(f.a)((function(e){return{Paper:{borderRadius:"5px",width:"100%",overflowX:"auto",boxShadow:"none"},Table:{},TableHead:{borderRadius:"10px"},TableBody:{borderRadius:"10px"},StyledHeaderTableRow:{borderRadius:"10px"},StyledHeaderTableCell:{padding:"7px",fontSize:"2vh",fontWeight:"800",color:e.palette.black,backgroundColor:e.palette.primary.lightBorder},StyledHeaderTableCellMapped:{padding:"7px",fontSize:"1.5vh",fontWeight:"700",color:e.palette.black,backgroundColor:e.palette.primary.lightBorder},StyledTableRow:{borderRadius:"10px","&:nth-of-type(odd)":{backgroundColor:e.palette.primary.lightBackground},"&:nth-of-type(even)":{backgroundColor:e.palette.white}},StyledTableCell:{padding:"7px",fontSize:"1.5vh",fontWeight:"700",color:e.palette.black},StyledTableCellMapped:{padding:"7px",fontSize:"1.5vh",fontWeight:"500",color:e.palette.black},StyledTableCellCheck:{color:e.palette.successGreen},List:{padding:0},ListItem:{padding:"4px",borderRadius:"5px",border:"2px solid ".concat(e.palette.primary.lightBorder)},ListItemText:{fontSize:"1.5vh",fontWeight:"500",color:e.palette.black}}})),pn=a(610),gn=a.n(pn);function hn(e){var t=un(),a=Object(n.useState)(),i=Object(d.a)(a,2),o=i[0],l=i[1],m=Object(n.useState)(),u=Object(d.a)(m,2),p=u[0],g=u[1];return Object(n.useEffect)((function(){function t(){return(t=Object(s.a)(c.a.mark((function t(){return c.a.wrap((function(t){for(;;)switch(t.prev=t.next){case 0:try{l(e.products),g(e.patent)}catch(a){console.log(a)}case 1:case"end":return t.stop()}}),t)})))).apply(this,arguments)}!function(){t.apply(this,arguments)}()}),[e]),o&&p?r.a.createElement(N.a,{className:t.Paper},r.a.createElement($a.a,{className:t.Table},r.a.createElement(an.a,{className:t.TableHead},r.a.createElement(nn.a,{className:t.StyledHeaderTableRow},r.a.createElement(tn.a,{className:t.StyledHeaderTableCell},"Patent"),r.a.createElement(tn.a,{className:t.StyledHeaderTableCell},"Patent Expiration Date"),Object.keys(o).map((function(e,a){return r.a.createElement(tn.a,{className:t.StyledHeaderTableCellMapped},"Product ",e)})))),r.a.createElement(en.a,{className:t.TableBody},p.map((function(e,a){return r.a.createElement(nn.a,{className:t.StyledTableRow,key:"Marketing"},r.a.createElement(tn.a,{className:t.StyledTableCell,component:"th",scope:"row"},e.patent_no,e.patent_use_code&&e.patent_definition?r.a.createElement(fa.a,{component:"nav","aria-labelledby":"nested-list-subheader",className:t.List},e.patent_use_code.map((function(a,n){return r.a.createElement(Ca.a,{button:!0,className:t.ListItem},r.a.createElement(L.a,{TransitionComponent:pe.a,title:e.patent_definition[n]},r.a.createElement(ya.a,{className:t.ListItemText},r.a.createElement(y.a,{className:t.ListItemText},a))))}))):r.a.createElement("div",null)),r.a.createElement(tn.a,{className:t.StyledTableCell,component:"th",scope:"row"},e.patent_expire_date),Object.keys(o).map((function(a,n){return r.a.createElement(tn.a,{className:t.StyledTableCellMapped},e.product_no.includes(a)?r.a.createElement(gn.a,{className:t.StyledTableCellCheck}):r.a.createElement("div",null))})))}))))):r.a.createElement("div",null)}var Tn=Object(f.a)((function(e){return{Paper:{borderRadius:"5px",width:"100%",overflowX:"auto",boxShadow:"none"},Table:{},TableHead:{borderRadius:"10px"},TableBody:{borderRadius:"10px"},StyledHeaderTableRow:{borderRadius:"10px"},StyledHeaderTableCell:{padding:"7px",fontSize:"2vh",fontWeight:"800",color:e.palette.black,backgroundColor:e.palette.primary.lightBorder},StyledHeaderTableCellMapped:{padding:"7px",fontSize:"1.5vh",fontWeight:"700",color:e.palette.black,backgroundColor:e.palette.primary.lightBorder},StyledTableRow:{borderRadius:"10px","&:nth-of-type(odd)":{backgroundColor:e.palette.primary.lightBackground},"&:nth-of-type(even)":{backgroundColor:e.palette.white}},StyledTableCell:{padding:"7px",fontSize:"1.5vh",fontWeight:"700",color:e.palette.black},StyledTableCellMapped:{padding:"7px",fontSize:"1.5vh",fontWeight:"500",color:e.palette.black},StyledTableCellCheck:{color:e.palette.successGreen}}}));function fn(e){var t=Tn(),a=Object(n.useState)(),i=Object(d.a)(a,2),o=i[0],l=i[1],m=Object(n.useState)(),u=Object(d.a)(m,2),p=u[0],g=u[1];return Object(n.useEffect)((function(){function t(){return(t=Object(s.a)(c.a.mark((function t(){return c.a.wrap((function(t){for(;;)switch(t.prev=t.next){case 0:try{l(e.products),g(e.exclusivity)}catch(a){console.log(a)}case 1:case"end":return t.stop()}}),t)})))).apply(this,arguments)}!function(){t.apply(this,arguments)}()}),[e]),o&&p?r.a.createElement(N.a,{className:t.Paper},r.a.createElement($a.a,{className:t.Table},r.a.createElement(an.a,{className:t.TableHead},r.a.createElement(nn.a,{className:t.StyledHeaderTableRow},r.a.createElement(tn.a,{className:t.StyledHeaderTableCell},"Exclusivity"),r.a.createElement(tn.a,{className:t.StyledHeaderTableCell},"Exclusivity Expiration Date"),Object.keys(o).map((function(e,a){return r.a.createElement(tn.a,{className:t.StyledHeaderTableCellMapped},"Product ",e)})))),r.a.createElement(en.a,{className:t.TableBody},p.map((function(e,a){return r.a.createElement(nn.a,{className:t.StyledTableRow,key:"Marketing"},r.a.createElement(L.a,{TransitionComponent:pe.a,title:e.exclusivity_definition},r.a.createElement(tn.a,{className:t.StyledTableCell,component:"th",scope:"row"},e.exclusivity_code)),r.a.createElement(tn.a,{className:t.StyledTableCell,component:"th",scope:"row"},e.exclusivity_date),Object.keys(o).map((function(a,n){return r.a.createElement(tn.a,{className:t.StyledTableCellMapped},e.product_no.includes(a)?r.a.createElement(gn.a,{className:t.StyledTableCellCheck}):r.a.createElement("div",null))})))}))))):r.a.createElement("div",null)}var An=a(170),En=a.n(An),bn=a(171),Nn=a.n(bn),Cn=a(172),Sn=a.n(Cn),yn=a(173),Dn=a.n(yn),_n=a(611),On=a.n(_n);function xn(e){var t=Qa(),a=Object(n.useContext)(Mt),i=a.state,o=(a.dispatch,Object(u.f)()),l=Object(n.useState)(),m=Object(d.a)(l,2),p=m[0],h=m[1],T=Object(n.useState)(!1),f=Object(d.a)(T,2),A=f[0],E=f[1],b=Object(n.useState)(!1),N=Object(d.a)(b,2),D=N[0],O=N[1],x=Object(n.useState)(),v=Object(d.a)(x,2),P=(v[0],v[1]),I=Object(n.useState)(),w=Object(d.a)(I,2),j=w[0],U=w[1],k=Object(n.useState)(0),M=Object(d.a)(k,2),F=(M[0],M[1],Object(n.useState)()),z=Object(d.a)(F,2),Y=(z[0],z[1],Object(n.useState)([{element:"#adminInfo",intro:"Administrative information: Accelerated approval, Fast Track, Breakthrough, Generic availability and Time for approval(number of days).",position:"top",tooltipClass:"myTooltipClass",highlightClass:"myHighlightClass"},{element:"#productInfo",intro:"Product Information: Formulation, Route, Approval Pathway, Number of Generics and indication and Usage from the latest label.",position:"right",tooltipClass:"myTooltipClass",highlightClass:"myHighlightClass"},{element:"#prodDetails",intro:"Product Details: Reference Listed Drug (RLD), Reference Standard (RS), Therapeutic Equivalents (TE), Strength, Marketing Status, Patent and Exclusivity (Dropdowns)",position:"top",tooltipClass:"myTooltipClass",highlightClass:"myHighlightClass"}])),V=Object(d.a)(Y,2),G=V[0],H=(V[1],Object(n.useState)(!1)),W=Object(d.a)(H,2),Q=W[0],J=W[1];Object(n.useEffect)((function(){function t(){return(t=Object(s.a)(c.a.mark((function t(){return c.a.wrap((function(t){for(;;)switch(t.prev=t.next){case 0:try{console.log(e.data),h(e.data),P({NDA:"#EA5252",BLA:"#70319F",ANDA:"#FFC100"}),U({351:"#9A31CD","351(a)":"#258B21","351(k)":"#02CED1","505(b)":"#F6A000","505(b)(2)":"#F6A000"})}catch(a){console.log(a)}case 1:case"end":return t.stop()}}),t)})))).apply(this,arguments)}!function(){t.apply(this,arguments)}()}),[]);return p?r.a.createElement("div",null,r.a.createElement(C.a,{container:!0},r.a.createElement(Ft.Steps,{enabled:Q,steps:G,showProgress:!0,scrollToElement:!0,initialStep:0,onExit:function(){J(!1)}}),r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"flex-start"},r.a.createElement(C.a,{xs:3,id:"adminInfo",alignItems:"flex-start"},r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"center"},r.a.createElement(C.a,{container:!0,justify:"flex-start",alignItems:"center",item:!0,xs:3},r.a.createElement(L.a,{TransitionComponent:pe.a,title:"Accelerated Approval: "+p.Accelerated_approval},"Yes"===p.Accelerated_approval?r.a.createElement(S.a,{alt:"Logo",src:En.a,className:t.ExtendedCardTopLogosYes}):r.a.createElement(S.a,{alt:"Logo",src:En.a,className:t.ExtendedCardTopLogosNo}))),r.a.createElement(C.a,{container:!0,justify:"flex-start",alignItems:"center",item:!0,xs:3},r.a.createElement(L.a,{TransitionComponent:pe.a,title:"Fast Track: "+p.Fasttrack},"Yes"===p.Fasttrack?r.a.createElement(S.a,{alt:"Logo",src:Sn.a,className:t.ExtendedCardTopLogosYes}):r.a.createElement(S.a,{alt:"Logo",src:Sn.a,className:t.ExtendedCardTopLogosNo}))),r.a.createElement(C.a,{container:!0,justify:"flex-start",alignItems:"center",item:!0,xs:3},r.a.createElement(L.a,{TransitionComponent:pe.a,title:"Breakthrough: "+p.Breakthrough},"Yes"===p.Breakthrough?r.a.createElement(S.a,{alt:"Logo",src:Nn.a,className:t.ExtendedCardTopLogosYes}):r.a.createElement(S.a,{alt:"Logo",src:Nn.a,className:t.ExtendedCardTopLogosNo}))),r.a.createElement(C.a,{container:!0,justify:"flex-start",alignItems:"center",item:!0,xs:3},r.a.createElement(L.a,{TransitionComponent:pe.a,title:"Generics: "+p.Generics},"Yes"===p.Generics?r.a.createElement(S.a,{alt:"Logo",src:Dn.a,className:t.ExtendedCardTopLogosYes}):r.a.createElement(S.a,{alt:"Logo",src:Dn.a,className:t.ExtendedCardTopLogosNo})))),r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"center"},r.a.createElement("h5",null,"Time for Approval (No. of days)"),p.time_to_approval&&"N/A"!=p.time_to_approval&&"NA"!=p.time_to_approval?r.a.createElement(Xa.a,{maxValue:p.time_to_approval>1095?p.time_to_approval:1095,value:p.time_to_approval,width:200,height:150,margin:{top:15,right:25,left:5,bottom:5},needleColor:"#000000",customSegmentStops:[0,365,730,p.time_to_approval>1095?p.time_to_approval:1095],segmentColors:["#66ff66"," #ffff66","\t#FF4500"]}):r.a.createElement("div",{style:{width:200,height:150}},"Capture in Progress")),r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"center"},p.tradeName.length>9?r.a.createElement(L.a,{TransitionComponent:pe.a,title:p.tradeName},r.a.createElement(y.a,{className:t.ExtendedCardBrandName},p.tradeName.substring(0,9),"...")):r.a.createElement(y.a,{className:t.ExtendedCardBrandName},p.tradeName))),r.a.createElement(C.a,{xs:9,container:!0,justify:"center",alignItems:"center"},r.a.createElement(R.a,{id:"productInfo"},r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"center",className:t.ExtendedCardLine1},r.a.createElement(y.a,{className:t.ExtendedCardTitle},p.activeIngredients)),r.a.createElement(C.a,{xs:12,container:!0,justify:"flex-start",alignItems:"center",className:t.ExtendedCardLine2},r.a.createElement(C.a,{container:!0,justify:"flex-start",alignItems:"center",item:!0,xs:3},r.a.createElement(y.a,{className:t.ExtendedCardFormulation},p.formulation)),r.a.createElement(C.a,{container:!0,justify:"flex-start",alignItems:"center",item:!0,xs:3},r.a.createElement(y.a,{className:t.ExtendedCardFormulation},p.route)),r.a.createElement(C.a,{container:!0,justify:"flex-start",alignItems:"center",item:!0,xs:3},r.a.createElement(y.a,{className:t.ExtendedCardApprovalPathway,style:{backgroundColor:j[p.approvalPathway]}},p.approvalPathway)),r.a.createElement(C.a,{container:!0,justify:"flex-start",alignItems:"center",item:!0,xs:3},"0"===p.generic_count||""===p.generic_count?r.a.createElement(y.a,{className:t.ExtendedCardGenericCount},"Generics: 0"):r.a.createElement(y.a,{className:t.ExtendedCardGenericCountClickable,onClick:function(){!function(e,t){o.push("/table/generics/".concat(e,"/").concat(t))}(p.appl_type,p.applno)}},r.a.createElement(On.a,{fontSize:"small"}),"Generics:"," ",p.generic_count))),r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"center",className:t.ExtendedCardLine3},r.a.createElement(y.a,{className:t.ExtendedCardLabelingTitle},"Labeling( Indication ) :"),r.a.createElement(y.a,{className:t.ExtendedCardLabeling},p.indications))))),r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"center"},r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"center"}),r.a.createElement(C.a,{xs:12,container:!0,id:"prodDetails",justify:"center",alignItems:"center",className:t.ExtendedCardProductsGrid},r.a.createElement(mn,{products:p.products})),r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"center"},r.a.createElement(_.a,{onClick:function(){E(!A)},className:t.ExtendedCardDropdownButton,"aria-expanded":A,"aria-label":"show more"},"Patents",r.a.createElement(Ka.a,{className:Object(ga.a)(t.expand,Object(g.a)({},t.expandClose,A))}))),r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"center",className:t.ExtendedCardPatentsGrid},r.a.createElement(ht.a,{className:t.ExtendedCardDropdown,in:!0===i.patentExpansion||A,timeout:"auto",unmountOnExit:!0},r.a.createElement(hn,{products:p.products,patent:p.patent}))),r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"center"},r.a.createElement(_.a,{onClick:function(){O(!D)},className:t.ExtendedCardDropdownButton,"aria-expanded":D,"aria-label":"show more"},"Exclusivity",r.a.createElement(Ka.a,{className:Object(ga.a)(t.expand,Object(g.a)({},t.expandClose,D))}))),r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"center",className:t.ExtendedCardExclusivityGrid},r.a.createElement(ht.a,{className:t.ExtendedCardDropdown,in:D,timeout:"auto",unmountOnExit:!0},r.a.createElement(fn,{products:p.products,exclusivity:p.exclusivity}))))),r.a.createElement(B.a,{"aria-label":"add",className:t.airplaneIcon,onClick:function(){window.scroll(0,0),J(!0)}},r.a.createElement(zt,null))):r.a.createElement("div",null)}var vn=function(e){var t=e.data,a=Wa();return r.a.createElement(n.Fragment,null,r.a.createElement(R.a,{display:"flex",flexDirection:"column",className:a.cardDetails},r.a.createElement(N.a,{elevation:0,className:a.paper},r.a.createElement(y.a,{variant:"h3"},"Details for : ",r.a.createElement("span",{className:a.highlightText},t.heading," - ",t.tradeName)),r.a.createElement(xn,{data:t}))))},Rn=Object(f.a)((function(e){return{paper:{borderRadius:e.spacing(3),padding:e.spacing(3)},cardDetails:{marginTop:e.spacing(15),paddingTop:e.spacing(10),height:"100%",width:"100%"},highlightText:{opacity:.6,fontWeight:"bold",textTransform:"uppercase"}}})),Pn=Object(f.a)((function(e){return{root:{backgroundColor:"white",margin:"10px 0px",padding:"2vh",borderRadius:"10px"},StudyDetailsheading:{fontSize:"1.7vh",fontWeight:"700",padding:"7px",color:"#0352CC"},StudyDetailsheading1:{fontSize:"1.8vh",fontWeight:"800",padding:"7px",color:"#848383"},StudyDetailsheadingTH:{padding:"7px",fontSize:"2vh",fontWeight:"800",color:e.palette.black,backgroundColor:e.palette.primary.lightBorder},StudyDetailsheadingTR:{padding:"7px",fontSize:"2vh",fontWeight:"800",color:e.palette.black,backgroundColor:e.palette.primary.lightBorder},StudyDetailsRow:{borderRadius:"10px","&:nth-of-type(odd)":{backgroundColor:e.palette.primary.lightBackground},"&:nth-of-type(even)":{backgroundColor:e.palette.white}},studySummaryValue:{display:"block"},adminSummaryRow:{fontSize:"1.7vh",fontWeight:"700",padding:"0px 12px",display:"contents"},adminSummaryRowLast:{fontSize:"1.7vh",fontWeight:"700",padding:"0px 12px"},adminSummaryHeader1:{textAlign:"left",fontWeight:"bolder",height:"9vh"},adminSummaryHeader:{textAlign:"left",fontWeight:"bolder",height:"9vh",padding:"7px"},adminSummaryValue1:{textAlign:"left",color:"#0352CC",height:"9vh"},adminSummaryValue:{textAlign:"left",color:"#0352CC",height:"9vh",padding:"7px"},studySumtr:{height:"20px",color:"#0352CC"},table:{width:"100%"},StudyDetailsroot:{width:"100%"},CardTopLogosYes:{width:"7vh",height:"3vh",color:e.palette.primary.main,opacity:"1"},CardTopLogosNo:{width:"7vh",height:"3vh",color:e.palette.primary.main,opacity:"0.2"}}}));a(296);var In=function(e){var t=Pn(),a=Object(n.useState)(),i=Object(d.a)(a,2),o=i[0],l=i[1],m=Object(n.useState)(),u=Object(d.a)(m,2),p=u[0],g=u[1],h=Object(n.useState)(),T=Object(d.a)(h,2),f=T[0],A=T[1],E=Object(n.useState)(!0),b=Object(d.a)(E,2),N=(b[0],b[1]),S=r.a.useState([]),y=Object(d.a)(S,2),D=(y[0],y[1],r.a.useState([])),_=Object(d.a)(D,2),O=(_[0],_[1],r.a.useState([])),x=Object(d.a)(O,2),v=(x[0],x[1],r.a.useState([])),R=Object(d.a)(v,2),P=(R[0],R[1],r.a.useState([])),I=Object(d.a)(P,2),w=(I[0],I[1],r.a.useState([])),j=Object(d.a)(w,2),B=(j[0],j[1],r.a.useState([])),U=Object(d.a)(B,2),k=(U[0],U[1],r.a.useState([])),M=Object(d.a)(k,2),F=(M[0],M[1],r.a.useState([])),z=Object(d.a)(F,2),Y=(z[0],z[1],r.a.useState([])),V=Object(d.a)(Y,2);V[0],V[1],Object(n.useEffect)((function(t){function a(){return(a=Object(s.a)(c.a.mark((function e(){return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:try{N(!1),console.log("application content res",t)}catch(a){console.log(a)}case 1:case"end":return e.stop()}}),e)})))).apply(this,arguments)}console.log("administrative props print inside use effect",e);var n=e.AdminSumRes.Administrative_Summary.Table_1;l(n),console.log("administrative props print Administrative Data ",o);var r=e.AdminSumRes&&e.AdminSumRes.Clinical&&e.AdminSumRes.Clinical.Safety_Dta_Table_3;g(r),console.log("safety Data ",p);var i=e.AdminSumRes&&e.AdminSumRes.Administrative_Summary&&e.AdminSumRes.Administrative_Summary.Study_Summary_Pie_Chart_1;A(i),function(){a.apply(this,arguments)}()}),[e]);var G=function(e){if("Orphan_status"!=e&&"CR_Letter"!=e&&"Fast_track"!=e&&"Accelerated_Approval"!=e&&"Review_Priority"!=e&&"Breakthrough_designation"!=e&&"CDER_Division"!=e){if("Number_of_resubmissions_numerical"==e)return"Number of resubmissions";if("Reason_for_CR_letter"==e)return"Reason for CR letter";if("Study_Indications"==e)return"Study Indications";if("Number_of_Studies"==e)return"Number of Studies";if("Pivotal_Evidence"==e)return"Pivotal Evidence";if("New_Efficacy_data"==e)return"New Efficacy data";if("New_Safety_data"==e)return"New Safety data";if("Number_of_Literature_Studies"==e)return"Number of Literature Studies";if("Number_of_Indication"==e)return"Number of Indication"}};return r.a.createElement(C.a,{container:!0,justify:"center",alignItems:"center",item:!0,xs:12},o?r.a.createElement(C.a,{container:!0},r.a.createElement(C.a,{xs:12,container:!0,style:{borderBottom:"1px solid #eee"}},f&&f.length>0&&void 0!=f?r.a.createElement(C.a,{container:!0,spacing:3,className:t.adminSummaryRow},r.a.createElement(C.a,{className:t.adminSummaryHeader,container:!0,item:!0,xs:6},"Type of studies"),r.a.createElement(C.a,{className:t.studySummaryValue,container:!0,item:!0,xs:2},r.a.createElement("tr",{className:t.studySumtr},"Phase 1"),r.a.createElement("tr",{className:t.studySumtr,style:{fontSize:"16px"}},f[0].value)),r.a.createElement(C.a,{className:t.studySummaryValue,container:!0,item:!0,xs:2},r.a.createElement("tr",{className:t.studySumtr},"Phase 2"),r.a.createElement("tr",{className:t.studySumtr,style:{fontSize:"16px"}},f[1].value)),r.a.createElement(C.a,{className:t.studySummaryValue,container:!0,item:!0,xs:2},r.a.createElement("tr",{className:t.studySumtr},"Phase 3"),r.a.createElement("tr",{className:t.studySumtr,style:{fontSize:"16px"}},f[2].value))):r.a.createElement(C.a,{container:!0,spacing:3,className:t.adminSummaryRow},r.a.createElement(C.a,{className:t.adminSummaryHeader,container:!0,item:!0,xs:6},"Type of studies"),r.a.createElement(C.a,{className:t.studySummaryValue,container:!0,item:!0,xs:6},"Capture in Progress"))),r.a.createElement(C.a,{xs:6,container:!0,style:{borderRight:"1px solid #eee"},height:100},o.map((function(e){return function(e){return console.log("inside admin sum table",e),Object.keys(e).map((function(a,n){return console.log("key and item",a,e[a]),"Pivotal_Evidence"==a||"New_Efficacy_data"==a||"New_Safety_data"==a||"Number_of_Literature_Studies"==a||"Number_of_Indication"==a?r.a.createElement(C.a,{container:!0,className:t.adminSummaryRow,height:"20%"},r.a.createElement(C.a,{className:t.adminSummaryHeader,container:!0,item:!0,xs:6},G(a)),r.a.createElement(L.a,{title:e[a],"aria-label":"Button Link"},e[a].length>40?r.a.createElement(L.a,{TransitionComponent:pe.a,title:e[a]},r.a.createElement(C.a,{container:!0,className:t.adminSummaryValue,item:!0,xs:6},e[a].substring(0,39),"...")):r.a.createElement(C.a,{container:!0,className:t.adminSummaryValue,item:!0,xs:6},e[a]))):void 0}))}(e)}))),r.a.createElement(C.a,{xs:6,container:!0,style:{marging:"10px"},height:100},o.map((function(e){return function(e){return console.log("inside admin sum table",e),Object.keys(e).map((function(a,n){return console.log("key and item",a,e[a]),"Study_Indications"==a||"Reason_for_CR_letter"==a||"Number_of_resubmissions_numerical"==a||"Number_of_Studies"==a?r.a.createElement(C.a,{container:!0,className:t.adminSummaryRow,height:"20%"},r.a.createElement(C.a,{className:t.adminSummaryHeader,container:!0,item:!0,xs:6},G(a)),r.a.createElement(L.a,{title:e[a],"aria-label":"Button Link"},e[a].length>40?r.a.createElement(L.a,{TransitionComponent:pe.a,title:e[a]},r.a.createElement(C.a,{container:!0,className:t.adminSummaryValue,item:!0,xs:6},e[a].substring(0,39),"...")):r.a.createElement(C.a,{container:!0,className:t.adminSummaryValue,item:!0,xs:6},e[a]))):void 0}))}(e)})),r.a.createElement(C.a,{container:!0,className:t.adminSummaryRow},r.a.createElement(C.a,{className:t.adminSummaryHeader,container:!0,item:!0,xs:6},"Safety Database"),p&&p.length>0?r.a.createElement(C.a,{container:!0,className:t.adminSummaryValue,item:!0,xs:6},p[0].Safety_Database):r.a.createElement(C.a,{container:!0,className:t.adminSummaryValue,item:!0,xs:6},"Capture in progress")))):r.a.createElement("div",null))},wn=a(815),Ln=a.n(wn),jn=a(816),Bn=a.n(jn),Un=a(817),kn=a.n(Un),Mn=a(492),Fn=a.n(Mn),zn=a(1116),Yn=a.n(zn),Vn=a(1117),Gn=a.n(Vn),Hn=a(818),Wn=a.n(Hn),Qn=(a(534),function(e){var t=Pn();console.log("Admin story",e.AdminStoryRes);return r.a.createElement(C.a,{container:!0,justify:"center",item:!0,xs:12},e.AdminStoryRes?r.a.createElement("div",{className:t.adminStoryRow},r.a.createElement(C.a,{container:!0,justify:"flex-start",item:!0,xs:3,style:{flexWrap:"inherit"}},e.AdminStoryRes.map((function(e){return function(e){return Object.keys(e).map((function(a,n){if("Orphan_status"==a||"CR_Letter"==a||"Fast_track"==a||"Accelerated_Approval"==a||"Review_Priority"==a||"Breakthrough_designation"==a){if("CR_Letter"==a)return"Yes"==e[a]?r.a.createElement(L.a,{TransitionComponent:pe.a,title:"CR Letter: Yes"},r.a.createElement(S.a,{alt:"Logo",src:Fn.a,className:t.CardTopLogosYes})):r.a.createElement(L.a,{TransitionComponent:pe.a,title:"CR Letter: No"},r.a.createElement(S.a,{alt:"Logo",src:Fn.a,className:t.CardTopLogosNo}));if("Orphan_status"==a)return"Yes"==e[a]?r.a.createElement(L.a,{TransitionComponent:pe.a,title:"Orphan status: Yes"},r.a.createElement(S.a,{alt:"Logo",src:Wn.a,className:t.CardTopLogosYes})):r.a.createElement(L.a,{TransitionComponent:pe.a,title:"Orphan status: No"},r.a.createElement(S.a,{alt:"Logo",src:Wn.a,className:t.CardTopLogosNo}));if("Fast_track"==a)return"Yes"==e[a]?r.a.createElement(L.a,{TransitionComponent:pe.a,title:"Fast Track: Yes"},r.a.createElement(S.a,{alt:"Logo",src:kn.a,className:t.CardTopLogosYes})):r.a.createElement(L.a,{TransitionComponent:pe.a,title:"Fast Track: No"},r.a.createElement(S.a,{alt:"Logo",src:kn.a,className:t.CardTopLogosNo}));if("Accelerated_Approval"==a)return"Yes"==e[a]?r.a.createElement(L.a,{TransitionComponent:pe.a,title:"Accelerated Approval: Yes"},r.a.createElement(S.a,{alt:"Logo",src:Ln.a,className:t.CardTopLogosYes})):r.a.createElement(L.a,{TransitionComponent:pe.a,title:"Accelerated Approval: No"},r.a.createElement(S.a,{alt:"Logo",src:Ln.a,className:t.CardTopLogosNo}));if("Review_Priority"==a)return"STANDARD"==e[a]?r.a.createElement(L.a,{TransitionComponent:pe.a,title:"Review Priority: STANDARD"},r.a.createElement(S.a,{alt:"Logo",src:Gn.a,className:t.CardTopLogosYes})):r.a.createElement(L.a,{TransitionComponent:pe.a,title:"Review Priority: PRIORITY"},r.a.createElement(S.a,{alt:"Logo",src:Yn.a,className:t.CardTopLogosNo}));if("Breakthrough_designation"==a)return"Yes"==e[a]?r.a.createElement(L.a,{TransitionComponent:pe.a,title:"Breakthrough designation: Yes"},r.a.createElement(S.a,{alt:"Logo",src:Bn.a,className:t.CardTopLogosYes})):r.a.createElement(L.a,{TransitionComponent:pe.a,title:"Breakthrough designation: No"},r.a.createElement(S.a,{alt:"Logo",src:Bn.a,className:t.CardTopLogosNo}))}}))}(e)})))):r.a.createElement("div",null))}),Jn=a(103);var Kn=a(1916),Zn=function(e){var t=Pn();console.log("Admin story",e.studyDetailsRes);Array.from(e.studyDetailsRes);console.log("before converted to array",e.studyDetailsRes),console.log("converted to array",[]);var a=Object.keys(e.studyDetailsRes);console.log("study details data",a);for(var n=[],i=0;i<7;i++)n[i]=Object.keys(e.studyDetailsRes[a[i]]);console.log("study details data study 1",n);for(var o=[],l=[],c=[],s=0;s<7;s++)n[s].length>=1&&(o[s]=e.studyDetailsRes[a[s]][0].Study_1,n[s].includes("1")&&(l[s]=e.studyDetailsRes[a[s]][1].Study_2),n[s].includes("2")&&(c[s]=e.studyDetailsRes[a[s]][2].Study_3));console.log("study 1 res",o),console.log("study 2 res",l),console.log("study3 res",c);return r.a.createElement(C.a,{container:!0,justify:"center",alignItems:"center",item:!0,xs:12},e.studyDetailsRes?r.a.createElement("div",{className:t.StudyDetailsroot},r.a.createElement(Kn.a,{component:N.a,style:{width:"100%"}},r.a.createElement($a.a,{className:t.table,"aria-label":"simple table"},r.a.createElement(an.a,null,r.a.createElement(nn.a,{className:t.StudyDetailsheadingTR},r.a.createElement(tn.a,null," "),o&&o.length>=1&&r.a.createElement(tn.a,{className:t.StudyDetailsheadingTH},"Study 1"),l&&l.length>=1&&r.a.createElement(tn.a,{className:t.StudyDetailsheadingTH},"Study 2"),c&&c.length>=1&&r.a.createElement(tn.a,{className:t.StudyDetailsheadingTH},"Study 3"))),r.a.createElement(en.a,{className:t.SDBody},0!==e.studyDetailsRes.Primary_Endpoint.length?r.a.createElement(nn.a,{className:t.StudyDetailsRow},r.a.createElement(tn.a,{className:t.StudyDetailsheading1,component:"th",scope:"row"},"Primary Endpoint"),e.studyDetailsRes.Primary_Endpoint.map((function(a){return Object.keys(a).map((function(a,n){return"Study_1"===a?r.a.createElement(tn.a,{className:t.StudyDetailsheading},e.studyDetailsRes.Primary_Endpoint[0].Study_1):"Study_2"===a?r.a.createElement(tn.a,{className:t.StudyDetailsheading},e.studyDetailsRes.Primary_Endpoint[1].Study_2):"Study_3"===a?r.a.createElement(tn.a,{className:t.StudyDetailsheading},e.studyDetailsRes.Primary_Endpoint[2].Study_3):void 0}))}))):r.a.createElement(nn.a,null,r.a.createElement(tn.a,{className:t.StudyDetailsheading1,component:"th",scope:"row"},"Primary Endpoint"),o.length>=1&&r.a.createElement(tn.a,{className:t.StudyDetailsheading}),l.length>=1&&r.a.createElement(tn.a,{className:t.StudyDetailsheading}),c.length>=1&&r.a.createElement(tn.a,{className:t.StudyDetailsheading})),0!==e.studyDetailsRes.Secondary_Endpoint_1.length?r.a.createElement(nn.a,{className:t.StudyDetailsRow},r.a.createElement(tn.a,{className:t.StudyDetailsheading1,component:"th",scope:"row"},"Secondary Endpoint 1"),e.studyDetailsRes.Secondary_Endpoint_1.map((function(a){return Object.keys(a).map((function(a,n){return"Study_1"===a?r.a.createElement(tn.a,{className:t.StudyDetailsheading},e.studyDetailsRes.Secondary_Endpoint_1[0].Study_1):"Study_2"===a?r.a.createElement(tn.a,{className:t.StudyDetailsheading},e.studyDetailsRes.Secondary_Endpoint_1[1].Study_2):"Study_3"===a?r.a.createElement(tn.a,{className:t.StudyDetailsheading},e.studyDetailsRes.Secondary_Endpoint_1[2].Study_3):void 0}))}))):r.a.createElement(nn.a,{className:t.StudyDetailsRow},r.a.createElement(tn.a,{className:t.StudyDetailsheading1,component:"th",scope:"row"},"Secondary Endpoint 1"),o.length>=1&&r.a.createElement(tn.a,{className:t.StudyDetailsheading}),l.length>=1&&r.a.createElement(tn.a,{className:t.StudyDetailsheading}),c.length>=1&&r.a.createElement(tn.a,{className:t.StudyDetailsheading})),0!==e.studyDetailsRes.Secondary_Endpoint_2.length?r.a.createElement(nn.a,{className:t.StudyDetailsRow},r.a.createElement(tn.a,{className:t.StudyDetailsheading1,component:"th",scope:"row"},"Secondary Endpoint 2"),e.studyDetailsRes.Secondary_Endpoint_2.map((function(a){return Object.keys(a).map((function(a,n){return"Study_1"===a?r.a.createElement(tn.a,{className:t.StudyDetailsheading},e.studyDetailsRes.Secondary_Endpoint_2[0].Study_1):"Study_2"===a?r.a.createElement(tn.a,{className:t.StudyDetailsheading},e.studyDetailsRes.Secondary_Endpoint_2[1].Study_2):"Study_3"===a?r.a.createElement(tn.a,{className:t.StudyDetailsheading},e.studyDetailsRes.Secondary_Endpoint_2[2].Study_3):void 0}))}))):r.a.createElement(nn.a,{className:t.StudyDetailsRow},r.a.createElement(tn.a,{className:t.StudyDetailsheading1,component:"th",scope:"row"},"Secondary Endpoint 2"),o.length>=1&&r.a.createElement(tn.a,{className:t.StudyDetailsheading}),l.length>=1&&r.a.createElement(tn.a,{className:t.StudyDetailsheading}),c.length>=1&&r.a.createElement(tn.a,{className:t.StudyDetailsheading})),0!==e.studyDetailsRes.Study_Type.length?r.a.createElement(nn.a,{className:t.StudyDetailsRow},r.a.createElement(tn.a,{className:t.StudyDetailsheading1,component:"th",scope:"row"},"Study Type"),e.studyDetailsRes.Study_Type.map((function(a){return Object.keys(a).map((function(a,n){return"Study_1"===a?r.a.createElement(tn.a,{className:t.StudyDetailsheading},e.studyDetailsRes.Study_Type[0].Study_1):"Study_2"===a?r.a.createElement(tn.a,{className:t.StudyDetailsheading},e.studyDetailsRes.Study_Type[1].Study_2):"Study_3"===a?r.a.createElement(tn.a,{className:t.StudyDetailsheading},e.studyDetailsRes.Study_Type[2].Study_3):void 0}))}))):r.a.createElement(nn.a,{className:t.StudyDetailsRow},r.a.createElement(tn.a,{className:t.StudyDetailsheading1,component:"th",scope:"row"},"Study Type"),o.length>=1&&r.a.createElement(tn.a,{className:t.StudyDetailsheading}),l.length>=1&&r.a.createElement(tn.a,{className:t.StudyDetailsheading}),c.length>=1&&r.a.createElement(tn.a,{className:t.StudyDetailsheading})),0!==e.studyDetailsRes.Control.length?r.a.createElement(nn.a,{className:t.StudyDetailsRow},r.a.createElement(tn.a,{className:t.StudyDetailsheading1,component:"th",scope:"row"},"Control"),e.studyDetailsRes.Control.map((function(a){return Object.keys(a).map((function(a,n){return"Study_1"===a?r.a.createElement(tn.a,{className:t.StudyDetailsheading},e.studyDetailsRes.Control[0].Study_1):"Study_2"===a?r.a.createElement(tn.a,{className:t.StudyDetailsheading},e.studyDetailsRes.Control[1].Study_2):"Study_3"===a?r.a.createElement(tn.a,{className:t.StudyDetailsheading},e.studyDetailsRes.Control[2].Study_3):void 0}))}))):r.a.createElement(nn.a,{className:t.StudyDetailsRow},r.a.createElement(tn.a,{className:t.StudyDetailsheading1,component:"th",scope:"row"},"Control"),o.length>=1&&r.a.createElement(tn.a,{className:t.StudyDetailsheading}),l.length>=1&&r.a.createElement(tn.a,{className:t.StudyDetailsheading}),c.length>=1&&r.a.createElement(tn.a,{className:t.StudyDetailsheading})),0!==e.studyDetailsRes.Site.length?r.a.createElement(nn.a,{className:t.StudyDetailsRow},r.a.createElement(tn.a,{className:t.StudyDetailsheading1,component:"th",scope:"row"},"Site"),e.studyDetailsRes.Site.map((function(a){return Object.keys(a).map((function(a,n){return"Study_1"===a?r.a.createElement(tn.a,{className:t.StudyDetailsheading},e.studyDetailsRes.Site[0].Study_1):"Study_2"===a?r.a.createElement(tn.a,{className:t.StudyDetailsheading},e.studyDetailsRes.Site[1].Study_2):"Study_3"===a?r.a.createElement(tn.a,{className:t.StudyDetailsheading},e.studyDetailsRes.Site[2].Study_3):void 0}))}))):r.a.createElement(nn.a,{className:t.StudyDetailsRow},r.a.createElement(tn.a,{className:t.StudyDetailsheading1,component:"th",scope:"row"},"Site"),o.length>=1&&r.a.createElement(tn.a,{className:t.StudyDetailsheading}),l.length>=1&&r.a.createElement(tn.a,{className:t.StudyDetailsheading}),c.length>=1&&r.a.createElement(tn.a,{className:t.StudyDetailsheading})))))):r.a.createElement("div",null))},Xn=(a(1598),function(e){Pn();return console.log("Time of Approval",e.TimeForApprovalRes),r.a.createElement(C.a,null,r.a.createElement("h5",null,"Time for Approval (No. of days)"),e.TimeForApprovalRes&&"N/A"!=e.TimeForApprovalRes&&"NA"!=e.TimeForApprovalRes?r.a.createElement(Xa.a,{width:200,height:150,maxValue:e.TimeForApprovalRes>1095?e.TimeForApprovalRes:1095,value:e.TimeForApprovalRes,margin:{top:15,right:25,left:5,bottom:5},needleColor:"#000000",customSegmentStops:[0,365,730,e.TimeForApprovalRes>1095?e.TimeForApprovalRes:1095],segmentColors:["#66ff66"," #ffff66","\t#FF4500"]}):r.a.createElement("div",null,"Capture in Progress"))}),qn=(a(1058),function(e){Pn();console.log("no of patients",e.NoOfPatientsRes);var t=Object(n.useState)(!1),a=Object(d.a)(t,2),i=(a[0],a[1],["#0088FE","#00C49F","#FFBB28","#FF8042"]);return r.a.createElement(C.a,null,r.a.createElement("h5",{style:{margin:"unset"}},"Number Of Patients"),e.NoOfPatientsRes&&e.NoOfPatientsRes.length>0?r.a.createElement("div",{style:{paddingBottom:"75.25%",position:"relative",height:0}},r.a.createElement("div",{style:{position:"absolute",top:"0",left:"0",width:"100%",height:"100%"}},r.a.createElement(Jn.g,{width:"99%"},r.a.createElement(Jn.b,{data:e.NoOfPatientsRes,margin:{top:15,right:25,left:5,bottom:5},interval:{XAxis:0}},r.a.createElement(Jn.h,null),r.a.createElement(Jn.i,{dataKey:"title",tick:{fontSize:10}}),r.a.createElement(Jn.j,{tick:{fontSize:10},label:{value:"Sample size",angle:-90,fontSize:10},position:"insideLeft",style:{textAnchor:"end",margin:"10"},angle:-45,textAnchor:"middle"}),r.a.createElement(Jn.a,{dataKey:"value",fill:"#8884d8"},r.a.createElement(Jn.d,{dataKey:"value",tick:{fontSize:5}}),e.NoOfPatientsRes&&e.NoOfPatientsRes.map((function(e,t){return r.a.createElement(Jn.c,{key:"cell-".concat(t),fill:i[t%i.length]})}))))))):r.a.createElement("div",null))}),$n=a(42);var er=function(e){Pn();var t=Object(n.useState)(),a=Object(d.a)(t,2),i=(a[0],a[1]),o=Object(n.useState)(),l=Object(d.a)(o,2),m=l[0],u=l[1],p=Object(n.useState)(!0),g=Object(d.a)(p,2),h=g[0],T=g[1],f=["#0088FE","#00C49F","#FFBB28","#FF8042"];return Object(n.useEffect)((function(){function t(){return(t=Object(s.a)(c.a.mark((function t(){var a,n,r,o,l,s,d;return c.a.wrap((function(t){for(;;)switch(t.prev=t.next){case 0:try{a=e.data,n=Object(It.a)(new Set(e.studyDurationRes)),console.log(a),r=[],o=new Map,l=Object($n.a)(n);try{for(l.s();!(s=l.n()).done;)d=s.value,o.has(d.title)||(o.set(d.title,!0),r.push({title:d.title,value:d.value}))}catch(c){l.e(c)}finally{l.f()}u(r),i(a),T(!1)}catch(m){console.log(m)}case 1:case"end":return t.stop()}}),t)})))).apply(this,arguments)}!function(){t.apply(this,arguments)}()}),[e.data]),!0===h?r.a.createElement("div",null,r.a.createElement("h4",{style:{margin:"unset"}},"Study Summary")):r.a.createElement(C.a,null,r.a.createElement("h5",{style:{margin:"unset"}},"Study Duration"),e.studyDurationRes&&e.studyDurationRes.length>0?r.a.createElement("div",{style:{paddingBottom:"75.25%",position:"relative",height:0}},r.a.createElement("div",{style:{position:"absolute",top:"0",left:"0",width:"100%",height:"100%"}},r.a.createElement(Jn.g,{width:"99%"},r.a.createElement(Jn.b,{data:m&&m,margin:{top:15,right:25,left:5,bottom:5},interval:{XAxis:0}},r.a.createElement(Jn.h,null),r.a.createElement(Jn.i,{dataKey:"title",tick:{fontSize:10}}),r.a.createElement(Jn.j,{tick:{fontSize:10},label:{value:"Study Duration in weeks",angle:-90,fontSize:10},position:"insideLeft",style:{textAnchor:"end",margin:"10"},angle:-45,textAnchor:"middle"}),r.a.createElement(Jn.a,{dataKey:"value",fill:"#8884d8"},e.studyDurationRes&&e.studyDurationRes.map((function(e,t){return r.a.createElement(Jn.c,{key:"cell-".concat(t),fill:f[t%f.length]})}))))))):r.a.createElement("div",null))},tr=a(113),ar=a(198);function nr(e){console.log("application content print props",e);var t=Pn(),a=Object(n.useState)(),i=Object(d.a)(a,2),o=(i[0],i[1],Object(n.useState)(!0)),l=Object(d.a)(o,2),c=(l[0],l[1],r.a.useState([])),s=Object(d.a)(c,2),m=(s[0],s[1],Object(n.useState)()),u=Object(d.a)(m,2),p=(u[0],u[1],Object(n.useState)()),g=Object(d.a)(p,2),h=(g[0],g[1]),T=Object(n.useState)(),f=Object(d.a)(T,2),A=f[0],E=f[1],b=Object(n.useState)(),N=Object(d.a)(b,2),S=N[0],y=N[1],D=Object(n.useState)(),_=Object(d.a)(D,2),O=_[0],x=_[1],v=Object(n.useState)(),R=Object(d.a)(v,2),P=R[0],I=R[1],w=Object(n.useState)(),L=Object(d.a)(w,2),j=L[0],B=L[1],U=Object(n.useState)(),k=Object(d.a)(U,2),M=k[0],F=k[1],z=Object(n.useState)(),Y=Object(d.a)(z,2),V=Y[0],G=Y[1],H=Object(n.useState)(),W=Object(d.a)(H,2),Q=W[0],J=W[1],K=Object(n.useState)([]),Z=Object(d.a)(K,2),X=(Z[0],Z[1]),q=Object(n.useState)(!0),$=Object(d.a)(q,2);$[0],$[1];Object(n.useEffect)((function(){!function(){try{console.log("application cob",e.applicationContentData),X(e.applicationContentData.success[0]);var t;t=Object.keys(e.applicationContentData.success[0]),console.log("key",t),h(t);var a=e.applicationContentData.success[0][t];E(a);var n=e.applicationContentData.success[0][t]&&e.applicationContentData.success[0][t].Administrative_Summary&&e.applicationContentData.success[0][t].Administrative_Summary.Table_1;y(n);var r=e.applicationContentData.success[0][t]&&e.applicationContentData.success[0][t].Clinical&&e.applicationContentData.success[0][t].Clinical.Study_Details_Table_2;x(r);var i=e.applicationContentData.success[0][t];I(i);var o=e.applicationContentData.success[0][t]&&e.applicationContentData.success[0][t].Administrative_Summary&&e.applicationContentData.success[0][t].Administrative_Summary.Time_of_Approval_No_of_days_Time_Chart_1;B(o);var l=e.applicationContentData.success[0][t]&&e.applicationContentData.success[0][t].Clinical&&e.applicationContentData.success[0][t].Clinical.No_of_Patients_Bar_Graph_1;F(l);var c=e.applicationContentData.success[0][t]&&e.applicationContentData.success[0][t].Clinical&&e.applicationContentData.success[0][t].Clinical.Study_Duration_Bar_Graph_2;G(c),console.log("data ApplicationContentRes",a);var s=e.applicationContentData.success[0][t].Administrative_Summary.Table_1;J(s)}catch(d){console.log(d)}}()}),[e]),console.log("application res",A);var ee={y:0,w:6,h:5},te={y:5,w:6,h:7},ae={x:6,w:6,h:12},ne={y:0,w:3,h:1},re={y:1,w:3,h:7},ie={y:0,x:3,w:3,h:8},oe={y:0,x:0,w:6,h:7},le={y:7,w:3,h:5},ce={y:7,x:3,w:3,h:5};return r.a.createElement(C.a,null,A?r.a.createElement(C.a,{container:!0,className:t.root},r.a.createElement("div",{style:{height:"100vh",width:"100%"}},r.a.createElement(ar.a,{columns:12,rows:12,gap:10,rowsHeight:{0:"40px"}},r.a.createElement(ar.a.Item,ee,r.a.createElement("div",{style:{height:"100%",border:"0.5px solid #b1bbe4",padding:"5px"}},r.a.createElement("h4",{style:{textAlign:"left",margin:"3px",color:"#0352CC",fontWeight:"900"}},"Administrative Summary"),r.a.createElement(ar.a,{columns:6,rows:2,gap:10,rowsHeight:{0:"40px"}},r.a.createElement(ar.a.Item,ne,r.a.createElement("div",{style:{padding:5,backgroundColor:"#f7fbff",height:"100%"}},console.log("Admin story res",S),S?r.a.createElement(Qn,{AdminStoryRes:S}):r.a.createElement("div",null))),r.a.createElement(ar.a.Item,re,r.a.createElement("div",{style:{padding:5,backgroundColor:"#f7fbff",height:"85%",fontSize:"1.7vh",fontWeight:"700",display:"flex",justifyContent:"center",alignItems:"center"}},Q?r.a.createElement(C.a,{container:!0,className:t.adminSummaryRowLast,style:{minHeight:"130px",margin:"auto",padding:"10px",alignItems:"center"}},r.a.createElement(C.a,{container:!0,item:!0,xs:6,className:t.adminSummaryHeader1},"CDER Division"),r.a.createElement(C.a,{container:!0,className:t.adminSummaryValue1,item:!0,xs:6},Q.map((function(e){return function(e){return Object.keys(e).map((function(a,n){if("CDER_Division"==a)return r.a.createElement(C.a,{container:!0,item:!0,xs:6,className:t.adminSummaryValue2},e[a])}))}(e)})))):r.a.createElement(C.a,{container:!0,className:t.adminSummaryRowLast,spacing:3,style:{minHeight:"130px",margin:"auto",padding:"10px"}},"Capture in Progress"))),r.a.createElement(ar.a.Item,ie,r.a.createElement("div",{style:{padding:5,backgroundColor:"#f7fbff",height:"88%"}},j?r.a.createElement(Xn,{TimeForApprovalRes:j}):r.a.createElement("div",null,"Capture in Progress")))))),r.a.createElement(ar.a.Item,te,r.a.createElement("div",{style:{height:"100%",border:"0.5px solid #b1bbe4"}},r.a.createElement("h4",{style:{textAlign:"left",margin:"3px",color:"#0352CC",fontWeight:"900"}},"Submission Summary"),r.a.createElement("div",{style:{padding:5,height:"92%",backgroundColor:"#f7fbff"}},P?r.a.createElement(In,{AdminSumRes:P}):r.a.createElement("div",null,"Capture in Progress")))),r.a.createElement(ar.a.Item,ae,r.a.createElement("div",{style:{height:"100%",border:"0.5px solid #b1bbe4",padding:"5px"}},r.a.createElement("h4",{style:{textAlign:"left",margin:"3px",color:"#0352CC",fontWeight:"900"}},"Clinical Studies Summary"),r.a.createElement(ar.a,{columns:6,rows:12,gap:10,rowsHeight:{0:"40px"}},r.a.createElement(ar.a.Item,oe,r.a.createElement("div",{style:{padding:10,backgroundColor:"#f7fbff",height:"100%",overflowY:"auto"}},O?r.a.createElement(Zn,{studyDetailsRes:O}):r.a.createElement("div",null,"Capture in Progress"))),r.a.createElement(ar.a.Item,le,r.a.createElement("div",{style:{height:"90%",backgroundColor:"#f7fbff"}},M?r.a.createElement(qn,{NoOfPatientsRes:M}):r.a.createElement("div",null,"Capture in Progress"))),r.a.createElement(ar.a.Item,ce,r.a.createElement("div",{style:{height:"90%",backgroundColor:"#f7fbff"}},V?r.a.createElement(er,{studyDurationRes:V}):r.a.createElement("div",null," Capture in Progress"))))))))):r.a.createElement(C.a,null,r.a.createElement("h4",null,"Capture in Progress")))}var rr=function(e){var t=e.data,a=Rn();return r.a.createElement(n.Fragment,null,r.a.createElement(R.a,{display:"flex",flexDirection:"column",className:a.cardDetails},r.a.createElement(N.a,{elevation:0,className:a.paper},r.a.createElement(y.a,{variant:"h3"},"Application content for : ",r.a.createElement("span",{className:a.highlightText},t.source,"/",t.category,"/",t.searchTerm," - ",t.tradeName)),r.a.createElement(nr,{applicationContentData:t}))))},ir=Object(f.a)((function(e){return{graphs:{marginTop:e.spacing(40)},paper:{borderRadius:e.spacing(3),paddingBottom:e.spacing(5),height:"60vh",width:"100%"},bar:{width:"100%"},highlightText:{opacity:.6,fontWeight:"bold",textTransform:"uppercase"}}})),or=function(e){var t=e.keys,a=e.index,i=e.data,o=e.margin,l=e.colors;return r.a.createElement(n.Fragment,null,r.a.createElement(Gt.a,{data:i&&i,enableGridY:!1,keys:t,indexBy:a,margin:o||{top:30,right:50,bottom:50,left:30},padding:.1,valueScale:{type:"linear"},indexScale:{type:"band",round:!0},colors:l||["#0E5A94","#318AC8","#008B8B","#3AB09E","#48E0A6","#1C2D59","#20A1C7"],colorBy:"index",borderRadius:2,theme:{axis:{fontSize:"14px",tickColor:"#000",ticks:{line:{stroke:"#555555"},text:{fill:"#1FBDCA",fontWeight:"bold"}}}},axisTop:null,axisRight:null,axisBottom:{tickSize:0,tickPadding:5,tickRotation:90,legend:"",legendPosition:"middle",legendOffset:0},axisLeft:{tickSize:0,tickPadding:5,tickRotation:0,legend:"",legendPosition:"middle",legendOffset:0},enableLabel:!1,labelSkipWidth:12,labelSkipHeight:12,labelTextColor:["#fff"],animate:!0,motionStiffness:90,motionDamping:15}))},lr=function(e){var t=e.data,a=ir();return r.a.createElement(n.Fragment,null,r.a.createElement(R.a,{display:"flex",flexDirection:"column",className:a.graphs},r.a.createElement(N.a,{elevation:0,className:a.paper},r.a.createElement(y.a,{variant:"h3"},t.title),r.a.createElement(y.a,{variant:"h3"},t.searchTerm),r.a.createElement(y.a,{variant:"h3"},t.subtitle),r.a.createElement(or,{keys:t.keys,index:t.index,colors:t.color?[t.color]:null,data:t&&t.graph,className:a.bar}))))},cr=Object(f.a)((function(e){return{root:{marginTop:e.spacing(30)},graph:{height:"100%"},container:{height:"60vh",paddingTop:e.spacing(3),width:"25%"},text:{marginTop:e.spacing(5),color:e.palette.biologics.pieText,fontSize:e.spacing(2),marginLeft:e.spacing(2)}}})),sr=Object(f.a)((function(e){return{root:{height:"100%"}}})),dr=function(e){var t=e.data,a=e.margin,i=sr();return r.a.createElement(n.Fragment,null,r.a.createElement(Wt.a,{className:i.root,data:t,margin:a||{top:40,right:40,bottom:20,left:30},innerRadius:.2,padAngle:.7,cornerRadius:0,startAngle:-50,colors:["#48E0A6","#0A467C","#008B8B","#318AC8"],sliceLabel:function(e){return e.value},borderWidth:1,borderColor:{from:"color",modifiers:[["darker",.2]]},radialLabelsLinkOffset:-10,radialLabelsLinkDiagonalLength:20,radialLabelsLinkHorizontalLength:10,radialLabelsSkipAngle:10,radialLabelsTextColor:"#1FBDCA",radialLabelsLinkColor:{from:"color"},sliceLabelsSkipAngle:10,sliceLabelsTextColor:"#fff",theme:{axis:{fontSize:"14px",tickColor:"#000",ticks:{line:{stroke:"#555555"},text:{fill:"#1FBDCA",fontWeight:"bold"}}}}}))},mr=function(e){var t=e.data,a=cr();return r.a.createElement(R.a,{className:a.root},r.a.createElement(y.a,{variant:"h3"},"Biologics"),r.a.createElement(y.a,{variant:"h3"},"Immunogenicity - Reporting status of immunogenicity data components (reported vs non reported)"),r.a.createElement(C.a,{container:!0,spacing:3,lg:12},t?t&&t.map((function(e){return r.a.createElement(C.a,{item:!0,lg:4,className:a.container},r.a.createElement(y.a,{className:a.text},e[0].label),r.a.createElement(dr,{className:a.graph,data:e,margin:{top:20,right:50,bottom:0,left:50}}))})):null))},ur=a(1127),pr=a(1166),gr=a(822),hr=a(308),Tr=a.n(hr),fr=Object(f.a)((function(e){var t,a;return{networkDiagram:{margin:"25px 0px",backgroundColor:"white",padding:"20px 10px",display:"flex",alignItems:"center",justifyContent:"center",height:"100%"},ParentNode:{fontSize:"2vh"},ndaNode:{fontSize:"1.5vh",fontWeight:"900",paddingTop:"12px",paddingRight:"12px",paddingLeft:"12px",paddingBottom:"6px"},Node:{fontSize:"1.5vh",fontWeight:"600",color:"black",paddingRight:"10px",paddingLeft:"10px",paddingBottom:"6px"},NodeCompare:(t={fontSize:"1.5vh",fontWeight:"600",color:"black",paddingRight:"10px",paddingLeft:"10px",paddingBottom:"6px",background:e.palette.biologics.gradient},Object(g.a)(t,"color","white"),Object(g.a)(t,"borderRadius","13px"),Object(g.a)(t,"paddingTop","6px"),Object(g.a)(t,"boxShadow","0 0 4px rgb(220, 220, 220, 0.5)"),t),NodeValue:{color:"#0352cc",fontSize:"1.5vh",fontWeight:"600",padding:"0 5px"},LabelTitle:{color:"#1C7D5D",fontWeight:"800",padding:"20px 0px 0px",fontSize:"3.5vh",fontFamily:"Constantia"},Label:{fontSize:"16px",textAlign:"left",fontWeight:"600"},".MuiDialogTitle-root":{padding:"0 24px"},node:{"&::after":{content:"",position:"absolute",top:"0px",height:"var(--tree-line-height)",boxSizing:"border-box",left:"50%",width:"0px"}},StyledErrorTypography:{fontSize:"2vh",padding:"15px",color:e.palette.black,borderRadius:"10px",backgroundColor:e.palette.primary.lightBorder,fontWeight:"700"},dialog:{height:"inherit",width:"inherit",backgroundImage:"url(".concat(Tr.a,")"),backgroundRepeat:"no-repeat",backgroundPosition:"center",backgroundSize:"cover",backgroundAttachment:"fixed"},selectLabelC:{background:"#33B187",color:"white",borderRadius:"10px 10px 0px 0px",marginBottom:"auto",fontSize:"2.3vh",padding:"13px 10px"},selectLabel:{background:"#33B187",color:"white",padding:"13px 10px",borderRadius:"10px 10px 0px 0px",marginBottom:"auto",fontSize:"2.3vh"},compareL:(a={height:"30px",margin:"5px",padding:"3px 20px",borderRadius:"13px",fontSize:"1.7vh",fontWeight:"bold",border:"2px solid #e3f1ff",boxShadow:"0 0 4px rgb(220, 220, 220,0.5)"},Object(g.a)(a,"borderRadius","20px"),Object(g.a)(a,"backgroundColor","#119E8A"),Object(g.a)(a,"color","#FFFFFF"),Object(g.a)(a,"cursor","pointer"),Object(g.a)(a,"margin","0 auto"),Object(g.a)(a,"display","flex"),Object(g.a)(a,"width","fit-content"),a),labelTitle:{fontSize:"1.4vh",fontWeight:500,paddingLeft:"5px",margin:"auto"},Dialog:{display:"flex",justifyContent:"center",alignItems:"center"}}})),Ar=a(247),Er=a.n(Ar),br=(a(1638),a(215)),Nr=a.n(br),Cr=a(255),Sr=a.n(Cr);function yr(){var e=Object(ur.a)(["\n    padding: 3vh;\n    border-radius: 8px;\n    display: inline-block;\n    cursor: pointer;\n    cursor: pointer;\n    color: #0352cc;\n    margin: 10px;\n    background-color: #f7fbff;\n    border-radius: 20px;\n    box-shadow: 0 0 4px rgb(220, 220, 220, 0.5);\n  "]);return yr=function(){return e},e}var Dr=function(e){var t=fr(),i=Object(n.useState)(""),o=Object(d.a)(i,2),l=o[0],m=o[1],u=Object(n.useState)(!1),p=Object(d.a)(u,2),g=(p[0],p[1]),h=Object(n.useState)(!1,{}),T=Object(d.a)(h,2),f=T[0],A=T[1],E=Object(n.useState)(),b=Object(d.a)(E,2),N=b[0],S=b[1],D=Object(n.useState)(),_=Object(d.a)(D,2),O=_[0],x=_[1],v=Object(n.useState)(),R=Object(d.a)(v,2),P=R[0],I=R[1],w=Object(n.useState)(),L=Object(d.a)(w,2),B=L[0],F=L[1],z=Object(n.useState)(!1),Y=Object(d.a)(z,2),V=Y[0],G=Y[1],H=Object(n.useState)(!1),W=Object(d.a)(H,2),Q=W[0],J=W[1],K=Object(n.useState)(),Z=Object(d.a)(K,2),X=(Z[0],Z[1],Object(n.useState)(!1,{})),q=Object(d.a)(X,2);q[0],q[1],Object(n.useEffect)((function(){var t=e.timeLinePageData.data.success.network_diagram;x(""),I("");for(var a=0;a<t.length;a++)"p"===t[a].flag&&x(t[a]),"c"===t[a].flag&&I(t[a]);m(t),ee()}),[e]);var $=pr.a.div(yr()),ee=function(){for(var e=0;e<l.length;e++)"p"===e.flag&&g(!0)},te=function(){var e=Object(s.a)(c.a.mark((function e(t){var n,r,i,o;return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:return G(!0),F(t),n={parent_object:O.nda,child_object:t},r=a(86).Base64,"developers:>;JQwa[zL!EX+f{?3{fjnK",i=r.encode("developers:>;JQwa[zL!EX+f{?3{fjnK"),"Basic "+i,e.next=9,Le(n).then((function(e){o=e})).catch((function(e){console.log(e)}));case 9:null!==o.data.success?(A([!0,{}]),S(o.data.success),J(!1)):(A([!1,{}]),ra.b.error(o.data.error),J(!0)),G(!1);case 11:case"end":return e.stop()}}),e)})));return function(t){return e.apply(this,arguments)}}();return r.a.createElement("div",null,""===P||""===O?r.a.createElement(y.a,{className:t.StyledErrorTypography},"No RLD Information data available"):r.a.createElement("div",null,l?r.a.createElement("div",{className:t.networkDiagram},l.map((function(a){return"p"===a.flag?r.a.createElement(gr.a,{className:t.ParentNode,lineWidth:"2px",lineColor:"grey",lineBorderRadius:"10px",label:r.a.createElement($,null,r.a.createElement("div",{className:t.ndaNode},a.nda),r.a.createElement("div",{className:t.Node},a.manufacturer,"|",a.approval_date),r.a.createElement("div",{className:t.Node},a.formulation_route),r.a.createElement("div",{className:t.Node},"Marketing Status: ",a.marketingstatus))},l.map((function(a){return"c"===a.flag?r.a.createElement(gr.b,{label:r.a.createElement($,{value:a.nda},r.a.createElement("div",{className:t.ndaNode,onClick:function(){return e.handleNetworkChild(a.nda)}}," ",a.nda),r.a.createElement("div",{className:t.Node},a.manufacturer,"|",a.approval_date),r.a.createElement("div",{className:t.Node},a.formulation_route),r.a.createElement("div",{className:t.Node},"Marketing Status: ",a.marketingstatus),r.a.createElement("div",{onClick:function(){return te(a.nda)},className:t.compareL},r.a.createElement("img",{style:{width:"15px"},src:Nr.a}),r.a.createElement(y.a,{className:t.labelTitle},"Compare Labels")))}):r.a.createElement("div",null)}))):r.a.createElement("div",null)}))):r.a.createElement("div",{className:t.networkDiagram},"No data to display")),r.a.createElement(U.a,{fullWidth:!0,maxWidth:"lg",onClose:function(){A([!1,{}])},"aria-labelledby":"customized-dialog-title",open:void 0!==f[0]&&f[0],classes:{paper:t.dialog}},r.a.createElement(M.a,{style:{padding:"0 24px"}},r.a.createElement(C.a,{container:!0},r.a.createElement(C.a,{container:!0,item:!0,xs:11,justify:"center",alignItems:"center",className:t.LabelTitle},r.a.createElement("img",{style:{width:"33px",paddingRight:"10px"},src:Nr.a}),"LABEL COMPARISON"),r.a.createElement(C.a,{container:!0,item:!0,xs:1,justify:"flex-end",alignItems:"center"},r.a.createElement(j.a,{"aria-label":"delete",className:t.ModalCloseIconButton,onClick:function(){A([!1,{}])}},r.a.createElement(Er.a,{className:t.ModalCloseIcon})))),r.a.createElement(C.a,{container:!0,item:!0,xs:12,justify:"center",alignItems:"center"})),r.a.createElement(k.a,{className:t.Dialog},r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"center",item:!0},r.a.createElement(C.a,{container:!0,item:!0,xs:12,justify:"center",alignItems:"center"},r.a.createElement(C.a,{container:!0,item:!0,xs:5,justify:"center",alignItems:"center",className:t.Label},r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"center",item:!0,className:t.selectLabelC},O&&O.nda)),r.a.createElement(C.a,{container:!0,item:!0,xs:1,justify:"center",alignItems:"center"},r.a.createElement("span",{style:{borderTop:"1px solid #a2a2a2",width:"100%",marginBottom:"-30%"}}),r.a.createElement("img",{style:{width:"28px"},src:Sr.a})),r.a.createElement(C.a,{container:!0,item:!0,xs:5,justify:"center",alignItems:"center",className:t.Label},r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"center",item:!0,className:t.selectLabel}," ",B&&B))),r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"flex-start",item:!0},r.a.createElement("div",{style:{height:"70vh",width:"100vw"}},V?r.a.createElement(tr.SemipolarLoading,{color:"#0352CC"}):!Q&&N?r.a.createElement("iframe",{style:{height:"100%",width:"100%"},src:N,allowFullScreen:!0}):r.a.createElement("div",{style:{display:"flex",justifyContent:"center",alignItems:"center",height:"100%"}},r.a.createElement(y.a,{className:t.StyledErrorTypography},"Sorry , we couldn't find any comparision to"," ",O&&O.nda," and ",B," label. Please try other document."))))))))},_r=function(e){var t=e.data,a=Rn();return r.a.createElement(n.Fragment,null,r.a.createElement(R.a,{display:"flex",flexDirection:"column",className:a.cardDetails},r.a.createElement(N.a,{elevation:0,className:a.paper},r.a.createElement(y.a,{variant:"h3"},"RLD Information for : ",r.a.createElement("span",{className:a.highlightText},t.source,"/",t.category,"/",t.searchTerm," - ",t.tradeName)),r.a.createElement(Dr,{timeLinePageData:t}))))},Or=a(239),xr=a.n(Or),vr=a(1060),Rr=Object(f.a)((function(e){return{root:{marginTop:e.spacing(2)},box:{width:"100%",height:"100%"},legendRoot:{width:"70%"},headings:{color:e.palette.biologics.textPrimary,fontWeight:"bold",fontSize:e.spacing(2)},legend:{color:e.palette.biologics.label,fontSize:e.spacing(2)},value:{color:e.palette.biologics.label,fontWeight:"bold",fontSize:e.spacing(2)},add:{fontSize:e.spacing(1.87),color:e.palette.navbar.button,cursor:"pointer"}}})),Pr=function(e){var t=e.data,a=Rr(),i=xr()((function(e){return{root:{width:"70%",height:e.spacing(1.5),borderRadius:e.spacing(2)},colorPrimary:{},bar:{borderRadius:e.spacing(2),background:e.palette.biologics.gradient}}}))(vr.a);return r.a.createElement(n.Fragment,null,r.a.createElement(C.a,{container:!0},r.a.createElement(C.a,{item:!0,lg:3},r.a.createElement(R.a,{py:1,display:"flex",flexDirection:"column",className:a.box},r.a.createElement(y.a,{className:a.headings,align:"left"},"Accelerated Approvals"),r.a.createElement(R.a,{mt:2,display:"flex",flexDirection:"row",justifyContent:"space-between",className:a.legendRoot},r.a.createElement(y.a,{className:a.legend},"Yes"),r.a.createElement(y.a,{className:a.legend},"No")),r.a.createElement(i,{value:t&&t.acceleratedApproval.yes,variant:"determinate"}),r.a.createElement(R.a,{display:"flex",flexDirection:"row",justifyContent:"space-between",className:a.legendRoot},r.a.createElement(y.a,{className:a.value},t&&t.acceleratedApproval.yes,"%"),r.a.createElement(y.a,{className:a.value},t&&t.acceleratedApproval.no,"%")))),r.a.createElement(C.a,{item:!0,lg:3},r.a.createElement(R.a,{py:1,display:"flex",flexDirection:"column",className:a.box},r.a.createElement(y.a,{className:a.headings,align:"left"},"Breakthrough Designation"),r.a.createElement(R.a,{mt:2,display:"flex",flexDirection:"row",justifyContent:"space-between",className:a.legendRoot},r.a.createElement(y.a,{className:a.legend},"Yes"),r.a.createElement(y.a,{className:a.legend},"No")),r.a.createElement(i,{value:t&&t.breakthroughDesignation.yes,variant:"determinate"}),r.a.createElement(R.a,{display:"flex",flexDirection:"row",justifyContent:"space-between",className:a.legendRoot},r.a.createElement(y.a,{className:a.value},t&&t.breakthroughDesignation.yes,"%"),r.a.createElement(y.a,{className:a.value},t&&t.breakthroughDesignation.no,"%")))),r.a.createElement(C.a,{item:!0,lg:3},r.a.createElement(R.a,{py:1,display:"flex",flexDirection:"column",className:a.box},r.a.createElement(y.a,{className:a.headings,align:"left"},"Fast Track"),r.a.createElement(R.a,{mt:2,display:"flex",flexDirection:"row",justifyContent:"space-between",className:a.legendRoot},r.a.createElement(y.a,{className:a.legend},"Yes"),r.a.createElement(y.a,{className:a.legend},"No")),r.a.createElement(i,{value:t&&t.fasttrack.yes,variant:"determinate"}),r.a.createElement(R.a,{display:"flex",flexDirection:"row",justifyContent:"space-between",className:a.legendRoot},r.a.createElement(y.a,{className:a.value},t&&t.fasttrack.yes,"%"),r.a.createElement(y.a,{className:a.value},t&&t.fasttrack.no,"%")))),r.a.createElement(C.a,{item:!0,lg:3},r.a.createElement(R.a,{py:1,display:"flex",flexDirection:"column",className:a.box},r.a.createElement(y.a,{className:a.headings,align:"left"},"Orphan Designation"),r.a.createElement(R.a,{mt:2,display:"flex",flexDirection:"row",justifyContent:"space-between",className:a.legendRoot},r.a.createElement(y.a,{className:a.legend},"Yes"),r.a.createElement(y.a,{className:a.legend},"No")),r.a.createElement(i,{value:t&&t.orphanStatus.yes,variant:"determinate"}),r.a.createElement(R.a,{display:"flex",flexDirection:"row",justifyContent:"space-between",className:a.legendRoot},r.a.createElement(y.a,{className:a.value},t&&t.orphanStatus.yes,"%"),r.a.createElement(y.a,{className:a.value},t&&t.orphanStatus.no,"%"))))))},Ir=Object(f.a)((function(e){return{root:{marginTop:e.spacing(2)},box:{width:"100%",height:"100%"},legendRoot:{width:"70%"},headings:{color:e.palette.biologics.textPrimary,fontWeight:"bold",fontSize:e.spacing(2)},legend:{color:e.palette.biologics.label,fontSize:e.spacing(2)},value:{color:e.palette.biologics.label,fontWeight:"bold",fontSize:e.spacing(2)},add:{fontSize:e.spacing(1.87),color:e.palette.navbar.button,cursor:"pointer"}}})),wr=function(e){var t=e.data,a=Ir(),i=xr()((function(e){return{root:{width:"70%",height:e.spacing(1.5),borderRadius:e.spacing(2)},colorPrimary:{},bar:{borderRadius:e.spacing(2),background:e.palette.biologics.gradient}}}))(vr.a);return r.a.createElement(n.Fragment,null,r.a.createElement(C.a,{container:!0},r.a.createElement(C.a,{item:!0,lg:3},r.a.createElement(R.a,{py:1,display:"flex",flexDirection:"column",className:a.box},r.a.createElement(y.a,{className:a.headings,align:"left"},"Accelerated Approvals"),r.a.createElement(R.a,{mt:2,display:"flex",flexDirection:"row",justifyContent:"space-between",className:a.legendRoot},r.a.createElement(y.a,{className:a.legend},"Yes"),r.a.createElement(y.a,{className:a.legend},"No")),r.a.createElement(i,{value:t&&t.acceleratedApproval.Yes,variant:"determinate"}),r.a.createElement(R.a,{display:"flex",flexDirection:"row",justifyContent:"space-between",className:a.legendRoot},r.a.createElement(y.a,{className:a.value},t&&t.acceleratedApproval.Yes,"%"),r.a.createElement(y.a,{className:a.value},t&&t.acceleratedApproval.No,"%")))),r.a.createElement(C.a,{item:!0,lg:3},r.a.createElement(R.a,{py:1,display:"flex",flexDirection:"column",className:a.box},r.a.createElement(y.a,{className:a.headings,align:"left"},"Breakthrough Designation"),r.a.createElement(R.a,{mt:2,display:"flex",flexDirection:"row",justifyContent:"space-between",className:a.legendRoot},r.a.createElement(y.a,{className:a.legend},"Yes"),r.a.createElement(y.a,{className:a.legend},"No")),r.a.createElement(i,{value:t&&t.breakthroughDesignation.Yes,variant:"determinate"}),r.a.createElement(R.a,{display:"flex",flexDirection:"row",justifyContent:"space-between",className:a.legendRoot},r.a.createElement(y.a,{className:a.value},t&&t.breakthroughDesignation.Yes,"%"),r.a.createElement(y.a,{className:a.value},t&&t.breakthroughDesignation.No,"%")))),r.a.createElement(C.a,{item:!0,lg:3},r.a.createElement(R.a,{py:1,display:"flex",flexDirection:"column",className:a.box},r.a.createElement(y.a,{className:a.headings,align:"left"},"Fast Track"),r.a.createElement(R.a,{mt:2,display:"flex",flexDirection:"row",justifyContent:"space-between",className:a.legendRoot},r.a.createElement(y.a,{className:a.legend},"Yes"),r.a.createElement(y.a,{className:a.legend},"No")),r.a.createElement(i,{value:t&&t.fasttrack.Yes,variant:"determinate"}),r.a.createElement(R.a,{display:"flex",flexDirection:"row",justifyContent:"space-between",className:a.legendRoot},r.a.createElement(y.a,{className:a.value},t&&t.fasttrack.Yes,"%"),r.a.createElement(y.a,{className:a.value},t&&t.fasttrack.No,"%"))))))},Lr=a(1917),jr=Object(f.a)((function(e){return{headings:{color:e.palette.biologics.textPrimary,fontWeight:"bold",fontSize:e.spacing(2)},graph:{display:"grid"},paper:{width:"100%"},circle:{gridRow:1,gridColumn:1,display:"grid",alignItems:"center",height:"200px",width:"200px"},bar:{gridRow:1,gridColumn:1,margin:"0 auto",zIndex:1},track:{gridRow:1,gridColumn:1,margin:"0 auto",color:e.palette.action.hover},text:{color:e.palette.biologics.radialGraphText,fontSize:e.spacing(2),marginLeft:e.spacing(2)},note:{color:e.palette.biologics.textSecondary,fontWeight:"medium",fontSize:e.spacing(2)},add:{fontSize:e.spacing(1.87),color:e.palette.navbar.button,cursor:"pointer"}}})),Br=function(e){var t=e.data,a=jr(),i=[200,160,120,80,40];return r.a.createElement(n.Fragment,null,r.a.createElement(R.a,{mt:1,display:"flex",flexDirection:"row",justifyContent:"space-evenly"},r.a.createElement(R.a,{className:a.graph},t?t&&t.map((function(e,t){return r.a.createElement(R.a,{key:t,className:a.circle},r.a.createElement(za.a,{size:i[t],value:e.value,thickness:2+t,variant:"static",color:"primary",style:{color:e.color},className:a.bar}),r.a.createElement(za.a,{size:i[t],value:100,thickness:2+t,variant:"determinate",className:a.track}))})):r.a.createElement(Lr.a,{variant:"circle",width:200,height:200})),r.a.createElement(R.a,{display:"flex",flexDirection:"column"},t?t&&t.map((function(e){return r.a.createElement(R.a,{mt:1,display:"flex",flexDirection:"row"},r.a.createElement(he.a,{fontSize:"small",className:a.icon,style:{color:e.color}}),r.a.createElement(y.a,{align:"left",className:a.text},e.value,"% \u2002 ",e.id))})):r.a.createElement(r.a.Fragment,null,r.a.createElement(Lr.a,{variant:"text",width:200}),r.a.createElement(Lr.a,{variant:"text",width:200}),r.a.createElement(Lr.a,{variant:"text",width:200}),r.a.createElement(Lr.a,{variant:"text",width:200}),r.a.createElement(Lr.a,{variant:"text",width:200})))))},Ur=Object(f.a)((function(e){return{main:{height:"100%",width:"100%"},GridTitle:{color:e.palette.black,textAlign:"left",fontSize:e.spacing(2),fontWeight:"bold"},GridContentBox:{height:"90%",width:"100%"},GraphImage:{width:"300px",height:"auto"},graphInnerGrid:{height:"100%",width:"100%",boxShadow:"none",borderRadius:0},graphInnerTitleGrid:{height:"5%",width:"100%",boxShadow:"none",borderRadius:0},graphInnergChartGrid:{height:"90%",width:"100%",boxShadow:"none",borderRadius:0},graphInnerMessageGrid:{height:"5%",width:"100%",boxShadow:"none",borderRadius:0},graphInnerMessage:{fontSize:"1.5vh",fontWeight:"500",color:e.palette.black,padding:"5px"},graphInnerTitle:{fontSize:"1.8vh",fontWeight:"700",color:e.palette.primary.main,padding:"5px",marginTop:"-2vh"},chart:{height:"96%",width:"100%",boxShadow:"none",borderRadius:0},paper:{height:"100%",width:"100%"},Dropdown:{width:"100%"},DropdownButton:{paddingLeft:"15px",width:"100%",marginTop:"1rem",marginBottom:"1rem",borderRadius:"15px",fontWeight:"400",textAlign:"left",textTransform:"none",backgroundColor:e.palette.primary.lightBorder,color:e.palette.black},DropdownButtonClosed:{paddingLeft:"15px",marginTop:"1rem",width:"100%",borderRadius:"15px",fontWeight:"400",textAlign:"left",textTransform:"none",backgroundColor:"#0E83DC",color:e.palette.white},expand:{color:e.palette.white,transform:"rotate(0deg)",transition:e.transitions.create("transform",{duration:e.transitions.duration.shortest})},expandClose:{color:e.palette.black,transform:"rotate(180deg)"},graphContainer:{width:"100%",height:"40vh",color:"#1FBDCA"},graphBox:{width:"100%"},apptype:{width:"100%",border:"1px solid #ccc",borderRadius:"5vh",height:"8vh",display:"flex",margin:"2.5vh 0"},percentage:{color:"#182B7F",fontWeight:"bold",margin:"0 8px"},type:{color:"#0E83DC",fontWeight:"800"},details:{display:"flex",width:"100%",margin:"13px 5px 0 5px"},paperContainer:{width:"100%",padding:"10px",margin:"0px 10px",paddingTop:"unset"},graphTitle:{padding:"0px 5px 15px",color:"#6D7D8A",fontWeight:"400",fontSize:"2vh"},cards:{width:"100%",padding:"15px 35px",height:"100%"},cardContent:{height:"100%"},paperCards:Object(g.a)({height:"inherit",width:"inherit",borderRadius:e.spacing(1.5)},"height","20vh"),number:{fontSize:e.spacing(3.5),color:e.palette.biologics.textPrimary,fontWeight:"bold"},cardText:{fontSize:"13px",color:e.palette.biologics.textSecondary}}})),kr=(a(1658),a(1674),a(256)),Mr=a.n(kr),Fr=a(644),zr=a.n(Fr);function Yr(e){var t,a,i=Ur(),o=Object(n.useState)(),l=Object(d.a)(o,2),m=(l[0],l[1],Object(n.useState)()),u=Object(d.a)(m,2),p=(u[0],u[1],Object(n.useState)()),h=Object(d.a)(p,2),T=(h[0],h[1],Object(n.useState)()),f=Object(d.a)(T,2),A=f[0],E=f[1],b=Object(n.useState)(),S=Object(d.a)(b,2),D=(S[0],S[1],Object(n.useState)()),_=Object(d.a)(D,2),O=(_[0],_[1],Object(n.useState)()),x=Object(d.a)(O,2),v=(x[0],x[1],function(e){return"".concat(Number(e).toFixed(0))}),P=Object(n.useState)(),I=Object(d.a)(P,2),w=I[0],L=I[1],j=Object(n.useState)(),B=Object(d.a)(j,2),U=B[0],k=B[1],M=Object(n.useState)(),F=Object(d.a)(M,2),z=F[0],Y=F[1],V=Object(n.useState)(),G=Object(d.a)(V,2),H=G[0],W=G[1],Q=Object(n.useState)(),J=Object(d.a)(Q,2),K=J[0],Z=J[1],X=Object(n.useState)(),q=Object(d.a)(X,2),$=q[0],ee=q[1],te=Object(n.useState)(),ae=Object(d.a)(te,2),ne=ae[0],re=ae[1],ie=Object(n.useState)(),oe=Object(d.a)(ie,2),le=oe[0],ce=oe[1],se=Object(n.useState)(),de=Object(d.a)(se,2),me=de[0],ue=de[1];return Object(n.useEffect)((function(){function t(){return(t=Object(s.a)(c.a.mark((function t(){var a,n;return c.a.wrap((function(t){for(;;)switch(t.prev=t.next){case 0:a=e.path,W(e&&e.path),"impact"===a?(console.log("graphdata",e.graphData),L(e&&e.graphData&&e.graphData.issueGraph),k(e&&e.graphData&&e.graphData.fulfillGraph),Y(e&&e.graphData&&e.graphData.issueToFulfill)):(Z(e&&e.graphDataSur&&e.graphDataSur.total),ce(e&&e.graphDataSur&&e.graphDataSur.issue),ue(e&&e.graphDataSur&&e.graphDataSur.completion),n=[],n=Object.keys(e.graphDataSur.status).map((function(t){return{id:t,label:t,value:e.graphDataSur.status[t]}})),E(n),n=[],n=Object.keys(e.graphDataSur.subpart).map((function(t){return{id:t,label:t,value:e.graphDataSur.subpart[t]}})),ee(n),re(e.graphDataSur.categories));case 3:case"end":return t.stop()}}),t)})))).apply(this,arguments)}!function(){t.apply(this,arguments)}()}),[e]),r.a.createElement(C.a,{container:!0,style:{padding:"20px 15px"}},H&&"impact"===H?r.a.createElement(C.a,{item:!0,xs:12,container:!0},r.a.createElement(C.a,{item:!0,xs:4,container:!0},r.a.createElement(C.a,{item:!0,xs:12,container:!0},r.a.createElement(y.a,{className:i.graphTitle},"Number of PMR/PMC issued by year (and fulfilled or released)")),r.a.createElement(C.a,{item:!0,xs:12,container:!0,style:{height:"40vh"}},r.a.createElement(Gt.a,{data:w,keys:["y"],indexBy:"x",margin:{top:5,right:10,bottom:50,left:40},borderRadius:2,padding:.4,defs:[{id:"gradientC",type:"linearGradient",colors:[{offset:40,color:"#54B9FF"},{offset:100,color:"#318AC8"}]}],fill:[{match:"*",id:"gradientC"}],colorBy:"index",axisTop:null,axisRight:null,axisBottom:{orient:"bottom",tickSize:1,tickPadding:5,tickRotation:0},theme:{axis:{ticks:{text:{fill:"#6D7D8A",fontWeight:"bold",fontSize:"11px"}}},legends:{text:{fontSize:"16px"}}},labelSkipWidth:12,labelSkipHeight:12,labelTextColor:"#ffffff",enableGridY:!1})),r.a.createElement(C.a,{item:!0,xs:12,container:!0},r.a.createElement(y.a,{className:i.graphTitle},"Number of PMR/PMC fulfilled or released by year")),r.a.createElement(C.a,{item:!0,xs:12,container:!0,style:{height:"40vh"}},r.a.createElement(Gt.a,{data:U,keys:["y"],indexBy:"x",margin:{top:5,right:10,bottom:50,left:40},borderRadius:2,padding:.4,defs:[{id:"gradientD",type:"linearGradient",colors:[{offset:40,color:"#48E0A6"},{offset:100,color:"#3AB09E"}]}],fill:[{match:"*",id:"gradientD"}],colorBy:"index",axisTop:null,axisRight:null,axisBottom:{orient:"bottom",tickSize:1,tickPadding:5,tickRotation:0},theme:{axis:{ticks:{text:{fill:"#6D7D8A",fontWeight:"bold",fontSize:"11px"}}},legends:{text:{fontSize:"16px"}}},labelSkipWidth:12,labelSkipHeight:12,labelTextColor:"#ffffff",enableGridY:!1}))),r.a.createElement(C.a,{item:!0,xs:8,container:!0,style:{paddingLeft:"40px"}},r.a.createElement(C.a,{item:!0,xs:12,container:!0},r.a.createElement(y.a,{className:i.graphTitle},"Number of PMR/PMC and Number of days from issue to fulfillment or release")),r.a.createElement(C.a,{item:!0,xs:12,container:!0,style:{height:"83vh"}},r.a.createElement(Gt.a,{data:z,keys:["days","number"],indexBy:"x",margin:{top:0,right:10,bottom:50,left:120},layout:"horizontal",groupMode:"grouped",borderRadius:2,padding:.2,valueScale:{type:"linear"},innerPadding:.1,gridXValues:5,defs:[{id:"dots",type:"linearGradient",colors:[{offset:40,color:"#318AC8"},{offset:100,color:"#54B9FF"}]},{id:"lines",type:"linearGradient",colors:[{offset:40,color:"#48E0A6"},{offset:100,color:"#3AB09E"}],spacing:10}],fill:[{match:{id:"days"},id:"dots"},{match:{id:"number"},id:"lines"}],colorBy:"index",axisTop:null,axisRight:null,axisBottom:{orient:"bottom",tickSize:1,tickPadding:5,tickRotation:0},theme:{axis:{ticks:{text:{fill:"#6D7D8A",fontWeight:"bold",fontSize:"11px"}}},legends:{text:{fontSize:"16px"}}},labelSkipWidth:12,labelSkipHeight:12,labelTextColor:"#ffffff",enableGridY:!1})))):r.a.createElement(C.a,{item:!0,xs:12,container:!0},r.a.createElement(C.a,{item:!0,xs:2,container:!0},r.a.createElement(C.a,{item:!0,xs:12,container:!0},r.a.createElement(y.a,{className:i.graphTitle}," Overview ")),r.a.createElement(C.a,{item:!0,xs:12,container:!0},r.a.createElement(R.a,{padding:2,display:"flex",flexDirection:"column",alignItems:"center",className:i.cards},r.a.createElement(N.a,{elevation:3,className:i.paperCards},r.a.createElement(R.a,{padding:1,display:"flex",flexDirection:"column",justifyContent:"space-evenly",alignItems:"center",className:i.cardContent},r.a.createElement("img",{style:{width:"30px"},src:zr.a}),r.a.createElement(y.a,{className:i.number},r.a.createElement(Mr.a,{className:"animatedNumber",value:String(K),formatValue:v,duration:"4000"})),r.a.createElement(y.a,{className:i.cardText},"Total"))))),r.a.createElement(C.a,{item:!0,xs:12,container:!0},r.a.createElement(R.a,{padding:2,display:"flex",flexDirection:"column",alignItems:"center",className:i.cards},r.a.createElement(N.a,{elevation:3,className:i.paperCards},r.a.createElement(R.a,{padding:1,display:"flex",flexDirection:"column",justifyContent:"space-evenly",alignItems:"center",className:i.cardContent},r.a.createElement("img",{style:{width:"30px"},src:zr.a}),r.a.createElement(y.a,{className:i.number},le&&le),r.a.createElement(y.a,{className:i.cardText},"issued in last 2 month"))))),r.a.createElement(C.a,{item:!0,xs:12,container:!0},r.a.createElement(R.a,{padding:2,display:"flex",flexDirection:"column",alignItems:"center",className:i.cards},r.a.createElement(N.a,{elevation:3,className:i.paperCards},r.a.createElement(R.a,{padding:1,display:"flex",flexDirection:"column",justifyContent:"space-evenly",alignItems:"center",className:i.cardContent},r.a.createElement("img",{style:{width:"30px"},src:zr.a}),r.a.createElement(y.a,{className:i.number},r.a.createElement(Mr.a,{className:"animatedNumber",value:String(me),formatValue:v,duration:"4000"})),r.a.createElement(y.a,{className:i.cardText},"Expected Completion in 12 months")))))),r.a.createElement(C.a,{item:!0,xs:5,container:!0},r.a.createElement(C.a,{item:!0,xs:12,container:!0},r.a.createElement(y.a,{className:i.graphTitle,style:{marginLeft:"10vh"}}," ","PMR / PMC Status")),r.a.createElement(C.a,{item:!0,xs:12,container:!0},r.a.createElement(R.a,{display:"flex",flexDirection:"column",justifyContent:"center",style:{width:"100%",padding:"0 2vh"}},r.a.createElement(R.a,{display:"flex",flexDirection:"row",justifyContent:"center",className:i.graphContainer},r.a.createElement(R.a,{display:"flex",flexDirection:"column",className:i.graphBox},r.a.createElement(Wt.a,(t={className:i.graph,data:A,margin:{top:40,right:10,bottom:40,left:40},innerRadius:.2,padAngle:.7,cornerRadius:3,startAngle:-50,borderWidth:0},Object(g.a)(t,"padAngle",2),Object(g.a)(t,"radialLabelsLinkStrokeWidth",3),Object(g.a)(t,"colors",["#48E0A6","#318AC8","#0A467C","#20A1C7"]),Object(g.a)(t,"sliceLabel",(function(e){return e.value})),Object(g.a)(t,"borderWidth",1),Object(g.a)(t,"borderColor",{from:"color",modifiers:[["darker",.2]]}),Object(g.a)(t,"radialLabelsLinkOffset",-10),Object(g.a)(t,"radialLabelsLinkDiagonalLength",20),Object(g.a)(t,"radialLabelsLinkHorizontalLength",10),Object(g.a)(t,"radialLabelsSkipAngle",10),Object(g.a)(t,"radialLabelsTextColor","#1FBDCA"),Object(g.a)(t,"radialLabelsLinkColor",{from:"color"}),Object(g.a)(t,"sliceLabelsSkipAngle",10),Object(g.a)(t,"sliceLabelsTextColor","#fff"),Object(g.a)(t,"theme",{axis:{fontSize:"14px",tickColor:"#000",ticks:{line:{stroke:"#555555"},text:{fill:"#1FBDCA",fontWeight:"bold"}}}}),t)))))),r.a.createElement(C.a,{item:!0,xs:12,container:!0},r.a.createElement(C.a,{item:!0,xs:12,container:!0},r.a.createElement(y.a,{style:{marginLeft:"10vh"},className:i.graphTitle}," ","Subpart")),r.a.createElement(R.a,{display:"flex",flexDirection:"column",justifyContent:"center",style:{width:"100%",padding:"0 2vh"}},r.a.createElement(R.a,{display:"flex",flexDirection:"row",justifyContent:"center",className:i.graphContainer},r.a.createElement(R.a,{display:"flex",flexDirection:"column",className:i.graphBox},r.a.createElement(Wt.a,(a={className:i.graph,data:$,margin:{top:40,right:10,bottom:40,left:40},innerRadius:.2,padAngle:.7,cornerRadius:3,startAngle:-50,borderWidth:0},Object(g.a)(a,"padAngle",2),Object(g.a)(a,"radialLabelsLinkStrokeWidth",3),Object(g.a)(a,"colors",["#48E0A6","#318AC8","#0A467C","#20A1C7"]),Object(g.a)(a,"sliceLabel",(function(e){return e.value})),Object(g.a)(a,"borderWidth",1),Object(g.a)(a,"borderColor",{from:"color",modifiers:[["darker",.2]]}),Object(g.a)(a,"radialLabelsLinkOffset",-10),Object(g.a)(a,"radialLabelsLinkDiagonalLength",20),Object(g.a)(a,"radialLabelsLinkHorizontalLength",10),Object(g.a)(a,"radialLabelsSkipAngle",10),Object(g.a)(a,"radialLabelsTextColor","#1FBDCA"),Object(g.a)(a,"radialLabelsLinkColor",{from:"color"}),Object(g.a)(a,"sliceLabelsSkipAngle",10),Object(g.a)(a,"sliceLabelsTextColor","#fff"),Object(g.a)(a,"theme",{axis:{fontSize:"14px",tickColor:"#000",ticks:{line:{stroke:"#555555"},text:{fill:"#6D7D8A",fontWeight:"bold"}}}}),a))))))),r.a.createElement(C.a,{item:!0,xs:5,container:!0},r.a.createElement(C.a,{item:!0,xs:12,container:!0},r.a.createElement(y.a,{className:i.graphTitle},"Number of PMRs/PMCs by categories")),r.a.createElement(C.a,{item:!0,xs:12,container:!0,style:{height:"83vh"}},r.a.createElement(Gt.a,{data:ne,keys:["number"],indexBy:"x",margin:{top:0,right:10,bottom:50,left:120},layout:"horizontal",groupMode:"grouped",borderRadius:2,padding:.3,defs:[{id:"dots",type:"linearGradient",colors:[{offset:-10,color:"#318AC8"},{offset:100,color:"#54B9FF"}]}],fill:[{match:{id:"number"},id:"dots"}],colorBy:"index",axisTop:null,axisRight:null,axisBottom:{orient:"bottom",tickSize:1,tickPadding:5,tickRotation:0},theme:{axis:{ticks:{text:{fill:"#6D7D8A",fontWeight:"bold",fontSize:"11px"}}},legends:{text:{fontSize:"16px"}}},labelSkipWidth:12,labelSkipHeight:12,labelTextColor:"#ffffff",enableGridY:!1})))))}var Vr=Object(f.a)((function(e){var t;return t={graphInnerGrid:{height:"100%",width:"100%",backgroundColor:e.palette.white,boxShadow:"none",borderRadius:0},graphInnerTitleGrid:{height:"5%",width:"100%",backgroundColor:e.palette.white,boxShadow:"none",borderRadius:0},graphInnergChartGrid:{height:"90%",width:"100%",backgroundColor:e.palette.white,boxShadow:"none",borderRadius:0},graphInnerMessageGrid:{height:"5%",width:"100%",backgroundColor:e.palette.white,boxShadow:"none",borderRadius:0},graphInnerMessage:{fontSize:"1.5vh",fontWeight:"500",color:e.palette.black,padding:"5px"},graphInnerTitle:{fontSize:"1.8vh",fontWeight:"700",color:e.palette.primary.main,padding:"5px",marginTop:"-2vh"},GridHeaderBreadcrumbs:{height:"8vh",backgroundColor:e.palette.white,marginBottom:"1vh",border:"8px solid ".concat(e.palette.primary.lightBackground)},chart:{height:"50vh !important",width:"100%",backgroundColor:e.palette.white,boxShadow:"none",borderRadius:0,marginTop:"-13vh !important"},Paper:{borderRadius:"5px",width:"100%",overflowX:"scroll",boxShadow:"none"},Table:{},TableHead:{borderRadius:"10px"},TableBody:{borderRadius:"10px"},StyledHeaderTableRow:{borderRadius:"10px"},StyledHeaderTableCell:{padding:"7px",fontSize:"2vh",fontWeight:"800",color:e.palette.black,backgroundColor:e.palette.primary.lightBorder},StyledHeaderTableCellMapped:{padding:"7px",fontSize:"1.5vh",fontWeight:"700",color:e.palette.black,backgroundColor:e.palette.primary.lightBorder},StyledTableRow:{borderRadius:"10px","&:nth-of-type(odd)":{backgroundColor:e.palette.primary.lightBackground},"&:nth-of-type(even)":{backgroundColor:e.palette.white}},StyledTableCell:{padding:"7px",fontSize:"1.5vh",fontWeight:"700",color:e.palette.black},StyledTableCellMapped:{height:"10vh",padding:"7px",fontSize:"1.5vh",fontWeight:"500",color:e.palette.black},StyledTableCellCheck:{color:e.palette.successGreen},Dropdown:{width:"100%"},DropdownTable:{width:"180vh",overflowX:"auto"},DropdownButton:{paddingLeft:"15px",width:"100%",marginTop:"1rem",marginBottom:"1rem",borderRadius:"15px",fontWeight:"400",textAlign:"left",textTransform:"none",backgroundColor:e.palette.primary.lightBorder,color:e.palette.black},expand:{color:e.palette.primary.main,transform:"rotate(0deg)",transition:e.transitions.create("transform",{duration:e.transitions.duration.shortest})},expandClose:{color:e.palette.primary.main,transform:"rotate(180deg)"},GridTitle:{color:e.palette.black,textAlign:"left",fontSize:"0.8rem",fontWeight:"bold",margin:"10px",fontFamily:"Roboto-Medium"},GridContentBox:{height:"34vh"}},Object(g.a)(t,"chart",{height:"98%",width:"100%",boxShadow:"none",borderRadius:0}),Object(g.a)(t,"paper",{boxShadow:"none",height:"100%",overflowY:"auto",padding:"10px",width:"100%"}),Object(g.a)(t,"main",{height:"100%",width:"100%"}),Object(g.a)(t,"Count",{margin:"0 auto",width:"93%",fontSize:"1.5rem",border:"1px solid #2E17821A",borderRadius:"5px",padding:"10px",boxShadow:"0px 3px 1px -2px #2E17821A, 0px 2px 2px 0px #2E17821A, 0px 1px 5px 0px #2E17821A"}),Object(g.a)(t,"trial",{color:"#B1BBE4",fontSize:"10px"}),Object(g.a)(t,"DropdownButtonClosed",{paddingLeft:"15px",marginTop:"1rem",width:"100%",borderRadius:"15px",fontWeight:"400",textAlign:"left",textTransform:"none",backgroundColor:"#0E83DC",color:e.palette.white}),Object(g.a)(t,"headings",{color:e.palette.biologics.textPrimary,fontWeight:"bold",fontSize:"14px",fontFamily:"Lato"}),Object(g.a)(t,"cards",{width:"100%",padding:"15px 35px",height:"100%"}),Object(g.a)(t,"cardContent",{height:"100%"}),Object(g.a)(t,"paperCards",{height:"inherit",width:"inherit",borderRadius:e.spacing(1.5)}),Object(g.a)(t,"paperIcon",{background:"linear-gradient(90deg, #29ABE2 0%, #39B54A 100%)",color:e.palette.white}),Object(g.a)(t,"number",{fontSize:e.spacing(3.5),color:e.palette.biologics.textPrimary,fontWeight:"bold"}),Object(g.a)(t,"cardText",{fontSize:e.spacing(2),color:e.palette.biologics.textSecondary}),Object(g.a)(t,"graphContainer",{width:"100%",height:"40vh",color:"#1FBDCA",padding:"10px"}),Object(g.a)(t,"graphContainerYear",{width:"100%",height:"40vh",color:"#1FBDCA",padding:"10px"}),Object(g.a)(t,"graphBox",{width:"100%",marginTop:"-10px"}),t}),{index:1});a(1675);function Gr(e){var t=Vr(),a=function(e){return"".concat(Number(e).toFixed(0))},i=Object(n.useState)(),o=Object(d.a)(i,2),l=o[0],m=o[1],u=Object(n.useState)(),p=Object(d.a)(u,2),h=p[0],T=p[1],f=Object(n.useState)(),A=Object(d.a)(f,2),E=A[0],b=A[1],S=Object(n.useState)(),D=Object(d.a)(S,2),_=D[0],O=D[1],x=Object(n.useState)(),v=Object(d.a)(x,2),P=v[0],I=v[1];return Object(n.useEffect)((function(){function t(){return(t=Object(s.a)(c.a.mark((function t(){return c.a.wrap((function(t){for(;;)switch(t.prev=t.next){case 0:m(e.phaseGraph),T(e.CTCount),b(e.CTMOcount),O(e.statusGraph),I(e.yearGraph);case 5:case"end":return t.stop()}}),t)})))).apply(this,arguments)}!function(){t.apply(this,arguments)}()}),[e]),r.a.createElement(C.a,{container:!0,spacing:3},r.a.createElement(C.a,{item:!0,xs:12,container:!0},r.a.createElement(C.a,{item:!0,xs:2,container:!0,style:{width:"100%"}},r.a.createElement(n.Fragment,null,r.a.createElement(R.a,{display:"flex",flexDirection:"column",justifyContent:"space-evenly",style:{height:"90%",width:"100%"}},r.a.createElement(y.a,{align:"left",className:t.headings},"Total Number of Trials"),r.a.createElement(R.a,{padding:2,display:"flex",flexDirection:"column",alignItems:"center",className:t.cards},r.a.createElement(N.a,{elevation:3,className:t.paperCards},r.a.createElement(R.a,{padding:1,display:"flex",flexDirection:"column",justifyContent:"space-evenly",alignItems:"center",className:t.cardContent},r.a.createElement(y.a,{className:t.number},r.a.createElement(Mr.a,{className:"animatedNumber",value:String(h),formatValue:a,duration:"4000"})),r.a.createElement(y.a,{className:t.cardText},"Trials"))))))),r.a.createElement(C.a,{item:!0,xs:10,container:!0},r.a.createElement(n.Fragment,null,r.a.createElement(R.a,{display:"flex",flexDirection:"column",justifyContent:"center",style:{width:"100%",padding:"0 0 0 2vh"}},r.a.createElement(R.a,{display:"flex",flexDirection:"row",justifyContent:"center",className:t.graphContainerYear},r.a.createElement(R.a,{display:"flex",flexDirection:"column",className:t.graphBox},r.a.createElement(y.a,{align:"left",className:t.headings},"Number of trials by year of completion"),r.a.createElement(Gt.a,{data:P,keys:["data"],indexBy:"name",margin:{top:5,right:10,bottom:50,left:40},borderRadius:2,padding:.1,colors:"#0E5A94",colorBy:"index",axisTop:null,axisRight:null,axisBottom:{orient:"bottom",tickSize:1,tickPadding:5,tickRotation:0},theme:{axis:{ticks:Object(g.a)({text:{fontSize:"10px",fill:"#ffffff"}},"text",{fill:"#1FBDCA",fontWeight:"bold",fontSize:"10px"})},legends:{text:{fontSize:"16px"}}},labelSkipWidth:12,labelSkipHeight:12,labelTextColor:"#ffffff",enableGridY:!1}))))))),r.a.createElement(C.a,{item:!0,xs:12,container:!0},r.a.createElement(C.a,{item:!0,xs:2,container:!0,style:{width:"100%"}},r.a.createElement(n.Fragment,null,r.a.createElement(R.a,{display:"flex",flexDirection:"column",justifyContent:"space-evenly",style:{height:"90%",width:"100%"}},r.a.createElement(y.a,{align:"left",className:t.headings},"Trials completing next 12 months"),r.a.createElement(R.a,{padding:2,display:"flex",flexDirection:"column",alignItems:"center",className:t.cards},r.a.createElement(N.a,{elevation:3,className:t.paperCards},r.a.createElement(R.a,{padding:1,display:"flex",flexDirection:"column",justifyContent:"space-evenly",alignItems:"center",className:t.cardContent},r.a.createElement(y.a,{className:t.number},r.a.createElement(Mr.a,{className:"animatedNumber",value:String(E),formatValue:a,duration:"1000"})),r.a.createElement(y.a,{className:t.cardText},"Trials"))))))),r.a.createElement(C.a,{item:!0,xs:5,container:!0},r.a.createElement(n.Fragment,null,r.a.createElement(R.a,{display:"flex",flexDirection:"column",justifyContent:"center",style:{width:"100%",padding:"0 2vh 1vh"}},r.a.createElement(R.a,{display:"flex",flexDirection:"row",justifyContent:"center",className:t.graphContainer},r.a.createElement(R.a,{display:"flex",flexDirection:"column",className:t.graphBox},r.a.createElement(y.a,{align:"left",className:t.headings},"Number of trials by phase"),r.a.createElement(Gt.a,{data:l,keys:["data"],indexBy:"name",margin:{top:5,right:20,bottom:50,left:100},layout:"horizontal",borderRadius:2,padding:.1,colors:"#008B8B",colorBy:"index",axisTop:null,axisRight:null,axisBottom:{orient:"bottom",tickSize:1,tickPadding:5,tickRotation:0},theme:{axis:{ticks:Object(g.a)({text:{fontSize:"10px",fill:"#ffffff"}},"text",{fill:"#1FBDCA",fontWeight:"bold",fontSize:"10px"})},legends:{text:{fontSize:"16px"}}},labelSkipWidth:12,labelSkipHeight:12,labelTextColor:"#ffffff",enableGridY:!1})))))),r.a.createElement(C.a,{item:!0,xs:5,container:!0},r.a.createElement(n.Fragment,null,r.a.createElement(R.a,{display:"flex",flexDirection:"column",justifyContent:"center",style:{width:"100%",padding:"0 0 1vh"}},r.a.createElement(R.a,{display:"flex",flexDirection:"row",justifyContent:"center",className:t.graphContainer},r.a.createElement(R.a,{display:"flex",flexDirection:"column",className:t.graphBox},r.a.createElement(y.a,{align:"left",className:t.headings},"Number of trials by recruitment status"),r.a.createElement(Gt.a,{data:_,keys:["data"],indexBy:"name",margin:{top:5,right:20,bottom:50,left:140},layout:"horizontal",borderRadius:2,padding:.1,colors:"#3AB09E",colorBy:"index",axisTop:null,axisRight:null,axisBottom:{orient:"bottom",tickSize:1,tickPadding:5,tickRotation:0},theme:{axis:{ticks:Object(g.a)({text:{fontSize:"10px",fill:"#ffffff"}},"text",{fill:"#1FBDCA",fontWeight:"bold",fontSize:"10px"})},legends:{text:{fontSize:"16px"}}},labelSkipWidth:12,labelSkipHeight:12,labelTextColor:"#ffffff",enableGridY:!1}))))))))}var Hr=function(){return r.a.createElement("svg",{version:"1.1",id:"Layer_1",xmlns:"http://www.w3.org/2000/svg",xlink:"http://www.w3.org/1999/xlink",width:"90",height:"90",x:"0px",y:"0px",viewBox:"0 0 1000 1000",style:{enableBackground:"new 0 0 1000 1000;"},space:"preserve"},r.a.createElement("style",{type:"text/css"},"        .st0{          fill:url(#SVGID_1_);        }        .st1{          fill:#FFFFFF;        }      "),r.a.createElement("g",null,r.a.createElement("g",null,r.a.createElement("linearGradient",{id:"SVGID_1_",gradientUnits:"userSpaceOnUse",x1:"280.5868",y1:"501.2192",x2:"738.0239",y2:"501.2192"},r.a.createElement("stop",{offset:"1.060230e-06",style:{stopColor:"#29ABE2"}}),r.a.createElement("stop",{offset:"1",style:{stopColor:"#39B54A"}})),r.a.createElement("path",{class:"st0",d:"M640.8,710.9c-4.5,0-8.3-3.3-11.1-6.2c-16.9-16-34-31.8-51-47.7c-3.5-3.3-7.7-5.7-12.4-7 c-33.3-9.9-69.7-22-91.9-50.3c-7.8-11-6.8-17.8,2.8-27.4c21.7-21.7,43.5-43.5,65.2-65.2c5.8-5.8,9.4-12.4,10.2-20.9 c1.1-12.7,15.3-25.2,27.7-25.1c13.1,0.1,27.7,13.3,29.1,26.5c1.1,10.1-5.1,27.2-21.4,30.3c-11.9,2.2-21.3,7.9-29.4,16.5 c-13.5,14.4-27.5,28.4-40.9,42.9c-8,8.6-8.2,10.5,1.9,16.2c38,22.9,89,44.7,128.3,12.4c13.6-9.7,36.5-27.4,50.1-56.7 c22.3-56.4-5.7-125.2-74.1-121.6c-13.4,1.2-21.3-20-10-26.2c10.7-5,6.4-12.1,3.5-17.9c-8.5-17.2-19.4-33-36.3-43 c-37.7-22.5-90.7-18-120.6,15c-16.7,16.7-32.7,45.6-17.9,68.4c9.8,16.1,0.1,38.7-18.3,42.1c-23,3.8-42.6-20.7-32.4-39.3 c6-12.7,9.6-8.2,14.4-36.1c1.1-6.4-2.3-10.8-8.4-10c-93,10.9-117.7,138.4-32.4,179.5c7.3,3,12.7,0.2,17.1-4.2 c47.2-46.7,94.3-93.4,140.1-141.4c4.3-4.3,5.1-9.8,6-14.9c3.2-17.9,14.9-24.1,27.5-25.6c11.7-1.3,27.6,13.3,29.6,25.8 c2.4,14.4-10.7,30-28,32.5c-6.1,0.9-10.9,3.3-15.2,7.4c-49.9,47-97.7,96.2-145.4,145.5c-16.8,17.3-18.2,16.4-39.6,6.9 c-42.3-18.9-67.5-52.2-75.3-98.2c-13.8-74.5,51.8-147.8,126.8-144.9c10.4,0,17.2-2.5,24-9.9c17.6-19.2,39.8-33.6,64.8-40.8 c18.7-6.2,35-9.1,55-4.4c49.5,7.6,86.8,45.9,100.6,92.7c2.1,6.9,5.1,10.7,12,13.1c47.9,14.4,74.5,62.1,72.1,109.8 c4.2,64.8-40.7,112.3-91.3,135.7c-7.6,3-12.7,5.7-8.6,10.6c9.4,11,19.2,21.6,29.2,32l8.1,8.3c5.4,5.5,1.5,14.8-6.3,14.8 L640.8,710.9z"}),r.a.createElement("path",{class:"st1",d:"M557.8,413.3c-6.7-0.2-10.8-4.6-10.6-11.3c0.3-6.7,4.9-11,11.5-10.4c6.6,0.6,10.1,4.6,10.4,11 C569.3,408.9,564.3,413.4,557.8,413.3z"}),r.a.createElement("path",{class:"st1",d:"M419.1,427.9c6,0.7,9,5.1,9.6,11.1c0.6,6.4-4.5,10.7-11.3,10.5c-7-0.2-9.9-4.4-10.2-10.8 C407,432.3,411.9,427.8,419.1,427.9z"}),r.a.createElement("path",{class:"st1",d:"M582,478.8c6.1-0.2,11.2,4.7,11,10.9c-0.3,6.4-3.6,10.4-10.3,10.5c-6.6,0.1-10.4-3.2-10.7-9.9 C571.5,483.4,575.4,479,582,478.8z"}))))},Wr=function(){var e=Ba(),t=Object(n.useContext)(Mt),a=t.state,i=t.dispatch,o=Object(n.useState)(),l=Object(d.a)(o,2),m=l[0],u=l[1];Object(n.useEffect)((function(){function e(){return(e=Object(s.a)(c.a.mark((function e(){var t,a;return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:try{t=new Date,console.log(t),a=t.getMonth()+1+"/"+t.getDate()+"/"+t.getFullYear(),u(a)}catch(n){console.log(n)}case 1:case"end":return e.stop()}}),e)})))).apply(this,arguments)}!function(){e.apply(this,arguments)}()}),[]);var p=function(){var e=Object(s.a)(c.a.mark((function e(t){var n,r;return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:return t.preventDefault(),n=document.getElementById("print"),console.log("state",a),r={filename:"ria-report-"+a.userStub.initials+"-"+m+".pdf"},e.next=6,i({type:wt.SET_LOADING,value:!0});case 6:return e.abrupt("return",Va()(n,r,Object(s.a)(c.a.mark((function e(){return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:return e.next=2,i({type:wt.SET_LOADING,value:!1});case 2:return e.next=4,i({type:wt.SET_CART_ITEMS,value:0});case 4:return e.next=6,i({type:wt.SET_REPORT,value:[]});case 6:return e.next=8,i({type:wt.SET_PDF_MESSAGE,value:"Your report is ready and downloaded"});case 8:case"end":return e.stop()}}),e)})))));case 7:case"end":return e.stop()}}),e)})));return function(t){return e.apply(this,arguments)}}(),g=function(){var e=Object(s.a)(c.a.mark((function e(t){return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:return t.preventDefault(),e.next=3,i({type:wt.SET_CART_ITEMS,value:0});case 3:case"end":return e.stop()}}),e)})));return function(t){return e.apply(this,arguments)}}();return r.a.createElement(n.Fragment,{className:e.root},r.a.createElement(R.a,{display:"flex",flexDirection:"row",justifyContent:"center",className:e.header},r.a.createElement(y.a,{variant:"h1"}),r.a.createElement(Ta.a,null,a.cartItems>0?r.a.createElement(r.a.Fragment,null,a.loading?r.a.createElement(za.a,{className:e.progress}):r.a.createElement(r.a.Fragment,null,r.a.createElement(_.a,{variant:"contained",className:e.btn,onClick:p},r.a.createElement(y.a,{variant:"body1"},"Download"),r.a.createElement(ka.a,{fontSize:"small"})),r.a.createElement(_.a,{variant:"contained",className:e.btn,onClick:g},r.a.createElement(y.a,{variant:"body1"},"Reset"),r.a.createElement(Fa.a,{fontSize:"small"})))):null)),a.cartItems>0?r.a.createElement(R.a,{className:e.previewContainer,display:"flex",justifyContent:""},r.a.createElement(R.a,{display:"flex",id:"print",flexDirection:"column",justifyContent:"center",className:e.preview},r.a.createElement(R.a,{display:"flex",justifyContent:"space-between"},r.a.createElement(Hr,null),r.a.createElement(y.a,{variant:"body1"},m)),r.a.createElement(R.a,{display:"flex",flexDirection:"column",justifyContent:"center"},r.a.createElement(y.a,{variant:"h1",className:e.heading},"Intelligence Report"),r.a.createElement(y.a,{variant:"body1"},r.a.createElement("b",null,"Prepared by "),": VivProAI"),r.a.createElement(y.a,{variant:"body1",align:"xw"},r.a.createElement("b",null,"Prepared for ")," :"," ",a.userStub.attributes["custom:user"]," ",r.a.createElement("br",null),r.a.createElement("b",null,"Subscription")," :"," ",a.userStub.attributes["custom:license"]),r.a.createElement(y.a,{variant:"subtitle2",align:"left"},"Unlock Regulatory Intelligence with RIA to:-",r.a.createElement("br",null),"-Decrease Time to Insights.",r.a.createElement("br",null),"-Receive Higher Quality Intelligence.",r.a.createElement("br",null),"-Efficient use of resources enabled by Technology!",r.a.createElement("br",null))),a.report&&a.report.map((function(t){return r.a.createElement(r.a.Fragment,null,"Home Report"===t.id?r.a.createElement(Ha,{data:t.data}):null,"Card Details"===t.id?r.a.createElement(vn,{data:t.data}):null,"Application Content"===t.id?r.a.createElement(rr,{data:t.data}):null,"RLD Information"===t.id?r.a.createElement(_r,{data:t.data}):null,"Bar Graph"===t.id?r.a.createElement(lr,{data:t.data}):null,"Immunogenicity Pie Charts"===t.id?r.a.createElement(mr,{data:t.data}):null,"Progress Bars"===t.id?r.a.createElement(r.a.Fragment,null,r.a.createElement(R.a,{display:"flex",flexDirection:"column",className:e.boxRoot},r.a.createElement(N.a,{elevation:0,className:e.paper},r.a.createElement(y.a,{variant:"h3"},t.title," - Business Intelligence"),"Biologics"===t.title?r.a.createElement(Pr,{data:t.data}):r.a.createElement(wr,{data:t.data})))):null,"Progress Graph"===t.id?r.a.createElement(r.a.Fragment,null,r.a.createElement(R.a,{display:"flex",flexDirection:"column",className:e.boxRoot},r.a.createElement(N.a,{elevation:0,className:e.paper},r.a.createElement(y.a,{variant:"h3"},"Biologics"),r.a.createElement(y.a,{variant:"h3"},"Immunogenicity - Overview"),r.a.createElement(Br,{data:t.data})))):null,"PMR"===t.id?r.a.createElement(r.a.Fragment,null,r.a.createElement(R.a,{display:"flex",flexDirection:"column",className:e.boxRoot},r.a.createElement(N.a,{elevation:0,className:e.paper},r.a.createElement(y.a,{variant:"h3"},"PMR - Insights"),r.a.createElement(Yr,{graphData:t.data})))):null,"Clinical Trials"===t.id?r.a.createElement(r.a.Fragment,null,r.a.createElement(R.a,{display:"flex",flexDirection:"column",className:e.boxRoot},r.a.createElement(N.a,{elevation:0,className:e.paper},r.a.createElement(y.a,{variant:"h3"},"Clinical Trials - ",t.data.searchTerm," "),r.a.createElement(y.a,{variant:"h3"},"Insights"),r.a.createElement(Gr,{phaseGraph:t.data.phaseGraph,CTCount:t.data.CTCount,CTMOcount:t.data.CTMOcount,statusGraph:t.data.statusGraph,yearGraph:t.data.yearGraph})))):null)})))):null,a.cartItems>0?null:r.a.createElement(y.a,{variant:"h3"},a.pdfMessage))},Qr=Object(f.a)((function(e){return{searchSpaceGridAdvanced:{height:"95%"},toggleButtonGroup:{height:"80%",borderRadius:"10px","& .MuiToggleButton-root.Mui-selected":{borderRadius:"10px !important",backgroundColor:e.palette.primary.lightBorder,color:e.palette.white}},toggleButtonIndivdual:{height:"100%",borderRadius:"10px !important",width:"7vh",border:"2px solid ".concat(e.palette.primary.lightBackground," !important"),"& .MuiToggleButton-root.Mui-selected":{borderRadius:"10px !important",backgroundColor:e.palette.primary.lightBorder,color:e.palette.white},"& .MuiToggleButton-label":{borderRadius:"10px !important",color:e.palette.primary.main,fontWeight:"400"}},AdvancedSearchIconAdd:{height:"3vh",width:"3vh",fontSize:"2vh",color:e.palette.white,backgroundColor:e.palette.successGreen,marginLeft:e.spacing(1),marginRight:e.spacing(1)},AdvancedSearchIconDelete:{height:"3vh",width:"3vh",fontSize:"2vh",color:e.palette.white,backgroundColor:e.palette.fatalRed,marginLeft:e.spacing(1),marginRight:e.spacing(1)}}})),Jr=a(409),Kr=a.n(Jr);function Zr(e){var t=Qr();return Object(n.useEffect)((function(){function e(){return(e=Object(s.a)(c.a.mark((function e(){return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:case 1:case"end":return e.stop()}}),e)})))).apply(this,arguments)}!function(){e.apply(this,arguments)}()}),[]),r.a.createElement(r.a.Fragment,null,r.a.createElement(R.a,{mt:2,display:"flex",flexDirection:"row",justifyContent:"space-between"},r.a.createElement(Ta.a,null,r.a.createElement(sa,{id:"categoryAdvanced",dropdownValue:e.i.Category,menuItems:["TA/Indication","Active Ingredient","Trade Name","Formulation","Route","Approval Date"],title:"Category",name:e.index,handleChange:e.CategoryClick}),r.a.createElement(J,{placeholder:"",handleChange:function(t){e.SearchClick(e.index,t.target.value)},id:e.index,value:e.i.Search,onKeyDown:e.handleAdvKeyPress,list:"dynamicSearchResult",name:"dynamicSearchResult"}),r.a.createElement("datalist",{id:"dynamicSearchResult"},e.dynamicSearchResultRes?e.dynamicSearchResultRes.map((function(e,t){return r.a.createElement("option",{key:t,value:e},e)})):r.a.createElement("div",null))),r.a.createElement(Ta.a,null,e.index===e.AdvancedSearches.length-1?r.a.createElement("div",null):r.a.createElement(mt.a,{exclusive:!0,name:e.index,onChange:function(t,a){e.ToggleClick(e.index,a)},"aria-label":"text alignment",value:e.i.Relation,className:t.toggleButtonGroup},r.a.createElement(dt.a,{value:"AND","aria-label":"AND",className:t.toggleButtonIndivdual},"AND"),r.a.createElement(dt.a,{value:"OR","aria-label":"OR",className:t.toggleButtonIndivdual},"OR"),r.a.createElement(dt.a,{value:"NOT","aria-label":"NOT",className:t.toggleButtonIndivdual},"NOT")),1==e.AdvancedSearches.length?r.a.createElement(j.a,{size:"small",className:t.AdvancedSearchIconAdd,onClick:e.AddClick},r.a.createElement(Ct.a,null)):e.index==e.AdvancedSearches.length-1&&4!==e.index?r.a.createElement(r.a.Fragment,null,r.a.createElement(j.a,{size:"small",className:t.AdvancedSearchIconAdd,onClick:e.AddClick},r.a.createElement(Ct.a,null)),r.a.createElement(j.a,{size:"small",value:e.index,className:t.AdvancedSearchIconDelete,onClick:function(){e.DeleteClick(e.index)}},r.a.createElement(Kr.a,null))):r.a.createElement(j.a,{size:"small",value:e.index,className:t.AdvancedSearchIconDelete,onClick:function(){e.DeleteClick(e.index)}},r.a.createElement(Kr.a,null)))))}var Xr=a(489),qr=function(){return r.a.createElement("svg",{version:"1.1",id:"Layer_1",svgjs:"http://svgjs.com/svgjs",width:"30.337",height:"30.337",xmlns:"http://www.w3.org/2000/svg",xlink:"http://www.w3.org/1999/xlink",x:"0px",y:"0px",viewBox:"0 0 512 512",style:{enableBackground:"new 0 0 512 512"},space:"preserve"},r.a.createElement("g",null,r.a.createElement("g",null,r.a.createElement("path",{class:"",fill:"#B1BBE4",d:"M322.5,135H84.9c-7.5,6.6-2.9,15,3.6,15h237.5C333.6,143.4,329,135,322.5,135L322.5,135z M317.5,45h-84.6 c-7.5,6.6-2.9,15,3.6,15H315v30H96V60h140.4c7.5-6.6,2.9-15-3.6-15H85.7c-2.6,0-4.7,2.1-4.7,4.7v50.7c0,2.6,2.1,4.7,4.7,4.7h239.6 c2.6,0,4.7-2.1,4.7-4.7V57.5C330,50.6,324.3,45,317.5,45L317.5,45z M322.5,165H84.9c-7.5,6.6-2.9,15,3.6,15h237.5 C333.6,173.4,329,165,322.5,165L322.5,165z M322.5,225h-87.5c-7.5,6.6-2.9,15,3.6,15h87.5C333.6,233.4,329,225,322.5,225z M322.5,195h-87.5c-7.5,6.6-2.9,15,3.6,15h87.5C333.6,203.4,329,195,322.5,195z M411,309.5v-17c0-18.1-12.9-33.3-30.1-36.8V29.7 c0-16.4-13.3-29.7-29.7-29.7H59.8C43.4,0,30.1,13.3,30.1,29.7v166.1C12.9,199.2,0,214.4,0,232.5l0,147.7c6.6,7.5,15,2.9,15-3.6 V224.7c0-8.1,6.6-14.7,14.7-14.7h154.2c8.5,0,15.9,5.8,18,14l6.6,26.6c2.9,11.4,13.1,19.4,24.9,19.4h148c8.1,0,14.7,6.6,14.7,14.7 v25.9c-48.8,7.2-86.5,49.3-86.5,100.2c0,36.4,19.3,68.4,48.3,86.2H37.5C25.1,497,15,486.9,15,474.5V370.3c-6.6-7.5-15-2.9-15,3.6 v108.4C0,498.7,13.3,512,29.7,512h343.8c4.9,0,9.6-0.9,14-2.7c20.8,4.9,44.1,3.4,67.6-6.9c21.8-9.6,39.2-27.3,48.3-49.3 C533.6,379.9,480.4,309.7,411,309.5L411,309.5z M365.9,255H233.3c-4.9,0-9.2-3.3-10.3-8.1l-6.6-26.6 c-3.7-14.9-17.1-25.4-32.5-25.4H45.1V29.7c0-8.1,6.6-14.7,14.7-14.7h291.5c8.1,0,14.7,6.6,14.7,14.7L365.9,255z M449.2,488.6 c-76.2,33.7-149.9-40-116.2-116.2c7.8-17.6,21.9-31.7,39.5-39.5c76.2-33.7,149.9,40,116.2,116.2 C480.9,466.7,466.7,480.9,449.2,488.6z M446.8,423h-11.1v-67.4c0-2.9-2.4-5.3-5.3-5.3h-39.2c-2.9,0-5.3,2.4-5.3,5.3V423l-13.5,0 c-0.9,0-1.7,0.2-2.5,0.6c-8.8,4.8-9.5,14.8-3.8,20.4l35.5,35.5c2.6,2.6,5.9,3.8,9.3,3.8s6.7-1.3,9.3-3.8l37.2-37.2 c0.6-0.6,1.1-1.4,1.3-2.2C461.3,430.5,454.7,423,446.8,423L446.8,423z M410.8,467.6L381.1,438h14.4c2.9,0,5.3-2.4,5.3-5.3v-67.4 h19.9v67.4c0,2.9,2.4,5.3,5.3,5.3h14.4L410.8,467.6z M287.6,358c6.5,0,11.1-8.4,3.6-15h-38.1v77.6c6.6,7.5,15,2.9,15-3.6v-26.4 H289c7.5-6.6,2.9-15-3.6-15h-17.3V358H287.6z M189.3,424.5L189.3,424.5c0.6,0,13.7-0.1,19-0.1c19.2-0.3,33.1-17.1,33.1-39.9 c0-23.9-13.6-40-33.8-40l-19.2,0c0,0-0.1,0-0.1,0c-4.1,0.6-6.6,3.9-6.6,7.5v0.1V416C181.7,420.2,185,424.6,189.3,424.5 L189.3,424.5z M207.6,359.5c13.8,0,18.8,12.9,18.8,25c0,17-9.2,24.7-18.4,24.9c-2.6,0-7.2,0.1-11.2,0.1c0-7.7-0.1-42-0.1-50 L207.6,359.5L207.6,359.5z M130.9,417v-21.7c4,0,8.6,0,11.2,0c14.8,0,26.8-11.9,26.8-26.4s-12-26.4-26.8-26.4h-18.7 c-3.7-0.1-7.7,3.3-7.5,7.5v70.6C122.6,428.1,130.9,423.6,130.9,417L130.9,417z M142.1,357.5c6.4,0,11.8,5.2,11.8,11.4 s-5.4,11.4-11.8,11.4c-2.6,0-7.1,0-11.1,0c0-4.1-0.1-18.6-0.1-22.9L142.1,357.5z"}))))},$r=function(){return r.a.createElement("svg",{xmlns:"http://www.w3.org/2000/svg",width:"30.337",height:"30.337",viewBox:"0 0 14.651 14.651"},r.a.createElement("g",{id:"Group_326","data-name":"Group 326",transform:"translate(0.25 0.25)"},r.a.createElement("circle",{id:"Ellipse_52","data-name":"Ellipse 52",cx:"7.075",cy:"7.075",r:"7.075",fill:"none",stroke:"#b1bbe4","stroke-linecap":"round","stroke-linejoin":"round",strokeWidth:".5px"}),r.a.createElement("path",{id:"Path_198","data-name":"Path 198",d:"M.405-6.525A3.013,3.013,0,0,1,.748-6.8a2.557,2.557,0,0,1,.41-.23,2.493,2.493,0,0,1,.48-.158A2.556,2.556,0,0,1,2.2-7.245a2.257,2.257,0,0,1,.732.115,1.752,1.752,0,0,1,.583.325A1.5,1.5,0,0,1,3.9-6.3a1.577,1.577,0,0,1,.14.675,1.726,1.726,0,0,1-.112.655,1.836,1.836,0,0,1-.285.483,2.242,2.242,0,0,1-.375.36l-.383.287a2.416,2.416,0,0,0-.307.27.523.523,0,0,0-.148.3l-.09.765h-.61l-.06-.83a.616.616,0,0,1,.085-.393,1.414,1.414,0,0,1,.275-.315,4.43,4.43,0,0,1,.375-.29,2.908,2.908,0,0,0,.382-.317,1.664,1.664,0,0,0,.3-.4,1.107,1.107,0,0,0,.12-.532.881.881,0,0,0-.085-.39.9.9,0,0,0-.23-.3,1.017,1.017,0,0,0-.342-.187,1.343,1.343,0,0,0-.423-.065A1.61,1.61,0,0,0,1.6-6.44a1.959,1.959,0,0,0-.368.165,2.14,2.14,0,0,0-.243.165.271.271,0,0,1-.152.075A.218.218,0,0,1,.64-6.15ZM1.38-.55A.635.635,0,0,1,1.428-.8a.628.628,0,0,1,.13-.2.612.612,0,0,1,.2-.135A.608.608,0,0,1,2-1.18a.608.608,0,0,1,.245.05.641.641,0,0,1,.2.135.641.641,0,0,1,.135.2.608.608,0,0,1,.05.245A.6.6,0,0,1,2.58-.3a.65.65,0,0,1-.135.2.608.608,0,0,1-.2.133A.635.635,0,0,1,2,.075.635.635,0,0,1,1.755.028a.58.58,0,0,1-.2-.133.636.636,0,0,1-.13-.2A.63.63,0,0,1,1.38-.55Z",transform:"translate(4.594 10.305)",fill:"#b1bbe4"})))},ei=function(){return r.a.createElement("svg",{xmlns:"http://www.w3.org/2000/svg",width:"30.337",height:"30.337",viewBox:"0 0 15.437 14.151"},r.a.createElement("g",{id:"index",transform:"translate(0 -1)"},r.a.createElement("g",{id:"Group_316","data-name":"Group 316",transform:"translate(5.789 4.216)"},r.a.createElement("path",{id:"Path_190","data-name":"Path 190",d:"M12.859,13.719a3.859,3.859,0,1,1,3.859-3.859A3.863,3.863,0,0,1,12.859,13.719Zm0-7.075a3.216,3.216,0,1,0,3.216,3.216A3.22,3.22,0,0,0,12.859,6.643Z",transform:"translate(-9 -6)",fill:"#b1bbe4"})),r.a.createElement("g",{id:"Group_317","data-name":"Group 317",transform:"translate(11.825 10.252)"},r.a.createElement("path",{id:"Path_191","data-name":"Path 191",d:"M21.675,19a.323.323,0,0,1-.228-.094l-2.969-2.969a.322.322,0,0,1,.455-.455L21.9,18.448a.321.321,0,0,1-.227.549Z",transform:"translate(-18.384 -15.385)",fill:"#b1bbe4"})),r.a.createElement("g",{id:"Group_318","data-name":"Group 318",transform:"translate(0 1)"},r.a.createElement("path",{id:"Path_192","data-name":"Path 192",d:"M11.256,1.643H.322A.322.322,0,0,1,.322,1H11.256a.322.322,0,1,1,0,.643Z",transform:"translate(0 -1)",fill:"#b1bbe4"})),r.a.createElement("g",{id:"Group_319","data-name":"Group 319",transform:"translate(0 14.507)"},r.a.createElement("path",{id:"Path_193","data-name":"Path 193",d:"M11.256,22.643H.322a.322.322,0,0,1,0-.643H11.256a.322.322,0,0,1,0,.643Z",transform:"translate(0 -22)",fill:"#b1bbe4"})),r.a.createElement("g",{id:"Group_320","data-name":"Group 320",transform:"translate(0 4.216)"},r.a.createElement("path",{id:"Path_194","data-name":"Path 194",d:"M5.467,6.643H.322A.322.322,0,0,1,.322,6H5.467a.322.322,0,1,1,0,.643Z",transform:"translate(0 -6)",fill:"#b1bbe4"})),r.a.createElement("g",{id:"Group_321","data-name":"Group 321",transform:"translate(0 11.291)"},r.a.createElement("path",{id:"Path_195","data-name":"Path 195",d:"M5.467,17.643H.322a.322.322,0,1,1,0-.643H5.467a.322.322,0,1,1,0,.643Z",transform:"translate(0 -17)",fill:"#b1bbe4"})),r.a.createElement("g",{id:"Group_322","data-name":"Group 322",transform:"translate(0 7.754)"},r.a.createElement("path",{id:"Path_196","data-name":"Path 196",d:"M4.181,12.143H.322a.322.322,0,1,1,0-.643H4.181a.322.322,0,1,1,0,.643Z",transform:"translate(0 -11.5)",fill:"#b1bbe4"}))))},ti=function(){var e=Object(n.useContext)(Mt).state;return r.a.createElement("svg",{xmlns:"http://www.w3.org/2000/svg",width:"37.612",height:"32",viewBox:"0 0 32 32"},r.a.createElement("style",{type:"text/css"},"        .core0{          fill:url(#SVGID_9_);        }      "),r.a.createElement("g",{id:"Viv32",transform:"translate(205.96 -1828.95)"},r.a.createElement("linearGradient",{id:"SVGID_9_",gradientUnits:"userSpaceOnUse",x1:"280.5868",y1:"501.2192",x2:"738.0239",y2:"501.2192"},r.a.createElement("stop",{offset:"1.060230e-06",style:{stopColor:"#29ABE2"}}),r.a.createElement("stop",{offset:"1",style:{stopColor:"#39B54A"}})),r.a.createElement("g",{id:"Group_356","data-name":"Group 356",transform:"translate(-605 1134)"},r.a.createElement("path",{id:"Path_240",class:"core"===e.module?"core0":"","data-name":"Path 240",d:"M423.666,726.382v-1.911h-3.612v1.911a.468.468,0,1,1-.935,0v-1.911h-3.612v1.911a.468.468,0,1,1-.935,0v-1.911H410.94v1.911a.468.468,0,1,1-.935,0v-1.911h-3.622v1.911a.468.468,0,1,1-.935,0v-1.911h-3.482A.467.467,0,0,1,401.5,724h0V720.52h-1.91a.468.468,0,0,1,0-.936h1.91v-3.623h-1.91a.468.468,0,0,1,0-.935h1.91v-3.613h-1.91a.468.468,0,0,1,0-.936h1.91v-3.613h-1.91a.468.468,0,0,1,0-.936h1.91v-3.613h-1.91a.468.468,0,0,1,0-.936h1.91V697.9a.467.467,0,0,1,.468-.468h3.482v-1.911a.467.467,0,0,1,.468-.468h0a.467.467,0,0,1,.468.468h0v1.911h3.622v-1.911a.467.467,0,0,1,.468-.468h0a.467.467,0,0,1,.468.468v1.911h3.612v-1.911a.467.467,0,0,1,.468-.468h0a.467.467,0,0,1,.468.468v1.911H419.1v-1.911a.468.468,0,1,1,.935,0v1.911h3.612v-1.911a.468.468,0,1,1,.935,0h0v1.911h3.492a.467.467,0,0,1,.468.468v3.484h1.91a.467.467,0,0,1,.468.468h0a.467.467,0,0,1-.468.468h-1.91v3.623h1.91a.467.467,0,0,1,.468.468h0a.467.467,0,0,1-.468.468h-1.91v3.613h1.91a.467.467,0,0,1,.468.468h0a.467.467,0,0,1-.468.468h-1.91v3.613h1.91a.467.467,0,0,1,.468.468h0a.467.467,0,0,1-.468.468h-1.91v3.613h1.91a.467.467,0,0,1,.468.468h0a.467.467,0,0,1-.468.468h-1.91V724a.467.467,0,0,1-.468.468h-3.492v1.911a.458.458,0,1,1-.915,0Zm-21.243-2.857h25.2V698.315h-25.2Zm20.835-1.473a.467.467,0,0,1-.468-.468h0a.467.467,0,0,1,.468-.468h1.95v-1.951a.468.468,0,1,1,.935,0v2.419a.467.467,0,0,1-.468.468Zm-18.885,0a.467.467,0,0,1-.468-.468h0v-2.419a.468.468,0,1,1,.935,0v1.951h1.95a.467.467,0,0,1,.468.468h0a.467.467,0,0,1-.468.468h-2.418Zm14.825-7.166-2.876-6.589h1.323l2.189,5.076,2.209-5.076h1.224l-2.866,6.589Zm-4.905,0V708.3h1.224v6.589Zm-4.766,0-2.876-6.589h1.323l2.189,5.076,2.209-5.076H413.6l-2.866,6.589Zm15.681-12.2v-1.951h-1.95a.468.468,0,0,1,0-.935h2.418a.467.467,0,0,1,.468.468v2.419a.468.468,0,1,1-.935,0Zm-21.3,0v-2.419a.467.467,0,0,1,.468-.468h2.418a.467.467,0,0,1,.468.468h0a.467.467,0,0,1-.468.468h-1.95v1.951a.468.468,0,1,1-.935,0Z",transform:"translate(0)",fill:"#b1bbe4"}),r.a.createElement("path",{id:"Path_241",class:"core"===e.module?"core0":"","data-name":"Path 241",d:"M423.667,726.383h.1v-2.011h-3.811v2.011a.368.368,0,1,1-.736,0v-2.011h-3.811v2.011a.368.368,0,1,1-.736,0v-2.011h-3.811v2.011a.368.368,0,1,1-.736,0v-2.011H406.3v2.011a.367.367,0,0,1-.368.368.374.374,0,0,1-.368-.368v-2.011h-3.582a.367.367,0,0,1-.368-.368h0v-3.583h-2.01a.368.368,0,0,1,0-.737h2.01v-3.822h-2.01a.368.368,0,0,1,0-.737h2.01v-3.812h-2.01a.368.368,0,0,1,0-.737h2.01v-3.812h-2.01a.368.368,0,0,1,0-.737h2.01v-3.812h-2.01a.368.368,0,0,1,0-.737h2.01V697.9a.374.374,0,0,1,.368-.368h3.582v-2.011a.367.367,0,0,1,.368-.368h0a.367.367,0,0,1,.368.368h0v2.011h3.821v-2.011a.367.367,0,0,1,.368-.368h0a.367.367,0,0,1,.368.368v2.011h3.811v-2.011a.367.367,0,0,1,.368-.368h0a.367.367,0,0,1,.368.368v2.011h3.811v-2.011a.368.368,0,1,1,.736,0v2.011h3.811v-2.011a.368.368,0,1,1,.736,0h0v2.011h3.592a.374.374,0,0,1,.368.368v3.583h2.01a.367.367,0,0,1,.368.368h0a.367.367,0,0,1-.368.368h-2.01v3.822h2.01a.367.367,0,0,1,.368.368h0a.367.367,0,0,1-.368.368h-2.01v3.812h2.01a.367.367,0,0,1,.368.368h0a.367.367,0,0,1-.368.368h-2.01v3.812h2.01a.367.367,0,0,1,.368.368h0a.367.367,0,0,1-.368.368h-2.01v3.812h2.01a.367.367,0,0,1,.368.368h0a.367.367,0,0,1-.368.368h-2.01V724a.367.367,0,0,1-.368.368H424.5v2.011a.368.368,0,1,1-.736,0h-.2a.567.567,0,1,0,1.134,0v-1.812h3.393a.567.567,0,0,0,.567-.567V720.62h1.811a.567.567,0,0,0,.567-.567h0a.567.567,0,0,0-.567-.567h-1.811v-3.414h1.811a.567.567,0,0,0,.567-.567h0a.567.567,0,0,0-.567-.567h-1.811v-3.414h1.811a.567.567,0,0,0,.567-.567h0a.567.567,0,0,0-.567-.567h-1.811v-3.414h1.811a.567.567,0,0,0,.567-.567h0a.567.567,0,0,0-.567-.567h-1.811v-3.424h1.811a.567.567,0,0,0,.567-.567h0a.567.567,0,0,0-.567-.567h-1.811V697.9a.567.567,0,0,0-.567-.567H424.7v-1.812h0a.567.567,0,1,0-1.134,0v1.812h-3.413v-1.812a.567.567,0,1,0-1.134,0v1.812h-3.413v-1.812a.567.567,0,0,0-.567-.567h0a.567.567,0,0,0-.567.567v1.812H411.06v-1.812a.567.567,0,0,0-.567-.567h0a.567.567,0,0,0-.567.567v1.812H406.5v-1.812h0a.567.567,0,0,0-.567-.567h0a.567.567,0,0,0-.567.567v1.812h-3.383a.567.567,0,0,0-.567.567v3.384h-1.811a.567.567,0,0,0,0,1.135h1.811v3.414h-1.811a.567.567,0,0,0,0,1.135h1.811v3.414h-1.811a.567.567,0,0,0,0,1.135h1.811v3.394h-1.811a.567.567,0,0,0,0,1.135h1.811v3.424h-1.811a.567.567,0,0,0,0,1.135h1.811v3.384h0a.567.567,0,0,0,.567.567h3.383v1.812a.567.567,0,1,0,1.134,0v-1.812h3.423v1.812a.567.567,0,1,0,1.134,0v-1.812h3.413v1.812a.567.567,0,1,0,1.134,0v-1.812h3.413v1.812a.567.567,0,1,0,1.134,0v-1.812h3.413v1.812h.1Zm-21.244-2.857v.1h25.3V698.215h-25.4v25.411h.1v-.1h.1V698.414h25v25.013h-25.1v.1h0Zm20.836-1.473v-.1a.367.367,0,0,1-.368-.368h0a.367.367,0,0,1,.368-.368h2.05v-2.05a.374.374,0,0,1,.368-.368.367.367,0,0,1,.368.368v2.419a.367.367,0,0,1-.368.368h-2.418v.2h2.418a.567.567,0,0,0,.567-.567v-2.419a.567.567,0,1,0-1.134,0v1.851h-1.851a.567.567,0,0,0-.567.567h0a.567.567,0,0,0,.567.567Zm-18.886,0v-.1a.367.367,0,0,1-.368-.368h0v-2.419a.368.368,0,1,1,.736,0v2.05h2.05a.367.367,0,0,1,.368.368h0a.367.367,0,0,1-.368.368h-2.418v.2h2.418a.567.567,0,0,0,.567-.567h0a.567.567,0,0,0-.567-.567H404.94v-1.851a.567.567,0,1,0-1.134,0v2.419h0a.567.567,0,0,0,.567.567Zm14.826-7.166.09-.04-2.816-6.45h1.1l2.259,5.225,2.279-5.225h1.005l-2.786,6.39H419.2v.1l.09-.04-.09.04v.1h1.274l2.955-6.788h-1.443l-2.139,4.927-2.119-4.927h-1.542l2.965,6.788h.07v-.1Zm-4.905,0h.1V708.4h1.025v6.39h-1.124v.1h0v.1h1.323V708.2h-1.423v6.788h.1v-.1Zm-4.766,0,.09-.04L406.8,708.4h1.1l2.259,5.225,2.279-5.225h1l-2.786,6.39h-1.134v.1l.09-.04-.09.04v.1H410.8l2.955-6.788h-1.443l-2.149,4.927-2.119-4.927H406.5l2.965,6.788h.07v-.1Zm15.682-12.2h.1v-2.05h-2.05a.368.368,0,0,1,0-.737h2.418a.367.367,0,0,1,.368.368v2.419a.367.367,0,0,1-.368.368h0a.374.374,0,0,1-.368-.368h-.1l.09.03h0l.01-.02v-.02h-.1l-.09-.03h0l-.01.02v.02a.573.573,0,0,0,.567.567h0a.567.567,0,0,0,.567-.567v-2.419a.567.567,0,0,0-.567-.567h-2.418a.567.567,0,0,0,0,1.135h1.851v1.851h.1l-.09-.03Zm-21.3,0h.1v-2.419a.367.367,0,0,1,.368-.368h2.418a.367.367,0,0,1,.368.368h0a.374.374,0,0,1-.368.368h-.01l.01.1v-.1h-2.05v2.05a.367.367,0,0,1-.368.368h0a.374.374,0,0,1-.368-.368h-.1l.1.02h0v-.02h-.1l-.1-.02h0v.02a.573.573,0,0,0,.567.567h0a.567.567,0,0,0,.567-.567v-1.851H406.8l-.01-.08v.08h.01l-.01-.08v.08a.567.567,0,0,0,.567-.567h0a.567.567,0,0,0-.567-.567h-2.418a.567.567,0,0,0-.567.567v2.419h.1l-.1-.02Z",fill:"#b1bbe4"}))))},ai=function(){var e=Object(n.useContext)(Mt).state;return r.a.createElement("svg",{xmlns:"http://www.w3.org/2000/svg",width:"31.998",height:"32",viewBox:"0 0 31.998 32"},r.a.createElement("style",{type:"text/css"},"        .st0{          fill:url(#SVGID_1_);        }        .a{          fill:#b1bbe4;        }      "),r.a.createElement("g",{id:"pills",transform:"translate(-0.013 0)"},r.a.createElement("linearGradient",{id:"SVGID_1_",gradientUnits:"userSpaceOnUse",x1:"280.5868",y1:"501.2192",x2:"738.0239",y2:"501.2192"},r.a.createElement("stop",{offset:"1.060230e-06",style:{stopColor:"#29ABE2"}}),r.a.createElement("stop",{offset:"1",style:{stopColor:"#39B54A"}})),r.a.createElement("path",{id:"Union_3",class:"505b2"===e.module?"st0":"","data-name":"Union 3",d:"M-2000.193-266.894a7.265,7.265,0,0,1,.009-10.267l.066-.067a7.2,7.2,0,0,1,10.193.067l.007.008a7.264,7.264,0,0,1-.007,10.267,7.245,7.245,0,0,1-5.132,2.12A7.23,7.23,0,0,1-2000.193-266.894Zm1.632-.569a5.764,5.764,0,0,0,7.581-.493,5.746,5.746,0,0,0,.494-7.581Zm-2.252-4.565a5.793,5.793,0,0,0,1.19,3.51l8.075-8.082a5.759,5.759,0,0,0-3.5-1.19A5.765,5.765,0,0,0-2000.812-272.028Zm-16.845.179a7.3,7.3,0,0,1-.007-10.311l6.1-6.092a.744.744,0,0,1,.284-.284l6.062-6.061.06-.059a7.285,7.285,0,0,1,10.311.059,7.293,7.293,0,0,1-.059,10.312l-6.084,6.1a.784.784,0,0,1-.1.12.785.785,0,0,1-.12.1l-6.091,6.114-.008.007a7.349,7.349,0,0,1-5.178,2.128A7.326,7.326,0,0,1-2017.658-271.849Zm1.055-9.257a5.814,5.814,0,0,0,0,8.194,5.862,5.862,0,0,0,8.24,0l5.68-5.7-8.2-8.217Zm12.445-12.445-5.673,5.673,8.2,8.2,5.665-5.68a5.8,5.8,0,0,0,0-8.194,5.778,5.778,0,0,0-4.1-1.695A5.778,5.778,0,0,0-2004.158-293.55Zm-1.273,5.9a.746.746,0,0,1,.015-1.056l2.588-2.544a.733.733,0,0,1,1.056.008.745.745,0,0,1-.015,1.055l-2.581,2.544-.008.007a.742.742,0,0,1-.519.209A.746.746,0,0,1-2005.43-287.653Z",transform:"translate(2019.807 296.766)",fill:"#b1bbe4"})))},ni=function(){return r.a.createElement("svg",{xmlns:"http://www.w3.org/2000/svg",width:"42.38",height:"32.112",viewBox:"0 0 42.38 32.112"},r.a.createElement("g",{id:"Group_373","data-name":"Group 373",transform:"translate(-46.62 -387.888)"},r.a.createElement("g",{id:"baby",transform:"translate(46.62 349.693)"},r.a.createElement("path",{id:"Union_4","data-name":"Union 4",d:"M-2019.105-328.978a4.936,4.936,0,0,1-3.514-4.714,4.936,4.936,0,0,1,3.514-4.715,16.029,16.029,0,0,1,15.291-11.285,16.027,16.027,0,0,1,15.29,11.285,4.935,4.935,0,0,1,3.516,4.715,4.937,4.937,0,0,1-3.515,4.715,16.03,16.03,0,0,1-15.291,11.285A16.029,16.029,0,0,1-2019.105-328.978Zm.695-4.714a14.612,14.612,0,0,0,14.6,14.6,14.612,14.612,0,0,0,14.6-14.6,14.616,14.616,0,0,0-13.413-14.548,8.642,8.642,0,0,0,3.714,3.295.7.7,0,0,1,.349.93.7.7,0,0,1-.64.411.707.707,0,0,1-.29-.063,10.021,10.021,0,0,1-4.767-4.613,14.48,14.48,0,0,0-5.149,1.11,13.686,13.686,0,0,0,7.346,6.583.7.7,0,0,1,.391.913.7.7,0,0,1-.652.441.7.7,0,0,1-.261-.05,14.907,14.907,0,0,1-8.1-7.282A14.61,14.61,0,0,0-2018.41-333.692Zm30.6,0a16.014,16.014,0,0,1-.284,3,3.526,3.526,0,0,0,1.687-3,3.529,3.529,0,0,0-1.687-3A16.024,16.024,0,0,1-1987.814-333.692Zm-33.4,0a3.529,3.529,0,0,0,1.686,3,16.005,16.005,0,0,1-.283-3,16.014,16.014,0,0,1,.283-3A3.53,3.53,0,0,0-2021.216-333.692Zm12.863,7.8a.764.764,0,0,1,0-1.081.764.764,0,0,1,1.081,0,4.99,4.99,0,0,0,7.049,0,.765.765,0,0,1,1.082,0,.765.765,0,0,1,0,1.081,6.472,6.472,0,0,1-4.606,1.909A6.47,6.47,0,0,1-2008.354-325.895Zm3.52-3.15a.764.764,0,0,1-.765-.764.764.764,0,0,1,.765-.765h2.04a.764.764,0,0,1,.764.765.764.764,0,0,1-.764.764Zm8.71-2.372a1.788,1.788,0,0,0-1.786-1.786,1.788,1.788,0,0,0-1.786,1.786.764.764,0,0,1-.765.764.764.764,0,0,1-.764-.764,3.319,3.319,0,0,1,3.316-3.316,3.318,3.318,0,0,1,3.315,3.316.764.764,0,0,1-.764.764A.764.764,0,0,1-1996.124-331.417Zm-11.809,0a1.788,1.788,0,0,0-1.786-1.786,1.788,1.788,0,0,0-1.786,1.786.764.764,0,0,1-.765.764.764.764,0,0,1-.764-.764,3.319,3.319,0,0,1,3.316-3.316,3.318,3.318,0,0,1,3.315,3.316.764.764,0,0,1-.765.764A.764.764,0,0,1-2007.932-331.417Z",transform:"translate(2022.62 387.888)",fill:"#b1bbe4"})),r.a.createElement("g",{id:"Group_370","data-name":"Group 370",transform:"translate(139.9 18.525)"},r.a.createElement("circle",{id:"Ellipse_56","data-name":"Ellipse 56",cx:"8",cy:"8",r:"8",transform:"translate(-66.9 385.475)",fill:"#b1bbe4"}),r.a.createElement("path",{id:"padlock",d:"M7.888,2.793H7.655V1.862a1.862,1.862,0,0,0-3.724,0v.931H3.7a.7.7,0,0,0-.7.7V6.75a.7.7,0,0,0,.7.7h4.19a.7.7,0,0,0,.7-.7V3.491A.7.7,0,0,0,7.888,2.793ZM4.552,1.862a1.241,1.241,0,0,1,2.483,0v.931H4.552ZM6.1,5.189V5.9a.31.31,0,1,1-.621,0V5.189a.621.621,0,1,1,.621,0Z",transform:"translate(-64.519 389.482)",fill:"#fff"}))))},ri=function(){var e=Object(n.useContext)(Mt).state;return r.a.createElement("svg",{xmlns:"http://www.w3.org/2000/svg",width:"37.612",height:"32",viewBox:"0 0 27 34.463"},r.a.createElement("style",{type:"text/css"},"        .st0{          fill:url(#SVGID_1_);        }        .a{          fill:#b1bbe4;        }      "),r.a.createElement("g",{id:"experiment-results",transform:"translate(-39.903 0)"},r.a.createElement("linearGradient",{id:"SVGID_1_",gradientUnits:"userSpaceOnUse",x1:"280.5868",y1:"501.2192",x2:"738.0239",y2:"501.2192"},r.a.createElement("stop",{offset:"1.060230e-06",style:{stopColor:"#29ABE2"}}),r.a.createElement("stop",{offset:"1",style:{stopColor:"#39B54A"}})),r.a.createElement("path",{id:"Union_5",class:"pmr"===e.module?"st0":"","data-name":"Union 5",d:"M3.392,34.463A3.4,3.4,0,0,1,0,31.07V5.015A3.4,3.4,0,0,1,3.392,1.623H7.539V0H19.461V1.623h4.147A3.4,3.4,0,0,1,27,5.015V31.07a3.4,3.4,0,0,1-3.392,3.393ZM1.4,5.015V31.07a1.992,1.992,0,0,0,1.99,1.99H23.608a1.992,1.992,0,0,0,1.99-1.99V5.015a1.992,1.992,0,0,0-1.99-1.99H19.461V4.647H7.539V3.025H3.392A1.992,1.992,0,0,0,1.4,5.015ZM8.942,3.244h9.117V1.4H8.942Zm-5.24,27v-1.4H19.54v1.4Zm0-3.428v-1.4h7.919v1.4ZM14.174,19.64A1.773,1.773,0,0,1,12.6,18.295l-.848-3.342a.392.392,0,0,0-.761,0l-.765,3.151a1.8,1.8,0,0,1-3.391.293l-.754-1.734a.391.391,0,0,0-.36-.236H3.7v-1.4H5.723a1.794,1.794,0,0,1,1.646,1.079l.754,1.734a.393.393,0,0,0,.741-.064l.765-3.151a1.768,1.768,0,0,1,1.734-1.372h.011a1.769,1.769,0,0,1,1.739,1.353l.848,3.342a.392.392,0,0,0,.736.069l.39-.839a1.794,1.794,0,0,1,3.109-.259l.02.03a.392.392,0,0,0,.651-.006l.73-1.109a1.791,1.791,0,0,1,1.5-.807h2.2v1.4H21.1a.392.392,0,0,0-.328.176l-.729,1.108a1.793,1.793,0,0,1-1.484.808h-.016a1.793,1.793,0,0,1-1.481-.781l-.02-.03a.392.392,0,0,0-.679.056l-.39.84a1.775,1.775,0,0,1-1.622,1.04C14.29,19.649,14.232,19.646,14.174,19.64Z",transform:"translate(39.903 0)",fill:"#b1bbe4"})))},ii=function(){return r.a.createElement("svg",{xmlns:"http://www.w3.org/2000/svg",width:"37.612",height:"32",viewBox:"0 0 27.845 30"},r.a.createElement("g",{id:"logout",transform:"translate(-17.6 0)"},r.a.createElement("g",{id:"Group_358","data-name":"Group 358",transform:"translate(17.6 0)"},r.a.createElement("g",{id:"Group_357","data-name":"Group 357",transform:"translate(0)"},r.a.createElement("path",{id:"Union_6","data-name":"Union 6",d:"M5.7,30A5.71,5.71,0,0,1,0,24.3V5.7A5.711,5.711,0,0,1,5.7,0H13.54a1.05,1.05,0,1,1,0,2.1H5.7A3.607,3.607,0,0,0,2.1,5.7V24.3a3.607,3.607,0,0,0,3.6,3.6h7.709a1.05,1.05,0,1,1,0,2.1Zm14.317-8.23a1.053,1.053,0,0,1,0-1.488L24.25,16.05H7.3a1.05,1.05,0,1,1,0-2.1H24.244L19.982,9.688A1.052,1.052,0,1,1,21.47,8.2l6.057,6.051a.9.9,0,0,1,.073.079l.013.013a.57.57,0,0,1,.049.067c.006.007.006.013.012.019a.415.415,0,0,1,.043.073.024.024,0,0,1,.006.013c.013.024.024.055.037.079.006.006.006.006.006.013a.5.5,0,0,1,.031.085c.006,0,.006.007.006.013.006.03.012.055.019.085a.059.059,0,0,1,.006.031.317.317,0,0,1,.012.073.537.537,0,0,1,.007.1.545.545,0,0,1-.007.1c-.006.024-.006.049-.012.073a.055.055,0,0,0-.006.03.463.463,0,0,1-.019.086c-.006,0-.006.006-.006.012-.013.03-.019.062-.031.086-.006.006-.006.006-.006.012-.013.03-.024.055-.037.08a.021.021,0,0,0-.006.012c-.012.024-.03.049-.043.073-.006.006-.006.013-.012.019a.485.485,0,0,1-.049.068l-.013.012a1.071,1.071,0,0,0-.079.086L21.5,21.77a1.05,1.05,0,0,1-1.482,0Z",fill:"#b1bbe4"})))))},oi=function(){var e=Object(n.useContext)(Mt).state;return r.a.createElement("svg",{xmlns:"http://www.w3.org/2000/svg",width:"37.612",height:"32",viewBox:"0 0 29.788 35.841"},r.a.createElement("defs",null,r.a.createElement("style",{type:"text/css"},"        .st0{          fill:url(#SVGID_1_);        }        .a{          fill:#b1bbe4;        }      ")),r.a.createElement("g",{transform:"translate(0 -0.05)"},r.a.createElement("linearGradient",{id:"SVGID_1_",gradientUnits:"userSpaceOnUse",x1:"280.5868",y1:"501.2192",x2:"738.0239",y2:"501.2192"},r.a.createElement("stop",{offset:"1.060230e-06",style:{stopColor:"#29ABE2"}}),r.a.createElement("stop",{offset:"1",style:{stopColor:"#39B54A"}})),r.a.createElement("path",{class:"biologics"===e.module?"st0":"a",d:"M29.229,2.931,15.04.063a.709.709,0,0,0-.275,0L.576,2.931a.708.708,0,0,0-.576.7V17.684A18.554,18.554,0,0,0,14.756,35.878a.709.709,0,0,0,.275,0A18.552,18.552,0,0,0,29.787,17.684V3.631a.693.693,0,0,0-.559-.7Zm-.851,14.752A17.131,17.131,0,0,1,14.9,34.444,17.131,17.131,0,0,1,1.419,17.684V4.222L14.9,1.5,28.377,4.222Z",transform:"translate(0 0)"}),r.a.createElement("path",{class:"biologics"===e.module?"st0":"a",d:"M46.011,78.539a2.909,2.909,0,0,0-4.017,0,2.831,2.831,0,0,0,0,4.008h0l2.341,2.341-1,1-2.341-2.341a.709.709,0,1,0-1.02.984l.018.018,5.693,5.693a.709.709,0,0,0,1.02-.984l-.018-.018L44.344,86.9l1-1,2.971,2.971v8.921a2.838,2.838,0,1,0,5.675,0v-8.93l2.971-2.971,1,1-2.341,2.341a.709.709,0,0,0,.984,1.02l.018-.018,5.693-5.693a.709.709,0,0,0-.984-1.02l-.018.018-2.341,2.341-1-1,2.341-2.341a2.831,2.831,0,0,0,0-4.008h0a2.909,2.909,0,0,0-4.017,0l-5.152,5.143ZM51.145,99.21a1.423,1.423,0,0,1-1.419-1.419V94.953h2.838v2.838A1.423,1.423,0,0,1,51.145,99.21Zm6.146-19.669a1.458,1.458,0,0,1,2,0,1.424,1.424,0,0,1,0,2l-2.847,2.847h0l-3.671,3.671a.7.7,0,0,0-.2.505v4.966H49.735V88.568a.718.718,0,0,0-.2-.505l-6.518-6.518a1.417,1.417,0,1,1,2-2.013l.009.009,5.64,5.64a.712.712,0,0,0,1,0Z",transform:"translate(-36.247 -70.58)"})))},li=function(){return r.a.createElement("svg",{xmlns:"http://www.w3.org/2000/svg",width:"37.612",height:"32",viewBox:"0 0 27.845 30"},r.a.createElement("defs",null),r.a.createElement("g",{transform:"translate(0)"},r.a.createElement("path",{class:"a",fill:"#b1bbe4",d:"M5.7,0A5.71,5.71,0,0,0,0,5.7V24.3A5.711,5.711,0,0,0,5.7,30H13.54a1.05,1.05,0,1,0,0-2.1H5.7a3.607,3.607,0,0,1-3.6-3.6V5.7A3.607,3.607,0,0,1,5.7,2.1h7.709a1.05,1.05,0,1,0,0-2.1ZM20.018,8.23a1.053,1.053,0,0,0,0,1.488L24.25,13.95H7.3a1.05,1.05,0,1,0,0,2.1H24.244l-4.262,4.262A1.052,1.052,0,1,0,21.47,21.8l6.057-6.051a.9.9,0,0,0,.073-.079l.013-.013a.57.57,0,0,0,.049-.067c.006-.007.006-.013.012-.019a.415.415,0,0,0,.043-.073.024.024,0,0,0,.006-.013c.013-.024.024-.055.037-.079.006-.006.006-.006.006-.013a.5.5,0,0,0,.031-.085c.006,0,.006-.007.006-.013.006-.03.012-.055.019-.085a.059.059,0,0,0,.006-.031.317.317,0,0,0,.012-.073.537.537,0,0,0,.007-.1.545.545,0,0,0-.007-.1c-.006-.024-.006-.049-.012-.073a.055.055,0,0,1-.006-.03.463.463,0,0,0-.019-.086c-.006,0-.006-.006-.006-.012-.013-.03-.019-.062-.031-.086-.006-.006-.006-.006-.006-.012-.013-.03-.024-.055-.037-.08a.021.021,0,0,1-.006-.012c-.012-.024-.03-.049-.043-.073-.006-.006-.006-.013-.012-.019a.485.485,0,0,0-.049-.068l-.013-.012a1.071,1.071,0,0,1-.079-.086L21.5,8.23a1.05,1.05,0,0,0-1.482,0Z",transform:"translate(27.845 30) rotate(180)"})))},ci=a(475),si=a.n(ci),di=Object(f.a)((function(e){return{MainText:{cursor:"auto",color:"#000000",fontFamily:"Ubuntu, Helvetica, Arial, sans-serif",fontSize:"18px",lineHeight:"1.5",textAlign:"center",fontWeight:"bold",padding:"15px"},subtext:{fontSize:"13px",lineHeight:"1.5",textAlign:"center",fontWeight:"600",padding:"10px"},remember:{fontSize:"13px",lineHeight:"1.5",textAlign:"center",fontWeight:"600",padding:"10px",color:"#008B8B"}}}),{index:1}),mi=function(e){var t=di(),a=Object(n.useState)(),i=Object(d.a)(a,2),o=i[0],l=i[1],m=Object(n.useState)(),u=Object(d.a)(m,2),p=u[0],g=u[1];return Object(n.useEffect)((function(){function t(){return(t=Object(s.a)(c.a.mark((function t(){return c.a.wrap((function(t){for(;;)switch(t.prev=t.next){case 0:try{g(e.module),l(e.license)}catch(a){}case 1:case"end":return t.stop()}}),t)})))).apply(this,arguments)}!function(){t.apply(this,arguments)}()})),r.a.createElement("div",null,console.log("hi",o),o?r.a.createElement(C.a,null,"Evaluation"!==o&&"Educational"!==o&&"Free"!==o&&"Free/Community"!==o||"pmr"!==p?null:r.a.createElement(C.a,null,r.a.createElement(j.a,{edge:"start",id:"pmrIcon",style:{zoom:1.3}},r.a.createElement(ri,null)),r.a.createElement(C.a,null,r.a.createElement(y.a,{className:t.MainText},"You don't have permission to access PMR"),r.a.createElement(y.a,{className:t.subtext},"You can always contact us using the button below and we will get back to you within 24 hours."),r.a.createElement(y.a,{className:t.remember},"Remember - we're glad to have you with us!")))):null)},ui=a(1918),pi=a(1919),gi=a(1135),hi=a.n(gi),Ti=a(1133),fi=a.n(Ti),Ai=a(1134),Ei=a.n(Ai),bi=a(1132),Ni=a.n(bi),Ci=Object(f.a)((function(e){return{root:Object(g.a)({background:e.palette.backgrounds.dark,boxShadow:"5px 0px 5px ".concat(e.palette.adminHome.grayText),height:e.spacing(7.5)},e.breakpoints.down("sm"),{height:e.spacing(6.5)}),vivLogo:{width:e.spacing(20),height:"100%",marginTop:e.spacing(-1)},linkBox:{width:e.spacing(40)},navIcon:{color:e.palette.white,cursor:"pointer"},menuIcon:{color:e.palette.adminHome.primaryBlack,fontWeight:"bold",fontSize:e.spacing(2.5)},menuText:{color:e.palette.adminHome.primaryBlack},headerIcon:{color:e.palette.common.grayBorder},cursorPointer:{cursor:"pointer"},container:{display:"flex",flexDirection:"row",justifyContent:"space-between",padding:e.spacing(0)},button:{background:e.palette.buttons.purple,color:e.palette.white,width:e.spacing(10),fontWeight:"bold",marginRight:e.spacing(.5),padding:e.spacing(1),borderRadius:e.spacing(1),"&:hover":{opacity:.8,background:e.palette.buttons.purple}},links:{marginRight:e.spacing(9),color:e.palette.common.primaryGray},navLinks:{color:e.palette.adminHome.grayText,fontSize:e.spacing(2),fontWeight:"bold",textDecoration:"none","&:hover":{color:e.palette.buttons.purple}},responsiveLogo:{cursor:"pointer"}}})),Si=function(){var e=Ci(),t=Object(n.useContext)(Mt),a=t.state,i=t.dispatch,o=Object(u.f)(),l=Object(n.useState)(),m=Object(d.a)(l,2),p=(m[0],m[1]),g=Object(n.useState)(null),h=Object(d.a)(g,2),f=h[0],A=h[1];Object(n.useEffect)((function(){(function(){var e=Object(s.a)(c.a.mark((function e(){var t;return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:return e.prev=0,e.next=3,T.a.currentUserInfo();case 3:return t=e.sent,e.next=6,i({type:wt.SET_MODULE,value:"admin"});case 6:if(console.log(t),t){e.next=11;break}o.push("/login"),e.next=13;break;case 11:return e.next=13,i({type:wt.SET_USER_STUB,value:t.attributes});case 13:p(t.attributes),e.next=19;break;case 16:e.prev=16,e.t0=e.catch(0),console.log(e.t0);case 19:case"end":return e.stop()}}),e,null,[[0,16]])})));return function(){return e.apply(this,arguments)}})()()}),[]);var E=function(){var e=Object(s.a)(c.a.mark((function e(){return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:return e.prev=0,e.next=3,T.a.signOut();case 3:return e.next=5,i({type:wt.SET_USER,value:null});case 5:o.push("/"),e.next=11;break;case 8:e.prev=8,e.t0=e.catch(0),console.log("error signing out: ",e.t0);case 11:case"end":return e.stop()}}),e,null,[[0,8]])})));return function(){return e.apply(this,arguments)}}();return r.a.createElement(ui.a,{elevation:3,position:"fixed",className:e.root},r.a.createElement(pi.a,{maxWidth:"lg",className:e.container},r.a.createElement(Ta.a,null,r.a.createElement(Xt.a,{href:"/admin"},r.a.createElement(R.a,{className:e.responsiveLogo},r.a.createElement("img",{src:Ni.a,className:e.vivLogo,alt:"logo"})))),r.a.createElement(Ta.a,null,r.a.createElement(R.a,{display:"flex",justifyContent:"space-evenly",className:e.linkBox},r.a.createElement(Xt.a,{underline:"none",href:"/admin/reviews"},r.a.createElement(y.a,{className:e.navLinks},"Data Curation")))),r.a.createElement(Ta.a,null,a.userStub&&a.userStub?r.a.createElement(r.a.Fragment,null,r.a.createElement(j.a,{onClick:function(e){A(e.currentTarget)}},r.a.createElement(fi.a,{className:e.navIcon})),r.a.createElement(Ea.a,{id:"simple-menu",anchorEl:f,getContentAnchorEl:null,keepMounted:!0,anchorOrigin:{vertical:"bottom",horizontal:"center"},transformOrigin:{vertical:"top",horizontal:"center"},open:Boolean(f),onClose:function(){A(null)}},r.a.createElement(la.a,null,r.a.createElement(Sa.a,null,r.a.createElement(Oa.a,{className:e.menuIcon,color:"primary",fontSize:"small"})),r.a.createElement(y.a,{className:e.username},a.userStub&&a.userStub["custom:user"])),r.a.createElement(la.a,null,r.a.createElement(Sa.a,null,r.a.createElement(Ei.a,{className:e.menuIcon,color:"primary",fontSize:"small"})),r.a.createElement(y.a,{className:e.username},a.userStub&&a.userStub["custom:role"])),r.a.createElement(vt.a,null),r.a.createElement(la.a,{button:!0,onClick:E},r.a.createElement(Sa.a,null,r.a.createElement(hi.a,{className:e.menuIcon,fontSize:"large"})),r.a.createElement(ya.a,{className:e.menuText},"Logout")),r.a.createElement(la.a,null))):null)))};function yi(e){var t,a,i=Object(u.f)(),o=Object(n.useContext)(Mt),l=o.state,m=o.dispatch,p=(Object(u.g)(),pa()),h=Object(n.useState)(""),f=Object(d.a)(h,2),A=f[0],E=f[1],b=Object(n.useState)(!1),O=Object(d.a)(b,2),x=O[0],v=O[1],P=Object(n.useState)("US FDA - Drug & Biologics"),I=Object(d.a)(P,2),L=I[0],B=I[1],M=Object(n.useState)([{Category:"TA/Indication",Search:"",Relation:"AND"}]),F=Object(d.a)(M,2),z=F[0],Y=F[1],G=r.a.useState(null),H=Object(d.a)(G,2),Q=H[0],K=H[1],Z=Object(n.useState)(null),X=Object(d.a)(Z,2),q=X[0],$=X[1],ee=Object(n.useState)(null),te=Object(d.a)(ee,2),ae=te[0],ne=(te[1],Object(n.useState)("")),re=Object(d.a)(ne,2),ie=re[0],oe=re[1],le=Object(n.useState)(""),ce=Object(d.a)(le,2),se=ce[0],de=ce[1],me=Object(n.useState)(),ue=Object(d.a)(me,2),pe=ue[0],ge=ue[1],Ae=Object(n.useState)(JSON.parse(localStorage.getItem("searchQuery"))),Ee=Object(d.a)(Ae,2),be=(Ee[0],Ee[1],Object(n.useState)(JSON.parse(localStorage.getItem("filters")))),Ne=Object(d.a)(be,2),Ce=(Ne[0],Ne[1],Object(n.useState)(null)),Se=Object(d.a)(Ce,2),ye=Se[0],Le=Se[1],je=Object(n.useState)(null),Be=Object(d.a)(je,2),Ue=Be[0],ke=Be[1],Me=Object(n.useState)(""),Fe=Object(d.a)(Me,2),ze=Fe[0],Ye=Fe[1],Ve=Object(n.useState)(""),Ge=Object(d.a)(Ve,2),He=Ge[0],We=Ge[1],Qe=Object(n.useState)("TA/Indication"),Je=Object(d.a)(Qe,2),Ke=Je[0],Ze=Je[1],Xe=Object(n.useState)(!1),qe=Object(d.a)(Xe,2),$e=qe[0],et=qe[1],tt=Object(n.useState)(null),at=Object(d.a)(tt,2),nt=at[0],rt=at[1],it=Object(n.useState)(null),ot=Object(d.a)(it,2),lt=ot[0],ct=ot[1],st=Object(n.useState)(null),dt=Object(d.a)(st,2),mt=dt[0],ut=dt[1],pt=Object(n.useState)(null),gt=Object(d.a)(pt,2),ht=gt[0],Tt=gt[1],ft=Object(n.useState)(null),At=Object(d.a)(ft,2),Et=At[0],bt=At[1],Nt=Object(n.useState)(null),Ct=Object(d.a)(Nt,2),St=Ct[0],yt=Ct[1],Dt=Object(n.useState)(null),_t=Object(d.a)(Dt,2),Ot=_t[0],xt=_t[1],Rt=Object(n.useState)(null),Pt=Object(d.a)(Rt,2),Lt=Pt[0],jt=Pt[1],Bt=Object(n.useState)("Route"),Ut=Object(d.a)(Bt,2),kt=Ut[0],Ft=Ut[1],zt=Object(n.useState)(),Yt=Object(d.a)(zt,2),Vt=Yt[0],Gt=Yt[1],Ht=Object(n.useState)(),Wt=Object(d.a)(Ht,2),Qt=Wt[0],Jt=Wt[1],Kt=Object(n.useState)([]),Zt=Object(d.a)(Kt,2),Xt=(Zt[0],Zt[1],Object(n.useState)()),qt=Object(d.a)(Xt,2),$t=(qt[0],qt[1]),ea=Object(n.useState)(),ta=Object(d.a)(ea,2),aa=ta[0],na=ta[1],ra=Object(n.useState)(!1),ia=Object(d.a)(ra,2),da=ia[0],ma=ia[1],ua=Object(n.useState)(),ba=Object(d.a)(ua,2),_a=ba[0],xa=ba[1],wa=r.a.useState(null),Ba=Object(d.a)(wa,2),Ua=Ba[0],ka=Ba[1],Ma=Boolean(Ua),Fa=Ma?"pmr-popover":void 0,za=function(e){K(e.currentTarget)},Ya=function(){var e=Object(s.a)(c.a.mark((function e(t){var a;return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:a=t.target.value,Gt(a);case 2:case"end":return e.stop()}}),e)})));return function(t){return e.apply(this,arguments)}}(),Va=function(){var e=Object(s.a)(c.a.mark((function e(){return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:return e.next=2,m({type:wt.SET_PDF_MESSAGE,value:"Nothing has been added to the report"});case 2:v(!1);case 3:case"end":return e.stop()}}),e)})));return function(){return e.apply(this,arguments)}}(),Ga=function(){$(null)},Ha=Boolean(q),Wa=Ha?"simple-popover":void 0;Boolean(ae);Object(n.useEffect)((function(){function e(){return(e=Object(s.a)(c.a.mark((function e(){var t,a,n,r,o;return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:return e.prev=0,console.log("Enter"),"biologics"===l.module?B("Biologics"):B("US FDA - Drug & Biologics"),e.next=5,T.a.currentAuthenticatedUser();case 5:return t=e.sent,$t(t),"Data Curator"===t.attributes["custom:role"]&&i.push("/admin"),e.next=10,m({type:wt.SET_USER_STUB,value:t.attributes});case 10:return oe(t.attributes.email),Ye(t.attributes["custom:status"]),de(t.attributes["custom:user"]),We(t.attributes["custom:license"]),a=t.attributes["custom:user"],n=a.substr(0,a.indexOf(" ")),r=a.split(" ").pop(),n=n.substr(0,1),r=r.substr(0,1),o=n+r,console.log("initial",o,n,r),na(o),e.next=24,m({type:wt.SET_USER_STUB,value:{attributes:t.attributes,initials:o}});case 24:e.next=29;break;case 26:e.prev=26,e.t0=e.catch(0),console.log(e.t0);case 29:case"end":return e.stop()}}),e,null,[[0,26]])})))).apply(this,arguments)}!function(){e.apply(this,arguments)}()}),[l.module]);var Qa=function(e){ke(e)},Ja=function(){var e=Object(s.a)(c.a.mark((function e(t){var a,n;return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:return t.preventDefault(),localStorage.removeItem("filterList"),localStorage.removeItem("filters"),a={"TA/Indication":"indications_and_usage","Active Ingredient":"substance_name","Trade Name":"brand_name",Formulation:"formulation",Route:"route","Approval Date":"approval_date"},n={},n="biologics"===l.module?{Biologics:"US"}:{"US FDA - Drug & Biologics":"US"},e.next=8,m({type:wt.SET_SEARCH_TERM,value:{source:L,category:Ke,searchTerm:"Approval Date"===Ke?"from "+nt+" to "+lt:A}});case 8:"Approval Date"===Ke?localStorage.setItem("navigation",JSON.stringify({cards:{url:"/search/label/".concat(l.module,"/").concat(a[Ke],"/rangeSearch/").concat(n[L],"?startDate=").concat(nt,"&endDate=").concat(lt),value:"".concat(L,"/").concat(Ke)}})):localStorage.setItem("navigation",JSON.stringify({cards:{url:"/search/label/".concat(l.module,"/").concat(a[Ke],"/").concat(A,"/").concat(n[L]),value:"".concat(L,"/").concat(Ke," - ").concat(A)}})),"Approval Date"===Ke?i.push("/search/label/".concat(l.module,"/").concat(a[Ke],"/rangeSearch/").concat(n[L],"?startDate=").concat(nt,"&endDate=").concat(lt)):i.push("/search/label/".concat(l.module,"/").concat(a[Ke],"/").concat(A,"/").concat(n[L]));case 10:case"end":return e.stop()}}),e)})));return function(t){return e.apply(this,arguments)}}(),Ka=function(){var e=Object(s.a)(c.a.mark((function e(t){var a,n,r,o,s,d,u,p,g,h,T,f,A,E,b,N,C,S,y,D,_,O,x;return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:for(t.preventDefault(),localStorage.removeItem("filterList"),localStorage.removeItem("filters"),a={"TA/Indication":"indications_and_usage","Active Ingredient":"active_ingredients","Trade Name":"trade_name",Formulation:"formulation",Route:"route","Approval Date":"approval_date"},n=[],r=[],o=[],s=[],d=0,u=z.length;d<u;d++)"AND"===z[d].Relation?(p={field:a[z[d].Category],values:z[d].Search},n.push(p)):"OR"===z[d].Relation?(g={field:a[z[d].Category],values:z[d].Search},r.push(g)):"NOT"===z[d].Relation&&(h={field:a[z[d].Category],values:z[d].Search},o.push(h)),ye&&Ue&&(T=new Intl.DateTimeFormat("en",{year:"numeric"}).format(ye),f=new Intl.DateTimeFormat("en",{month:"2-digit"}).format(ye),A=new Intl.DateTimeFormat("en",{day:"2-digit"}).format(ye),E="".concat(T,"-").concat(f,"-").concat(A),T=new Intl.DateTimeFormat("en",{year:"numeric"}).format(Ue),f=new Intl.DateTimeFormat("en",{month:"2-digit"}).format(Ue),A=new Intl.DateTimeFormat("en",{day:"2-digit"}).format(Ue),b="".concat(T,"-").concat(f,"-").concat(A),N={field:"approval_date",values:[E,b]},s.push(N));return C={and:n,or:r,not:o,filter:s},e.next=12,m({type:wt.SET_ADVANCE_SEARCH,value:C});case 12:for(localStorage.setItem("advanceSearch",JSON.stringify(C)),S=[],y=[],D=[],_=[],O=0,x=z.length;O<x;O++)"AND"===z[O].Relation&&(x>1&&O<x-1?(_.push("".concat(z[O].Category," - ").concat(z[O].Search," AND ")),S.push("".concat(z[O].Category," -")),y.push(" ".concat(z[O].Search)),D.push(" AND ")):(_.push("".concat(z[O].Category," - ").concat(z[O].Search)),S.push("".concat(z[O].Category," -")),y.push(" ".concat(z[O].Search)))),"OR"===z[O].Relation&&(x>1?O<x-1?(_.push("".concat(z[O].Category," - ").concat(z[O].Search," OR ")),S.push("".concat(z[O].Category," -")),y.push(" ".concat(z[O].Search)),D.push(" OR ")):(_.push("".concat(z[O].Category," - ").concat(z[O].Search)),S.push("".concat(z[O].Category," -")),y.push(" ".concat(z[O].Search))):(_.push("".concat(z[O].Category,"-").concat(z[O].Search)),S.push("".concat(z[O].Category," -")),y.push("".concat(z[O].Search)))),"NOT"===z[O].Relation&&(x>1?O<x-1?(_.push("".concat(z[O].Category," - ").concat(z[O].Search," NOT ")),S.push("".concat(z[O].Category," -")),y.push(" ".concat(z[O].Search)),D.push(" NOT ")):(_.push("".concat(z[O].Category," - ").concat(z[O].Search)),S.push("".concat(z[O].Category," -")),y.push(" ".concat(z[O].Search))):(_.push("".concat(z[O].Category,"-").concat(z[O].Search)),S.push("".concat(z[O].Category," -")),y.push(" ".concat(z[O].Search))));localStorage.setItem("navigation",JSON.stringify({cards:{url:"/search/advance/".concat(l.module),value:"".concat(L,"/Advanced Search"),advValue:"".concat(_),adv:S,advSearch:y,advRelation:D}})),i.push("/search/advance/".concat(l.module)),$(null);case 21:case"end":return e.stop()}}),e)})));return function(t){return e.apply(this,arguments)}}(),Za=function(){var e=Object(s.a)(c.a.mark((function e(t){var a,n;return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:for(a=0,n=z.length;a<n;a++)z[a].Search.length>=2&&("Trade Name"===z[a].Category?De(z[a].Search).then((function(e){for(var t=[],a=e.data.success,n=0;n<a.length;n++)t.push(a[n].trade_name);ge(t)})).catch((function(e){console.log(e)})):"Active Ingredient"===z[a].Category?_e(z[a].Search).then((function(e){for(var t=[],a=e.data.success,n=0;n<a.length;n++)t.push(a[n].active_ingredients);ge(t)})).catch((function(e){console.log(e)})):"Formulation"===z[a].Category?Oe(z[a].Search).then((function(e){for(var t=[],a=e.data.success,n=0;n<a.length;n++)t.push(a[n].formulation);ge(t)})).catch((function(e){console.log(e)})):"Route"===z[a].Category?xe(z[a].Search).then((function(e){for(var t=[],a=e.data.success,n=0;n<a.length;n++)t.push(a[n].route);ge(t)})).catch((function(e){console.log(e)})):ve(z[a].Search).then((function(e){for(var t=[],a=e.data.success,n=0;n<a.length;n++)t.push(a[n].title);ge(t)})).catch((function(e){console.log(e)})));case 1:case"end":return e.stop()}}),e)})));return function(t){return e.apply(this,arguments)}}(),Xa=function(){var e=Object(s.a)(c.a.mark((function e(t){return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:"biologics"===l.module?t.target.value.length>=2&&("Trade Name"===Ke?(a=t.target.value,Te.get("/clignosis/tradeNameSearch/bla/".concat(a),{headers:{Authorization:fe}})).then((function(e){for(var t=[],a=e.data.success,n=0;n<a.length;n++)t.push(a[n].trade_name);ge(t)})).catch((function(e){console.log(e)})):"Active Ingredient"===Ke?Pe(t.target.value).then((function(e){for(var t=[],a=e.data.success,n=0;n<a.length;n++)t.push(a[n].active_ingredients);ge(t)})).catch((function(e){console.log(e)})):"Formulation"===Ke?Ie(t.target.value).then((function(e){for(var t=[],a=e.data.success,n=0;n<a.length;n++)t.push(a[n].formulation);ge(t)})).catch((function(e){console.log(e)})):"Route"===Ke?we(t.target.value).then((function(e){for(var t=[],a=e.data.success,n=0;n<a.length;n++)t.push(a[n].route);ge(t)})).catch((function(e){console.log(e)})):Re(t.target.value).then((function(e){for(var t=[],a=e.data.success,n=0;n<a.length;n++)t.push(a[n].title);ge(t)})).catch((function(e){console.log(e)}))):t.target.value.length>=2&&("Trade Name"===Ke?De(t.target.value).then((function(e){for(var t=[],a=e.data.success,n=0;n<a.length;n++)t.push(a[n].trade_name);ge(t)})).catch((function(e){console.log(e)})):"Active Ingredient"===Ke?_e(t.target.value).then((function(e){for(var t=[],a=e.data.success,n=0;n<a.length;n++)t.push(a[n].active_ingredients);ge(t)})).catch((function(e){console.log(e)})):"Formulation"===Ke?Oe(t.target.value).then((function(e){for(var t=[],a=e.data.success,n=0;n<a.length;n++)t.push(a[n].formulation);ge(t)})).catch((function(e){console.log(e)})):"Route"===Ke?xe(t.target.value).then((function(e){for(var t=[],a=e.data.success,n=0;n<a.length;n++)t.push(a[n].route);ge(t)})).catch((function(e){console.log(e)})):ve(t.target.value).then((function(e){for(var t=[],a=e.data.success,n=0;n<a.length;n++)t.push(a[n].title);ge(t)})).catch((function(e){console.log(e)})));case 1:case"end":return e.stop()}var a}),e)})));return function(t){return e.apply(this,arguments)}}(),qa=function(){var e=Object(s.a)(c.a.mark((function e(t){var a,n,r,o;return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:return t.preventDefault(),a={},n={},r={},"Route"===kt?(a.from=Vt.toUpperCase(),a.to=Qt.toUpperCase()):"Formulation"===kt&&(n.from=Vt.toUpperCase(),n.to=Qt.toUpperCase()),null!==Et&&null!==St&&(r.from=Et,r.to=St),o={route:a,formulations:n,dates:r},e.next=9,m({type:wt.SET_ADVANCE_SEARCH,value:o});case 9:localStorage.setItem("advanceSearch",JSON.stringify(o)),localStorage.setItem("navigation",JSON.stringify({cards:{url:"/search/advance/".concat(l.module),value:"".concat(L,"/Advanced Search"),text:"Showing Results for ".concat(kt," from ").concat(Vt," to ").concat(Qt)}})),i.push("/search/advance/".concat(l.module)),$(null);case 13:case"end":return e.stop()}}),e)})));return function(t){return e.apply(this,arguments)}}(),$a=function(){var e=Object(s.a)(c.a.mark((function e(t){return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:B(t.target.value);case 1:case"end":return e.stop()}}),e)})));return function(t){return e.apply(this,arguments)}}(),en=function(){var e=Object(s.a)(c.a.mark((function e(t){return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:t.preventDefault(),i.push("/registration");case 2:case"end":return e.stop()}}),e)})));return function(t){return e.apply(this,arguments)}}(),tn=function(){var e=Object(s.a)(c.a.mark((function e(t){return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:et("Approval Date"===t.target.value),Ze(t.target.value),E("");case 3:case"end":return e.stop()}}),e)})));return function(t){return e.apply(this,arguments)}}(),an=function(){var e=Object(It.a)(z);e.push({Category:"TA/Indication",Search:"",Relation:"AND"}),Y(e)},nn=function(e){var t=Object(It.a)(z);t.splice(e,1),Y(t)},rn=function(){var e=Object(s.a)(c.a.mark((function e(t,a){var n;return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:(n=Object(It.a)(z))[t].Search=a,Y(n);case 3:case"end":return e.stop()}}),e)})));return function(t,a){return e.apply(this,arguments)}}(),on=function(e){var t=Object(It.a)(z);t[e.target.name].Category=e.target.value,t[e.target.name].Search="",Y(t)},ln=function(e,t){var a=Object(It.a)(z);a[e].Relation=t,Y(a)},cn=Object(n.useState)(!1),sn=Object(d.a)(cn,2),dn=sn[0],mn=sn[1];return r.a.createElement("div",{className:p.root},r.a.createElement(Aa.a,null),"/registration"===window.location.pathname?null:r.a.createElement(R.a,{elavation:0,position:"fixed",className:Object(ga.a)(p.appBar,Object(g.a)({},p.appBarShift,dn))},r.a.createElement(R.a,{display:"flex",justifyContent:"space-between"},"pmr"!==l.module?r.a.createElement(Ta.a,null,r.a.createElement(R.a,{id:"quickSearch",padding:1,display:"flex",justifyContent:"space-evenly",className:p.navBox},r.a.createElement(sa,{className:p.dropdown,id:"filterTerm",dropdownValue:L,menuItems:"biologics"===l.module?["Biologics",""]:["US FDA - Drug & Biologics",""],title:"Source",handleChange:$a}),r.a.createElement(sa,{id:"categoryTerm",className:p.dropdown,dropdownValue:Ke,menuItems:["TA/Indication","Active Ingredient","Trade Name","Formulation","Route","Approval Date",""],title:"Category",handleChange:tn}),$e?r.a.createElement(r.a.Fragment,null,r.a.createElement(R.a,{display:"flex",flexDirection:"row",justifyContent:"",alignItems:"",className:p.box},r.a.createElement("form",{onSubmit:Ja},r.a.createElement(W.a,null,r.a.createElement(Pa.a,{utils:Ra.default},r.a.createElement(Ia.b,{className:p.AdvancedSearchDatePicker,value:mt,label:"From",keyboardIcon:r.a.createElement(La.a,{className:p.calendarIcon}),InputProps:{classes:{input:p.resize}},onChange:function(e){return function(e){var t=e.getDate()<10?"0"+e.getDate():String(e.getDate()),a=e.getMonth()<10?"0"+(e.getMonth()+1):String(e.getMonth()+1),n=String(e.getFullYear())+"-"+a+"-"+t;console.log(n),ut(e),rt(n)}(e)},format:"MM/dd/yyyy"}))),r.a.createElement(W.a,null,r.a.createElement(Pa.a,{utils:Ra.default},r.a.createElement(Ia.b,{className:p.AdvancedSearchDatePicker,value:ht,label:"To",keyboardIcon:r.a.createElement(La.a,{className:p.calendarIcon}),InputProps:{classes:{input:p.resize}},onChange:function(e){return function(e){var t=e.getDate()<10?"0"+e.getDate():String(e.getDate()),a=e.getMonth()<10?"0"+(e.getMonth()+1):String(e.getMonth()+1),n=String(e.getFullYear())+"-"+a+"-"+t;Tt(e),ct(n)}(e)},format:"MM/dd/yyyy"}))),r.a.createElement(W.a,null,r.a.createElement(j.a,{type:"submit"},r.a.createElement(V,null)))))):r.a.createElement(r.a.Fragment,null,r.a.createElement("form",{onSubmit:Ja},r.a.createElement(J,{placeholder:"Quick Search . . .",handleChange:function(e){E(e.target.value.toLowerCase())},value:A,id:"searchTerm",onKeyDown:Xa,list:"dynamicSearchResult",name:"dynamicSearchResult"}),r.a.createElement("datalist",{id:"dynamicSearchResult"},pe?pe.map((function(e,t){return r.a.createElement("option",{key:t,value:e},e)})):r.a.createElement("div",null)),r.a.createElement(W.a,null,r.a.createElement(j.a,{type:"submit"},r.a.createElement(V,null))))),r.a.createElement(W.a,null,r.a.createElement(j.a,{id:"advanceSearch",onClick:function(e){$(e.currentTarget)}},r.a.createElement(ei,null))),"505b2"!==l.module?r.a.createElement(ja.a,{id:Wa,open:Ha,anchorEl:q,onClose:Ga,anchorOrigin:{vertical:"bottom",horizontal:"left"},transformOrigin:{vertical:"top",horizontal:"left"}},r.a.createElement(R.a,{padding:1,display:"flex",flexDirection:"column",justifyContent:"space-between"},r.a.createElement(R.a,{display:"flex",flexDirection:"row",justifyContent:"center",alignItems:"center",className:p.popoverBox},r.a.createElement(y.a,{className:p.popoverTitle,variant:"subtitle2"},"Select the Approval dates:"),r.a.createElement(Pa.a,{utils:Ra.default},r.a.createElement(Ia.b,{className:p.AdvancedSearchDatePicker,format:"MM/dd/yyyy",maxDate:new Date,id:"date-picker-dialog",label:"From",keyboardIcon:r.a.createElement(La.a,{className:p.calendarIcon}),InputProps:{classes:{input:p.resize}},value:ye,onChange:function(e){Le(e)},KeyboardButtonProps:{"aria-label":"change date"}})),ye?r.a.createElement(Pa.a,{utils:Ra.default},r.a.createElement(Ia.b,{className:p.AdvancedSearchDatePicker,format:"MM/dd/yyyy",id:"date-picker-dialog",label:"To",keyboardIcon:r.a.createElement(La.a,{className:p.calendarIcon}),InputProps:{classes:{input:p.resize}},minDate:ye,maxDate:new Date,value:Ue,onChange:Qa,KeyboardButtonProps:{"aria-label":"change date"}})):r.a.createElement(Pa.a,{utils:Ra.default},r.a.createElement(Ia.b,{className:p.AdvancedSearchDatePicker,format:"MM/dd/yyyy",id:"date-picker-dialog",label:"To",keyboardIcon:r.a.createElement(La.a,{className:p.calendarIcon}),InputProps:{classes:{input:p.resize}},maxDate:new Date,value:Ue,onChange:Qa,KeyboardButtonProps:{"aria-label":"change date"}}))),r.a.createElement(R.a,{className:p.popoverBox},z.map((function(e,t){return r.a.createElement(Zr,{key:t,CategoryClick:on,SearchClick:rn,ToggleClick:ln,AddClick:an,DeleteClick:nn,AdvancedSearches:z,handleAdvKeyPress:Za,i:e,index:t})}))),r.a.createElement(R.a,{className:p.popoverBox},r.a.createElement(_.a,{onClick:Ka,variant:"contained",className:p.btn},"Search")))):r.a.createElement(ja.a,{id:Wa,open:Ha,anchorEl:q,onClose:Ga,anchorOrigin:{vertical:"bottom",horizontal:"left"},transformOrigin:{vertical:"top",horizontal:"left"}},r.a.createElement(R.a,{padding:2},r.a.createElement("form",{onSubmit:qa},r.a.createElement(R.a,{display:"flex",flexDirection:"row",justifyContent:"space-between",alignItems:"center"},r.a.createElement(y.a,null,"Select the approval dates:"),r.a.createElement(Pa.a,{utils:Ra.default},r.a.createElement(Ia.b,{className:p.AdvancedSearchDatePicker,value:Ot,label:"From",keyboardIcon:r.a.createElement(La.a,{className:p.calendarIcon}),InputProps:{classes:{input:p.resize}},onChange:function(e){return function(e){var t=e.getDate()<10?"0"+e.getDate():String(e.getDate()),a=e.getMonth()<10?"0"+(e.getMonth()+1):String(e.getMonth()+1),n=String(e.getFullYear())+"-"+a+"-"+t;console.log(n),xt(e),bt(n)}(e)},format:"MM/dd/yyyy"})),r.a.createElement(Pa.a,{utils:Ra.default},r.a.createElement(Ia.b,{className:p.AdvancedSearchDatePicker,value:Lt,label:"To",keyboardIcon:r.a.createElement(La.a,{className:p.calendarIcon}),InputProps:{classes:{input:p.resize}},onChange:function(e){return function(e){var t=e.getDate()<10?"0"+e.getDate():String(e.getDate()),a=e.getMonth()<10?"0"+(e.getMonth()+1):String(e.getMonth()+1),n=String(e.getFullYear())+"-"+a+"-"+t;jt(e),yt(n)}(e)},format:"MM/dd/yyyy"}))),r.a.createElement(R.a,{mt:1,display:"flex",flexDirection:"row",justifyContent:"space-between"},r.a.createElement(W.a,null,r.a.createElement(R.a,{className:p.dropdownAdv,justifyContent:"flex-start",alignItems:"flex-start"},r.a.createElement(oa.a,{className:p.dropdownLabel,shrink:!0,htmlFor:"age-native-label-placeholder"},"Category"),r.a.createElement(ca.a,{value:kt,onChange:function(e){Ft(e.target.value)},disableUnderline:!0},r.a.createElement(la.a,{value:"Route"},"Route"),r.a.createElement(la.a,{value:"Formulation"},"Formulation"),r.a.createElement(la.a,{value:"Formulation"},"Formulation")))),r.a.createElement(W.a,null,r.a.createElement(D.a,{required:!0,onChange:Ya,className:p.textField,id:"filled-search",placeholder:"From",InputProps:{disableUnderline:!0,type:"search"}})),r.a.createElement(W.a,null,r.a.createElement(D.a,{required:!0,onChange:function(e){Jt(e.target.value)},className:p.textField,id:"filled-search",InputProps:{disableUnderline:!0},placeholder:"To",type:"search"})),r.a.createElement(W.a,null,r.a.createElement(_.a,{type:"submit"},r.a.createElement(V,null))))))))):r.a.createElement(Ta.a,null,r.a.createElement(R.a,null,"/pmr/impact"===window.location.pathname?r.a.createElement(y.a,{style:{color:"#3AB09E",fontSize:"15px",textAlign:"left",fontWeight:"600"}},"IMPACT OF FDA POSTMARKETING REQUIREMENTS AND COMMITMENTS"):r.a.createElement(y.a,{style:{color:"#3AB09E",fontSize:"15px",textAlign:"left",fontWeight:"600"}},"SURVEILLANCE FOR FDA POSTMARKETING REQUIREMENTS AND COMMITMENTS"))),r.a.createElement(Ta.a,null,"jp@clignosis.ai"===ie||"harshada.dolas@saama.com"===ie||"vivek.mishra@saama.com"===ie||"harshadadolas24@gmail.com"===ie||"yogesh@clignosis.ai"===ie?r.a.createElement(j.a,null,r.a.createElement(Oa.a,{color:"primary",fontSize:"large",onClick:en})):r.a.createElement("span",null),r.a.createElement(j.a,{onClick:function(){v(!0)}},r.a.createElement(Da.a,{badgeContent:l.cartItems,className:p.badge,color:"error"},r.a.createElement(qr,null))),r.a.createElement(Xr.a,{open:x,className:p.modal,onClose:function(){return v(!x)},"aria-labelledby":"simple-modal-title","aria-describedby":"simple-modal-description"},r.a.createElement(N.a,{elavation:3,className:p.modalContainer},r.a.createElement(R.a,{display:"flex",justifyContent:"flex-end"},r.a.createElement(j.a,{onClick:Va},r.a.createElement(Na.a,{color:"primary",fontSize:"small"}))),r.a.createElement(Wr,null))),r.a.createElement(j.a,{onClick:function(e){e.preventDefault(),i.push("/help")}},r.a.createElement($r,null)),r.a.createElement(j.a,{onClick:za},r.a.createElement(S.a,{onClick:za,className:p.avatar},aa&&aa)),r.a.createElement(Ea.a,{id:"simple-menu",anchorEl:Q,getContentAnchorEl:null,keepMounted:!0,anchorOrigin:{vertical:"bottom",horizontal:"center"},transformOrigin:{vertical:"top",horizontal:"center"},open:Boolean(Q),onClose:function(){K(null)}},r.a.createElement(la.a,null,r.a.createElement(Sa.a,null,r.a.createElement(Oa.a,{className:p.navIcon,color:"primary",fontSize:"small"})),r.a.createElement(y.a,{className:p.username},se&&se.substr(0,se.indexOf(" ")))),r.a.createElement(la.a,null,r.a.createElement(Sa.a,null,r.a.createElement(va.a,{className:p.navIcon,color:"primary",fontSize:"small"})),r.a.createElement(y.a,{className:p.emailText},He&&He," ")),r.a.createElement(la.a,null,r.a.createElement(Sa.a,{className:p.statusIcon},r.a.createElement(he.a,{fontSize:"small"})),r.a.createElement(y.a,{className:p.emailText},ze&&ze)),r.a.createElement(vt.a,null),r.a.createElement(la.a,null,r.a.createElement(_.a,{className:p.logoutBtn,onClick:e.logOutMethod},"Logout")),r.a.createElement(la.a,null))))),"/help"===window.location.pathname||"/registration"===window.location.pathname?null:r.a.createElement(ha.a,{variant:"permanent",className:Object(ga.a)(p.drawer,(t={},Object(g.a)(t,p.drawerOpen,dn),Object(g.a)(t,p.drawerClose,!dn),t)),classes:{paper:Object(ga.a)((a={},Object(g.a)(a,p.drawerOpen,dn),Object(g.a)(a,p.drawerClose,!dn),a))}},r.a.createElement(_.a,{onClick:function(){return i.push("/")}},r.a.createElement(j.a,{size:"small"},dn?r.a.createElement("img",{src:si.a,className:p.vivLogo,alt:"logo"}):r.a.createElement(Hr,null))),r.a.createElement(fa.a,null,r.a.createElement(Ca.a,{button:!0,onClick:function(){return i.push("/")}},r.a.createElement(Sa.a,null,r.a.createElement(j.a,{id:"coreIcon",edge:"start"},r.a.createElement(ti,null))),r.a.createElement(ya.a,null,"Core")),r.a.createElement(Ca.a,{button:!0,onClick:function(){return i.push("/505b2")}},r.a.createElement(Sa.a,null,r.a.createElement(j.a,{id:"tabletIcon",edge:"start"},r.a.createElement(Da.a,{badgeContent:"beta",classes:{badge:p.badgeBeta}},r.a.createElement(ai,null)))),r.a.createElement(ya.a,null,"505 (B) (2)")),r.a.createElement(Ca.a,{button:!0,onClick:function(){return i.push("/")}},r.a.createElement(Sa.a,null,r.a.createElement(j.a,{id:"pediatricIcon",edge:"start"},r.a.createElement(ni,null))),r.a.createElement(ya.a,null,"Pediatric")),r.a.createElement(Ca.a,{button:!0,onClick:function(){return i.push("/biologics")}},r.a.createElement(Sa.a,null,r.a.createElement(j.a,{id:"blaIcon",edge:"start"},r.a.createElement(oi,null))),r.a.createElement(ya.a,null,"Biologics")),"Evaluation"!==He&&"Educational"!==He&&"Free"!==He?r.a.createElement(Ca.a,{button:!0,onClick:function(e){ka(e.currentTarget)}},r.a.createElement(Sa.a,null,r.a.createElement(j.a,{edge:"start",id:"pmrIcon"},r.a.createElement(ri,null))),r.a.createElement(ya.a,null,"PMR")):r.a.createElement(Ca.a,{button:!0,onClick:function(){ma(!0),xa("pmr")}},r.a.createElement(Sa.a,null,r.a.createElement(j.a,{edge:"start",id:"pmrIcon"},r.a.createElement(ri,null))),r.a.createElement(ya.a,null,"PMR")),r.a.createElement(Ca.a,{className:p.toggleDrawerIcon,button:!0,onClick:function(){mn(!dn)}},r.a.createElement(Sa.a,null,r.a.createElement(j.a,{edge:"start"},dn?r.a.createElement(li,null):r.a.createElement(ii,null))),r.a.createElement(ya.a,null,"Close")))),r.a.createElement(ja.a,{id:Fa,open:Ma,anchorEl:Ua,onClose:function(){ka(null)},anchorOrigin:{vertical:"top",horizontal:"right"},transformOrigin:{vertical:"top",horizontal:"left"}},r.a.createElement(R.a,{display:"flex",flexDirection:"column",className:p.pmrOption},r.a.createElement(_.a,{onClick:function(){i.push("/pmr/surveillance"),ka(null)}},r.a.createElement(y.a,{className:p.drawerOption},r.a.createElement(he.a,{className:p.pmrStatus}),"PMR Surveillance")),r.a.createElement(vt.a,null),r.a.createElement(_.a,{onClick:function(){i.push("/pmr/impact"),ka(null)}},r.a.createElement(y.a,{className:p.drawerOption1},"PMR Impact")))),r.a.createElement(U.a,{fullWidth:!0,maxWidth:"sm",onClose:function(){ma(!1)},"aria-labelledby":"customized-dialog-title",open:da},r.a.createElement(k.a,{className:p.BotDialog},r.a.createElement(C.a,{style:{height:"10px"},container:!0,item:!0,xs:12,justify:"flex-end",alignItems:"center"},r.a.createElement(j.a,{"aria-label":"delete",className:p.ModalCloseIconButton,onClick:function(){ma(!1)}},r.a.createElement(w.a,{className:p.ModalCloseIcon}))),He?r.a.createElement(mi,{license:He,module:_a}):null)))}var Di=a(391),_i={white:"#FFFFFF",black:"#000000",successGreen:"#2ecc71",fatalRed:"#cd2653",type:"light",common:{primaryBlack:"#3B3B3B",otherBlack:"#040D14",primaryGray:"#848383",errorRed:"#FF0000",orangeDark:"#d56201",orange:"#FF9C28",facebookMainColor:"#3b5998",contrastMainColor:"#4548cb",grayBorder:"#B8B8B8",grayLight:"#f5f5f5",grayAvatar:"#bdbdbd",grayTextLight:"#d2d2d2",grayTextDark:"#727272",badge:"#e74c3c"},primary:{lightBorder:"#e3f1ff",lightBackground:"#f7fbff",light:"#0352CC",main:"#0352CC",dark:"#DD861F",lighter:"#3AB09E",contrastText:"#FFFFFF",blueShadow:"rgb(76, 192, 196,0.3)",shadow:"rgb(220, 220, 220,0.5)",darkShadow:"rgb(153, 153, 153,0.5)"},secondary:{light:"#ffbba7",main:"#3AB09E",dark:"#DD5228",lighter:"#ffbba7",contrastText:"#FFFFFF"},bot:{lightBackground:"#f1fbf7",buttonBackground:"#33b187",darkBackground:"#d3f7ea",filterBackground:"#028b8b"},error:{main:"#e74c3c"},background:{default:"#FFFFFF"},icon:{primary:"#B8B8B8",hover:"#F4F4F4"},gradient:{primaryFrom:"#3AB09E",primaryTo:"#0352CC",secondaryFrom:"#0352CC",secondaryTo:"#3AB09E"},home:{title:"#0B54A1",border:"#b1bbe4",heading:"#0B54A1",subheading:"#008B8B"},navbar:{border:"#2B43A6",grayBackground:"#F0F2FD",avatar:"#b1bbe4",button:"#3AB09E",breadcrumb:"#9E9E9E"},biologics:{textPrimary:"#1D262D",gradient:"linear-gradient(90deg, #29ABE2 0%, #39B54A 100%)",textSecondary:"#B1BBE4",radialGraphText:"#182B7F",pieText:"#0B54A1",primary:"#0E83DC",secondary:"#40C4FF",label:"#1FBDCA"},texts:{placeholder:"#646774"},backgrounds:{dark:"#101328",light:"#282d4f"},buttons:{purple:"#a593f2"},adminHome:{grayText:"#aaadb0",greenText:"#008B8B",primaryBlack:"#3B3B3B",paperBackground:"#f5f8fe"},review:{label:"#d0d5eb"},variants:{grayTextLight:"#767676",boxBorder:"#707070",boxShadow:"#00000029",title:"#030303",description:"#636465"}},Oi={fontFamily:["Lato","-apple-system","BlinkMacSystemFont",'"Segoe UI"',"Roboto",'"Helvetica Neue"',"Arial","sans-serif",'"Apple Color Emoji"','"Segoe UI Emoji"','"Segoe UI Symbol"'].join(","),fontSize:20,htmlFontSize:20,h1:{fontWeight:700,fontSize:"2rem",color:_i.primary.main},title:{fontFamily:["Oswald","sans-serif"].join(","),fontWeight:700,fontSize:"3rem",color:_i.primary.main,letterSpacing:"3px",marginBottom:10},subtitle1:{fontSize:"1.875rem",color:_i.common.primaryGray,fontWeight:"bold",lineHeight:1.3},h2:{fontSize:"2rem",color:_i.common.primaryBlack,fontWeight:400,lineHeight:1.2},h3:{fontFamily:["Lato","sans-serif"].join(","),fontSize:"1.125rem",color:_i.black,lineHeight:2,fontWeight:"regular",textTransform:"capitalize",letterSpacing:"1px"},button:{fontFamily:["Oswald","sans-serif"].join(",")},body1:{marginRight:"3px",fontSize:"2vh",lineHeight:1.25},body2:{}},xi=a(1136),vi=a.n(xi),Ri={easeInOut:"cubic-bezier(0.4, 0, 0.2, 1)",easeOut:"cubic-bezier(0.0, 0, 0.2, 1)",easeIn:"cubic-bezier(0.4, 0, 1, 1)",sharp:"cubic-bezier(0.4, 0, 0.6, 1)"},Pi={shortest:150,shorter:200,short:250,standard:300,complex:375,enteringScreen:225,leavingScreen:195},Ii=function(e){return"".concat(Math.round(e),"ms")},wi={easing:Ri,duration:Pi,create:function(){var e=arguments.length>0&&void 0!==arguments[0]?arguments[0]:["all"],t=arguments.length>1&&void 0!==arguments[1]?arguments[1]:{},a=t.duration,n=void 0===a?Pi.standard:a,r=t.easing,i=void 0===r?Ri.easeInOut:r;return(Array.isArray(e)?e:[e]).map((function(e){return"".concat(e," ").concat("string"===typeof n?n:Ii(n)," ").concat(i)})).join(",")},getAutoHeightDuration:function(e){if(!e)return 0;var t=e/36;return Math.round(10*(4+15*Math.pow(t,.25)+t/5))}},Li=["xs","sm","md","lg","xl"],ji={xs:0,sm:600,md:960,lg:1280,xl:1920};function Bi(e){return"@media (min-width:".concat("number"===typeof ji[e]?ji[e]:e).concat("px",")")}function Ui(e,t){var a=Li.indexOf(t)+1;return a===Li.length?Bi(e):"@media (min-width:".concat(ji[e]).concat("px",") and ")+"(max-width:".concat(ji[Li[a]]-.05).concat("px",")")}var ki,Mi={keys:Li,values:ji,up:Bi,down:function(e){var t=Li.indexOf(e)+1,a=ji[Li[t]];return t===Li.length?Bi("xs"):"@media (max-width:".concat(("number"===typeof a&&t>0?a:e)-.05).concat("px",")")},between:Ui,only:function(e){return Ui(e,e)},width:function(e){return ji[e]}},Fi=8,zi={gutters:function(e){return Object(Y.a)(Object(Y.a)({paddingLeft:2*Fi,paddingRight:2*Fi},e),{},Object(g.a)({},Mi.up("sm"),Object(Y.a)({paddingLeft:3*Fi,paddingRight:3*Fi},e[Mi.up("sm")])))},toolbar:(ki={minHeight:56},Object(g.a)(ki,"".concat(Mi.up("xs")," and (orientation: landscape)"),{minHeight:48}),Object(g.a)(ki,Mi.up("sm"),{minHeight:64}),ki)},Yi=Object(Di.a)({spacing:8,palette:_i,typography:Oi,overrides:vi.a,transitions:wi,breakpoints:Mi,mixins:zi,zIndex:{search:1150,dateCard:1150,searchDiv:1100,mobileStepper:1e3,speedDial:1050,appBar:1100,drawer:1200,modal:1300,snackbar:1400,tooltip:1500}}),Vi=(a(1676),a(1137)),Gi=a.n(Vi),Hi=a(1923),Wi=a(1924),Qi=a(1925),Ji=a(1906),Ki=a(217),Zi=a.n(Ki),Xi=Object(f.a)((function(e){var t;return t={appBar:{zIndex:e.zIndex.drawer+1,backgroundColor:e.palette.white,transition:e.transitions.create(["width","margin"],{easing:e.transitions.easing.sharp,duration:e.transitions.duration.leavingScreen,backgroundColor:"#FFFFFF !important"})},container:{height:"100vh",minWidth:"100vw",margin:"0",padding:"0",overflow:"hidden"},mainLogo:{cursor:"pointer",height:"4vh",width:"auto"},guideMain:{height:"89vh",minWidth:"90vw",margin:"0",padding:"0"},matToolbarmatPrimary:{background:"#1d96dd",color:"#fff"},listSubHead:{float:"left",fontSize:"14px"},ArrowForwardIosIcon:{fontSize:"8px !important",fontWeight:"bold"},text:{marginTop:e.spacing(1)},ml3:{marginLeft:"56px",marginTop:"3px"},step3:{margin:"10px",marginLeft:"0px"},root:{display:"flex"},drawer:{flexShrink:0},drawerPaper:{position:"fixed",top:"84px",zIndex:1,overflow:"hidden"},toolbar:e.mixins.toolbar,content:{flexGrow:1,marginTop:e.spacing(2),backgroundColor:e.palette.background.default,padding:e.spacing(3)},menu:{background:"#ff00ff",marginBottom:"3px solid #aaa"},guideContent:{borderBottom:"1px solid #ccc",padding:"10px",margin:"15px",textAlign:"left",backgroundColor:"white"}},Object(g.a)(t,"content",{padding:"10px",marginLeft:"270px"}),Object(g.a)(t,"title",{textAlign:"left",color:e.palette.navbar.button,fontWeight:"bold"}),Object(g.a)(t,"HeaderBg",{backgroundColor:"#ffff"}),Object(g.a)(t,"logoutImg",{position:"absolute",right:"20px",top:"9px"}),Object(g.a)(t,"brochureImage",{width:e.spacing(80),height:e.spacing(37)}),Object(g.a)(t,"riaSteppers",{marginTop:e.spacing(2),width:e.spacing(60),height:e.spacing(20)}),Object(g.a)(t,"riaApplication",{marginLeft:e.spacing(5),width:e.spacing(64),height:e.spacing(40)}),Object(g.a)(t,"riaArchitecture",{marginTop:e.spacing(1),width:e.spacing(100),height:e.spacing(47)}),Object(g.a)(t,"riaList",{marginTop:e.spacing(2),marginLeft:e.spacing(5),width:e.spacing(100),height:e.spacing(28)}),Object(g.a)(t,"riaFilter",{marginLeft:e.spacing(5),width:e.spacing(30),height:e.spacing(40)}),Object(g.a)(t,"riaAnalytic",{marginTop:e.spacing(1),marginLeft:e.spacing(5),width:e.spacing(80),height:e.spacing(50)}),Object(g.a)(t,"riaClinical",{marginTop:e.spacing(1),marginLeft:e.spacing(5),width:e.spacing(100),height:e.spacing(61)}),Object(g.a)(t,"riaBot",{marginTop:e.spacing(1),marginLeft:e.spacing(5),width:e.spacing(100),border:"1px solid ".concat(e.palette.home.border),height:e.spacing(49)}),Object(g.a)(t,"riaReg360",{marginTop:e.spacing(1),marginLeft:e.spacing(5),width:e.spacing(100),height:e.spacing(47)}),Object(g.a)(t,"riaExtendedCard",{marginTop:e.spacing(1),marginLeft:e.spacing(5),width:e.spacing(100),height:e.spacing(44)}),Object(g.a)(t,"riaSearchList",{marginTop:e.spacing(2),marginLeft:e.spacing(5),width:e.spacing(80),height:e.spacing(22)}),Object(g.a)(t,"riaManage",{marginTop:e.spacing(2),marginLeft:e.spacing(5),width:e.spacing(28),height:e.spacing(30)}),Object(g.a)(t,"sublist",{marginTop:e.spacing(2),marginLeft:e.spacing(2)}),Object(g.a)(t,"image",{display:"flex",overflow:"hidden",position:"relative",fontSize:"1.4285714285714286rem",alignItems:"center",flexShrink:"0",fontFamily:"Lato,sans-serif",lineHeight:"1",userSelect:"none",borderRadius:"50%",justifyContent:"center"}),Object(g.a)(t,"sumRoot",{}),Object(g.a)(t,"expanded",{color:"#035CC !important"}),Object(g.a)(t,"subMenuCss",{fontSize:"13px",marginLeft:"25px",marginBottom:"-10px",color:"#848383"}),Object(g.a)(t,"quationDot",{fontSize:"8px !important",fontWeight:"bold"}),Object(g.a)(t,"answerArrow",{fontSize:"12px !important",fontWeight:"bold",marginLeft:"2px"}),Object(g.a)(t,"contentDiv",{marginTop:"-23px"}),Object(g.a)(t,"headings",{color:"#4c4c4c",fontSize:"18px",fontWeight:"bold",top:"31px",right:"85px",position:"absolute",borderRight:"1px solid #ccc",paddingRight:"10px"}),Object(g.a)(t,"subIconPosition",{marginTop:"5px",fontSize:"8px !important",fontWeight:"bold"}),Object(g.a)(t,"tableBorder",{border:"1px solid #ccc"}),Object(g.a)(t,"tableHeaderColor",{backgroundColor:e.palette.navbar.button}),Object(g.a)(t,"avatar",{background:e.palette.navbar.avatar,fontSize:e.spacing(2.5),fontWeight:"bold",textTransform:"uppercase",opacity:.9}),Object(g.a)(t,"username",{color:e.palette.common.primaryBlack,fontWeight:"bold",fontSize:e.spacing(2.5)}),Object(g.a)(t,"emailText",{color:e.palette.common.primaryBlack,opacity:.8,fontWeight:"bold",fontSize:e.spacing(2)}),Object(g.a)(t,"statusIcon",{color:e.palette.successGreen}),Object(g.a)(t,"logoutBtn",{fontSize:e.spacing(2),width:"100%",fontWeight:"500",borderRadius:"10px",background:e.palette.navbar.button,color:e.palette.white}),Object(g.a)(t,"navIcon",{color:"#ced6e0"}),t})),qi=a(183),$i=a.n(qi),eo=a(1138),to=a.n(eo),ao=a(1139),no=a.n(ao),ro=a(1140),io=a.n(ro),oo=a(1141),lo=a.n(oo),co=a(1142),so=a.n(co),mo=a(1143),uo=a.n(mo),po=a(1144),go=a.n(po),ho=a(1145),To=a.n(ho),fo=a(1146),Ao=a.n(fo),Eo=a(1147),bo=a.n(Eo),No=a(1148),Co=a.n(No),So=a(1149),yo=a.n(So);function Do(e){var t=Xi(),a=Object(n.useState)(!1),i=Object(d.a)(a,2),o=(i[0],i[1],Object(n.useState)(null)),l=Object(d.a)(o,2),m=l[0],p=(l[1],Object(u.f)(),Object(n.useState)("")),g=Object(d.a)(p,2),h=g[0],f=g[1],A=Object(n.useState)(""),E=Object(d.a)(A,2),b=(E[0],E[1]),N=Object(n.useState)(""),C=Object(d.a)(N,2),D=C[0],O=C[1],x=Object(n.useState)(""),v=Object(d.a)(x,2),P=v[0],I=v[1],w=Object(n.useState)(),L=Object(d.a)(w,2),B=(L[0],L[1]),U=r.a.useState(null),k=Object(d.a)(U,2),M=k[0],F=k[1],z=Object(n.useState)(),Y=Object(d.a)(z,2),V=Y[0],G=Y[1];Object(n.useEffect)((function(){function e(){return(e=Object(s.a)(c.a.mark((function e(){var t,a,n,r,i;return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:return e.prev=0,e.next=3,T.a.currentAuthenticatedUser();case 3:t=e.sent,B(t),b(t.attributes.email),O(t.attributes["custom:status"]),f(t.attributes["custom:user"]),I(t.attributes["custom:license"]),a=t.attributes["custom:user"],n=a.substr(0,a.indexOf(" ")),r=a.split(" ").pop(),n=n.substr(0,1),r=r.substr(0,1),i=n+r,console.log("initial",i,n,r),G(i),e.next=22;break;case 19:e.prev=19,e.t0=e.catch(0),console.log(e.t0);case 22:case"end":return e.stop()}}),e,null,[[0,19]])})))).apply(this,arguments)}!function(){e.apply(this,arguments)}()}),[]);Boolean(m);return r.a.createElement("div",{className:t.root},r.a.createElement(Aa.a,null),r.a.createElement(ui.a,{position:"fixed",className:t.appBar},r.a.createElement(R.a,{display:"flex",justifyContent:"space-between"},r.a.createElement(Ta.a,null,r.a.createElement(Xt.a,{href:"/"},r.a.createElement(Hr,null))),r.a.createElement(Ta.a,null,r.a.createElement(j.a,null,r.a.createElement(S.a,{onClick:function(e){F(e.currentTarget)},className:t.avatar},V&&V)),r.a.createElement(Ea.a,{id:"simple-menu",anchorEl:M,getContentAnchorEl:null,keepMounted:!0,anchorOrigin:{vertical:"bottom",horizontal:"center"},transformOrigin:{vertical:"top",horizontal:"center"},open:Boolean(M),onClose:function(){F(null)}},r.a.createElement(la.a,null,r.a.createElement(Sa.a,null,r.a.createElement(Oa.a,{className:t.navIcon,fontSize:"small"})),r.a.createElement(y.a,{className:t.username},h&&h.substr(0,h.indexOf(" ")))),r.a.createElement(la.a,null,r.a.createElement(Sa.a,null,r.a.createElement(va.a,{className:t.navIcon,fontSize:"small"})),r.a.createElement(y.a,{className:t.emailText},P&&P)),r.a.createElement(la.a,null,r.a.createElement(Sa.a,{className:t.statusIcon},r.a.createElement(he.a,{fontSize:"small"})),r.a.createElement(y.a,{className:t.emailText},D&&D)),r.a.createElement(vt.a,null),r.a.createElement(la.a,null,r.a.createElement(_.a,{className:t.logoutBtn,onClick:e.logOutMethod},"Logout")),r.a.createElement(la.a,null))))),r.a.createElement(ha.a,{className:t.drawer,variant:"permanent",classes:{paper:t.drawerPaper},anchor:"left"},_o.map((function(e,a){return r.a.createElement(Hi.a,{id:e.name,title:e.name,className:t.sumRoot},r.a.createElement(Wi.a,{className:t.expanded,expandIcon:r.a.createElement(Ka.a,null)},e.name),r.a.createElement(vt.a,null),e.content.map((function(e,a){return r.a.createElement(Qi.a,{className:t.subMenuCss,title:e,onClick:function(){return function(e){if(null!=e){var t=document.getElementById(e).offsetTop;window.scrollTo({top:t-70,behavior:"smooth"})}}(e)}},e)})))}))),r.a.createElement("main",{className:t.content},r.a.createElement("div",{className:t.toolbar}),r.a.createElement("div",{class:t.guideContent,CliGnosisAI:!0,id:"VivproAI"},r.a.createElement("div",{class:t.title},r.a.createElement(he.a,{className:t.quationDot})," What is VivproAI?"),r.a.createElement("div",null,r.a.createElement("p",null,r.a.createElement($i.a,{className:t.answerArrow})," VivproAI  is a revolutionary software platform to unlock regulatory intelligence and make evidence-based business decisions at lightning speed, for pharmaceutical, biotech and device developers, CROs and investors.",r.a.createElement("br",null),r.a.createElement($i.a,{className:t.answerArrow})," VivproAI is a platform that captures publicly available data related to pharmaceutical products. VivproAI has curated FDA, EMA and ClinicalTrials.gov data sources from various locations (Drugs@FDA, AccessFDA, OpenFDA, Orangebook, Pediatrics, Devices, Biologics etc.) and in different formats (text files, excel files, csv, json, pdf documents etc.)."))),r.a.createElement("div",{class:t.guideContent,RIA:!0,id:"RIA"},r.a.createElement("div",{class:t.title},r.a.createElement(he.a,{className:t.quationDot})," What is RIA?"),r.a.createElement("div",null,r.a.createElement($i.a,{className:t.answerArrow})," RIA application focuses on regulatory information that is currently unstructured, unfriendly and unwieldy. It is managed using outdated technology. Further, there is no formal regulatory training. Consequently, companies spend valuable time searching for information and hire diverse regulatory experts and rely on their direct experience. Regulatory Intelligence Assistant (RIA) is an application within VivproAI platform to brings deliver harmonized data them in order to provides a consolidated view for industry experts and drug manufacturers in order to get an insight of regulatory challenges that may arise during a drug approval.",r.a.createElement("br",null),r.a.createElement($i.a,{className:t.answerArrow}),"RIA saves time and offers high quality information by automating the task to Search, Collect, Curate, Summarize and Analyze, so the user can focus on the Strategy.",r.a.createElement(R.a,{display:"flex",justifyContent:"flex-start"},r.a.createElement("img",{src:Gi.a,alt:"image",className:t.brochureImage})))),r.a.createElement("div",{class:t.guideContent,Login:!0,id:"Login"},r.a.createElement("div",{class:t.title},r.a.createElement(he.a,{className:t.quationDot})," How to Login into RIA?"),r.a.createElement("div",null,r.a.createElement("p",null,r.a.createElement($i.a,{className:t.answerArrow})," Please use log-in credentials supplied when you purchased access license to RIA. Please enter login details (username and password). Note that login credentials are case sensitive."))),r.a.createElement("div",{class:t.guideContent,id:"Password Reset"},r.a.createElement("div",{class:t.title},r.a.createElement(he.a,{className:t.quationDot})," How to do Reset Password for RIA?"),r.a.createElement("div",null,r.a.createElement("p",null," ",r.a.createElement($i.a,{className:t.answerArrow}),"You can reset the password by clicking on the link Reset Password."))),r.a.createElement("div",{class:t.guideContent,id:"Data sources included in RIA"},r.a.createElement("div",{class:t.title},r.a.createElement(he.a,{className:t.quationDot})," What data sources are included in RIA?"),r.a.createElement("div",null,r.a.createElement("p",null,r.a.createElement($i.a,{className:t.answerArrow})," VivproAI has curated data for NDAs, BLAs, ANDAs, PMAs, PMNs, DENs and Clinical trials from various locations.",r.a.createElement(R.a,{display:"flex",justifyContent:"flex-start"},r.a.createElement("img",{src:to.a,alt:"steppers",className:t.riaSteppers})),r.a.createElement("img",{src:no.a,alt:"architecture",className:t.riaArchitecture})))),r.a.createElement("div",{class:t.guideContent,id:"how to search"},r.a.createElement("div",{class:t.title},r.a.createElement(he.a,{className:t.quationDot})," How do I search and what search features are available in RIA?"),r.a.createElement("div",{className:t.contentDiv},r.a.createElement("p",null,r.a.createElement(fa.a,null,r.a.createElement(y.a,{className:t.text},"The user can search for"),r.a.createElement(Ca.a,null,r.a.createElement(Zi.a,{className:t.ArrowForwardIosIcon}),"list of all drugs and brands by \u2018TA/Indication\u2019 or"),r.a.createElement(Ca.a,null,r.a.createElement(Zi.a,{className:t.ArrowForwardIosIcon}),"list of brands by \u2018Active Ingredient\u2019 or"),r.a.createElement(Ca.a,null,r.a.createElement(Zi.a,{className:t.ArrowForwardIosIcon}),"a drug by a \u2018Trade Name\u2019"),r.a.createElement(Ca.a,null,r.a.createElement(Zi.a,{className:t.ArrowForwardIosIcon}),"by \u201cformulation\u201d"),r.a.createElement(Ca.a,null,r.a.createElement(Zi.a,{className:t.ArrowForwardIosIcon}),"by \u201croute\u201d"),r.a.createElement(Ca.a,null,r.a.createElement(Zi.a,{className:t.ArrowForwardIosIcon}),"by \u201cApproval Date\u201d range"),r.a.createElement(Ca.a,null,r.a.createElement(Zi.a,{className:t.ArrowForwardIosIcon}),"or combinations of the above")),r.a.createElement(y.a,{className:t.text},"Search process is as a follows"),r.a.createElement(y.a,null,"1. select respective database (US FDA- Drugs and Biologics, EU EMA - Drugs and Biologics, US DA - Devices)"),r.a.createElement(y.a,null,"2. select respective category (TA/Indication, Active Ingredient, Trade Name, Formulation, Route, Approval Date)"),r.a.createElement(y.a,null,"3. Enter a search string  and  and press enter or hit search button."),r.a.createElement(y.a,{className:t.text},"Follow the same process for Advanced search")))),r.a.createElement("div",{class:t.guideContent,id:"Search results"},r.a.createElement("div",{class:t.title},r.a.createElement(he.a,{className:t.quationDot}),"What does RIA provide for search results?"),r.a.createElement("div",null,r.a.createElement("p",null,r.a.createElement(fa.a,{component:"ul"},r.a.createElement("ul",null,r.a.createElement("li",null,"RIA manages the flow information to provide the users with the most accurate information in a step-by-step manner by managing the information overload as well as provide users ability to customize results for their project needs."))),r.a.createElement(fa.a,null,r.a.createElement(Ji.a,{className:t.listSubHead},"If user searches by a \u2018TA/Indication\u2019"),r.a.createElement(Ca.a,null,"Step 1: Application View provide list of all active ingredients for which the \u201csearch term\u201d matches with the indication and usage section of the label. Provide unique applications approved for respective active ingredient along with basic information for the application such as Brand Name, Approval Pathway, Formulation, Sponsor name, Accelerated approval, Breakthrough designation, Fast Track and Generic status."),r.a.createElement("img",{src:io.a,alt:"image",className:t.riaApplication}),r.a.createElement(Ca.a,{className:t.sublist},r.a.createElement("b",null,"1A: Filters")," The user can narrow down the list of application based on various filters"),r.a.createElement("img",{src:lo.a,alt:"filter-image",className:t.riaFilter}),r.a.createElement(Ca.a,{className:t.sublist},r.a.createElement("b",null,"1B: Analytic View"),"The user can create a business ready report for those applications by capturing  Approval timelines, Business Intelligence, Immunogenicity, if applicable."),r.a.createElement(R.a,{display:"flex",justifyContent:"flex-start"},r.a.createElement("img",{src:so.a,alt:"filter-image",className:t.riaAnalytic})),r.a.createElement("li",{className:t.sublist},r.a.createElement(y.a,null,r.a.createElement("b",null,"1C: List View")),r.a.createElement(y.a,null,"For all selected brand names, the use receives a set of information.Tabular results with one row for each brand name with the following fields (Active Ingredients, Trade Name, Application Type, Application Number, Approval Pathway, First Approval Date, Formulation, Route,Accelerated Approval, Breakthrough,FastTrack, Generics, Sponsor Name):")),r.a.createElement(R.a,{display:"flex",justifyContent:"flex-start"},r.a.createElement("img",{src:uo.a,alt:"filter-image",className:t.riaList})),r.a.createElement("li",{className:t.sublist},r.a.createElement(y.a,null,r.a.createElement("b",null,"1D: Manage Applications ")," if the user removed an application from the view, it can be retrieved using manage applications function")),r.a.createElement(R.a,{display:"flex",justifyContent:"flex-start"},r.a.createElement("img",{src:go.a,alt:"filter-image",className:t.riaManage})),r.a.createElement("li",{className:t.sublist},r.a.createElement(y.a,null,r.a.createElement("b",null,"1E: Search List "),"  the view the synomyms and MeSH tree used for the search")),r.a.createElement(R.a,{display:"flex",justifyContent:"flex-start"},r.a.createElement("img",{src:To.a,alt:"filter-image",className:t.riaSearchList})),r.a.createElement(Ca.a,null,r.a.createElement("b",null,"Step 2: ")," For a selected application user can review additional details (Indication, Time for approval, Patent, Exclusivity)"),r.a.createElement("img",{src:Ao.a,alt:"extended-card",className:t.riaExtendedCard}),r.a.createElement("li",null,r.a.createElement("b",null,"Step 3: ")," If the user is interested in particulars of an NDA/Brand name, the user can select a particular application from the extended view to obtain the following information",r.a.createElement("ul",null,r.a.createElement("li",null,"Timeline View: Approval History for a selected application",r.a.createElement("ul",null,r.a.createElement("li",null,"All documents (Letters, Labels and Reviews)"))),r.a.createElement("li",null,"RLD information, for 505(B)(2) applications"),r.a.createElement("li",null,"Applications content: Highlights from Summary Basis of Approval"),r.a.createElement("li",null,"Post Marketing Requirements/Commitments"))),r.a.createElement(R.a,{display:"flex",justifyContent:"flex-start"},r.a.createElement("img",{src:bo.a,alt:"reg360",className:t.riaReg360})))))),r.a.createElement("div",{class:t.guideContent},r.a.createElement("div",{class:t.title},r.a.createElement(he.a,{className:t.quationDot})," Can I control the amount of information within RIA?"),r.a.createElement("div",null,r.a.createElement("p",null,r.a.createElement(y.a,null,"Yes, RIA provides users ability to customize results for their project needs at several steps."),r.a.createElement("ul",null,r.a.createElement("li",null,"A summary and widget link to clinicaltrials.gov data for \u201cTA/Indication\u201d is provided. The users will be directed to a new tab to explore clinical trials."),r.a.createElement("li",null,"If needed, user can remove an application to narrow down the results"),r.a.createElement("li",null,"If needed, user can filter results based on 12 different characteristics such as Active Ingredient, Approval year,  Formulation, Approval Pathway and Route etc."))))),r.a.createElement("div",{class:t.guideContent},r.a.createElement("div",{class:t.title},r.a.createElement(y.a,null,r.a.createElement(he.a,{className:t.quationDot})," Does RIA allow searching for Clinical Trials?")),r.a.createElement(y.a,null,"Yes, RIA provides clinical trial widget in Step 1 after searching for TA/Indication or Active ingredient. The result then can be narrowed down based on filters and then downloaded as graphs/tables."),r.a.createElement(R.a,{display:"flex",justifyContent:"flex-start"},r.a.createElement("img",{src:Co.a,alt:"clinical",className:t.riaClinical}))),r.a.createElement("div",{class:t.guideContent},r.a.createElement("div",{class:t.title},r.a.createElement(y.a,null,r.a.createElement(he.a,{className:t.quationDot}),"Does RIA have machine learning capability?")),r.a.createElement(y.a,null,"Yes, RIA is equipped with Ask-RIA (ARIA), a machine learning system that can search summary basis of approval documents and provide suggested answer as well as other possible answers with a link to document where the contents exist. The user can also filter the results."),r.a.createElement(y.a,null,"The same capability is available on single application where the scope is to search for that application only."),r.a.createElement(R.a,{display:"flex",justifyContent:"flex-start"},r.a.createElement("img",{src:yo.a,alt:"clinical",className:t.riaBot}))),r.a.createElement("div",{class:t.guideContent},r.a.createElement("div",{class:t.title},r.a.createElement(y.a,null,r.a.createElement(he.a,{className:t.quationDot})," How do I ensure accuracy of search results within RIA?")),r.a.createElement("div",null,r.a.createElement("p",null,r.a.createElement($i.a,{className:t.answerArrow}),"The VivproAI Platform uses Centaur approach to create KaaS by Digitizing data in a contextual manner augmented by human expertise We check on quality and accuracy of data using machine and human expertise. However, it is possible that some information may be missing or unavailable. If you find any inaccurate or missing information, please report using the Contact Us link at the bottom of the application."))),r.a.createElement("div",{class:t.guideContent,target:!0,id:"Terms and abbreviations"},r.a.createElement("div",{class:t.title},r.a.createElement(he.a,{className:t.quationDot})," Terms and Abbreviations"),r.a.createElement("div",null,r.a.createElement("p",null,r.a.createElement($i.a,{className:t.answerArrow}),"The following terms and abbreviations are used in this guide:"),r.a.createElement("p",null,r.a.createElement($a.a,{className:t.tableBorder},r.a.createElement(an.a,{className:t.tableHeaderColor},r.a.createElement(nn.a,null,r.a.createElement(tn.a,{className:t.tableBorder},"Term"),r.a.createElement(tn.a,null,"Definition"))),r.a.createElement(en.a,null,Oo.map((function(e){return r.a.createElement(nn.a,null,r.a.createElement(tn.a,{className:t.tableBorder},e.Term),r.a.createElement(tn.a,null,e.Definition))}))))))),r.a.createElement("div",{class:t.guideContent,target:!0,id:"Widget"},r.a.createElement("div",{class:t.title},r.a.createElement(he.a,{className:t.quationDot})," Widget"),r.a.createElement("div",null,r.a.createElement("p",null,r.a.createElement($i.a,{className:t.answerArrow}),"Contact Us: A lightweight form to send help requests directly within the RIA platform at the bottom of the Page."))),r.a.createElement("div",{class:t.guideContent,target:!0,id:"Web Portal"},r.a.createElement("div",{class:t.title},r.a.createElement(he.a,{className:t.quationDot})," Web Portal"),r.a.createElement("div",{style:{marginTop:"-28px"}},r.a.createElement($i.a,{className:t.answerArrow,style:{marginBottom:"-40px"}}),r.a.createElement("ol",null,r.a.createElement("li",null,"1. This is a full form to send help requests with",r.a.createElement("a",{href:"https://clignosis.atlassian.net/servicedesk/customer/portals",target:"_blank"}," ","more details.")),r.a.createElement("li",null,"2. We recommend to create an account with the same email used to access the RIA platform (but preferably different password)")))),r.a.createElement("div",{class:t.guideContent,target:!0,id:"Browsers Supported"},r.a.createElement("div",{class:t.title},r.a.createElement(he.a,{className:t.quationDot})," What is the recommended web browser for VivproAI RIA application?"),r.a.createElement("div",null,r.a.createElement("p",null," ",r.a.createElement($i.a,{className:t.answerArrow})," Google Chrome, Mozilla Firefox, Safari, Microsoft Edge"))),r.a.createElement("div",{class:t.guideContent,target:!0,id:"Browsers Not Supported"},r.a.createElement("div",{class:t.title},r.a.createElement(he.a,{className:t.quationDot})," What browser is not compatible with RIA application?"),r.a.createElement("div",null,r.a.createElement("p",null,r.a.createElement($i.a,{className:t.answerArrow})," Internet Explorer")))))}var _o=[{name:"General",content:["VivproAI","RIA"]},{name:"Login and Password",content:["Login","Password Reset"]},{name:"Datasets",content:["Data sources included in RIA"]},{name:"Search Features",content:["how to search","Search results"]},{name:"Terms and Abbreviations",content:["Terms and abbreviations"]},{name:"Technical Support",content:["Widget","Web Portal"]},{name:"Browsers Supported",content:["Browsers Supported","Browsers Not Supported"]}],Oo=[{Term:"ANDA",Definition:"Abbreviated New Drug Application"},{Term:"BLA",Definition:"Biologics Licensing Application"},{Term:"DEN",Definition:"DeNovo Classification"},{Term:"Infographics",Definition:"A visual image, such as a chart or diagram used to represent information or data"},{Term:"PMA",Definition:"Premarket Approval"},{Term:"PMN",Definition:"Premarket Notification"},{Term:"PMR/C",Definition:"Post Marketing Requirements/Commitments"},{Term:"NDA",Definition:"New Drug Application"},{Term:"UI ",Definition:"User Interface"},{Term:"Approval Pathway",Definition:"Section under which a drug application was submitted.Eg 505(b),  505(b)(2), 505(j) etc"}];a(1677);var xo=function(e){return r.a.createElement("div",null,"Forgot Password")},vo=a(77),Ro=a(83),Po=a(156),Io=a(158),wo=Object(f.a)((function(e){return{}})),Lo=function(e){var t=e.errorMessage;wo();return r.a.createElement(r.a.Fragment,null,r.a.createElement(pi.a,{maxWidth:"lg"},r.a.createElement(R.a,{component:"span",display:"flex",flexDirection:"column",textAlign:"center",m:1},r.a.createElement(y.a,null,t))))},jo=function(e){Object(Po.a)(a,e);var t=Object(Io.a)(a);function a(e){var n;return Object(vo.a)(this,a),(n=t.call(this,e)).state={hasError:!1,errorMessage:""},n}return Object(Ro.a)(a,[{key:"componentDidCatch",value:function(e){this.setState({hasError:!0,errorMessage:e.message})}},{key:"render",value:function(){return this.state.hasError?r.a.createElement(Lo,{errorMessage:this.state.errorMessage}):this.props.children}}]),a}(n.Component),Bo=a(1940),Uo=a(832),ko=Object(f.a)((function(e){var t,a,n;return n={root:{marginTop:e.spacing(8),padding:e.spacing(2),marginLeft:e.spacing(9)+1,width:"calc(100% - ".concat(e.spacing(9)+1,"px)")},Tableroot:{width:"100%",margin:"10px",overflowX:"scroll"},GridHeaderBreadcrumbs:{height:"8vh",backgroundColor:e.palette.white,margin:0},bannerRoot:{},GridHeaderParent:{backgroundColor:e.palette.white,margin:0,padding:e.spacing(1)},paperContainer:{width:"100%",borderRadius:e.spacing(1.25),padding:e.spacing(1)},GridCardTabs:{backgroundColor:e.palette.white,margin:0,width:"100%"},GridCardTopFilters:{margin:e.spacing(2)},ModalButton:{fontSize:"2vh",fontWeight:"500",borderRadius:"10px",color:e.palette.primary.main,border:"2px solid ".concat(e.palette.primary.lightBorder)},sortSelectGrid:{}},Object(g.a)(n,"sortSelectGrid",{marginTop:e.spacing(1)}),Object(g.a)(n,"sortTabSelect",{borderRadius:e.spacing(1.25),color:e.palette.biologics.textPrimary,backgroundColor:e.palette.white,border:"1px solid #CDD4F7",width:e.spacing(20),marginLeft:e.spacing(.5),"&:hover":{backgroundColor:"#FFF"}}),Object(g.a)(n,"CardsSwipableView",{width:"100%",height:"100%"}),Object(g.a)(n,"CardTabs",{backgroundColor:e.palette.white,margin:0,fontFamily:"Roboto",color:e.palette.black,width:"100%"}),Object(g.a)(n,"CardTab",{backgroundColor:e.palette.white,margin:0}),Object(g.a)(n,"Modal",{width:"50%",height:"50%"}),Object(g.a)(n,"ManageCardsDivision",{backgroundColor:e.palette.primary.lightBackground,marginTop:"2vh",marginBottom:"2vh"}),Object(g.a)(n,"GridCardsParent",{height:"90%"}),Object(g.a)(n,"GridFilters",{width:"100%",paddingRight:e.spacing(1),marginTop:e.spacing(2),backgroundColor:e.palette.white}),Object(g.a)(n,"GridCards",{width:"100%",marginTop:e.spacing(2),backgroundColor:e.palette.white}),Object(g.a)(n,"GridTimeline",{backgroundColor:e.palette.white}),Object(g.a)(n,"GridPagination",{marginTop:e.spacing(2),backgroundColor:e.palette.white,width:"100%"}),Object(g.a)(n,"TimelineGridBox",{height:"100%",width:"100%",marginTop:e.spacing(1),boxShadow:"none",borderRadius:"10px"}),Object(g.a)(n,"CardsDivisionDivider",{backgroundColor:e.palette.primary.lightBackground,height:"3px",marginTop:"1vh",marginLeft:"10vh",marginRight:"10vh"}),Object(g.a)(n,"CardsDivisionTitle",{width:"fit-content",paddingLeft:e.spacing(2),fontVariant:"small-caps",color:e.palette.black,fontWeight:"900",fontSize:"2vh"}),Object(g.a)(n,"applicationTypeColor",{marginRight:e.spacing(1),borderRadius:"10px",fontWeight:"900",fontSize:"1.3vh"}),Object(g.a)(n,"DisplayBannerLogo",{marginLeft:e.spacing(5)}),Object(g.a)(n,"DisplayBannerText",{marginLeft:e.spacing(1),color:e.palette.navbar.button,fontWeight:"600",fontSize:e.spacing(4)}),Object(g.a)(n,"DisplayBannerTextClinical",{marginLeft:e.spacing(1),textDecoration:"underline",color:e.palette.navbar.button,fontWeight:"600",fontSize:e.spacing(4)}),Object(g.a)(n,"DisplayBannerName",{marginLeft:e.spacing(1),color:e.palette.black,fontWeight:"600",fontSize:e.spacing(2)}),Object(g.a)(n,"clinicalTrialsBox",{cursor:"pointer"}),Object(g.a)(n,"BannerIconButton",{marginLeft:e.spacing(5),color:"#0E83DC"}),Object(g.a)(n,"bannerSideIcons",{fontSize:e.spacing(4)}),Object(g.a)(n,"filterBox",{width:"100%"}),Object(g.a)(n,"Card",{height:"100%",width:"90%",margin:"1.5vh",backgroundColor:e.palette.primary.lightBackground,borderRadius:"10px",boxShadow:"5px 5px 10px ".concat(e.palette.primary.lightBorder," !important")}),Object(g.a)(n,"CardHeader",{width:"100%",height:"2.3vh",padding:"0 !important"}),Object(g.a)(n,"CardIconTile",{paddingLeft:"8px",paddingRight:"8px",marginTop:"-2vh"}),Object(g.a)(n,"CardHeaderIconButton",{}),Object(g.a)(n,"CardHeaderIcon",{height:"2.3vh",width:"2.3vh",fontSize:"1.8vh",color:e.palette.fatalRed}),Object(g.a)(n,"CardsLine1",{padding:e.spacing(1)}),Object(g.a)(n,"CardsLine2",{paddingTop:e.spacing(1),paddingLeft:e.spacing(1),paddingRight:e.spacing(1)}),Object(g.a)(n,"CardContent",{cursor:"pointer",paddingTop:"2px",paddingBottom:"10px !important"}),Object(g.a)(n,"CardTitle",{width:"90%",textAlign:"left",color:e.palette.primary.main,fontWeight:"900",fontSize:"1.5vh"}),Object(g.a)(n,"CardFormulation",{borderRadius:"10px",width:"80%",height:"fit-content",textAlign:"center",fontWeight:"900",fontSize:"1.5vh",color:e.palette.black,backgroundColor:e.palette.primary.lightBorder}),Object(g.a)(n,"CardApprovalPathway",{borderRadius:"10px",width:"100%",height:"2vh",textAlign:"center",color:e.palette.white,fontWeight:"900",fontSize:"1.5vh"}),Object(g.a)(n,"CardBrandName",{width:"100%",color:e.palette.primary.main,fontWeight:"900",opacity:"0.5",textAlign:"left",fontSize:"3vh",fontStyle:"oblique"}),Object(g.a)(n,"CardTopLogosYes",{width:"3vh",height:"3vh",color:e.palette.primary.main,opacity:"1"}),Object(g.a)(n,"CardTopLogosNo",{width:"3vh",height:"3vh",color:e.palette.primary.main,opacity:"0.2"}),Object(g.a)(n,"Pagination",{"& .MuiPaginationItem-root":{backgroundColor:"".concat(e.palette.primary.lightBorder," !important"),color:e.palette.black,fontWeight:"900"},"& .Mui-selected":{backgroundColor:"".concat(e.palette.primary.main," !important"),color:e.palette.white,fontWeight:"900"}}),Object(g.a)(n,"paper",{position:"absolute",width:400,backgroundColor:e.palette.background.paper,border:"2px solid #000",boxShadow:e.shadows[5],padding:e.spacing(2,4,3)}),Object(g.a)(n,"CardExtendedTitle",{cursor:"pointer",display:"flex",alignItems:"center",borderRadius:"10px",padding:e.spacing(1),width:"fit-content",backgroundColor:e.palette.navbar.button,textAlign:"center",margin:"auto",color:e.palette.white,fontWeight:"900",fontSize:e.spacing(2)}),Object(g.a)(n,"add",{fontSize:e.spacing(1.87),color:e.palette.navbar.button,cursor:"pointer",textTransform:"capitalize",marginTop:e.spacing(-.5)}),Object(g.a)(n,"btnModal",{background:"none",border:"none",color:"#0352cc",borderBottom:"1px solid #0352cc"}),Object(g.a)(n,"CardsDialogActions",{width:"100%",justifyContent:"center"}),Object(g.a)(n,"botIconFAB",{left:e.spacing(2),bottom:e.spacing(10),zIndex:e.zIndex.drawer+2,position:"fixed"}),Object(g.a)(n,"airplaneIcon",{position:"fixed",zIndex:e.zIndex.drawer+2,bottom:e.spacing(2),left:e.spacing(2)}),Object(g.a)(n,"botIcon",{height:"100%",width:"100%"}),Object(g.a)(n,"botIntroPopup",{fontWeight:"900",fontSize:"2vh",padding:"4px",borderRadius:"10px",color:e.palette.primary.main,backgroundColor:e.palette.primary.lightBackground}),Object(g.a)(n,"botTextPopup",{fontSize:"1.5vh",padding:"4px",color:e.palette.white,opacity:1}),Object(g.a)(n,"headerStyle",{backgroundColor:"#039be5",color:"#ffff"}),Object(g.a)(n,"exModal",{position:"relative"}),Object(g.a)(n,"Dialog",{minHeight:"70vh"}),Object(g.a)(n,"BotDialog",{minHeight:"70vh",padding:0}),Object(g.a)(n,"DialogTitle",{color:e.palette.primary.main,fontWeight:"900",fontSize:"3vh",padding:"12px"}),Object(g.a)(n,"ModalTitle",{padding:0}),Object(g.a)(n,"ModalCloseIconButton",{padding:0,color:e.palette.navbar.button}),Object(g.a)(n,"ModalCloseIcon",{color:e.palette.biologics.textPrimary}),Object(g.a)(n,"CardsDialogActions",{width:"100%",justifyContent:"center"}),Object(g.a)(n,"daCell",{width:"33.33%",minHeight:"55px",padding:"4px",position:"relative",borderBottom:"1px solid #ccc",borderRight:"1px solid #ccc",wordBreak:"break-all",fontSize:"2vh",fontWeight:"bold"}),Object(g.a)(n,"daRow",{height:"100%",width:"100%",display:"flex",flexWrap:"wrap"}),Object(g.a)(n,"searchList",{outline:0,width:"600px !important",overflowX:"hidden",overflowY:"auto",margin:"0",height:"560px"}),Object(g.a)(n,"common360SwipableView",{width:"100%",minHeight:"70vh"}),Object(g.a)(n,"TimeLine",{backgroundColor:"rgb(0, 130, 217)",border:"8px solid ".concat(e.palette.primary.lightBackground),color:"white",display:"flex",padding:"2px"}),Object(g.a)(n,"RegTitle",{fontWeight:"600",fontSize:"2.8vh",color:"white",textAlign:"end"}),Object(g.a)(n,"RegBannerTitle",{textAlign:"left",color:"white",fontWeight:"600",fontSize:"1.5vh"}),Object(g.a)(n,"RegBannerText",{textAlign:"left",color:"white",fontWeight:"600",fontSize:"2.8vh",whiteSpace:"nowrap",overflow:"hidden",textOverflow:"ellipsis",maxWidth:"350px"}),Object(g.a)(n,"emptyFilters",{width:"100%"}),Object(g.a)(n,"ErrorParent",{marginTop:e.spacing(8),padding:e.spacing(2),marginLeft:e.spacing(9)+1,width:"calc(100% - ".concat(e.spacing(9)+1,"px)")}),Object(g.a)(n,"StyledErrorTypography",{fontSize:"2vh",padding:"15px",color:e.palette.black,borderRadius:"10px",backgroundColor:e.palette.primary.lightBorder,fontWeight:"700"}),Object(g.a)(n,"StyledErrorLine2Typography",{fontSize:"1.5vh",padding:"15px",color:e.palette.primary.main,fontWeight:"900"}),Object(g.a)(n,"ErrorGrid",{padding:e.spacing(3)}),Object(g.a)(n,"ErrorIcon",{height:"9vh",width:"auto",backgroundColor:e.palette.white}),Object(g.a)(n,"dropdownContainer",{width:e.spacing(30),background:e.palette.white,borderRadius:e.spacing(1),border:"1px solid #CDD4F7","&:hover":{backgroundColor:"#FFF"}}),Object(g.a)(n,"dropdownText",{color:e.palette.biologics.textPrimary,fontWeight:"bold"}),Object(g.a)(n,"CloudText",{fontWeight:"700",fontSize:"1rem"}),Object(g.a)(n,"CloudTextLarge",{fontWeight:"800",fontSize:"1.2rem"}),Object(g.a)(n,"CloudTextSmall",{fontWeight:"600",fontSize:"0.7rem"}),Object(g.a)(n,"WordCloudBox",{width:"100%",height:"100%",minHeight:"60vh"}),Object(g.a)(n,"WordCloudToolTip",{width:"fit-content",padding:"10px",paddingLeft:"20px",paddingRight:"20px",borderRadius:"10px",color:e.palette.white}),Object(g.a)(n,"TableBodyRows",{"&:nth-of-type(odd)":{padding:"0",backgroundColor:e.palette.primary.lightBackground},"&:nth-of-type(even)":{padding:"0",backgroundColor:e.palette.white}}),Object(g.a)(n,"TableHeadCells",{boxShadow:"none",border:"none",fontWeight:"700"}),Object(g.a)(n,"TableCellTypography",{fontSize:"1.5vh"}),Object(g.a)(n,"Textfield",{marginBottom:e.spacing(2),border:"none",marginLeft:e.spacing(1),borderRadius:"15px",minWidth:e.spacing(45),height:"100%",minHeight:"50px",fontSize:"1.8vh",background:e.palette.navbar.grayBackground,color:e.palette.black,paddingLeft:"10px"}),Object(g.a)(n,"Textfield",{marginBottom:e.spacing(2),border:"none",marginLeft:e.spacing(1),borderRadius:"15px",minWidth:e.spacing(45),height:"100%",minHeight:"50px",fontSize:"1.8vh",background:e.palette.navbar.grayBackground,color:e.palette.black,paddingLeft:"10px"}),Object(g.a)(n,"Button",{fontSize:"0.8rem",textTransform:"none",fontWeight:"400",minHeight:"50px",padding:"10px",background:e.palette.navbar.grayBackground,borderRadius:"10px",borderBottomLeftRadius:"0px",borderTopLeftRadius:"0px",marginBottom:e.spacing(2)}),Object(g.a)(n,"ResetButton",(t={fontSize:"0.8rem",borderRadius:"10px",maxHeight:"50px",minHeight:"50px",fontWeight:"400",textTransform:"none",backgroundColor:e.palette.primary.lightBorder,color:e.palette.black},Object(g.a)(t,"fontSize",e.spacing(2)),Object(g.a)(t,"padding",0),Object(g.a)(t,"marginLeft","20px"),t)),Object(g.a)(n,"ErrorTypography",(a={fontWeight:"700",fontSize:"0.8rem",padding:"20px",marginLeft:"20px"},Object(g.a)(a,"fontSize","0.8rem"),Object(g.a)(a,"maxHeight","50px"),Object(g.a)(a,"minHeight","50px"),Object(g.a)(a,"color",e.palette.fatalRed),a)),Object(g.a)(n,"TableBodyCells",{boxShadow:"none",border:"none"}),Object(g.a)(n,"Form",{width:"100%"}),Object(g.a)(n,"TableBodyCellBox",{height:"50px",minWidth:"100px",overflowY:"auto",boxShadow:"none",border:"none"}),Object(g.a)(n,"TableBodyCellBoxBig",{height:"70px",minWidth:"300px",overflowY:"auto",boxShadow:"none",border:"none"}),Object(g.a)(n,"TableCellTypography",{fontSize:"0.7rem"}),n})),Mo=a(1935),Fo=a(1941),zo=a(1811),Yo=a(1942),Vo=a(1934),Go=a(351),Ho=a.n(Go),Wo=a(1155),Qo=a.n(Wo),Jo=a(1154),Ko=a.n(Jo),Zo=a(1153),Xo=a.n(Zo),qo=Object(f.a)((function(e){return{TimelineAlternateBox:{backgroundColor:e.palette.primary.lightBackground,marginTop:"4px",marginBottom:"4px",borderBottom:"2px solid ".concat(e.palette.primary.lightBorder)},TimelineDotGreen:{backgroundColor:"".concat(e.palette.successGreen," !important"),height:"2vh",width:"2vh",boxShadow:"0 0 3px ".concat(e.palette.successGreen," !important"),border:"1px solid ".concat(e.palette.white," !important")},DateHeader:{height:"3vh",fontSize:"1.5vh",width:"15vh",lineHeight:"3vh",backgroundColor:e.palette.successGreen,color:e.palette.white,boxShadow:"0 0 3px ".concat(e.palette.successGreen," !important"),border:"1px solid ".concat(e.palette.white," !important"),borderRadius:"20px",fontWeight:"900"},TimelineTitle:{padding:"4px",paddingLeft:e.spacing(1),textAlign:"left",color:e.palette.primary.main,fontWeight:"900",fontSize:"1.5vh"},TimelineDivisionDivider:{width:"90%",backgroundColor:e.palette.white,height:"2px"},TimelinesLine1:{padding:e.spacing(1)},TimelinesLine2:{padding:e.spacing(1)},TimelineContent:{cursor:"pointer",paddingTop:"2px",paddingBottom:"10px !important"},TimelineSponsorName:{width:"90%",textAlign:"left",color:e.palette.primary.main,fontWeight:"900",fontSize:"1.5vh"},TimelineFormulation:{borderRadius:"10px",width:"80%",height:"fit-content",textAlign:"center",fontWeight:"900",fontSize:"1.5vh",color:e.palette.black,backgroundColor:e.palette.primary.lightBorder},TimelineApprovalPathway:{borderRadius:"10px",width:"100%",height:"2vh",textAlign:"center",color:e.palette.white,fontWeight:"900",fontSize:"1.5vh"},TimelineBrandName:{width:"100%",color:e.palette.primary.main,fontWeight:"900",opacity:"0.5",textAlign:"left",fontSize:"3vh",fontStyle:"oblique"},TimelineIconTile:{paddingLeft:"8px",paddingRight:"8px"},TimelineBrandNameLeft:{width:"100%",color:e.palette.primary.main,fontWeight:"900",opacity:"0.5",textAlign:"right",fontSize:"3vh",fontStyle:"oblique"},TimelineTopLogosYes:{width:"3vh",height:"3vh",color:e.palette.primary.main,opacity:"1"},TimelineTopLogosNo:{width:"3vh",height:"3vh",color:e.palette.primary.main,opacity:"0.2"}}})),$o=a(1926),el=a(1927),tl=a(1929),al=a(1931),nl=a(1928),rl=a(1932),il=a(1930);function ol(e){var t=qo(),a=Object(n.useState)(),i=Object(d.a)(a,2),o=i[0],l=i[1],m=Object(n.useState)(),u=Object(d.a)(m,2),p=u[0],g=u[1],h=Object(n.useState)(),T=Object(d.a)(h,2),f=T[0],A=T[1];return Object(n.useEffect)((function(){function t(){return(t=Object(s.a)(c.a.mark((function t(){return c.a.wrap((function(t){for(;;)switch(t.prev=t.next){case 0:try{g({NDA:"#EA5252",BLA:"#70319F",ANDA:"#FFC100"}),A({351:"#9A31CD","351(a)":"#258B21","351(k)":"#02CED1","505(b)":"#F6A000"}),l(e.data)}catch(a){console.log(a)}case 1:case"end":return t.stop()}}),t)})))).apply(this,arguments)}!function(){t.apply(this,arguments)}()}),[e]),o?r.a.createElement("div",null,r.a.createElement(C.a,{container:!0},r.a.createElement(C.a,{container:!0,item:!0,xs:3}),r.a.createElement(C.a,{container:!0,item:!0,xs:6},"Oldest"===e.sort?r.a.createElement($o.a,{align:"alternate"},Object.keys(o).map((function(e,a){return r.a.createElement(el.a,{align:"alternate",className:t.TimelineItem},r.a.createElement(nl.a,null,a%2===0?r.a.createElement(C.a,{xs:12,container:!0,justify:"flex-end",alignItems:"center"},r.a.createElement(y.a,{className:t.DateHeader},r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"center"},e))):r.a.createElement(C.a,{xs:12,container:!0,justify:"flex-start",alignItems:"center"},r.a.createElement(y.a,{className:t.DateHeader},r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"center"},e)))),a===Object.keys(o).length-1?r.a.createElement(tl.a,null,r.a.createElement(il.a,{className:t.TimelineDotGreen})):r.a.createElement(tl.a,null,r.a.createElement(il.a,{className:t.TimelineDotGreen}),r.a.createElement(al.a,null)),r.a.createElement(rl.a,{className:t.TimelineTab},r.a.createElement("div",{className:t.TimelineGridBox},o[e].map((function(n,i){return r.a.createElement(C.a,{container:!0},a%2===0?r.a.createElement(C.a,{container:!0,justify:"center",alignItems:"center",className:t.TimelineAlternateBox,style:{borderRadius:"10px",padding:"5px",borderRight:"10px solid ".concat(p[n.appl_type])}},r.a.createElement(C.a,{container:!0,justify:"center",alignItems:"center",item:!0,xs:12,className:t.TimelineIconTile},r.a.createElement(C.a,{container:!0,justify:"flex-start",alignItems:"center",item:!0,xs:3},r.a.createElement(L.a,{TransitionComponent:pe.a,title:"Accelerated Approval: "+n.Accelerated_approval},"Yes"===n.Accelerated_approval?r.a.createElement(S.a,{alt:"Logo",src:En.a,className:t.TimelineTopLogosYes}):r.a.createElement(S.a,{alt:"Logo",src:En.a,className:t.TimelineTopLogosNo}))),r.a.createElement(C.a,{container:!0,justify:"flex-start",alignItems:"center",item:!0,xs:3},r.a.createElement(L.a,{TransitionComponent:pe.a,title:"Fast Track: "+n.Fasttrack},"Yes"===n.Fasttrack?r.a.createElement(S.a,{alt:"Logo",src:Sn.a,className:t.TimelineTopLogosYes}):r.a.createElement(S.a,{alt:"Logo",src:Sn.a,className:t.TimelineTopLogosNo}))),r.a.createElement(C.a,{container:!0,justify:"flex-start",alignItems:"center",item:!0,xs:3},r.a.createElement(L.a,{TransitionComponent:pe.a,title:"Breakthrough: "+n.Breakthrough},"Yes"===n.Breakthrough?r.a.createElement(S.a,{alt:"Logo",src:Nn.a,className:t.TimelineTopLogosYes}):r.a.createElement(S.a,{alt:"Logo",src:Nn.a,className:t.TimelineTopLogosNo}))),r.a.createElement(C.a,{container:!0,justify:"flex-start",alignItems:"center",item:!0,xs:3},r.a.createElement(L.a,{TransitionComponent:pe.a,title:"Generics: "+n.Generics},"Yes"===n.Generics?r.a.createElement(S.a,{alt:"Logo",src:Dn.a,className:t.TimelineTopLogosYes}):r.a.createElement(S.a,{alt:"Logo",src:Dn.a,className:t.TimelineTopLogosNo})))),r.a.createElement(C.a,{item:!0,xs:12,container:!0,justify:"flex-start",alignItems:"center",className:t.topTimelineGrid},n.activeIngredients.length>9?r.a.createElement(L.a,{TransitionComponent:pe.a,title:n.activeIngredients},r.a.createElement(y.a,{className:t.TimelineTitle},n.activeIngredients.substring(0,10),"...")):r.a.createElement(y.a,{className:t.TimelineTitle},n.activeIngredients)),r.a.createElement(C.a,{container:!0,justify:"flex-start",alignItems:"center",item:!0,xs:12,className:t.TimelinesLine1},r.a.createElement(C.a,{container:!0,justify:"flex-start",alignItems:"center",item:!0,xs:9},n.tradeName.length>9?r.a.createElement(L.a,{TransitionComponent:pe.a,title:n.tradeName},r.a.createElement(y.a,{className:t.TimelineBrandName},n.tradeName.substring(0,10),"...")):r.a.createElement(y.a,{className:t.TimelineBrandName},n.tradeName)),r.a.createElement(C.a,{container:!0,justify:"flex-start",alignItems:"center",item:!0,xs:3},r.a.createElement(y.a,{className:t.TimelineApprovalPathway,style:{backgroundColor:f[n.approvalPathway]}},n.approvalPathway))),r.a.createElement(C.a,{container:!0,justify:"center",alignItems:"center",item:!0,xs:12,className:t.TimelinesLine2},r.a.createElement(C.a,{container:!0,justify:"flex-start",alignItems:"center",item:!0,xs:7},r.a.createElement(y.a,{className:t.TimelineFormulation},n.formulation)),r.a.createElement(C.a,{container:!0,justify:"flex-start",alignItems:"center",item:!0,xs:5},n.sponsorName.length>10?r.a.createElement(L.a,{TransitionComponent:pe.a,title:n.sponsorName},r.a.createElement(y.a,{className:t.TimelineSponsorName},n.sponsorName.substring(0,9),"...")):r.a.createElement(y.a,{className:t.TimelineSponsorName},n.sponsorName)))):r.a.createElement(C.a,{container:!0,className:t.TimelineAlternateBox,justify:"center",alignItems:"center",style:{borderRadius:"10px",padding:"5px",borderLeft:"10px solid ".concat(p[n.appl_type])}},r.a.createElement(C.a,{container:!0,justify:"center",alignItems:"center",item:!0,xs:12,className:t.TimelineIconTile},r.a.createElement(C.a,{container:!0,justify:"flex-end",alignItems:"center",item:!0,xs:3},"Yes"===n.Accelerated_approval?r.a.createElement(S.a,{alt:"Logo",src:En.a,className:t.TimelineTopLogosYes}):r.a.createElement(S.a,{alt:"Logo",src:En.a,className:t.TimelineTopLogosNo})),r.a.createElement(C.a,{container:!0,justify:"flex-end",alignItems:"center",item:!0,xs:3},"Yes"===n.Fasttrack?r.a.createElement(S.a,{alt:"Logo",src:Sn.a,className:t.TimelineTopLogosYes}):r.a.createElement(S.a,{alt:"Logo",src:Sn.a,className:t.TimelineTopLogosNo})),r.a.createElement(C.a,{container:!0,justify:"flex-end",alignItems:"center",item:!0,xs:3},"Yes"===n.Breakthrough?r.a.createElement(S.a,{alt:"Logo",src:Nn.a,className:t.TimelineTopLogosYes}):r.a.createElement(S.a,{alt:"Logo",src:Nn.a,className:t.TimelineTopLogosNo})),r.a.createElement(C.a,{container:!0,justify:"flex-end",alignItems:"center",item:!0,xs:3},"Yes"===n.Generics?r.a.createElement(S.a,{alt:"Logo",src:Dn.a,className:t.TimelineTopLogosYes}):r.a.createElement(S.a,{alt:"Logo",src:Dn.a,className:t.TimelineTopLogosNo}))),r.a.createElement(C.a,{item:!0,xs:12,container:!0,justify:"flex-end",alignItems:"center",className:t.topTimelineGrid},n.activeIngredients.length>9?r.a.createElement(L.a,{TransitionComponent:pe.a,title:n.activeIngredients},r.a.createElement(y.a,{className:t.TimelineTitle},n.activeIngredients.substring(0,10),"...")):r.a.createElement(y.a,{className:t.TimelineTitle},n.activeIngredients)),r.a.createElement(C.a,{container:!0,justify:"flex-start",alignItems:"center",item:!0,xs:12,className:t.TimelinesLine1},r.a.createElement(C.a,{container:!0,justify:"flex-start",alignItems:"center",item:!0,xs:3},r.a.createElement(y.a,{className:t.TimelineApprovalPathway,style:{backgroundColor:f[n.approvalPathway]}},n.approvalPathway)),r.a.createElement(C.a,{container:!0,justify:"flex-start",alignItems:"center",item:!0,xs:9},n.tradeName.length>9?r.a.createElement(L.a,{TransitionComponent:pe.a,title:n.tradeName},r.a.createElement(y.a,{className:t.TimelineBrandNameLeft},n.tradeName.substring(0,10),"...")):r.a.createElement(y.a,{className:t.TimelineBrandNameLeft},n.tradeName))),r.a.createElement(C.a,{container:!0,justify:"center",alignItems:"center",item:!0,xs:12,className:t.TimelinesLine2},r.a.createElement(C.a,{container:!0,justify:"flex-end",alignItems:"center",item:!0,xs:5},n.sponsorName.length>10?r.a.createElement(L.a,{TransitionComponent:pe.a,title:n.sponsorName},r.a.createElement(y.a,{className:t.TimelineSponsorName},n.sponsorName.substring(0,9),"...")):r.a.createElement(y.a,{className:t.TimelineSponsorName},n.sponsorName)),r.a.createElement(C.a,{container:!0,justify:"flex-end",alignItems:"center",item:!0,xs:7},r.a.createElement(y.a,{className:t.TimelineFormulation},n.formulation)))),i===o[e].length-1?r.a.createElement("div",null):r.a.createElement(vt.a,{variant:"middle",className:t.TimelineDivisionDivider}))})))))}))):r.a.createElement($o.a,{align:"alternate"},Object.keys(o).reverse().map((function(e,a){return r.a.createElement(el.a,{align:"alternate",className:t.TimelineItem},r.a.createElement(nl.a,null,a%2===0?r.a.createElement(C.a,{xs:12,container:!0,justify:"flex-end",alignItems:"center"},r.a.createElement(y.a,{className:t.DateHeader},r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"center"},e))):r.a.createElement(C.a,{xs:12,container:!0,justify:"flex-start",alignItems:"center"},r.a.createElement(y.a,{className:t.DateHeader},r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"center"},e)))),a===Object.keys(o).length-1?r.a.createElement(tl.a,null,r.a.createElement(il.a,{className:t.TimelineDotGreen})):r.a.createElement(tl.a,null,r.a.createElement(il.a,{className:t.TimelineDotGreen}),r.a.createElement(al.a,null)),r.a.createElement(rl.a,{className:t.TimelineTab},r.a.createElement("div",{className:t.TimelineGridBox},o[e].map((function(n,i){return r.a.createElement(C.a,{container:!0},a%2===0?r.a.createElement(C.a,{container:!0,justify:"center",alignItems:"center",className:t.TimelineAlternateBox,style:{borderRadius:"10px",padding:"5px",borderRight:"10px solid ".concat(p[n.appl_type])}},r.a.createElement(C.a,{container:!0,justify:"center",alignItems:"center",item:!0,xs:12,className:t.TimelineIconTile},r.a.createElement(C.a,{container:!0,justify:"flex-start",alignItems:"center",item:!0,xs:3},r.a.createElement(L.a,{TransitionComponent:pe.a,title:"Accelerated Approval: "+n.Accelerated_approval},"Yes"===n.Accelerated_approval?r.a.createElement(S.a,{alt:"Logo",src:En.a,className:t.TimelineTopLogosYes}):r.a.createElement(S.a,{alt:"Logo",src:En.a,className:t.TimelineTopLogosNo}))),r.a.createElement(C.a,{container:!0,justify:"flex-start",alignItems:"center",item:!0,xs:3},r.a.createElement(L.a,{TransitionComponent:pe.a,title:"Fast Track: "+n.Fasttrack},"Yes"===n.Fasttrack?r.a.createElement(S.a,{alt:"Logo",src:Sn.a,className:t.TimelineTopLogosYes}):r.a.createElement(S.a,{alt:"Logo",src:Sn.a,className:t.TimelineTopLogosNo}))),r.a.createElement(C.a,{container:!0,justify:"flex-start",alignItems:"center",item:!0,xs:3},r.a.createElement(L.a,{TransitionComponent:pe.a,title:"Breakthrough: "+n.Breakthrough},"Yes"===n.Breakthrough?r.a.createElement(S.a,{alt:"Logo",src:Nn.a,className:t.TimelineTopLogosYes}):r.a.createElement(S.a,{alt:"Logo",src:Nn.a,className:t.TimelineTopLogosNo}))),r.a.createElement(C.a,{container:!0,justify:"flex-start",alignItems:"center",item:!0,xs:3},r.a.createElement(L.a,{TransitionComponent:pe.a,title:"Generics: "+n.Generics},"Yes"===n.Generics?r.a.createElement(S.a,{alt:"Logo",src:Dn.a,className:t.TimelineTopLogosYes}):r.a.createElement(S.a,{alt:"Logo",src:Dn.a,className:t.TimelineTopLogosNo})))),r.a.createElement(C.a,{item:!0,xs:12,container:!0,justify:"flex-start",alignItems:"center",className:t.topTimelineGrid},n.activeIngredients.length>9?r.a.createElement(L.a,{TransitionComponent:pe.a,title:n.activeIngredients},r.a.createElement(y.a,{className:t.TimelineTitle},n.activeIngredients.substring(0,10),"...")):r.a.createElement(y.a,{className:t.TimelineTitle},n.activeIngredients)),r.a.createElement(C.a,{container:!0,justify:"flex-start",alignItems:"center",item:!0,xs:12,className:t.TimelinesLine1},r.a.createElement(C.a,{container:!0,justify:"flex-start",alignItems:"center",item:!0,xs:9},n.tradeName.length>9?r.a.createElement(L.a,{TransitionComponent:pe.a,title:n.tradeName},r.a.createElement(y.a,{className:t.TimelineBrandName},n.tradeName.substring(0,10),"...")):r.a.createElement(y.a,{className:t.TimelineBrandName},n.tradeName)),r.a.createElement(C.a,{container:!0,justify:"flex-start",alignItems:"center",item:!0,xs:3},r.a.createElement(y.a,{className:t.TimelineApprovalPathway,style:{backgroundColor:f[n.approvalPathway]}},n.approvalPathway))),r.a.createElement(C.a,{container:!0,justify:"center",alignItems:"center",item:!0,xs:12,className:t.TimelinesLine2},r.a.createElement(C.a,{container:!0,justify:"flex-start",alignItems:"center",item:!0,xs:7},r.a.createElement(y.a,{className:t.TimelineFormulation},n.formulation)),r.a.createElement(C.a,{container:!0,justify:"flex-start",alignItems:"center",item:!0,xs:5},n.sponsorName.length>10?r.a.createElement(L.a,{TransitionComponent:pe.a,title:n.sponsorName},r.a.createElement(y.a,{className:t.TimelineSponsorName},n.sponsorName.substring(0,9),"...")):r.a.createElement(y.a,{className:t.TimelineSponsorName},n.sponsorName)))):r.a.createElement(C.a,{container:!0,className:t.TimelineAlternateBox,justify:"center",alignItems:"center",style:{borderRadius:"10px",padding:"5px",borderLeft:"10px solid ".concat(p[n.appl_type])}},r.a.createElement(C.a,{container:!0,justify:"center",alignItems:"center",item:!0,xs:12,className:t.TimelineIconTile},r.a.createElement(C.a,{container:!0,justify:"flex-end",alignItems:"center",item:!0,xs:3},"Yes"===n.Accelerated_approval?r.a.createElement(S.a,{alt:"Logo",src:En.a,className:t.TimelineTopLogosYes}):r.a.createElement(S.a,{alt:"Logo",src:En.a,className:t.TimelineTopLogosNo})),r.a.createElement(C.a,{container:!0,justify:"flex-end",alignItems:"center",item:!0,xs:3},"Yes"===n.Fasttrack?r.a.createElement(S.a,{alt:"Logo",src:Sn.a,className:t.TimelineTopLogosYes}):r.a.createElement(S.a,{alt:"Logo",src:Sn.a,className:t.TimelineTopLogosNo})),r.a.createElement(C.a,{container:!0,justify:"flex-end",alignItems:"center",item:!0,xs:3},"Yes"===n.Breakthrough?r.a.createElement(S.a,{alt:"Logo",src:Nn.a,className:t.TimelineTopLogosYes}):r.a.createElement(S.a,{alt:"Logo",src:Nn.a,className:t.TimelineTopLogosNo})),r.a.createElement(C.a,{container:!0,justify:"flex-end",alignItems:"center",item:!0,xs:3},"Yes"===n.Generics?r.a.createElement(S.a,{alt:"Logo",src:Dn.a,className:t.TimelineTopLogosYes}):r.a.createElement(S.a,{alt:"Logo",src:Dn.a,className:t.TimelineTopLogosNo}))),r.a.createElement(C.a,{item:!0,xs:12,container:!0,justify:"flex-end",alignItems:"center",className:t.topTimelineGrid},n.activeIngredients.length>9?r.a.createElement(L.a,{TransitionComponent:pe.a,title:n.activeIngredients},r.a.createElement(y.a,{className:t.TimelineTitle},n.activeIngredients.substring(0,10),"...")):r.a.createElement(y.a,{className:t.TimelineTitle},n.activeIngredients)),r.a.createElement(C.a,{container:!0,justify:"flex-start",alignItems:"center",item:!0,xs:12,className:t.TimelinesLine1},r.a.createElement(C.a,{container:!0,justify:"flex-start",alignItems:"center",item:!0,xs:3},r.a.createElement(y.a,{className:t.TimelineApprovalPathway,style:{backgroundColor:f[n.approvalPathway]}},n.approvalPathway)),r.a.createElement(C.a,{container:!0,justify:"flex-start",alignItems:"center",item:!0,xs:9},n.tradeName.length>9?r.a.createElement(L.a,{TransitionComponent:pe.a,title:n.tradeName},r.a.createElement(y.a,{className:t.TimelineBrandNameLeft},n.tradeName.substring(0,10),"...")):r.a.createElement(y.a,{className:t.TimelineBrandNameLeft},n.tradeName))),r.a.createElement(C.a,{container:!0,justify:"center",alignItems:"center",item:!0,xs:12,className:t.TimelinesLine2},r.a.createElement(C.a,{container:!0,justify:"flex-end",alignItems:"center",item:!0,xs:5},n.sponsorName.length>10?r.a.createElement(L.a,{TransitionComponent:pe.a,title:n.sponsorName},r.a.createElement(y.a,{className:t.TimelineSponsorName},n.sponsorName.substring(0,9),"...")):r.a.createElement(y.a,{className:t.TimelineSponsorName},n.sponsorName)),r.a.createElement(C.a,{container:!0,justify:"flex-end",alignItems:"center",item:!0,xs:7},r.a.createElement(y.a,{className:t.TimelineFormulation},n.formulation)))),i===o[e].length-1?r.a.createElement("div",null):r.a.createElement(vt.a,{variant:"middle",className:t.TimelineDivisionDivider}))})))))})))),r.a.createElement(C.a,{container:!0,item:!0,xs:3}))):r.a.createElement("div",null)}a(541);var ll=a(310),cl=a.n(ll);Object(P.a)((function(e){return{tooltip:{marginTop:"-11vh",marginLeft:"-1vh",width:"fit-content",padding:"10px",paddingLeft:"20px",paddingRight:"20px",borderRadius:"10px",color:e.palette.white,border:"2px solid ".concat(e.palette.primary.lightBorder)}}}))(L.a);var sl=function(e){var t=ko(),a=Object(n.useContext)(Mt),i=(a.state,a.dispatch,Object(n.useState)()),o=Object(d.a)(i,2),l=o[0],m=o[1],u=Object(n.useState)(),p=Object(d.a)(u,2),g=p[0],h=p[1],T=Object(n.useState)(1),f=Object(d.a)(T,2),A=f[0],E=f[1],b=Object(n.useState)(),C=Object(d.a)(b,2),S=C[0],D=C[1],O=Object(n.useState)(!0),x=Object(d.a)(O,2),v=x[0],P=x[1],I=Object(n.useState)(!0),w=Object(d.a)(I,2),B=w[0],U=w[1],k=Object(n.useState)("activeIngredients"),M=Object(d.a)(k,2),F=M[0],z=M[1],Y=Object(n.useState)("Active Ingredients"),G=Object(d.a)(Y,2),H=G[0],W=G[1],Q=Object(n.useState)(),J=Object(d.a)(Q,2),Z=J[0],X=J[1],q=Object(n.useState)([]),$=Object(d.a)(q,2),ee=$[0],te=$[1],ae=Object(n.useState)([]),ne=Object(d.a)(ae,2),re=(ne[0],ne[1]),ie=Object(n.useState)(),oe=Object(d.a)(ie,2),le=oe[0],ce=oe[1],se=Object(n.useState)(),de=Object(d.a)(se,2),me=(de[0],de[1],Object(n.useState)([{field:"appl_type",title:"Appl_Type"},{field:"applno",title:"Appl_Num"},{field:"activeIngredients",title:"Active_Ingredients"},{field:"approvalPathway",title:"Approval_Pathway"},{field:"tradeName",title:"Trade_Name"},{field:"sponsorName",title:"Sponsor_Name"},{field:"formulation",title:"Formulation"},{field:"route",title:"Route"},{field:"FirstApproval_year",title:"First_Approval_year"},{field:"firstApprovalDate",title:"First_Approval_Date"},{field:"marketingStatus",title:"Marketing_Status"},{field:"exclusivity_date",title:"Exclusivity_Date"},{field:"patent_expire_date",title:"Patent_Expire_Date"},{field:"Generics",title:"Generics"},{field:"rld",title:"RLD"},{field:"rs",title:"RS"},{field:"Accelerated_approval",title:"Accelerated_Approval"},{field:"Breakthrough",title:"Breakthrough"},{field:"Fasttrack",title:"Fast_Track"}])),ue=Object(d.a)(me,2),pe=ue[0],ge=(ue[1],Object(n.useState)(!0)),he=Object(d.a)(ge,2),Te=(he[0],he[1],Object(n.useState)(["Active Ingredients","Trade Name","Application Type","Application Number","Approval Pathway","First Approval Date","Formulation","Route","Accelerated Approval","Breakthrough","Fasttrack","Generics","Sponsor Name"])),fe=Object(d.a)(Te,2),Ae=fe[0];fe[1],Object(n.useEffect)((function(){console.log("print props data here",e);var t=new Date,a=t.getMonth()+1+"/"+t.getDate()+"/"+t.getFullYear();X("ria-application-"+a+".csv");var n=[],r=[],i=e.tableData&&e.tableData;if(i.map((function(e){var t={};pe.map((function(a){Object.keys(e).map((function(n,r){a.field===n&&(t[a.title]=e[n])}))})),n.push(t)})),n.length<50)m(n);else{for(var o=0;o<50;o++)r.push(n[o]);m(r)}te(i);var l=[];if(S){for(var c=0;c<i.length;c++)if(void 0!==i[c][F]&&null!==i[c][F]){var s=i[c][F];(s=s.toLowerCase()).includes(S)&&l.push(i[c])}re(l)}if(l.length>0){l.length<50?h(1):l.length%50===0?h(l.length/50):h(1+~~(l.length/50));var d=l.slice(50*(A-1),50*A);ce(d),re(l)}else if(S&&0===l.length){ce([])}else{i.length<50?h(1):i.length%50===0?h(i.length/50):h(1+~~(i.length/50));var u=i.slice(50*(A-1),50*A);ce(u),re(i)}P(!1)}),[A,B,e.tableData]);var Ee=function(){var e=Object(s.a)(c.a.mark((function e(t){return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:t.preventDefault(),U(!B);case 2:case"end":return e.stop()}}),e)})));return function(t){return e.apply(this,arguments)}}(),be=function(){var e=Object(s.a)(c.a.mark((function e(t){return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:"Breakthrough"===t.target.value?(z("Breakthrough"),W("Breakthrough")):"Accelerated Approval"===t.target.value?(z("Accelerated_approval"),W("Accelerated Approval")):"Route"===t.target.value?(z("route"),W("Route")):"Formulation"===t.target.value?(z("formulation"),W("Formulation")):"First Approval Date"===t.target.value?(z("firstApprovalDate"),W("First Approval Date")):"Approval Pathway"===t.target.value?(z("approvalPathway"),W("Approval Pathway")):"Application Number"===t.target.value?(z("applno"),W("Application Number")):"Application Type"===t.target.value?(z("appl_type"),W("Application Type")):"Trade Name"===t.target.value?(z("tradeName"),W("Trade Name")):"Active Ingredients"===t.target.value?(z("activeIngredients"),W("Active Ingredients")):"Fasttrack"===t.target.value?(z("Fasttrack"),W("Fasttrack")):"Generics"===t.target.value?(z("Generics"),W("Generics")):"Sponsor Name"===t.target.value&&(z("sponsorName"),W("Sponsor Name"));case 1:case"end":return e.stop()}}),e)})));return function(t){return e.apply(this,arguments)}}(),Ne=[{field:"activeIngredients",title:"Active Ingredients"},{field:"tradeName",title:"Trade Name"},{field:"appl_type",title:"Application Type"},{field:"applno",title:"Application Number"},{field:"approvalPathway",title:"Approval Pathway"},{field:"firstApprovalDate",title:"First Approval Date"},{field:"formulation",title:"Formulation"},{field:"route",title:"Route"},{field:"Accelerated_approval",title:"Accelerated Approval"},{field:"Breakthrough",title:"Breakthrough"},{field:"Fasttrack",title:"Fasttrack"},{field:"Generics",title:"Generics"},{field:"sponsorName",title:"Sponsor Name"}];function Ce(e){var t;try{t=JSON.parse(localStorage.getItem("lockContent"))}catch(a){t={}}return"number"!==typeof t[e]&&(t[e]=0),t[e]++,localStorage.setItem("lockContent",JSON.stringify(t)),t[e]}return!1===v&&ee.length>0?r.a.createElement(r.a.Fragment,null,r.a.createElement(R.a,{display:"flex",justifyContent:"flex-start"},r.a.createElement("form",{id:"clinicalSearch",onSubmit:Ee,className:t.Form},r.a.createElement(R.a,{display:"flex",justifyContent:"flex-start"},r.a.createElement(sa,{id:"filter",menuItems:Ae,dropdownValue:H,title:"Column",name:"filter",handleChange:be}),r.a.createElement(K,{placeholder:"Search keyword",id:"searchTerm",value:S,handleChange:function(e){D(String(e.target.value).toLowerCase())},name:"searchTerm"}),r.a.createElement(j.a,{type:"submit",className:t.Button},r.a.createElement(V,null)),r.a.createElement(_.a,{className:t.ResetButton,onClick:function(){D(""),U(!B)}},"Reset"),S&&0===le.length?r.a.createElement(y.a,{className:t.ErrorTypography},"No Results, Please press the Reset button"):null)),r.a.createElement(L.a,{placement:"left-start",title:r.a.createElement(y.a,null,"50 Records available for download")},r.a.createElement("div",{style:{padding:"3px 0 0 10px"}},l?r.a.createElement(st.CSVLink,{data:l,filename:Z,onClick:Object(s.a)(c.a.mark((function e(){return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:Ce("ExcelDownloads");case 1:case"end":return e.stop()}}),e)})))},r.a.createElement("img",{src:cl.a,style:{width:"33px",height:"42px"}})):r.a.createElement("div",null)))),r.a.createElement(N.a,{className:t.Tableroot},r.a.createElement($a.a,{className:t.table,"aria-label":"caption table"},r.a.createElement(an.a,null,le?r.a.createElement(nn.a,{className:t.TableHeadRow},Ne.map((function(e){return Object.keys(ee[0]).map((function(a,n){if(e.field==a)return r.a.createElement(tn.a,{className:t.TableHeadCells,align:"left"},e.title)}))}))):r.a.createElement(nn.a,{className:t.TableHeadRow})),r.a.createElement(en.a,null,le.map((function(e){return r.a.createElement(nn.a,{className:t.TableBodyRows},Ne.map((function(a){return Object.keys(e).map((function(n,i){if(a.field===n)return r.a.createElement(tn.a,{className:t.TableBodyCells,align:"left"},r.a.createElement(R.a,{className:t.TableBodyCellBox},r.a.createElement(y.a,{className:t.TableCellTypography},e[n])))}))})))}))))),r.a.createElement("div",{className:"pagination"},r.a.createElement(Fo.a,{count:g,onChange:function(e,t){E(t)}}))):null},dl=function(){return r.a.createElement("svg",{xmlns:"http://www.w3.org/2000/svg",xlink:"http://www.w3.org/1999/xlink",width:"37",height:"32",viewBox:"0 0 133 133"},r.a.createElement("image",{id:"Asset_1_4x","data-name":"Asset 1@4x",width:"133",height:"133",href:"data:img/png;base64,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"}))},ml=function(){Object(n.useContext)(Mt).state;return r.a.createElement("svg",{xmlns:"http://www.w3.org/2000/svg",xlink:"http://www.w3.org/1999/xlink",width:"37",height:"32",viewBox:"0 0 172 124"},r.a.createElement("image",{id:"Asset_2_4x","data-name":"Asset 2@4x",width:"172",height:"124",href:"data:img/png;base64,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"}))},ul=function(){Object(n.useContext)(Mt).state;return r.a.createElement("svg",{xmlns:"http://www.w3.org/2000/svg",xlink:"http://www.w3.org/1999/xlink",width:"37",height:"32",viewBox:"0 0 167 204"},r.a.createElement("image",{id:"Asset_3_4x","data-name":"Asset 3@4x",width:"167",height:"204",href:"data:img/png;base64,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"}))},pl=Object(f.a)((function(e){return{root:{width:"100%",borderRadius:e.spacing(1.25),padding:e.spacing(1)},FilterText:{color:e.palette.black,fontSize:"1rem",padding:"10px"},ResetButton:{fontWeight:"400",borderRadius:"10px",textTransform:"none",border:"1px solid ".concat(e.palette.black),backgroundColor:"transparent",color:e.palette.black,fontSize:e.spacing(2),padding:0,marginRight:"10px"},FilterSearch:{border:"2px solid ".concat(e.palette.primary.lightBorder),borderRadius:"10px",width:"100%",height:"100%",minHeight:"40px",fontSize:"2vh",backgroundColor:e.palette.primary.lightBackground,color:e.palette.black}}})),gl=Object(f.a)((function(e){var t;return{AutoCompleteSearch:{border:"2px solid ".concat(e.palette.bot.filterBackground),borderRadius:"10px",width:"100%",height:"100%",minHeight:"40px",fontSize:"0.8rem",backgroundColor:e.palette.bot.lightBackground,color:e.palette.black,"& .MuiInputBase-input":{color:e.palette.black,fontSize:"0.8rem",opacity:1,"& .MuiAutocomplete-option":{backgroundColor:e.palette.bot.filterBackground,color:e.palette.black,fontSize:"0.8rem",textAlign:"left"}},"& .MuiChip-root":{backgroundColor:e.palette.bot.filterBackground,color:e.palette.black},"& .MuiAutocomplete-option":{backgroundColor:e.palette.bot.filterBackground,color:e.palette.black,fontSize:"0.8rem",textAlign:"left"}},AutoCompleteSearchTextfield:{border:"2px solid ".concat(e.palette.bot.filterBackground),borderRadius:"10px",width:"100%",height:"100%",minHeight:"40px",fontSize:"0.8rem",backgroundColor:e.palette.bot.lightBackground,color:e.palette.black,"& .MuiInputBase-input":{color:e.palette.black,fontSize:"0.8rem",opacity:1,"& .MuiAutocomplete-option":{backgroundColor:e.palette.bot.filterBackground,color:e.palette.black,fontSize:"0.8rem",textAlign:"left"}},"& .MuiChip-root":{backgroundColor:e.palette.bot.filterBackground,color:e.palette.black},"& .MuiAutocomplete-option":{backgroundColor:e.palette.bot.filterBackground,color:e.palette.black,fontSize:"0.8rem",textAlign:"left"}},FilterTitle:{fontSize:"0.8rem",margin:"5px",fontWeight:"500",padding:"10px",paddingRight:"0px",color:e.palette.black,borderRadius:"10px",textAlign:"left"},FilterTitleButton:(t={fontSize:"1.2rem",cursor:"pointer",margin:"5px",marginTop:"15px"},Object(g.a)(t,"marginTop","15px"),Object(g.a)(t,"color",e.palette.black),t),FilterOption:{textAlign:"left",fontSize:"0.6rem",fontWeight:"400",color:e.palette.black},FilterChecked:{padding:0,margin:0,paddingRight:"5px"}}})),hl=r.a.createElement(ft.a,{fontSize:"small"}),Tl=r.a.createElement(Et.a,{fontSize:"small"});function fl(e){Object(n.useEffect)((function(){function e(){return(e=Object(s.a)(c.a.mark((function e(){return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:case"end":return e.stop()}}),e)})))).apply(this,arguments)}!function(){e.apply(this,arguments)}()}),[e]);var t=gl(),a=Object(n.useState)(!1),i=Object(d.a)(a,2),o=i[0],l=i[1];return r.a.createElement("div",{className:t.root},r.a.createElement(R.a,{display:"flex",justifyContent:"space-between",onClick:function(){l(!o)},style:{cursor:"pointer"}},r.a.createElement(y.a,{className:t.FilterTitle,"aria-expanded":o},e.title),r.a.createElement(Ct.a,{className:t.FilterTitleButton})),r.a.createElement(ht.a,{in:o,timeout:"auto",unmountOnExit:!0},r.a.createElement(pt.a,{multiple:!0,defaultValue:e.selected?e.selected:null,onChange:function(t,a){return function(t){e.handleChange(e.filterType,t)}(a)},id:"tags-outlined",options:e.options,disableCloseOnSelect:!0,renderOption:function(a,n){var i=n.selected;return r.a.createElement(r.a.Fragment,null,parseInt(e.filterCount[a])>0?r.a.createElement("div",null,r.a.createElement(R.a,{display:"flex"},r.a.createElement(bt.a,{icon:hl,checkedIcon:Tl,style:{marginRight:8},checked:i,className:t.FilterChecked}),r.a.createElement(y.a,{className:t.FilterOption},a+"  ("+e.filterCount[a]+")"))):r.a.createElement("div",null,r.a.createElement(R.a,{display:"flex"},r.a.createElement(bt.a,{icon:hl,checkedIcon:Tl,style:{marginRight:8},checked:i,className:t.FilterChecked}),r.a.createElement(y.a,{className:t.FilterOption},a))))},className:t.AutoCompleteSearch,renderInput:function(a){return r.a.createElement(D.a,Object.assign({},a,{className:t.AutoCompleteSearchTextField,variant:"outlined",placeholder:e.placeholder}))}})))}var Al=Object(f.a)((function(e){var t;return{FilterTitle:{fontSize:"0.8rem",margin:"5px",fontWeight:"500",padding:"10px",paddingRight:"0px",color:e.palette.black,borderRadius:"10px",textAlign:"left"},FilterTitleButton:(t={fontSize:"1.2rem",cursor:"pointer",margin:"5px",marginTop:"15px"},Object(g.a)(t,"marginTop","15px"),Object(g.a)(t,"color",e.palette.black),t),toggleButtonGroup:{borderRadius:"10px","& .MuiToggleButton-root.Mui-selected":{borderRadius:"10px !important",backgroundColor:e.palette.bot.filterBackground,color:e.palette.white}},toggleButtonIndivdual:{borderRadius:"10px !important",border:"2px solid ".concat(e.palette.bot.lightBackground," !important"),"& .MuiToggleButton-root.Mui-selected":{borderRadius:"10px !important",backgroundColor:e.palette.bot.filterBackground,color:e.palette.white},"& .MuiToggleButton-label":{borderRadius:"10px !important",color:e.palette.primary.main,fontWeight:"400"}}}}));function El(e){var t=Al(),a=Object(n.useState)(!1),i=Object(d.a)(a,2),o=i[0],l=i[1];return r.a.createElement("div",{className:t.root},r.a.createElement(R.a,{display:"flex",justifyContent:"space-between",onClick:function(){l(!o)},style:{cursor:"pointer"}},r.a.createElement(y.a,{className:t.FilterTitle,"aria-expanded":o},e.title),r.a.createElement(Ct.a,{className:t.FilterTitleButton})),r.a.createElement(ht.a,{in:o,timeout:"auto",unmountOnExit:!0},r.a.createElement(mt.a,{exclusive:!0,name:e.filterType,onChange:function(t,a){!function(t){e.handleChange(e.filterType,t)}(a)},"aria-label":"text alignment",value:e.selected,className:t.toggleButtonGroup},r.a.createElement(dt.a,{value:["Yes"],"aria-label":"YES",className:t.toggleButtonIndivdual},"YES"),r.a.createElement(dt.a,{value:["No"],"aria-label":"NO",className:t.toggleButtonIndivdual},"NO"),r.a.createElement(dt.a,{value:["Yes","No"],"aria-label":"ALL",className:t.toggleButtonIndivdual},"ALL"))))}var bl=Object(f.a)((function(e){var t;return{FilterTitle:{fontSize:"0.8rem",margin:"5px",fontWeight:"500",padding:"10px",paddingRight:"0px",color:e.palette.black,borderRadius:"10px",textAlign:"left"},FilterTitleButton:(t={fontSize:"1.2rem",cursor:"pointer",margin:"5px",marginTop:"15px"},Object(g.a)(t,"marginTop","15px"),Object(g.a)(t,"color",e.palette.black),t),RangeSlider:{paddingTop:"10px",paddingBottom:"10px",width:"80%"}}}));function Nl(e){var t=bl(),a=Object(n.useState)(!1),i=Object(d.a)(a,2),o=i[0],l=i[1];return r.a.createElement("div",{className:t.root},r.a.createElement(R.a,{display:"flex",justifyContent:"space-between",onClick:function(){l(!o)},style:{cursor:"pointer"}},r.a.createElement(y.a,{className:t.FilterTitle,"aria-expanded":o},e.title),r.a.createElement(Ct.a,{className:t.FilterTitleButton})),r.a.createElement(ht.a,{in:o,timeout:"auto",unmountOnExit:!0},r.a.createElement(Ot.a,{className:t.RangeSlider,value:e.selected,min:e.options[0],max:e.options[1],onChange:function(t,a){!function(t){e.handleChange(e.filterType,t)}(a)},valueLabelDisplay:"auto","aria-labelledby":"range-slider"})))}function Cl(e){var t=pl(),a=Object(n.useState)(e.cardsData),i=Object(d.a)(a,2),o=i[0],l=(i[1],Object(n.useState)(!1)),m=Object(d.a)(l,2),u=m[0],p=m[1],g={active_ingredients:[],breakthrough:["Yes","No"],first_approval_year:[1930,parseInt((new Date).getFullYear())],patent_expire_date:[parseInt((new Date).getFullYear()),2050],exclusivity_date:[parseInt((new Date).getFullYear()),2050],application_type:[],application_number:[],approval_pathway:[],formulation:[],route:[],sponsor_name:[],trade_name:[],accelerated_approval:["Yes","No"],fasttrack:["Yes","No"]};e.filters&&(g=e.filters);var h=Object(n.useState)(g),T=Object(d.a)(h,2),f=T[0],A=T[1],E={active_ingredients:{},application_type:{},application_number:{},approval_pathway:{},formulation:{},route:{},sponsor_name:{},trade_name:{}};for(var b in o)for(var C=0;C<o[b].length;C++)b in E.active_ingredients?E.active_ingredients[b]=E.active_ingredients[b]+1:E.active_ingredients[b]=1,o[b][C].appl_type in E.application_type?E.application_type[o[b][C].appl_type]=E.application_type[o[b][C].appl_type]+1:E.application_type[o[b][C].appl_type]=1,o[b][C].applno in E.application_number?E.application_number[o[b][C].applno]=E.application_number[o[b][C].applno]+1:E.application_number[o[b][C].applno]=1,o[b][C].approvalPathway in E.approval_pathway?E.approval_pathway[o[b][C].approvalPathway]=E.approval_pathway[o[b][C].approvalPathway]+1:E.approval_pathway[o[b][C].approvalPathway]=1,o[b][C].formulation in E.formulation?E.formulation[o[b][C].formulation]=E.formulation[o[b][C].formulation]+1:E.formulation[o[b][C].formulation]=1,o[b][C].route in E.route?E.route[o[b][C].route]=E.route[o[b][C].route]+1:E.route[o[b][C].route]=1,o[b][C].sponsorName in E.sponsor_name?E.sponsor_name[o[b][C].sponsorName]=E.sponsor_name[o[b][C].sponsorName]+1:E.sponsor_name[o[b][C].sponsorName]=1,o[b][C].sponsorName in E.trade_name?E.trade_name[o[b][C].tradeName]=E.trade_name[o[b][C].tradeName]+1:E.trade_name[o[b][C].tradeName]=1;var S=Object(n.useState)(E),D=Object(d.a)(S,2),O=D[0],x=D[1],v={active_ingredients:[],breakthrough:["Yes","No"],first_approval_year:[1930,parseInt((new Date).getFullYear())],patent_expire_date:[parseInt((new Date).getFullYear()),2050],exclusivity_date:[parseInt((new Date).getFullYear()),2050],application_type:[],application_number:[],approval_pathway:[],formulation:[],route:[],sponsor_name:[],trade_name:[],accelerated_approval:["Yes","No"],fasttrack:["Yes","No"]};e.allFilters&&(v=e.allFilters);var P=Object(n.useState)(v),I=Object(d.a)(P,2),w=I[0],L=I[1];Object(n.useEffect)((function(){function e(){return(e=Object(s.a)(c.a.mark((function e(){var t,a,n;return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:try{for(a in t={active_ingredients:{},application_type:{},application_number:{},approval_pathway:{},formulation:{},route:{},sponsor_name:{},trade_name:{}},o)for(n=0;n<o[a].length;n++)a in t.active_ingredients?t.active_ingredients[a]=t.active_ingredients[a]+1:t.active_ingredients[a]=1,o[a][n].appl_type in t.application_type?t.application_type[o[a][n].appl_type]=t.application_type[o[a][n].appl_type]+1:t.application_type[o[a][n].appl_type]=1,o[a][n].applno in t.application_number?t.application_number[o[a][n].applno]=t.application_number[o[a][n].applno]+1:t.application_number[o[a][n].applno]=1,o[a][n].approvalPathway in t.approval_pathway?t.approval_pathway[o[a][n].approvalPathway]=t.approval_pathway[o[a][n].approvalPathway]+1:t.approval_pathway[o[a][n].approvalPathway]=1,o[a][n].formulation in t.formulation?t.formulation[o[a][n].formulation]=t.formulation[o[a][n].formulation]+1:t.formulation[o[a][n].formulation]=1,o[a][n].route in t.route?t.route[o[a][n].route]=t.route[o[a][n].route]+1:t.route[o[a][n].route]=1,o[a][n].sponsorName in t.sponsor_name?t.sponsor_name[o[a][n].sponsorName]=t.sponsor_name[o[a][n].sponsorName]+1:t.sponsor_name[o[a][n].sponsorName]=1,o[a][n].sponsorName in t.trade_name?t.trade_name[o[a][n].tradeName]=t.trade_name[o[a][n].tradeName]+1:t.trade_name[o[a][n].tradeName]=1;x(t)}catch(r){console.log(r)}case 1:case"end":return e.stop()}}),e)})))).apply(this,arguments)}!function(){e.apply(this,arguments)}()}),[]),Object(n.useEffect)((function(){function e(){return(e=Object(s.a)(c.a.mark((function e(){var t,a,n;return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:try{for(a in t={active_ingredients:[],breakthrough:["Yes","No"],first_approval_year:[1930,parseInt((new Date).getFullYear())],patent_expire_date:[parseInt((new Date).getFullYear()),2050],exclusivity_date:[parseInt((new Date).getFullYear()),2050],application_type:[],application_number:[],approval_pathway:[],formulation:[],route:[],sponsor_name:[],trade_name:[],accelerated_approval:["Yes","No"],fasttrack:["Yes","No"]},o)for(t.active_ingredients.includes(a)||t.active_ingredients.push(a),n=0;n<o[a].length;n++)t.application_type.includes(o[a][n].appl_type)||t.application_type.push(o[a][n].appl_type),t.application_number.includes(o[a][n].applno)||t.application_number.push(o[a][n].applno),t.approval_pathway.includes(o[a][n].approvalPathway)||t.approval_pathway.push(o[a][n].approvalPathway),t.formulation.includes(o[a][n].formulation)||t.formulation.push(o[a][n].formulation),t.route.includes(o[a][n].route)||t.route.push(o[a][n].route),t.sponsor_name.includes(o[a][n].sponsorName)||t.sponsor_name.push(o[a][n].sponsorName),t.trade_name.includes(o[a][n].tradeName)||t.trade_name.push(o[a][n].tradeName);L(t),localStorage.removeItem("filterList"),localStorage.setItem("filterList",JSON.stringify(t))}catch(r){console.log(r)}case 1:case"end":return e.stop()}}),e)})))).apply(this,arguments)}!function(){e.apply(this,arguments)}()}),[e,u]);var j=function(){var t=Object(s.a)(c.a.mark((function t(a){var n,r,i,l,s,d,m,u,p,g,h,T,f,A,E,b,N,C,S,y,D,_,O,v,R;return c.a.wrap((function(t){for(;;)switch(t.prev=t.next){case 0:for(m in 0===a.active_ingredients.length&&(a.active_ingredients=w.active_ingredients),0===a.formulation.length&&(a.formulation=w.formulation),0===a.route.length&&(a.route=w.route),0===a.application_type.length&&(a.application_type=w.application_type),0===a.application_number.length&&(a.application_number=w.application_number),0===a.approval_pathway.length&&(a.approval_pathway=w.approval_pathway),0===a.sponsor_name.length&&(a.sponsor_name=w.sponsor_name),0===a.trade_name.length&&(a.trade_name=w.trade_name),n={},console.log(a),r=0,i=[],l=0,s=[],d=!1,console.log(o),o)if(a.active_ingredients.includes(m)){for(u=[],p=0;p<o[m].length;p++)if(d=!1,parseInt(o[m][p].FirstApproval_year)>=a.first_approval_year[0]&&parseInt(o[m][p].FirstApproval_year)<=a.first_approval_year[1]&&a.formulation.includes(o[m][p].formulation)&&a.route.includes(o[m][p].route)&&a.application_number.includes(o[m][p].applno)&&a.application_type.includes(o[m][p].appl_type)&&a.approval_pathway.includes(o[m][p].approvalPathway)&&a.sponsor_name.includes(o[m][p].sponsorName)&&a.trade_name.includes(o[m][p].tradeName)&&a.accelerated_approval.includes(o[m][p].Accelerated_approval)&&a.breakthrough.includes(o[m][p].Breakthrough)&&a.fasttrack.includes(o[m][p].Fasttrack)){if(a.patent_expire_date[0]===parseInt((new Date).getFullYear())&&2050===a.patent_expire_date[1])d=!0;else if(o[m][p].patent_expire_date.length>0)for(g=0;g<o[m][p].patent_expire_date.length;g++)o[m][p].patent_expire_date[g]&&parseInt(o[m][p].patent_expire_date[g].split("-").shift())>=a.patent_expire_date[0]&&parseInt(o[m][p].patent_expire_date[g].split("-").shift())<=a.patent_expire_date[1]&&(d=!0);else d=!1;if(d)if(a.exclusivity_date[0]===parseInt((new Date).getFullYear())&&2050===a.exclusivity_date[1])u.push(o[m][p]),i.includes(m)||(i.push(m),r+=1),s.includes(o[m][p].formulation)||(s.push(o[m][p].formulation),l+=1);else if(o[m][p].exclusivity_date.length>0)for(h=0;h<o[m][p].exclusivity_date.length;h++)o[m][p].exclusivity_date[h]&&parseInt(o[m][p].exclusivity_date[h].split("-").shift())>=a.exclusivity_date[0]&&parseInt(o[m][p].exclusivity_date[h].split("-").shift())<=a.exclusivity_date[1]&&(u.push(o[m][p]),i.includes(m)||(i.push(m),r+=1),s.includes(o[m][p].formulation)||(s.push(o[m][p].formulation),l+=1))}u.length>0&&(n[m]=u)}for(A in console.log(n),T={active_Ingredients:String(r),formulationType:String(l)},f={active_ingredients:{},application_type:{},application_number:{},approval_pathway:{},formulation:{},route:{},sponsor_name:{},trade_name:{}},n)for(E=0;E<n[A].length;E++)A in f.active_ingredients?f.active_ingredients[A]=f.active_ingredients[A]+1:f.active_ingredients[A]=1,n[A][E].appl_type in f.application_type?f.application_type[n[A][E].appl_type]=f.application_type[n[A][E].appl_type]+1:f.application_type[n[A][E].appl_type]=1,n[A][E].applno in f.application_number?f.application_number[n[A][E].applno]=f.application_number[n[A][E].applno]+1:f.application_number[n[A][E].applno]=1,n[A][E].approvalPathway in f.approval_pathway?f.approval_pathway[n[A][E].approvalPathway]=f.approval_pathway[n[A][E].approvalPathway]+1:f.approval_pathway[n[A][E].approvalPathway]=1,n[A][E].formulation in f.formulation?f.formulation[n[A][E].formulation]=f.formulation[n[A][E].formulation]+1:f.formulation[n[A][E].formulation]=1,n[A][E].route in f.route?f.route[n[A][E].route]=f.route[n[A][E].route]+1:f.route[n[A][E].route]=1,n[A][E].sponsorName in f.sponsor_name?f.sponsor_name[n[A][E].sponsorName]=f.sponsor_name[n[A][E].sponsorName]+1:f.sponsor_name[n[A][E].sponsorName]=1,n[A][E].sponsorName in f.trade_name?f.trade_name[n[A][E].tradeName]=f.trade_name[n[A][E].tradeName]+1:f.trade_name[n[A][E].tradeName]=1;for(_ in x(f),b=Object.keys(f.application_number),e.setApplicationsList(b),"Ascending"===e.sort?(N=n,C={},Object.keys(N).sort().forEach((function(e){C[e]=N[e]})),n=C):"Descending"===e.sort&&(S=n,y={},Object.keys(S).sort().reverse().forEach((function(e){y[e]=S[e]})),n=y),D={},n)for(O=0;O<n[_].length;O++)n[_][O].FirstApproval_year in D?(v=n[_][O],D[n[_][O].FirstApproval_year].push(v)):(R=n[_][O],D[n[_][O].FirstApproval_year]=[],D[n[_][O].FirstApproval_year].push(R));e.updateCardsFunction(n,T,D),e.updateFiltersFunction(a);case 29:case"end":return t.stop()}}),t)})));return function(e){return t.apply(this,arguments)}}(),B=function(){var e=Object(s.a)(c.a.mark((function e(t,a){var n;return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:console.log(t),console.log(a),(n=Object(Y.a)({},f))[t]=a,A(n),"first_approval_year"!=t&&"patent_expire_date"!=t&&"exclusivity_date"!=t&&1===a.length&&ra.b.info("We are fetching information for you"),j(n),p(!u);case 8:case"end":return e.stop()}}),e)})));return function(t,a){return e.apply(this,arguments)}}(),U=function(){var e=Object(s.a)(c.a.mark((function e(){var t;return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:t={active_ingredients:[],breakthrough:["Yes","No"],first_approval_year:[1930,parseInt((new Date).getFullYear())],patent_expire_date:[parseInt((new Date).getFullYear()),2050],exclusivity_date:[parseInt((new Date).getFullYear()),2050],application_type:[],application_number:[],approval_pathway:[],formulation:[],route:[],sponsor_name:[],trade_name:[],accelerated_approval:["Yes","No"],fasttrack:["Yes","No"]},A(t),j(t),p(!u);case 4:case"end":return e.stop()}}),e)})));return function(){return e.apply(this,arguments)}}();return r.a.createElement(N.a,{elevation:3,className:t.root},r.a.createElement(R.a,{display:"flex",justifyContent:"space-between"},r.a.createElement(y.a,{className:t.FilterText},"Filters"),r.a.createElement(_.a,{onClick:U,className:t.ResetButton},"Reset")),r.a.createElement(fl,{title:String(f.active_ingredients.length)===String(w.active_ingredients.length)||0===f.active_ingredients.length?"Active Ingredient ("+String(w.active_ingredients.length)+")":"Active Ingredient ("+String(f.active_ingredients.length)+"/"+String(w.active_ingredients.length)+")",filterType:"active_ingredients",selected:f.active_ingredients.length!==w.active_ingredients.length?f.active_ingredients:[],handleChange:B,options:w.active_ingredients,placeholder:"Typer here ...",filterCount:O.active_ingredients}),r.a.createElement(Nl,{title:"First Approval Year",filterType:"first_approval_year",selected:f.first_approval_year,handleChange:B,options:w.first_approval_year}),r.a.createElement(Nl,{title:"Patent Expiration Date",filterType:"patent_expire_date",selected:f.patent_expire_date,handleChange:B,options:w.patent_expire_date}),r.a.createElement(Nl,{title:"Exclusivity Date",filterType:"exclusivity_date",selected:f.exclusivity_date,handleChange:B,options:w.exclusivity_date}),r.a.createElement(fl,{title:String(f.formulation.length)===String(w.formulation.length)||0===f.formulation.length?"Formulation ("+String(w.formulation.length)+")":"Formulation ("+String(f.formulation.length)+"/"+String(w.formulation.length)+")",filterType:"formulation",selected:f.formulation.length!==w.formulation.length?f.formulation:[],handleChange:B,options:w.formulation,placeholder:"Typer here ...",filterCount:O.formulation}),r.a.createElement(fl,{title:String(f.route.length)===String(w.route.length)||0===f.route.length?"Route ("+String(w.route.length)+")":"Route ("+String(f.route.length)+"/"+String(w.route.length)+")",filterType:"route",selected:f.route.length!==w.route.length?f.route:[],handleChange:B,options:w.route,placeholder:"Typer here ...",filterCount:O.route}),r.a.createElement(fl,{title:String(f.application_number.length)===String(w.application_number.length)||0===f.application_number.length?"Application Number ("+String(w.application_number.length)+")":"Application Number ("+String(f.application_number.length)+"/"+String(w.application_number.length)+")",filterType:"application_number",selected:f.application_number.length!==w.application_number.length?f.application_number:[],handleChange:B,options:w.application_number,placeholder:"Typer here ...",filterCount:O.application_number}),r.a.createElement(fl,{title:String(f.application_type.length)===String(w.application_type.length)||0===f.application_type.length?"Application Type ("+String(w.application_type.length)+")":"Application Type ("+String(f.application_type.length)+"/"+String(w.application_type.length)+")",filterType:"application_type",selected:f.application_type.length!==w.application_type.length?f.application_type:[],handleChange:B,options:w.application_type,placeholder:"Typer here ...",filterCount:O.application_type}),r.a.createElement(fl,{title:String(f.approval_pathway.length)===String(w.approval_pathway.length)||0===f.approval_pathway.length?"Approval Pathway ("+String(w.approval_pathway.length)+")":"Approval Pathway ("+String(f.approval_pathway.length)+"/"+String(w.approval_pathway.length)+")",filterType:"approval_pathway",selected:f.approval_pathway.length!==w.approval_pathway.length?f.approval_pathway:[],handleChange:B,options:w.approval_pathway,placeholder:"Typer here ...",filterCount:O.approval_pathway}),r.a.createElement(fl,{title:String(f.sponsor_name.length)===String(w.sponsor_name.length)||0===f.sponsor_name.length?"Sponsor Name ("+String(w.sponsor_name.length)+")":"Sponsor Name ("+String(f.sponsor_name.length)+"/"+String(w.sponsor_name.length)+")",filterType:"sponsor_name",selected:f.sponsor_name.length!==w.sponsor_name.length?f.sponsor_name:[],handleChange:B,options:w.sponsor_name,placeholder:"Typer here ...",filterCount:O.sponsor_name}),r.a.createElement(fl,{title:String(f.trade_name.length)===String(w.trade_name.length)||0===f.trade_name.length?"Trade Name ("+String(w.trade_name.length)+")":"Trade Name ("+String(f.trade_name.length)+"/"+String(w.trade_name.length)+")",filterType:"trade_name",selected:f.trade_name.length!==w.trade_name.length?f.trade_name:[],handleChange:B,options:w.trade_name,placeholder:"Typer here ...",filterCount:O.trade_name}),r.a.createElement(El,{title:"Breakthrough",filterType:"breakthrough",selected:f.breakthrough,handleChange:B}),r.a.createElement(El,{title:"Acceletated Approval",filterType:"accelerated_approval",selected:f.accelerated_approval,handleChange:B}),r.a.createElement(El,{title:"Fast Track",filterType:"fasttrack",selected:f.fasttrack,handleChange:B}))}var Sl=Object(f.a)((function(e){return{Breadcrumbs:{paddingLeft:"16px"},link:{cursor:"pointer"},showing:{fontWeight:400},category:{fontWeight:700,fontStyle:"initial"},search:{fontWeight:700,fontStyle:"initial",textTransform:"uppercase",color:"#282828"}}})),yl=a(1947),Dl=a(598),_l=a.n(Dl),Ol=function(e){var t=Sl(),a=Object(u.f)(),i=(Object(u.g)(),Object(n.useState)("")),o=Object(d.a)(i,2),l=(o[0],o[1]),m=Object(n.useState)(""),p=Object(d.a)(m,2),g=(p[0],p[1]),h=Object(n.useState)(""),T=Object(d.a)(h,2),f=(T[0],T[1]),A=Object(n.useState)(),E=Object(d.a)(A,2),b=(E[0],E[1]),N=Object(n.useState)(),C=Object(d.a)(N,2),S=C[0],D=C[1];Object(n.useEffect)((function(){function t(){return(t=Object(s.a)(c.a.mark((function t(){var a,n,r;return c.a.wrap((function(t){for(;;)switch(t.prev=t.next){case 0:try{D(JSON.parse(localStorage.getItem("navigation"))),"?"===(a=e.search.split("/"))[0].charAt(0)&&(a[0]=a[0].substring(1)),"rangeSearch"==a[1]?l("results"):l(a[1]),f({indications_and_usage:"TA/Indication",substance_name:"Active Ingredient",brand_name:"Trade Name",formulation:"Formulation",route:"Route",approval_date:"Approval Date"}[a[0]]),n={US:"US FDA - Drug & Biologics",EU:"EU EMA - Drug & Biologics","":"US FDA - Devices"},a[2].includes("?")?(r=a[2].split("?"),g(n[r[0]])):g(n[a[2]]),e.lastItem&&b(e.lastItem)}catch(i){}case 1:case"end":return t.stop()}}),t)})))).apply(this,arguments)}!function(){t.apply(this,arguments)}()}),[e]);return r.a.createElement("div",null,r.a.createElement(yl.a,{separator:r.a.createElement(_l.a,{fontSize:"small"}),"aria-label":"breadcrumb",className:t.Breadcrumbs},r.a.createElement(Xt.a,{color:"inherit",onClick:function(e){e.preventDefault(),a.push({pathname:"/"})},className:t.link},r.a.createElement(y.a,null,"Home")),r.a.createElement(Xt.a,{color:"inherit",onClick:function(){return e=S&&S.cards.url,localStorage.setItem("navigation",JSON.stringify({cards:S.cards})),void a.push(e);var e},className:t.link},r.a.createElement(y.a,null,S&&S.cards.value||null)),S&&S.regulatory?r.a.createElement(Xt.a,{color:"inherit",onClick:function(){return e=S&&S.regulatory.url,void a.push(e);var e},className:t.link},r.a.createElement(y.a,null,S&&S.regulatory.value||null)):null,S&&S.clinicalTrial?r.a.createElement(Xt.a,{color:"inherit",onClick:function(){return e=S&&S.clinicalTrial.url,void a.push(e);var e},className:t.link},r.a.createElement(y.a,null,S&&S.clinicalTrial.value||null)):null),r.a.createElement(yl.a,{separator:r.a.createElement(_l.a,{fontSize:"small"}),"aria-label":"breadcrumb",className:t.Breadcrumbs},S&&S.cards.advValue?r.a.createElement(y.a,{style:{fontStyle:"italic",fontWeight:"600",fontSize:"1.8vh",marginTop:"3px"}},r.a.createElement("span",{className:t.showing},"Showing results for")," ",S.cards.adv.map((function(e,a){return r.a.createElement("span",null,r.a.createElement("span",{className:t.category},S.cards.adv[a])," ",r.a.createElement("span",{className:t.search},"'",S.cards.advSearch[a],"'"),r.a.createElement("span",null,S.cards.advRelation&&S.cards.advRelation[a]))}))):null,S&&S.cards.text?r.a.createElement(y.a,null,S.cards.text):null))},xl=Object(f.a)((function(e){return{root:{height:"100%",background:e.palette.white,marginTop:e.spacing(8),padding:e.spacing(2),marginLeft:e.spacing(9)+1,width:"calc(100% - ".concat(e.spacing(9)+1,"px)")},airplaneIcon:{position:"fixed",zIndex:e.zIndex.drawer+2,bottom:e.spacing(2),left:e.spacing(2)},dropdownBox:{marginBottom:e.spacing(3)},dropdownContainer:{width:e.spacing(30),background:e.palette.white,borderRadius:e.spacing(1),border:"1px solid #CDD4F7","&:hover":{backgroundColor:"#FFF"}},dropdownText:{color:e.palette.biologics.textPrimary,fontWeight:"bold"},grid2:{},headings:{color:e.palette.biologics.textPrimary,fontWeight:"bold",fontSize:e.spacing(2)},percentages:{marginTop:e.spacing(2)},add:{fontSize:e.spacing(1.87),color:e.palette.navbar.button,cursor:"pointer"},botIconFAB:{left:e.spacing(2),bottom:e.spacing(10),zIndex:e.zIndex.drawer+2,position:"fixed"},botIcon:{height:"100%",width:"100%"},botIntroPopup:{fontWeight:"900",fontSize:"2vh",padding:"4px",borderRadius:"10px",color:e.palette.primary.main,backgroundColor:e.palette.primary.lightBackground},botTextPopup:{fontSize:"1.5vh",padding:"4px",color:e.palette.white,opacity:1},ModalTitle:{padding:0},ModalCloseIconButton:{padding:0,marginBottom:"-20px",marginLeft:"-20px",color:e.palette.navbar.button},ModalCloseIcon:{color:e.palette.biologics.textPrimary},Dialog:{minHeight:"70vh",padding:0}}})),vl=Object(f.a)((function(e){return{headings:{color:e.palette.biologics.textPrimary,fontWeight:"bold",fontSize:e.spacing(2)},cards:{width:"100%",padding:e.spacing(1),height:"75vh"},cardContent:{height:"100%"},paper:Object(g.a)({width:"80%",height:"35%",marginTop:e.spacing(2),borderRadius:e.spacing(1.5)},e.breakpoints.up("xl"),{height:e.spacing(25),width:e.spacing(25)}),paperIcon:{background:e.palette.biologics.gradient,color:e.palette.white},number:{fontSize:e.spacing(3.5),color:e.palette.biologics.textPrimary,fontWeight:"bold"},cardText:{fontSize:e.spacing(2),color:e.palette.biologics.textSecondary}}})),Rl=function(e){var t=e.data,a=vl(),i=function(e){return"".concat(Number(e).toFixed(0))};return r.a.createElement(n.Fragment,null,r.a.createElement(R.a,{display:"flex",flexDirection:"column",justifyContent:""},r.a.createElement(y.a,{align:"left",className:a.headings},"Overview"),r.a.createElement(R.a,{display:"flex",flexDirection:"column",alignItems:"",className:a.cards},t?t&&t.map((function(e){return r.a.createElement(N.a,{elevation:2,className:a.paper},r.a.createElement(R.a,{padding:1,display:"flex",flexDirection:"column",justifyContent:"space-evenly",alignItems:"center",className:a.cardContent},r.a.createElement(y.a,{className:a.number},r.a.createElement(Mr.a,{className:"animatedNumber",value:String(e.count),formatValue:i,duration:"1000"})),r.a.createElement(y.a,{className:a.cardText},e.id)))})):r.a.createElement(R.a,{ml:5,display:"flex",flexDirection:"column",alignItems:"",className:a.cards},r.a.createElement(Lr.a,{className:a.paper}),r.a.createElement(Lr.a,{className:a.paper}),r.a.createElement(Lr.a,{className:a.paper})))))},Pl=Object(f.a)((function(e){return{graphContainer:Object(g.a)({width:"100%"},e.breakpoints.up("xl"),{}),paper:{height:"100%",width:"90%",marginRight:e.spacing(2),padding:e.spacing(1),borderRadius:e.spacing(1.25)},graphBox:Object(g.a)({height:"50vh"},e.breakpoints.up("xl"),{height:"60vh"}),graph:{width:"100%"},headings:{color:e.palette.biologics.textPrimary,fontWeight:"bold",fontSize:e.spacing(2)},add:{fontSize:e.spacing(1.87),color:e.palette.navbar.button,cursor:"pointer"}}})),Il=function(e){var t=e.data,a=Pl(),i=Object(n.useContext)(Mt),o=i.state,l=i.dispatch,d=function(){var e=Object(s.a)(c.a.mark((function e(){return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:return e.next=2,l({type:wt.SET_CART_ITEMS,value:o.cartItems+1});case 2:return e.next=4,l({type:wt.SET_REPORT,value:{id:"Bar Graph",data:{title:"Biologics",subtitle:"Business Intelligence - Approval by Year",graph:t&&t.approvalYearGraph,keys:["count"],index:"year",color:"#0E5A94"}}});case 4:case"end":return e.stop()}}),e)})));return function(){return e.apply(this,arguments)}}(),m=function(){var e=Object(s.a)(c.a.mark((function e(){return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:return e.next=2,l({type:wt.SET_CART_ITEMS,value:o.cartItems+1});case 2:return e.next=4,l({type:wt.SET_REPORT,value:{id:"Bar Graph",data:{title:"Biologics",subtitle:"Business Intelligence - Approvals Time, Days from Filling",graph:t&&t.approvalTimeGraph,keys:["count"],index:"year",color:"#008B8B"}}});case 4:case"end":return e.stop()}}),e)})));return function(){return e.apply(this,arguments)}}();return r.a.createElement(n.Fragment,null,r.a.createElement(C.a,{container:!0,lg:12},r.a.createElement(C.a,{item:!0,lg:6},r.a.createElement(R.a,{display:"flex",flexDirection:"column",className:a.graphBox},r.a.createElement(R.a,{mr:5,display:"flex",flexDirection:"row",justifyContent:"space-between"},r.a.createElement(y.a,{className:a.headings},"Approval by Year"),r.a.createElement(y.a,{onClick:d,className:a.add},r.a.createElement(ta,null)," Add to report")),t&&t?r.a.createElement(or,{keys:["count"],colors:["#0E5A94"],index:"year",data:t&&t.approvalYearGraph}):r.a.createElement(Lr.a,{variant:"rect",height:"90%",width:"90%"}))),r.a.createElement(C.a,{item:!0,lg:6},r.a.createElement(R.a,{display:"flex",flexDirection:"column",className:a.graphBox},r.a.createElement(R.a,{mr:5,display:"flex",flexDirection:"row",justifyContent:"space-between"},r.a.createElement(y.a,{className:a.headings},"Approvals Time, Days from Filling"),r.a.createElement(y.a,{onClick:m,className:a.add},r.a.createElement(ta,null)," Add to report")),t&&t?r.a.createElement(or,{className:a.graph,keys:["count"],colors:["#008B8B"],index:"year",data:t&&t.approvalTimeGraph}):r.a.createElement(Lr.a,{variant:"rect",height:"90%",width:"90%"})))))},wl=function(e){var t=e.accelerated_approval,i=e.fastrack,o=e.breakthrough_designation,l=e.yearGraph,m=e.activeIngredients,u=e.formulations,p=e.blaCount,g=xl(),h=Object(n.useContext)(Mt),T=h.state,f=h.dispatch,A=Object(n.useState)(),E=Object(d.a)(A,2),b=E[0],N=E[1],S=Object(n.useState)(),D=Object(d.a)(S,2),_=D[0],O=D[1],x=Object(n.useState)(),v=Object(d.a)(x,2),P=v[0],I=v[1];Object(n.useEffect)((function(){function e(){return(e=Object(s.a)(c.a.mark((function e(){var n,r,s,d,g,h,T,f,A,E,b,C,S,y,D,_;return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:return e.prev=0,n=a(86).Base64,"developers:>;JQwa[zL!EX+f{?3{fjnK",r=n.encode("developers:>;JQwa[zL!EX+f{?3{fjnK"),"Basic "+r,e.next=7,ze().then((function(e){s=e})).catch((function(e){console.log(e)}));case 7:d={acceleratedApproval:t||s.data.Success.business_intelligence.Accelerated_Approval,breakthroughDesignation:o||s.data.Success.business_intelligence.Breakthrough_designation,fasttrack:i||s.data.Success.business_intelligence.Fast_track,orphanStatus:s.data.Success.business_intelligence.Orphan_status},N(d),g=[],h=Object($n.a)(s.data.Success.business_intelligence.approvaltimeGraph);try{for(h.s();!(T=h.n()).done;)f=T.value,A=f.year,E=parseInt(f.count),g.push({count:E,year:A})}catch(c){h.e(c)}finally{h.f()}g.sort((function(e,t){return parseInt(e.year)-parseInt(t.year)})),b=[],C=Object($n.a)(l||s.data.Success.business_intelligence.approvalyearGraph);try{for(C.s();!(S=C.n()).done;)y=S.value,D=y.year,_=parseInt(y.count),b.push({count:_,year:D})}catch(c){C.e(c)}finally{C.f()}b.sort((function(e,t){return parseInt(e.year)-parseInt(t.year)})),O({approvalTimeGraph:g,approvalYearGraph:b}),I([{id:"BLA",count:p||s.data.Success.business_intelligence.bla_count},{id:"Active Ingredients",count:m||s.data.Success.business_intelligence.activeIngredients},{id:"Formulations",count:u||s.data.Success.business_intelligence.formulations}]),e.next=25;break;case 22:e.prev=22,e.t0=e.catch(0),console.log(e.t0);case 25:case"end":return e.stop()}}),e,null,[[0,22]])})))).apply(this,arguments)}!function(){e.apply(this,arguments)}()}),[]);var w=function(){var e=Object(s.a)(c.a.mark((function e(){return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:return e.next=2,f({type:wt.SET_CART_ITEMS,value:T.cartItems+1});case 2:return e.next=4,f({type:wt.SET_REPORT,value:{id:"Progress Bars",title:"Biologics",data:b}});case 4:case"end":return e.stop()}}),e)})));return function(){return e.apply(this,arguments)}}();return r.a.createElement(n.Fragment,null,r.a.createElement(C.a,{container:!0},r.a.createElement(C.a,{item:!0,lg:2},r.a.createElement(Rl,{data:P})),r.a.createElement(C.a,{item:!0,lg:10},r.a.createElement(C.a,{item:!0,lg:12},r.a.createElement(Il,{data:_})),r.a.createElement(C.a,{item:!0,lg:12},r.a.createElement(R.a,{mr:2,display:"flex",alignItems:"center",justifyContent:"flex-end",className:g.percentages},r.a.createElement(y.a,{onClick:w,className:g.add},r.a.createElement(ta,null)," Add to report")),r.a.createElement(Pr,{data:b})))))},Ll=Object(f.a)((function(e){return{container:Object(g.a)({height:e.spacing(35),width:"100%"},e.breakpoints.up("xl"),{height:e.spacing(45)}),headings:{color:e.palette.biologics.textPrimary,fontWeight:"bold",fontSize:e.spacing(2)},graph:{height:"100%"},add:{fontSize:e.spacing(1.87),color:e.palette.navbar.button,cursor:"pointer"}}})),jl=function(e){var t=e.data,a=Ll(),i=Object(n.useContext)(Mt),o=i.state,l=i.dispatch,d=function(){var e=Object(s.a)(c.a.mark((function e(){return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:return e.next=2,l({type:wt.SET_CART_ITEMS,value:o.cartItems+1});case 2:return e.next=4,l({type:wt.SET_REPORT,value:{id:"Bar Graph",data:{title:"Biologics",subtitle:"Immunogenicity - Approval by Year",searchTerm:o.searchTerm?o.searchTerm.searchTerm:"",color:"#0E5A94",graph:t&&t,keys:["count"],index:"year"}}});case 4:case"end":return e.stop()}}),e)})));return function(){return e.apply(this,arguments)}}();return r.a.createElement(n.Fragment,null,r.a.createElement(R.a,{display:"flex",alignItems:"center",justifyContent:"space-between",className:a.root},r.a.createElement(y.a,{className:a.headings},"Approval by Year"),r.a.createElement(y.a,{onClick:d,className:a.add},r.a.createElement(ta,null)," Add to report")),r.a.createElement(R.a,{display:"flex",className:a.container},t&&t?r.a.createElement(or,{keys:["count"],colors:["#0E5A94"],index:"year",margin:{top:50,right:0,bottom:50,left:60},data:t&&t}):r.a.createElement(Lr.a,{variant:"rect",height:"90%",width:"100%"})))},Bl=Object(f.a)((function(e){return{container:{height:e.spacing(30),padding:0,width:"25%"},headings:{color:e.palette.biologics.textPrimary,fontWeight:"bold",fontSize:e.spacing(2)},graph:{height:"100%"},text:{color:e.palette.biologics.pieText,fontSize:e.spacing(2),marginLeft:e.spacing(2)},skeleton:{width:"100%"},add:{fontSize:e.spacing(1.87),color:e.palette.navbar.button,cursor:"pointer"}}})),Ul=function(e){var t=e.data,a=Bl(),i=Object(n.useContext)(Mt),o=i.state,l=i.dispatch,d=function(){var e=Object(s.a)(c.a.mark((function e(){return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:return e.next=2,l({type:wt.SET_CART_ITEMS,value:o.cartItems+1});case 2:return e.next=4,l({type:wt.SET_REPORT,value:{id:"Immunogenicity Pie Charts",data:t&&t}});case 4:case"end":return e.stop()}}),e)})));return function(){return e.apply(this,arguments)}}();return r.a.createElement(n.Fragment,null,r.a.createElement(R.a,{mr:0,display:"flex",alignItems:"center",justifyContent:"space-between",className:a.root},r.a.createElement(y.a,{className:a.headings},"Reporting status of immunogenicity data components - Reported vs No Report (NR) vs No Label (NL) vs No Assessment (NA)"),r.a.createElement(y.a,{onClick:d,className:a.add},r.a.createElement(ta,null)," Add to report")),r.a.createElement(R.a,{mt:2,display:"flex",flexDirection:"row",justifyContent:"",alignItems:"flex-start",className:a.constainer},t?t&&t.map((function(e){return r.a.createElement(R.a,{display:"flex",flexDirection:"column",justifyContent:"",className:a.container},r.a.createElement(y.a,{className:a.text},e[0].label),r.a.createElement(dr,{data:e}))})):r.a.createElement(R.a,{display:"flex",justifyContent:"space-evenly",flexDirection:"row",className:a.skeleton},r.a.createElement(Lr.a,{variant:"circle",width:200,height:200}),r.a.createElement(Lr.a,{variant:"circle",width:200,height:200}),r.a.createElement(Lr.a,{variant:"circle",width:200,height:200}),r.a.createElement(Lr.a,{variant:"circle",width:200,height:200}),r.a.createElement(Lr.a,{variant:"circle",width:200,height:200}))))},kl=function(e){var t=e.overviewGraph,i=e.reportingGraph,o=e.yearGraph,l=xl(),m=Object(n.useContext)(Mt),u=m.state,p=m.dispatch,g=Object(n.useState)(),h=Object(d.a)(g,2),T=h[0],f=h[1],A=Object(n.useState)(),E=Object(d.a)(A,2),b=E[0],N=E[1],S=Object(n.useState)(),D=Object(d.a)(S,2),_=D[0],O=D[1];Object(n.useEffect)((function(){function e(){return(e=Object(s.a)(c.a.mark((function e(){var n,r,l,s,m,u,p,g,h,T,A;return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:return e.prev=0,console.log("Immun enter"),console.log(t),console.log(i),console.log(o),n=a(86).Base64,"developers:>;JQwa[zL!EX+f{?3{fjnK",r=n.encode("developers:>;JQwa[zL!EX+f{?3{fjnK"),"Basic "+r,e.next=11,ze().then((function(e){l=e})).catch((function(e){console.log(e)}));case 11:s=t||l.data.Success.Immunogenicity.overviewGraph,m=["#0E5A94","#318AC8","#008B8B","#3AB09E","#48E0A6","#1C2D59","#20A1C7"],u=Object($n.a)(s.entries());try{for(u.s();!(p=u.n()).done;)g=Object(d.a)(p.value,2),h=g[0],g[1].color=m[h]}catch(c){u.e(c)}finally{u.f()}f(s),(T=o||l.data.Success.Immunogenicity.yearGraph).sort((function(e,t){return parseInt(e.year)-parseInt(t.year)})),N(T),A=i||l.data.Success.Immunogenicity.reportingGraph,O(A),e.next=26;break;case 23:e.prev=23,e.t0=e.catch(0),console.log(e.t0);case 26:case"end":return e.stop()}}),e,null,[[0,23]])})))).apply(this,arguments)}!function(){e.apply(this,arguments)}()}),[]);var x=function(){var e=Object(s.a)(c.a.mark((function e(){return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:return e.next=2,p({type:wt.SET_CART_ITEMS,value:u.cartItems+1});case 2:return e.next=4,p({type:wt.SET_REPORT,value:{id:"Progress Graph",data:T}});case 4:case"end":return e.stop()}}),e)})));return function(){return e.apply(this,arguments)}}();return r.a.createElement(n.Fragment,null,r.a.createElement(C.a,{container:!0},r.a.createElement(C.a,{item:!0,lg:6},r.a.createElement(R.a,{mr:2,display:"flex",alignItems:"center",justifyContent:"space-between"},r.a.createElement(y.a,{align:"left",className:l.headings},"Overview"),r.a.createElement(y.a,{onClick:x,className:l.add},r.a.createElement(ta,null)," Add to report")),r.a.createElement(Br,{data:T})),r.a.createElement(C.a,{item:!0,lg:6},r.a.createElement(jl,{data:b})),r.a.createElement(C.a,{item:!0,lg:12},_&&0!==_.length?r.a.createElement(Ul,{data:_}):null)))},Ml=a(831),Fl=Object(P.a)((function(e){return{tooltip:{marginTop:"-11vh",marginLeft:"-1vh",width:"fit-content",padding:"10px",paddingLeft:"20px",paddingRight:"20px",borderRadius:"10px",color:e.palette.white,border:"2px solid ".concat(e.palette.primary.lightBorder)}}}))(L.a);function zl(e){var t=ko(),i=Object(n.useContext)(Mt),o=i.state,l=i.dispatch,m=Object(u.g)(),p=new URLSearchParams(Object(u.g)().search),g=Object(n.useState)(e),h=Object(d.a)(g,2),T=h[0],f=(h[1],Object(u.f)()),A=Object(n.useState)(),E=Object(d.a)(A,2),b=E[0],D=E[1],O=Object(n.useState)(!0),x=Object(d.a)(O,2),v=x[0],P=x[1],I=Object(n.useState)(!1),F=Object(d.a)(I,2),V=F[0],G=F[1],H=Object(n.useState)(),Q=Object(d.a)(H,2),J=Q[0],K=Q[1],Z=Object(n.useState)([]),X=Object(d.a)(Z,2),q=X[0],$=X[1],ae=Object(n.useState)(1),ne=Object(d.a)(ae,2),re=ne[0],ie=ne[1],oe=Object(n.useState)(),le=Object(d.a)(oe,2),ce=le[0],se=le[1],de=Object(n.useState)(),me=Object(d.a)(de,2),ue=me[0],ge=me[1],he=Object(n.useState)(),Te=Object(d.a)(he,2),fe=Te[0],Ae=Te[1],Ee=Object(n.useState)([]),be=Object(d.a)(Ee,2),Ne=be[0],Ce=be[1],Se=Object(n.useState)([]),ye=Object(d.a)(Se,2),De=(ye[0],ye[1]),_e=Object(n.useState)([]),Oe=Object(d.a)(_e,2),xe=Oe[0],ve=Oe[1],Re=Object(n.useState)(!0),Pe=Object(d.a)(Re,2),Ie=Pe[0],we=Pe[1],Le=Object(n.useState)(!0),je=Object(d.a)(Le,2),Be=je[0],Ue=je[1],ke=Object(n.useState)(0),Me=Object(d.a)(ke,2),Fe=Me[0],ze=Me[1],Ve=Object(n.useState)("Oldest"),Ge=Object(d.a)(Ve,2),He=Ge[0],We=Ge[1],Ze=Object(n.useState)("Ascending"),qe=Object(d.a)(Ze,2),$e=qe[0],et=qe[1],tt=Object(n.useState)(!1,{}),at=Object(d.a)(tt,2),nt=at[0],rt=at[1],it=Object(n.useState)(!1),ot=Object(d.a)(it,2),lt=ot[0],ct=ot[1],st=Object(n.useState)(!1),dt=Object(d.a)(st,2),mt=dt[0],ut=dt[1],pt=Object(n.useState)(),gt=Object(d.a)(pt,2),ht=gt[0],Tt=gt[1],ft=Object(n.useState)([]),At=Object(d.a)(ft,2),Et=At[0],bt=At[1],Nt=Object(n.useState)(null),Ct=Object(d.a)(Nt,2),St=(Ct[0],Ct[1],Object(n.useState)([])),yt=Object(d.a)(St,2),Dt=(yt[0],yt[1]),_t=Object(n.useState)(0),Ot=Object(d.a)(_t,2),xt=Ot[0],Rt=Ot[1],Pt=Object(n.useState)([]),It=Object(d.a)(Pt,2),Lt=It[0],jt=It[1],Bt=Object(n.useState)([]),Ut=Object(d.a)(Bt,2),kt=Ut[0],Vt=Ut[1],Gt=Object(n.useState)(!1),Ht=Object(d.a)(Gt,2),Wt=Ht[0],Qt=Ht[1],Jt=Wt?"SearchList-popover":void 0,Kt=Object(n.useState)([]),Zt=Object(d.a)(Kt,2),Xt=Zt[0],qt=Zt[1],$t=Object(n.useState)([]),ea=Object(d.a)($t,2),aa=ea[0],na=ea[1],ra=Object(n.useState)(),ia=Object(d.a)(ra,2),oa=(ia[0],ia[1]),sa=Object(n.useState)(),da=Object(d.a)(sa,2),ma=(da[0],da[1]),ua=Object(n.useState)(!0),pa=Object(d.a)(ua,2),ga=pa[0],ha=pa[1],fa=Object(n.useState)([]),Aa=Object(d.a)(fa,2),Ea=Aa[0],ba=Aa[1],Ca=Object(n.useState)("First Approval Time"),Sa=Object(d.a)(Ca,2),ya=Sa[0],Da=Sa[1],_a=r.a.useState(!1),Oa=Object(d.a)(_a,2),xa=Oa[0],va=Oa[1],Ra=Object(n.useState)(),Pa=Object(d.a)(Ra,2),Ia=Pa[0],wa=Pa[1],La=Object(n.useState)(),ja=Object(d.a)(La,2),Ba=ja[0],Ua=ja[1],ka=Object(n.useState)(),Ma=Object(d.a)(ka,2),Fa=Ma[0],za=Ma[1],Ya=Object(n.useState)(),Va=Object(d.a)(Ya,2),Ga=Va[0],Ha=Va[1],Wa=Object(n.useState)(!1),Qa=Object(d.a)(Wa,2),Ja=Qa[0],Ka=Qa[1],Za=Object(n.useState)(),Xa=Object(d.a)(Za,2),qa=Xa[0],$a=Xa[1],en=Object(n.useState)([{element:"#applicationView",intro:'Application View provides list of all active ingredients for which the "search term" matches with the indication and usage section of the prescribing information. Provides unique applications (NDA or BLA) approved for respective active ingredient along with basic information (Sponsor name, Brand Name, Formulation, Approval Pathway etc.)',position:"left",tooltipClass:"myTooltipClass",highlightClass:"myHighlightClass"},{element:"#filters",intro:"The user can narrow down the list of application based on various Filters",position:"right",tooltipClass:"myTooltipClass",highlightClass:"myHighlightClass"},{element:"#summaryMetrics",intro:"Summary metrics for applications displayed including a link for clinical trials widget",position:"bottom",tooltipClass:"myTooltipClass",highlightClass:"myHighlightClass"},{element:"#analyticView",intro:"The user can create a business ready report for applications by capturing Approval timelines, Business Intelligence, Immunogenicity, if applicable using Analytic View",position:"bottom",tooltipClass:"myTooltipClass",highlightClass:"myHighlightClass"},{element:"#meshTerms",intro:"The synonyms and MeSH tree terms used for the search using Search list",position:"bottom",tooltipClass:"myTooltipClass",highlightClass:"myHighlightClass"},{element:"#listView",intro:"For all selected brand names, the user can download tabular results with one row for each brand name with the following fields (Active Ingredients, Trade Name, Application Type, Application Number, Approval Pathway, First Approval Date, Formulation, Route, Accelerated Approval, Breakthrough, FastTrack, Generic information using List View",position:"left",tooltipClass:"myTooltipClass",highlightClass:"myHighlightClass"},{element:"#manageApplications",intro:"If the user removed an application from the view, it can be retrieved using Manage Applications function.",position:"bottom",tooltipClass:"myTooltipClass",highlightClass:"myHighlightClass"},{element:"#bot",intro:"Ask-RIA (ARIA) a question to search summary basis of approvals for the listed applications",position:"right",tooltipClass:"myTooltipClass",highlightClass:"myHighlightClass"}]),tn=Object(d.a)(en,2),an=tn[0],nn=(tn[1],Object(n.useState)(!1)),rn=Object(d.a)(nn,2),on=rn[0],ln=rn[1];Object(n.useEffect)((function(){ve([])}),[Ja]),Object(n.useEffect)((function(){function t(){return(t=Object(s.a)(c.a.mark((function t(){var n,r,i,s,d,m,u,g,h,T,f,A,E,b,N,C,S,y,_,O,x,v,R,I,w,L,j,B,U,k,M;return c.a.wrap((function(t){for(;;)switch(t.prev=t.next){case 0:return t.prev=0,P(!0),[],we(!0),n=JSON.parse(localStorage.getItem("navigation")),localStorage.setItem("navigation",JSON.stringify({cards:n.cards})),console.log("THE query parameter is "+n.cards),t.next=9,l({type:wt.SET_MODULE,value:e.match.params.module});case 9:if(r=[],i=a(86).Base64,"developers:>;JQwa[zL!EX+f{?3{fjnK",s=i.encode("developers:>;JQwa[zL!EX+f{?3{fjnK"),"Basic "+s,"label"!==e.match.params.searchType){t.next=43;break}if(d=[],"approval_date"!==e.match.params.category){t.next=29;break}if(m={category:e.match.params.category,source:e.match.params.source,search:e.match.params.search,query:"?startDate=".concat(p.get("startDate"),"&endDate=").concat(p.get("endDate"))+"".concat("biologics"===e.match.params.module?"&isBLA=True":"")},"505b2"!==e.match.params.module){t.next=24;break}return t.next=21,Je(m);case 21:d=t.sent,t.next=27;break;case 24:return t.next=26,Qe(m);case 26:d=t.sent;case 27:t.next=39;break;case 29:if(u={category:e.match.params.category,source:e.match.params.source,search:e.match.params.search,query:"".concat("biologics"===e.match.params.module?"?isBLA=True":"")},"505b2"!==e.match.params.module){t.next=36;break}return t.next=33,Je(u);case 33:d=t.sent,t.next=39;break;case 36:return t.next=38,Qe(u);case 38:d=t.sent;case 39:d.data.Success||P(!1),"biologics"===o.module&&(wa(d.data.Success.overviewGraph),Ua(d.data.Success.reportingGraph),za(d.data.Success.yearGraph),Ha(d.data.Success.business_intelligence)),r=d.data.Success,K(d.data.Success.Stats);case 43:if("advance"!==e.match.params.searchType){t.next=60;break}if(g={data:o.advancedSearch||JSON.parse(localStorage.getItem("advanceSearch")),query:"".concat("biologics"===e.match.params.module?"?isBLA=True":"")},h=[],"505b2"!==o.module){t.next=52;break}return t.next=49,Xe(g);case 49:h=t.sent,t.next=55;break;case 52:return t.next=54,Ke(g);case 54:h=t.sent;case 55:console.log(h),r=h.data.Success,K(h.data.Success.Stats),0===Object.keys(r.cards).length&&P(!1),K(h.data.Success.Stats);case 60:if(qt([]),Tt([]),Object.keys(xe).length>0&&(Ka(!0),ve([])),f=(T=r).synonyms&&T.synonyms.sort(),A=T.synonyms&&T.dataAvailable.sort(),E=[],A)for(b=0;b<A.length;b++)E.push({text:A[b],value:b+1});if(jt(E),N=[],f)for(C=0;C<f.length;C++)N.push({text:f[C],value:C+1});Vt(N),Dt([{key:"Synonyms",value:f||[]},{key:"Data Availabele",value:A||[]}]),S=T.dataListing,na(S),oa(T.cards),y=[],"Ascending"===$e?(_=T.cards,O={},Object.keys(_).sort().forEach((function(e){O[e]=_[e]})),T.cards=O):"Descending"===$e&&(x=T.cards,v={},Object.keys(x).sort().reverse().forEach((function(e){v[e]=x[e]})),T.cards=v),D(Math.ceil((Object.keys(T.cards).length-1)/50)),R={},I=0;case 83:if(!(I<Object.keys(T.cards).length)){t.next=105;break}if(!(R[Object.keys(T.cards)[I]]in xe)){t.next=101;break}if(Object.values(T.cards)[I]!=xe[R[Object.keys(T.cards)[I]]]){t.next=89;break}return t.abrupt("continue",102);case 89:w=0;case 90:if(!(w<Object.values(T.cards)[I].length)){t.next=99;break}if(!(Object.values(T.cards)[I][w]in xe[R[Object.keys(T.cards)[I]]])){t.next=95;break}return t.abrupt("continue",96);case 95:R[Object.keys(T.cards)[I]].push(Object.values(T.cards)[I][w]);case 96:w++,t.next=90;break;case 99:t.next=102;break;case 101:R[Object.keys(T.cards)[I]]=Object.values(T.cards)[I];case 102:I++,t.next=83;break;case 105:for(L in R)"undefined"==L&&delete R[void 0];for(B in Ce(R),De(R),j={},se({NDA:"#EA5252",BLA:"#70319F",ANDA:"#FFC100"}),ge({351:"#9A31CD","351(a)":"#258B21","351(k)":"#02CED1","505(b)":"#F6A000","505(b)(2)":"#F6A000"}),R)for(U=0;U<R[B].length;U++)y.push(R[B][U].applno),R[B][U].FirstApproval_year in j?(k=R[B][U],j[R[B][U].FirstApproval_year].push(k)):(M=R[B][U],j[R[B][U].FirstApproval_year]=[],j[R[B][U].FirstApproval_year].push(M));e.filters&&ma(e.filters),$(y),Ae(j),we(!1),setTimeout((function(){ha(!1)}),5e3),t.next=126;break;case 121:t.prev=121,t.t0=t.catch(0),P(!1),we(!1),console.log(t.t0);case 126:case"end":return t.stop()}}),t,null,[[0,121]])})))).apply(this,arguments)}!function(){t.apply(this,arguments)}()}),[xe,m]),Object(n.useEffect)((function(){function e(){return(e=Object(s.a)(c.a.mark((function e(){var t,a,n,r;return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:try{"Ascending"===$e?(t=Ne,a={},Object.keys(t).sort().forEach((function(e){a[e]=t[e]})),Ce(a)):"Descending"===$e&&(n=Ne,r={},Object.keys(n).sort().reverse().forEach((function(e){r[e]=n[e]})),Ce(r))}catch(i){}case 1:case"end":return e.stop()}}),e)})))).apply(this,arguments)}!function(){e.apply(this,arguments)}()}),[$e]),Object(n.useEffect)((function(){function e(){return(e=Object(s.a)(c.a.mark((function e(){var t,a;return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:try{for(D(Math.ceil((Object.keys(Ne).length-1)/50)),t={},a=50*(re-1);a<50*re;a++)t[Object.keys(Ne)[a]]=Object.values(Ne)[a];delete t.undefined,ba(t)}catch(n){console.log(n)}case 1:case"end":return e.stop()}}),e)})))).apply(this,arguments)}!function(){e.apply(this,arguments)}()}),[re,Ne]);var cn=function(){var t=Object(s.a)(c.a.mark((function t(a){var n,r;return c.a.wrap((function(t){for(;;)switch(t.prev=t.next){case 0:return a.preventDefault(),n=nt[1],r=JSON.parse(localStorage.getItem("navigation")),n.heading=r.cards.value,n.searchTerm=e.searchTerm,n.category=e.category,n.source=e.source,t.next=9,l({type:wt.SET_CART_ITEMS,value:o.cartItems+1});case 9:return t.next=11,l({type:wt.SET_PATENT_EXPANSION,value:!0});case 11:return t.next=13,l({type:wt.SET_REPORT,value:{id:"Card Details",data:n}});case 13:return t.next=15,l({type:wt.SET_CARD_DETAILS,value:n});case 15:case"end":return t.stop()}}),t)})));return function(e){return t.apply(this,arguments)}}();function sn(e){return{id:"full-width-tabSearch-".concat(e),"aria-controls":"full-width-tabpanelSearch-".concat(e)}}var dn=function(){ct(!0)},mn=function(){ct(!1)},un=function(){ut(!0)},pn=function(){ut(!1)},gn=function(){for(var e=[],t=0;t<aa.length;t++)for(var a=0;a<q.length;a++)q[a]===aa[t].applno&&e.push(aa[t]);console.log("table res",e),$a(e)},hn=function(){var e=Object(s.a)(c.a.mark((function e(t,a,n){var r;return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:Ae(n),r={active_Ingredients:a.active_Ingredients,formulationType:a.formulationType,clinical_trials:J.clinical_trials},K(r),Ce(t);case 4:case"end":return e.stop()}}),e)})));return function(t,a,n){return e.apply(this,arguments)}}(),Tn=function(){var e=Object(s.a)(c.a.mark((function e(t){return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:ma(t),localStorage.setItem("filters",JSON.stringify(t));case 2:case"end":return e.stop()}}),e)})));return function(t){return e.apply(this,arguments)}}(),fn=function(){var e=Object(s.a)(c.a.mark((function e(t){var a,n;return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:return e.next=2,Ye(t.appl_type+t.applno).then((function(e){a=e})).catch((function(e){console.log(e)}));case 2:n=a.data.success[0],rt([!0,n]);case 4:case"end":return e.stop()}}),e)})));return function(t){return e.apply(this,arguments)}}(),An={getWordTooltip:function(e){return"".concat(e.text)}};return v?Ie?r.a.createElement(tr.SemipolarLoading,{color:"#0352CC"}):r.a.createElement(C.a,{container:!0,className:t.root},r.a.createElement(Ft.Steps,{enabled:on,steps:an,onBeforeChange:function(e){0===e&&ze(0),3===e&&(Qt(!1),ze(1)),4===e&&(pn(),Qt(!0)),5===e&&(Qt(!1),mn(),gn(),un()),6===e&&(pn(),dn()),7===e&&mn()},initialStep:0,onExit:function(){ln(!1)}}),r.a.createElement(C.a,{container:!0,item:!0,xs:12,justify:"flex-start",alignItems:"center",className:t.GridHeaderBreadcrumbs},r.a.createElement(Ol,{search:e.search,url:"labelSearch/".concat(e.match.params.category,"/").concat(e.match.params.search,"/").concat(e.match.params.source)})),r.a.createElement(C.a,{item:!0,xs:12,className:t.bannerRoot},r.a.createElement(N.a,{elevation:3,className:t.paperContainer},r.a.createElement(R.a,{display:"flex",justifyContent:"space-between"},r.a.createElement(Ta.a,null,r.a.createElement(S.a,{variant:"square",className:t.applicationTypeColor,style:{backgroundColor:"#EA5252"}},"NDA"),r.a.createElement(S.a,{variant:"square",className:t.applicationTypeColor,style:{backgroundColor:"#70319F"}},"BLA")),r.a.createElement(Ta.a,{id:"summaryMetrics"},J.active_Ingredients?r.a.createElement(r.a.Fragment,null,r.a.createElement(ul,null),r.a.createElement(y.a,{className:t.DisplayBannerName},"Active Ingredient"),r.a.createElement(y.a,{className:t.DisplayBannerText},J.active_Ingredients)):null,J.formulationType?r.a.createElement(r.a.Fragment,null,r.a.createElement("div",{className:t.DisplayBannerLogo},r.a.createElement(ml,null)),r.a.createElement(y.a,{className:t.DisplayBannerName},"Formulation"),r.a.createElement(y.a,{className:t.DisplayBannerText},J.formulationType)):null,J.clinical_trials?r.a.createElement(R.a,{display:"flex",justifyContent:"center",alignItems:"center",className:t.clinicalTrialsBox,onClick:function(){!function(e){var t=JSON.parse(localStorage.getItem("navigation"));t.clinicalTrial={url:"/clinicalTrials/".concat(e.match.params.module,"/").concat(e.match.params.category,"/").concat(e.match.params.search),value:"Clinical Trials"},localStorage.setItem("navigation",JSON.stringify(t)),f.push("/clinicalTrials/".concat(e.match.params.module,"/").concat(e.match.params.category,"/").concat(e.match.params.search))}(T)}},r.a.createElement("div",{className:t.DisplayBannerLogo},r.a.createElement(dl,null)),r.a.createElement(y.a,{class:"cln",className:t.DisplayBannerName},"Clinical Trials"),r.a.createElement(y.a,{className:t.DisplayBannerTextClinical},J.clinical_trials)):null),r.a.createElement(Ta.a,null,r.a.createElement(r.a.Fragment,null,r.a.createElement(L.a,{TransitionComponent:pe.a,title:"Search List"},r.a.createElement(j.a,{"aria-label":"show 0",color:"primary",className:t.BannerIconButton,id:"meshTerms",onClick:function(){Qt(!0)}},r.a.createElement(Xo.a,{className:t.bannerSideIcons})))),r.a.createElement(r.a.Fragment,null,r.a.createElement(L.a,{TransitionComponent:pe.a,title:"List View"},r.a.createElement(j.a,{"aria-label":"show 0",color:"primary",id:"listView",className:t.BannerIconButton,onClick:function(){gn(),un()}},r.a.createElement(Ko.a,{className:t.bannerSideIcons})))),r.a.createElement(r.a.Fragment,null,r.a.createElement(L.a,{TransitionComponent:pe.a,title:"Manage Applications"},r.a.createElement(j.a,{"aria-label":"show 0",color:"primary",id:"manageApplications",className:t.BannerIconButton,onClick:dn},r.a.createElement(Qo.a,{className:t.bannerSideIcons})))))))),2!==Fe?r.a.createElement(C.a,{container:!0,justify:"center",alignItems:"flex-start",item:!0,xs:2,className:t.GridFilters},aa?r.a.createElement(R.a,{id:"filters",className:t.filterBox},r.a.createElement(Cl,{allFilters:e.allFilters,filters:e.filters,updateCardsFunction:hn,updateFiltersFunction:Tn,cardsData:Ne,setApplicationsList:$})):r.a.createElement("div",{className:t.emptyFilters})):r.a.createElement(C.a,{container:!0,justify:"center",alignItems:"flex-start",item:!0,xs:2,className:t.GridFilters}),r.a.createElement(C.a,{container:!0,item:!0,xs:10,className:t.GridCards},r.a.createElement(N.a,{elevation:3,className:t.paperContainer},r.a.createElement(C.a,{container:!0,justify:"center",alignItems:"flex-start",item:!0,xs:12,className:t.GridCardTabs},r.a.createElement(Yo.a,{className:t.CardTabs,value:Fe,onChange:function(e,t){ze(t)},indicatorColor:"secondary",variant:"fullWidth","aria-label":"full width tabs example"},r.a.createElement(Vo.a,{id:"applicationView",className:t.CardTabs,label:"Application View"}),r.a.createElement(Vo.a,{id:"analyticView",className:t.CardTabs,label:"Analytic View"}))),0===Fe?r.a.createElement(R.a,{display:"flex",justifyContent:"flex-end",className:t.GridCardTopFilters},r.a.createElement(W.a,{className:t.sortTab},r.a.createElement(ca.a,{disableUnderline:!0,className:t.sortTabSelect,value:$e,onChange:function(e){et(e.target.value)}},r.a.createElement(la.a,{className:t.dropdownText,value:"Ascending"},"Ascending(A-Z)"),r.a.createElement(la.a,{className:t.dropdownText,value:"Descending"},"Descending(Z-A)"),r.a.createElement(la.a,{className:t.dropdownText,value:"Date(Oldest)"},"Date(Oldest)")))):null,1===Fe?r.a.createElement(r.a.Fragment,null,r.a.createElement(R.a,{display:"flex",justifyContent:"center",className:t.GridCardTopFilters},r.a.createElement(W.a,{className:t.formControl},r.a.createElement(ca.a,{labelId:"demo-controlled-open-select-label",id:"demo-controlled-open-select",variant:"standard",disableUnderline:!0,MenuProps:{anchorOrigin:{vertical:"bottom",horizontal:"left"},transformOrigin:{vertical:"top",horizontal:"left"},getContentAnchorEl:null},open:xa,onClose:function(){va(!1)},onOpen:function(){va(!0)},value:ya,onChange:function(e){Da(e.target.value)},className:t.dropdownContainer},r.a.createElement(la.a,{value:"First Approval Time",className:t.dropdownText},"First Approval Time"),"biologics"===o.module?r.a.createElement(la.a,{value:"Immunogenicity",className:t.dropdownText},"Immunogenicity"):null,r.a.createElement(la.a,{value:30})))),"First Approval Time"===ya?r.a.createElement(R.a,{display:"flex",justifyContent:"flex-end"},r.a.createElement(W.a,{className:t.sortTab},r.a.createElement(ca.a,{disableUnderline:!0,className:t.sortTabSelect,value:He,onChange:function(e){We(e.target.value)}},r.a.createElement(la.a,{value:"Oldest"},"Oldest"),r.a.createElement(la.a,{value:"Earliest"},"Earliest"),r.a.createElement(la.a,{value:"Date(Oldest)"})))):null):null,r.a.createElement(C.a,{container:!0,item:!0,xs:12,className:t.GridCardTopFilters},r.a.createElement("div",null,r.a.createElement(U.a,{fullWidth:!0,maxWidth:"lg",onClose:function(){G(!1)},"aria-labelledby":"customized-dialog-title",open:V},r.a.createElement(M.a,{className:t.ModalTitle},r.a.createElement(C.a,{container:!0},r.a.createElement(C.a,{container:!0,item:!0,xs:12,justify:"flex-end",alignItems:"center"},r.a.createElement(j.a,{"aria-label":"delete",className:t.ModalCloseIconButton,onClick:function(){G(!1)}},r.a.createElement(w.a,{className:t.ModalCloseIcon}))))),r.a.createElement(k.a,{className:t.BotDialog},r.a.createElement(Yt,{data:q}))),r.a.createElement(U.a,{fullWidth:!0,maxWidth:"lg",id:Jt,open:Wt,onClose:function(){Qt(!1)},"aria-labelledby":"customized-dialog-title"},r.a.createElement(M.a,{className:t.ModalTitle},r.a.createElement(R.a,{display:"flex",flexDirection:"row-reverse"},r.a.createElement(j.a,{"aria-label":"delete",className:t.ModalCloseIconButton,onClick:function(){return Qt(!1)}},r.a.createElement(w.a,{className:t.ModalCloseIcon})))),r.a.createElement(k.a,{className:t.Dialog},r.a.createElement(Yo.a,{className:t.CardTabs,value:xt,onChange:function(e,t){Rt(t)},indicatorColor:"primary",textColor:"primary",variant:"fullWidth","aria-label":"full width tabs example"},r.a.createElement(Vo.a,Object.assign({className:t.CardTabs,label:"Data Available"},sn(0))),r.a.createElement(Vo.a,Object.assign({className:t.CardTabs,label:"Synonyms"},sn(1)))),r.a.createElement(R.a,{className:t.WordCloudBox,display:"flex",alignItems:"center",justifyContent:"center"},r.a.createElement(C.a,{container:!0,item:!0,xs:12},r.a.createElement(Ho.a,{index:xt,onChangeIndex:function(e){Rt(e)},className:t.CardsSwipableView},r.a.createElement("div",{role:"tabpanel",hidden:0!==xt,id:"full-width-tabpanelSearch-0}","aria-labelledby":"full-width-tabSearch-0"},0===xt&&r.a.createElement("div",{className:t.daRow},Lt.length>0?r.a.createElement(Ml.a,{words:Lt,callbacks:An,options:{colors:["#0352CC","#3AB09E","#33b187","#1CBBEF"],rotations:2,rotationAngles:[-0,0],fontFamily:"impact",spiral:"archimedean"}}):null)),r.a.createElement("div",{role:"tabpanel",hidden:1!==xt,id:"full-width-tabpanelSearch-1}","aria-labelledby":"full-width-tabSearch-1"},1===xt&&r.a.createElement("div",{className:t.daRow},kt.length>0?r.a.createElement(Ml.a,{words:kt,callbacks:An,options:{colors:["#0352CC","#3AB09E","#33b187","#1CBBEF"],rotations:2,rotationAngles:[-0,0],fontFamily:"impact",spiral:"archimedean"}}):null))))))),r.a.createElement(U.a,{open:mt,fullWidth:!0,maxWidth:"lg",onClose:pn,"aria-labelledby":"alert-dialog-title","aria-describedby":"alert-dialog-description"},r.a.createElement(M.a,{id:"alert-dialog-title"},r.a.createElement(C.a,{container:!0},r.a.createElement(C.a,{container:!0,item:!0,xs:11,justify:"center",alignItems:"center"},r.a.createElement(y.a,{className:t.DialogTitle},"List View")),r.a.createElement(C.a,{container:!0,item:!0,xs:1,justify:"flex-end",alignItems:"center"},r.a.createElement(j.a,{"aria-label":"delete",className:t.ModalCloseIconButton,onClick:pn},r.a.createElement(w.a,{className:t.ModalCloseIcon}))))),r.a.createElement(k.a,null,r.a.createElement("div",{className:"tableViewClass"},qa?r.a.createElement(sl,{tableData:qa}):r.a.createElement("div",null)))),lt&&r.a.createElement(U.a,{open:lt,onClose:mn,"aria-labelledby":"alert-dialog-title","aria-describedby":"alert-dialog-description",style:{minHeight:"275px"}},r.a.createElement(M.a,{id:"alert-dialog-title"},r.a.createElement(C.a,{container:!0},r.a.createElement(C.a,{container:!0,item:!0,xs:10,justify:"center",alignItems:"center"},r.a.createElement(y.a,{className:t.DialogTitle},"Manage Applications")),r.a.createElement(C.a,{container:!0,item:!0,xs:2,justify:"flex-end",alignItems:"center"},r.a.createElement(j.a,{"aria-label":"delete",className:t.ModalCloseIconButton,onClick:mn},r.a.createElement(w.a,{className:t.ModalCloseIcon}))))),r.a.createElement(k.a,null,Xt&&Object.keys(Xt).map((function(e,a){return r.a.createElement(C.a,{container:!0,justify:"flex-start",alignItems:"center",item:!0,xs:12,className:t.ManageCardsDivision},r.a.createElement(C.a,{container:!0,justify:"flex-start",alignItems:"center",item:!0,xs:8},r.a.createElement(y.a,{className:t.CardsDivisionTitle},e)),r.a.createElement(C.a,{container:!0,justify:"flex-start",alignItems:"center",item:!0,xs:4},Xt&&Xt[e].map((function(t,a){return r.a.createElement("div",{key:a},t.applno,r.a.createElement("input",{type:"checkbox",value:t.applno,key:t.applno,onChange:function(a){return function(e,t,a,n){var r=void 0==ht?[]:ht;r[e.target.value]=e.target.checked,Tt(r);var i=Et;if(!0===r[e.target.value])a in i?i[a].push(t):i[a]=[t];else{for(var o=Object.keys(i),l=[],c=0;c<o.length;c++)if(a!==o[c]&&(l[o[c]]=i[o[c]]),a===o[c])for(var s=0;s<i[o[c]].length;s++)t!==i[o[c]][s]&&(a in l?l[a].push(i[o[c]][s]):l[a]=[i[o[c]][s]]);i=l}bt(i)}(a,t,e)}}))}))))}))),r.a.createElement(zo.a,null,r.a.createElement(_.a,{color:"primary",onClick:mn},"Cancel"),r.a.createElement(_.a,{color:"primary",autoFocus:!0,onClick:function(){var e=Et,t=Object(Y.a)({},Ne),a=Object.assign(Xt),n=fe;Object.keys(e).forEach((function(a){t.hasOwnProperty(a)?e[a].forEach((function(e){t[a].push(e)})):t[a]=e[a]})),Object.keys(a).map((function(e){if(e in Et)for(var t in a[e])for(var r in Et[e])if(a[e][t].applno===Et[e][r].applno){a[e].splice(t,1);var i=Et[e][r];n[Et[e][r].FirstApproval_year]=[i],Ae(n)}0==a[e].length&&delete a[e],qt([]),qt(a)}));var r=t,i={};Object.keys(r).sort().forEach((function(e){i[e]=r[e]})),Ce(i);var o=[];for(var l in i)for(var c=0;c<i[l].length;c++)o.push(i[l][c].applno);$(o),bt([]),ct(!1)}},"Save"))))),r.a.createElement(C.a,{container:!0,item:!0,xs:12,className:"cardsPageSwipe",style:{height:"100%"}},r.a.createElement(Ho.a,{index:Fe,onChangeIndex:function(e){ze(e)},className:t.CardsSwipableView},r.a.createElement("div",{role:"tabpanel",hidden:0!==Fe,id:"full-width-tabpanel-0}","aria-labelledby":"full-width-tab-0"},0===Fe&&r.a.createElement("div",null,Ea&&Ea?r.a.createElement("div",null,Ea&&Object.keys(Ea).map((function(e,a){return r.a.createElement("div",{className:t.CardsDivision,key:e},r.a.createElement(y.a,{className:t.CardsDivisionTitle},e),r.a.createElement(C.a,{container:!0,justify:"flex-start",alignItems:"center",item:!0,xs:12},Ea&&Ea[e].map((function(a,n){return r.a.createElement(C.a,{container:!0,justify:"flex-start",alignItems:"center",item:!0,xs:3,key:n},r.a.createElement(ee.a,{className:t.Card,style:{borderLeft:"10px solid ".concat(ce[a.appl_type])}},r.a.createElement(Mo.a,{className:t.CardHeader,action:r.a.createElement(j.a,{"aria-label":"delete",className:t.CardHeaderIconButton,onClick:function(){!function(e,t,a){Ne[a].splice(e,1);0==Ne[a].length&&delete Ne[a],Ce(Ne);var n=[];for(var r in Ne)for(var i=0;i<Ne[r].length;i++)n.push(Ne[r][i].applno);$(n);var o;o=Object.keys(fe);for(var l=0;l<o.length;l++)if(o[l]===t.FirstApproval_year){var c=fe[t.FirstApproval_year].indexOf(t);fe[t.FirstApproval_year].splice(c,1);0==fe[t.FirstApproval_year].length&&delete fe[t.FirstApproval_year],Ae((function(e){return e}))}ve([]);var s=xe;a in s?s[a].push(t):s[a]=[t],ve(s),qt(s),Ue(!0!==Be)}(n,a,e)}},r.a.createElement(w.a,{className:t.CardHeaderIcon}))}),r.a.createElement(te.a,{className:t.CardContent,onClick:function(){return fn(a)}},r.a.createElement(C.a,{container:!0,justify:"center",alignItems:"center",item:!0,xs:10,className:t.CardIconTile},r.a.createElement(C.a,{container:!0,justify:"flex-start",alignItems:"center",item:!0,xs:3},r.a.createElement(L.a,{TransitionComponent:pe.a,title:"Accelerated Approval: "+a.Accelerated_approval},"Yes"===a.Accelerated_approval?r.a.createElement(S.a,{alt:"Logo",src:En.a,className:t.CardTopLogosYes}):r.a.createElement(S.a,{alt:"Logo",src:En.a,className:t.CardTopLogosNo}))),r.a.createElement(C.a,{container:!0,justify:"flex-start",alignItems:"center",item:!0,xs:3},r.a.createElement(L.a,{TransitionComponent:pe.a,title:"Fast Track: "+a.Fasttrack},"Yes"===a.Fasttrack?r.a.createElement(S.a,{alt:"Logo",src:Sn.a,className:t.CardTopLogosYes}):r.a.createElement(S.a,{alt:"Logo",src:Sn.a,className:t.CardTopLogosNo}))),r.a.createElement(C.a,{container:!0,justify:"flex-start",alignItems:"center",item:!0,xs:3},r.a.createElement(L.a,{TransitionComponent:pe.a,title:"Breakthrough: "+a.Breakthrough},"Yes"===a.Breakthrough?r.a.createElement(S.a,{alt:"Logo",src:Nn.a,className:t.CardTopLogosYes}):r.a.createElement(S.a,{alt:"Logo",src:Nn.a,className:t.CardTopLogosNo}))),r.a.createElement(C.a,{container:!0,justify:"flex-start",alignItems:"center",item:!0,xs:3},r.a.createElement(L.a,{TransitionComponent:pe.a,title:"Generics: "+a.Generics},"Yes"===a.Generics?r.a.createElement(S.a,{alt:"Logo",src:Dn.a,className:t.CardTopLogosYes}):r.a.createElement(S.a,{alt:"Logo",src:Dn.a,className:t.CardTopLogosNo})))),r.a.createElement(C.a,{container:!0,justify:"flex-start",alignItems:"center",item:!0,xs:12,className:t.CardsLine1},r.a.createElement(C.a,{container:!0,justify:"flex-start",alignItems:"center",item:!0,xs:8},a.tradeName.length>8?r.a.createElement(L.a,{TransitionComponent:pe.a,title:a.tradeName},r.a.createElement(y.a,{className:t.CardBrandName},a.tradeName.substring(0,8),"...")):r.a.createElement(y.a,{className:t.CardBrandName},a.tradeName)),r.a.createElement(C.a,{container:!0,justify:"flex-start",alignItems:"center",item:!0,xs:4},r.a.createElement(y.a,{className:t.CardApprovalPathway,style:{backgroundColor:ue[a.approvalPathway]}},a.approvalPathway))),r.a.createElement(C.a,{container:!0,justify:"center",alignItems:"center",item:!0,xs:12,className:t.CardsLine2},r.a.createElement(C.a,{container:!0,justify:"flex-start",alignItems:"center",item:!0,xs:7},r.a.createElement(y.a,{className:t.CardFormulation},a.formulation)),r.a.createElement(C.a,{container:!0,justify:"flex-start",alignItems:"center",item:!0,xs:5},a.sponsorName.length>8?r.a.createElement(L.a,{TransitionComponent:pe.a,title:a.sponsorName},r.a.createElement(y.a,{className:t.CardTitle},a.sponsorName.substring(0,7),"...")):r.a.createElement(y.a,{className:t.CardTitle},a.sponsorName))))))}))),r.a.createElement(vt.a,{variant:"middle",className:t.CardsDivisionDivider}))}))):r.a.createElement("div",null))),r.a.createElement("div",{role:"tabpanel",hidden:1!==Fe,id:"full-width-tabpanel-1}","aria-labelledby":"full-width-tab-1"},1===Fe&&r.a.createElement("div",{className:t.TimelineGridBox},r.a.createElement(R.a,{mt:2},"Business Intelligence"===ya?r.a.createElement(wl,{info:Ga,accelerated_approval:Ga&&Ga.Accelerated_Approval,fastrack:Ga&&Ga.Fast_track,breakthrough_designation:Ga&&Ga.Breakthrough_designation,yearGraph:Ga&&Ga.approvalyearGraph,activeIngredients:J&&J.active_Ingredients,formulations:J&&J.formulationType,blaCount:Ga&&Ga.bla_count}):null,"Immunogenicity"===ya?r.a.createElement(kl,{overviewGraph:Ia,reportingGraph:Ba,yearGraph:Fa}):null,"First Approval Time"===ya&&fe?r.a.createElement(ol,{data:fe,sort:He}):null))),r.a.createElement("div",{role:"tabpanel",hidden:2!==Fe,id:"full-width-tabpanel-2}","aria-labelledby":"full-width-tab-2"},2===Fe&&r.a.createElement("div",{className:"tableViewClass"},qa?r.a.createElement(sl,{tableData:qa}):r.a.createElement("div",null))))))),r.a.createElement(C.a,{container:!0,justify:"center",alignItems:"center",item:!0,xs:12,className:t.GridPagination},1!==Fe?r.a.createElement(Fo.a,{count:b,page:re,onChange:function(e,t){ie(t),document.body.scrollTop=0,document.documentElement.scrollTop=0},className:t.Pagination,size:"large",siblingCount:3,shape:"rounded"}):r.a.createElement("div",null)),r.a.createElement(U.a,{className:t.exModal,fullWidth:!0,maxWidth:"lg",onClose:function(){rt([!1,{}])},"aria-labelledby":"customized-dialog-title",open:void 0!==nt[0]&&nt[0]},r.a.createElement(M.a,null,r.a.createElement(R.a,{display:"flex",justifyContent:"space-between"},r.a.createElement(Ta.a,null,nt[1]?r.a.createElement(y.a,{className:t.CardExtendedTitle,onClick:function(){!function(e,t,a,n,r){var i=JSON.parse(localStorage.getItem("navigation"));i.regulatory={url:"/regulatory360/".concat(o.module,"/").concat(t,"/").concat(e,"?approvalPathway=").concat(a,"&activeIngredient=").concat(r,"&tradeName=").concat(n),value:"Regulatory360:".concat(t).concat(e)},localStorage.setItem("navigation",JSON.stringify(i)),f.push("/regulatory360/".concat(o.module,"/").concat(t,"/").concat(e,"?approvalPathway=").concat(a,"&activeIngredient=").concat(r,"&tradeName=").concat(n))}(nt[1].applno,nt[1].appl_type,nt[1].approvalPathway||"none",nt[1].tradeName,nt[1].activeIngredients)}},r.a.createElement(On.a,{fontSize:"small"})," ",nt[1].appl_type+nt[1].applno):null),r.a.createElement(Ta.a,null,r.a.createElement(j.a,{"aria-label":"delete",className:t.ModalCloseIconButton,fontSize:"small",onClick:function(){rt([!1,{}])}},r.a.createElement(Na.a,{className:t.ModalCloseIcon})))),r.a.createElement(R.a,{display:"flex",justifyContent:"flex-end"},r.a.createElement(_.a,{onClick:cn},r.a.createElement(y.a,{className:t.add},r.a.createElement(ta,null)," Add to report")))),r.a.createElement(k.a,{className:t.Dialog},nt[1]?r.a.createElement(xn,{data:nt[1]}):r.a.createElement("div",null))),r.a.createElement(Fl,{placement:"right-start",open:ga,title:r.a.createElement(r.a.Fragment,null,r.a.createElement(y.a,{className:t.botIntroPopup},"Hi I'm ARIA"),r.a.createElement(y.a,{className:t.botTextPopup},"I can help you find information in Approval Documents."),r.a.createElement(y.a,{className:t.botTextPopup},"Ask me questions"))},r.a.createElement(B.a,{"aria-label":"add",id:"bot",className:t.botIconFAB,onClick:function(){return G(!0)}},r.a.createElement("img",{className:t.botIcon,src:z.a}))),r.a.createElement(B.a,{"aria-label":"add",className:t.airplaneIcon,onClick:function(){return ln(!0)}},r.a.createElement(zt,null))):r.a.createElement(C.a,{container:!0,spacing:2,justify:"center",alignItems:"center",className:t.ErrorParent},r.a.createElement(C.a,{container:!0,item:!0,xs:12,justify:"center",alignItems:"center",className:t.ErrorGrid},r.a.createElement(Hr,null)),r.a.createElement(C.a,{container:!0,item:!0,xs:12,justify:"center",alignItems:"center",className:t.ErrorGrid},r.a.createElement(y.a,{className:t.StyledErrorTypography},"Sorry, we couldn\u2019t find any results. Please refine the search criteria.")),r.a.createElement(C.a,{container:!0,item:!0,xs:12,justify:"center",alignItems:"center",className:t.ErrorGrid},r.a.createElement(y.a,{className:t.StyledErrorLine2Typography},"You can always contact us using the button below and we will get back to you within 24 hours.")))}var Yl=Object(P.a)((function(e){return{tooltip:{marginTop:"-11vh",marginLeft:"-1vh",width:"fit-content",padding:"10px",paddingLeft:"20px",paddingRight:"20px",borderRadius:"10px",color:e.palette.white,border:"2px solid ".concat(e.palette.primary.lightBorder)}}}))(L.a),Vl=function(){var e=xl(),t=Object(n.useContext)(Mt),a=(t.state,t.dispatch),i=Object(n.useState)("Business Intelligence"),o=Object(d.a)(i,2),l=o[0],m=o[1],u=r.a.useState(!1),p=Object(d.a)(u,2),g=p[0],h=p[1],T=Object(n.useState)(!1),f=Object(d.a)(T,2),A=f[0],E=f[1],b=Object(n.useState)(!0),N=Object(d.a)(b,2),S=N[0],D=N[1],_=Object(n.useState)([{element:"#blaStats",intro:"Business intelligence view provides graphs by number of approvals by year, approval time for original application as well as proportion approved by accelerated approval, breakthrough designation, Fast Track and Orphan designation",position:"right",tooltipClass:"myTooltipClass",highlightClass:"myHighlightClass"},{element:"#blaStats",intro:"Immunogenicity view for biologics provides summary of biologics type, number of approvals by year and important immunogenicity information included in the label (ADA incidence, Neutralizing Activity, Impact on PK, Efficacy and Safety)",position:"right",tooltipClass:"myTooltipClass",highlightClass:"myHighlightClass"}]),O=Object(d.a)(_,2),x=O[0],v=(O[1],Object(n.useState)(!1)),P=Object(d.a)(v,2),I=P[0],L=P[1];Object(n.useEffect)((function(){function e(){return(e=Object(s.a)(c.a.mark((function e(){return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:return e.prev=0,e.next=3,a({type:wt.SET_MODULE,value:"biologics"});case 3:setTimeout((function(){D(!1)}),5e3),e.next=9;break;case 6:e.prev=6,e.t0=e.catch(0),console.log(e.t0);case 9:case"end":return e.stop()}}),e,null,[[0,6]])})))).apply(this,arguments)}!function(){e.apply(this,arguments)}()}),[a]);return r.a.createElement(R.a,{className:e.root},r.a.createElement(Ft.Steps,{enabled:I,steps:x,showProgress:!0,scrollToElement:!0,initialStep:0,onBeforeChange:function(e){0===e&&m("Business Intelligence"),1===e&&m("Immunogenicity")},onExit:function(){L(!1)}}),r.a.createElement(R.a,{display:"flex",justifyContent:"flex-start",alignItems:"center",className:e.dropdownBox},r.a.createElement(W.a,{className:e.formControl},r.a.createElement(ca.a,{labelId:"demo-controlled-open-select-label",id:"blaStats",variant:"standard",disableUnderline:!0,MenuProps:{anchorOrigin:{vertical:"bottom",horizontal:"left"},transformOrigin:{vertical:"top",horizontal:"left"},getContentAnchorEl:null},open:g,onClose:function(){h(!1)},onOpen:function(){h(!0)},value:l,onChange:function(e){m(e.target.value)},className:e.dropdownContainer},r.a.createElement(la.a,{value:"Business Intelligence",className:e.dropdownText},"Business Intelligence"),r.a.createElement(la.a,{value:"Immunogenicity",className:e.dropdownText},"Immunogenicity"),r.a.createElement(la.a,{value:30})))),"Business Intelligence"===l?r.a.createElement(wl,null):null,"Immunogenicity"===l?r.a.createElement(kl,{values:[25,45,75,12,90]}):null,r.a.createElement(U.a,{fullWidth:!0,maxWidth:"lg",onClose:function(){E(!1)},"aria-labelledby":"customized-dialog-title",open:A},r.a.createElement(M.a,{className:e.ModalTitle},r.a.createElement(C.a,{container:!0},r.a.createElement(C.a,{container:!0,item:!0,xs:12,justify:"flex-end",alignItems:"center"},r.a.createElement(j.a,{"aria-label":"delete",className:e.ModalCloseIconButton,onClick:function(){E(!1)}},r.a.createElement(w.a,{className:e.ModalCloseIcon}))))),r.a.createElement(k.a,{className:e.Dialog},r.a.createElement(Yt,{page:"BLA"}))),r.a.createElement(Yl,{placement:"right-start",open:S,title:r.a.createElement(r.a.Fragment,null,r.a.createElement(y.a,{className:e.botIntroPopup},"Hi I'm ARIA"),r.a.createElement(y.a,{className:e.botTextPopup},"I can help you find information in Approval Documents."),r.a.createElement(y.a,{className:e.botTextPopup},"Ask me questions"))},r.a.createElement(B.a,{"aria-label":"add",className:e.botIconFAB,onClick:function(){return E(!0)}},r.a.createElement("img",{className:e.botIcon,src:z.a}))),r.a.createElement(B.a,{"aria-label":"add",className:e.airplaneIcon,onClick:function(){window.scroll(0,0),L(!0)}},r.a.createElement(zt,null)))},Gl=Object(f.a)((function(e){var t;return t={airplaneIcon:{position:"fixed",zIndex:e.zIndex.drawer+2,bottom:e.spacing(2),left:e.spacing(2)},graphInnerGrid:{height:"100%",width:"100%",backgroundColor:e.palette.white,boxShadow:"none",borderRadius:0},graphInnerTitleGrid:{height:"5%",width:"100%",backgroundColor:e.palette.white,boxShadow:"none",borderRadius:0},graphInnergChartGrid:{height:"90%",width:"100%",backgroundColor:e.palette.white,boxShadow:"none",borderRadius:0},graphInnerMessageGrid:{height:"5%",width:"100%",backgroundColor:e.palette.white,boxShadow:"none",borderRadius:0},graphInnerMessage:{fontSize:"1.5vh",fontWeight:"500",color:e.palette.black,padding:"5px"},graphInnerTitle:{fontSize:"1.8vh",fontWeight:"700",color:e.palette.primary.main,padding:"5px",marginTop:"-2vh"},GridHeaderBreadcrumbs:{backgroundColor:e.palette.white},chart:{height:"50vh !important",width:"100%",backgroundColor:e.palette.white,boxShadow:"none",borderRadius:0,marginTop:"-13vh !important"},Paper:{borderRadius:"5px",width:"100%",overflowX:"scroll",boxShadow:"none"},Table:{},TableHead:{borderRadius:"10px"},TableBody:{borderRadius:"10px"},StyledHeaderTableRow:{borderRadius:"10px"},StyledHeaderTableCell:{padding:"7px",fontSize:"2vh",fontWeight:"800",color:e.palette.black,backgroundColor:e.palette.primary.lightBorder},StyledHeaderTableCellMapped:{padding:"7px",fontSize:"1.5vh",fontWeight:"700",color:e.palette.black,backgroundColor:e.palette.primary.lightBorder},StyledTableRow:{borderRadius:"10px","&:nth-of-type(odd)":{backgroundColor:e.palette.primary.lightBackground},"&:nth-of-type(even)":{backgroundColor:e.palette.white}},StyledTableCell:{padding:"7px",fontSize:"1.5vh",fontWeight:"700",color:e.palette.black},StyledTableCellMapped:{height:"10vh",padding:"7px",fontSize:"1.5vh",fontWeight:"500",color:e.palette.black},StyledTableCellCheck:{color:e.palette.successGreen},Dropdown:{width:"100%"},DropdownTable:{width:"90vw",overflowX:"auto"},DropdownButton:{paddingLeft:"15px",width:"100%",marginTop:"1rem",marginBottom:"1rem",borderRadius:"15px",fontWeight:"400",textAlign:"left",textTransform:"none",backgroundColor:e.palette.primary.lightBorder,color:e.palette.black},expand:{color:e.palette.primary.main,transform:"rotate(0deg)",transition:e.transitions.create("transform",{duration:e.transitions.duration.shortest})},expandClose:{color:e.palette.primary.main,transform:"rotate(180deg)"},GridTitle:{color:e.palette.black,textAlign:"left",fontSize:"0.8rem",fontWeight:"bold",margin:"10px",fontFamily:"Roboto-Medium"},GridContentBox:{height:"34vh"}},Object(g.a)(t,"chart",{height:"98%",width:"100%",boxShadow:"none",borderRadius:0}),Object(g.a)(t,"paper",{boxShadow:"none",height:"100%",overflowY:"auto",padding:"10px",width:"100%"}),Object(g.a)(t,"main",{marginTop:e.spacing(8),padding:e.spacing(2),marginLeft:e.spacing(9)+1,width:"calc(100% - ".concat(e.spacing(9)+1,"px)")}),Object(g.a)(t,"Count",{margin:"0 auto",width:"93%",fontSize:"1.5rem",border:"1px solid #2E17821A",borderRadius:"5px",padding:"10px",boxShadow:"0px 3px 1px -2px #2E17821A, 0px 2px 2px 0px #2E17821A, 0px 1px 5px 0px #2E17821A"}),Object(g.a)(t,"trial",{color:"#B1BBE4",fontSize:"10px"}),Object(g.a)(t,"DropdownButtonClosed",{paddingLeft:"15px",marginTop:"1rem",width:"100%",borderRadius:"15px",fontWeight:"400",textAlign:"left",textTransform:"none",backgroundColor:"#0E83DC",color:e.palette.white,"&:hover":{color:"black"}}),Object(g.a)(t,"cards",{width:"100%",paddingLeft:"unset",height:"35vh"}),Object(g.a)(t,"cardContent",{height:"100%"}),Object(g.a)(t,"paperCards",{height:"80%",width:"26vh",borderRadius:e.spacing(1.5)}),Object(g.a)(t,"paperIcon",{background:e.palette.biologics.primary,color:e.palette.white}),Object(g.a)(t,"number",{fontSize:e.spacing(3.5),color:e.palette.biologics.textPrimary,fontWeight:"bold"}),Object(g.a)(t,"cardText",{fontSize:e.spacing(2),color:e.palette.biologics.textSecondary}),Object(g.a)(t,"graphContainer",{width:"100%",height:"39vh",color:"#1FBDCA"}),Object(g.a)(t,"graphBox",{width:"100%"}),Object(g.a)(t,"headings",{fontSize:e.spacing(2.5),color:"#0E83DC",marginLeft:e.spacing(.5),cursor:"pointer"}),Object(g.a)(t,"add",{fontSize:e.spacing(1.87),color:e.palette.navbar.button,cursor:"pointer",textTransform:"capitalize"}),Object(g.a)(t,"filterSidebar",{backgroundColor:"".concat(e.palette.bot.filterBackground," !important"),minWidth:"40vh",maxWidth:"40vh",padding:"16px",height:"100%"}),Object(g.a)(t,"arrowForward",{color:"#ffffff",fontSize:"4vh"}),Object(g.a)(t,"sidebarFilter",{color:"#ffffff",fontSize:"3vh",float:"right"}),Object(g.a)(t,"filterIconHead",{display:"flex",padding:"15px 30px"}),Object(g.a)(t,"list",{borderBottom:"1px solid #F0F2FD",padding:"10px",color:"#F0F2FD","font-size":"2vh",textAlign:"initial"}),Object(g.a)(t,"plusIcon",{display:"inline",float:"right"}),Object(g.a)(t,"innerDiv",{marginTop:"20%"}),Object(g.a)(t,"dropdownHeading",{fontSize:"14px",fontWeight:"bold",fontFamily:"lato"}),t}),{index:1}),Hl=a(1156),Wl=Object(f.a)((function(e){var t,a;return{root:{width:"94vw",overflowX:"scroll"},TableHeadRow:{backgroundColor:e.palette.primary.lightBorder},TableHeadCells:{boxShadow:"none",border:"none",fontWeight:"700"},TableBodyRows:{"&:nth-of-type(odd)":{padding:"0",backgroundColor:e.palette.primary.lightBackground},"&:nth-of-type(even)":{padding:"0",backgroundColor:e.palette.white}},TableBodyCells:{boxShadow:"none",border:"none"},TableBodyCellBox:{height:"70px",minWidth:"100px",overflowY:"auto",boxShadow:"none",border:"none"},TableBodyCellBoxBig:{height:"70px",minWidth:"300px",overflowY:"auto",boxShadow:"none",border:"none"},TableCellTypography:{fontSize:"0.9rem"},Form:{width:"100%"},Textfield:{marginBottom:e.spacing(2),border:"none",marginLeft:e.spacing(1),borderRadius:"15px",minWidth:e.spacing(45),height:"100%",minHeight:"50px",fontSize:"1.8vh",background:e.palette.navbar.grayBackground,color:e.palette.black,paddingLeft:"10px"},Button:{fontSize:"0.8rem",textTransform:"none",fontWeight:"400",minHeight:"50px",padding:"10px",background:e.palette.navbar.grayBackground,borderRadius:"10px",borderBottomLeftRadius:"0px",borderTopLeftRadius:"0px",marginBottom:e.spacing(2)},ResetButton:(t={fontSize:"0.8rem",borderRadius:"10px",maxHeight:"50px",minHeight:"50px",fontWeight:"400",textTransform:"none",backgroundColor:e.palette.primary.lightBorder,color:e.palette.black},Object(g.a)(t,"fontSize",e.spacing(2)),Object(g.a)(t,"padding",0),Object(g.a)(t,"marginLeft","20px"),t),ErrorTypography:(a={fontWeight:"700",fontSize:"0.8rem",padding:"20px",marginLeft:"20px"},Object(g.a)(a,"fontSize","0.8rem"),Object(g.a)(a,"maxHeight","50px"),Object(g.a)(a,"minHeight","50px"),Object(g.a)(a,"color",e.palette.fatalRed),a)}})),Ql=(a(122),r.a.createElement(ft.a,{fontSize:"small"})),Jl=r.a.createElement(Et.a,{fontSize:"small"});function Kl(e){var t=Object(n.useState)(),a=Object(d.a)(t,2),i=a[0],o=a[1],l=Object(n.useState)(1),m=Object(d.a)(l,2),u=m[0],p=m[1],g=Object(n.useState)(),h=Object(d.a)(g,2),T=h[0],f=h[1],A=Object(n.useState)([]),E=Object(d.a)(A,2),b=E[0],C=E[1],S=Object(n.useState)(),D=Object(d.a)(S,2),O=D[0],x=D[1],v=Object(n.useState)("StudyDesign"),P=Object(d.a)(v,2),I=P[0],w=P[1],B=Object(n.useState)("Designs"),F=Object(d.a)(B,2),z=F[0],Y=F[1],G=Object(n.useState)([]),H=Object(d.a)(G,2),W=H[0],Q=H[1],J=Object(n.useState)([]),Z=Object(d.a)(J,2),X=(Z[0],Z[1],Object(n.useState)()),q=Object(d.a)(X,2),$=q[0],ee=q[1],te=Object(n.useState)(!0),ae=Object(d.a)(te,2),ne=ae[0],re=ae[1],ie=Object(n.useState)(!0),oe=Object(d.a)(ie,2),le=oe[0],ce=oe[1],se=Object(n.useState)(),de=Object(d.a)(se,2),me=(de[0],de[1],Wl()),ue=Object(n.useState)([{key:"nct_id",label:"NCT Number",isChecked:!0},{key:"status",label:"Status",isChecked:!0},{key:"StudyType",label:"Study Type",isChecked:!0},{key:"Phase",label:"Phase",isChecked:!0},{key:"Age",label:"Age",isChecked:!0},{key:"NumberEnrolled",label:"Number Enrolled",isChecked:!0},{key:"Interventions",label:"Interventions",isChecked:!0},{key:"StudyDesign",label:"Designs",isChecked:!0},{key:"Measure",label:"Outcome Measures",isChecked:!0},{key:"Sponsor_Colalborators",label:"Sponsors/Collaborator",isChecked:!0},{key:"condition",label:"Conditions",isChecked:!0},{key:"TrialAcronym",label:"Trial Acronym",isChecked:!1},{key:"StudyStart",label:"Study Start",isChecked:!1},{key:"FirstPosted",label:"First Posted",isChecked:!1},{key:"LastUpdatePosted",label:"Last Update Posted",isChecked:!1},{key:"ResulsFirstPosted",label:"Results First Posted",isChecked:!1},{key:"PrimaryCompletion",label:"Primary Completion",isChecked:!1},{key:"StudyCompletion",label:"Study Completion",isChecked:!1},{key:"Other_IDs",label:"Other IDs",isChecked:!1},{key:"FunderType",label:"Funder Type",isChecked:!1},{key:"Sex",label:"Gender Description",isChecked:!1},{key:"location",label:"Locations",isChecked:!1}]),pe=Object(d.a)(ue,2),ge=pe[0],he=(pe[1],Object(n.useState)()),Te=Object(d.a)(he,2),fe=(Te[0],Te[1],Object(n.useState)()),Ae=Object(d.a)(fe,2),Ee=(Ae[0],Ae[1],Object(n.useState)(!1,{})),be=Object(d.a)(Ee,2),Ne=be[0],Ce=be[1],Se=Object(n.useState)(!0),ye=Object(d.a)(Se,2),De=(ye[0],ye[1],Object(n.useState)()),_e=Object(d.a)(De,2),Oe=_e[0],xe=_e[1],ve=Object(n.useState)(),Re=Object(d.a)(ve,2),Pe=Re[0],Ie=Re[1],we=function(){var e=Object(s.a)(c.a.mark((function e(t){return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:t.preventDefault(),ce(!le);case 2:case"end":return e.stop()}}),e)})));return function(t){return e.apply(this,arguments)}}(),Le=function(){var e=Object(s.a)(c.a.mark((function e(t){return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:"NCT Number"===t.target.value?(w("nct_id"),Y("NCT Number")):"Status"===t.target.value?(w("status"),Y("Status")):"Study Type"===t.target.value?(w("StudyType"),Y("Study Type")):"Phase"===t.target.value?(w("Phase"),Y("Phase")):"Age"===t.target.value?(w("Age"),Y("Age")):"Number Enrolled"===t.target.value?(w("NumberEnrolled"),Y("Number Enrolled")):"Interventions"===t.target.value?(w("Interventions"),Y("Interventions")):"Designs"===t.target.value?(w("StudyDesign"),Y("Designs")):"Outcome Measures"===t.target.value?(w("Measure"),Y("Outcome Measures")):"Conditions"===t.target.value?(w("condition"),Y("Conditions")):"Sponsors/Collaborator"===t.target.value&&(w("Sponsor_Colalborators"),Y("Sponsors/Collaborator"));case 1:case"end":return e.stop()}}),e)})));return function(t){return e.apply(this,arguments)}}();Object(n.useEffect)((function(){}),[]),Object(n.useEffect)((function(){function t(){return(t=Object(s.a)(c.a.mark((function t(){var a,n,r,i,l,s,d,m;return c.a.wrap((function(t){for(;;)switch(t.prev=t.next){case 0:if(a=new Date,n=a.getMonth()+1+"/"+a.getDate()+"/"+a.getFullYear(),xe("ria-clinicaltrials-"+n+".csv"),r=e.tableData&&e.tableData,C(r),i=[],!O){t.next=20;break}l=0;case 8:if(!(l<r.length)){t.next=19;break}if(void 0!==r[l][I]&&null!==r[l][I]){t.next=13;break}return t.abrupt("continue",16);case 13:r[l][I].toLowerCase().includes(O)&&i.push(r[l]);case 16:l++,t.next=8;break;case 19:Q(i);case 20:ee(["NCT Number","Status","Study Type","Phase","Age","Number Enrolled","Interventions","Designs","Outcome Measures","Conditions","Sponsors/Collaborator",""]),i.length>0?(i.length<50?o(1):i.length%50===0?o(i.length/50):o(1+~~(i.length/50)),s=i.slice(50*(u-1),50*u),f(s),e.updateGraphs(i),Q(i)):O&&0===i.length?(f(d=[]),e.updateGraphs(d)):(r.length<50?o(1):r.length%50===0?o(r.length/50):o(1+~~(r.length/50)),m=r.slice(50*(u-1),50*u),f(m),e.updateGraphs(r),Q(r)),re(!1);case 24:case"end":return t.stop()}}),t)})))).apply(this,arguments)}!function(){t.apply(this,arguments)}()}),[u,le,e.tableData]),Object(n.useEffect)((function(){var e=[],t=[];if(W.map((function(t){var a={};Object.keys(t).map((function(e,n){ge.map((function(n){n.key===e&&!0===n.isChecked&&(a[n.label]=t[e])}))})),e.push(a)})),e.length<=49)Ie(e);else{for(var a=0;a<50;a++)t.push(e[a]);Ie(t)}}),[W]);var je=function(e){var t,a=ge,n=Object($n.a)(a);try{for(n.s();!(t=n.n()).done;){var r=t.value;r.key==e.target.value&&(r.isChecked=e.target.checked)}}catch(i){n.e(i)}finally{n.f()}ce(!le)};return!1===ne&&b.length>0?r.a.createElement("div",{className:"complianceDashboard"},r.a.createElement(R.a,{display:"flex",justifyContent:"flex-start"},r.a.createElement("form",{id:"clinicalSearch",onSubmit:we,className:me.Form},r.a.createElement(R.a,{display:"flex",justifyContent:"flex-start"},r.a.createElement(sa,{id:"filter",menuItems:$,dropdownValue:z,title:"Column",name:"filter",handleChange:Le}),r.a.createElement(K,{placeholder:"Search keyword",id:"searchTerm",value:O,handleChange:function(e){x(String(e.target.value).toLowerCase())},name:"searchTerm"}),r.a.createElement(j.a,{type:"submit",className:me.Button},r.a.createElement(V,null)),r.a.createElement(_.a,{className:me.ResetButton,onClick:function(){x(""),ce(!le)}},"Reset"),O&&0===T.length?r.a.createElement(y.a,{className:me.ErrorTypography},"No Results, Please press the Reset button"):null)),r.a.createElement(L.a,{placement:"left-start",title:r.a.createElement(y.a,null,"50 Records available for download")},r.a.createElement("div",{style:{padding:"3px 0 0 10px"}},Pe?r.a.createElement(st.CSVLink,{data:Pe,filename:Oe},r.a.createElement("img",{src:cl.a,style:{width:"33px",height:"42px"}})):r.a.createElement("div",null)))),r.a.createElement(U.a,{fullWidth:!0,maxWidth:"sm",onClose:function(){Ce([!1,{}])},"aria-labelledby":"customized-dialog-title",open:void 0!==Ne[0]&&Ne[0]},r.a.createElement(M.a,null,"Hide/Show Columns"),ge?r.a.createElement(k.a,null,ge.map((function(e){return r.a.createElement("div",null,r.a.createElement("div",{class:"col-sm-6 pull-left"},e.label),r.a.createElement("div",{class:"col-sm-6"},r.a.createElement("label",{class:"customCheckboxContainer pull-right"},r.a.createElement(bt.a,{label:e.label,icon:Ql,checkedIcon:Jl,style:{marginRight:8},value:e.key,checked:e.isChecked,onChange:je}),r.a.createElement("span",{class:"checkmark"}))))}))):r.a.createElement("div",null)),r.a.createElement(N.a,{className:me.root},r.a.createElement($a.a,{className:me.table,"aria-label":"caption table"},r.a.createElement(an.a,null,T?r.a.createElement(nn.a,{className:me.TableHeadRow},ge.map((function(e){return Object.keys(b[0]).map((function(t,a){if(e.key==t&&!0===e.isChecked)return r.a.createElement(tn.a,{className:me.TableHeadCells,align:"left"},e.label)}))}))):r.a.createElement(nn.a,{className:me.TableHeadRow})),r.a.createElement(en.a,null,T.map((function(e){return r.a.createElement(nn.a,{className:me.TableBodyRows},ge.map((function(t){return Object.keys(e).map((function(a,n){if(t.key===a&&!0===t.isChecked)return r.a.createElement(tn.a,{className:me.TableBodyCells,align:"left"},"nct_id"===a?r.a.createElement(R.a,{className:me.TableBodyCellBox},r.a.createElement(Xt.a,{target:"_blank",rel:"noopener",href:"https://clinicaltrials.gov/ct2/show/"+e[a]},r.a.createElement(y.a,{className:me.TableCellTypography},e[a]))):"StudyDesign"===a||"Measure"===a?r.a.createElement(R.a,{className:me.TableBodyCellBoxBig},r.a.createElement(y.a,{className:me.TableCellTypography},e[a])):r.a.createElement(R.a,{className:me.TableBodyCellBox},r.a.createElement(y.a,{className:me.TableCellTypography},e[a])))}))})))}))))),r.a.createElement("div",{className:"pagination"},r.a.createElement(Fo.a,{count:i,onChange:function(e,t){p(t)}}))):null}a(1739);var Zl=a(1950),Xl=Object(f.a)((function(e){return{root:{width:"100%"},FilterText:{color:e.palette.white,fontSize:"1rem",padding:"10px"},FilterSearch:{borderRadius:"10px",width:"100%",height:"100%",minHeight:"40px",fontSize:"2vh",backgroundColor:e.palette.bot.lightBackground,color:e.palette.black},ResetButton:{fontWeight:"400",borderRadius:"10px",textTransform:"none",border:"1px solid ".concat(e.palette.white),backgroundColor:"transparent",color:e.palette.white,fontSize:e.spacing(2),padding:0,marginRight:"10px"},Divider:{backgroundColor:e.palette.white,color:e.palette.white,height:"0.5px"}}})),ql=Object(f.a)((function(e){var t;return{AutoCompleteSearch:{border:"2px solid ".concat(e.palette.bot.filterBackground),borderRadius:"10px",width:"100%",height:"100%",minHeight:"40px",fontSize:"0.8rem",backgroundColor:e.palette.bot.lightBackground,color:e.palette.black,"& .MuiInputBase-input":{color:e.palette.black,fontSize:"0.8rem",opacity:1,"& .MuiAutocomplete-option":{backgroundColor:e.palette.bot.filterBackground,color:e.palette.black,fontSize:"0.8rem",textAlign:"left"}},"& .MuiChip-root":{backgroundColor:e.palette.bot.filterBackground,color:e.palette.black},"& .MuiAutocomplete-option":{backgroundColor:e.palette.bot.filterBackground,color:e.palette.black,fontSize:"0.8rem",textAlign:"left"}},AutoCompleteSearchTextfield:{border:"2px solid ".concat(e.palette.bot.filterBackground),borderRadius:"10px",width:"100%",height:"100%",minHeight:"40px",fontSize:"0.8rem",backgroundColor:e.palette.bot.lightBackground,color:e.palette.black,"& .MuiInputBase-input":{color:e.palette.black,fontSize:"0.8rem",opacity:1,"& .MuiAutocomplete-option":{backgroundColor:e.palette.bot.filterBackground,color:e.palette.black,fontSize:"0.8rem",textAlign:"left"}},"& .MuiChip-root":{backgroundColor:e.palette.bot.filterBackground,color:e.palette.black},"& .MuiAutocomplete-option":{backgroundColor:e.palette.bot.filterBackground,color:e.palette.black,fontSize:"0.8rem",textAlign:"left"}},FilterTitle:{fontSize:"0.8rem",margin:"5px",fontWeight:"500",padding:"10px",paddingRight:"0px",color:e.palette.white,borderRadius:"10px",textAlign:"left"},FilterTitleButton:(t={fontSize:"1.2rem",cursor:"pointer",margin:"5px",marginTop:"15px"},Object(g.a)(t,"marginTop","15px"),Object(g.a)(t,"color",e.palette.white),t),FilterOption:{textAlign:"left",fontSize:"0.6rem",fontWeight:"400",color:e.palette.black},FilterChecked:{padding:0,margin:0,paddingRight:"5px"}}})),$l=r.a.createElement(ft.a,{fontSize:"small"}),ec=r.a.createElement(Et.a,{fontSize:"small"});function tc(e){Object(n.useEffect)((function(){function e(){return(e=Object(s.a)(c.a.mark((function e(){return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:case"end":return e.stop()}}),e)})))).apply(this,arguments)}!function(){e.apply(this,arguments)}()}),[e]);var t=ql(),a=Object(n.useState)(!1),i=Object(d.a)(a,2),o=i[0],l=i[1];return r.a.createElement("div",{className:t.root},r.a.createElement(R.a,{display:"flex",justifyContent:"space-between",onClick:function(){l(!o)},style:{cursor:"pointer"}},r.a.createElement(y.a,{className:t.FilterTitle,"aria-expanded":o},e.title),r.a.createElement(Ct.a,{className:t.FilterTitleButton})),r.a.createElement(ht.a,{in:o,timeout:"auto",unmountOnExit:!0},r.a.createElement(pt.a,{multiple:!0,defaultValue:e.selected?e.selected:null,onChange:function(t,a){return function(t){ra.b.info("We are fetching information for you"),e.handleChange(e.filterType,t)}(a)},id:"tags-outlined",options:e.options,disableCloseOnSelect:!0,renderOption:function(a,n){var i=n.selected;return r.a.createElement(r.a.Fragment,null,parseInt(e.filterCount[a])>0?r.a.createElement("div",null,r.a.createElement(R.a,{display:"flex"},r.a.createElement(bt.a,{icon:$l,checkedIcon:ec,style:{marginRight:8},checked:i,className:t.FilterChecked}),r.a.createElement(y.a,{className:t.FilterOption},a+"  ("+e.filterCount[a]+")"))):r.a.createElement("div",null,r.a.createElement(R.a,{display:"flex"},r.a.createElement(bt.a,{icon:$l,checkedIcon:ec,style:{marginRight:8},checked:i,className:t.FilterChecked}),r.a.createElement(y.a,{className:t.FilterOption},a))))},className:t.AutoCompleteSearch,renderInput:function(a){return r.a.createElement(D.a,Object.assign({},a,{className:t.AutoCompleteSearchTextField,variant:"outlined",placeholder:e.placeholder}))}})))}function ac(e){var t=Xl(),a=Object(n.useState)(e.data),i=Object(d.a)(a,2),o=i[0];i[1];console.log("Length",e.data.length);for(var l=Object(n.useState)(!1),m=Object(d.a)(l,2),u=m[0],p=m[1],g=Object(n.useState)({Interventions:[],Status:[],Phase:[],Sex:[],Age:[],Sponsor_Colalborators:[]}),h=Object(d.a)(g,2),T=h[0],f=h[1],A={Interventions:{},Status:{},Phase:{},Sex:{},Age:{},Sponsor_Colalborators:{}},E=0;E<o.length;E++)o[E].Interventions in A.Interventions?A.Interventions[o[E].Interventions]=A.Interventions[o[E].Interventions]+1:A.Interventions[o[E].Interventions]=1,o[E].status in A.Status?A.Status[o[E].status]=A.Status[o[E].status]+1:A.Status[o[E].status]=1,o[E].Phase in A.Phase?A.Phase[o[E].Phase]=A.Phase[o[E].Phase]+1:A.Phase[o[E].Phase]=1,o[E].Sex in A.Sex?A.Sex[o[E].Sex]=A.Sex[o[E].Sex]+1:A.Sex[o[E].Sex]=1,o[E].Age in A.Age?A.Age[o[E].Age]=A.Age[o[E].Age]+1:A.Age[o[E].Age]=1,o[E].Sponsor_Colalborators in A.Sponsor_Colalborators?A.Sponsor_Colalborators[o[E].Sponsor_Colalborators]=A.Sponsor_Colalborators[o[E].Sponsor_Colalborators]+1:A.Sponsor_Colalborators[o[E].Sponsor_Colalborators]=1;var b=Object(n.useState)(A),N=Object(d.a)(b,2),C=N[0],S=N[1],D=Object(n.useState)(e.filters),O=Object(d.a)(D,2),x=O[0],v=O[1],P=Object(n.useState)(!1),I=Object(d.a)(P,2),w=I[0],L=I[1];Object(n.useEffect)((function(){function t(){return(t=Object(s.a)(c.a.mark((function t(){var a,n,r,i,l,s,d,m,u,p,g,h;return c.a.wrap((function(t){for(;;)switch(t.prev=t.next){case 0:try{for(e.filters&&!w?v(e.filters):v({Interventions:[],Status:[],Phase:[],Sex:[],Age:[],Sponsor_Colalborators:[]}),a=Object(Y.a)({},T),n=0;n<o.length;n++)a.Interventions.includes([o[n].Interventions])||a.Interventions.push(o[n].Interventions),a.Status.includes(o[n].status)||a.Status.push(o[n].status),a.Phase.includes(o[n].Phase)||a.Phase.push(o[n].Phase),a.Sex.includes(o[n].Sex)||a.Sex.push(o[n].Sex),a.Age.includes(o[n].Age)||a.Age.push(o[n].Age),a.Sponsor_Colalborators.includes(o[n].Sponsor_Colalborators)||a.Sponsor_Colalborators.push(o[n].Sponsor_Colalborators);for(r in a)a[r]=a[r].filter((function(e){return null!==e}));for(i in a)a[i]=a[i].filter((function(e){return void 0!==e}));for(d in f(a),0===(l=Object(Y.a)({},x)).Interventions.length&&(l.Interventions=a.Interventions),0===l.Status.length&&(l.Status=a.Status),0===l.Phase.length&&(l.Phase=a.Phase),0===l.Sex.length&&(l.Sex=a.Sex),0===l.Age.length&&(l.Age=a.Age),0===l.Sponsor_Colalborators.length&&(l.Sponsor_Colalborators=a.Sponsor_Colalborators),s=[],l)l[d]=l[d].filter((function(e){return null!==e}));for(m in l)l[m]=l[m].filter((function(e){return void 0!==e}));for(console.log(l),u=[],p=0;p<o.length;p++)l.Interventions.includes(o[p].Interventions)&&l.Status.includes(o[p].status)&&l.Phase.includes(o[p].Phase)&&l.Sex.includes(o[p].Sex)&&l.Age.includes(o[p].Age)&&l.Sponsor_Colalborators.includes(o[p].Sponsor_Colalborators)?s.push(o[p]):u.push(o[p]);for(e.handleFilterChange(x),e.handleRowsChange(s),console.log("others",u),g={Interventions:{},Status:{},Phase:{},Sex:{},Age:{},Sponsor_Colalborators:{}},h=0;h<s.length;h++)s[h].Interventions in g.Interventions?g.Interventions[s[h].Interventions]=g.Interventions[s[h].Interventions]+1:g.Interventions[s[h].Interventions]=1,s[h].status in g.Status?g.Status[s[h].status]=g.Status[s[h].status]+1:g.Status[s[h].status]=1,s[h].Phase in g.Phase?g.Phase[s[h].Phase]=g.Phase[s[h].Phase]+1:g.Phase[s[h].Phase]=1,s[h].Sex in g.Sex?g.Sex[s[h].Sex]=g.Sex[s[h].Sex]+1:g.Sex[s[h].Sex]=1,s[h].Age in g.Age?g.Age[s[h].Age]=g.Age[s[h].Age]+1:g.Age[s[h].Age]=1,s[h].Sponsor_Colalborators in g.Sponsor_Colalborators?g.Sponsor_Colalborators[s[h].Sponsor_Colalborators]=g.Sponsor_Colalborators[s[h].Sponsor_Colalborators]+1:g.Sponsor_Colalborators[s[h].Sponsor_Colalborators]=1;S(g)}catch(c){console.log(c)}case 1:case"end":return t.stop()}}),t)})))).apply(this,arguments)}!function(){t.apply(this,arguments)}()}),[u]);var j=function(){var e=Object(s.a)(c.a.mark((function e(t,a){var n;return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:(n=x)[t]=a,v(n),p(!u);case 4:case"end":return e.stop()}}),e)})));return function(t,a){return e.apply(this,arguments)}}(),B=function(){var e=Object(s.a)(c.a.mark((function e(){return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:v({Interventions:[],Status:[],Phase:[],Sex:[],Age:[],Sponsor_Colalborators:[]}),L(!1),p(!u);case 4:case"end":return e.stop()}}),e)})));return function(){return e.apply(this,arguments)}}();return console.log(x),r.a.createElement("div",{className:t.root},r.a.createElement(R.a,{display:"flex",justifyContent:"space-between"},r.a.createElement(y.a,{className:t.FilterText},"Filters"),r.a.createElement(_.a,{onClick:B,className:t.ResetButton},"Reset")),r.a.createElement(tc,{title:String(x.Status.length)===String(T.Status.length)||0===x.Status.length?"Status ("+String(T.Status.length)+")":"Status ("+String(x.Status.length)+"/"+String(T.Status.length)+")",selected:x.Status,filterType:"Status",handleChange:j,options:T.Status,placeholder:"Typer here ...",filterCount:C.Status}),r.a.createElement(tc,{title:String(x.Phase.length)===String(T.Phase.length)||0===x.Phase.length?"Phase ("+String(T.Phase.length)+")":"Phase ("+String(x.Phase.length)+"/"+String(T.Phase.length)+")",selected:x.Phase,filterType:"Phase",handleChange:j,options:T.Phase,placeholder:"Typer here ...",filterCount:C.Phase}),r.a.createElement(tc,{title:String(x.Sex.length)===String(T.Sex.length)||0===x.Sex.length?"Gender Description ("+String(T.Sex.length)+")":"Gender Description ("+String(x.Sex.length)+"/"+String(T.Sex.length)+")",selected:x.Sex,filterType:"Sex",handleChange:j,options:T.Sex,placeholder:"Typer here ...",filterCount:C.Sex}),r.a.createElement(tc,{title:String(x.Age.length)===String(T.Age.length)||0===x.Age.length?"Age ("+String(T.Age.length)+")":"Age ("+String(x.Age.length)+"/"+String(T.Age.length)+")",selected:x.Age,filterType:"Age",handleChange:j,options:T.Age,placeholder:"Typer here ...",filterCount:C.Age}))}var nc=function(){return r.a.createElement("svg",{xmlns:"http://www.w3.org/2000/svg",width:"14.357",height:"14.357",viewBox:"0 0 11.357 11.357"},r.a.createElement("path",{id:"filter_1_","data-name":"filter (1)",fill:"#0E83DC",d:"M10.529,0H.828A.829.829,0,0,0,0,.828v1.1a.833.833,0,0,0,.268.611l3.8,3.479a.589.589,0,0,1,.192.436V11a.355.355,0,0,0,.552.3l1.919-1.279A.826.826,0,0,0,7.1,9.329V6.45a.591.591,0,0,1,.192-.436l3.8-3.48a.829.829,0,0,0,.268-.61V.828A.829.829,0,0,0,10.529,0Z"}))};var rc=function(e){var t=Gl(),i=Object(u.f)(),o=Object(n.useContext)(Mt),l=o.state,m=o.dispatch,p=Object(n.useState)(!0),h=Object(d.a)(p,2),T=h[0],f=h[1],A=Object(n.useState)(),E=Object(d.a)(A,2),b=E[0],N=E[1],S=Object(n.useState)(),D=Object(d.a)(S,2),O=D[0],x=D[1],v=Object(n.useState)(),P=Object(d.a)(v,2),I=(P[0],P[1]),w=Object(n.useState)(),L=Object(d.a)(w,2),j=L[0],U=L[1],k=Object(n.useState)(0),M=Object(d.a)(k,2),F=(M[0],M[1],Object(n.useState)(5)),z=Object(d.a)(F,2),Y=(z[0],z[1],Object(n.useState)(!0)),V=Object(d.a)(Y,2),G=V[0],H=V[1],W=Object(n.useState)(!1),Q=Object(d.a)(W,2),J=Q[0],K=Q[1],Z=Object(n.useState)(),X=Object(d.a)(Z,2),q=X[0],$=X[1],ee=Object(n.useState)(),te=Object(d.a)(ee,2),ae=te[0],ne=te[1],re=Object(n.useState)(),ie=Object(d.a)(re,2),oe=ie[0],le=ie[1],ce=Object(n.useState)(!1),se=Object(d.a)(ce,2),de=se[0],me=se[1],ue=Object(n.useState)(),pe=Object(d.a)(ue,2),ge=pe[0],he=pe[1],Te=Object(n.useState)(),fe=Object(d.a)(Te,2),Ae=fe[0],Ee=fe[1],be=Object(n.useState)({Interventions:[],Status:[],Phase:[],Sex:[],Age:[],Sponsor_Colalborators:[]}),Ne=Object(d.a)(be,2),Ce=Ne[0],Se=Ne[1],ye=Object(n.useState)([{element:"#clinicalInsights",intro:"Clinical trial insights provides graphs by number of trials by year of completion, by phase and recruitment status",position:"bottom",tooltipClass:"myTooltipClass",highlightClass:"myHighlightClass"},{element:"#clinicalFilters",intro:"Ability to filter by key trial criteria",position:"left",tooltipClass:"myTooltipClass",highlightClass:"myHighlightClass"},{element:"#clinicalOverall",intro:" Clinical trial overall results provides a tabular view of clinical trial and important protocol elements that can be customized",position:"top",tooltipClass:"myTooltipClass",highlightClass:"myHighlightClass"}]),De=Object(d.a)(ye,2),_e=De[0],Oe=(De[1],Object(n.useState)(!1)),xe=Object(d.a)(Oe,2),ve=xe[0],Re=xe[1];Object(n.useEffect)((function(){function t(){return(t=Object(s.a)(c.a.mark((function t(){var n,r,o,l,s,d,u,p,g,h,T,A,E,b,C,S,y,D,_,v,R,P,w,L,j,B,k;return c.a.wrap((function(t){for(;;)switch(t.prev=t.next){case 0:return t.prev=0,f(!0),t.next=4,m({type:wt.SET_MODULE,value:e.match.params.module});case 4:return n=a(86).Base64,"developers:>;JQwa[zL!EX+f{?3{fjnK",r=n.encode("developers:>;JQwa[zL!EX+f{?3{fjnK"),"Basic "+r,t.next=10,Be(e.match.params.category,e.match.params.search).then((function(e){o=e})).catch((function(e){console.log(e)}));case 10:N(o.data.Success.ct_data),he(o.data.Success.ct_data),l=[],$(o.data.Success.clinical_trials),s=[],d={},u=Object($n.a)(o.data.Success.ct_data);try{for(u.s();!(p=u.n()).done;)g=p.value.status,d[g]={status:g,y:d[g]?d[g].y+1:1}}catch(c){u.e(c)}finally{u.f()}for(h=Object.values(d),console.log("status data",h),T=0;T<h.length;T++)l.push({data:h[T].y,name:h[T].status});for(le(l),A={statusgraph:l},s.push(A),console.log(s),l=[],E=["Early Phase 1","Phase 1","Phase 1/Phase 2","Phase 2","Phase 2/Phase 3","Phase 3","Phase 4","N/A","missing"],b=0;b<E.length;b++)for(C=0;C<o.data.Success.phase_graph.length;C++)E[b]===o.data.Success.phase_graph[C].name&&l.push({data:o.data.Success.phase_graph[C].data[0],name:o.data.Success.phase_graph[C].name});for(x(l),console.log("Phasegraph",O),S={id:"y",color:"hsl(206\xb0, 88%, 46%)",data:l},s.push([S]),y=[],console.log(o.data.Success.gender_graph),D=0;D<o.data.Success.gender_graph.length;D++)y.push({data:o.data.Success.gender_graph[D].data[0],name:o.data.Success.gender_graph[D].name});for(I(y),l=[],d={},_=o.data.Success.ct_data,v=0;v<_.length;v++)_[v].Year=Le(_[v].StudyCompletion);console.log("year added",_),R=Object($n.a)(_);try{for(R.s();!(P=R.n()).done;)w=P.value.Year,d[w]={Year:w,y:d[w]?d[w].y+1:1}}catch(c){R.e(c)}finally{R.f()}for(L=Object.values(d),j=0;j<L.length;j++)"number"===typeof L[j].Year?l.push({data:L[j].y,name:L[j].Year.toString()}):l.push({data:L[j].y,name:L[j].Year});for(console.log("year graph",l),U(l),B={yearGraph:l},s.push([B]),k=0;k<o.data.Success.year_graph.length;k++)"2020"===o.data.Success.year_graph[k].name&&(ne(o.data.Success.year_graph[k].data[0]),s.CTMOcount=o.data.Success.year_graph[k].data[0]);console.log("graphDatatemp",s),Ee(s),f(!1),t.next=59;break;case 55:t.prev=55,t.t0=t.catch(0),i.push("/"),console.log(t.t0);case 59:case"end":return t.stop()}}),t,null,[[0,55]])})))).apply(this,arguments)}!function(){t.apply(this,arguments)}()}),[]);var Pe=function(){var e=Object(s.a)(c.a.mark((function e(){return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:return e.next=2,m({type:wt.SET_CART_ITEMS,value:l.cartItems+1});case 2:return e.next=4,m({type:wt.SET_REPORT,value:{id:"Clinical Trials",data:{phaseGraph:O,CTCount:q,CTMOcount:ae,statusGraph:oe,yearGraph:j,searchTerm:l.searchTerm?l.searchTerm.searchTerm:""}}});case 4:case"end":return e.stop()}}),e)})));return function(){return e.apply(this,arguments)}}(),Ie=function(){var e=Object(s.a)(c.a.mark((function e(t){var a,n,r,i,o,l,s,d,m,u,p,g,h,T,f,A,E,b,N,C,S,y;return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:a=[],n={},r=Object($n.a)(t);try{for(r.s();!(i=r.n()).done;)o=i.value.status,n[o]={status:o,y:n[o]?n[o].y+1:1}}catch(c){r.e(c)}finally{r.f()}for(l=Object.values(n),console.log("status data",l),s=0;s<l.length;s++)a.push({data:l[s].y,name:l[s].status});le(a),a=[],n={},d=["Early Phase 1","Phase 1","Phase 1/Phase 2","Phase 2","Phase 2/Phase 3","Phase 3","Phase 4","N/A","missing",""],m=Object($n.a)(t);try{for(m.s();!(u=m.n()).done;)p=u.value.Phase,n[p]={Phase:p,y:n[p]?n[p].y+1:1}}catch(c){m.e(c)}finally{m.f()}for(g=Object.values(n),console.log("Phase data",g),h=0;h<d.length;h++)for(T=0;T<g.length;T++)d[h]===g[T].Phase&&a.push({data:g[T].y,name:g[T].Phase});for(x(a),console.log("phase graph",a),a=[],n={},f=t,A=0;A<f.length;A++)f[A].Year=Le(f[A].StudyCompletion);console.log("year added",f),E=Object($n.a)(f);try{for(E.s();!(b=E.n()).done;)N=b.value.Year,n[N]={Year:N,y:n[N]?n[N].y+1:1}}catch(c){E.e(c)}finally{E.f()}for(C=Object.values(n),S=0;S<C.length;S++)a.push({data:C[S].y,name:C[S].Year.toString()});for(console.log("year graph",a),U(a),y=0;y<a.length;y++)"2020"===a[y].name&&ne(a[y].data);$(t.length);case 31:case"end":return e.stop()}}),e)})));return function(t){return e.apply(this,arguments)}}(),we=function(){var e=Object(s.a)(c.a.mark((function e(t){return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:N(t),Ie(t);case 2:case"end":return e.stop()}}),e)})));return function(t){return e.apply(this,arguments)}}(),Le=function(e){return new Date(e).getFullYear()};return T?r.a.createElement(tr.SemipolarLoading,{color:"#0352CC"}):r.a.createElement("div",{className:t.main},r.a.createElement(Ft.Steps,{enabled:ve,steps:_e,showProgress:!0,scrollToElement:!0,initialStep:0,onBeforeChange:function(e){1===e&&K(!0)},onExit:function(){Re(!1)}}),r.a.createElement(R.a,{display:"flex",flexDirection:"row",justifyContent:"space-between",className:t.header},r.a.createElement(R.a,null,r.a.createElement(Ol,{lastItem:"Clinical Trials"})),r.a.createElement(R.a,{id:"clinicalFilters",display:"flex",flexDirection:"row",alignItems:"center",onClick:function(){return me(!0)}},r.a.createElement(nc,null),r.a.createElement(y.a,{className:t.headings},"Filters"))),r.a.createElement(Zl.a,{anchor:"right",open:de,onClose:function(){return me(!1)},onOpen:function(){return me(!0)}},r.a.createElement("div",{className:t.filterSidebar},r.a.createElement("div",{className:t.innerDiv},r.a.createElement("div",{className:t.filterIconHead},r.a.createElement(Zi.a,{onClick:function(){return me(!1)},className:t.arrowForward})),r.a.createElement(ac,{data:ge,filters:Ce,handleFilterChange:function(e){Se(e)},handleRowsChange:we,KeyDescriptions:Hl.KeyDescriptions})))),r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"center"},r.a.createElement(_.a,{onClick:function(){H(!G)},className:G?t.DropdownButton:t.DropdownButtonClosed,"aria-expanded":G,"aria-label":"show more"},r.a.createElement(C.a,{xs:12,id:"clinicalInsights",container:!0,justify:"center",alignItems:"center"},r.a.createElement(C.a,{xs:3,container:!0,justify:"flex-start",alignItems:"center",className:t.dropdownHeading},"Insights"),r.a.createElement(C.a,{xs:9,container:!0,justify:"flex-end",alignItems:"center"},r.a.createElement(Ka.a,{className:Object(ga.a)(t.expand,Object(g.a)({},t.expandClose,G))}))))),r.a.createElement(C.a,{xs:12,container:!0,className:t.InsightssGrid,style:{background:"white"}},r.a.createElement(ht.a,{className:t.Dropdown,in:G,timeout:"auto",unmountOnExit:!0},r.a.createElement(R.a,{display:"flex",justifyContent:"flex-end"},r.a.createElement(_.a,{onClick:Pe},r.a.createElement(y.a,{className:t.add}," ",r.a.createElement(ta,null)," Add to report"))),O?r.a.createElement(Gr,{graphData:Ae,phaseGraph:O,CTCount:q,CTMOcount:ae,statusGraph:oe,yearGraph:j}):r.a.createElement("div",null))),r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"center"},r.a.createElement(_.a,{onClick:function(){K(!J)},className:J?t.DropdownButton:t.DropdownButtonClosed,"aria-expanded":J,"aria-label":"show more"},r.a.createElement(C.a,{xs:12,id:"clinicalOverall",container:!0,justify:"center",alignItems:"center"},r.a.createElement(C.a,{xs:3,container:!0,justify:"flex-start",alignItems:"center",className:t.dropdownHeading},"Overall Results"),r.a.createElement(C.a,{xs:9,container:!0,justify:"flex-end",alignItems:"center"},r.a.createElement(Ka.a,{className:Object(ga.a)(t.expand,Object(g.a)({},t.expandClose,J))}))))),r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"center",className:t.TablesGrid},r.a.createElement(ht.a,{className:t.Dropdown,in:J,timeout:"auto",unmountOnExit:!0},b?r.a.createElement(Kl,{tableData:b&&b,updateGraphs:Ie}):r.a.createElement("div",null))),r.a.createElement(B.a,{"aria-label":"add",className:t.airplaneIcon,onClick:function(){Re(!0)}},r.a.createElement(zt,null)))},ic=Object(f.a)((function(e){var t;return t={main:{marginTop:e.spacing(8),padding:e.spacing(2),marginLeft:e.spacing(9)+1,width:"calc(100% - ".concat(e.spacing(9)+1,"px)"),"& .MuiDrawer-paperAnchorRight":{borderRadius:"10px 0 0 10px"}},airplaneIcon:{position:"fixed",zIndex:e.zIndex.drawer+2,bottom:e.spacing(2),left:e.spacing(2)},GridTitle:{color:e.palette.black,textAlign:"left",fontSize:"1rem",fontWeight:"400",margin:"10px"},add:{fontSize:e.spacing(1.87),color:e.palette.navbar.button,cursor:"pointer",textTransform:"capitalize"},GridContentBox:{height:"90%",width:"100%",minWidth:"300px"},GraphImage:{width:"300px",height:"auto"},graphInnerGrid:{height:"100%",width:"100%",boxShadow:"none",borderRadius:0},graphInnerTitleGrid:{height:"5%",width:"100%",boxShadow:"none",borderRadius:0},graphInnergChartGrid:{height:"90%",width:"100%",boxShadow:"none",borderRadius:0},graphInnerMessageGrid:{height:"5%",width:"100%",boxShadow:"none",borderRadius:0},graphInnerMessage:{fontSize:"1.5vh",fontWeight:"500",color:e.palette.black,padding:"5px"},graphInnerTitle:{fontSize:"1.8vh",fontWeight:"700",color:e.palette.primary.main,padding:"5px",marginTop:"-2vh"},chart:{height:"96%",width:"100%",boxShadow:"none",borderRadius:0},paper:{boxShadow:"none",height:"100%"},header:{width:"100%"},note:{color:e.palette.biologics.textSecondary,fontWeight:"medium",fontSize:e.spacing(2)},Dropdown:{width:"100%"},DropdownButton:{paddingLeft:"15px",width:"100%",marginTop:"1rem",marginBottom:"1rem",borderRadius:"15px",fontWeight:"400",textAlign:"left",textTransform:"none",backgroundColor:e.palette.primary.lightBorder,color:e.palette.black},DropdownButtonClosed:{paddingLeft:"15px",marginTop:"1rem",width:"100%",borderRadius:"15px",fontWeight:"400",textAlign:"left",textTransform:"none",backgroundColor:"#0E83DC",color:e.palette.white,"&:hover":{color:"black"}},expand:{color:e.palette.white,transform:"rotate(0deg)",transition:e.transitions.create("transform",{duration:e.transitions.duration.shortest})},expandClose:{color:e.palette.black,transform:"rotate(180deg)"},graphContainer:{width:"100%",height:"35vh",color:"#1FBDCA"},graphBox:{width:"100%"},apptype:{width:"100%",border:"1px solid #ccc",borderRadius:"5vh",height:"6vh",display:"flex",margin:"2.5vh 0"},percentage:{color:"#182B7F",fontWeight:"bold",margin:"0 8px"},type:{color:"#0E83DC",fontWeight:"800"},details:{display:"flex",width:"100%",margin:"13px 5px 0 5px"},headings:{fontSize:e.spacing(1.7),color:"#6D7D8A",marginLeft:e.spacing(.5),cursor:"pointer"},filterSidebar:{backgroundColor:"#3AB09E !important",minWidth:"40vh",maxWidth:"40vh",padding:"16px",height:"100%"},arrowForward:{color:"#ffffff",fontSize:"4vh"},sidebarFilter:{color:"#ffffff",fontSize:"3vh",float:"right"},filterIconHead:{display:"flex",padding:"15px 30px"},list:{borderBottom:"1px solid #F0F2FD",padding:"10px",color:"#F0F2FD","font-size":"2vh",textAlign:"initial"},plusIcon:{display:"inline",float:"right"},innerDiv:{marginTop:"20%"},dropdownHeading:{fontSize:"14px",fontWeight:"bold",fontFamily:"lato"},CardTabs:{backgroundColor:e.palette.white,margin:0,fontWeight:600,minWidth:"165px",width:"max-content",minHeight:"45px",height:"max-content",fontFamily:'Lato,-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,"Helvetica Neue",Arial,sans-serif,"Apple Color Emoji","Segoe UI Emoji","Segoe UI Symbol"',textTransform:"none","& .MuiTab-wrapper":{fontSize:"2vh",width:"max-content"},"&.Mui-selected":{border:"0.5px solid #00000029",borderBottom:"1px solid white !important",borderTop:"0.5px solid #00000029 !important",background:"white !important",color:"#707070 !important"},"& .MuiTab-fullWidth":{borderRadius:"5px 5px 0 0",opacity:"initial",color:"white",borderBottom:"0.5px solid #00000029",boxShadow:"-5px 0px 6px #00000029",background:"transparent linear-gradient(284deg, #37B465 0%, #29ABE2 100%) 0% 0% no-repeat padding-box"}}},Object(g.a)(t,"paper",{width:"100%",padding:e.spacing(2),marginTop:e.spacing(1),borderRadius:e.spacing(1.25),marginBottom:e.spacing(1)}),Object(g.a)(t,"common360SwipableView",{width:"100%",overflow:"hidden !important"}),t})),oc=Object(f.a)((function(e){var t,a,n;return{root:{overflowX:"scroll",boxShadow:"unset !important"},complianceDashboard:{margin:"20px 15px !important"},table:{border:"unset !important",borderCollapse:"separate",borderSpacing:"0px 7px"},TableHeadCells:{boxShadow:"none",border:"none",fontWeight:"500",color:"#3AB09E",fontSize:"12px",padding:"unset",paddingBottom:"10px",lineHeight:"1.5"},TableBodyRows:{margin:"10px","-moz-box-shadow":"0 0 5px rgba(0,0,0,0.1)","-webkit-box-shadow":"0 0 5px rgba(0,0,0,0.1)","box-shadow":"0 0 5px rgba(0,0,0,0.1)"},TableBodyCells:{boxShadow:"none",border:"none",padding:"unset"},TableBodyCellBox:{height:"70px",minWidth:"130px",overflowY:"auto",boxShadow:"none",border:"none",paddingTop:"15px",paddingRight:"5px",paddingBottom:"15px"},TableBodyCellBoxT:{height:"60px",minWidth:"130px",overflowY:"auto",boxShadow:"none",border:"none",paddingTop:"15px",paddingRight:"5px",paddingBottom:"15px"},TableBodyCellBoxBig:{height:"70px",minWidth:"300px",overflowY:"auto",boxShadow:"none",border:"none",paddingTop:"15px",paddingRight:"15px",paddingBottom:"15px"},TableCellTypography:{fontSize:"0.7rem",color:"#6D7D8A",fontWeight:"600"},Form:{width:"100%"},Textfield:{marginBottom:e.spacing(2),border:"none",marginLeft:e.spacing(1),borderRadius:"15px",minWidth:e.spacing(45),height:"100%",minHeight:"50px",fontSize:"2vh",background:e.palette.navbar.grayBackground,color:e.palette.black},Button:{fontSize:"0.8rem",textTransform:"none",fontWeight:"400",minHeight:"50px",padding:"10px 5px",borderRadius:"10px",borderBottomLeftRadius:"0px",borderTopLeftRadius:"0px",marginBottom:e.spacing(2)},customCheckboxContainer:{display:"block",position:"relative",paddingLeft:"35px",marginBottom:"12px",cursor:"pointer",fontSize:"22px",userSelect:"none"},ResetButton:(t={fontSize:"0.8rem",borderRadius:"10px",maxHeight:"50px",minHeight:"50px",fontWeight:"400",textTransform:"none",color:e.palette.black},Object(g.a)(t,"fontSize",e.spacing(1.6)),Object(g.a)(t,"fontFamily",'Lato,-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,"Helvetica Neue",Arial,sans-serif,"Apple Color Emoji","Segoe UI Emoji","Segoe UI Symbol"'),Object(g.a)(t,"padding",0),Object(g.a)(t,"marginLeft","20px"),t),ErrorTypography:(a={fontWeight:"700",fontSize:"0.8rem",padding:"20px",marginLeft:"20px"},Object(g.a)(a,"fontSize","0.8rem"),Object(g.a)(a,"maxHeight","50px"),Object(g.a)(a,"minHeight","50px"),Object(g.a)(a,"color",e.palette.fatalRed),a),".MuiTable-root":{border:"unset !important"},nda:{padding:"5px",margin:"10px",marginLeft:"0px"},ndasupl:{padding:"5px",margin:"10px",marginLeft:"0px",marginRight:"20px",color:"#318AC8",flex:"none"},selectLabel:{background:"#33B187",color:"white",padding:"13px 10px",borderRadius:"15px",marginBottom:"auto",fontSize:"0.8rem"},dialog:{height:"inherit",backgroundImage:"url(".concat(Tr.a,")"),backgroundRepeat:"no-repeat",backgroundPosition:"center",backgroundSize:"cover",backgroundAttachment:"fixed"},compareN:(n={height:"30px",margin:"5px",padding:"3px 20px",borderRadius:"13px",fontSize:"1.7vh",fontWeight:"bold",border:"2px solid #e3f1ff",boxShadow:"0 0 4px rgb(220, 220, 220,0.5)"},Object(g.a)(n,"borderRadius","20px"),Object(g.a)(n,"backgroundColor","#119E8A"),Object(g.a)(n,"color","#FFFFFF"),Object(g.a)(n,"cursor","pointer"),Object(g.a)(n,"margin","10px auto"),Object(g.a)(n,"display","flex"),Object(g.a)(n,"width","fit-content"),n),labelTitle:{fontSize:"1.4vh",fontWeight:500,paddingLeft:"5px",margin:"auto"},selectLabelC:{background:"#33B187",color:"white",borderRadius:"10px 10px 0px 0px",marginBottom:"auto",fontSize:"0.8rem",padding:"13px 10px"},LabelComparisionDate:{fontSize:"0.8rem",fontWeight:600,padding:"5px"}}})),lc=a(620),cc=a.n(lc),sc=a(621),dc=a.n(sc),mc=a(1092),uc=function(){return r.a.createElement("svg",{xmlns:"http://www.w3.org/2000/svg",width:"17",height:"17",viewBox:"0 0 17 17"},r.a.createElement("defs",null,r.a.createElement("style",null,"      .tick1 {        fill: #cdcdcd;      }      ")),r.a.createElement("path",{class:"tick1",d:"M5.015,6.885l-1.19,1.19L7.65,11.9l8.5-8.5L14.96,2.21,7.65,9.52ZM15.3,8.5A6.8,6.8,0,1,1,8.5,1.7a6.629,6.629,0,0,1,1.87.255L11.73.6A10.346,10.346,0,0,0,8.5,0,8.5,8.5,0,1,0,17,8.5Z"}))},pc=function(){return r.a.createElement("svg",{xmlns:"http://www.w3.org/2000/svg",width:"17",height:"17",viewBox:"0 0 17 17"},r.a.createElement("defs",null,r.a.createElement("style",null,"        .tick {          fill: #33b187;        }        ")),r.a.createElement("path",{class:"tick",d:"M5.015,6.885l-1.19,1.19L7.65,11.9l8.5-8.5L14.96,2.21,7.65,9.52ZM15.3,8.5A6.8,6.8,0,1,1,8.5,1.7a6.629,6.629,0,0,1,1.87.255L11.73.6A10.346,10.346,0,0,0,8.5,0,8.5,8.5,0,1,0,17,8.5Z"}))},gc=a(411),hc=a.n(gc),Tc=a(412),fc=a.n(Tc),Ac=a(1157),Ec=a.n(Ac),bc=a(622),Nc=a.n(bc),Cc=a(623),Sc=a.n(Cc),yc=a(624),Dc=a.n(yc),_c=a(625),Oc=a.n(_c),xc=a(626),vc=a.n(xc),Rc=a(627),Pc=a.n(Rc),Ic=a(628),wc=a.n(Ic),Lc=a(629),jc=a.n(Lc),Bc=a(630),Uc=a.n(Bc),kc=a(425),Mc=a.n(kc),Fc=(a(122),r.a.createElement(ft.a,{fontSize:"small"})),zc=r.a.createElement(Et.a,{fontSize:"small"});function Yc(e){var t=Object(n.useState)(),a=Object(d.a)(t,2),i=a[0],o=a[1],l=Object(n.useState)(1),m=Object(d.a)(l,2),u=m[0],p=m[1],h=Object(n.useState)(e.data),T=Object(d.a)(h,2),f=T[0],A=T[1],E=Object(n.useState)(e.ColNames),b=Object(d.a)(E,2),S=b[0],D=(b[1],Object(n.useState)()),O=Object(d.a)(D,2),x=O[0],v=O[1],P=Object(n.useState)("PMR/PMC Description"),I=Object(d.a)(P,2),w=I[0],B=I[1],F=Object(n.useState)([]),z=Object(d.a)(F,2),Y=z[0],V=z[1],G=Object(n.useState)([]),H=Object(d.a)(G,2),W=H[0],Q=H[1],J=Object(n.useState)([]),K=Object(d.a)(J,2),X=K[0],q=K[1],$=Object(n.useState)([]),ee=Object(d.a)($,2),te=(ee[0],ee[1],Object(n.useState)()),ae=Object(d.a)(te,2),ne=ae[0],re=ae[1],ie=Object(n.useState)(!0),oe=Object(d.a)(ie,2),le=oe[0],ce=oe[1],se=Object(n.useState)(!0),de=Object(d.a)(se,2),me=de[0],ue=de[1],pe=Object(n.useState)(!1,{}),ge=Object(d.a)(pe,2),he=ge[0],Te=ge[1],fe=Object(n.useState)(),Ae=Object(d.a)(fe,2),Ee=Ae[0],be=Ae[1],Ne=Object(n.useState)(),Ce=Object(d.a)(Ne,2),Se=Ce[0],ye=Ce[1],De=Object(n.useState)(),_e=Object(d.a)(De,2),Oe=_e[0],xe=_e[1],ve=Object(n.useState)(),Re=Object(d.a)(ve,2),Pe=Re[0],Ie=Re[1],we=Object(n.useState)(!1),je=Object(d.a)(we,2),Be=je[0],Ue=je[1],ke=Object(n.useState)(!1),Me=Object(d.a)(ke,2),Fe=Me[0],ze=Me[1],Ye=Object(n.useState)(),Ve=Object(d.a)(Ye,2),Ge=Ve[0],He=Ve[1],We=Object(n.useState)(e.category),Qe=Object(d.a)(We,2),Je=(Qe[0],Qe[1]),Ke=Object(n.useState)([{columnKey:"pmr_issued_label",columnName:"Tools/Resources",isChecked:!0},{columnKey:"appl_type",columnName:"Application/Submission Details",isChecked:!0},{columnKey:"product",columnName:"Product Name",isChecked:!0},{columnKey:"approval_date",columnName:"Approval Date",isChecked:!0},{columnKey:"cmt_number",columnName:"PMR/PMC Number",isChecked:!0},{columnKey:"cmt_desc",columnName:"PMR/PMC Description",isChecked:!0},{columnKey:"time_to_fulfillment",columnName:"Time(days) to fulfillment",isChecked:!0},{columnKey:"subpart_description",columnName:"Subpart Flag",isChecked:!0},{columnKey:"sponsor",columnName:"Applicant Name",isChecked:!0},{columnKey:"category",columnName:"Category",isChecked:!0},{columnKey:"pmr_status",columnName:"Status",isChecked:!0},{columnKey:"aa_status",columnName:"Approval Tracks",isChecked:!0}]),Ze=Object(d.a)(Ke,2),Xe=Ze[0],qe=Ze[1],$e=Object(n.useState)(!0),et=Object(d.a)($e,2),tt=(et[0],et[1]),at=oc(),nt=function(){var e=Object(s.a)(c.a.mark((function e(t){return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:t.preventDefault(),ue(!me);case 2:case"end":return e.stop()}}),e)})));return function(t){return e.apply(this,arguments)}}(),rt=function(){var e=Object(s.a)(c.a.mark((function e(t){return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:B(t.target.value);case 1:case"end":return e.stop()}}),e)})));return function(t){return e.apply(this,arguments)}}();Object(n.useEffect)((function(){function t(){return(t=Object(s.a)(c.a.mark((function t(){var a,n,r,i,l,s,d,m,p,g,h,T,f,E,b,N,C,y,D,_,O,v,R,P,I,L,j,B,U,k,M,F,z,Y,G,H,W,J,K,Z,X,q,$,ee,te,ae,ne,ie,oe,le,se,de,me,ue,pe,ge,he,Te,fe,Ae,Ee,Ne,Ce,Se,ye,De,_e,Oe,xe,ve,Re,Pe;return c.a.wrap((function(t){for(;;)switch(t.prev=t.next){case 0:if(a=e.data,console.log("table data",a),Je(e.category),e.category,V(a),n=new Date,r=n.getMonth()+1+"/"+n.getDate()+"/"+n.getFullYear(),be("ria-pmr-"+r+".csv"),i=[],x)for(l=Object.keys(S).find((function(e){return S[e]===w})),s=0;s<a.length;s++)String(a[s][l]).toLowerCase().includes(x)&&i.push(a[s]);else i=a;if(d=[],i.length<=49)Q(i);else{for(m=0;m<50;m++)d.push(i[m]);Q(d)}if(e.data[0]){for(p=["product","appl_type","approval_date","cmt_number","cmt_desc","time_to_fulfillment","subpart_description","sponsor","category","pmr_status",""],g=0;g<p.length;g++)p[g]=S[p[g]];re(p)}else;if(0===i.length&&(h=[],T=[],f=[],e.setGraphState({issueGraph:h,fulfillGraph:T,issueToFulfill:f})),i.length>0)for(E=0;E<i.length;E++)(b=i[E].cmt_number).includes("-")&&(b=b.split("-"),i[E].cmt_number=b[b.length-1]);if(i.length>0)if(i.length<50?o(1):i.length%50===0?o(i.length/50):o(1+~~(i.length/50)),N=i.slice(50*(u-1),50*u),A(N),C=[],i.length<=49)Q(i);else{for(y=0;y<50;y++)C.push(i[y]);Q(C)}else if(x&&0===i.length)A([]);else if(a.length<50?o(1):a.length%50===0?o(a.length/50):o(1+~~(a.length/50)),D=a.slice(50*(u-1),50*u),A(D),_=[],i.length<=49)Q(i);else{for(O=0;O<50;O++)_.push(i[O]);Q(_)}if(v=[],R=[],P=[],i!==[]){I={},L=Object($n.a)(i);try{for(L.s();!(j=L.n()).done;)B=j.value.issued_year,I[B]={issued_year:B,y:I[B]?I[B].y+1:1}}catch(c){L.e(c)}finally{L.f()}for(U=Object.values(I),k=0;k<U.length;k++)v.push({y:U[k].y,x:U[k].issued_year});I={},M=Object($n.a)(i);try{for(M.s();!(F=M.n()).done;)z=F.value.fulfilled_year,I[z]={fulfilled_year:z,y:I[z]?I[z].y+1:1}}catch(c){M.e(c)}finally{M.f()}for(U=Object.values(I),Y=0;Y<U.length;Y++)R.push({y:U[Y].y,x:U[Y].fulfilled_year});for(G=[],H=0;H<i.length;H++)for(W=0;W<i[H].categoryArr.length;W++)G.push(i[H].categoryArr[W]);for(Object(It.a)(new Set(G)),J=[],K=0;K<i.length;K++)for(Z=0;Z<i[K].categoryArr.length;Z++)X={x:i[K].categoryArr[Z],days:i[K].time_to_fulfillment},J.push(X);for(I={},q=[],$=0,ee=J;$<ee.length;$++)te=ee[$],ae=te.x,te.days,I[ae]={x:ae,number:I[ae]?I[ae].number+1:1};for(q.push(I),P=Object.keys(I).map((function(e){return I[e]})),ne=0,ie=0,oe=0,le=0,se=0,de=0,me=0,ue=0,pe=0,ge=0,he=0,Te=0,fe=0,Ae=0,Ee=0,Ne=0,Ce=0,Se=0,ye=0,De=0,[],_e=0;_e<J.length;_e++)"Efficacy"===J[_e].x?ne=parseInt(J[_e].days)+ne:"Immunogenicity"===J[_e].x?ie=parseInt(J[_e].days)+ie:"Pediatric"===J[_e].x?oe=parseInt(J[_e].days)+oe:"Safety"===J[_e].x?le=parseInt(J[_e].days)+le:"Preclinical"===J[_e].x?se=parseInt(J[_e].days)+se:"Renal Impairment"===J[_e].x?de=parseInt(J[_e].days)+de:"Lactation"===J[_e].x?me=parseInt(J[_e].days)+me:"Observational"===J[_e].x?ue=parseInt(J[_e].days)+ue:"Miscellaneous"===J[_e].x?pe=parseInt(J[_e].days)+pe:"Other"===J[_e].x?ge=parseInt(J[_e].days)+ge:"BA"===J[_e].x?he=parseInt(J[_e].days)+he:"DDI"===J[_e].x?Te=parseInt(J[_e].days)+Te:"Dosing"===J[_e].x?fe=parseInt(J[_e].days)+fe:"BE"===J[_e].x?Ae=parseInt(J[_e].days)+Ae:"Food effect"===J[_e].x?Ee=parseInt(J[_e].days)+Ee:"Hepatic Impairment"===J[_e].x?Ne=parseInt(J[_e].days)+Ne:"Pharmacogenetics"===J[_e].x?Ce=parseInt(J[_e].days)+Ce:"Mass balance"===J[_e].x?Se=parseInt(J[_e].days)+Se:"Pregnancy"===J[_e].x?ye=parseInt(J[_e].days)+ye:"QTc"===J[_e].x&&(De=parseInt(J[_e].days)+De);for(Oe=0;Oe<P.length;Oe++)"Efficacy"===P[Oe].x?(ne/=parseInt(P[Oe].number),P[Oe].days=ne):"Immunogenicity"===P[Oe].x?(ie/=parseInt(P[Oe].number),P[Oe].days=ie):"Pediatric"===P[Oe].x?(oe/=parseInt(P[Oe].number),P[Oe].days=oe):"Safety"===P[Oe].x?(le/=parseInt(P[Oe].number),P[Oe].days=le):"Preclinical"===P[Oe].x?(se/=parseInt(P[Oe].number),P[Oe].days=se):"Renal Impairment"===P[Oe].x?(de/=parseInt(P[Oe].number),P[Oe].days=de):"Miscellaneous"===P[Oe].x?(pe/=parseInt(P[Oe].number),P[Oe].days=pe):"Observational"===P[Oe].x?(ue/=parseInt(P[Oe].number),P[Oe].days=ue):"Lactation"===P[Oe].x?(me/=parseInt(P[Oe].number),P[Oe].days=me):"Other"===P[Oe].x?(ge/=parseInt(P[Oe].number),P[Oe].days=ge):"BA"===P[Oe].x?(he/=parseInt(P[Oe].number),P[Oe].days=he):"DDI"===P[Oe].x?(Te/=parseInt(P[Oe].number),P[Oe].days=Te):"Dosing"===P[Oe].x?(fe/=parseInt(P[Oe].number),P[Oe].days=fe):"BE"===P[Oe].x?(Ae/=parseInt(P[Oe].number),P[Oe].days=Ae):"Food effect"===P[Oe].x?(Ee/=parseInt(P[Oe].number),P[Oe].days=Ee):"Hepatic Impairment"===P[Oe].x?(Ne/=parseInt(P[Oe].number),P[Oe].days=Ne):"Pharmacogenetics"===P[Oe].x?(Ce/=parseInt(P[Oe].number),P[Oe].days=Ce):"Mass balance"===P[Oe].x?(Se/=parseInt(P[Oe].number),P[Oe].days=Se):"Pregnancy"===P[Oe].x?(ye/=parseInt(P[Oe].number),P[Oe].days=ye):"QTc"===P[Oe].x&&(De/=parseInt(P[Oe].number),P[Oe].days=De);for(xe=0;xe<P.length;xe++)P[xe].days=parseInt(P[xe].days);for(ve=0;ve<P.length;ve++)for(Re=Object.keys(P[0]),Pe=0;Pe<Re.length;Pe++)P.sort((function(e,t){return parseFloat(e.days)-parseFloat(t.days)})),"number"===typeof P[ve][Re[Pe]]&&(P[ve][Re[Pe]]=""+P[ve][Re[Pe]]);e.setGraphState({issueGraph:v,fulfillGraph:R,issueToFulfill:P})}ce(!1);case 21:case"end":return t.stop()}}),t)})))).apply(this,arguments)}!function(){t.apply(this,arguments)}()}),[u,me,e.data]);var it=function(e){var t,a=Xe,n=Object($n.a)(a);try{for(n.s();!(t=n.n()).done;){var r=t.value;r.columnKey==e.target.value&&(r.isChecked=e.target.checked)}}catch(o){n.e(o)}finally{n.f()}qe(a);var i=Xe.every((function(e){return 1==e.isChecked}));tt(i),ue(!me)},ot=function(){var e=Object(s.a)(c.a.mark((function e(t,a){var n,r;return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:return n={parent_object:t,child_object:a},"issuedLabel"==Object.keys(t)?xe("Issued Label"):xe("Proximal Label"),Ie("Fulfilled Label"),e.next=5,Le(n).then((function(e){r=e})).catch((function(e){console.log(e)}));case 5:null!==r.data.success?ye(r.data.success):(null===r.data.success||""===r.data.success||r.data.error.length>0)&&ra.b.error(r.data.error);case 6:case"end":return e.stop()}}),e)})));return function(t,a){return e.apply(this,arguments)}}();return!1===le&&Y.length>0?r.a.createElement("div",{className:"complianceDashboard",style:{margin:"20px 15px"}},r.a.createElement(R.a,{display:"flex",justifyContent:"flex-start"},r.a.createElement("form",{onSubmit:nt,className:at.Form},r.a.createElement(R.a,{display:"flex",id:"pmrSearchBox",justifyContent:"flex-start"},r.a.createElement(ma,{id:"filter",menuItems:ne,dropdownValue:w,name:"filter",handleChange:rt}),r.a.createElement(j.a,{type:"submit",className:at.Button},r.a.createElement("img",{src:cc.a})),r.a.createElement(Z,{placeholder:"Search keyword",id:"searchTerm",value:x,handleChange:function(e){v(String(e.target.value).toLowerCase())},name:"searchTerm"}),r.a.createElement(_.a,{className:at.ResetButton,onClick:function(){v(""),ue(!me)}},r.a.createElement("img",{style:{width:"15px",paddingRight:"5px",opacity:.7},src:Ec.a}),"Reset"),x&&0===f.length?r.a.createElement(y.a,{className:at.ErrorTypography},"No Results, Please press the Reset button"):null)),r.a.createElement(L.a,{placement:"left-start",title:r.a.createElement(y.a,null,"50 Records available for download")},r.a.createElement("div",{style:{padding:"3px 0 0 10px"}},f?r.a.createElement(st.CSVLink,{data:W,filename:Ee},r.a.createElement("img",{src:dc.a,style:{width:"18px",height:"40px"}})):r.a.createElement("div",null)))),r.a.createElement(U.a,{fullWidth:!0,maxWidth:"sm",onClose:function(){Te([!1,{}])},"aria-labelledby":"customized-dialog-title",open:void 0!==he[0]&&he[0]},r.a.createElement(M.a,null,"Hide/Show Columns"),Xe?r.a.createElement(k.a,null,Xe.map((function(e){return r.a.createElement("div",null,r.a.createElement("div",{class:"col-sm-6 pull-left"},e.columnName),r.a.createElement("div",{class:"col-sm-6"},r.a.createElement("label",{class:"customCheckboxContainer pull-right"},r.a.createElement(bt.a,{label:e.columnName,icon:Fc,checkedIcon:zc,style:{marginRight:8},value:e.columnKey,checked:e.isChecked,onChange:it}),r.a.createElement("span",{class:"checkmark"}))))}))):r.a.createElement("div",null)),0!==f.length?r.a.createElement(r.a.Fragment,null,r.a.createElement(N.a,{className:at.root},r.a.createElement($a.a,{className:at.table,"aria-label":"caption table"},r.a.createElement(an.a,null,r.a.createElement(nn.a,{className:at.TableHeadRow},Xe.map((function(e){return Object.keys(Y[0]).map((function(t,a){if(e.columnKey===t&&!0===e.isChecked)return r.a.createElement(tn.a,{className:at.TableHeadCells,align:"left"},r.a.createElement(mc.a,null,S[t]))}))})))),r.a.createElement(en.a,null,f.map((function(e){return r.a.createElement(nn.a,{style:{margin:"10px"},className:at.TableBodyRows},Xe.map((function(t){return Object.keys(e).map((function(a,n){var i,o,l,c;if(t.columnKey===a&&!0===t.isChecked)return r.a.createElement(tn.a,{className:at.TableBodyCells,align:"left"},"NCT1"===a?r.a.createElement(R.a,(i={justifyContent:"center"},Object(g.a)(i,"justifyContent","center"),Object(g.a)(i,"className",at.TableBodyCellBox),i),r.a.createElement(Xt.a,{target:"_blank",rel:"noopener",href:"https://clinicaltrials.gov/ct2/show/"+e[a]},r.a.createElement(y.a,{className:at.TableCellTypography},e[a]))):"cmt_desc"===a?r.a.createElement(R.a,(o={justifyContent:"center"},Object(g.a)(o,"justifyContent","center"),Object(g.a)(o,"className",at.TableBodyCellBoxBig),o),r.a.createElement(y.a,{className:at.TableCellTypography},e[a])):"appl_type"===a?r.a.createElement(R.a,Object(g.a)({className:at.TableBodyCellBox,justifyContent:"center"},"justifyContent","center"),r.a.createElement(y.a,{className:at.TableCellTypography,style:{display:"flex"}},"NDA"===e[a]?r.a.createElement("div",{className:at.nda,style:{background:"#EA5252",color:"white",borderRadius:"5px"}}," ",e[a]):"BLA"===e[a]?r.a.createElement("div",{className:at.nda,style:{background:"#70319F",color:"white",borderRadius:"5px"}}," ",e[a]):null,r.a.createElement("div",{className:at.nda,style:{color:"#6D7D8A"}},"#",e.appl_num),r.a.createElement("div",{className:at.ndasupl},e.supplement_type_fulfilled,"-",e.supplement_num_fulfilled))):"time_to_fulfillment"===a?r.a.createElement(R.a,Object(g.a)({className:at.TableBodyCellBoxT,justifyContent:"center"},"justifyContent","center"),r.a.createElement(y.a,{className:at.TableCellTypography},r.a.createElement("img",{style:{"padding-right":"5px",width:"16px"},src:Uc.a}),e[a])):"product"===a?r.a.createElement(R.a,Object(g.a)({className:at.TableBodyCellBoxT,justifyContent:"center"},"justifyContent","center"),r.a.createElement(y.a,{className:at.TableCellTypography,style:{color:"#4D4D4D !important"}},e[a])):"pmr_issued_label"===a?r.a.createElement(R.a,{className:at.TableBodyCellBox,style:{display:"flex","flex-direction":"column","justify-content":"center"}},r.a.createElement("img",{style:{width:"20px",margin:"0 auto"},onClick:function(){return function(e){q(e),console.log(e);var t=e.pmr_issued_label,a=e.proximal_label_link,n=e.fulfilled_label_link,r={issuedLabel:t,proximalLabel:a,fulfilledLabel:n};console.log("comparefiles",r),He(r),""===t&&""===a&&""===n?ra.b.error("Multiple label not available for comparision"):Ue(!0)}(e)},src:Nr.a})):"aa_status"===a?r.a.createElement(R.a,(l={justifyContent:"center"},Object(g.a)(l,"justifyContent","center"),Object(g.a)(l,"className",at.TableBodyCellBox),Object(g.a)(l,"style",{display:"flex","justify-content":"center"}),l),"yes"===e[a]?r.a.createElement("img",{style:{width:"17px",height:"20px",margin:"auto"},src:Sc.a}):r.a.createElement("img",{style:{width:"17px",height:"20px",margin:"auto"},src:Nc.a}),"yes"===e.bt_status?r.a.createElement("img",{style:{width:"17px",height:"20px",margin:"auto"},src:Dc.a}):r.a.createElement("img",{style:{width:"17px",height:"20px",margin:"auto"},src:Oc.a}),"yes"===e.ft_status?r.a.createElement("img",{style:{width:"17px",height:"20px",margin:"auto"},src:vc.a}):r.a.createElement("img",{style:{width:"17px",height:"20px",margin:"auto"},src:Pc.a}),"yes"===e.or_status?r.a.createElement("img",{style:{width:"17px",height:"20px",margin:"auto"},src:wc.a}):r.a.createElement("img",{style:{width:"17px",height:"20px",margin:"auto"},src:jc.a})):r.a.createElement(R.a,(c={justifyContent:"center"},Object(g.a)(c,"justifyContent","center"),Object(g.a)(c,"className",at.TableBodyCellBox),c),r.a.createElement(y.a,{className:at.TableCellTypography},e[a])))}))})))}))))),r.a.createElement("div",{className:"pagination"},r.a.createElement(Fo.a,{count:i,onChange:function(e,t){p(t)}})),r.a.createElement(U.a,{fullWidth:!0,maxWidth:"lg",onClose:function(){Ue(!1)},"aria-labelledby":"customized-dialog-title",open:void 0!==Be&&Be,classes:{paper:at.dialog}},r.a.createElement(M.a,{style:{padding:"0 24px"}},r.a.createElement(C.a,{container:!0},r.a.createElement(C.a,{container:!0,item:!0,xs:11,justify:"center",alignItems:"center",className:at.LabelTitle},r.a.createElement("img",{style:{width:"33px",paddingRight:"10px"},src:Nr.a}),"LABEL COMPARISON"),r.a.createElement(C.a,{container:!0,item:!0,xs:1,justify:"flex-end",alignItems:"center"},r.a.createElement(j.a,{"aria-label":"delete",className:at.ModalCloseIconButton,onClick:function(){Ue(!1),ze(!1)}},r.a.createElement(Er.a,{className:at.ModalCloseIcon})))),r.a.createElement(C.a,{container:!0,item:!0,xs:12,justify:"center",alignItems:"center"})),r.a.createElement(k.a,{className:at.Dialog},r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"center",style:{height:"100%"},item:!0},!1===Fe?r.a.createElement(C.a,{style:{display:"contents"}},r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"center",style:{display:"inline-flex",padding:"30px"}},r.a.createElement(C.a,{xs:3,container:!0,justify:"center",alignItems:"center",item:!0},r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"center",item:!0,className:at.selectLabel}," ","Most Proximal Label"," (",X.supplement_type_proximal,"-",X.supplement_num_proximal,")"),r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"center",item:!0},r.a.createElement(y.a,{className:at.LabelComparisionDate},X.approval_date_proximal))),r.a.createElement(C.a,{xs:1,container:!0,justify:"center",alignItems:"center",item:!0},r.a.createElement("span",{style:{borderTop:"1px solid #a2a2a2",width:"100%",marginBottom:"-25%"}}),r.a.createElement("img",{style:{width:"28px",marginTop:"-5px"},src:Sr.a})),r.a.createElement(C.a,{xs:3,container:!0,justify:"center",alignItems:"center",item:!0},r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"center",item:!0,className:at.selectLabel}," ","PMR/PMC Fulfilled Label"," (",X.supplement_type_fulfilled,"-",X.supplement_num_fulfilled,")"),r.a.createElement(y.a,{className:at.LabelComparisionDate},X.supplement_date_fulfilled)),r.a.createElement(C.a,{xs:1,container:!0,justify:"end",alignItems:"end",item:!0,style:{cursor:"pointer",paddingLeft:"20px"}},r.a.createElement("img",{onClick:function(){ot(Ge.proximalLabel,Ge.fulfilledLabel),ze(!0)},style:{width:"20px"},src:Mc.a}))),r.a.createElement(C.a,{xs:12,style:{display:"inline-flex",padding:"30px"},container:!0,justify:"center",alignItems:"center"},r.a.createElement(C.a,{xs:3,container:!0,justify:"center",alignItems:"center",item:!0},r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"center",item:!0,className:at.selectLabel}," ","PMR/PMC Issued Label"," (",X.supplement_type,"-",X.supplement_num,")"),r.a.createElement(y.a,{className:at.LabelComparisionDate},X.approval_date)),r.a.createElement(C.a,{xs:1,container:!0,justify:"center",alignItems:"center",item:!0},r.a.createElement("span",{style:{borderTop:"1px solid #a2a2a2",width:"100%",marginBottom:"-25%"}}),r.a.createElement("img",{style:{width:"28px",marginTop:"-5px"},src:Sr.a})),r.a.createElement(C.a,{xs:3,container:!0,justify:"center",alignItems:"center",item:!0},r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"center",item:!0,className:at.selectLabel}," ","PMR/PMC Fulfilled Label"," (",X.supplement_type_fulfilled,"-",X.supplement_num_fulfilled,")"),r.a.createElement(y.a,{className:at.LabelComparisionDate},X.supplement_date_fulfilled)),r.a.createElement(C.a,{xs:1,container:!0,justify:"end",alignItems:"end",item:!0,style:{paddingLeft:"20px"}},r.a.createElement("img",{onClick:function(){ot(Ge.issuedLabel,Ge.fulfilledLabel),ze(!0)},style:{cursor:"pointer",width:"20px"},src:Mc.a})))):Se?r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"flex-start",item:!0},r.a.createElement(C.a,{container:!0,item:!0,xs:12,justify:"center",alignItems:"center"},r.a.createElement(C.a,{container:!0,item:!0,xs:5,justify:"center",alignItems:"center",className:at.Label},r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"center",item:!0,className:at.selectLabelC}," ",Oe&&Oe)),r.a.createElement(C.a,{container:!0,item:!0,xs:1,justify:"center",alignItems:"center"},r.a.createElement("span",{style:{borderTop:"1px solid #a2a2a2",width:"100%",marginBottom:"-25%"}}),r.a.createElement("img",{style:{width:"28px",marginTop:"-5px"},src:fc.a})),r.a.createElement(C.a,{container:!0,item:!0,xs:5,justify:"center",alignItems:"center",className:at.Label},r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"center",item:!0,className:at.selectLabelC}," ",Pe&&Pe))),r.a.createElement(C.a,{container:!0,item:!0,xs:12,justify:"center",alignItems:"center"},r.a.createElement("div",{style:{height:"62vh",width:"100vw"}},r.a.createElement("iframe",{style:{height:"100%",width:"100%"},src:Se,allowFullScreens:!0}))),r.a.createElement(C.a,{container:!0,item:!0,xs:12,justify:"center",alignItems:"center"},r.a.createElement(C.a,{container:!0,item:!0,justify:"center",alignItems:"center",onClick:function(){return ze(!1)},className:at.compareN},r.a.createElement("img",{style:{width:"15px"},src:hc.a}),r.a.createElement(y.a,{className:at.labelTitle},"New Compare")))):r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"flex-start",item:!0},r.a.createElement("div",{style:{height:"80vh",width:"100vw"}},r.a.createElement(tr.SemipolarLoading,{color:"#0352CC"}))))))):null):null}var Vc=Object(f.a)((function(e){var t,a,n;return{root:{overflowX:"scroll",boxShadow:"unset !important"},complianceDashboard:{margin:"20px 15px !important"},table:{border:"unset !important",borderCollapse:"separate",borderSpacing:"0px 7px"},TableHeadCells:{boxShadow:"none",border:"none",fontWeight:"700",color:"#3AB09E",fontSize:"13px",padding:"unset",lineHeight:"1.5"},TableBodyRows:{margin:"10px","-moz-box-shadow":"0 0 5px rgba(0,0,0,0.1)","-webkit-box-shadow":"0 0 5px rgba(0,0,0,0.1)","box-shadow":"0 0 5px rgba(0,0,0,0.1)"},TableBodyCells:{boxShadow:"none",border:"none",padding:"unset"},TableBodyCellBox:{height:"70px",minWidth:"130px",overflowY:"auto",boxShadow:"none",border:"none",padding:"5px"},TableBodyCellBoxT:{height:"70px",minWidth:"130px",overflowY:"auto",boxShadow:"none",border:"none",padding:"5px"},TableBodyCellBoxBig:{height:"70px",minWidth:"300px",overflowY:"auto",boxShadow:"none",border:"none",padding:"5px"},TableCellTypography:{fontSize:"0.9rem",color:"#6D7D8A",fontWeight:"600"},Form:{width:"100%"},Textfield:{marginBottom:e.spacing(2),border:"none",marginLeft:e.spacing(1),borderRadius:"15px",minWidth:e.spacing(45),height:"100%",minHeight:"50px",fontSize:"2vh",background:e.palette.navbar.grayBackground,color:e.palette.black},Button:{fontSize:"0.8rem",textTransform:"none",fontWeight:"400",minHeight:"50px",padding:"10px 5px",borderRadius:"10px",borderBottomLeftRadius:"0px",borderTopLeftRadius:"0px",marginBottom:e.spacing(2)},customCheckboxContainer:{display:"block",position:"relative",paddingLeft:"35px",marginBottom:"12px",cursor:"pointer",fontSize:"22px",userSelect:"none"},ResetButton:(t={fontSize:"0.8rem",borderRadius:"10px",maxHeight:"50px",minHeight:"50px",fontWeight:"400",textTransform:"none",color:e.palette.black},Object(g.a)(t,"fontSize",e.spacing(1.6)),Object(g.a)(t,"padding",0),Object(g.a)(t,"marginLeft","20px"),t),ErrorTypography:(a={fontWeight:"700",fontSize:"0.8rem",padding:"20px",marginLeft:"20px"},Object(g.a)(a,"fontSize","0.8rem"),Object(g.a)(a,"maxHeight","50px"),Object(g.a)(a,"minHeight","50px"),Object(g.a)(a,"color",e.palette.fatalRed),a),".MuiTable-root":{border:"unset !important"},nda:{padding:"5px",margin:"10px"},ndasupl:{padding:"5px",margin:"10px",color:"#318AC8",flex:"none"},selectLabel:{background:"#33B187",color:"white",padding:"13px 10px",borderRadius:"15px",marginBottom:"auto",fontSize:"2.3vh"},dialog:{height:"inherit",backgroundImage:"url(".concat(Tr.a,")"),backgroundRepeat:"no-repeat",backgroundPosition:"center",backgroundSize:"cover",backgroundAttachment:"fixed"},compareN:(n={height:"30px",margin:"5px",padding:"3px 20px",borderRadius:"13px",fontSize:"1.7vh",fontWeight:"bold",border:"2px solid #e3f1ff",boxShadow:"0 0 4px rgb(220, 220, 220,0.5)"},Object(g.a)(n,"borderRadius","20px"),Object(g.a)(n,"backgroundColor","#119E8A"),Object(g.a)(n,"color","#FFFFFF"),Object(g.a)(n,"cursor","pointer"),Object(g.a)(n,"margin","10px auto"),Object(g.a)(n,"display","flex"),Object(g.a)(n,"width","fit-content"),n),labelTitle:{fontSize:"1.4vh",fontWeight:500,paddingLeft:"5px",margin:"auto"},selectLabelC:{background:"#33B187",color:"white",borderRadius:"10px 10px 0px 0px",marginBottom:"auto",fontSize:"2.3vh",padding:"13px 10px"}}})),Gc=(a(122),r.a.createElement(ft.a,{fontSize:"small"})),Hc=r.a.createElement(Et.a,{fontSize:"small"});function Wc(e){var t=Object(n.useState)(),a=Object(d.a)(t,2),i=a[0],o=a[1],l=Object(n.useState)(1),m=Object(d.a)(l,2),u=m[0],p=m[1],g=Object(n.useState)(e.data),h=Object(d.a)(g,2),T=h[0],f=h[1],A=Object(n.useState)(e.ColNames),E=Object(d.a)(A,2),b=E[0],S=(E[1],Object(n.useState)()),D=Object(d.a)(S,2),O=D[0],x=D[1],v=Object(n.useState)("PMR/PMC Description"),P=Object(d.a)(v,2),I=P[0],w=P[1],B=Object(n.useState)([]),F=Object(d.a)(B,2),z=F[0],Y=F[1],V=Object(n.useState)([]),G=Object(d.a)(V,2),H=G[0],W=G[1],Q=Object(n.useState)([]),J=Object(d.a)(Q,2),K=(J[0],J[1],Object(n.useState)()),X=Object(d.a)(K,2),q=X[0],$=X[1],ee=Object(n.useState)(!0),te=Object(d.a)(ee,2),ae=te[0],ne=te[1],re=Object(n.useState)(!0),ie=Object(d.a)(re,2),oe=ie[0],le=ie[1],ce=Object(n.useState)(!1,{}),se=Object(d.a)(ce,2),de=se[0],me=se[1],ue=Object(n.useState)(),pe=Object(d.a)(ue,2),ge=pe[0],he=pe[1],Te=Object(n.useState)(),fe=Object(d.a)(Te,2),Ae=fe[0],Ee=fe[1],be=Object(n.useState)(),Ne=Object(d.a)(be,2),Ce=Ne[0],Se=Ne[1],ye=Object(n.useState)(),De=Object(d.a)(ye,2),_e=De[0],Oe=De[1],xe=Object(n.useState)(!1),ve=Object(d.a)(xe,2),Re=ve[0],Pe=ve[1],Ie=Object(n.useState)(!1),we=Object(d.a)(Ie,2),je=we[0],Be=we[1],Ue=Object(n.useState)(),ke=Object(d.a)(Ue,2),Me=ke[0],Fe=ke[1],ze=Object(n.useState)([{columnKey:"appl_type",columnName:"Application/Submission Details",isChecked:!0},{columnKey:"product",columnName:"Product Name",isChecked:!0},{columnKey:"approval_date",columnName:"Approval Date",isChecked:!0},{columnKey:"cmt_description",columnName:"PMR/PMC Description",isChecked:!0},{columnKey:"cmt_no",columnName:"PMR/PMC Number",isChecked:!0},{columnKey:"subpart_approval_description",columnName:"Subpart Flag",isChecked:!0},{columnKey:"Sponsor",columnName:"Applicant Name",isChecked:!0},{columnKey:"category",columnName:"Category",isChecked:!0},{columnKey:"aa_status",columnName:"Approval Tracks",isChecked:!0}]),Ye=Object(d.a)(ze,2),Ve=Ye[0],Ge=Ye[1],He=Object(n.useState)(!0),We=Object(d.a)(He,2),Qe=(We[0],We[1]),Je=Vc(),Ke=function(){var e=Object(s.a)(c.a.mark((function e(t){return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:t.preventDefault(),le(!oe);case 2:case"end":return e.stop()}}),e)})));return function(t){return e.apply(this,arguments)}}(),Ze=function(){var e=Object(s.a)(c.a.mark((function e(t){return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:w(t.target.value);case 1:case"end":return e.stop()}}),e)})));return function(t){return e.apply(this,arguments)}}();Object(n.useEffect)((function(){function t(){return(t=Object(s.a)(c.a.mark((function t(){var a,n,r,i,l,s,d,m,p,g,h,T,A,E,N,C,S,y,D,_,x,v,R,P,w,L,j,B,U,k,M,F,z,V,G,H,Q,J,K,Z,X,q,ee,te,ae,re,ie,oe,le;return c.a.wrap((function(t){for(;;)switch(t.prev=t.next){case 0:if(a=e.data,Y(a),n=new Date,r=n.getMonth()+1+"/"+n.getDate()+"/"+n.getFullYear(),he("ria-pmr-"+r+".csv"),i=[],O)for(l=Object.keys(b).find((function(e){return b[e]===I})),s=0;s<a.length;s++)String(a[s][l]).toLowerCase().includes(O)&&i.push(a[s]);else i=a;if(d=[],i.length<=49)W(i);else{for(m=0;m<50;m++)d.push(i[m]);W(d)}if(e.data[0]){for(p=["product","approval_date","cmt_description","cmt_no","subpart_approval_description","Sponsor","category",""],g=0;g<p.length;g++)p[g]=b[p[g]];$(p)}else;if(0===i.length&&(h=[],T=[],A=[],e.setGraphState({total:void 0,issue:void 0,completion:void 0,status:h,subpart:T,categories:A})),i.length>0)if(i.length<50?o(1):i.length%50===0?o(i.length/50):o(1+~~(i.length/50)),E=i.slice(50*(u-1),50*u),f(E),N=[],i.length<=49)W(i);else{for(C=0;C<50;C++)N.push(i[C]);W(N)}else if(O&&0===i.length)f([]);else if(a.length<50?o(1):a.length%50===0?o(a.length/50):o(1+~~(a.length/50)),S=a.slice(50*(u-1),50*u),f(S),y=[],i.length<=49)W(i);else{for(D=0;D<50;D++)y.push(i[D]);W(y)}_=i.length,R=[],P=[],w={},L=[],j=Object($n.a)(i);try{for(j.s();!(B=j.n()).done;)"yes"===(U=B.value.issued_in_last_two_months)&&(w[U]={issued_in_last_two_months:U,y:w[U]?w[U].y+1:1})}catch(c){j.e(c)}finally{j.f()}(L=Object.values(w)).length>0&&(x=L[0].y),w={},k=Object($n.a)(i);try{for(k.s();!(M=k.n()).done;)"yes"===(F=M.value.expected_completion_in_twelve_months)&&(w[F]={expected_completion_in_twelve_months:F,y:w[F]?w[F].y+1:1})}catch(c){k.e(c)}finally{k.f()}for(L=[],(L=Object.values(w)).length>0&&(v=L[0].y),z=0;z<i.length;z++)void 0===P[i[z].subpart_approval_description]?P[i[z].subpart_approval_description]=1:P[i[z].subpart_approval_description]+=1,void 0===R[i[z].status_CMT]?R[i[z].status_CMT]=1:R[i[z].status_CMT]+=1;for(V=[],G=[],H=0;H<i.length;H++)for(Q=0;Q<i[H].category.length;Q++)G.push(i[H].category[Q]);for(Object(It.a)(new Set(G)),J=[],K=0;K<i.length;K++)if(1===i[K].category.length)Z={x:i[K].category,number:i[K].category?i[K].category.y+1:1},J.push(Z);else if(i[K].category.length>1)for(X=0;X<i[K].category.length;X++)q={x:i[K].category[X]},J.push(q);for(w={},ee=[],te=0,ae=J;te<ae.length;te++)re=ae[te].x,w[re]={x:re,number:w[re]?w[re].number+1:1};for(ee.push(w),V=Object.keys(w).map((function(e){return w[e]})),ie=0;ie<V.length;ie++)for(oe=Object.keys(V[0]),le=0;le<oe.length;le++)V.sort((function(e,t){return parseFloat(e.number)-parseFloat(t.number)})),"number"===typeof V[ie][oe[le]]&&(V[ie][oe[le]]=""+V[ie][oe[le]]);e.setGraphState({total:_,issue:x,completion:v,status:R,subpart:P,categories:V}),ne(!1);case 42:case"end":return t.stop()}}),t)})))).apply(this,arguments)}console.log("survelance"),function(){t.apply(this,arguments)}()}),[u,oe,e.data]);var Xe=function(e){var t,a=Ve,n=Object($n.a)(a);try{for(n.s();!(t=n.n()).done;){var r=t.value;r.columnKey==e.target.value&&(r.isChecked=e.target.checked)}}catch(o){n.e(o)}finally{n.f()}Ge(a);var i=Ve.every((function(e){return 1==e.isChecked}));Qe(i),le(!oe)},qe=function(){var e=Object(s.a)(c.a.mark((function e(t,a){var n,r;return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:return n={parent_object:t,child_object:a},"issuedLabel"==Object.keys(t)?Se("Issued Label"):Se("Proximal Label"),Oe("Fulfilled Label"),e.next=5,Le(n).then((function(e){r=e})).catch((function(e){console.log(e)}));case 5:null!==r.data.success?Ee(r.data.success):ra.b.error(r.data.error);case 6:case"end":return e.stop()}}),e)})));return function(t,a){return e.apply(this,arguments)}}();return!1===ae&&z.length>0?r.a.createElement("div",{className:"complianceDashboard",style:{margin:"20px 15px"}},r.a.createElement(R.a,{display:"flex",justifyContent:"flex-start"},r.a.createElement("form",{onSubmit:Ke,className:Je.Form},r.a.createElement(R.a,{display:"flex",id:"pmrSearchBox",justifyContent:"flex-start"},r.a.createElement(ma,{id:"filter",menuItems:q,dropdownValue:I,name:"filter",handleChange:Ze}),r.a.createElement(j.a,{type:"submit",className:Je.Button},r.a.createElement("img",{src:cc.a})),r.a.createElement(Z,{placeholder:"Search keyword",id:"searchTerm",value:O,handleChange:function(e){x(String(e.target.value).toLowerCase())},name:"searchTerm"}),r.a.createElement(_.a,{className:Je.ResetButton,onClick:function(){x(""),le(!oe)}},"Reset"),O&&0===T.length?r.a.createElement(y.a,{className:Je.ErrorTypography},"No Results, Please press the Reset button"):null)),r.a.createElement(L.a,{placement:"left-start",title:r.a.createElement(y.a,null,"50 Records available for download")},r.a.createElement("div",{style:{padding:"3px 0 0 10px"}},T?r.a.createElement(st.CSVLink,{data:H,filename:ge},r.a.createElement("img",{src:dc.a,style:{width:"18px",height:"40px"}})):r.a.createElement("div",null)))),r.a.createElement(U.a,{fullWidth:!0,maxWidth:"sm",onClose:function(){me([!1,{}])},"aria-labelledby":"customized-dialog-title",open:void 0!==de[0]&&de[0]},r.a.createElement(M.a,null,"Hide/Show Columns"),Ve?r.a.createElement(k.a,null,Ve.map((function(e){return r.a.createElement("div",null,r.a.createElement("div",{class:"col-sm-6 pull-left"},e.columnName),r.a.createElement("div",{class:"col-sm-6"},r.a.createElement("label",{class:"customCheckboxContainer pull-right"},r.a.createElement(bt.a,{label:e.columnName,icon:Gc,checkedIcon:Hc,style:{marginRight:8},value:e.columnKey,checked:e.isChecked,onChange:Xe}),r.a.createElement("span",{class:"checkmark"}))))}))):r.a.createElement("div",null)),0!==T.length?r.a.createElement(r.a.Fragment,null,r.a.createElement(N.a,{className:Je.root},r.a.createElement($a.a,{className:Je.table,"aria-label":"caption table"},r.a.createElement(an.a,null,r.a.createElement(nn.a,{className:Je.TableHeadRow},Ve.map((function(e){return Object.keys(z[0]).map((function(t,a){if(e.columnKey===t&&!0===e.isChecked)return r.a.createElement(tn.a,{className:Je.TableHeadCells,align:"left"},r.a.createElement(mc.a,null,b[t]))}))})))),r.a.createElement(en.a,null,T.map((function(e){return r.a.createElement(nn.a,{style:{margin:"10px"},className:Je.TableBodyRows},Ve.map((function(t){return Object.keys(e).map((function(a,n){if(t.columnKey===a&&!0===t.isChecked)return r.a.createElement(tn.a,{className:Je.TableBodyCells,align:"left"},"NCT1"===a?r.a.createElement(R.a,{className:Je.TableBodyCellBox},r.a.createElement(Xt.a,{target:"_blank",rel:"noopener",href:"https://clinicaltrials.gov/ct2/show/"+e[a]},r.a.createElement(y.a,{className:Je.TableCellTypography},e[a]))):"cmt_description"===a?r.a.createElement(R.a,{className:Je.TableBodyCellBoxBig},r.a.createElement(y.a,{className:Je.TableCellTypography},e[a])):"appl_type"===a?r.a.createElement(R.a,{className:Je.TableBodyCellBox},r.a.createElement(y.a,{className:Je.TableCellTypography,style:{display:"flex"}},"NDA"===e[a]?r.a.createElement("div",{className:Je.nda,style:{background:"#EA5252",color:"white",borderRadius:"5px"}}," ",e[a]):"BLA"===e[a]?r.a.createElement("div",{className:Je.nda,style:{background:"#70319F",color:"white",borderRadius:"5px"}}," ",e[a]):null,r.a.createElement("div",{className:Je.nda,style:{color:"#6D7D8A"}},"#",e.appl_num),r.a.createElement("div",{className:Je.ndasupl},e.supplement_type_fufilled,"-",e.supplement_num_fufilled))):"time_to_fulfillment"===a?r.a.createElement(R.a,{className:Je.TableBodyCellBoxT},r.a.createElement(y.a,{className:Je.TableCellTypography},r.a.createElement("img",{style:{"padding-right":"5px",width:"16px"},src:Uc.a}),e[a])):"product"===a?r.a.createElement(R.a,{className:Je.TableBodyCellBoxT},r.a.createElement(y.a,{className:Je.TableCellTypography,style:{color:"#4D4D4D !important"}},e[a],r.a.createElement("div",null,"(",e.active_ingredient,")"))):"pmr_issued_label"===a?r.a.createElement(R.a,{className:Je.TableBodyCellBox,style:{display:"flex","flex-direction":"column","justify-content":"center"}},r.a.createElement("img",{style:{width:"20px",margin:"0 auto"},onClick:function(){return function(e){var t=e.pmr_issued_label,a=e.proximal_label_link,n=e.fulfilled_label_link,r={issuedLabel:t,proximalLabel:a,fulfilledLabel:n};console.log("comparefiles",r),Fe(r),""===t&&""===a&&""===n?ra.b.error("Multiple label not available for comparision"):Pe(!0)}(e)},src:Nr.a})):"aa_status"===a?r.a.createElement(R.a,{className:Je.TableBodyCellBox,style:{display:"flex","justify-content":"center"}},"yes"===e[a]?r.a.createElement("img",{style:{width:"17px",height:"20px",margin:"auto"},src:Sc.a}):r.a.createElement("img",{style:{width:"17px",height:"20px",margin:"auto"},src:Nc.a}),"yes"===e.bt_status?r.a.createElement("img",{style:{width:"17px",height:"20px",margin:"auto"},src:Dc.a}):r.a.createElement("img",{style:{width:"17px",height:"20px",margin:"auto"},src:Oc.a}),"yes"===e.ft_status?r.a.createElement("img",{style:{width:"17px",height:"20px",margin:"auto"},src:vc.a}):r.a.createElement("img",{style:{width:"17px",height:"20px",margin:"auto"},src:Pc.a}),"yes"===e.or_status?r.a.createElement("img",{style:{width:"17px",height:"20px",margin:"auto"},src:wc.a}):r.a.createElement("img",{style:{width:"17px",height:"20px",margin:"auto"},src:jc.a})):r.a.createElement(R.a,{className:Je.TableBodyCellBox},r.a.createElement(y.a,{className:Je.TableCellTypography},e[a])))}))})))}))))),r.a.createElement("div",{className:"pagination"},r.a.createElement(Fo.a,{count:i,onChange:function(e,t){p(t)}})),r.a.createElement(U.a,{fullWidth:!0,maxWidth:"lg",onClose:function(){Pe(!1)},"aria-labelledby":"customized-dialog-title",open:void 0!==Re&&Re,classes:{paper:Je.dialog}},r.a.createElement(M.a,{style:{padding:"0 24px"}},r.a.createElement(C.a,{container:!0},r.a.createElement(C.a,{container:!0,item:!0,xs:11,justify:"center",alignItems:"center",className:Je.LabelTitle},r.a.createElement("img",{style:{width:"33px",paddingRight:"10px"},src:Nr.a}),"LABEL COMPARISON"),r.a.createElement(C.a,{container:!0,item:!0,xs:1,justify:"flex-end",alignItems:"center"},r.a.createElement(j.a,{"aria-label":"delete",className:Je.ModalCloseIconButton,onClick:function(){Pe(!1),Be(!1)}},r.a.createElement(Er.a,{className:Je.ModalCloseIcon})))),r.a.createElement(C.a,{container:!0,item:!0,xs:12,justify:"center",alignItems:"center"})),r.a.createElement(k.a,{className:Je.Dialog},r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"flex-start",item:!0},!1===je?r.a.createElement(C.a,{style:{display:"contents"}},r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"center",style:{display:"inline-flex",padding:"30px"}},r.a.createElement(C.a,{xs:3,container:!0,justify:"center",alignItems:"center",item:!0},r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"center",item:!0,className:Je.selectLabel}," ","Most Proximal Label"," ")),r.a.createElement(C.a,{xs:1,container:!0,justify:"center",alignItems:"center",item:!0},r.a.createElement("span",{style:{borderTop:"1px solid #a2a2a2",width:"100%",marginBottom:"-25%"}}),r.a.createElement("img",{style:{width:"28px",marginTop:"-5px"},src:Sr.a})),r.a.createElement(C.a,{xs:3,container:!0,justify:"center",alignItems:"center",item:!0},r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"center",item:!0,className:Je.selectLabel}," ","PMR Fulfilled Label"," ")),r.a.createElement(C.a,{xs:1,container:!0,justify:"end",alignItems:"end",item:!0,style:{paddingLeft:"20px"}},r.a.createElement("img",{onClick:function(){qe(Me.proximalLabel,Me.fulfilledLabel),Be(!0)},style:{width:"20px"},src:Mc.a}))),r.a.createElement(C.a,{xs:12,style:{display:"inline-flex",padding:"30px"},container:!0,justify:"center",alignItems:"center"},r.a.createElement(C.a,{xs:3,container:!0,justify:"center",alignItems:"center",item:!0},r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"center",item:!0,className:Je.selectLabel}," ","PMR Issued Label"," ")),r.a.createElement(C.a,{xs:1,container:!0,justify:"center",alignItems:"center",item:!0},r.a.createElement("span",{style:{borderTop:"1px solid #a2a2a2",width:"100%",marginBottom:"-25%"}}),r.a.createElement("img",{style:{width:"28px",marginTop:"-5px"},src:Sr.a})),r.a.createElement(C.a,{xs:3,container:!0,justify:"center",alignItems:"center",item:!0},r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"center",item:!0,className:Je.selectLabel}," ","PMR Fulfilled Label"," ")),r.a.createElement(C.a,{xs:1,container:!0,justify:"end",alignItems:"end",item:!0,style:{paddingLeft:"20px"}},r.a.createElement("img",{onClick:function(){qe(Me.issuedLabel,Me.fulfilledLabel),Be(!0)},style:{width:"20px"},src:Mc.a})))):Ae?r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"flex-start",item:!0},r.a.createElement(C.a,{container:!0,item:!0,xs:12,justify:"center",alignItems:"center"},r.a.createElement(C.a,{container:!0,item:!0,xs:5,justify:"center",alignItems:"center",className:Je.Label},r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"center",item:!0,className:Je.selectLabelC}," ",Ce&&Ce)),r.a.createElement(C.a,{container:!0,item:!0,xs:1,justify:"center",alignItems:"center"},r.a.createElement("span",{style:{borderTop:"1px solid #a2a2a2",width:"100%",marginBottom:"-25%"}}),r.a.createElement("img",{style:{width:"28px",marginTop:"-5px"},src:fc.a})),r.a.createElement(C.a,{container:!0,item:!0,xs:5,justify:"center",alignItems:"center",className:Je.Label},r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"center",item:!0,className:Je.selectLabelC}," ",_e&&_e))),r.a.createElement(C.a,{container:!0,item:!0,xs:12,justify:"center",alignItems:"center"},r.a.createElement("div",{style:{height:"62vh",width:"100vw"}},r.a.createElement("iframe",{style:{height:"100%",width:"100%"},src:Ae,allowFullScreens:!0}))),r.a.createElement(C.a,{container:!0,item:!0,xs:12,justify:"center",alignItems:"center"},r.a.createElement(C.a,{container:!0,item:!0,justify:"center",alignItems:"center",onClick:function(){return Be(!1)},className:Je.compareN},r.a.createElement("img",{style:{width:"15px"},src:hc.a}),r.a.createElement(y.a,{className:Je.labelTitle},"New Compare")))):r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"flex-start",item:!0},r.a.createElement("div",{style:{height:"80vh",width:"100vw"}},r.a.createElement(tr.SemipolarLoading,{color:"#0352CC"}))))))):null):null}var Qc=a(823),Jc=Object(f.a)((function(e){return{root:{width:"100%"},FilterText:{color:e.palette.white,fontSize:"1rem",padding:"10px"},FilterSearch:{borderRadius:"10px",width:"100%",height:"100%",minHeight:"40px",fontSize:"2vh",backgroundColor:e.palette.bot.lightBackground,color:e.palette.black},ResetButton:{fontWeight:"400",borderRadius:"10px",textTransform:"none",border:"1px solid ".concat(e.palette.white),backgroundColor:"transparent",color:e.palette.white,fontSize:e.spacing(2),padding:0,marginRight:"10px"},Divider:{backgroundColor:e.palette.white,color:e.palette.white,height:"0.5px"}}})),Kc=Object(f.a)((function(e){var t;return{AutoCompleteSearch:{border:"2px solid ".concat(e.palette.bot.filterBackground),borderRadius:"10px",width:"100%",height:"100%",minHeight:"40px",fontSize:"0.8rem",backgroundColor:e.palette.bot.lightBackground,color:e.palette.black,"& .MuiInputBase-input":{color:e.palette.black,fontSize:"0.8rem",opacity:1,"& .MuiAutocomplete-option":{backgroundColor:e.palette.bot.filterBackground,color:e.palette.black,fontSize:"0.8rem",textAlign:"left"}},"& .MuiChip-root":{backgroundColor:e.palette.bot.filterBackground,color:e.palette.black},"& .MuiAutocomplete-option":{backgroundColor:e.palette.bot.filterBackground,color:e.palette.black,fontSize:"0.8rem",textAlign:"left"}},AutoCompleteSearchTextfield:{border:"2px solid ".concat(e.palette.bot.filterBackground),borderRadius:"10px",width:"100%",height:"100%",minHeight:"40px",fontSize:"0.8rem",backgroundColor:e.palette.bot.lightBackground,color:e.palette.black,"& .MuiInputBase-input":{color:e.palette.black,fontSize:"0.8rem",opacity:1,"& .MuiAutocomplete-option":{backgroundColor:e.palette.bot.filterBackground,color:e.palette.black,fontSize:"0.8rem",textAlign:"left"}},"& .MuiChip-root":{backgroundColor:e.palette.bot.filterBackground,color:e.palette.black},"& .MuiAutocomplete-option":{backgroundColor:e.palette.bot.filterBackground,color:e.palette.black,fontSize:"0.8rem",textAlign:"left"}},FilterTitle:{fontSize:"0.8rem",margin:"5px",fontWeight:"500",padding:"10px",paddingRight:"0px",color:e.palette.white,borderRadius:"10px",textAlign:"left"},FilterTitleButton:(t={fontSize:"1.2rem",cursor:"pointer",margin:"5px",marginTop:"15px"},Object(g.a)(t,"marginTop","15px"),Object(g.a)(t,"color",e.palette.white),t),FilterOption:{textAlign:"left",fontSize:"0.6rem",fontWeight:"400",color:e.palette.black},FilterChecked:{padding:0,margin:0,paddingRight:"5px"}}})),Zc=r.a.createElement(ft.a,{fontSize:"small"}),Xc=r.a.createElement(Et.a,{fontSize:"small"});function qc(e){Object(n.useEffect)((function(){function e(){return(e=Object(s.a)(c.a.mark((function e(){return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:case"end":return e.stop()}}),e)})))).apply(this,arguments)}!function(){e.apply(this,arguments)}()}),[e]);var t=Kc(),a=Object(n.useState)(!1),i=Object(d.a)(a,2),o=i[0],l=i[1];return r.a.createElement("div",{className:t.root},r.a.createElement(R.a,{display:"flex",justifyContent:"space-between",onClick:function(){l(!o)},style:{cursor:"pointer"}},r.a.createElement(y.a,{className:t.FilterTitle,"aria-expanded":o},e.title),r.a.createElement(Ct.a,{className:t.FilterTitleButton})),r.a.createElement(ht.a,{in:o,timeout:"auto",unmountOnExit:!0},r.a.createElement(pt.a,{multiple:!0,defaultValue:e.selected?e.selected:null,onChange:function(t,a){return function(t){1===t.length&&ra.b.info("We are fetching information for you"),e.handleChange(e.filterType,t)}(a)},id:"tags-outlined",options:e.options,disableCloseOnSelect:!0,renderOption:function(a,n){var i=n.selected;return r.a.createElement(r.a.Fragment,null,parseInt(e.filterCount[a])>0?r.a.createElement("div",null,r.a.createElement(R.a,{display:"flex"},r.a.createElement(bt.a,{icon:Zc,checkedIcon:Xc,style:{marginRight:8},checked:i,className:t.FilterChecked}),r.a.createElement(y.a,{className:t.FilterOption},a+"  ("+e.filterCount[a]+")"))):r.a.createElement("div",null,r.a.createElement(R.a,{display:"flex"},r.a.createElement(bt.a,{icon:Zc,checkedIcon:Xc,style:{marginRight:8},checked:i,className:t.FilterChecked}),r.a.createElement(y.a,{className:t.FilterOption},a))))},className:t.AutoCompleteSearch,renderInput:function(a){return r.a.createElement(D.a,Object.assign({},a,{className:t.AutoCompleteSearchTextField,variant:"outlined",placeholder:e.placeholder}))}})))}Object(f.a)((function(e){var t;return{FilterTitle:{fontSize:"0.8rem",margin:"5px",fontWeight:"500",padding:"10px",paddingRight:"0px",color:e.palette.white,borderRadius:"10px",textAlign:"left"},FilterTitleButton:(t={fontSize:"1.2rem",cursor:"pointer",margin:"5px",marginTop:"15px"},Object(g.a)(t,"marginTop","15px"),Object(g.a)(t,"color",e.palette.white),t),RangeSlider:{paddingTop:"10px",paddingBottom:"10px",width:"80%"}}}));function $c(e){for(var t=Jc(),a=Object(n.useState)(e.data),i=Object(d.a)(a,2),o=i[0],l=(i[1],Object(n.useState)(!1)),m=Object(d.a)(l,2),u=m[0],p=m[1],g=Object(n.useState)(),h=Object(d.a)(g,2),T=(h[0],h[1]),f=Object(n.useState)({appl_type:[],category:[],subpart_description:[],sponsor:[],product:[]}),A=Object(d.a)(f,2),E=A[0],b=A[1],N=Object(n.useState)(e.filters),C=Object(d.a)(N,2),S=C[0],D=C[1],O={appl_type:{},category:{},subpart_description:{},sponsor:{},product:{}},x=0;x<o.length;x++){o[x].appl_type in O.appl_type?O.appl_type[o[x].appl_type]=O.appl_type[o[x].appl_type]+1:O.appl_type[o[x].appl_type]=1;for(var v=0;v<o[x].categoryArr.length;v++)o[x].categoryArr[v]in O.category?O.category[o[x].categoryArr[v]]=O.category[o[x].categoryArr[v]]+1:O.category[o[x].categoryArr[v]]=1;o[x].subpart_description in O.subpart_description?O.subpart_description[o[x].subpart_description]=O.subpart_description[o[x].subpart_description]+1:O.subpart_description[o[x].subpart_description]=1,o[x].sponsor in O.sponsor?O.sponsor[o[x].sponsor]=O.sponsor[o[x].sponsor]+1:O.sponsor[o[x].sponsor]=1,o[x].product in O.product?O.product[o[x].product]=O.product[o[x].product]+1:O.product[o[x].product]=1}var P=Object(n.useState)(O),I=Object(d.a)(P,2),w=I[0],L=I[1],j=Object(n.useState)(!1),B=Object(d.a)(j,2),U=B[0],k=B[1],M=Object(n.useState)(),F=Object(d.a)(M,2),z=(F[0],F[1]);Object(n.useEffect)((function(){function t(){return(t=Object(s.a)(c.a.mark((function t(){var a,n,r,i,l,s,d,m,u,p,g,h,T,f,A,N;return c.a.wrap((function(t){for(;;)switch(t.prev=t.next){case 0:try{for(a=[],n=0;n<o.length;n++)for(r=0;r<o[n].categoryArr.length;r++)a.push(o[n].categoryArr[r]);for(i=Object(It.a)(new Set(a)),z(i),e.filters&&!U?D(e.filters):D({appl_type:[],category:[],subpart_description:[],sponsor:[],product:[]}),l=Object(Y.a)({},E),s=0;s<o.length;s++){for(l.appl_type.includes(o[s].appl_type)||l.appl_type.push(o[s].appl_type),d=0;d<o[s].categoryArr.length;d++)l.category.includes(o[s].categoryArr[d])||l.category.push(o[s].categoryArr[d]);l.subpart_description.includes(o[s].subpart_description)||l.subpart_description.push(o[s].subpart_description),l.sponsor.includes(o[s].sponsor)||l.sponsor.push(o[s].sponsor),l.product.includes(o[s].product)||l.product.push(o[s].product)}for(m in l)l[m]=l[m].filter((function(e){return void 0!==e}));for(g in b(l),0===(u=Object(Y.a)({},S)).appl_type.length&&(u.appl_type=l.appl_type),0===u.category.length&&(u.category=l.category),0===u.subpart_description.length&&(u.subpart_description=l.subpart_description),0===u.sponsor.length&&(u.sponsor=l.sponsor),0===u.product.length&&(u.product=l.product),p=[],u)u[g]=u[g].filter((function(e){return void 0!==e}));for([],h=0;h<o.length;h++)if(u.appl_type.includes(o[h].appl_type)&&u.subpart_description.includes(o[h].subpart_description)&&u.sponsor.includes(o[h].sponsor)&&u.product.includes(o[h].product)){for(T=[],f=0;f<o[h].categoryArr.length;f++)u.category.includes(o[h].categoryArr[f])&&T.push(o[h]);0!=T.length&&p.push(T[0])}for(e.handleFilterChange(S),e.handleRowsChange(p,S.category),A={appl_type:{},category:{},subpart_description:{},sponsor:{},product:{}},N=0;N<p.length;N++)p[N].appl_type in A.appl_type?A.appl_type[p[N].appl_type]=A.appl_type[p[N].appl_type]+1:A.appl_type[p[N].appl_type]=1,p[N].category in A.category?A.category[p[N].category]=A.category[p[N].category]+1:A.category[p[N].category]=1,p[N].subpart_description in A.subpart_description?A.subpart_description[p[N].subpart_description]=A.subpart_description[p[N].subpart_description]+1:A.subpart_description[p[N].subpart_description]=1,p[N].sponsor in A.sponsor?A.sponsor[p[N].sponsor]=A.sponsor[p[N].sponsor]+1:A.sponsor[p[N].sponsor]=1,p[N].product in A.product?A.product[p[N].product]=A.product[p[N].product]+1:A.product[p[N].product]=1;L(A)}catch(c){console.log(c)}case 1:case"end":return t.stop()}}),t)})))).apply(this,arguments)}!function(){t.apply(this,arguments)}()}),[u]);var V=function(){var e=Object(s.a)(c.a.mark((function e(t,a){var n;return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:"category "===t&&T(a),k(!1),(n=S)[t]=a,D(n),p(!u);case 6:case"end":return e.stop()}}),e)})));return function(t,a){return e.apply(this,arguments)}}(),G=function(){var e=Object(s.a)(c.a.mark((function e(){var t;return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:t={appl_type:[],category:[],subpart_description:[],sponsor:[],product:[]},k(!0),D(t),p(!u);case 4:case"end":return e.stop()}}),e)})));return function(){return e.apply(this,arguments)}}();return r.a.createElement("div",{className:t.root},r.a.createElement(R.a,{display:"flex",justifyContent:"space-between"},r.a.createElement(y.a,{className:t.FilterText},"Filters"),r.a.createElement(_.a,{onClick:G,className:t.ResetButton},"Reset")),r.a.createElement(qc,{title:String(S.appl_type.length)===String(E.appl_type.length)||0===S.appl_type.length?"Application Type ("+String(E.appl_type.length)+")":"Application Type ("+String(S.appl_type.length)+"/"+String(E.appl_type.length)+")",selected:S.appl_type,filterType:"appl_type",handleChange:V,options:E.appl_type,placeholder:"Typer here ...",filterCount:w.appl_type}),r.a.createElement(qc,{title:String(S.category.length)===String(E.category.length)||0===S.category.length?"PMR/PMC Category ("+String(E.category.length)+")":"PMR/PMC Category ("+String(S.category.length)+"/"+String(E.category.length)+")",selected:S.category,filterType:"category",handleChange:V,options:E.category,placeholder:"Typer here ...",filterCount:w.category}),r.a.createElement(qc,{title:String(S.subpart_description.length)===String(E.subpart_description.length)||0===S.subpart_description.length?"Subpart Flag ("+String(E.subpart_description.length)+")":"Subpart Flag ("+String(S.subpart_description.length)+"/"+String(E.subpart_description.length)+")",selected:S.subpart_description,filterType:"subpart_description",handleChange:V,options:E.subpart_description,placeholder:"Typer here ...",filterCount:w.subpart_description}),r.a.createElement(qc,{title:String(S.sponsor.length)===String(E.sponsor.length)||0===S.sponsor.length?"Sponsor ("+String(E.sponsor.length)+")":"Sponsor ("+String(S.sponsor.length)+"/"+String(E.sponsor.length)+")",selected:S.sponsor,filterType:"sponsor",handleChange:V,options:E.sponsor,placeholder:"Typer here ...",filterCount:w.sponsor}),r.a.createElement(qc,{title:String(S.product.length)===String(E.product.length)||0===S.product.length?"Product ("+String(E.product.length)+")":"Product ("+String(S.product.length)+"/"+String(E.product.length)+")",selected:S.product,filterType:"product",handleChange:V,options:E.product,placeholder:"Typer here ...",filterCount:w.product}))}var es=a(1158),ts=a.n(es),as=a(96),ns=Object(f.a)((function(e){return{root:{width:"100%"},FilterText:{color:e.palette.white,fontSize:"1rem",padding:"10px"},FilterSearch:{borderRadius:"10px",width:"100%",height:"100%",minHeight:"40px",fontSize:"2vh",backgroundColor:e.palette.bot.lightBackground,color:e.palette.black},ResetButton:{fontWeight:"400",borderRadius:"10px",textTransform:"none",border:"1px solid ".concat(e.palette.white),backgroundColor:"transparent",color:e.palette.white,fontSize:e.spacing(2),padding:0,marginRight:"10px"},Divider:{backgroundColor:e.palette.white,color:e.palette.white,height:"0.5px"}}})),rs=Object(f.a)((function(e){var t;return{AutoCompleteSearch:{border:"2px solid ".concat(e.palette.bot.filterBackground),borderRadius:"10px",width:"100%",height:"100%",minHeight:"40px",fontSize:"0.8rem",backgroundColor:e.palette.bot.lightBackground,color:e.palette.black,"& .MuiInputBase-input":{color:e.palette.black,fontSize:"0.8rem",opacity:1,"& .MuiAutocomplete-option":{backgroundColor:e.palette.bot.filterBackground,color:e.palette.black,fontSize:"0.8rem",textAlign:"left"}},"& .MuiChip-root":{backgroundColor:e.palette.bot.filterBackground,color:e.palette.black},"& .MuiAutocomplete-option":{backgroundColor:e.palette.bot.filterBackground,color:e.palette.black,fontSize:"0.8rem",textAlign:"left"}},AutoCompleteSearchTextfield:{border:"2px solid ".concat(e.palette.bot.filterBackground),borderRadius:"10px",width:"100%",height:"100%",minHeight:"40px",fontSize:"0.8rem",backgroundColor:e.palette.bot.lightBackground,color:e.palette.black,"& .MuiInputBase-input":{color:e.palette.black,fontSize:"0.8rem",opacity:1,"& .MuiAutocomplete-option":{backgroundColor:e.palette.bot.filterBackground,color:e.palette.black,fontSize:"0.8rem",textAlign:"left"}},"& .MuiChip-root":{backgroundColor:e.palette.bot.filterBackground,color:e.palette.black},"& .MuiAutocomplete-option":{backgroundColor:e.palette.bot.filterBackground,color:e.palette.black,fontSize:"0.8rem",textAlign:"left"}},FilterTitle:{fontSize:"0.8rem",margin:"5px",fontWeight:"500",padding:"10px",paddingRight:"0px",color:e.palette.white,borderRadius:"10px",textAlign:"left"},FilterTitleButton:(t={fontSize:"1.2rem",cursor:"pointer",margin:"5px",marginTop:"15px"},Object(g.a)(t,"marginTop","15px"),Object(g.a)(t,"color",e.palette.white),t),FilterOption:{textAlign:"left",fontSize:"0.6rem",fontWeight:"400",color:e.palette.black},FilterChecked:{padding:0,margin:0,paddingRight:"5px"}}})),is=r.a.createElement(ft.a,{fontSize:"small"}),os=r.a.createElement(Et.a,{fontSize:"small"});function ls(e){Object(n.useEffect)((function(){function e(){return(e=Object(s.a)(c.a.mark((function e(){return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:case"end":return e.stop()}}),e)})))).apply(this,arguments)}!function(){e.apply(this,arguments)}()}),[e]);var t=rs(),a=Object(n.useState)(!1),i=Object(d.a)(a,2),o=i[0],l=i[1];return r.a.createElement("div",{className:t.root},r.a.createElement(R.a,{display:"flex",justifyContent:"space-between",onClick:function(){l(!o)},style:{cursor:"pointer"}},r.a.createElement(y.a,{className:t.FilterTitle,"aria-expanded":o},e.title),r.a.createElement(Ct.a,{className:t.FilterTitleButton})),r.a.createElement(ht.a,{in:o,timeout:"auto",unmountOnExit:!0},r.a.createElement(pt.a,{multiple:!0,defaultValue:e.selected?e.selected:null,onChange:function(t,a){return function(t){1===t.length&&ra.b.info("We are fetching information for you"),e.handleChange(e.filterType,t)}(a)},id:"tags-outlined",options:e.options,disableCloseOnSelect:!0,renderOption:function(a,n){var i=n.selected;return r.a.createElement(r.a.Fragment,null,parseInt(e.filterCount[a])>0?r.a.createElement("div",null,r.a.createElement(R.a,{display:"flex"},r.a.createElement(bt.a,{icon:is,checkedIcon:os,style:{marginRight:8},checked:i,className:t.FilterChecked}),r.a.createElement(y.a,{className:t.FilterOption},a+"  ("+e.filterCount[a]+")"))):r.a.createElement("div",null,r.a.createElement(R.a,{display:"flex"},r.a.createElement(bt.a,{icon:is,checkedIcon:os,style:{marginRight:8},checked:i,className:t.FilterChecked}),r.a.createElement(y.a,{className:t.FilterOption},a))))},className:t.AutoCompleteSearch,renderInput:function(a){return r.a.createElement(D.a,Object.assign({},a,{className:t.AutoCompleteSearchTextField,variant:"outlined",placeholder:e.placeholder}))}})))}Object(f.a)((function(e){var t;return{FilterTitle:{fontSize:"0.8rem",margin:"5px",fontWeight:"500",padding:"10px",paddingRight:"0px",color:e.palette.white,borderRadius:"10px",textAlign:"left"},FilterTitleButton:(t={fontSize:"1.2rem",cursor:"pointer",margin:"5px",marginTop:"15px"},Object(g.a)(t,"marginTop","15px"),Object(g.a)(t,"color",e.palette.white),t),RangeSlider:{paddingTop:"10px",paddingBottom:"10px",width:"80%"}}}));function cs(e){for(var t=ns(),a=Object(n.useState)(e.data),i=Object(d.a)(a,2),o=i[0],l=(i[1],Object(n.useState)(!1)),m=Object(d.a)(l,2),u=m[0],p=m[1],g=Object(n.useState)(),h=Object(d.a)(g,2),T=(h[0],h[1]),f=Object(n.useState)({appl_type:[],status_CMT:[],subpart_approval_description:[],Sponsor:[],product:[]}),A=Object(d.a)(f,2),E=A[0],b=A[1],N=Object(n.useState)(e.filters),C=Object(d.a)(N,2),S=C[0],D=C[1],O={appl_type:{},status_CMT:{},subpart_approval_description:{},Sponsor:{},product:{}},x=0;x<o.length;x++)o[x].appl_type in O.appl_type?O.appl_type[o[x].appl_type]=O.appl_type[o[x].appl_type]+1:O.appl_type[o[x].appl_type]=1,o[x].status_CMT in O.status_CMT?O.status_CMT[o[x].status_CMT]=O.status_CMT[o[x].status_CMT]+1:O.status_CMT[o[x].status_CMT]=1,o[x].subpart_approval_description in O.subpart_approval_description?O.subpart_approval_description[o[x].subpart_approval_description]=O.subpart_approval_description[o[x].subpart_approval_description]+1:O.subpart_approval_description[o[x].subpart_approval_description]=1,o[x].Sponsor in O.Sponsor?O.Sponsor[o[x].Sponsor]=O.Sponsor[o[x].Sponsor]+1:O.Sponsor[o[x].Sponsor]=1,o[x].product in O.product?O.product[o[x].product]=O.product[o[x].product]+1:O.product[o[x].product]=1;var v=Object(n.useState)(O),P=Object(d.a)(v,2),I=P[0],w=P[1],L=Object(n.useState)(!1),j=Object(d.a)(L,2),B=j[0],U=j[1],k=Object(n.useState)(),M=Object(d.a)(k,2);M[0],M[1];Object(n.useEffect)((function(){function t(){return(t=Object(s.a)(c.a.mark((function t(){var a,n,r,i,l,s,d,m,u;return c.a.wrap((function(t){for(;;)switch(t.prev=t.next){case 0:try{for(e.filters&&!B?D(e.filters):D({appl_type:[],status_CMT:[],subpart_approval_description:[],Sponsor:[],product:[]}),a=Object(Y.a)({},E),n=0;n<o.length;n++)a.appl_type.includes(o[n].appl_type)||a.appl_type.push(o[n].appl_type),a.status_CMT.includes(o[n].status_CMT)||a.status_CMT.push(o[n].status_CMT),a.subpart_approval_description.includes(o[n].subpart_approval_description)||a.subpart_approval_description.push(o[n].subpart_approval_description),a.Sponsor.includes(o[n].Sponsor)||a.Sponsor.push(o[n].Sponsor),a.product.includes(o[n].product)||a.product.push(o[n].product);for(r in a)a[r]=a[r].filter((function(e){return void 0!==e}));for(s in b(a),0===(i=Object(Y.a)({},S)).appl_type.length&&(i.appl_type=a.appl_type),0===i.status_CMT.length&&(i.status_CMT=a.status_CMT),0===i.subpart_approval_description.length&&(i.subpart_approval_description=a.subpart_approval_description),0===i.Sponsor.length&&(i.Sponsor=a.Sponsor),0===i.product.length&&(i.product=a.product),l=[],i)i[s]=i[s].filter((function(e){return void 0!==e}));for([],d=0;d<o.length;d++)i.appl_type.includes(o[d].appl_type)&&i.subpart_approval_description.includes(o[d].subpart_approval_description)&&i.Sponsor.includes(o[d].Sponsor)&&i.product.includes(o[d].product)&&i.status_CMT.includes(o[d].status_CMT)&&l.push(o[d]);for(e.handleFilterChange(S),e.handleRowsChange(l,S.status_CMT),m={appl_type:{},status_CMT:{},subpart_approval_description:{},Sponsor:{},product:{}},u=0;u<l.length;u++)l[u].appl_type in m.appl_type?m.appl_type[l[u].appl_type]=m.appl_type[l[u].appl_type]+1:m.appl_type[l[u].appl_type]=1,l[u].status_CMT in m.status_CMT?m.status_CMT[l[u].status_CMT]=m.status_CMT[l[u].status_CMT]+1:m.status_CMT[l[u].status_CMT]=1,l[u].subpart_approval_description in m.subpart_approval_description?m.subpart_approval_description[l[u].subpart_approval_description]=m.subpart_approval_description[l[u].subpart_approval_description]+1:m.subpart_approval_description[l[u].subpart_approval_description]=1,l[u].Sponsor in m.Sponsor?m.Sponsor[l[u].Sponsor]=m.Sponsor[l[u].Sponsor]+1:m.Sponsor[l[u].Sponsor]=1,l[u].PRODUCT in m.product?m.product[l[u].product]=m.product[l[u].product]+1:m.product[l[u].product]=1;w(m)}catch(c){console.log(c)}case 1:case"end":return t.stop()}}),t)})))).apply(this,arguments)}!function(){t.apply(this,arguments)}()}),[u]);var F=function(){var e=Object(s.a)(c.a.mark((function e(t,a){var n;return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:console.log("selected value",t,a),"category "===t&&T(a),U(!1),(n=S)[t]=a,D(n),p(!u);case 7:case"end":return e.stop()}}),e)})));return function(t,a){return e.apply(this,arguments)}}(),z=function(){var e=Object(s.a)(c.a.mark((function e(){var t;return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:t={appl_type:[],status_CMT:[],subpart_approval_description:[],Sponsor:[],product:[]},U(!0),D(t),p(!u);case 4:case"end":return e.stop()}}),e)})));return function(){return e.apply(this,arguments)}}();return r.a.createElement("div",{className:t.root},r.a.createElement(R.a,{display:"flex",justifyContent:"space-between"},r.a.createElement(y.a,{className:t.FilterText},"Filters"),r.a.createElement(_.a,{onClick:z,className:t.ResetButton},"Reset")),r.a.createElement(ls,{title:String(S.appl_type.length)===String(E.appl_type.length)||0===S.appl_type.length?"Application Type ("+String(E.appl_type.length)+")":"Application Type ("+String(S.appl_type.length)+"/"+String(E.appl_type.length)+")",selected:S.appl_type,filterType:"appl_type",handleChange:F,options:E.appl_type,placeholder:"Typer here ...",filterCount:I.appl_type}),r.a.createElement(ls,{title:String(S.status_CMT.length)===String(E.status_CMT.length)||0===S.status_CMT.length?"PMR commitment Status ("+String(E.status_CMT.length)+")":"PMR commitment Status ("+String(S.status_CMT.length)+"/"+String(E.status_CMT.length)+")",selected:S.status_CMT,filterType:"status_CMT",handleChange:F,options:E.status_CMT,placeholder:"Typer here ...",filterCount:I.status_CMT}),r.a.createElement(ls,{title:String(S.subpart_approval_description.length)===String(E.subpart_approval_description.length)||0===S.subpart_approval_description.length?"Subpart Flag ("+String(E.subpart_approval_description.length)+")":"Subpart Flag ("+String(S.subpart_approval_description.length)+"/"+String(E.subpart_approval_description.length)+")",selected:S.subpart_approval_description,filterType:"subpart_approval_description",handleChange:F,options:E.subpart_approval_description,placeholder:"Typer here ...",filterCount:I.subpart_approval_description}),r.a.createElement(ls,{title:String(S.Sponsor.length)===String(E.Sponsor.length)||0===S.Sponsor.length?"Sponsor ("+String(E.Sponsor.length)+")":"Sponsor ("+String(S.Sponsor.length)+"/"+String(E.Sponsor.length)+")",selected:S.Sponsor,filterType:"Sponsor",handleChange:F,options:E.Sponsor,placeholder:"Typer here ...",filterCount:I.Sponsor}),r.a.createElement(ls,{title:String(S.product.length)===String(E.product.length)||0===S.product.length?"Product ("+String(E.product.length)+")":"Product ("+String(S.product.length)+"/"+String(E.product.length)+")",selected:S.product,filterType:"product",handleChange:F,options:E.product,placeholder:"Typer here ...",filterCount:I.product}))}function ss(){var e=ic(),t=Object(n.useContext)(Mt),a=(t.state,t.dispatch),i=Object(n.useState)(),o=Object(d.a)(i,2),l=(o[0],o[1],Object(n.useState)(!0)),m=Object(d.a)(l,2),u=(m[0],m[1],Object(n.useState)()),p=Object(d.a)(u,2),g=(p[0],p[1],Object(n.useState)(!1)),h=Object(d.a)(g,2),T=(h[0],h[1]),f=Object(n.useState)({appl_type:[],category:[],subpart_description:[],sponsor:[],product:[]}),A=Object(d.a)(f,2),E=A[0],b=A[1],N=Object(n.useState)({appl_type:[],status_CMT:[],subpart_approval_description:[],Sponsor:[],product:[]}),S=Object(d.a)(N,2),D=S[0],_=S[1],O=Object(n.useState)(!1),x=Object(d.a)(O,2),v=x[0],P=x[1],I=Object(n.useState)(!0),w=Object(d.a)(I,2),L=w[0],j=w[1],U=Object(n.useState)(0),k=Object(d.a)(U,2),M=k[0],F=k[1],z=Object(n.useState)([{element:"#pmrInsights",intro:"PMR Insights provides summary of PMR by application type, PMR/C status, Subpart Status and relevant sample size from clinicaltrials.gov",position:"bottom",tooltipClass:"myTooltipClass",highlightClass:"myHighlightClass"},{element:"#pmrOverall",intro:"PMR Overall results provides a tabular view of PMR/C and clinical trial  details",position:"top",tooltipClass:"myTooltipClass",highlightClass:"myHighlightClass"}]),Y=Object(d.a)(z,2),V=Y[0],G=(Y[1],Object(n.useState)(!1)),H=Object(d.a)(G,2),W=H[0],Q=H[1],J=Object(n.useState)(),K=Object(d.a)(J,2),Z=K[0],X=K[1],q=Object(n.useState)(),$=Object(d.a)(q,2),ee=$[0],te=$[1],ae=Object(n.useState)(),ne=Object(d.a)(ae,2),re=ne[0],ie=ne[1],oe=Object(n.useState)(),le=Object(d.a)(oe,2),ce=le[0],se=le[1],de=Object(n.useState)(),me=Object(d.a)(de,2),ue=me[0],pe=me[1],ge=Object(n.useState)([]),he=Object(d.a)(ge,2),Te=he[0],fe=he[1],Ae=Object(n.useState)(),Ee=Object(d.a)(Ae,2),be=Ee[0],Ne=Ee[1],Ce=Object(n.useState)(),ye=Object(d.a)(Ce,2),De=ye[0],_e=ye[1];Object(n.useEffect)((function(){function e(){return(e=Object(s.a)(c.a.mark((function e(){var t,n,r,i,o,l,s,d,m,u,p,g,h,T,f,A,E,b,N,C,S,y,D,_,O,x,v,R,P,I,w,L,B,U,k,M,F,z,Y,V;return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:return e.prev=0,j(!0),t=(t=(t=window.location.pathname).split("/"))[t.length-1],e.next=7,a({type:wt.SET_MODULE,value:"pmr"});case 7:if(Ne(t),"impact"!==t){e.next=29;break}return e.next=11,Se(t);case 11:for(n=e.sent,r=n.data,console.log("updated data",r),[],[],l=[],i=r.Success.stats.issue_year,o=r.Success.stats.fulfillment_year,l=r.Success.stats.category_graph,s=0;s<l.length;s++)l.sort((function(e,t){return parseFloat(e.days)-parseFloat(t.days)}));for(d=r.Success.pmr_impact_table,m=[],u=0;u<d.length;u++)m=d[u].category.split(","),d[u].categoryArr=m,d[u].product="".concat(d[u].trade_name," (").concat(d[u].active_ingredient,")");te(d),ie(d),X({issueGraph:i,fulfillGraph:o,issueToFulfill:l}),e.next=32;break;case 29:if(se(as),pe(as),as!==[]){p=as.length,g=[],h=[],A={},E=[],b=Object($n.a)(as);try{for(b.s();!(N=b.n()).done;)"yes"===(C=N.value.issued_in_last_two_months)&&(A[C]={issued_in_last_two_months:C,y:A[C]?A[C].y+1:1})}catch(c){b.e(c)}finally{b.f()}(E=Object.values(A)).length>0&&(T=E[0].y),A={},S=Object($n.a)(as);try{for(S.s();!(y=S.n()).done;)"yes"===(D=y.value.expected_completion_in_twelve_months)&&(A[D]={expected_completion_in_twelve_months:D,y:A[D]?A[D].y+1:1})}catch(c){S.e(c)}finally{S.f()}for(E=[],(E=Object.values(A)).length>0&&(f=E[0].y),_=0;_<as.length;_++)void 0===h[as[_].subpart_approval_description]?h[as[_].subpart_approval_description]=1:h[as[_].subpart_approval_description]+=1,void 0===g[as[_].status_CMT]?g[as[_].status_CMT]=1:g[as[_].status_CMT]+=1;for(O=[],x=[],v=0;v<as.length;v++)for(R=0;R<as[v].category.length;R++)x.push(as[v].category[R]);for(Object(It.a)(new Set(x)),P=[],I=0;I<as.length;I++)if(1===as[I].category.length)w={x:as[I].category,number:as[I].category?as[I].category.y+1:1},P.push(w);else if(as[I].category.length>1)for(L=0;L<as[I].category.length;L++)B={x:as[I].category[L]},P.push(B);for(A={},U=[],k=0,M=P;k<M.length;k++)F=M[k].x,A[F]={x:F,number:A[F]?A[F].number+1:1};for(U.push(A),O=Object.keys(A).map((function(e){return A[e]})),z=0;z<O.length;z++)for(Y=Object.keys(O[0]),V=0;V<Y.length;V++)O.sort((function(e,t){return parseFloat(e.number)-parseFloat(t.number)})),"number"===typeof O[z][Y[V]]&&(O[z][Y[V]]=""+O[z][Y[V]]);_e({total:p,issue:T,completion:f,status:g,subpart:h,categories:O})}case 32:j(!1),e.next=38;break;case 35:e.prev=35,e.t0=e.catch(0),console.log(e.t0);case 38:case"end":return e.stop()}}),e,null,[[0,35]])})))).apply(this,arguments)}!function(){e.apply(this,arguments)}()}),[window.location.pathname]);var Oe=function(){var e=Object(s.a)(c.a.mark((function e(t){return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:fe(t);case 1:case"end":return e.stop()}}),e)})));return function(t){return e.apply(this,arguments)}}(),xe=function(){var e=Object(s.a)(c.a.mark((function e(t,a){var n,r,i,o,l,s,d,m,u,p,g,h,T,f,A,E,b,N,C,S,y,D,_,O,x,v,R,P,I,w,L,j,B,U,k,M,F,z,Y,V,G,H,W,Q,J,K,Z,q,$,ee,ae,ne,re,ie,oe,le,ce,de,me,ue,pe,ge,he,Te,Ae,Ee,Ne,Ce,Se,ye,De,Oe,xe,ve,Re,Pe,Ie,we,Le,je;return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:if(fe(a),"impact"===be){if(te(t),n=[],r=[],t!==[]){i={},o=Object($n.a)(t);try{for(o.s();!(l=o.n()).done;)s=l.value.issued_year,i[s]={issued_year:s,y:i[s]?i[s].y+1:1}}catch(c){o.e(c)}finally{o.f()}for(d=Object.values(i),m=0;m<d.length;m++)n.push({y:d[m].y,x:d[m].issued_year});i={},u=Object($n.a)(t);try{for(u.s();!(p=u.n()).done;)g=p.value.fulfilled_year,i[g]={fulfilled_year:g,y:i[g]?i[g].y+1:1}}catch(c){u.e(c)}finally{u.f()}for(d=Object.values(i),h=0;h<d.length;h++)r.push({y:d[h].y,x:d[h].fulfilled_year});for(T=[],f=0;f<t.length;f++)for(A=0;A<t[f].categoryArr.length;A++)T.push(t[f].categoryArr[A]);for(Object(It.a)(new Set(T)),E=[],b=0;b<t.length;b++)for(N=0;N<t[b].categoryArr.length;N++)C={x:t[b].categoryArr[N],days:t[b].time_to_fulfillment},E.push(C);for(i={},S=[],y=0,D=E;y<D.length;y++)_=D[y],O=_.x,_.days,i[O]={x:O,number:i[O]?i[O].number+1:1};for(S.push(i),x=Object.keys(i).map((function(e){return i[e]})),v=0,R=0,P=0,I=0,w=0,L=0,j=0,B=0,U=0,k=0,M=0,F=0,z=0,Y=0,V=0,G=0,H=0,W=0,Q=0,J=0,[],K=0;K<E.length;K++)"Efficacy"===E[K].x?v=parseInt(E[K].days)+v:"Immunogenicity"===E[K].x?R=parseInt(E[K].days)+R:"Pediatric"===E[K].x?P=parseInt(E[K].days)+P:"Safety"===E[K].x?I=parseInt(E[K].days)+I:"Preclinical"===E[K].x?w=parseInt(E[K].days)+w:"Renal Impairment"===E[K].x?L=parseInt(E[K].days)+L:"Lactation"===E[K].x?j=parseInt(E[K].days)+j:"Observational"===E[K].x?B=parseInt(E[K].days)+B:"Miscellaneous"===E[K].x?U=parseInt(E[K].days)+U:"Other"===E[K].x?k=parseInt(E[K].days)+k:"BA"===E[K].x?M=parseInt(E[K].days)+M:"DDI"===E[K].x?F=parseInt(E[K].days)+F:"Dosing"===E[K].x?z=parseInt(E[K].days)+z:"BE"===E[K].x?Y=parseInt(E[K].days)+Y:"Food effect"===E[K].x?V=parseInt(E[K].days)+V:"Hepatic Impairment"===E[K].x?G=parseInt(E[K].days)+G:"Pharmacogenetics"===E[K].x?H=parseInt(E[K].days)+H:"Mass balance"===E[K].x?W=parseInt(E[K].days)+W:"Pregnancy"===E[K].x?Q=parseInt(E[K].days)+Q:"QTc"===E[K].x&&(J=parseInt(E[K].days)+J);for(Z=0;Z<x.length;Z++)"Efficacy"===x[Z].x?(v/=parseInt(x[Z].number).toFixed(1),x[Z].days=v):"Immunogenicity"===x[Z].x?(R/=parseInt(x[Z].number).toFixed(1),x[Z].days=R):"Pediatric"===x[Z].x?(P/=parseInt(x[Z].number).toFixed(1),x[Z].days=P):"Safety"===x[Z].x?(I/=parseInt(x[Z].number).toFixed(1),x[Z].days=I):"Preclinical"===x[Z].x?(w/=parseInt(x[Z].number).toFixed(1),x[Z].days=w):"Renal Impairment"===x[Z].x?(L/=parseInt(x[Z].number).toFixed(1),x[Z].days=L):"Miscellaneous"===x[Z].x?(U/=parseInt(x[Z].number).toFixed(1),x[Z].days=U):"Observational"===x[Z].x?(B/=parseInt(x[Z].number).toFixed(1),x[Z].days=B):"Lactation"===x[Z].x?(j/=parseInt(x[Z].number).toFixed(1),x[Z].days=j):"Other"===x[Z].x?(k/=parseInt(x[Z].number).toFixed(1),x[Z].days=k):"BA"===x[Z].x?(M/=parseInt(x[Z].number).toFixed(1),x[Z].days=M):"DDI"===x[Z].x?(F/=parseInt(x[Z].number).toFixed(1),x[Z].days=F):"Dosing"===x[Z].x?(z/=parseInt(x[Z].number).toFixed(1),x[Z].days=z):"BE"===x[Z].x?(Y/=parseInt(x[Z].number).toFixed(1),x[Z].days=Y):"Food effect"===x[Z].x?(V/=parseInt(x[Z].number).toFixed(1),x[Z].days=V):"Hepatic Impairment"===x[Z].x?(G/=parseInt(x[Z].number).toFixed(1),x[Z].days=G):"Pharmacogenetics"===x[Z].x?(H/=parseInt(x[Z].number).toFixed(1),x[Z].days=H):"Mass balance"===x[Z].x?(W/=parseInt(x[Z].number).toFixed(1),x[Z].days=W):"Pregnancy"===x[Z].x?(Q/=parseInt(x[Z].number).toFixed(1),x[Z].days=Q):"QTc"===x[Z].x&&(J/=parseInt(x[Z].number).toFixed(1),x[Z].days=J);for(q=0;q<x.length;q++)x[q].days=parseInt(x[q].days);for($=0;$<x.length;$++)for(ee=Object.keys(x[0]),ae=0;ae<ee.length;ae++)x.sort((function(e,t){return parseFloat(e.days)-parseFloat(t.days)})),"number"===typeof x[$][ee[ae]]&&(x[$][ee[ae]]=""+x[$][ee[ae]])}console.log("myData",x),X({issueGraph:n,fulfillGraph:r,issueToFulfill:x})}else if(se(t),console.log("category",a),t!==[]){ne=t.length,ie=[],oe=[],i={},ce=[],de=Object($n.a)(t);try{for(de.s();!(me=de.n()).done;)"yes"===(ue=me.value.issued_in_last_two_months)&&(i[ue]={issued_in_last_two_months:ue,y:i[ue]?i[ue].y+1:1})}catch(c){de.e(c)}finally{de.f()}(ce=Object.values(i)).length>0&&(re=ce[0].y),i={},pe=Object($n.a)(t);try{for(pe.s();!(ge=pe.n()).done;)"yes"===(he=ge.value.expected_completion_in_twelve_months)&&(i[he]={expected_completion_in_twelve_months:he,y:i[he]?i[he].y+1:1})}catch(c){pe.e(c)}finally{pe.f()}for(ce=[],(ce=Object.values(i)).length>0&&(le=ce[0].y),Te=0;Te<t.length;Te++)void 0===oe[t[Te].subpart_approval_description]?oe[t[Te].subpart_approval_description]=1:oe[t[Te].subpart_approval_description]+=1,void 0===ie[t[Te].status_CMT]?ie[t[Te].status_CMT]=1:ie[t[Te].status_CMT]+=1;for(Ae=[],Ee=[],Ne=0;Ne<t.length;Ne++)for(Ce=0;Ce<t[Ne].category.length;Ce++)Ee.push(t[Ne].category[Ce]);for(Object(It.a)(new Set(Ee)),Se=[],ye=0;ye<t.length;ye++)if(1===t[ye].category.length)De={x:t[ye].category,number:t[ye].category?t[ye].category.y+1:1},Se.push(De);else if(t[ye].category.length>1)for(Oe=0;Oe<t[ye].category.length;Oe++)xe={x:t[ye].category[Oe]},Se.push(xe);for(i={},ve=[],Re=0,Pe=Se;Re<Pe.length;Re++)Ie=Pe[Re].x,i[Ie]={x:Ie,number:i[Ie]?i[Ie].number+1:1};for(ve.push(i),Ae=Object.keys(i).map((function(e){return i[e]})),we=0;we<Ae.length;we++)for(Le=Object.keys(Ae[0]),je=0;je<Le.length;je++)Ae.sort((function(e,t){return parseFloat(e.number)-parseFloat(t.number)})),"number"===typeof Ae[we][Le[je]]&&(Ae[we][Le[je]]=""+Ae[we][Le[je]]);_e({total:ne,issue:re,completion:le,status:ie,subpart:oe,categories:Ae})}case 2:case"end":return e.stop()}}),e)})));return function(t,a){return e.apply(this,arguments)}}();return L?r.a.createElement(tr.SemipolarLoading,{color:"#0352CC"}):r.a.createElement("div",{className:e.main},r.a.createElement(Ft.Steps,{enabled:W,steps:V,showProgress:!0,scrollToElement:!0,initialStep:0,onBeforeChange:function(e){1===e&&T(!0),1===e&&F(2)},onExit:function(){Q(!1)}}),r.a.createElement(Zl.a,{anchor:"right",open:v,onClose:function(){return P(!1)},onOpen:function(){return P(!0)}},r.a.createElement("div",{className:e.filterSidebar},r.a.createElement("div",{className:e.innerDiv},r.a.createElement("div",{className:e.filterIconHead},r.a.createElement(Zi.a,{onClick:function(){return P(!1)},className:e.arrowForward})),"impact"===be?r.a.createElement($c,{data:re,filters:E,handleFilterChange:function(e){b(e)},handleRowsChange:xe,setselectedCategory:Oe}):r.a.createElement(cs,{data:ue,filters:D,handleFilterChange:function(e){_(e)},handleRowsChange:xe,setselectedCategory:Oe})))),r.a.createElement(C.a,{xs:12,container:!0,style:{borderBottom:"0.7px solid #C7C7C7"}},r.a.createElement(C.a,{item:!0,style:{width:"30px"}}),r.a.createElement(C.a,{xs:4,item:!0,style:{marginBottom:"-1px"}},r.a.createElement(Yo.a,{className:e.CardTabs,value:M,onChange:function(e,t){F(t)},indicatorColor:"white",variant:"fullWidth","aria-label":"full width tabs example",boxShadow:3},r.a.createElement(Vo.a,{id:"timelineView",className:e.CardTabs,label:r.a.createElement("div",{style:{display:"inline-flex"}}," ","Insights"," ")}),r.a.createElement(Vo.a,{id:"timelineView",className:e.CardTabs,label:r.a.createElement("div",{style:{display:"inline-flex"}}," ","PMR/PMC Details"," ")}))),r.a.createElement(C.a,{xs:6}),r.a.createElement(C.a,{style:{width:"4%"}}),r.a.createElement(C.a,{xs:1,style:{margin:"5px"}},r.a.createElement(R.a,{id:"pmrFilters",display:"flex",flexDirection:"row",alignItems:"end",onClick:function(){return P(!0)},style:{margin:"8px"}},r.a.createElement("img",{style:{width:"15px"},src:ts.a}),r.a.createElement(y.a,{className:e.headings},"Filters")))),r.a.createElement(C.a,{container:!0,item:!0,xs:12,className:"swipe360"},r.a.createElement(Ho.a,{className:e.common360SwipableView,index:M,onChangeIndex:function(e){F(e)}},r.a.createElement("div",{role:"tabpanel",hidden:0!==M,id:"full-width-tabpanel-0}","aria-labelledby":"full-width-tab-0"},0===M&&r.a.createElement("div",{className:e.TimelineGridBox},"impact"===be&&Z?r.a.createElement(Yr,{graphData:Z,path:be}):De?r.a.createElement(Yr,{graphDataSur:De,path:be}):null)),r.a.createElement("div",{role:"tabpanel",hidden:1!==M,id:"full-width-tabpanel-0}","aria-labelledby":"full-width-tab-0"},1===M&&r.a.createElement("div",{className:e.TimelineGridBox},"impact"===be?r.a.createElement(Yc,{data:ee,setGraphState:X,ColNames:Qc.ColNames4,path:be,category:Te}):r.a.createElement(Wc,{data:ce,setGraphState:_e,ColNames:Qc.ColNames3,path:be,category:Te}))))),r.a.createElement(B.a,{"aria-label":"add",className:e.airplaneIcon,onClick:function(){Q(!0)}},r.a.createElement(zt,null)))}var ds=Object(f.a)((function(e){var t,a,n,r,i;return i={root:{marginTop:e.spacing(8),marginLeft:e.spacing(9)+1,width:"calc(100% - ".concat(e.spacing(9)+1,"px)")},headerClass:{backgroundColor:"blue"},GridHeaderBreadcrumbs:{height:"8vh",backgroundColor:e.palette.white,margin:0,border:"8px solid ".concat(e.palette.primary.lightBackground)},TableMat:{overflowX:"auto"},Dialog:{minHeight:"70vh"},CardsDialogActions:{width:"100%",justifyContent:"center"},botIconFAB:{margin:0,top:"auto",left:20,bottom:20,zIndex:e.zIndex.drawer+2,height:"8vh",width:"8vh",backgroundColor:e.palette.white,right:"auto",position:"fixed"},botIcon:{height:"100%",width:"100%"},TableHeadRow:{backgroundColor:e.palette.primary.lightBorder},botIntroPopup:{fontWeight:"900",fontSize:"2vh",padding:"4px",borderRadius:"10px",color:e.palette.primary.main,backgroundColor:e.palette.primary.lightBackground},botTextPopup:{fontSize:"1.5vh",padding:"4px",color:e.palette.white,opacity:1},TableBodyRows:{"&:nth-of-type(odd)":{padding:"0",backgroundColor:e.palette.primary.lightBackground},"&:nth-of-type(even)":{padding:"0",backgroundColor:e.palette.white}},TableHeadCells:{boxShadow:"none",border:"none",fontWeight:"700",padding:"10px",lineHeight:"1.5"},TableCellTypography:{fontSize:"1.5vh"},Textfield:{marginBottom:e.spacing(2),border:"none",marginLeft:e.spacing(1),borderRadius:"15px",minWidth:e.spacing(45),height:"100%",minHeight:"50px",fontSize:"1.8vh",background:e.palette.navbar.grayBackground,color:e.palette.black,paddingLeft:"10px"}},Object(g.a)(i,"Textfield",{marginBottom:e.spacing(2),border:"none",marginLeft:e.spacing(1),borderRadius:"15px",minWidth:e.spacing(45),height:"100%",minHeight:"50px",fontSize:"1.8vh",background:e.palette.navbar.grayBackground,color:e.palette.black,paddingLeft:"10px"}),Object(g.a)(i,"Button",{fontSize:"0.8rem",textTransform:"none",fontWeight:"400",minHeight:"50px",padding:"10px",background:e.palette.navbar.grayBackground,borderRadius:"10px",borderBottomLeftRadius:"0px",borderTopLeftRadius:"0px",marginBottom:e.spacing(2)}),Object(g.a)(i,"ResetButton",(t={fontSize:"0.8rem",borderRadius:"10px",maxHeight:"50px",minHeight:"50px",fontWeight:"400",textTransform:"none",backgroundColor:e.palette.primary.lightBorder,color:e.palette.black},Object(g.a)(t,"fontSize",e.spacing(2)),Object(g.a)(t,"padding",0),Object(g.a)(t,"marginLeft","20px"),t)),Object(g.a)(i,"ErrorTypography",(a={fontWeight:"700",fontSize:"0.8rem",padding:"20px",marginLeft:"20px"},Object(g.a)(a,"fontSize","0.8rem"),Object(g.a)(a,"maxHeight","50px"),Object(g.a)(a,"minHeight","50px"),Object(g.a)(a,"color",e.palette.fatalRed),a)),Object(g.a)(i,"TableBodyCells",{boxShadow:"none",border:"none",padding:"9px"}),Object(g.a)(i,"Tableroot",{width:"100%",margin:"10px",overflowX:"scroll"}),Object(g.a)(i,"boxmat",{padding:"15px 10px",paddingBottom:"unset"}),Object(g.a)(i,".MuiTableCell-root",{padding:"5px !important",fontSize:"1.5vh !important"}),Object(g.a)(i,"Form",{width:"100%"}),Object(g.a)(i,"Button",{fontSize:"0.8rem",textTransform:"none",fontWeight:"400",minHeight:"50px",padding:"10px",background:e.palette.navbar.grayBackground,borderRadius:"10px",borderBottomLeftRadius:"0px",borderTopLeftRadius:"0px",marginBottom:e.spacing(2)}),Object(g.a)(i,"ResetButton",(n={fontSize:"0.8rem",borderRadius:"10px",maxHeight:"50px",minHeight:"50px",fontWeight:"400",textTransform:"none",backgroundColor:e.palette.primary.lightBorder,color:e.palette.black},Object(g.a)(n,"fontSize",e.spacing(2)),Object(g.a)(n,"padding",0),Object(g.a)(n,"marginLeft","20px"),n)),Object(g.a)(i,"ErrorTypography",(r={fontWeight:"700",fontSize:"0.8rem",padding:"20px",marginLeft:"20px"},Object(g.a)(r,"fontSize","0.8rem"),Object(g.a)(r,"maxHeight","50px"),Object(g.a)(r,"minHeight","50px"),Object(g.a)(r,"color",e.palette.fatalRed),r)),Object(g.a)(i,"TableBodyCellBox",{height:"50px",minWidth:"100px",overflowY:"auto",boxShadow:"none",border:"none"}),Object(g.a)(i,"TableBodyCellBoxBig",{height:"70px",minWidth:"300px",overflowY:"auto",boxShadow:"none",border:"none"}),Object(g.a)(i,"TableCellTypography",{fontSize:"0.7rem"}),i})),ms=a(1159),us=a.n(ms),ps=a(782),gs=a.n(ps),hs=a(792),Ts=a.n(hs),fs=a(783),As=a.n(fs),Es=a(790),bs=a.n(Es),Ns=a(632),Cs=a.n(Ns),Ss=a(631),ys=a.n(Ss),Ds=a(784),_s=a.n(Ds),Os=a(785),xs=a.n(Os),vs=a(787),Rs=a.n(vs),Ps=a(788),Is=a.n(Ps),ws=a(789),Ls=a.n(ws),js=a(786),Bs=a.n(js),Us=a(791),ks=a.n(Us),Ms=a(793),Fs=a.n(Ms),zs=(Object(n.forwardRef)((function(e,t){return r.a.createElement(gs.a,Object.assign({},e,{ref:t}))})),Object(n.forwardRef)((function(e,t){return r.a.createElement(As.a,Object.assign({},e,{ref:t}))})),Object(n.forwardRef)((function(e,t){return r.a.createElement(ys.a,Object.assign({},e,{ref:t}))})),Object(n.forwardRef)((function(e,t){return r.a.createElement(_s.a,Object.assign({},e,{ref:t}))})),Object(n.forwardRef)((function(e,t){return r.a.createElement(Cs.a,Object.assign({},e,{ref:t}))})),Object(n.forwardRef)((function(e,t){return r.a.createElement(xs.a,Object.assign({},e,{ref:t}))})),Object(n.forwardRef)((function(e,t){return r.a.createElement(Bs.a,Object.assign({},e,{ref:t}))})),Object(n.forwardRef)((function(e,t){return r.a.createElement(Rs.a,Object.assign({},e,{ref:t}))})),Object(n.forwardRef)((function(e,t){return r.a.createElement(Is.a,Object.assign({},e,{ref:t}))})),Object(n.forwardRef)((function(e,t){return r.a.createElement(Ls.a,Object.assign({},e,{ref:t}))})),Object(n.forwardRef)((function(e,t){return r.a.createElement(Cs.a,Object.assign({},e,{ref:t}))})),Object(n.forwardRef)((function(e,t){return r.a.createElement(bs.a,Object.assign({},e,{ref:t}))})),Object(n.forwardRef)((function(e,t){return r.a.createElement(ys.a,Object.assign({},e,{ref:t}))})),Object(n.forwardRef)((function(e,t){return r.a.createElement(ks.a,Object.assign({},e,{ref:t}))})),Object(n.forwardRef)((function(e,t){return r.a.createElement(Ts.a,Object.assign({},e,{ref:t}))})),Object(n.forwardRef)((function(e,t){return r.a.createElement(Kr.a,Object.assign({},e,{ref:t}))})),Object(n.forwardRef)((function(e,t){return r.a.createElement(Fs.a,Object.assign({},e,{ref:t}))})),Object(P.a)((function(e){return{tooltip:{marginTop:"-9vh",marginLeft:"-1vh",width:"fit-content",padding:"10px",paddingLeft:"20px",paddingRight:"20px",borderRadius:"10px",color:e.palette.white,border:"2px solid ".concat(e.palette.primary.lightBorder)}}}))(L.a));var Ys=function(e){var t=Object(n.useState)(1),a=Object(d.a)(t,2),i=a[0],o=(a[1],Object(n.useState)(!1)),l=Object(d.a)(o,2),m=l[0],u=l[1],p=Object(n.useState)([]),g=Object(d.a)(p,2),h=(g[0],g[1]),T=Object(n.useState)(!0),f=Object(d.a)(T,2),A=f[0],E=f[1],b=Object(n.useState)(),S=Object(d.a)(b,2),D=(S[0],S[1]),O=Object(n.useState)(),x=Object(d.a)(O,2),v=(x[0],x[1]),P=Object(n.useState)(!0),I=Object(d.a)(P,2),w=I[0],F=I[1],z=Object(n.useState)(),Y=Object(d.a)(z,2),G=Y[0],H=Y[1],W=Object(n.useState)(),Q=Object(d.a)(W,2),J=Q[0],Z=Q[1],X=Object(n.useState)(1),q=Object(d.a)(X,2),$=q[0],ee=q[1],te=Object(n.useState)(),ae=Object(d.a)(te,2),ne=ae[0],re=ae[1],ie=Object(n.useState)(!0),oe=Object(d.a)(ie,2),le=(oe[0],oe[1],Object(n.useState)(!0)),ce=Object(d.a)(le,2),se=ce[0],de=ce[1],me=Object(n.useState)("activeIngredientsSalt"),ue=Object(d.a)(me,2),pe=ue[0],ge=ue[1],he=Object(n.useState)("Active Ingredients Salt"),Te=Object(d.a)(he,2),fe=Te[0],Ae=Te[1],be=Object(n.useState)(),Ne=Object(d.a)(be,2),Ce=Ne[0],Se=Ne[1],ye=Object(n.useState)([]),De=Object(d.a)(ye,2),_e=De[0],Oe=De[1],xe=Object(n.useState)([]),ve=Object(d.a)(xe,2),Re=(ve[0],ve[1]),Pe=Object(n.useState)(),Ie=Object(d.a)(Pe,2),we=Ie[0],Le=Ie[1],je=Object(n.useState)(["Active Ingredients Salt","Anda","Formulation","Trade Name","First Filing Date","First Approval Date","Approval Pathway","Strength","Marketing Status","Review Priority","Rld","Route","Rs","Sponsor Name","TE Code"]),Be=Object(d.a)(je,2),Ue=Be[0],ke=(Be[1],ds()),Me=[{field:"activeIngredientsSalt",title:"Active Ingredients Salt",headerStyle:{backgroundColor:"#e3f1ff",color:"#000000",padding:"7px",fontSize:"2vh",fontWeight:"800"},cellStyle:{padding:"7px",fontSize:"1.5vh",fontWeight:"700"}},{field:"anda",title:"Anda",headerStyle:{backgroundColor:"#e3f1ff",color:"#000000",padding:"7px",fontSize:"2vh",fontWeight:"800"},cellStyle:{padding:"7px",fontSize:"1.5vh",fontWeight:"700"}},{field:"formulation",title:"Formulation",headerStyle:{backgroundColor:"#e3f1ff",color:"#000000",padding:"7px",fontSize:"2vh",fontWeight:"800"},cellStyle:{padding:"7px",fontSize:"1.5vh",fontWeight:"700"}},{field:"tradeName",title:"Trade Name",headerStyle:{backgroundColor:"#e3f1ff",color:"#000000",padding:"7px",fontSize:"2vh",fontWeight:"800"},cellStyle:{padding:"7px",fontSize:"1.5vh",fontWeight:"700"}},{field:"Strength",title:"Strength",headerStyle:{backgroundColor:"#e3f1ff",color:"#000000",padding:"7px",fontSize:"2vh",fontWeight:"800"},cellStyle:{padding:"7px",fontSize:"1.5vh",fontWeight:"700"}},{field:"approvalPathway",title:"Approval Pathway",headerStyle:{backgroundColor:"#e3f1ff",color:"#000000",padding:"7px",fontSize:"2vh",fontWeight:"800"},cellStyle:{padding:"7px",fontSize:"1.5vh",fontWeight:"700"}},{field:"firstApprovalDate",title:"First Approval Date",headerStyle:{backgroundColor:"#e3f1ff",color:"#000000",padding:"7px",fontSize:"2vh",fontWeight:"800"},cellStyle:{padding:"7px",fontSize:"1.5vh",fontWeight:"700"}},{field:"firstFilingDate",title:"First Filing Date",type:"datetime",headerStyle:{backgroundColor:"#e3f1ff",color:"#000000",padding:"7px",fontSize:"2vh",fontWeight:"800"},cellStyle:{padding:"7px",fontSize:"1.5vh",fontWeight:"700"}},{field:"marketingStatus",title:"Marketing Status",headerStyle:{backgroundColor:"#e3f1ff",color:"#000000",padding:"7px",fontSize:"2vh",fontWeight:"800"},cellStyle:{padding:"7px",fontSize:"1.5vh",fontWeight:"700"}},{field:"reviewPriority",title:"Review Priority",headerStyle:{backgroundColor:"#e3f1ff",color:"#000000",padding:"7px",fontSize:"2vh",fontWeight:"800"},cellStyle:{padding:"7px",fontSize:"1.5vh",fontWeight:"700"}},{field:"rld",title:"Rld",headerStyle:{backgroundColor:"#e3f1ff",color:"#000000",padding:"7px",fontSize:"2vh",fontWeight:"800"},cellStyle:{padding:"7px",fontSize:"1.5vh",fontWeight:"700"}},{field:"route",title:"Route",headerStyle:{backgroundColor:"#e3f1ff",color:"#000000",padding:"7px",fontSize:"2vh",fontWeight:"800"},cellStyle:{padding:"7px",fontSize:"1.5vh",fontWeight:"700"}},{field:"rs",title:"Rs",headerStyle:{backgroundColor:"#e3f1ff",color:"#000000",padding:"7px",fontSize:"2vh",fontWeight:"800"},cellStyle:{padding:"7px",fontSize:"1.5vh",fontWeight:"700"}},{field:"sponsorName",title:"Sponsor Name",headerStyle:{backgroundColor:"#e3f1ff",color:"#000000",padding:"7px",fontSize:"2vh",fontWeight:"800"},cellStyle:{padding:"7px",fontSize:"1.5vh",fontWeight:"700"}},{field:"teCode",title:"TE Code",headerStyle:{backgroundColor:"#e3f1ff",color:"#000000",padding:"7px",fontSize:"2vh",fontWeight:"800"},cellStyle:{padding:"7px",fontSize:"1.5vh",fontWeight:"700"}}];Object(n.useEffect)((function(){E(!0),v(e.match.params.type+e.match.params.number),D(e.match.params.number),console.log("The generic props are"+e.match.params.type+e.match.params.number),Fe(e.match.params.type+e.match.params.number),setTimeout((function(){F(!1)}),3e3)}),[i,e.match.params.number,e.match.params.type,$,se]);var Fe=function(){var e=Object(s.a)(c.a.mark((function e(t){return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:Ee(t).then((function(e){console.log(e.data),e.data.Success.dataListing.forEach((function(e){if(""!==e.firstApprovalDate){var t=new Date(e.firstApprovalDate);e.firstApprovalDate=t.toUTCString()}if(""!==e.firstFilingDate){var a=new Date(e.firstFilingDate);e.firstFilingDate=a.toUTCString()}if(""!==e.exclusivity_date){for(var n=["Jan","Feb","Mar","Apr","May","Jun","Jul","Aug","Sep","Oct","Nov","Dec"],r="",i=e.exclusivity_date.split(","),o=0;o<i.length;o++)if(" "!==i[o]&&""!==i[o]&&" ''"!==i[o]&&"''"!==i[o]){var l=parseInt(i[o]),c=new Date(l);r+="".concat(n[c.getUTCMonth()]," ").concat(c.getUTCDate(),", ").concat(c.getUTCFullYear(),"; ")}return e.exclusivity_date=r,e.exclusivity_date}if(""!==e.patent_expire_date){for(var s=["Jan","Feb","Mar","Apr","May","Jun","Jul","Aug","Sep","Oct","Nov","Dec"],d="",m=e.patent_expire_date.split(","),u=0;u<m.length;u++)if(" "!==m[u]&&""!==m[u]&&" ''"!==m[u]&&"''"!==m[u]){var p=parseInt(m[u]),g=new Date(p);d+="".concat(s[g.getUTCMonth()]," ").concat(g.getUTCDate(),", ").concat(g.getUTCFullYear(),"; ")}return e.patent_expire_date=d,e.patent_expire_date}if(""!==e.submission_date){for(var h=["Jan","Feb","Mar","Apr","May","Jun","Jul","Aug","Sep","Oct","Nov","Dec"],T="",f=e.submission_date.split(","),A=0;A<f.length;A++)if(" "!==f[A]&&""!==f[A]&&" ''"!==f[A]&&"''"!==f[A]){var E=parseInt(f[A]),b=new Date(E);T+="".concat(h[b.getUTCMonth()]," ").concat(b.getUTCDate(),", ").concat(b.getUTCFullYear(),"; ")}return e.submission_date=T,e.submission_date}})),h(e.data.Success.dataListing);var t=new Date,a=t.getMonth()+1+"/"+t.getDate()+"/"+t.getFullYear();Se("ria-application-"+a+".csv");var n=[];if(e.data.Success.dataListing.length<50)H(e.data.Success.dataListing);else{for(var r=0;r<50;r++)n.push(e.data.Success.dataListing[r]);H(n)}var i=e.data.Success.dataListing&&e.data.Success.dataListing;Oe(i);var o=[];if(ne){for(var l=0;l<i.length;l++)if(void 0!==i[l][pe]&&null!==i[l][pe]){var c=i[l][pe];(c=c.toLowerCase()).includes(ne)&&o.push(i[l])}Re(o)}if(o.length>0){o.length<50?Z(1):o.length%50===0?Z(o.length/50):Z(1+~~(o.length/50));var s=o.slice(50*($-1),50*$);Le(s),Re(o)}else if(ne&&0===o.length){Le([])}else{i.length<50?Z(1):i.length%50===0?Z(i.length/50):Z(1+~~(i.length/50));var d=i.slice(50*($-1),50*$);Le(d),Re(i)}E(!1)})).catch((function(e){console.log(e)}));case 1:case"end":return e.stop()}}),e)})));return function(t){return e.apply(this,arguments)}}(),ze=function(){var e=Object(s.a)(c.a.mark((function e(t){return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:t.preventDefault(),de(!se);case 2:case"end":return e.stop()}}),e)})));return function(t){return e.apply(this,arguments)}}(),Ye=function(){var e=Object(s.a)(c.a.mark((function e(t){return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:"Active Ingredients Salt"===t.target.value?(ge("activeIngredientsSalt"),Ae("Active Ingredients Salt")):"Anda"===t.target.value?(ge("anda"),Ae("Anda")):"Route"===t.target.value?(ge("route"),Ae("Route")):"Formulation"===t.target.value?(ge("formulation"),Ae("Formulation")):"First Approval Date"===t.target.value?(ge("firstApprovalDate"),Ae("First Approval Date")):"Approval Pathway"===t.target.value?(ge("approvalPathway"),Ae("Approval Pathway")):"Rld"===t.target.value?(ge("rld"),Ae("Rld")):"Marketing Status"===t.target.value?(ge("marketingStatus"),Ae("Marketing Status")):"Trade Name"===t.target.value?(ge("tradeName"),Ae("Trade Name")):"Active Ingredients"===t.target.value?(ge("activeIngredients"),Ae("Active Ingredients")):"First Filing Date"===t.target.value?(ge("firstFilingDate"),Ae("First Filing Date")):"Strength"===t.target.value?(ge("Strength"),Ae("Strength")):"Sponsor Name"===t.target.value?(ge("sponsorName"),Ae("Sponsor Name")):"Rs"===t.target.value?(ge("rs"),Ae("Rs")):"TE Code"===t.target.value&&(ge("teCode"),Ae("TE Code"));case 1:case"end":return e.stop()}}),e)})));return function(t){return e.apply(this,arguments)}}();return A?r.a.createElement(tr.SemipolarLoading,{color:"#0352CC"}):r.a.createElement(C.a,{container:!0,className:ke.root},r.a.createElement(C.a,{container:!0,item:!0,xs:12,justify:"flex-start",alignItems:"center",className:ke.GridHeaderBreadcrumbs},r.a.createElement(Ol,{search:e.search,lastItem:"Generic Table : "+e.applicationType+e.applicationNumber})),r.a.createElement(C.a,{xs:12,className:ke.TableMat},r.a.createElement(R.a,{display:"flex",justifyContent:"flex-start",className:ke.boxmat},r.a.createElement("form",{id:"clinicalSearch",onSubmit:ze,className:ke.Form},r.a.createElement(R.a,{display:"flex",justifyContent:"flex-start"},r.a.createElement(sa,{id:"filter",menuItems:Ue,dropdownValue:fe,title:"Column",name:"filter",handleChange:Ye}),r.a.createElement(K,{placeholder:"Search keyword",id:"searchTerm",value:ne,handleChange:function(e){re(String(e.target.value).toLowerCase())},name:"searchTerm"}),r.a.createElement(j.a,{type:"submit",className:ke.Button},r.a.createElement(V,null)),r.a.createElement(_.a,{className:ke.ResetButton,onClick:function(){re(""),de(!se)}},"Reset"),ne&&0===we.length?r.a.createElement(y.a,{className:ke.ErrorTypography},"No Results, Please press the Reset button"):null)),r.a.createElement(L.a,{placement:"left-start",title:r.a.createElement(y.a,null,"50 Records available for download")},r.a.createElement("div",{style:{padding:"3px 0 0 10px"}},G?r.a.createElement(st.CSVLink,{data:G,filename:Ce},r.a.createElement("img",{src:cl.a,style:{width:"33px",height:"42px"}})):r.a.createElement("div",null)))),r.a.createElement(N.a,{className:ke.Tableroot},r.a.createElement($a.a,{className:ke.table,"aria-label":"caption table"},r.a.createElement(an.a,null,we?r.a.createElement(nn.a,{className:ke.TableHeadRow},Me.map((function(e){return Object.keys(_e[0]).map((function(t,a){if(e.field==t)return r.a.createElement(tn.a,{className:ke.TableHeadCells,align:"left"},e.title)}))}))):r.a.createElement(nn.a,{className:ke.TableHeadRow})),r.a.createElement(en.a,null,we.map((function(e){return r.a.createElement(nn.a,{className:ke.TableBodyRows},Me.map((function(t){return Object.keys(e).map((function(a,n){if(t.field===a)return r.a.createElement(tn.a,{className:ke.TableBodyCells,align:"left"},r.a.createElement(R.a,{className:ke.TableBodyCellBox},r.a.createElement(y.a,{className:ke.TableCellTypography},e[a])))}))})))}))))),r.a.createElement("div",{className:"pagination"},r.a.createElement(Fo.a,{count:J,onChange:function(e,t){ee(t)}})),r.a.createElement(U.a,{fullWidth:!0,maxWidth:"lg",onClose:function(){u(!1)},"aria-labelledby":"customized-dialog-title",open:m},r.a.createElement(M.a,null,"A R I A"),r.a.createElement(k.a,{className:ke.Dialog},r.a.createElement(Yt,{data:[e.applicationNumber]}))),r.a.createElement(zs,{placement:"right-start",open:w,title:r.a.createElement(r.a.Fragment,null,r.a.createElement(y.a,{className:ke.botIntroPopup},"Hi I'm ARIA"),r.a.createElement(y.a,{className:ke.botTextPopup},"I can help you find information in Approval Documents."),r.a.createElement(y.a,{className:ke.botTextPopup},"Ask me questions"))},r.a.createElement(B.a,{"aria-label":"add",className:ke.botIconFAB,onClick:function(){return u(!0)}},r.a.createElement("img",{className:ke.botIcon,alt:"botLogo",src:us.a})))))},Vs=Object(f.a)((function(e){var t;return t={root:{marginTop:e.spacing(8),padding:e.spacing(2),marginLeft:e.spacing(9)+1,width:"calc(100% - ".concat(e.spacing(9)+1,"px)")},common360SwipableView:{width:"100%",minHeight:"70vh"},airplaneIcon:{position:"fixed",zIndex:e.zIndex.drawer+2,bottom:e.spacing(2),left:e.spacing(2)},add:{fontSize:e.spacing(1.87),color:e.palette.navbar.button,cursor:"pointer",marginTop:e.spacing(1),textTransform:"capitalize"},GridHeaderBreadcrumbs:{height:"8vh",backgroundColor:e.palette.white,margin:0},Dialog:{minHeight:"70vh"},CardsDialogActions:{width:"100%",justifyContent:"center"},botIconFAB:{left:e.spacing(2),bottom:e.spacing(10),zIndex:e.zIndex.drawer+2,position:"fixed"},botIcon:{height:"100%",width:"100%"},botIntroPopup:{fontWeight:"900",fontSize:"2vh",padding:"4px",borderRadius:"10px",color:e.palette.primary.main,backgroundColor:e.palette.primary.lightBackground},botTextPopup:{fontSize:"1.5vh",padding:"4px",color:e.palette.white,opacity:1},TimeLine:{background:"white",color:"#0352CC",display:"flex",borderRadius:"5px",padding:"2px"},RegTitle:{fontWeight:"600",fontSize:"2.8vh",color:"#0352CC",textAlign:"end"},RegBannerTitle:{textAlign:"left",color:e.palette.biologics.textPrimary,fontWeight:"600",fontSize:e.spacing(2)},RegBannerText:{textAlign:"left",color:e.palette.navbar.button,fontWeight:"600",fontSize:e.spacing(2)},RegBannerTitleend:{textAlign:"left",color:e.palette.biologics.textPrimary,fontWeight:"600",fontSize:e.spacing(2)},RegBannerTextend:{textAlign:"left",color:e.palette.navbar.button,fontWeight:"600",fontSize:e.spacing(2)},GridCardTabs:{marginTop:e.spacing(2)},CardTabs:{backgroundColor:e.palette.white,margin:0,width:"100%","& .MuiTab-wrapper":{fontSize:"1.7vh"},"&.Mui-selected":{border:"0.5px solid",borderBottom:"1px solid white !important",backgroundColor:"white !important"},"& .MuiTab-fullWidth":{borderBottom:"0.5px solid"}},paper:{width:"100%",padding:e.spacing(2),marginTop:e.spacing(1),borderRadius:e.spacing(1.25),marginBottom:e.spacing(1)},TimeLineReg:{color:e.palette.navbar.button,fontFamily:"Lato",fontSize:e.spacing(3),fontWeight:"bold"},TimelineIcon:{color:"white",textAlign:"center",background:"grey",width:"4vh",height:"4vh",margin:"0px 5px","& .MuiAvatar-img":{height:"2vh",width:"2.5vh"}},ModalTitle:{padding:0},ModalCloseIconButton:{padding:0,marginBottom:"-20px",marginLeft:"-20px",color:e.palette.navbar.button},ModalCloseIcon:{color:e.palette.biologics.textPrimary}},Object(g.a)(t,"Dialog",{minHeight:"70vh",padding:0}),Object(g.a)(t,"& .MuiAvatar-root.MuiAvatar-circle.makeStyles-TimelineIcon-179",{width:"5vh",height:"5vh"}),Object(g.a)(t,"& .MuiTab-textColorPrimary.Mui-selected",{TimelineIcon:{color:"white",textAlign:"center",background:"blue","& .MuiAvatar-img":{height:"2.6vh",width:"3.75vh"}}}),Object(g.a)(t,"BetaBadge",{"& .MuiBadge-badge":{zIndex:"101010",height:"14px",fontSize:"12px",textTransform:"none"}}),Object(g.a)(t,".react-swipeable-view-container",{height:"100% !important"}),Object(g.a)(t,"StyledErrorTypography",{fontSize:"2vh",padding:"15px",color:e.palette.black,borderRadius:"10px",backgroundColor:e.palette.primary.lightBorder,fontWeight:"700"}),Object(g.a)(t,"ErrorGrid",{display:"flex",justifyContent:"center",alignItems:"center",padding:"50px"}),t}),{index:1}),Gs=Object(f.a)((function(e){var t,a,n,r,i;return{main:{height:"95%",width:"100%"},MainGrid:{marginTop:"0.5rem",height:"100%"},GridTimelineMain:{backgroundColor:e.palette.white,boxShadow:"none",borderRadius:0},GridChat:{height:"60vh",backgroundColor:e.palette.white,boxShadow:"none",borderRadius:0,borderRight:"16px solid ".concat(e.palette.primary.lightBackground)},GridTimeline:{height:"100%",backgroundColor:e.palette.white,boxShadow:"none",borderRadius:0,borderLeft:"16px solid ".concat(e.palette.primary.lightBackground)},TimelineIcon:{border:"2px solid ".concat(e.palette.primary.lightBackground)},TimelineTab:{marginBottom:"4vh",boxShadow:"none"},TimelineGridBox:{height:"100%",width:"100%",margin:0,borderRadius:e.spacing(1.25),border:"1px solid ".concat(e.palette.home.border),boxShadow:"0 0 4px ".concat(e.palette.primary.shadow)},TimelineItem:{},TimelineIconButton:{},TimelineExpand:{width:"60%"},TimelineDotGreen:{backgroundColor:"".concat(e.palette.successGreen," !important"),height:"3vh",width:"3vh","& .MuiTypography-root":{width:"3vh",height:"3vh",fontWeight:"900",fontSize:"1.5vh",color:"".concat(e.palette.white," !important"),textAlign:"center",margin:"0 auto"},boxShadow:"0 0 3px ".concat(e.palette.primary.main," !important"),border:"1px solid ".concat(e.palette.white," !important")},TimelineDotRed:{backgroundColor:"".concat(e.palette.primary.main," !important"),height:"3vh",width:"3vh","& .MuiTypography-root":{width:"3vh",height:"3vh",fontWeight:"900",fontSize:"1.5vh",color:"".concat(e.palette.white," !important"),textAlign:"center",margin:"0 auto"},boxShadow:"0 0 3px ".concat(e.palette.primary.main," !important"),border:"1px solid ".concat(e.palette.white," !important")},DateHeader:{height:"3vh",fontSize:"1.5vh",width:"15vh",lineHeight:"3vh",backgroundColor:e.palette.successGreen,color:e.palette.white,boxShadow:"0 0 3px ".concat(e.palette.successGreen," !important"),border:"1px solid ".concat(e.palette.white," !important"),borderRadius:"20px",fontWeight:"900"},TimelineTitle:{paddingLeft:e.spacing(2),paddingRight:e.spacing(2),paddingTop:e.spacing(2),paddingBottom:e.spacing(1),color:e.palette.primary.main,fontWeight:"900",fontSize:"1.5vh"},TimelineLine2:{paddingLeft:e.spacing(2),paddingRight:e.spacing(2),paddingTop:e.spacing(1),paddingBottom:e.spacing(1),color:e.palette.primary.main,fontWeight:"700",fontSize:"1.4vh"},TimelineDescriptionLeft:{paddingLeft:e.spacing(2),paddingRight:e.spacing(2),color:e.palette.black,fontSize:"1.5vh",textAlign:"left"},TimelineDescriptionRight:{paddingLeft:e.spacing(2),paddingRight:e.spacing(2),color:e.palette.black,fontSize:"1.5vh",textAlign:"right"},DropdownDiv:{width:"100%"},LinksGrid:{margin:"0.5vh"},CardDropdown:{width:"100%"},CardDropdownButton:{width:"100%",fontSize:"1.5vh",fontWeight:"500",backgroundColor:e.palette.primary.lightBackground,border:"2px solid ".concat(e.palette.primary.lightBorder),color:e.palette.primary.main},disabledButton:{color:"#f7c94c"},expand:{transform:"rotate(0deg)",transition:e.transitions.create("transform",{duration:e.transitions.duration.shortest})},expandClose:{transform:"rotate(180deg)"},AdvancedSearchDatePicker:{width:e.spacing(20),marginLeft:e.spacing(1),borderRadius:"10px",border:"2px solid ".concat(e.palette.primary.lightBorder),"& .MuiInput":{border:"2px solid ".concat(e.palette.primary.lightBorder)},"& .MuiFormLabel-root":{marginLeft:e.spacing(1),color:e.palette.primary.main},"& .MuiInput-underline:before":{border:"none"},"& .MuiInput-underline:after":{border:"none"},"& .MuiInput-underline:hover":{border:"none"},"& .MuiInput-underline:focus":{border:"none"}},Base:{width:"100%",float:"rigth",paddingBottom:"10px"},btn:{marginLeft:e.spacing(1),fontSize:"3vh",border:"1px solid ".concat(e.palette.biologics.textPrimary),fontWeight:"500",borderRadius:"10px",background:"none",color:e.palette.biologics.textPrimary},box:{alignItems:"end",float:"right",marginRight:"10px"},showTabsList:{height:"30px",display:"flex",alignItems:"center",padding:"3px 20px",borderRadius:"13px",fontSize:"1.7vh",fontWeight:"bold",background:e.palette.biologics.gradient,color:"white",cursor:"pointer",margin:"auto 5px"},showTabsListNo:(t={height:"30px",margin:"5px",padding:"3px 20px",borderRadius:"13px",fontSize:"1.7vh",fontWeight:"bold",border:"2px solid #e3f1ff",boxShadow:"0 0 4px rgb(220, 220, 220,0.5)"},Object(g.a)(t,"borderRadius","20px"),Object(g.a)(t,"backgroundColor","#f7fbff"),Object(g.a)(t,"color","black"),Object(g.a)(t,"cursor","pointer"),Object(g.a)(t,"margin","auto 5px"),t),filterParent:{width:"60vh"},selectAll:(a={height:"30px",margin:"5px",padding:"3px 20px",borderRadius:"13px",fontSize:"1.7vh",fontWeight:"bold",border:"2px solid #e3f1ff",boxShadow:"0 0 4px rgb(220, 220, 220,0.5)"},Object(g.a)(a,"borderRadius","20px"),Object(g.a)(a,"backgroundColor","#f7fbff"),Object(g.a)(a,"color",e.palette.navbar.button),Object(g.a)(a,"cursor","pointer"),a),mostRecent:(n={margin:"5px",padding:"3px 20px",borderRadius:"13px",fontSize:"1.25vh",fontWeight:"bold",border:"2px solid #e3f1ff",boxShadow:"0 0 4px rgb(220, 220, 220,0.5)"},Object(g.a)(n,"borderRadius","20px"),Object(g.a)(n,"backgroundColor","#f7fbff"),Object(g.a)(n,"color",e.palette.navbar.button),Object(g.a)(n,"cursor","pointer"),n),resize:{fontSize:e.spacing(1.85),marginLeft:e.spacing(1),width:"100%"},compareL:(r={height:"30px",margin:"5px",padding:"3px 20px",borderRadius:"13px",fontSize:"1.7vh",fontWeight:"bold",border:"2px solid #e3f1ff",boxShadow:"0 0 4px rgb(220, 220, 220,0.5)"},Object(g.a)(r,"borderRadius","20px"),Object(g.a)(r,"backgroundColor","#119E8A"),Object(g.a)(r,"color","#FFFFFF"),Object(g.a)(r,"cursor","pointer"),Object(g.a)(r,"margin","0 auto"),Object(g.a)(r,"display","flex"),Object(g.a)(r,"width","fit-content"),r),compareText:{padding:"10px",borderBottom:"1px solid #ccc",width:"100%",textAlign:"justify",display:"flex",margin:"10px 20px 0px 20px"},checkboxIcon:{margin:"unset",width:"100%",justifyContent:"center"},labelTitle:{fontSize:"1.4vh",fontWeight:500,paddingLeft:"5px",margin:"auto"},dialog:{height:"inherit",width:"inherit",backgroundImage:"url(".concat(Tr.a,")"),backgroundRepeat:"no-repeat",backgroundPosition:"center",backgroundSize:"cover",backgroundAttachment:"fixed"},compareBox:{backgroundColor:"white",height:"65vh",overflowY:"scroll"},selectLabel:{background:"#33B187",color:"white",padding:"13px 10px",borderRadius:"10px 10px 0px 0px",marginBottom:"auto",fontSize:"2.3vh"},Dialog:{display:"flex",justifyContent:"center",alignItems:"center"},twoBox:{background:"white",height:"65vh",overflowY:"auto"},labelDate:{fontSize:"1.6vh",fontWeight:"800"},labelSup:{fontSize:"1.6vh",fontWeight:"570"},labelChange:{fontSize:"1.6vh",fontWeight:"500",padding:"10px 0px"},LabelTitle:{color:"#1C7D5D",fontWeight:"800",padding:"20px 0px 0px",fontSize:"3.5vh",fontFamily:"Constantia"},labelDateGreen:{fontSize:"1.6vh",fontWeight:"800",color:"#33B187"},labelSupGreen:{fontSize:"1.6vh",fontWeight:"570",color:"#33B187"},labelChangeGreen:{fontSize:"1.6vh",fontWeight:"500",padding:"10px 0px",color:"#33B187"},compareN:(i={height:"30px",margin:"5px",padding:"3px 20px",borderRadius:"13px",fontSize:"1.7vh",fontWeight:"bold",border:"2px solid #e3f1ff",boxShadow:"0 0 4px rgb(220, 220, 220,0.5)"},Object(g.a)(i,"borderRadius","20px"),Object(g.a)(i,"backgroundColor","#119E8A"),Object(g.a)(i,"color","#FFFFFF"),Object(g.a)(i,"cursor","pointer"),Object(g.a)(i,"margin","10px auto"),Object(g.a)(i,"display","flex"),Object(g.a)(i,"width","fit-content"),i),selectLabelC:{background:"#33B187",color:"white",borderRadius:"10px 10px 0px 0px",marginBottom:"auto",fontSize:"2.3vh",padding:"13px 10px"},textField:{color:"white"},StyledErrorTypography:{fontSize:"2vh",padding:"15px",color:e.palette.black,borderRadius:"10px",backgroundColor:e.palette.primary.lightBorder,fontWeight:"700"}}})),Hs=a(1162),Ws=a.n(Hs),Qs=Object(f.a)((function(e){return{Paper:{borderRadius:"5px",width:"100%",overflowX:"auto",boxShadow:"none"},Table:{},TableHead:{borderRadius:"10px"},TableBody:{borderRadius:"10px"},StyledHeaderTableRow:{borderRadius:"10px"},StyledHeaderTableCell:{padding:"7px",fontSize:"2vh",fontWeight:"800",color:e.palette.black,backgroundColor:e.palette.primary.lightBorder},StyledHeaderTableCellMapped:{padding:"7px",fontSize:"1.5vh",fontWeight:"700",color:e.palette.black,backgroundColor:e.palette.primary.lightBorder},StyledTableRow:{borderRadius:"10px","&:nth-of-type(odd)":{backgroundColor:e.palette.primary.lightBackground},"&:nth-of-type(even)":{backgroundColor:e.palette.white}},StyledTableCell:{padding:"7px",fontSize:"1.5vh",fontWeight:"700",color:e.palette.black},StyledTableCellMapped:{padding:"7px",fontSize:"1.5vh",fontWeight:"500",color:e.palette.black},StyledTableCellCheck:{color:e.palette.successGreen},List:{padding:0},ListItem:{padding:"4px",borderRadius:"5px",border:"2px solid ".concat(e.palette.primary.lightBorder)},ListItemText:{cursor:"pointer",borderRadius:"10px",width:"fit-content",textDecoration:"underline",backgroundColor:e.palette.white,textAlign:"center",margin:"auto",color:e.palette.primary.main,fontWeight:"700",fontSize:"1.5vh"},Document:{borderRadius:"20px",boxShadow:"0px 0px 10px ".concat(e.palette.primary.lightBorder," !important")},PageNumberText:{fontSize:"1.7vh",fontWeight:"900",color:e.palette.black,textAlign:"center",marginLeft:"10px",marginBottom:"10px",marginRight:"10px",padding:"5px",backgroundColor:e.palette.white,height:"100%"},PageNumberInput:{fontSize:"1.7vh",fontWeight:"900",color:e.palette.black,textAlign:"center",padding:"5px",border:"none",borderRadius:"10px",width:e.spacing(5),backgroundColor:e.palette.primary.lightBorder,height:"100%"}}})),Js=(a(1089),a(634)),Ks=(Object(f.a)((function(e){return{root:{height:"100%",width:"100%"},CustomButton:{fontWeight:"500",borderRadius:"10px",background:e.palette.biologics.gradient,color:e.palette.white},CustomMainButton:{fontSize:"3vh",height:"100%",fontWeight:"500",borderRadius:"10px",background:"linear-gradient(to bottom, ".concat(e.palette.gradient.primaryFrom," 10%, ").concat(e.palette.gradient.primaryTo," 90%)"),color:e.palette.white},CustomIconButton:{},CustomImageButton:{}}})),a(795)),Zs=a.n(Ks);function Xs(e){var t=Qs(),a=Object(n.useState)(),i=Object(d.a)(a,2),o=i[0],l=i[1],m=Object(n.useState)(!1,{}),u=Object(d.a)(m,2),p=u[0],g=u[1],h=Object(n.useState)(null),T=Object(d.a)(h,2),f=(T[0],T[1],Object(n.useState)(1)),A=Object(d.a)(f,2),E=(A[0],A[1],Object(n.useState)()),b=Object(d.a)(E,2),S=(b[0],b[1]),y=Object(n.useState)(!1),D=Object(d.a)(y,2),_=D[0],O=D[1];Object(n.useEffect)((function(){function t(){return(t=Object(s.a)(c.a.mark((function t(){return c.a.wrap((function(t){for(;;)switch(t.prev=t.next){case 0:try{l(e.links)}catch(a){console.log(a)}case 1:case"end":return t.stop()}}),t)})))).apply(this,arguments)}!function(){t.apply(this,arguments)}()}),[e]),Object(n.useEffect)((function(){function e(){return(e=Object(s.a)(c.a.mark((function e(){return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:try{O(!0)}catch(t){console.log(t)}case 1:case"end":return e.stop()}}),e)})))).apply(this,arguments)}!function(){e.apply(this,arguments)}()}),[p]);return o?r.a.createElement(N.a,{className:t.Paper},r.a.createElement($a.a,{className:t.Table},r.a.createElement(en.a,{className:t.TableBody},o.map((function(e,a){return r.a.createElement(nn.a,{className:t.StyledTableRow,key:"Marketing"},r.a.createElement(tn.a,{className:t.StyledTableCell,component:"th",scope:"row"},r.a.createElement(Xt.a,{key:e.link,className:t.ListItemText,onClick:function(){g([!0,e.link]),S(e.link)}},e.name," ",r.a.createElement(Zs.a,{fontSize:"small"}))))})))),r.a.createElement(U.a,{fullWidth:!0,maxWidth:"lg",onClose:function(){g([!1,{}])},"aria-labelledby":"customized-dialog-title",open:void 0!==p[0]&&p[0]},r.a.createElement(M.a,null,r.a.createElement(C.a,{container:!0},r.a.createElement(C.a,{container:!0,item:!0,xs:11,justify:"center",alignItems:"center"}),r.a.createElement(C.a,{container:!0,item:!0,xs:1,justify:"flex-end",alignItems:"center"},r.a.createElement(j.a,{"aria-label":"delete",className:t.ModalCloseIconButton,onClick:function(){g([!1,{}])}},r.a.createElement(Er.a,{className:t.ModalCloseIcon}))))),r.a.createElement(k.a,{className:t.Dialog},r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"flex-start",item:!0},r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"flex-start",item:!0},_&&p[1]?r.a.createElement("iframe",{style:{height:"85vh",width:"100vw",boxShadow:"0px 0px 10px #e3f1ff",border:"unset",borderRadius:"10px"},src:p[1],id:"MyFrame"}):null))))):r.a.createElement("div",null)}var qs=a(1161),$s=a.n(qs),ed=a(1070);function td(e){var t=Gs(),a=Object(n.useState)(""),i=Object(d.a)(a,2),o=i[0],l=i[1],m=Object(n.useState)(),u=Object(d.a)(m,2),p=u[0],h=u[1],T=Object(n.useState)(!0),f=Object(d.a)(T,2),A=f[0],E=f[1],b=Object(n.useState)(!1),N=Object(d.a)(b,2),S=N[0],D=N[1],O=Object(n.useState)(!1),x=Object(d.a)(O,2),v=x[0],P=x[1],I=Object(n.useState)(!1),w=Object(d.a)(I,2),B=w[0],F=w[1],z=Object(n.useState)(),Y=Object(d.a)(z,2),V=Y[0],G=Y[1],H=Object(n.useState)(),Q=Object(d.a)(H,2),J=Q[0],K=Q[1],Z=Object(n.useState)(),X=Object(d.a)(Z,2),q=X[0],$=X[1],ee=Object(n.useState)(),te=Object(d.a)(ee,2),ae=te[0],ne=te[1],re=Object(n.useState)(),ie=Object(d.a)(re,2),oe=ie[0],le=ie[1],ce=Object(n.useState)(),se=Object(d.a)(ce,2),de=se[0],me=se[1],ue=Object(n.useState)(),ge=Object(d.a)(ue,2),he=ge[0],Te=ge[1],fe=Object(n.useState)(),Ae=Object(d.a)(fe,2),Ee=Ae[0],be=Ae[1],Ne=Object(n.useState)(!1),Ce=Object(d.a)(Ne,2),Se=Ce[0],ye=Ce[1],De=Object(n.useState)(!1),_e=Object(d.a)(De,2),Oe=_e[0],xe=_e[1],ve=Object(n.useState)(!1),Re=Object(d.a)(ve,2),Pe=Re[0],Ie=Re[1],we=Object(n.useState)(),je=Object(d.a)(we,2),Be=je[0],Ue=je[1],ke=Object(n.useState)(!1),Me=Object(d.a)(ke,2),Fe=Me[0],ze=Me[1],Ye=Object(n.useState)(),Ve=Object(d.a)(Ye,2),Ge=Ve[0],He=Ve[1],We=Object(n.useState)(),Qe=Object(d.a)(We,2),Je=Qe[0],Ke=Qe[1],Ze=Object(n.useState)(),Xe=Object(d.a)(Ze,2),qe=(Xe[0],Xe[1]),$e=Object(n.useState)(),et=Object(d.a)($e,2),tt=(et[0],et[1]),at=Object(n.useState)(),nt=Object(d.a)(at,2),rt=nt[0],it=nt[1],ot=Object(n.useState)(),lt=Object(d.a)(ot,2),ct=lt[0],st=lt[1],dt=Object(n.useState)(),mt=Object(d.a)(dt,2),ut=mt[0],pt=mt[1],gt=Object(n.useState)(),Tt=Object(d.a)(gt,2),ft=Tt[0],At=Tt[1],Et=Object(n.useState)(),Nt=Object(d.a)(Et,2),Ct=(Nt[0],Nt[1]),St=Object(n.useState)(),yt=Object(d.a)(St,2),Dt=yt[0],_t=yt[1];Object(n.useEffect)((function(){function t(){return(t=Object(s.a)(c.a.mark((function t(){var a,n,r,i,o,l,s,d,m,u,p,g,T,f,A,b,N;return c.a.wrap((function(t){for(;;)switch(t.prev=t.next){case 0:console.log(e);try{for(a=e.timeLineData,n=a.data.success.original,a.data.success.original,r=[],i=[],be(n),o=0;o<n.length;o++)i.push(n[o].description),l={name:vt(n[o].description),type:n[o].name,description:n[o].description,isActive:!1},r.push(l);for(i=Object(It.a)(new Set(i)),s=[],d=new Map,m=0,u=r;m<u.length;m++)p=u[m],d.has(p.description)||(d.set(p.description,!0),s.push({name:p.name,type:p.type,description:p.description,isActive:p.isActive}));for(g=!1,T=!1,f=0;f<s.length;f++)"Efficacy"===s[f].name?(s[f].isActive=!0,g=!0):"ORIG"===s[f].type&&(s[f].isActive=!0,T=!0),""===s[f].name&&(s[f].name="Missing");for(!1===T&&!1===g&&(s[0].isActive=!0),console.log("result",s),Te(s),A=[],b=0;b<n.length;b++)for(N=0;N<s.length;N++)n[b].description===s[N].description&&!0===s[N].isActive&&A.push(n[b]);me(s),h(A),le(n),G(n[n.length-1].x),K(n[0].x),E(!1)}catch(c){console.log(c)}case 2:case"end":return t.stop()}}),t)})))).apply(this,arguments)}!function(){t.apply(this,arguments)}()}),[]);var Ot,xt=function(){var e=Object(s.a)(c.a.mark((function e(t){var a,n,r;return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:if(t.preventDefault(),console.log("selected date",q,ae),console.log("base date",V,J),a=[],V<J){for(n=0;n<oe.length;n++)for(r=0;r<de.length;r++)!0===de[r].isActive&&de[r].description===oe[n].description&&oe[n].x>=V&&oe[n].x<=J&&a.push(oe[n]);console.log("uspdated list",a),h(a)}else ra.b.error("From Date should not be greater than To Date");case 5:case"end":return e.stop()}}),e)})));return function(t){return e.apply(this,arguments)}}(),vt=function(e){return"Manufacturing (CMC)"===e&&(e="CMC"),e.includes("Type")&&(e=e.split("-").pop()),e},Rt=function(e){e.isActive=!e.isActive,console.log(de);for(var t=[],a=0;a<Ee.length;a++)for(var n=0;n<he.length;n++)Ee[a].description===he[n].description&&!0===he[n].isActive&&t.push(Ee[a]);me(he),h(t);for(var r=0,i=0;i<he.length;i++)1==he[i].isActive&&r++;r===he.length?ye(!0):ye(!1),t.length>=1&&(G(t[t.length-1].x),K(t[0].x)),console.log(t)},Pt=function(e,t){console.log("label1",e.file_links.label[0]),Ke(e.file_links.label[0]),He(e.x),At(e),Ue(t),ze(!1)},wt=function(){var e=Object(s.a)(c.a.mark((function e(t,a){var n,r,i;return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:for(console.log("label1",t.file_links.label[0]),qe(t.file_links.label[0].link),tt(a),n={parent_object:Je.link,child_object:t.file_links.label[0].link},r=[],i=0;i<oe.length;i++)0!==oe[i].file_links.label.length&&r.push(oe[i].file_links.label[0].name);return Ct(r),st(Je.name),pt(t.file_links.label[0].name),e.next=11,Le(n).then((function(e){it(e.data.success)})).catch((function(e){console.log(e)}));case 11:case"end":return e.stop()}}),e)})));return function(t,a){return e.apply(this,arguments)}}();return A&&p?r.a.createElement("div",null,r.a.createElement(tr.SemipolarLoading,{color:"#0352CC"})):r.a.createElement("div",{className:t.main},r.a.createElement(C.a,{container:!0,spacing:3,className:t.MainGrid},r.a.createElement(C.a,{container:!0,item:!0,xs:12,className:t.GridTimelineMain},p?r.a.createElement(C.a,{container:!0,item:!0,xs:12,className:t.GridTimelineMain},r.a.createElement(C.a,{container:!0,xs:12,className:t.Base},de?r.a.createElement(C.a,{item:!0,xs:7,style:{display:"inline-flex"}},r.a.createElement("div",{style:{borderRight:"2px solid #e3f1ff",margin:"auto 5px"}},r.a.createElement("div",{onClick:function(){return function(){var e=!1;if(!0===Se?(ye(!1),e=!1):(ye(!0),e=!0),!0===e)for(var t=0;t<he.length;t++)he[t].isActive=!0;else if(!1===e)for(var a=0;a<he.length;a++)he[a].isActive=!1;for(var n=[],r=0;r<Ee.length;r++)for(var i=0;i<he.length;i++)Ee[r].description===he[i].description&&!0===he[i].isActive&&n.push(Ee[r]);me(he),h(n),n.length>=1&&(G(n[n.length-1].x),K(n[0].x))}()},className:t.selectAll},Se?"Deselect All":"Select All")),de.map((function(e){return!0===e.isActive?r.a.createElement("div",{onClick:function(){return Rt(e)},className:t.showTabsList},e.name," "):r.a.createElement("div",{onClick:function(){return Rt(e)},className:t.showTabsListNo},e.name," ")}))):r.a.createElement("span",null),r.a.createElement(C.a,{item:!0,xs:5},r.a.createElement(R.a,(Ot={padding:1,display:"flex",justifyContent:"space-evenly",className:t.navBox},Object(g.a)(Ot,"display","flex"),Object(g.a)(Ot,"flexDirection","row"),Object(g.a)(Ot,"justifyContent","end"),Object(g.a)(Ot,"alignItems","end"),Object(g.a)(Ot,"className",t.box),Ot),r.a.createElement(W.a,null,r.a.createElement(Pa.a,{utils:Ra.default},r.a.createElement(Ia.b,{className:t.AdvancedSearchDatePicker,value:V,label:"From",keyboardIcon:r.a.createElement(La.a,{className:t.calendarIcon}),InputProps:{classes:{input:t.resize}},onChange:function(e){return function(e){var t=e.getDate()<10?"0"+e.getDate():String(e.getDate()),a=e.getMonth()<10?"0"+(e.getMonth()+1):String(e.getMonth()+1),n=String(e.getFullYear())+"-"+a+"-"+t;console.log(n),G(n),$(n)}(e)},format:"MM/dd/yyyy"}))),r.a.createElement(W.a,null,r.a.createElement(Pa.a,{utils:Ra.default},r.a.createElement(Ia.b,{className:t.AdvancedSearchDatePicker,value:J,label:"To",keyboardIcon:r.a.createElement(La.a,{className:t.calendarIcon}),InputProps:{classes:{input:t.resize}},onChange:function(e){return function(e){var t=e.getDate()<10?"0"+e.getDate():String(e.getDate()),a=e.getMonth()<10?"0"+(e.getMonth()+1):String(e.getMonth()+1),n=String(e.getFullYear())+"-"+a+"-"+t;K(n),ne(n)}(e)},format:"MM/dd/yyyy"}))),r.a.createElement(W.a,null,r.a.createElement(_.a,{variant:"contained",onClick:xt,className:t.btn},r.a.createElement($s.a,{fontSize:"small"})))))),r.a.createElement(C.a,{item:!0,xs:12,style:{paddingBottom:"12px"}},r.a.createElement("div",{onClick:function(){return function(){var e=[];oe.map((function(t,a){0!==t.file_links.label.length&&e.push(t)})),1===e.length?ra.b.error("Multiple label not available for comparision"):xe(!0),_t(e[0])}()},className:t.compareL},r.a.createElement("img",{style:{width:"15px"},src:Nr.a}),r.a.createElement(y.a,{className:t.labelTitle},"Compare Labels"))),r.a.createElement("div",{xs:12,style:{width:"100%"}},r.a.createElement($o.a,{align:"alternate"},p.map((function(e,a){return r.a.createElement(el.a,{align:"alternate",className:t.TimelineItem},r.a.createElement(nl.a,null,a%2===0?r.a.createElement(C.a,{xs:12,container:!0,justify:"flex-end",alignItems:"center"},r.a.createElement(y.a,{className:t.DateHeader},r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"center"},e.x))):r.a.createElement(C.a,{xs:12,container:!0,justify:"flex-start",alignItems:"center"},r.a.createElement(y.a,{className:t.DateHeader},r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"center"},e.x)))),a===p.length-1?r.a.createElement(tl.a,null,r.a.createElement(il.a,{className:Object(ga.a)(t.TimelineDotGreen,Object(g.a)({},t.TimelineDotRed,"ORIG"!==e.name))},r.a.createElement(y.a,null,e.submissionsno))):r.a.createElement(tl.a,null,r.a.createElement(il.a,{className:Object(ga.a)(t.TimelineDotGreen,Object(g.a)({},t.TimelineDotRed,"ORIG"!==e.name))},r.a.createElement(y.a,null,e.submissionsno)),r.a.createElement(al.a,null)),r.a.createElement(rl.a,{className:t.TimelineTab},r.a.createElement(C.a,{container:!0,className:t.TimelineGridBox},a%2===0?r.a.createElement(C.a,{container:!0},r.a.createElement(C.a,{item:!0,xs:12,container:!0,justify:"flex-start",alignItems:"center",className:t.topTimelineGrid},r.a.createElement(y.a,{className:t.TimelineTitle},e.name)),r.a.createElement(C.a,{item:!0,xs:12,container:!0,justify:"flex-start",alignItems:"center",className:t.topTimelineGrid},r.a.createElement(y.a,{className:t.TimelineLine2},e.description)),r.a.createElement(C.a,{item:!0,xs:12,container:!0,justify:"flex-start",alignItems:"center",className:t.topTimelineGrid},r.a.createElement(y.a,{className:t.TimelineDescriptionRight},e.change.map((function(e,t){return r.a.createElement("p",null,'" . . . ',e,' . . . "')}))))):r.a.createElement(C.a,{container:!0},r.a.createElement(C.a,{item:!0,xs:12,container:!0,justify:"flex-end",alignItems:"center",className:t.topTimelineGrid},r.a.createElement(y.a,{className:t.TimelineTitle},e.name)),r.a.createElement(C.a,{item:!0,xs:12,container:!0,justify:"flex-end",alignItems:"center",className:t.topTimelineGrid},r.a.createElement(y.a,{className:t.TimelineLine2},e.description)),r.a.createElement(C.a,{item:!0,xs:12,container:!0,justify:"flex-end",alignItems:"center",className:t.topTimelineGrid},r.a.createElement(y.a,{className:t.TimelineDescriptionRight},e.change.map((function(e,t){return r.a.createElement("p",null,'" . . . ',e,' . . . "')}))))),r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"center",className:t.bottomTimelineGrid},r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"center"},0===e.file_links.label.length&&0===e.file_links.review.length&&0===e.file_links.letter.length?r.a.createElement(L.a,{TransitionComponent:pe.a,title:"No Documents present at the source"},r.a.createElement(j.a,{className:t.disabledButton,"aria-label":"show more"},r.a.createElement(Ws.a,null))):r.a.createElement(j.a,{className:Object(ga.a)(t.expand,Object(g.a)({},t.expandClose,a===o)),onClick:function(){!function(e){o===e?(l(""),F(""),D(""),P("")):l(e)}(a)},"aria-expanded":a===o,"aria-label":"show more"},r.a.createElement(Ka.a,null))),r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"center"},r.a.createElement(ht.a,{in:a===o,timeout:"auto",unmountOnExit:!0},r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"center"},r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"center"},0!==e.file_links.review.length?r.a.createElement("div",{className:t.DropdownDiv},r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"center"},r.a.createElement(_.a,{onClick:function(){!function(e){F(B===e?"":e)}(a)},className:t.CardDropdownButton,"aria-expanded":a===B,"aria-label":"show more"},"Review Documents",r.a.createElement(Ka.a,{className:Object(ga.a)(t.expand,Object(g.a)({},t.expandClose,a===B))}))),r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"center",className:t.LinksGrid},r.a.createElement(ht.a,{className:t.CardDropdown,in:a===B,timeout:"auto",unmountOnExit:!0},r.a.createElement(Xs,{links:e.file_links.review})))):r.a.createElement("div",null)),r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"center"},0!==e.file_links.label.length?r.a.createElement("div",{className:t.DropdownDiv},r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"center"},r.a.createElement(_.a,{onClick:function(){!function(e){D(S===e?"":e)}(a)},className:t.CardDropdownButton,"aria-expanded":a===S,"aria-label":"show more"},"Labels",r.a.createElement(Ka.a,{className:Object(ga.a)(t.expand,Object(g.a)({},t.expandClose,a===S))}))),r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"center",className:t.LinksGrid},r.a.createElement(ht.a,{className:t.CardDropdown,in:a===S,timeout:"auto",unmountOnExit:!0},r.a.createElement(Xs,{links:e.file_links.label})))):r.a.createElement("div",null)),r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"center"},0!==e.file_links.letter.length?r.a.createElement("div",{className:t.DropdownDiv},r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"center"},r.a.createElement(_.a,{onClick:function(){!function(e){P(v===e?"":e)}(a)},className:t.CardDropdownButton,"aria-expanded":a===v,"aria-label":"show more"},"Approval Letters",r.a.createElement(Ka.a,{className:Object(ga.a)(t.expand,Object(g.a)({},t.expandClose,a===v))}))),r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"center",className:t.LinksGrid},r.a.createElement(ht.a,{className:t.CardDropdown,in:a===v,timeout:"auto",unmountOnExit:!0},r.a.createElement(Xs,{links:e.file_links.letter})))):r.a.createElement("div",null)))))))))}))))):r.a.createElement("div",null))),r.a.createElement(U.a,{fullWidth:!0,maxWidth:"lg",onClose:function(){xe(!1)},"aria-labelledby":"customized-dialog-title",open:void 0!==Oe&&Oe,classes:{paper:t.dialog}},r.a.createElement(M.a,{style:{padding:"0 24px"}},r.a.createElement(C.a,{container:!0},r.a.createElement(C.a,{container:!0,item:!0,xs:11,justify:"center",alignItems:"center",className:t.LabelTitle},r.a.createElement("img",{style:{width:"33px",paddingRight:"10px"},src:Nr.a}),"LABEL COMPARISON"),r.a.createElement(C.a,{container:!0,item:!0,xs:1,justify:"flex-end",alignItems:"center"},r.a.createElement(j.a,{"aria-label":"delete",className:t.ModalCloseIconButton,onClick:function(){xe(!1),Ie(!1)}},r.a.createElement(Er.a,{className:t.ModalCloseIcon})))),r.a.createElement(C.a,{container:!0,item:!0,xs:12,justify:"center",alignItems:"center"})),r.a.createElement(k.a,{className:t.Dialog},r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"flex-start",item:!0},!1===Pe?r.a.createElement(C.a,{xs:6,container:!0,justify:"center",alignItems:"center",item:!0},r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"center",item:!0,className:t.selectLabel}," ","Select a label for Comparison"," "),r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"start",item:!0,className:t.compareBox},oe&&oe.map((function(e,a){return 0!==e.file_links.label.length?r.a.createElement(C.a,{className:t.compareText},Dt===e?r.a.createElement(C.a,{xs:11},r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"center",item:!0,style:{display:"inline-flex"}},r.a.createElement(C.a,{xs:2,container:!0,justify:"start",alignItems:"flex-start",item:!0,className:t.labelDate}," ",e.x),r.a.createElement(C.a,{xs:2,container:!0,justify:"start",alignItems:"flex-start",item:!0,className:t.labelSup},e.name,"-",e.submissionsno),r.a.createElement(C.a,{xs:2,container:!0,justify:"start",alignItems:"flex-start",item:!0,className:t.labelSup},e.description),r.a.createElement(C.a,{xs:6,container:!0,justify:"start",alignItems:"flex-start",item:!0,className:t.labelSup},r.a.createElement("div",{className:t.mostRecent},"Most Resent Label"))),r.a.createElement(C.a,{xs:11,container:!0,justify:"center",alignItems:"center",item:!0,className:t.labelChange},e.change)):r.a.createElement(C.a,{xs:11},r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"center",item:!0,style:{display:"inline-flex"}},r.a.createElement(C.a,{xs:2,container:!0,justify:"start",alignItems:"flex-start",item:!0,className:t.labelDate}," ",e.x),r.a.createElement(C.a,{xs:2,container:!0,justify:"start",alignItems:"flex-start",item:!0,className:t.labelSup},e.name,"-",e.submissionsno),r.a.createElement(C.a,{xs:8,container:!0,justify:"start",alignItems:"flex-start",item:!0,className:t.labelSup},e.description)),r.a.createElement(C.a,{xs:11,container:!0,justify:"center",alignItems:"center",item:!0,className:t.labelChange},e.change)),r.a.createElement(C.a,{xs:1},r.a.createElement(ed.a,{className:t.checkboxIcon,control:r.a.createElement(bt.a,{icon:r.a.createElement(uc,null),checkedIcon:r.a.createElement(pc,null),name:"checkedH",onChange:function(){Pt(e,a),Ie(!0)},value:e.x}),label:""}))):null})))):!1===Fe?r.a.createElement(C.a,{style:{display:"contents"}},r.a.createElement(C.a,{xs:5,container:!0,justify:"center",alignItems:"center",item:!0},r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"center",item:!0,className:t.selectLabel}," ","Select a label for Comparison"," "),r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"start",item:!0,className:t.twoBox},oe&&oe.map((function(e,a){return 0!==e.file_links.label.length?r.a.createElement(C.a,{className:t.compareText},Dt===e?r.a.createElement(C.a,{xs:11},r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"center",item:!0,style:{display:"inline-flex"}},ft===e?r.a.createElement(C.a,{xs:3,container:!0,justify:"start",alignItems:"flex-start",item:!0,className:t.labelDateGreen}," ",e.x):r.a.createElement(C.a,{xs:3,container:!0,justify:"start",alignItems:"flex-start",item:!0,className:t.labelDate}," ",e.x),ft===e?r.a.createElement(C.a,{xs:2,container:!0,justify:"start",alignItems:"flex-start",item:!0,className:t.labelSupGreen},e.name,"-",e.submissionsno):r.a.createElement(C.a,{xs:2,container:!0,justify:"start",alignItems:"flex-start",item:!0,className:t.labelSup},e.name,"-",e.submissionsno),ft===e?r.a.createElement(C.a,{xs:3,container:!0,justify:"start",alignItems:"flex-start",item:!0,className:t.labelSupGreen},e.description):r.a.createElement(C.a,{xs:3,container:!0,justify:"start",alignItems:"flex-start",item:!0,className:t.labelSup},e.description),r.a.createElement(C.a,{xs:4,container:!0,justify:"start",alignItems:"flex-start",item:!0,className:t.labelSup},r.a.createElement("div",{className:t.mostRecent},"Most Resent Label"))),ft===e?r.a.createElement(C.a,{xs:11,container:!0,justify:"center",alignItems:"center",item:!0,className:t.labelChangeGreen},e.change):r.a.createElement(C.a,{xs:11,container:!0,justify:"center",alignItems:"center",item:!0,className:t.labelChange},e.change)):r.a.createElement(C.a,{xs:11},r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"center",item:!0,style:{display:"inline-flex"}},ft===e?r.a.createElement(C.a,{xs:3,container:!0,justify:"start",alignItems:"flex-start",item:!0,className:t.labelDateGreen}," ",e.x):r.a.createElement(C.a,{xs:3,container:!0,justify:"start",alignItems:"flex-start",item:!0,className:t.labelDate}," ",e.x),ft===e?r.a.createElement(C.a,{xs:2,container:!0,justify:"start",alignItems:"flex-start",item:!0,className:t.labelSupGreen},e.name,"-",e.submissionsno):r.a.createElement(C.a,{xs:2,container:!0,justify:"start",alignItems:"flex-start",item:!0,className:t.labelSup},e.name,"-",e.submissionsno),ft===e?r.a.createElement(C.a,{xs:7,container:!0,justify:"start",alignItems:"flex-start",item:!0,className:t.labelSupGreen},e.description):r.a.createElement(C.a,{xs:7,container:!0,justify:"start",alignItems:"flex-start",item:!0,className:t.labelSup},e.description)),ft===e?r.a.createElement(C.a,{xs:11,container:!0,justify:"center",alignItems:"center",item:!0,className:t.labelChangeGreen},e.change):r.a.createElement(C.a,{xs:11,container:!0,justify:"center",alignItems:"center",item:!0,className:t.labelChange},e.change)),r.a.createElement(C.a,{xs:1},r.a.createElement(ed.a,{className:t.checkboxIcon,control:r.a.createElement(bt.a,{icon:r.a.createElement(uc,null),checkedIcon:r.a.createElement(pc,null),name:"checkedH",onChange:function(){Pt(e,a)},value:Be,checked:a===Be&&Be}),label:""}))):null})))),r.a.createElement(C.a,{xs:1,container:!0,justify:"center",alignItems:"center",item:!0},r.a.createElement("span",{style:{borderTop:"1px solid #a2a2a2",width:"100%",marginBottom:"-30%"}}),r.a.createElement("img",{style:{width:"28px"},src:fc.a})),r.a.createElement(C.a,{xs:5,container:!0,justify:"center",alignItems:"center",item:!0},r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"center",item:!0,className:t.selectLabel}," ","Select a label for Comparison"," "),r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"start",item:!0,className:t.twoBox},oe&&oe.map((function(e,a){return 0!==e.file_links.label.length&&e.x>Ge?r.a.createElement(C.a,{className:t.compareText},r.a.createElement(C.a,{xs:11},r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"center",item:!0,style:{display:"inline-flex"}},r.a.createElement(C.a,{xs:3,container:!0,justify:"start",alignItems:"flex-start",item:!0,className:t.labelDate}," ",e.x),r.a.createElement(C.a,{xs:2,container:!0,justify:"start",alignItems:"flex-start",item:!0,className:t.labelSup},e.name,"-",e.submissionsno),r.a.createElement(C.a,{xs:7,container:!0,justify:"start",alignItems:"flex-start",item:!0,className:t.labelSup},e.description)),r.a.createElement(C.a,{xs:11,container:!0,justify:"center",alignItems:"center",item:!0,className:t.labelChange},e.change)),r.a.createElement(C.a,{xs:1},r.a.createElement(ed.a,{className:t.checkboxIcon,control:r.a.createElement(bt.a,{icon:r.a.createElement(uc,null),checkedIcon:r.a.createElement(pc,null),name:"checkedH",onChange:function(){wt(e,a),ze(!0)}}),label:""}))):null})),Dt===ft?r.a.createElement(C.a,{style:{display:"flex",justifyContent:"center",alignItems:"center",height:"100%"}},r.a.createElement(y.a,{className:t.StyledErrorTypography},"Please select earlier label")):null))):rt?r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"flex-start",item:!0},r.a.createElement(C.a,{container:!0,item:!0,xs:12,justify:"center",alignItems:"center"},r.a.createElement(C.a,{container:!0,item:!0,xs:5,justify:"center",alignItems:"center",className:t.Label},r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"center",item:!0,className:t.selectLabelC}," ",ct&&ct)),r.a.createElement(C.a,{container:!0,item:!0,xs:1,justify:"center",alignItems:"center"},r.a.createElement("span",{style:{borderTop:"1px solid #a2a2a2",width:"100%",marginBottom:"-30%"}}),r.a.createElement("img",{style:{width:"28px"},src:Sr.a})),r.a.createElement(C.a,{container:!0,item:!0,xs:5,justify:"center",alignItems:"center",className:t.Label},r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"center",item:!0,className:t.selectLabel}," ",ut&&ut))),r.a.createElement(C.a,{container:!0,item:!0,xs:12,justify:"center",alignItems:"center"},r.a.createElement("div",{style:{height:"62vh",width:"100vw"}},r.a.createElement("iframe",{style:{height:"100%",width:"100%"},src:rt,allowFullScreens:!0}))),r.a.createElement(C.a,{container:!0,item:!0,xs:12,justify:"center",alignItems:"center"},r.a.createElement(C.a,{container:!0,item:!0,justify:"center",alignItems:"center",onClick:function(){return Ie(!1)},className:t.compareN},r.a.createElement("img",{style:{width:"15px"},src:hc.a}),r.a.createElement(y.a,{className:t.labelTitle},"New Compare")))):r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"flex-start",item:!0},r.a.createElement("div",{style:{height:"80vh",width:"100vw"}},r.a.createElement(tr.SemipolarLoading,{color:"#0352CC"})))))))}var ad=Object(f.a)((function(e){return{main:{height:"100%"},Background:{padding:"20px",width:"100%",borderRadius:"20px",boxShadow:"0px 0px 10px ".concat(e.palette.primary.lightBorder," !important")},Document:{borderRadius:"20px",boxShadow:"0px 0px 10px ".concat(e.palette.primary.lightBorder," !important")},ListItem:{marginBottom:"10px",padding:"10px",borderRadius:"10px",backgroundColor:e.palette.white,border:"2px solid ".concat(e.palette.primary.lightBorder)},ListItemText:{fontSize:"1.7vh",fontWeight:"900",color:e.palette.black,textAlign:"center"},PageNumberText:{fontSize:"1.7vh",fontWeight:"900",color:e.palette.black,textAlign:"center",marginLeft:"10px",marginBottom:"10px",marginRight:"10px",padding:"5px",backgroundColor:e.palette.white,height:"100%"},PageNumberInput:{fontSize:"1.7vh",fontWeight:"900",color:e.palette.black,textAlign:"center",padding:"5px",border:"none",borderRadius:"10px",width:e.spacing(5),backgroundColor:e.palette.primary.lightBorder,height:"100%"}}}));function nd(e){var t=ad(),a=Object(n.useState)(e.data.Success.link),i=Object(d.a)(a,2),o=i[0],l=i[1],m=Object(n.useState)(e.data.Success.link),u=Object(d.a)(m,2),p=u[0],g=(u[1],Object(n.useState)(null)),h=Object(d.a)(g,2),T=(h[0],h[1],Object(n.useState)(1)),f=Object(d.a)(T,2),A=(f[0],f[1]),E=Object(n.useState)(!1),b=Object(d.a)(E,2),N=b[0],S=b[1];Object(n.useEffect)((function(){function e(){return(e=Object(s.a)(c.a.mark((function e(){return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:try{S(!0)}catch(t){console.log(t)}case 1:case"end":return e.stop()}}),e)})))).apply(this,arguments)}!function(){e.apply(this,arguments)}()}),[o]);var D=function(e){S(!1),isNaN(e)?A(1):l(p+"#page=".concat(e))};return r.a.createElement("div",{className:t.main},r.a.createElement(C.a,{container:!0},r.a.createElement(C.a,{xs:2,container:!0,justify:"center",alignItems:"flex-start",item:!0},r.a.createElement(fa.a,{component:"nav","aria-label":"contacts",className:t.Background},/^\d+$/.test(e.data.Success.clinical_pharmacology)?r.a.createElement(Ca.a,{className:t.ListItem,button:!0,onClick:function(){D(parseInt(e.data.Success.clinical_pharmacology))}},r.a.createElement(ya.a,null,r.a.createElement(y.a,{className:t.ListItemText},"Clinical Pharmacology"))):null,/^\d+$/.test(e.data.Success.clinical_studies)?r.a.createElement(Ca.a,{className:t.ListItem,button:!0,onClick:function(){D(parseInt(e.data.Success.clinical_studies))}},r.a.createElement(ya.a,null,r.a.createElement(y.a,{className:t.ListItemText},"Clinical Studies"))):null,/^\d+$/.test(e.data.Success.dosage_and_administration)?r.a.createElement(Ca.a,{className:t.ListItem,button:!0,onClick:function(){D(parseInt(e.data.Success.dosage_and_administration))}},r.a.createElement(ya.a,null,r.a.createElement(y.a,{className:t.ListItemText},"Dosage and Administration"))):null)),r.a.createElement(C.a,{xs:10,container:!0,justify:"center",alignItems:"flex-start",item:!0},r.a.createElement(C.a,{xs:8,container:!0,justify:"center",alignItems:"flex-start",item:!0},r.a.createElement(C.a,{xs:12,container:!0,justify:"center",alignItems:"flex-start",item:!0,style:{paddingTop:"20px"}},N&&o?r.a.createElement("iframe",{style:{height:"85vh",width:"100vw",boxShadow:"0px 0px 10px #e3f1ff",border:"unset",borderRadius:"10px"},src:o,id:"MyFrame"}):null)))))}Js.a.GlobalWorkerOptions.workerSrc="//cdnjs.cloudflare.com/ajax/libs/pdf.js/".concat(Js.a.version,"/pdf.worker.js");var rd=Object(f.a)((function(e){var t,a;return{root:{width:"94vw",overflowX:"scroll"},TableHeadRow:{backgroundColor:e.palette.primary.lightBorder},TableHeadCells:{boxShadow:"none",border:"none",fontWeight:"700"},TableBodyRows:{"&:nth-of-type(odd)":{padding:"0",backgroundColor:e.palette.primary.lightBackground},"&:nth-of-type(even)":{padding:"0",backgroundColor:e.palette.white}},TableBodyCells:{boxShadow:"none",border:"none"},TableBodyCellBox:{height:"70px",minWidth:"100px",overflowY:"auto",boxShadow:"none",border:"none"},TableBodyCellBoxBig:{height:"70px",minWidth:"300px",overflowY:"auto",boxShadow:"none",border:"none"},TableCellTypography:{fontSize:"0.9rem"},Form:{width:"100%"},Textfield:{marginBottom:e.spacing(2),border:"none",marginLeft:e.spacing(1),borderRadius:"15px",minWidth:e.spacing(45),height:"100%",minHeight:"50px",fontSize:"2vh",background:e.palette.navbar.grayBackground,color:e.palette.black},Button:{fontSize:"0.8rem",textTransform:"none",fontWeight:"400",minHeight:"50px",padding:"10px",background:e.palette.navbar.grayBackground,borderRadius:"10px",borderBottomLeftRadius:"0px",borderTopLeftRadius:"0px",marginBottom:e.spacing(2)},customCheckboxContainer:{display:"block",position:"relative",paddingLeft:"35px",marginBottom:"12px",cursor:"pointer",fontSize:"22px",userSelect:"none"},ResetButton:(t={fontSize:"0.8rem",borderRadius:"10px",maxHeight:"50px",minHeight:"50px",fontWeight:"400",textTransform:"none",backgroundColor:e.palette.primary.lightBorder,color:e.palette.black},Object(g.a)(t,"fontSize",e.spacing(2)),Object(g.a)(t,"padding",0),Object(g.a)(t,"marginLeft","20px"),t),ErrorTypography:(a={fontWeight:"700",fontSize:"0.8rem",padding:"20px",marginLeft:"20px"},Object(g.a)(a,"fontSize","0.8rem"),Object(g.a)(a,"maxHeight","50px"),Object(g.a)(a,"minHeight","50px"),Object(g.a)(a,"color",e.palette.fatalRed),a)}})),id=(a(122),r.a.createElement(ft.a,{fontSize:"small"})),od=r.a.createElement(Et.a,{fontSize:"small"});function ld(e){var t=Object(n.useState)(),a=Object(d.a)(t,2),i=a[0],o=a[1],l=Object(n.useState)(1),m=Object(d.a)(l,2),u=m[0],p=m[1],g=Object(n.useState)(e.data),h=Object(d.a)(g,2),T=h[0],f=h[1],A=Object(n.useState)(e.ColNames),E=Object(d.a)(A,2),b=E[0],C=(E[1],Object(n.useState)()),S=Object(d.a)(C,2),D=S[0],O=S[1],x=Object(n.useState)("Commitment Description"),v=Object(d.a)(x,2),P=v[0],I=v[1],w=Object(n.useState)([]),L=Object(d.a)(w,2),B=L[0],F=L[1],z=Object(n.useState)([]),Y=Object(d.a)(z,2),G=Y[0],H=Y[1],W=Object(n.useState)(),Q=Object(d.a)(W,2),J=Q[0],Z=Q[1],X=Object(n.useState)(!0),q=Object(d.a)(X,2),$=q[0],ee=q[1],te=Object(n.useState)(!0),ae=Object(d.a)(te,2),ne=ae[0],re=ae[1],ie=Object(n.useState)(!1,{}),oe=Object(d.a)(ie,2),le=oe[0],ce=oe[1],se=Object(n.useState)(),de=Object(d.a)(se,2),me=de[0],ue=de[1],pe=Object(n.useState)([{columnKey:"CMT_ID",columnName:"Commitment ID",isChecked:!0},{columnKey:"CMT_NUMBER",columnName:"Commitment Number",isChecked:!0},{columnKey:"CMT_DOC_TYPE",columnName:"Application Type",isChecked:!0},{columnKey:"NDA_NUMBER",columnName:"Application Number",isChecked:!0},{columnKey:"CMT_DOC_TYPE_NO",columnName:"Submission Number",isChecked:!0},{columnKey:"PRODUCT",columnName:"Product",isChecked:!0},{columnKey:"NDA_BLA_APPROVAL_DATE",columnName:"Approval Date",isChecked:!0},{columnKey:"CMT_DESC",columnName:"Commitment Description",isChecked:!0},{columnKey:"CMT_STATUS",columnName:"Commitment Status",isChecked:!0},{columnKey:"SUBPART_FLAG",columnName:"Subpart Flag",isChecked:!0},{columnKey:"NCT1",columnName:"NCT ID",isChecked:!0},{columnKey:"LastCTUpdate1",columnName:"Last Update Date",isChecked:!0},{columnKey:"N1",columnName:"Sample Size",isChecked:!0},{columnKey:"APPLICANT",columnName:"Applicant",isChecked:!0},{columnKey:"CMT_STATUS_DESC",columnName:"Commitment Status Description",isChecked:!0},{columnKey:"STUDY_TYPE",columnName:"Study type",isChecked:!0},{columnKey:"STUDY_START_DATE",columnName:"Study start date",isChecked:!0},{columnKey:"PROTOCOL_SUBMISSION_DATE",columnName:"Protocol Submission Date",isChecked:!0},{columnKey:"FINAL_RPT_RECV_DATE",columnName:"Final Report Received Data",isChecked:!0},{columnKey:"ANNUAL_RPT_DUE_DATE",columnName:"Annual report due date",isChecked:!0},{columnKey:"ANNUAL_RPT_RECV_DATE",columnName:"Annual report rececived date",isChecked:!0},{columnKey:"FINAL_REPORT_DUE_DATE",columnName:"Final report due date",isChecked:!0}]),ge=Object(d.a)(pe,2),he=ge[0],Te=ge[1],fe=Object(n.useState)(!0),Ae=Object(d.a)(fe,2),Ee=(Ae[0],Ae[1]),be=rd(),Ne=function(){var e=Object(s.a)(c.a.mark((function e(t){return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:t.preventDefault(),re(!ne);case 2:case"end":return e.stop()}}),e)})));return function(t){return e.apply(this,arguments)}}(),Ce=function(){var e=Object(s.a)(c.a.mark((function e(t){return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:I(t.target.value);case 1:case"end":return e.stop()}}),e)})));return function(t){return e.apply(this,arguments)}}();Object(n.useEffect)((function(){function t(){return(t=Object(s.a)(c.a.mark((function t(){var a,n,r,i,l,s,d,m,p,g,h;return c.a.wrap((function(t){for(;;)switch(t.prev=t.next){case 0:for(a=e.data,n=0;n<a.length;n++)r={NDA_NUMBER:a[n].NDA_NUMBER,CMT_STATUS:a[n].CMT_STATUS,SUBPART_FLAG:a[n].SUBPART_FLAG,FINAL_REPORT_DUE_DATE:a[n].FINAL_REPORT_DUE_DATE,CMT_NUMBER:a[n].CMT_NUMBER,CMT_DESC:a[n].CMT_DESC},a[n]=r;if(F(a),i=new Date,l=i.getMonth()+1+"/"+i.getDate()+"/"+i.getFullYear(),ue("ria-pmr-"+l+".csv"),s=[],D)for(d=Object.keys(b).find((function(e){return b[e]===P})),n=0;n<a.length;n++)String(a[n][d]).toLowerCase().includes(D)&&s.push(a[n]);else s=a;if(H(s),e.data[0]){for(m=Object.keys(e.data[0]),p=0;p<m.length;p++)m[p]=b[m[p]];Z(m)}else;s.length>0?(s.length<50?o(1):s.length%50===0?o(s.length/50):o(1+~~(s.length/50)),g=s.slice(50*(u-1),50*u),f(g),H(s)):D&&0===s.length?f([]):(a.length<50?o(1):a.length%50===0?o(a.length/50):o(1+~~(a.length/50)),h=a.slice(50*(u-1),50*u),f(h),H(a)),ee(!1);case 12:case"end":return t.stop()}}),t)})))).apply(this,arguments)}!function(){t.apply(this,arguments)}()}),[u,ne,e.data]);var Se=function(e){var t,a=he,n=Object($n.a)(a);try{for(n.s();!(t=n.n()).done;){var r=t.value;r.columnKey==e.target.value&&(r.isChecked=e.target.checked)}}catch(o){n.e(o)}finally{n.f()}Te(a);var i=he.every((function(e){return 1==e.isChecked}));Ee(i),re(!ne)};return!1===$&&B.length>0?r.a.createElement("div",{className:"complianceDashboard"},r.a.createElement(R.a,{display:"flex",justifyContent:"flex-start"},r.a.createElement("form",{onSubmit:Ne,className:be.Form},r.a.createElement(R.a,{display:"flex",id:"pmrSearchBox",justifyContent:"flex-start"},r.a.createElement(sa,{id:"filter",menuItems:J,dropdownValue:P,title:"Column",name:"filter",handleChange:Ce}),r.a.createElement(K,{placeholder:"Search keyword",id:"searchTerm",value:D,handleChange:function(e){O(String(e.target.value).toLowerCase())},name:"searchTerm"}),r.a.createElement(j.a,{type:"submit",className:be.Button},r.a.createElement(V,null)),r.a.createElement(_.a,{className:be.ResetButton,onClick:function(){O(""),re(!ne)}},"Reset"),D&&0===T.length?r.a.createElement(y.a,{className:be.ErrorTypography},"No Results, Please press the Reset button"):null)),r.a.createElement("div",{style:{padding:"3px 0 0 10px"}},T?r.a.createElement(st.CSVLink,{data:G,filename:me},r.a.createElement("img",{src:cl.a,style:{width:"33px",height:"42px"}})):r.a.createElement("div",null))),r.a.createElement(U.a,{fullWidth:!0,maxWidth:"sm",onClose:function(){ce([!1,{}])},"aria-labelledby":"customized-dialog-title",open:void 0!==le[0]&&le[0]},r.a.createElement(M.a,null,"Hide/Show Columns"),he?r.a.createElement(k.a,null,he.map((function(e){return r.a.createElement("div",null,r.a.createElement("div",{class:"col-sm-6 pull-left"},e.columnName),r.a.createElement("div",{class:"col-sm-6"},r.a.createElement("label",{class:"customCheckboxContainer pull-right"},r.a.createElement(bt.a,{label:e.columnName,icon:id,checkedIcon:od,style:{marginRight:8},value:e.columnKey,checked:e.isChecked,onChange:Se}),r.a.createElement("span",{class:"checkmark"}))))}))):r.a.createElement("div",null)),0!==T.length?r.a.createElement(r.a.Fragment,null,r.a.createElement(N.a,{className:be.root},r.a.createElement($a.a,{className:be.table,"aria-label":"caption table"},r.a.createElement(an.a,null,r.a.createElement(nn.a,{className:be.TableHeadRow},he.map((function(e){return Object.keys(B[0]).map((function(t,a){if(e.columnKey===t&&!0===e.isChecked)return r.a.createElement(tn.a,{className:be.TableHeadCells,align:"left"},r.a.createElement(mc.a,null,b[t]))}))})))),r.a.createElement(en.a,null,T.map((function(e){return r.a.createElement(nn.a,{className:be.TableBodyRows},he.map((function(t){return Object.keys(e).map((function(a,n){if(t.columnKey===a&&!0===t.isChecked)return r.a.createElement(tn.a,{className:be.TableBodyCells,align:"left"},"NCT1"===a?r.a.createElement(R.a,{className:be.TableBodyCellBox},r.a.createElement(Xt.a,{target:"_blank",rel:"noopener",href:"https://clinicaltrials.gov/ct2/show/"+e[a]},r.a.createElement(y.a,{className:be.TableCellTypography},e[a]))):"CMT_DESC"===a?r.a.createElement(R.a,{className:be.TableBodyCellBoxBig},r.a.createElement(y.a,{className:be.TableCellTypography},e[a])):r.a.createElement(R.a,{className:be.TableBodyCellBox},r.a.createElement(y.a,{className:be.TableCellTypography},e[a])))}))})))}))))),r.a.createElement("div",{className:"pagination"},r.a.createElement(Fo.a,{count:i,onChange:function(e,t){p(t)}}))):null):null}var cd=a(824),sd=a(825),dd=a.n(sd),md=a(826),ud=a.n(md),pd=a(827),gd=a.n(pd),hd=a(828),Td=a.n(hd),fd=a(829),Ad=a.n(fd),Ed=Object(P.a)((function(e){return{tooltip:{marginTop:"-11vh",marginLeft:"-1vh",width:"fit-content",padding:"10px",paddingLeft:"20px",paddingRight:"20px",borderRadius:"10px",color:e.palette.white,border:"2px solid ".concat(e.palette.primary.lightBorder)}}}))(L.a);var bd=function(e){var t=Vs(),a=(Object(u.f)(),new URLSearchParams(Object(u.g)().search)),i=Object(n.useContext)(Mt),o=i.state,l=i.dispatch,m=Object(n.useState)(cd.pmc_commitments),p=Object(d.a)(m,2),g=p[0],h=p[1],T=Object(n.useState)(!1),f=Object(d.a)(T,2),A=f[0],E=f[1],b=Object(n.useState)(0),D=Object(d.a)(b,2),O=D[0],x=D[1],v=Object(n.useState)(),P=Object(d.a)(v,2),I=(P[0],P[1]),F=Object(n.useState)(),Y=Object(d.a)(F,2),V=(Y[0],Y[1],Object(n.useState)()),G=Object(d.a)(V,2),H=(G[0],G[1],Object(n.useState)()),W=Object(d.a)(H,2),Q=(W[0],W[1],Object(n.useState)()),J=Object(d.a)(Q,2),K=J[0],Z=J[1],X=Object(n.useState)(),q=Object(d.a)(X,2),$=q[0],ee=q[1],te=Object(n.useState)(!0),ae=Object(d.a)(te,2),ne=ae[0],re=ae[1],ie=Object(n.useState)(),oe=Object(d.a)(ie,2),le=oe[0],ce=oe[1],se=Object(n.useState)(),de=Object(d.a)(se,2),me=de[0],ue=de[1],ge=Object(n.useState)(!0),he=Object(d.a)(ge,2),Te=he[0],fe=he[1],Ae=Object(n.useState)(),Ee=Object(d.a)(Ae,2),Se=Ee[0],De=Ee[1],_e=Object(n.useState)(),Oe=Object(d.a)(_e,2),xe=Oe[0],ve=Oe[1],Re=Object(n.useState)(),Pe=Object(d.a)(Re,2),Ie=Pe[0],we=Pe[1],Le=Object(n.useState)(),je=Object(d.a)(Le,2),Be=je[0],Ue=je[1],Me=Object(n.useState)(!1),Fe=Object(d.a)(Me,2),ze=Fe[0],Ve=Fe[1],Ge=Object(n.useState)([{element:"#timelineView",intro:"Approval history within Regulatory 360 provides a timeline history of the application starting with Original approval and all supplements including ability to select types of supplements (Labeling, Efficacy etc) as well as filter using specific date range",position:"top",tooltipClass:"myTooltipClass",highlightClass:"myHighlightClass"},{element:"#applicationContent",intro:"Application contents within Regulatory 360 provides Administrative summary, Clinical Studies Summary and Submission Summary (Number of studies, number of indications etc)",position:"bottom",tooltipClass:"myTooltipClass",highlightClass:"myHighlightClass"},{element:"#pmrcView",intro:"PMR/C within Regulatory 360 provides post marketing requirements and ccommitment issued at the time of approcal",position:"top",tooltipClass:"myTooltipClass",highlightClass:"myHighlightClass"},{element:"#labelView",intro:"Label view allows review of the latest label and reach a specific section",position:"bottom",tooltipClass:"myTooltipClass",highlightClass:"myHighlightClass"}]),He=Object(d.a)(Ge,2),We=He[0],Qe=(He[1],Object(n.useState)(!1)),Je=Object(d.a)(Qe,2),Ke=Je[0],Ze=Je[1],Xe=function(){Ze(!1)},qe=function(e){0===e&&x(0),1===e&&(ot(),x(2)),2===e&&(rt(),x(3)),3===e&&(it(),x(4))};Object(n.useEffect)((function(){function t(){return(t=Object(s.a)(c.a.mark((function t(){var n,r,i,s,d,m,u,p,g,T,f,A;return c.a.wrap((function(t){for(;;)switch(t.prev=t.next){case 0:return t.prev=0,t.next=3,Ce(e.match.params.number);case 3:return n=t.sent,console.log(n),h(n.data),t.next=8,l({type:wt.SET_MODULE,value:e.match.params.module});case 8:if(!1!==ze){t.next=26;break}return r=e.match.params.number,i=e.match.params.type+e.match.params.number,s=a.get("approvalPathway"),d=a.get("activeIngredient"),m=a.get("tradeName"),t.next=16,ke(e.match.params.number).then((function(e){u=e})).catch((function(e){console.log(e)}));case 16:Z(u),ve(d),we(m),De(s),ue(i),ce(r),et(i),setTimeout((function(){re(!1)}),3e3),t.next=42;break;case 26:return fe(!0),t.next=29,Ye(me).then((function(e){p=e})).catch((function(e){console.log(e)}));case 29:g=p.data.success[0].activeIngredients,T=p.data.success[0].approvalPathway,f=p.data.success[0].tradeName,ve(g),we(f),De(T),tt("timelineView"),at(0),(A=JSON.parse(localStorage.getItem("navigation"))).regulatory={url:"/regulatory360/".concat(o.module,"/").concat(me,"?approvalPathway=").concat(T,"&activeIngredient=").concat(g,"&tradeName=").concat(f),value:"Regulatory360:".concat(me)},localStorage.setItem("navigation",JSON.stringify(A)),et(me),fe(!1);case 42:t.next=47;break;case 44:t.prev=44,t.t0=t.catch(0),console.log(t.t0);case 47:case"end":return t.stop()}}),t,null,[[0,44]])})))).apply(this,arguments)}!function(){t.apply(this,arguments)}()}),[e,le,me,Se]);var $e,et=function(){var e=Object(s.a)(c.a.mark((function e(t){var a;return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:return fe(!0),e.next=3,ye(t);case 3:a=e.sent,ee(a),fe(!1);case 6:case"end":return e.stop()}}),e)})));return function(t){return e.apply(this,arguments)}}(),tt=function(e,t){x(t)},at=function(e){x(e)},nt=function(){var e=Object(s.a)(c.a.mark((function e(t){var a;return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:fe(!0),console.log("network nda2",t),ue(t),a=t.slice(-6),ce(a),Ve(!0),fe(!1);case 7:case"end":return e.stop()}}),e)})));return function(t){return e.apply(this,arguments)}}(),rt=function(){var e=Object(s.a)(c.a.mark((function e(){return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:return e.next=2,Ne(le).then((function(e){var t=e.data.success[0].pmr;I(t)})).catch((function(e){console.log(e)}));case 2:case"end":return e.stop()}}),e)})));return function(){return e.apply(this,arguments)}}(),it=function(){var e=Object(s.a)(c.a.mark((function e(){var t;return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:return e.next=2,ke(le).then((function(e){t=e})).catch((function(e){console.log(e)}));case 2:Z(t);case 3:case"end":return e.stop()}}),e)})));return function(){return e.apply(this,arguments)}}(),ot=function(){var e=Object(s.a)(c.a.mark((function e(){return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:return e.next=2,be(le).then((function(e){console.log(e.data),Ue(e.data)})).catch((function(e){console.log(e)}));case 2:case"end":return e.stop()}}),e)})));return function(){return e.apply(this,arguments)}}(),lt=function(){var e=Object(s.a)(c.a.mark((function e(t){return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:return t.preventDefault(),Be.searchTerm=o.searchTerm.searchTerm,Be.source=o.searchTerm.source,Be.category=o.searchTerm.category,Be.tradeName=Ie,e.next=7,l({type:wt.SET_CART_ITEMS,value:o.cartItems+1});case 7:return e.next=9,l({type:wt.SET_APPLICATION_CONTENT,value:Be});case 9:return e.next=11,l({type:wt.SET_REPORT,value:{id:"Application Content",data:Be}});case 11:case"end":return e.stop()}}),e)})));return function(t){return e.apply(this,arguments)}}(),ct=function(){var e=Object(s.a)(c.a.mark((function e(t){return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:return t.preventDefault(),$.searchTerm=o.searchTerm.searchTerm,$.source=o.searchTerm.source,$.category=o.searchTerm.category,$.tradeName=Ie,e.next=7,l({type:wt.SET_CART_ITEMS,value:o.cartItems+1});case 7:return e.next=9,l({type:wt.SET_APPLICATION_CONTENT,value:Be});case 9:return e.next=11,l({type:wt.SET_REPORT,value:{id:"RLD Information",data:$}});case 11:case"end":return e.stop()}}),e)})));return function(t){return e.apply(this,arguments)}}(),st=function(){et(me)};return Te?r.a.createElement("div",{className:t.root},r.a.createElement(Ft.Steps,{enabled:Ke,steps:We,showProgress:!0,scrollToElement:!0,initialStep:0,onBeforeChange:qe,onExit:Xe}),r.a.createElement(C.a,{container:!0,justify:"center",alignItems:"center",item:!0,xs:12,className:t.GridCards}),r.a.createElement(R.a,{display:"flex",justifyContent:"flex-start"},r.a.createElement(y.a,{className:t.TimeLineReg},"Regulatory 360")),r.a.createElement(N.a,{elevation:2,className:t.paper},r.a.createElement(C.a,{justify:"center",alignItems:"center",item:!0,xs:12,className:t.TimeLine},r.a.createElement(C.a,{xs:4,container:!0,justify:"left",alignItems:"left",item:!0},r.a.createElement(y.a,{className:t.RegBannerTitle},"Active Ingredient :",r.a.createElement(L.a,{title:xe&&xe,"aria-label":"Button Link"},xe&&xe.length>40?r.a.createElement(L.a,{TransitionComponent:pe.a,title:xe},r.a.createElement(y.a,{className:t.RegBannerText},xe.substring(0,39),"...")):r.a.createElement(y.a,{className:t.RegBannerText},xe))))," ",r.a.createElement(C.a,{xs:4,container:!0,justify:"center",alignItems:"center",item:!0,style:{marginLeft:"15px",paddingLeft:"5px"}},r.a.createElement(y.a,{className:t.RegBannerTitle},"Drug :"," ",r.a.createElement(L.a,{title:Ie,"aria-label":"Button Link"},Ie&&Ie.length>40?r.a.createElement(L.a,{TransitionComponent:pe.a,title:Ie},r.a.createElement(y.a,{className:t.RegBannerText},Ie.substring(0,39),"...")):r.a.createElement(y.a,{className:t.RegBannerText},Ie)))),r.a.createElement(C.a,{xs:4,justify:"end",alignItems:"end"},r.a.createElement(C.a,{xs:8,justify:"end",alignItems:"end",style:{paddingLeft:"5px"}}),r.a.createElement(C.a,{xs:4,justify:"end",alignItems:"end",style:{paddingLeft:"5px",float:"right"}},r.a.createElement(y.a,{className:t.RegBannerTitleend},"Application :",r.a.createElement(L.a,{title:me,"aria-label":"Button Link"},r.a.createElement(y.a,{className:t.RegBannerTextend},me))))))),r.a.createElement(C.a,{container:!0,item:!0,xs:12,className:t.GridCardTabs},r.a.createElement(Yo.a,{className:t.CardTabs,value:O,onChange:tt,indicatorColor:"white",variant:"fullWidth","aria-label":"full width tabs example",boxShadow:3}," ",r.a.createElement(Vo.a,{id:"timelineView",className:t.CardTabs,label:r.a.createElement("div",{style:{display:"inline-flex"}}," ",r.a.createElement(S.a,{alt:"Logo",src:dd.a,className:t.TimelineIcon}),"Timeline View"," "),onClick:st}),"505(b)(2)"===Se?r.a.createElement(Vo.a,{id:"rldTab",className:t.CardTabs,label:r.a.createElement("div",{style:{display:"inline-flex"}}," ",r.a.createElement(S.a,{alt:"Logo",src:ud.a,className:t.TimelineIcon}),"RLD Information"," ")}):r.a.createElement("div",{style:{width:"0px"}}),r.a.createElement(Vo.a,{id:"applicationContent",className:t.CardTabs,label:r.a.createElement("div",{style:{display:"inline-flex"}}," ",r.a.createElement(S.a,{alt:"Logo",src:Ad.a,className:t.TimelineIcon}),"Applications Content"," "),onClick:ot}),r.a.createElement(Vo.a,{id:"pmrcView",className:t.CardTabs,label:r.a.createElement("div",{style:{display:"inline-flex"}}," ",r.a.createElement(S.a,{alt:"Logo",src:Td.a,className:t.TimelineIcon}),"PMR/C"," "),onClick:rt}),r.a.createElement(Vo.a,{id:"labelView",className:t.CardTabs,label:r.a.createElement("div",{style:{display:"inline-flex"}}," ",r.a.createElement(S.a,{alt:"Logo",src:gd.a,className:t.TimelineIcon}),"Prescribing Information"," "),onClick:it})),r.a.createElement(tr.SemipolarLoading,{color:"#0352CC"}))):r.a.createElement("div",{className:t.root},r.a.createElement(Ft.Steps,{enabled:Ke,steps:We,showProgress:!0,scrollToElement:!0,initialStep:0,onBeforeChange:qe,onExit:Xe}),r.a.createElement(C.a,{container:!0,justify:"center",alignItems:"center",item:!0,xs:12,className:t.GridCards}),r.a.createElement(C.a,{container:!0,item:!0,xs:12,justify:"flex-start",alignItems:"center",className:t.GridHeaderBreadcrumbs},r.a.createElement(C.a,{container:!0,item:!0,xs:8,justify:"flex-start",alignItems:"center",className:t.GridHeaderBreadcrumbs},r.a.createElement(Ol,{search:e.search,lastItem:"Regulatory 360: "+me})),r.a.createElement(C.a,{container:!0,item:!0,xs:4,justify:"flex-end",alignItems:"center",className:t.GridHeaderBreadcrumbs},r.a.createElement(R.a,{display:"flex",justify:"flex-end",justifyContent:"flex-end"},r.a.createElement(y.a,{className:t.TimeLineReg},"Regulatory 360")))),r.a.createElement(N.a,{elevation:2,className:t.paper},r.a.createElement(C.a,{justify:"center",alignItems:"center",item:!0,xs:12,className:t.TimeLine},r.a.createElement(C.a,{xs:4,container:!0,justify:"left",alignItems:"left",item:!0},r.a.createElement(y.a,{className:t.RegBannerTitle},"Active Ingredient :",r.a.createElement(L.a,{title:xe&&xe,"aria-label":"Button Link"},xe&&xe.length>40?r.a.createElement(L.a,{TransitionComponent:pe.a,title:xe},r.a.createElement(y.a,{className:t.RegBannerText},xe.substring(0,39),"...")):r.a.createElement(y.a,{className:t.RegBannerText},xe))))," ",r.a.createElement(C.a,{xs:4,container:!0,justify:"center",alignItems:"center",item:!0,style:{marginLeft:"15px",paddingLeft:"5px"}},r.a.createElement(y.a,{className:t.RegBannerTitle},"Drug :"," ",r.a.createElement(L.a,{title:Ie,"aria-label":"Button Link"},Ie.length>40?r.a.createElement(L.a,{TransitionComponent:pe.a,title:Ie},r.a.createElement(y.a,{className:t.RegBannerText},Ie.substring(0,39),"...")):r.a.createElement(y.a,{className:t.RegBannerText},Ie)))),r.a.createElement(C.a,{xs:4,justify:"end",alignItems:"end"},r.a.createElement(C.a,{xs:8,justify:"end",alignItems:"end",style:{paddingLeft:"5px"}}),r.a.createElement(C.a,{xs:4,justify:"end",alignItems:"end",style:{paddingLeft:"5px",float:"right"}},r.a.createElement(y.a,{className:t.RegBannerTitleend},"Application :",r.a.createElement(L.a,{title:me,"aria-label":"Button Link"},r.a.createElement(y.a,{className:t.RegBannerTextend},me))))))),r.a.createElement(C.a,null,r.a.createElement(C.a,{container:!0,item:!0,xs:12,className:t.GridCardTabs},r.a.createElement(Yo.a,{className:t.CardTabs,value:O,onChange:tt,indicatorColor:"white",variant:"fullWidth","aria-label":"full width tabs example"}," ",r.a.createElement(Vo.a,Object.assign({id:"timelineView",className:t.CardTabs,label:r.a.createElement("div",{style:{display:"inline-flex"}}," ",r.a.createElement(S.a,{alt:"Logo",src:dd.a,className:t.TimelineIcon}),"Timeline View"," ")},{id:"full-width-tab-".concat($e=0),"aria-controls":"full-width-tabpanel-".concat($e)},{onClick:st})),"505(b)(2)"===Se?r.a.createElement(Vo.a,{id:"rldTab",className:t.CardTabs,label:r.a.createElement("div",{style:{display:"inline-flex"}}," ",r.a.createElement(S.a,{alt:"Logo",src:ud.a,className:t.TimelineIcon}),"RLD Information"," ")}):r.a.createElement("div",{style:{width:"0px"}}),r.a.createElement(Vo.a,{id:"applicationContent",className:t.CardTabs,label:r.a.createElement("div",{style:{display:"inline-flex"}}," ",r.a.createElement(S.a,{alt:"Logo",src:Ad.a,className:t.TimelineIcon}),r.a.createElement(Da.a,{badgeContent:"Beta",color:"primary",className:t.BetaBadge},"Applications Content"," ")),onClick:ot}),r.a.createElement(Vo.a,{id:"pmrcView",className:t.CardTabs,label:r.a.createElement("div",{style:{display:"inline-flex"}}," ",r.a.createElement(S.a,{alt:"Logo",src:Td.a,className:t.TimelineIcon}),"PMR/C"," "),onClick:rt}),r.a.createElement(Vo.a,{id:"labelView",className:t.CardTabs,label:r.a.createElement("div",{style:{display:"inline-flex"}}," ",r.a.createElement(S.a,{alt:"Logo",src:gd.a,className:t.TimelineIcon}),"Prescribing Information"," "),onClick:it}))),r.a.createElement(C.a,{container:!0,item:!0,xs:12,className:"swipe360"},r.a.createElement(Ho.a,{className:t.common360SwipableView,index:O,onChangeIndex:at},r.a.createElement("div",{role:"tabpanel",hidden:0!==O,id:"full-width-tabpanel-0}","aria-labelledby":"full-width-tab-0"},0===O&&r.a.createElement("div",{className:t.TimelineGridBox},$?r.a.createElement(td,{timeLineData:$}):r.a.createElement("div",null))),r.a.createElement("div",{role:"tabpanel",hidden:1!==O,id:"full-width-tabpanel-1}","aria-labelledby":"full-width-tab-1"},1===O&&r.a.createElement("div",{className:t.TimelineGridBox},r.a.createElement(R.a,{display:"flex",justifyContent:"flex-end"},r.a.createElement(_.a,{onClick:ct},r.a.createElement(y.a,{className:t.add},r.a.createElement(ta,null)," Add to Report"))),$&&r.a.createElement(Dr,{timeLinePageData:$,handleNetworkChild:nt}))),r.a.createElement("div",{role:"tabpanel",hidden:2!==O,id:"full-width-tabpanel-2}","aria-labelledby":"full-width-tab-2"},r.a.createElement(R.a,{display:"flex",justifyContent:"flex-end"},r.a.createElement(_.a,{onClick:lt},r.a.createElement(y.a,{className:t.add},r.a.createElement(ta,null)," Add to Report"))),2===O&&r.a.createElement("div",{className:t.TimelineGridBox},Be?r.a.createElement(nr,{applicationContentData:Be}):r.a.createElement("div",null))),r.a.createElement("div",{role:"tabpanel",hidden:3!==O,id:"full-width-tabpanel-6}","aria-labelledby":"full-width-tab-6"},3===O&&r.a.createElement("div",{className:t.TimelineGridBox},r.a.createElement("div",{className:"tableViewClass"},g&&0===g.length?r.a.createElement(C.a,{container:!0,item:!0,xs:12,justify:"center",alignItems:"center",className:t.ErrorGrid},r.a.createElement(y.a,{className:t.StyledErrorTypography},"No data available")):r.a.createElement(ld,{data:g,ColNames:cd.ColNames})))),r.a.createElement("div",{role:"tabpanel",hidden:4!==O,id:"full-width-tabpanel-5}","aria-labelledby":"full-width-tab-5"},4===O&&r.a.createElement("div",{className:t.TimelineGridBox,style:{backgroundColor:"white",textAlign:"justify",padding:"10px"}},K&&K.data.Success?r.a.createElement(nd,{data:K.data}):r.a.createElement(y.a,null,"Capture in Progress"))))),r.a.createElement(U.a,{fullWidth:!0,maxWidth:"lg",onClose:function(){E(!1)},"aria-labelledby":"customized-dialog-title",open:A},r.a.createElement(M.a,{className:t.ModalTitle},r.a.createElement(C.a,{container:!0},r.a.createElement(C.a,{container:!0,item:!0,xs:12,justify:"flex-end",alignItems:"center"},r.a.createElement(j.a,{"aria-label":"delete",className:t.ModalCloseIconButton,onClick:function(){E(!1)}},r.a.createElement(w.a,{className:t.ModalCloseIcon}))))),r.a.createElement(k.a,{className:t.Dialog},r.a.createElement(Yt,{data:[le]}))),r.a.createElement(Ed,{placement:"right-start",open:ne,title:r.a.createElement(r.a.Fragment,null,r.a.createElement(y.a,{className:t.botIntroPopup},"Hi I'm ARIA"),r.a.createElement(y.a,{className:t.botTextPopup},"I can help you find information in Approval Documents."),r.a.createElement(y.a,{className:t.botTextPopup},"Ask me questions"))},r.a.createElement(B.a,{"aria-label":"add",className:t.botIconFAB,onClick:function(){return E(!0)}},r.a.createElement("img",{className:t.botIcon,src:z.a})))),r.a.createElement(B.a,{"aria-label":"add",className:t.airplaneIcon,onClick:function(){window.scroll(0,0),Ze(!0)}},r.a.createElement(zt,null)))},Nd=a(355),Cd=a.n(Nd),Sd=a(356),yd=a.n(Sd),Dd=Object(f.a)((function(e){return{root:{background:e.palette.backgrounds.dark,height:"100vh"},container:{paddingTop:e.spacing(10)},navbar:{background:e.palette.white},navText:{color:e.palette.common.primaryGray,fontSize:e.spacing(3),fontWeight:"bold"},header:{width:"100%"},heading:{fontSize:e.spacing(5),color:e.palette.buttons.purple,fontWeight:"bold"},subheading:{marginTop:e.spacing(1),color:e.palette.review.label},icon:{color:e.palette.successGreen,fontSize:e.spacing(25)},errorIcon:{color:e.palette.fatalRed,fontSize:e.spacing(25)},tableIcon:{color:e.palette.successGreen},legends:{marginRight:e.spacing(1)},tableErrorIcon:{color:e.palette.fatalRed},vivLogo:{width:e.spacing(20),height:e.spacing(9)},tbBody:{background:e.palette.backgrounds.light},table:{marginTop:e.spacing(3)},tableHeader:{background:e.palette.backgrounds.dark},tableHeading:{fontSize:e.spacing(2),color:e.palette.white},tbText:{color:e.palette.white}}})),_d=function(){var e=Dd(),t=Object(n.useState)(),a=Object(d.a)(t,2),i=a[0],o=a[1];return Object(n.useEffect)((function(){function e(){return(e=Object(s.a)(c.a.mark((function e(){var t;return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:return e.prev=0,e.next=3,Ae();case 3:t=e.sent,o(t.data),e.next=10;break;case 7:e.prev=7,e.t0=e.catch(0),console.log(e.t0);case 10:case"end":return e.stop()}}),e,null,[[0,7]])})))).apply(this,arguments)}!function(){e.apply(this,arguments)}()}),[]),r.a.createElement(R.a,{className:e.root},r.a.createElement(pi.a,{className:e.container},r.a.createElement(R.a,{display:"flex",flexDirection:"column",justifyContent:"center",className:e.header},r.a.createElement(R.a,null,i&&"UP"===i.final_status?r.a.createElement(Cd.a,{className:e.icon,fontSize:"small"}):r.a.createElement(yd.a,{className:e.errorIcon,fontSize:"small"})),i&&"UP"===i.final_status?r.a.createElement(r.a.Fragment,null,r.a.createElement(y.a,{className:e.heading},"Ria is up and running"),r.a.createElement(y.a,{className:e.subheading},"Click ",r.a.createElement(Xt.a,{href:"/"},"here")," to go back")):r.a.createElement(y.a,{className:e.heading},"Ria is facing some issues")),r.a.createElement(R.a,{className:e.table},r.a.createElement(Kn.a,{component:N.a},r.a.createElement($a.a,{"aria-label":"customized table"},r.a.createElement(an.a,{className:e.tableHeader},r.a.createElement(nn.a,null,r.a.createElement(tn.a,{className:e.tableHeading},"Current Status by Service"),r.a.createElement(tn.a,{className:e.tableHeading,align:"right"},r.a.createElement(R.a,{display:"flex",flexDirection:"row",justifyContent:"flex-end",alignItems:"center"},r.a.createElement(Cd.a,{className:e.tableIcon,fontSize:"small"}),r.a.createElement(y.a,{className:e.legends},"No issues"),r.a.createElement(yd.a,{className:e.tableErrorIcon,fontSize:"small"}),r.a.createElement(y.a,null,"Outage"))))),r.a.createElement(en.a,{className:e.tbBody},r.a.createElement(nn.a,null,r.a.createElement(tn.a,{className:e.tbText},"Backend Server"),r.a.createElement(tn.a,{align:"right"},i&&"ok"===i.health?r.a.createElement(Cd.a,{className:e.tableIcon,fontSize:"small"}):r.a.createElement(yd.a,{className:e.tableErrorIcon,fontSize:"small"}))),r.a.createElement(nn.a,null,r.a.createElement(tn.a,{className:e.tbText},"Elastic Search"),r.a.createElement(tn.a,{align:"right"},i&&"UP"===i.elasticSearch.status?r.a.createElement(Cd.a,{className:e.tableIcon,fontSize:"small"}):r.a.createElement(yd.a,{className:e.tableErrorIcon,fontSize:"small"}))),r.a.createElement(nn.a,null,r.a.createElement(tn.a,{className:e.tbText},"Database"),r.a.createElement(tn.a,{align:"right"},i&&"UP"===i.database.status?r.a.createElement(Cd.a,{className:e.tableIcon,fontSize:"small"}):r.a.createElement(yd.a,{className:e.tableErrorIcon,fontSize:"small"}))),r.a.createElement(nn.a,null,r.a.createElement(tn.a,{className:e.tbText},"Kendra Index"),r.a.createElement(tn.a,{align:"right"},i&&"UP"===i.kendra.status?r.a.createElement(Cd.a,{className:e.tableIcon,fontSize:"small"}):r.a.createElement(yd.a,{className:e.tableErrorIcon,fontSize:"small"})))))))))},Od=Object(f.a)((function(e){return{root:{height:"100%",background:e.palette.white,marginTop:e.spacing(8),padding:e.spacing(2),marginLeft:e.spacing(9)+1,width:"calc(100% - ".concat(e.spacing(9)+1,"px)")},airplaneIcon:{position:"fixed",zIndex:e.zIndex.drawer+2,bottom:e.spacing(2),left:e.spacing(2)},dropdownBox:{marginBottom:e.spacing(3)},dropdownContainer:{width:e.spacing(30),background:e.palette.white,borderRadius:e.spacing(1),border:"1px solid #CDD4F7","&:hover":{backgroundColor:"#FFF"}},dropdownText:{color:e.palette.biologics.textPrimary,fontWeight:"bold"},headings:{color:e.palette.biologics.textPrimary,fontWeight:"bold",fontSize:e.spacing(2)},percentages:{marginTop:e.spacing(2)},add:{fontSize:e.spacing(1.87),color:e.palette.navbar.button,cursor:"pointer"},botIconFAB:{left:e.spacing(2),bottom:e.spacing(10),zIndex:e.zIndex.drawer+2,position:"fixed"},botIcon:{height:"100%",width:"100%"},botIntroPopup:{fontWeight:"900",fontSize:"2vh",padding:"4px",borderRadius:"10px",color:e.palette.primary.main,backgroundColor:e.palette.primary.lightBackground},botTextPopup:{fontSize:"1.5vh",padding:"4px",color:e.palette.white,opacity:1},ModalTitle:{padding:0},ModalCloseIconButton:{padding:0,marginBottom:"-20px",marginLeft:"-20px",color:e.palette.navbar.button},ModalCloseIcon:{color:e.palette.biologics.textPrimary},Dialog:{minHeight:"70vh",padding:0}}})),xd=Object(f.a)((function(e){return{headings:{color:e.palette.biologics.textPrimary,fontWeight:"bold",fontSize:e.spacing(2)},cards:{width:"100%",padding:e.spacing(1),height:"75vh"},cardContent:{height:"100%"},paper:Object(g.a)({width:"80%",height:"35%",marginTop:e.spacing(2),borderRadius:e.spacing(1.5)},e.breakpoints.up("xl"),{height:e.spacing(25),width:e.spacing(25)}),paperIcon:{background:e.palette.biologics.gradient,color:e.palette.white},number:{fontSize:e.spacing(3.5),color:e.palette.biologics.textPrimary,fontWeight:"bold"},cardText:{fontSize:e.spacing(2),color:e.palette.biologics.textSecondary}}})),vd=function(e){var t=e.data,a=xd(),i=function(e){return"".concat(Number(e).toFixed(0))};return r.a.createElement(n.Fragment,null,r.a.createElement(R.a,{display:"flex",flexDirection:"column",justifyContent:""},r.a.createElement(y.a,{align:"left",className:a.headings},"Overview"),r.a.createElement(R.a,{display:"flex",flexDirection:"column",alignItems:"",className:a.cards},t?t&&t.map((function(e){return r.a.createElement(N.a,{elevation:2,className:a.paper},r.a.createElement(R.a,{padding:1,display:"flex",flexDirection:"column",justifyContent:"space-evenly",alignItems:"center",className:a.cardContent},r.a.createElement(y.a,{className:a.number},r.a.createElement(Mr.a,{className:"animatedNumber",value:String(e.count),formatValue:i,duration:"1000"})),r.a.createElement(y.a,{className:a.cardText},e.id)))})):r.a.createElement(R.a,{ml:5,display:"flex",flexDirection:"column",alignItems:"",className:a.cards},r.a.createElement(Lr.a,{className:a.paper}),r.a.createElement(Lr.a,{className:a.paper}),r.a.createElement(Lr.a,{className:a.paper})))))},Rd=Object(f.a)((function(e){return{graphContainer:Object(g.a)({width:"100%"},e.breakpoints.up("xl"),{}),paper:{height:"100%",width:"90%",marginRight:e.spacing(2),padding:e.spacing(1),borderRadius:e.spacing(1.25)},graphBox:Object(g.a)({height:"50vh"},e.breakpoints.up("xl"),{height:"60vh"}),graph:{width:"100%"},headings:{color:e.palette.biologics.textPrimary,fontWeight:"bold",fontSize:e.spacing(2)},add:{fontSize:e.spacing(1.87),color:e.palette.navbar.button,cursor:"pointer"}}})),Pd=function(e){var t=e.data,a=Rd(),i=Object(n.useContext)(Mt),o=i.state,l=i.dispatch,d=function(){var e=Object(s.a)(c.a.mark((function e(){return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:return e.next=2,l({type:wt.SET_CART_ITEMS,value:o.cartItems+1});case 2:return e.next=4,l({type:wt.SET_REPORT,value:{id:"Bar Graph",data:{title:"505(b)(2)",subtitle:"Business Intelligence - Approval by Year",graph:t&&t.approvalYearGraph,keys:["count"],index:"year",color:"#0E5A94"}}});case 4:case"end":return e.stop()}}),e)})));return function(){return e.apply(this,arguments)}}(),m=function(){var e=Object(s.a)(c.a.mark((function e(){return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:return e.next=2,l({type:wt.SET_CART_ITEMS,value:o.cartItems+1});case 2:return e.next=4,l({type:wt.SET_REPORT,value:{id:"Bar Graph",data:{title:"505(b)(2)",subtitle:"Business Intelligence - Approvals Time, Days from Filling",graph:t&&t.approvalTimeGraph,keys:["count"],index:"year",color:"#008B8B"}}});case 4:case"end":return e.stop()}}),e)})));return function(){return e.apply(this,arguments)}}();return r.a.createElement(n.Fragment,null,r.a.createElement(C.a,{container:!0,lg:12},r.a.createElement(C.a,{item:!0,lg:6},r.a.createElement(R.a,{display:"flex",flexDirection:"column",className:a.graphBox},r.a.createElement(R.a,{mr:5,display:"flex",flexDirection:"row",justifyContent:"space-between"},r.a.createElement(y.a,{className:a.headings},"Approval by Year"),r.a.createElement(y.a,{onClick:d,className:a.add},r.a.createElement(ta,null)," Add to report")),t&&t?r.a.createElement(or,{keys:["count"],colors:["#0E5A94"],index:"year",data:t&&t.approvalYearGraph}):r.a.createElement(Lr.a,{variant:"rect",height:"90%",width:"90%"}))),r.a.createElement(C.a,{item:!0,lg:6},r.a.createElement(R.a,{display:"flex",flexDirection:"column",className:a.graphBox},r.a.createElement(R.a,{mr:5,display:"flex",flexDirection:"row",justifyContent:"space-between"},r.a.createElement(y.a,{className:a.headings},"Approvals Time, Days from Filling"),r.a.createElement(y.a,{onClick:m,className:a.add},r.a.createElement(ta,null)," Add to report")),t&&t?r.a.createElement(or,{className:a.graph,keys:["count"],colors:["#008B8B"],index:"year",data:t&&t.approvalTimeGraph}):r.a.createElement(Lr.a,{variant:"rect",height:"90%",width:"90%"})))))},Id=function(e){var t=e.accelerated_approval,a=e.fastrack,i=e.breakthrough_designation,o=e.yearGraph,l=e.activeIngredients,m=e.formulations,u=e.blaCount,p=Od(),g=Object(n.useContext)(Mt),h=g.state,T=g.dispatch,f=Object(n.useState)(),A=Object(d.a)(f,2),E=A[0],b=A[1],N=Object(n.useState)(),S=Object(d.a)(N,2),D=S[0],_=S[1],O=Object(n.useState)(),x=Object(d.a)(O,2),v=x[0],P=x[1];Object(n.useEffect)((function(){function e(){return(e=Object(s.a)(c.a.mark((function e(){var n,r,s,d,p,g,h,T,f,A,E,N,C,S;return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:return e.prev=0,e.next=3,Ze();case 3:n=e.sent,console.log(n.data),r={acceleratedApproval:t||n.data.Success.accelerated_approval,breakthroughDesignation:i||n.data.Success.breakthrough_designation,fasttrack:a||n.data.Success.fasttrack},b(r),s=[],d=Object($n.a)(n.data.Success.approval_time);try{for(d.s();!(p=d.n()).done;)g=p.value,h=g.year,T=parseInt(g.count),s.push({count:T,year:h})}catch(c){d.e(c)}finally{d.f()}f=[],A=Object($n.a)(o||n.data.Success.approval_year);try{for(A.s();!(E=A.n()).done;)N=E.value,C=N.year,S=parseInt(N.count),f.push({count:S,year:C})}catch(c){A.e(c)}finally{A.f()}_({approvalTimeGraph:s,approvalYearGraph:f}),P([{id:"Active Ingredients",count:u||n.data.Success.active_ingredients},{id:"Formulations",count:l||n.data.Success.formulations},{id:"Routes",count:m||n.data.Success.route}]),e.next=21;break;case 18:e.prev=18,e.t0=e.catch(0),console.log(e.t0);case 21:case"end":return e.stop()}}),e,null,[[0,18]])})))).apply(this,arguments)}!function(){e.apply(this,arguments)}()}),[]);var I=function(){var e=Object(s.a)(c.a.mark((function e(){return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:return e.next=2,T({type:wt.SET_CART_ITEMS,value:h.cartItems+1});case 2:return e.next=4,T({type:wt.SET_REPORT,value:{id:"Progress Bars",title:"505(b)(2)",data:E}});case 4:case"end":return e.stop()}}),e)})));return function(){return e.apply(this,arguments)}}();return r.a.createElement(n.Fragment,null,r.a.createElement(C.a,{container:!0},r.a.createElement(C.a,{item:!0,lg:2},r.a.createElement(vd,{data:v})),r.a.createElement(C.a,{item:!0,lg:10},r.a.createElement(C.a,{item:!0,lg:12},r.a.createElement(Pd,{data:D})),r.a.createElement(C.a,{item:!0,lg:12},r.a.createElement(R.a,{mr:2,display:"flex",alignItems:"center",justifyContent:"flex-end",className:p.percentages},r.a.createElement(y.a,{onClick:I,className:p.add},r.a.createElement(ta,null)," Add to report")),r.a.createElement(wr,{data:E})))))},wd=Object(P.a)((function(e){return{tooltip:{marginTop:"-11vh",marginLeft:"-1vh",width:"fit-content",padding:"10px",paddingLeft:"20px",paddingRight:"20px",borderRadius:"10px",color:e.palette.white,border:"2px solid ".concat(e.palette.primary.lightBorder)}}}))(L.a),Ld=function(){var e=Od(),t=Object(n.useContext)(Mt),a=(t.state,t.dispatch),i=Object(n.useState)("Business Intelligence"),o=Object(d.a)(i,2),l=o[0],m=o[1],u=r.a.useState(!1),p=Object(d.a)(u,2),g=p[0],h=p[1],T=Object(n.useState)(!1),f=Object(d.a)(T,2),A=f[0],E=f[1],b=Object(n.useState)(!0),N=Object(d.a)(b,2),S=N[0],D=(N[1],Object(n.useState)([{element:"#approvalPathwayStats",intro:"Business intelligence view provides graphs by number of approvals by year, approval time for original application as well as proportion approved by accelerated approval, breakthrough designation, Fast Track and Orphan designation",position:"right",tooltipClass:"myTooltipClass",highlightClass:"myHighlightClass"}])),_=Object(d.a)(D,2),O=_[0],x=(_[1],Object(n.useState)(!1)),v=Object(d.a)(x,2),P=v[0],I=v[1];Object(n.useEffect)((function(){function e(){return(e=Object(s.a)(c.a.mark((function e(){return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:return e.prev=0,e.next=3,a({type:wt.SET_MODULE,value:"505b2"});case 3:e.next=8;break;case 5:e.prev=5,e.t0=e.catch(0),console.log(e.t0);case 8:case"end":return e.stop()}}),e,null,[[0,5]])})))).apply(this,arguments)}!function(){e.apply(this,arguments)}()}),[a]);return r.a.createElement(R.a,{className:e.root},r.a.createElement(Ft.Steps,{enabled:P,steps:O,showProgress:!0,scrollToElement:!0,initialStep:0,onExit:function(){I(!1)}}),r.a.createElement(R.a,{display:"flex",justifyContent:"flex-start",alignItems:"center",className:e.dropdownBox},r.a.createElement(W.a,{className:e.formControl},r.a.createElement(ca.a,{labelId:"demo-controlled-open-select-label",id:"approvalPathwayStats",variant:"standard",disableUnderline:!0,MenuProps:{anchorOrigin:{vertical:"bottom",horizontal:"left"},transformOrigin:{vertical:"top",horizontal:"left"},getContentAnchorEl:null},open:g,onClose:function(){h(!1)},onOpen:function(){h(!0)},value:l,onChange:function(e){m(e.target.value)},className:e.dropdownContainer},r.a.createElement(la.a,{value:"Business Intelligence",className:e.dropdownText},"Business Intelligence"),r.a.createElement(la.a,{value:30})))),"Business Intelligence"===l?r.a.createElement(Id,null):null,r.a.createElement(U.a,{fullWidth:!0,maxWidth:"lg",onClose:function(){E(!1)},"aria-labelledby":"customized-dialog-title",open:A},r.a.createElement(M.a,{className:e.ModalTitle},r.a.createElement(C.a,{container:!0},r.a.createElement(C.a,{container:!0,item:!0,xs:12,justify:"flex-end",alignItems:"center"},r.a.createElement(j.a,{"aria-label":"delete",className:e.ModalCloseIconButton,onClick:function(){E(!1)}},r.a.createElement(w.a,{className:e.ModalCloseIcon}))))),r.a.createElement(k.a,{className:e.Dialog},r.a.createElement(Yt,{page:"505b2"}))),r.a.createElement(wd,{placement:"right-start",open:S,title:r.a.createElement(r.a.Fragment,null,r.a.createElement(y.a,{className:e.botIntroPopup},"Hi I'm ARIA"),r.a.createElement(y.a,{className:e.botTextPopup},"I can help you find information in Approval Documents."),r.a.createElement(y.a,{className:e.botTextPopup},"Ask me questions"))},r.a.createElement(B.a,{"aria-label":"add",className:e.botIconFAB,onClick:function(){return E(!0)}},r.a.createElement("img",{className:e.botIcon,src:z.a}))),r.a.createElement(B.a,{"aria-label":"add",className:e.airplaneIcon,onClick:function(){window.scroll(0,0),I(!0)}},r.a.createElement(zt,null)))},jd=a(1938),Bd=a(1943),Ud=function(){var e=Object(n.useContext)(Mt),t=e.state,a=e.dispatch,i=function(e,t){"clickaway"!==t&&a({type:wt.SET_ALERT,value:{message:null,status:!1}})};return r.a.createElement(r.a.Fragment,null,r.a.createElement(jd.a,{open:t.alert&&t.alert.status,autoHideDuration:6e3,onClose:i},r.a.createElement(Bd.a,{onClose:i,severity:"error"},t.alert&&t.alert.message)))},kd=Object(f.a)((function(e){return{root:{height:"100vh",background:e.palette.backgrounds.dark},container:{paddingTop:e.spacing(10)},subHeading:{color:e.palette.adminHome.grayText,fontSize:e.spacing(2),fontWeight:"light"},heading:{fontSize:e.spacing(4),color:e.palette.white,fontWeight:"light"},name:{marginLeft:e.spacing(1),color:e.palette.white,textTransform:"capitalize",fontWeight:"bold",fontSize:e.spacing(4)},divider:{marginTop:e.spacing(2)},grids:{marginTop:e.spacing(2)},paper:{width:"80%",height:e.spacing(15),borderRadius:e.spacing(1.5),background:"linear-gradient(to right, #96deda, #50c9c3)","&:hover":{opacity:".8"}},paperBox:{height:"100%"},cardText:{color:e.palette.primaryBlack,fontWeight:"bold",textDecoration:"none"}}})),Md=function(){var e=kd(),t=Object(n.useContext)(Mt),a=t.state,i=t.dispatch,o=Object(n.useState)(),l=Object(d.a)(o,2),m=l[0],u=l[1];return Object(n.useEffect)((function(){(function(){var e=Object(s.a)(c.a.mark((function e(){var t;return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:return e.prev=0,e.next=3,T.a.currentUserInfo();case 3:return t=e.sent,u(t.attributes),e.next=7,i({type:wt.SET_MODULE,value:"admin"});case 7:e.next=12;break;case 9:e.prev=9,e.t0=e.catch(0),console.log(e.t0);case 12:case"end":return e.stop()}}),e,null,[[0,9]])})));return function(){return e.apply(this,arguments)}})()()}),[]),r.a.createElement(R.a,{className:e.root},r.a.createElement(pi.a,{maxWidth:"lg",className:e.container},r.a.createElement(R.a,{display:"flex",flexDirection:"row",justifyContent:"center",alignItems:"center"},r.a.createElement(y.a,{className:e.heading},"Welcome back "),r.a.createElement(y.a,{className:e.name},a.userStub&&a.userStub["custom:user"],",")),r.a.createElement(y.a,{align:"center",className:e.subHeading},"These are the things you can do..."),r.a.createElement(vt.a,{className:e.divider}),r.a.createElement(C.a,{container:!0,className:e.grids},r.a.createElement(C.a,{item:!0,xs:12,lg:4},r.a.createElement(R.a,{padding:1},r.a.createElement(Xt.a,{href:"/admin/reviews",underline:"none"},r.a.createElement(N.a,{elevation:2,className:e.paper},r.a.createElement(R.a,{display:"flex",justifyContent:"center",alignItems:"center",className:e.paperBox},r.a.createElement(y.a,{className:e.cardText},"Data Curation")))))),m&&"Admin"===m["custom:role"]?r.a.createElement(C.a,{item:!0,xs:12,lg:4},r.a.createElement(R.a,{padding:1},r.a.createElement(Xt.a,{href:"/admin/dashboard",underline:"none"},r.a.createElement(N.a,{elevation:2,className:e.paper},r.a.createElement(R.a,{display:"flex",justifyContent:"center",alignItems:"center",className:e.paperBox},r.a.createElement(y.a,{className:e.cardText},"Dashboard")))))):null,r.a.createElement(C.a,{item:!0,xs:12,lg:4},r.a.createElement(R.a,{padding:1},r.a.createElement(Xt.a,{href:"/admin/pmr/review",underline:"none"},r.a.createElement(N.a,{elevation:2,className:e.paper},r.a.createElement(R.a,{display:"flex",justifyContent:"center",alignItems:"center",className:e.paperBox},r.a.createElement(y.a,{className:e.cardText},"PMR Data Curation")))))),r.a.createElement(C.a,{item:!0,xs:12,lg:4},r.a.createElement(R.a,{padding:1},r.a.createElement(Xt.a,{href:"/admin/status",underline:"none"},r.a.createElement(N.a,{elevation:2,className:e.paper},r.a.createElement(R.a,{display:"flex",justifyContent:"center",alignItems:"center",className:e.paperBox},r.a.createElement(y.a,{className:e.cardText},"Status")))))))))},Fd=a(1945),zd=a(1072),Yd=Object(f.a)((function(e){return{root:{background:e.palette.backgrounds.dark,height:"100vh"},container:{},firstForm:{width:"100%",height:"100%"},btn:{height:"100%"},dividerRoot:{marginTop:e.spacing(2),marginBottom:e.spacing(2)},divider:{width:"40%",background:e.palette.white,opacity:.6},or:{fontWeight:"bold",fontSize:e.spacing(2),fontFamily:"Encode",color:e.palette.white},banner:{width:"100%",height:"100%",borderRadius:e.spacing(2),background:e.palette.backgrounds.light},formHeadings:{textAlign:"center",padding:e.spacing(2),borderRadius:e.spacing(2),fontWeight:"bold",fontSize:e.spacing(3),color:e.palette.buttons.purple},label:{fontSize:e.spacing(2),color:e.palette.review.label,fontWeight:"bold"},radioLabel:{fontFamily:"Roboto",color:e.palette.white},radio:{color:e.palette.buttons.purple,fill:e.palette.black},textfield:{marginTop:e.spacing(.5),height:e.spacing(6),background:e.palette.backgrounds.dark,borderRadius:e.spacing(1.5),display:"flex",justifyContent:"center",alignItems:"center"},input:{color:e.palette.white,padding:e.spacing(1),"&::placeholder":{color:e.palette.white,padding:e.spacing(1)}},dropdownContainer:{marginTop:e.spacing(.5),height:e.spacing(6),background:e.palette.backgrounds.dark,width:"100%",display:"flex",justifyContent:"flex-start",color:e.palette.white,padding:e.spacing(1),borderRadius:e.spacing(1)},icon:{color:e.palette.white},dropdownText:{color:e.palette.adminHome.primaryBlack,fontWeight:"bold"},button:{background:e.palette.buttons.purple,fontFamily:"Roboto",color:e.palette.white,width:e.spacing(25),padding:e.spacing(1),borderRadius:e.spacing(6),"&:hover":{opacity:.8,background:e.palette.buttons.purple}}}})),Vd=function(){var e=Yd(),t=Object(u.f)(),a=Object(n.useContext)(Mt).dispatch,i=Object(n.useState)("Letter"),o=Object(d.a)(i,2),l=o[0],m=o[1],p=Object(n.useState)(!1),g=Object(d.a)(p,2),h=g[0],T=g[1],f=Object(n.useState)(),A=Object(d.a)(f,2),E=A[0],b=A[1],S=Object(n.useState)(),O=Object(d.a)(S,2),x=O[0],v=O[1],P=Object(n.useState)("SUPPL"),I=Object(d.a)(P,2),w=I[0],L=I[1],j=Object(n.useState)(!1),B=Object(d.a)(j,2),U=(B[0],B[1]),k=Object(n.useState)(),M=Object(d.a)(k,2),F=M[0],z=M[1],Y=function(){var e=Object(s.a)(c.a.mark((function e(n){var r,i,o;return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:if(n.preventDefault(),3==F.split("-").length){e.next=7;break}return e.next=5,a({type:Mt.SET_ALERT,value:{status:!0,message:"Enter a valid hiphenated input. Eg: 004782-SUPPL-171"}});case 5:e.next=12;break;case 7:r=F.split("-")[0],i=F.split("-")[1].toUpperCase(),o=F.split("-")[2],t.push("/admin/".concat(r,"/").concat(i,"/").concat(o,"/letter")),U(!0);case 12:case"end":return e.stop()}}),e)})));return function(t){return e.apply(this,arguments)}}();return r.a.createElement(R.a,{className:e.root,display:"flex",alignItems:"center"},r.a.createElement(pi.a,{maxWidth:"lg",className:e.container},r.a.createElement(N.a,{elevation:1,className:e.banner},r.a.createElement(y.a,{className:e.formHeadings},"Enter the details to review the document"),r.a.createElement("form",{onSubmit:Y},r.a.createElement(C.a,{container:!0,spacing:1},r.a.createElement(C.a,{item:!0,xs:12,lg:6},r.a.createElement(R.a,{margin:1,display:"flex",flexDirection:"column"},r.a.createElement(y.a,{align:"left",className:e.label},"Application Number"),r.a.createElement(D.a,{required:!0,className:e.textfield,onChange:function(e){var t=e.target.value;z(t)},fullWidth:!0,id:"standard-basic",placeholder:"Enter a key. Eg: 004782-ORIG-1",InputProps:{classes:{input:e.input},disableUnderline:!0}}))),r.a.createElement(C.a,{item:!0,xs:12,lg:6},r.a.createElement(R.a,{margin:1,display:"flex",alignItems:"center",className:e.btn},r.a.createElement(_.a,{type:"submit",variant:"contained",className:e.button},"Submit"))))),r.a.createElement(R.a,{display:"flex",flexDirection:"row",justifyContent:"space-evenly",alignItems:"center",className:e.dividerRoot},r.a.createElement(vt.a,{className:e.divider}),r.a.createElement(y.a,{className:e.or},"OR"),r.a.createElement(vt.a,{className:e.divider})),r.a.createElement("form",{onSubmit:function(e){e.preventDefault(),t.push("/admin/".concat(E,"/").concat(w,"/").concat(x,"/").concat(l)),U(!0)}},r.a.createElement(C.a,{container:!0,spacing:4},r.a.createElement(C.a,{item:!0,xs:12,lg:4},r.a.createElement(R.a,{margin:1,flexDirection:"column"},r.a.createElement(y.a,{align:"left",className:e.label},"Application Number"),r.a.createElement(D.a,{required:!0,className:e.textfield,onChange:function(e){b(e.target.value)},fullWidth:!0,id:"standard-basic",placeholder:"Enter an application number",InputProps:{classes:{input:e.input},disableUnderline:!0}}))),r.a.createElement(C.a,{item:!0,xs:12,lg:4},r.a.createElement(R.a,{margin:1,flexDirection:"column"},r.a.createElement(y.a,{align:"left",className:e.label},"Submission Id"),r.a.createElement(R.a,{display:"flex",flexDirection:"row",justifyContent:"space-evenly"},r.a.createElement(zd.a,{row:!0,"aria-label":"submissionType",name:"submissionType",value:w,onChange:function(e){L(e.target.value)}},r.a.createElement(ed.a,{value:"SUPPL",className:e.radioLabel,control:r.a.createElement(Fd.a,{color:"default",className:e.radio}),label:"SUPPL",labelPlacement:"end"}),r.a.createElement(ed.a,{value:"ORIG",className:e.radioLabel,control:r.a.createElement(Fd.a,{color:"default",className:e.radio}),label:"ORIG",labelPlacement:"end"})),r.a.createElement(D.a,{onChange:function(e){var t=e.target.value;v(t)},type:"number",required:!0,className:e.textfield,placeholder:"Enter number",InputProps:{classes:{input:e.input},disableUnderline:!0}})))),r.a.createElement(C.a,{item:!0,xs:12,lg:4},r.a.createElement(R.a,{margin:1,flexDirection:"column"},r.a.createElement(y.a,{align:"left",className:e.label},"Select a document type"),r.a.createElement(ca.a,{id:"blaStats",variant:"standard",disableUnderline:!0,required:!0,MenuProps:{anchorOrigin:{vertical:"bottom",horizontal:"left"},transformOrigin:{vertical:"top",horizontal:"left"},getContentAnchorEl:null},open:h,onClose:function(){T(!1)},onOpen:function(){T(!0)},value:l,onChange:function(e){m(e.target.value)},className:e.dropdownContainer,inputProps:{classes:{icon:e.icon}}},r.a.createElement(la.a,{value:"Letter",className:e.dropdownText},"Letter"),r.a.createElement(la.a,{value:"",className:e.dropdownText}))))),r.a.createElement(R.a,{padding:2,display:"flex",justifyContent:"center"},r.a.createElement(_.a,{type:"submit",variant:"contained",className:e.button},"Submit"))))))},Gd=a(1936);function Hd(e){return e.target.value}var Wd=Object(f.a)((function(e){return{root:Object(g.a)({minHeight:"100vh",height:"100%",background:e.palette.backgrounds.dark},e.breakpoints.down("sm"),{height:"100%"}),container:{paddingTop:e.spacing(10)},grid:{minHeight:"70vh"},reviewBox:{background:e.palette.backgrounds.light,height:"100%",width:"100%",borderRadius:e.spacing(1.5)},heading:{marginTop:e.spacing(.5),color:e.palette.white,fontSize:e.spacing(3),fontWeight:"bold",fontFamily:"Roboto"},label:Object(g.a)({fontSize:e.spacing(2),color:e.palette.review.label,fontWeight:"bold"},e.breakpoints.down("xl"),{fontSize:e.spacing(2.5)}),jointBox:{width:"100%"},addBtn:{marginTop:e.spacing(2),background:e.palette.review.label,height:e.spacing(4),borderRadius:e.spacing(1.5)},details:Object(g.a)({color:"#6f7594",fontSize:e.spacing(1.5)},e.breakpoints.down("xl"),{fontSize:e.spacing(2)}),textfield:{marginTop:e.spacing(.5),background:e.palette.backgrounds.dark,borderRadius:e.spacing(1.5),"::-webkit-calendar-picker-indicator":{filter:"invert(1)"}},"::-webkit-calendar-picker-indicator":{filter:"invert(1)"},credit:{marginTop:e.spacing(1),width:"100%"},crdates:{color:e.palette.white,fontSize:e.spacing(2)},crLabel:{color:e.palette.review.label,fontSize:e.spacing(1.5)},textarea:{marginTop:e.spacing(.5),background:e.palette.backgrounds.dark,borderRadius:e.spacing(1.5)},input:Object(g.a)({color:e.palette.white,fontSize:e.spacing(1.5),marginLeft:e.spacing(1),"&::placeholder":{color:e.palette.white,fontSize:e.spacing(1)}},e.breakpoints.down("xl"),{fontSize:e.spacing(2)}),button:{background:e.palette.buttons.purple,color:e.palette.white,width:e.spacing(25),fontWeight:"bold",marginRight:e.spacing(.5),padding:e.spacing(1),borderRadius:e.spacing(6),"&:hover":{opacity:.8,background:e.palette.buttons.purple}},dialog:{background:e.palette.white},confirm:{background:e.palette.buttons.purple,color:e.palette.white,fontWeight:"bold",borderRadius:e.spacing(6),"&:hover":{opacity:.8,background:e.palette.buttons.purple}},dropdownContainer:{marginTop:e.spacing(.5),height:e.spacing(4),background:e.palette.backgrounds.dark,width:"100%",color:e.palette.white,padding:e.spacing(1),borderRadius:e.spacing(1)},icon:{color:e.palette.white},dropdownText:{color:e.palette.adminHome.primaryBlack,fontWeight:"bold"},pdfContainer:Object(g.a)({height:"100%",width:"100%",borderRadius:e.spacing(1.5),background:e.palette.backgrounds.light},e.breakpoints.down("sm"),{minHeight:"80vh"}),pdf:{height:"100%",width:"100%",borderRadius:e.spacing(1.5)},notAvailable:{color:e.palette.white,fontSize:e.spacing(3),fontWeight:"bold"}}})),Qd=function(e){var t=Wd(),a=Object(u.f)(),i=Object(n.useContext)(Mt),o=i.state,l=i.dispatch,m=Object(n.useState)(),p=Object(d.a)(m,2),g=p[0],h=p[1],f=Object(n.useState)(),A=Object(d.a)(f,2),E=A[0],b=A[1],N=Object(n.useState)(),S=Object(d.a)(N,2),O=S[0],x=S[1],v=Object(n.useState)(),P=Object(d.a)(v,2),I=P[0],w=P[1],L=Object(n.useState)(),j=Object(d.a)(L,2),B=j[0],F=j[1],z=Object(n.useState)(),Y=Object(d.a)(z,2),V=Y[0],G=Y[1],H=Object(n.useState)(),W=Object(d.a)(H,2),Q=(W[0],W[1]),J=Object(n.useState)(),K=Object(d.a)(J,2),Z=(K[0],K[1]),X=Object(n.useState)(),q=Object(d.a)(X,2),$=q[0],ee=q[1],te=Object(n.useState)(),ae=Object(d.a)(te,2),ne=(ae[0],ae[1]),re=Object(n.useState)("Qced"),ie=Object(d.a)(re,2),oe=ie[0],le=ie[1],ce=Object(n.useState)(!1),se=Object(d.a)(ce,2),de=se[0],me=se[1],ue=Object(n.useState)(!1),pe=Object(d.a)(ue,2),ge=pe[0],he=pe[1],Te=Object(n.useState)(!1),fe=Object(d.a)(Te,2),Ae=fe[0],Ee=fe[1],be=Object(n.useState)(""),Ne=Object(d.a)(be,2),Ce=Ne[0],Se=Ne[1],ye=Object(n.useState)(!1),De=Object(d.a)(ye,2),_e=De[0],Oe=De[1],xe=Object(n.useState)(!1),ve=Object(d.a)(xe,2),Re=ve[0],Pe=ve[1],Ie=Object(n.useState)(""),we=Object(d.a)(Ie,2),Le=we[0],je=we[1],Be=Object(n.useState)(""),Ue=Object(d.a)(Be,2),ke=Ue[0],Me=Ue[1],Fe=Object(n.useState)(),ze=Object(d.a)(Fe,2),Ye=ze[0],Ve=ze[1],Ge=Object(n.useState)(""),He=Object(d.a)(Ge,2),We=He[0],Qe=He[1],Je=Object(n.useState)(""),Ke=Object(d.a)(Je,2),Ze=Ke[0],Xe=Ke[1],et=Object(n.useState)(),tt=Object(d.a)(et,2),at=tt[0],nt=tt[1],rt=Object(n.useState)(),it=Object(d.a)(rt,2),ot=it[0],lt=it[1],ct=function(){Ee(!1)};Object(n.useEffect)((function(){function t(){return(t=Object(s.a)(c.a.mark((function t(){var n,r,i,o;return c.a.wrap((function(t){for(;;)switch(t.prev=t.next){case 0:return t.prev=0,t.next=3,T.a.currentUserInfo();case 3:return n=t.sent,console.log(n),nt(n.attributes.email),lt(n.attributes["custom:user"]),t.next=9,qe(e.match.params.app,e.match.params.subtype,e.match.params.subno,e.match.params.doctype);case 9:if(void 0!==(r=t.sent)){t.next=14;break}return t.next=13,l({type:wt.SET_ALERT,value:{status:!0,message:"Enter valid information"}});case 13:a.push("/admin/reviews");case 14:"Venu''dfsf'gd''",console.log("Venu''dfsf'gd''".replace(/''/g,'"').replace(/'/g,'"')),console.log(r.data.Success.complete_response),h(r.data.Success),b(r.data.Success.approval_pathway),x(r.data.Success.sponsor_name),w(r.data.Success.signatory_division),F(r.data.Success.signatory_office),G(r.data.Success.filing_date),i=r.data.Success.complete_response.length>0?JSON.stringify(JSON.parse(r.data.Success.complete_response.replace(/''/g,'"').replace(/'/g,'"'))):"",console.log(i),Q(i),Se(i),o=r.data.Success.approvable_letter.length>0?JSON.stringify(JSON.parse(r.data.Success.approvable_letter.replace(/'/g,'"'))):"",Z(o),Ve(o),ee(r.data.Success.indication),ne(r.data.Success.status),t.next=40;break;case 34:return t.prev=34,t.t0=t.catch(0),console.log(t.t0),t.next=39,l({type:wt.SET_ALERT,value:{status:!0,message:"Enter valid information"}});case 39:a.push("/admin/reviews");case 40:case"end":return t.stop()}}),t,null,[[0,34]])})))).apply(this,arguments)}!function(){t.apply(this,arguments)}()}),[e.match.params.app,e.match.params.subtype,e.match.params.subno,e.match.params.doctype]);var st=function(){var e=Object(s.a)(c.a.mark((function e(){return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:Ee(!0);case 1:case"end":return e.stop()}}),e)})));return function(){return e.apply(this,arguments)}}(),dt=function(){var e=Object(s.a)(c.a.mark((function e(){var t;return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:return t={appl_no:g.key.split("-")[0],approvable_letter:Ye,approval_pathway:E,complete_response:Ce,filing_date:V,indication:$,key:g.key,label_path:g.label_path,letter_path:g.letter_path,review_path:g.review_path,signatory_division:I,signatory_office:B,sponsor_name:O,status:oe,submission_no:g.submission_no,submission_type:g.submission_type,curator_email:at,curator_name:ot},console.log(t),e.next=4,$e(t);case 4:a.push("/admin/reviews");case 5:case"end":return e.stop()}}),e)})));return function(){return e.apply(this,arguments)}}(),mt=function(){var e=Object(s.a)(c.a.mark((function e(t){var a,n,r;return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:t.preventDefault(),a={},""==Ce?(n=[],""!=Le&&(a["FDA Issue date"]=Le),""!=ke&&(a["Submission date"]=ke),n.push(a),Se(JSON.stringify(n)),Oe(!0)):Ce.length>0&&(r=[],r=_e?JSON.parse(Ce):[],""!=Le&&(a["FDA Issue date"]=Le),""!=ke&&(a["Submission date"]=ke),r.push(a),Se(JSON.stringify(r)),Oe(!0)),je(""),Me("");case 5:case"end":return e.stop()}}),e)})));return function(t){return e.apply(this,arguments)}}(),ut=function(){var e=Object(s.a)(c.a.mark((function e(t){var a,n,r;return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:t.preventDefault(),a={},""==Ye?(n=[],""!=We&&(a["FDA Issue date"]=We),""!=Ze&&(a["Submission date"]=Ze),n.push(a),Ve(JSON.stringify(n)),Pe(!0)):(r=[],r=Re?JSON.parse(Ye):[],""!=We&&(a["FDA Issue date"]=We),""!=Ze&&(a["Submission date"]=Ze),r.push(a),Ve(JSON.stringify(r)),Pe(!0)),Qe(""),Xe("");case 5:case"end":return e.stop()}}),e)})));return function(t){return e.apply(this,arguments)}}();return r.a.createElement(R.a,{className:t.root},r.a.createElement(pi.a,{maxWidth:"lg",className:t.container},de?null:r.a.createElement(R.a,{display:"flex",padding:1,flexDirection:"row",justifyContent:"flex-start"},r.a.createElement(_.a,{className:t.button,onClick:function(){return a.push("/admin/reviews")},variant:"contained"},"Go back"),r.a.createElement(_.a,{className:t.button,onClick:function(){return me(!0)},variant:"contained"},"Edit")),r.a.createElement(C.a,{container:!0,spacing:2},r.a.createElement(C.a,{item:!0,xs:12,lg:6,className:t.grid},r.a.createElement(R.a,{className:t.reviewBox,justifyContent:"center",alignItems:"space-evenly"},r.a.createElement(y.a,{align:"center",className:t.heading},g&&g.appl_no," ",g&&g.submission_type,"-",g&&g.submission_no),r.a.createElement(R.a,{padding:1},r.a.createElement(y.a,{align:"left",className:t.label},"Sponsor Name"),de?r.a.createElement(D.a,{className:t.textfield,fullWidth:!0,value:O,onChange:function(e){return x(Hd(e))},id:"standard-basic",placeholder:"Enter sponsor name",InputProps:{classes:{input:t.input},disableUnderline:!0}}):null,de?null:r.a.createElement(y.a,{align:"left",className:t.details},g&&g.sponsor_name)),r.a.createElement(R.a,{padding:1,display:"flex",flexDirection:"row",justifyContent:"space-between"},r.a.createElement(R.a,{pr:1,display:"flex",flexDirection:"column",className:t.jointBox},r.a.createElement(y.a,{align:"left",className:t.label},"Approval Pathway"),de?r.a.createElement(D.a,{className:t.textfield,fullWidth:!0,value:E,onChange:function(e){return b(Hd(e))},id:"standard-basic",placeholder:"Enter the approval pathaway",InputProps:{classes:{input:t.input},disableUnderline:!0}}):null,de?null:r.a.createElement(y.a,{align:"left",className:t.details},g&&g.approval_pathway)),r.a.createElement(R.a,{display:"flex",flexDirection:"column",className:t.jointBox},r.a.createElement(y.a,{align:"left",className:t.label},"Filing Date"),de?r.a.createElement(D.a,{id:"date",type:"date",onChange:function(e){return G(Hd(e))},defaultValue:V&&V,className:t.textfield,InputProps:{classes:{input:t.input},disableUnderline:!0},InputLabelProps:{shrink:!0,classes:{label:t.input}},KeyboardButtonProps:{"aria-label":"change date",classes:{icon:t.input}}}):null,de?null:r.a.createElement(y.a,{align:"left",className:t.details},g&&g.filing_date))),r.a.createElement(R.a,{padding:1},r.a.createElement(y.a,{align:"left",className:t.label},"Complete Response"),de?r.a.createElement(r.a.Fragment,null,r.a.createElement(y.a,{className:t.crdates},Ce),r.a.createElement(R.a,{display:"flex",flexDirection:"row",justifyContent:"space-evenly",className:t.credit},r.a.createElement(R.a,{display:"flex",flexDirection:"column"},r.a.createElement(y.a,{className:t.crLabel},"FDA Issue Date"),r.a.createElement(D.a,{id:"date",type:"date",onChange:function(e){return je(Hd(e))},value:Le&&Le,className:t.textfield,InputProps:{classes:{input:t.input},disableUnderline:!0},InputLabelProps:{shrink:!0,classes:{label:t.input}},KeyboardButtonProps:{"aria-label":"change date",classes:{icon:t.input}}})),r.a.createElement(R.a,{display:"flex",flexDirection:"column"},r.a.createElement(y.a,{className:t.crLabel},"Submission Date"),r.a.createElement(D.a,{id:"date",type:"date",onChange:function(e){return Me(Hd(e))},value:ke&&ke,className:t.textfield,InputProps:{classes:{input:t.input},disableUnderline:!0},InputLabelProps:{shrink:!0,classes:{label:t.input}},KeyboardButtonProps:{"aria-label":"change date",classes:{icon:t.input}}})),r.a.createElement(_.a,{variant:"contained",className:t.addBtn,onClick:mt},"Add"))):null,de?null:r.a.createElement(y.a,{align:"left",className:t.details},g&&g.complete_response.replace(/''/g,'"').replace(/'/g,'"'))),r.a.createElement(R.a,{padding:1},r.a.createElement(y.a,{align:"left",className:t.label},"Approvable Letter"),de?r.a.createElement(r.a.Fragment,null,r.a.createElement(y.a,{className:t.crdates},Ye),r.a.createElement(R.a,{display:"flex",flexDirection:"row",justifyContent:"space-evenly",className:t.credit},r.a.createElement(R.a,{display:"flex",flexDirection:"column"},r.a.createElement(y.a,{className:t.crLabel},"FDA Issue Date"),r.a.createElement(D.a,{id:"date",type:"date",onChange:function(e){return Qe(Hd(e))},value:We&&We,className:t.textfield,InputProps:{classes:{input:t.input},disableUnderline:!0},InputLabelProps:{shrink:!0,classes:{label:t.input}},KeyboardButtonProps:{"aria-label":"change date",classes:{icon:t.input}}})),r.a.createElement(R.a,{display:"flex",flexDirection:"column"},r.a.createElement(y.a,{className:t.crLabel},"Submission Date"),r.a.createElement(D.a,{id:"date",type:"date",onChange:function(e){return Xe(Hd(e))},value:Ze&&Ze,className:t.textfield,InputProps:{classes:{input:t.input},disableUnderline:!0},InputLabelProps:{shrink:!0,classes:{label:t.input}},KeyboardButtonProps:{"aria-label":"change date",classes:{icon:t.input}}})),r.a.createElement(_.a,{variant:"contained",className:t.addBtn,onClick:ut},"Add"))):null,de?null:r.a.createElement(y.a,{align:"left",className:t.details},g&&g.approvable_letter.replace(/''/g,'"').replace(/'/g,'"'))),r.a.createElement(R.a,{padding:1},r.a.createElement(y.a,{align:"left",className:t.label},"Indication (Label changes)"),de?r.a.createElement(D.a,{className:t.textarea,fullWidth:!0,multiline:!0,rowsMin:3,rowsMax:4,value:$,onChange:function(e){return ee(Hd(e))},id:"standard-basic",placeholder:"Enter indication",InputProps:{classes:{input:t.input},disableUnderline:!0}}):null,de?null:r.a.createElement(y.a,{align:"left",className:t.details},g&&g.indication)),r.a.createElement(R.a,{padding:1},r.a.createElement(y.a,{align:"left",className:t.label},"Signatory Division"),de?r.a.createElement(D.a,{className:t.textfield,fullWidth:!0,value:I,onChange:function(e){return w(Hd(e))},id:"standard-basic",placeholder:"Enter signatory Division",InputProps:{classes:{input:t.input},disableUnderline:!0}}):null,de?null:r.a.createElement(y.a,{align:"left",className:t.details},g&&g.signatory_division)),r.a.createElement(R.a,{padding:1},r.a.createElement(y.a,{align:"left",className:t.label},"Signature Office"),de?r.a.createElement(D.a,{className:t.textfield,fullWidth:!0,value:B,onChange:function(e){return F(Hd(e))},id:"standard-basic",placeholder:"Enter signatory office",InputProps:{classes:{input:t.input},disableUnderline:!0}}):null,de?null:r.a.createElement(y.a,{align:"left",className:t.details},g&&g.signatory_office)),r.a.createElement(R.a,{padding:1,display:"flex",flexDirection:"column"},r.a.createElement(y.a,{align:"left",className:t.label},"Status"),de?r.a.createElement(ca.a,{id:"blaStats",variant:"standard",disableUnderline:!0,required:!0,MenuProps:{anchorOrigin:{vertical:"bottom",horizontal:"left"},transformOrigin:{vertical:"top",horizontal:"left"},getContentAnchorEl:null},open:ge,onClose:function(){he(!1)},onOpen:function(){he(!0)},value:oe,onChange:function(e){return le(Hd(e))},className:t.dropdownContainer,inputProps:{classes:{icon:t.icon}}},r.a.createElement(la.a,{value:"Qced",className:t.dropdownText},"Qced"),r.a.createElement(la.a,{value:"No Document",className:t.dropdownText},"No Document"),r.a.createElement(la.a,{value:"Escalate",className:t.dropdownText},"Escalate"),r.a.createElement(la.a,{value:"",className:t.dropdownText})):null,de?null:r.a.createElement(y.a,{align:"left",className:t.details},g&&g.status)),r.a.createElement(R.a,{padding:1,display:"flex",justifyContent:"center"},de?r.a.createElement(R.a,{display:"flex",flexDirection:"row"},r.a.createElement(_.a,{className:t.button,onClick:function(){return me(!1)},variant:"contained"},"Cancel"),r.a.createElement(_.a,{className:t.button,disabled:!(!o.userStub||"Admin"===o.userStub["custom:role"]||!g||"Qced"!==g.status),onClick:st,variant:"contained"},"Submit"),r.a.createElement(U.a,{open:Ae,onClose:ct,"aria-labelledby":"alert-dialog-title","aria-describedby":"alert-dialog-description"},r.a.createElement(R.a,{className:t.dialog},r.a.createElement(M.a,{id:"alert-dialog-title"},"Confirm Submission"),r.a.createElement(k.a,null,r.a.createElement(Gd.a,{id:"alert-dialog-description"},"Are you sure you want to submit the changes?")),r.a.createElement(zo.a,null,r.a.createElement(_.a,{onClick:ct,className:t.confirm},"No"),r.a.createElement(_.a,{onClick:dt,className:t.confirm,autoFocus:!0},"Yes"))))):null))),r.a.createElement(C.a,{item:!0,xs:12,lg:6},g&&g.pdf_url?r.a.createElement(R.a,{display:"flex",className:t.pdfContainer},r.a.createElement("iframe",{title:"pdf",src:g&&g.pdf_url,className:t.pdf})):null,g&&g.pdf_url?null:r.a.createElement(R.a,{display:"flex",justifyContent:"center",alignItems:"center",className:t.pdfContainer},r.a.createElement(y.a,{className:t.notAvailable},"No pdf is available"))))))},Jd=Object(f.a)((function(e){return{root:{height:"100vh",background:e.palette.backgrounds.dark},container:{paddingTop:e.spacing(10)},heading:{fontSize:e.spacing(2.5),fontWeight:"bold",color:e.palette.review.label},paper:{marginTop:e.spacing(1),width:e.spacing(25),height:e.spacing(25)},paperBox:{width:"100%",height:"100%"},cnt:{color:e.palette.black,fontSize:e.spacing(3),fontWeight:"bold"}}})),Kd=function(){var e=Jd(),t=Object(n.useContext)(Mt),a=(t.state,t.dispatch),i=Object(u.f)(),o=Object(n.useState)(),l=Object(d.a)(o,2),m=l[0],p=l[1];return Object(n.useEffect)((function(){(function(){var e=Object(s.a)(c.a.mark((function e(){var t;return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:return e.prev=0,e.next=3,T.a.currentUserInfo();case 3:return"Admin"!=e.sent.attributes["custom:role"]&&i.push("/admin"),e.next=7,Ae();case 7:return t=e.sent,p(t.data.draftable_api_count),e.next=11,a({type:wt.SET_MODULE,value:"admin"});case 11:e.next=16;break;case 13:e.prev=13,e.t0=e.catch(0),console.log(e.t0);case 16:case"end":return e.stop()}}),e,null,[[0,13]])})));return function(){return e.apply(this,arguments)}})()()}),[]),r.a.createElement(R.a,{className:e.root},r.a.createElement(pi.a,{maxWidth:"lg",className:e.container},r.a.createElement(C.a,{container:!0},r.a.createElement(C.a,{item:!0,xs:12,lg:4},r.a.createElement(R.a,{display:"flex"},r.a.createElement(y.a,{className:e.heading},"Draftable Count")),r.a.createElement(N.a,{elevation:2,className:e.paper},r.a.createElement(R.a,{display:"flex",justifyContent:"center",alignItems:"center",className:e.paperBox},r.a.createElement(y.a,{className:e.cnt},m&&m),r.a.createElement(y.a,{className:e.cnt},"times")))))))},Zd=Object(f.a)((function(e){return{root:{background:e.palette.backgrounds.dark,height:"100vh"},container:{},firstForm:{width:"100%",height:"100%"},btn:{height:"100%"},dividerRoot:{marginTop:e.spacing(2),marginBottom:e.spacing(2)},divider:{width:"40%",background:e.palette.white,opacity:.6},or:{fontWeight:"bold",fontSize:e.spacing(2),fontFamily:"Encode",color:e.palette.white},banner:{width:"100%",height:"100%",borderRadius:e.spacing(2),background:e.palette.backgrounds.light},formHeadings:{textAlign:"center",padding:e.spacing(2),borderRadius:e.spacing(2),fontWeight:"bold",fontSize:e.spacing(3),color:e.palette.buttons.purple},label:{fontSize:e.spacing(2),color:e.palette.review.label,fontWeight:"bold"},radioLabel:{fontFamily:"Roboto",color:e.palette.white},radio:{color:e.palette.buttons.purple,fill:e.palette.black},textfield:{marginTop:e.spacing(.5),height:e.spacing(6),background:e.palette.backgrounds.dark,width:e.spacing(50),borderRadius:e.spacing(1.5),display:"flex",justifyContent:"center",alignItems:"center"},input:{color:e.palette.white,padding:e.spacing(1),"&::placeholder":{color:e.palette.white,padding:e.spacing(1)}},dropdownContainer:{marginTop:e.spacing(.5),height:e.spacing(6),background:e.palette.backgrounds.dark,width:"100%",display:"flex",justifyContent:"flex-start",color:e.palette.white,padding:e.spacing(1),borderRadius:e.spacing(1)},icon:{color:e.palette.white},dropdownText:{color:e.palette.adminHome.primaryBlack,fontWeight:"bold"},button:{background:e.palette.buttons.purple,fontFamily:"Roboto",color:e.palette.white,width:e.spacing(25),padding:e.spacing(1),borderRadius:e.spacing(6),"&:hover":{opacity:.8,background:e.palette.buttons.purple}}}})),Xd=function(){var e=Zd(),t=Object(u.f)(),a=(Object(n.useContext)(Mt).dispatch,Object(n.useState)()),i=Object(d.a)(a,2),o=i[0],l=i[1],m=function(){var e=Object(s.a)(c.a.mark((function e(a){var n;return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:a.preventDefault(),n=o.toUpperCase(),t.push("/admin/pmr/review/".concat(n));case 3:case"end":return e.stop()}}),e)})));return function(t){return e.apply(this,arguments)}}();return r.a.createElement(R.a,{className:e.root,display:"flex",alignItems:"center"},r.a.createElement(pi.a,{maxWidth:"lg",className:e.container},r.a.createElement(N.a,{elevation:1,className:e.banner},r.a.createElement(y.a,{className:e.formHeadings},"Enter details to qc PMR data"),r.a.createElement("form",{onSubmit:m},r.a.createElement(C.a,{container:!0,spacing:1},r.a.createElement(C.a,{item:!0,xs:12,lg:12},r.a.createElement(R.a,{display:"flex",flexDirection:"row",justifyContent:"center"},r.a.createElement(R.a,{margin:1,display:"flex",flexDirection:"column"},r.a.createElement(y.a,{align:"left",className:e.label},"Application Number"),r.a.createElement(D.a,{required:!0,className:e.textfield,onChange:function(e){var t=e.target.value;l(t)},fullWidth:!0,id:"standard-basic",placeholder:"Enter a key. Eg: NDA-004782-ORIG-1",InputProps:{classes:{input:e.input},disableUnderline:!0}})),r.a.createElement(R.a,{mt:4,display:"flex",alignItems:"center",className:e.btn},r.a.createElement(_.a,{type:"submit",variant:"contained",className:e.button},"Submit")))))))))},qd=a(1944),$d=Object(f.a)((function(e){return{root:Object(g.a)({minHeight:"100vh",height:"100%",background:e.palette.backgrounds.dark},e.breakpoints.down("sm"),{height:"100%"}),container:{paddingTop:e.spacing(10)},grid:{minHeight:"70vh"},reviewBox:{marginTop:e.spacing(1),background:e.palette.backgrounds.light,width:"100%",borderRadius:e.spacing(1.5)},searchBoxContainer:{padding:e.spacing(1),marginTop:e.spacing(1),background:e.palette.backgrounds.light,borderRadius:e.spacing(1.5)},searchBox:{},heading:{marginTop:e.spacing(.5),color:e.palette.white,fontSize:e.spacing(3),fontWeight:"bold",fontFamily:"Roboto"},label:Object(g.a)({fontSize:e.spacing(2),color:e.palette.review.label,fontWeight:"bold"},e.breakpoints.down("xl"),{fontSize:e.spacing(2.5)}),jointBox:{width:"100%"},addBtn:{marginTop:e.spacing(.5),marginLeft:e.spacing(.5),background:e.palette.review.label,height:e.spacing(4),textTransform:"capitaliaze",borderRadius:e.spacing(1.5)},details:Object(g.a)({color:"#6f7594",fontSize:e.spacing(1.5)},e.breakpoints.down("xl"),{fontSize:e.spacing(2)}),textfield:{marginTop:e.spacing(.5),background:e.palette.backgrounds.dark,borderRadius:e.spacing(1.5),"::-webkit-calendar-picker-indicator":{filter:"invert(1)"}},"::-webkit-calendar-picker-indicator":{filter:"invert(1)"},credit:{marginTop:e.spacing(1),width:"100%"},crdates:{color:e.palette.white,fontSize:e.spacing(2)},crLabel:{color:e.palette.review.label,fontSize:e.spacing(1.5)},textarea:{marginTop:e.spacing(.5),background:e.palette.backgrounds.dark,borderRadius:e.spacing(1.5)},input:Object(g.a)({color:e.palette.white,fontSize:e.spacing(1.5),marginLeft:e.spacing(1),"&::placeholder":{color:e.palette.white,fontSize:e.spacing(1)}},e.breakpoints.down("xl"),Object(g.a)({fontSize:e.spacing(2)},"fontSize",e.spacing(2))),button:{background:e.palette.buttons.purple,color:e.palette.white,width:e.spacing(25),fontWeight:"bold",marginRight:e.spacing(.5),padding:e.spacing(1),borderRadius:e.spacing(6),"&:hover":{opacity:.8,background:e.palette.buttons.purple}},dialog:{background:e.palette.white},confirm:{background:e.palette.buttons.purple,color:e.palette.white,fontWeight:"bold",borderRadius:e.spacing(6),"&:hover":{opacity:.8,background:e.palette.buttons.purple}},dropdownContainer:{marginTop:e.spacing(.5),height:e.spacing(4),background:e.palette.backgrounds.dark,width:"100%",color:e.palette.white,padding:e.spacing(1),borderRadius:e.spacing(1)},icon:{color:e.palette.white},dropdownText:{color:e.palette.adminHome.primaryBlack,fontWeight:"bold"},pdfContainer:Object(g.a)({height:"100%",width:"100%",minHeight:"80vh",borderRadius:e.spacing(1.5),background:e.palette.backgrounds.light},e.breakpoints.down("sm"),{minHeight:"80vh"}),pdf:{height:"100%",width:"100%",borderRadius:e.spacing(1.5)},notAvailable:{color:e.palette.white,fontSize:e.spacing(3),fontWeight:"bold"}}})),em=function(e){var t=$d(),a=Object(u.f)(),i=Object(n.useContext)(Mt),o=i.state,l=i.dispatch,m=Object(n.useState)(!1),p=Object(d.a)(m,2),g=p[0],h=p[1],f=Object(n.useState)(!1),A=Object(d.a)(f,2),E=A[0],b=A[1],N=Object(n.useState)(!1),S=Object(d.a)(N,2),O=S[0],x=S[1],v=Object(n.useState)(),P=Object(d.a)(v,2),I=P[0],w=P[1],L=Object(n.useState)(),j=Object(d.a)(L,2),B=j[0],U=j[1],k=Object(n.useState)(),M=Object(d.a)(k,2),F=M[0],z=M[1],Y=Object(n.useState)(),V=Object(d.a)(Y,2),G=V[0],H=V[1],W=Object(n.useState)(),Q=Object(d.a)(W,2),J=Q[0],K=Q[1],Z=Object(n.useState)(),X=Object(d.a)(Z,2),q=(X[0],X[1]),$=Object(n.useState)(),ee=Object(d.a)($,2),te=ee[0],ae=ee[1],ne=Object(n.useState)(),re=Object(d.a)(ne,2),ie=re[0],oe=re[1],le=Object(n.useState)(),ce=Object(d.a)(le,2),se=ce[0],de=ce[1],me=Object(n.useState)(),ue=Object(d.a)(me,2),pe=ue[0],ge=ue[1],he=Object(n.useState)("ACCELERATED APPROVAL REQUIREMENTS"),Ae=Object(d.a)(he,2),Ee=Ae[0],be=Ae[1],Ne=Object(n.useState)("Qced"),Ce=Object(d.a)(Ne,2),Se=Ce[0],ye=Ce[1],De=Object(n.useState)(!1),_e=Object(d.a)(De,2),Oe=_e[0],xe=_e[1],ve=Object(n.useState)(),Re=Object(d.a)(ve,2),Pe=Re[0],Ie=Re[1],we=Object(n.useState)(),Le=Object(d.a)(we,2),je=Le[0],Be=Le[1],Ue=Object(n.useState)(),ke=Object(d.a)(Ue,2),Me=ke[0],Fe=ke[1];Object(n.useEffect)((function(){function t(){return(t=Object(s.a)(c.a.mark((function t(){var n,r;return c.a.wrap((function(t){for(;;)switch(t.prev=t.next){case 0:return t.prev=0,t.next=3,T.a.currentUserInfo();case 3:return n=t.sent,Ie(n.attributes.email),Be(n.attributes["custom:user"]),t.next=8,et(e.match.params.key);case 8:if(!((r=t.sent).data.Success.length<1)){t.next=13;break}return t.next=12,l({type:wt.SET_ALERT,value:{status:!0,message:"Enter valid information"}});case 12:a.push("/admin/pmr/review");case 13:w(r.data.Success),r.data.Success.forEach((function(e){"No Data"!==e.s3_path&&Fe(e.pdf_url)})),oe({"ACCELERATED APPROVAL REQUIREMENTS":"Accelerated Approval","REQUIRED PEDIATRIC ASSESSMENTS":"Pediatric Research Equity Act","POSTMARKETING REQUIREMENTS UNDER 505(o)(3)":"FDAAA Section 505(o)(3)","POSTMARKETING COMMITMENTS SUBJECT TO REPORTING REQUIREMENTS UNDER SECTION 506B":"PMC(R)","POSTMARKETING COMMITMENTS NOT SUBJECT TO REPORTING REQUIREMENTS UNDER SECTION 506B":"PMC(NR)","SUBPART I APPROVAL REQUIREMENTS":"Animal Efficacy Rule","FULFILLMENT OF POSTMARKETING REQUIREMENT/COMMITTMENT":"FULFILLMENT OF POSTMARKETING REQUIREMENT","RELEASE FROM POSTMARKETING REQUIREMENT/COMMITTMENT":"RELEASE FROM POSTMARKETING REQUIREMENT","N/A":"N/A"}),de(["ACCELERATED APPROVAL REQUIREMENTS","REQUIRED PEDIATRIC ASSESSMENTS","POSTMARKETING REQUIREMENTS UNDER 505(o)(3)","POSTMARKETING COMMITMENTS SUBJECT TO REPORTING REQUIREMENTS UNDER SECTION 506B","POSTMARKETING COMMITMENTS NOT SUBJECT TO REPORTING REQUIREMENTS UNDER SECTION 506B","SUBPART I APPROVAL REQUIREMENTS","FULFILLMENT OF POSTMARKETING REQUIREMENT/COMMITTMENT","RELEASE FROM POSTMARKETING REQUIREMENT/COMMITTMENT","N/A"]),ae({"ACCELERATED APPROVAL REQUIREMENTS":"H","REQUIRED PEDIATRIC ASSESSMENTS":"P","POSTMARKETING REQUIREMENTS UNDER 505(o)(3)":"F","POSTMARKETING COMMITMENTS SUBJECT TO REPORTING REQUIREMENTS UNDER SECTION 506B":"PMC(R)","POSTMARKETING COMMITMENTS NOT SUBJECT TO REPORTING REQUIREMENTS UNDER SECTION 506B":"PMC(NR)","SUBPART I APPROVAL REQUIREMENTS":"E","FULFILLMENT OF POSTMARKETING REQUIREMENT/COMMITTMENT":"","RELEASE FROM POSTMARKETING REQUIREMENT/COMMITTMENT":"","N/A":"N/A"}),t.next=26;break;case 21:return t.prev=21,t.t0=t.catch(0),t.next=25,l({type:wt.SET_ALERT,value:{status:!0,message:"Enter valid information"}});case 25:a.push("/admin/pmr/review");case 26:case"end":return t.stop()}}),t,null,[[0,21]])})))).apply(this,arguments)}!function(){t.apply(this,arguments)}()}),[Oe]);var ze=function(){var e=Object(s.a)(c.a.mark((function e(){return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:z({id:Object(qd.a)(),key:I[0].key,appl_type:I[0].appl_type,appl_num:I[0].appl_num,supplement_type:I[0].supplement_type,supplement_num:I[0].supplement_num,s3_path:I[0].s3_path,category:""}),h(!1),U(null),H(null),K(null),be("ACCELERATED APPROVAL REQUIREMENTS"),q(null);case 7:case"end":return e.stop()}}),e)})));return function(){return e.apply(this,arguments)}}(),Ye=function(){var e=Object(s.a)(c.a.mark((function e(){var t,a;return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:return e.prev=0,e.next=3,n=B,Te.get("/clignosis/admin/pmr/review/id/".concat(n),{headers:{Authorization:fe}});case 3:t=e.sent,a=t.data.Success[0],z(a),H(a.cmt_number),K(a.cmt_desc),be(a.section),e.next=15;break;case 11:return e.prev=11,e.t0=e.catch(0),e.next=15,l({type:wt.SET_ALERT,value:{status:!0,message:"Enter valid information"}});case 15:case"end":return e.stop()}var n}),e,null,[[0,11]])})));return function(){return e.apply(this,arguments)}}(),Ve=function(){var e=Object(s.a)(c.a.mark((function e(){var t;return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:return e.prev=0,console.log(te["ACCELERATED APPROVAL REQUIREMENTS"]),t={id:F.id,key:F.key,appl_type:F.appl_type,appl_num:F.appl_num,supplement_type:F.supplement_type,supplement_num:F.supplement_num,cmt_number:G,cmt_desc:J,subpart_flag:te[Ee],subpart_description:ie[Ee],status:Se,section:Ee,s3_path:F.s3_path,category:F.category,curator_email:Pe,curator_name:je},console.log(t),e.next=6,tt(t);case 6:a.push("/admin/pmr/review/".concat(F.key)),window.location.reload(),z(null),h(!1),U(null),xe(!0),e.next=18;break;case 14:return e.prev=14,e.t0=e.catch(0),e.next=18,l({type:wt.SET_ALERT,value:{status:!0,message:e.t0}});case 18:case"end":return e.stop()}}),e,null,[[0,14]])})));return function(){return e.apply(this,arguments)}}();return r.a.createElement(R.a,{className:t.root},r.a.createElement(pi.a,{maxWidth:"lg",className:t.container},g?null:r.a.createElement(r.a.Fragment,null,r.a.createElement(R.a,{display:"flex",padding:1,flexDirection:"row",justifyContent:"flex-start"},r.a.createElement(_.a,{className:t.button,onClick:function(){return a.push("/admin/pmr/review")},variant:"contained"},"Go back"),r.a.createElement(_.a,{className:t.button,onClick:function(){return h(!0)},variant:"contained"},"Edit"))),r.a.createElement(C.a,{container:!0,spacing:2},r.a.createElement(C.a,{item:!0,xs:12,lg:6},r.a.createElement(R.a,{className:t.searchBoxContainer,justifyContent:"center",alignItems:"space-evenly"},r.a.createElement(R.a,{display:"flex",flexDirection:"column",justifyContent:"space-around",className:t.searchBox},r.a.createElement(y.a,{align:"left",className:t.label},"Select the CMT number to edit"),r.a.createElement(R.a,{display:"flex",flexDirection:"row",padding:1},r.a.createElement(ca.a,{id:"pmrReviewSearch",variant:"standard",disableUnderline:!0,required:!0,MenuProps:{anchorOrigin:{vertical:"bottom",horizontal:"left"},transformOrigin:{vertical:"top",horizontal:"left"},getContentAnchorEl:null},open:E,onClose:function(){return b(!1)},onOpen:function(){return b(!0)},value:B,onChange:function(e){return U(Hd(e))},className:t.dropdownContainer,inputProps:{classes:{icon:t.icon}}},I&&I.map((function(e,a){return r.a.createElement(la.a,{value:e.id,className:t.dropdownText},a+1,") ",e.cmt_number)})),r.a.createElement(la.a,{value:"",className:t.dropdownText},"''")),r.a.createElement(_.a,{type:"submit",className:t.addBtn,onClick:Ye},"Search"),r.a.createElement(_.a,{className:t.addBtn,onClick:ze},"Add")))),F&&F?r.a.createElement(R.a,{className:t.reviewBox,justifyContent:"center",alignItems:"space-evenly"},r.a.createElement(R.a,{padding:1},r.a.createElement(y.a,{align:"left",className:t.label},"CMT Number"),g?r.a.createElement(D.a,{className:t.textfield,fullWidth:!0,value:G,onChange:function(e){return H(Hd(e))},id:"standard-basic",placeholder:"Enter cmt number",InputProps:{classes:{input:t.input},disableUnderline:!0}}):null,g?null:r.a.createElement(y.a,{align:"left",className:t.details},F&&F.cmt_number)),r.a.createElement(R.a,{padding:1},r.a.createElement(y.a,{align:"left",className:t.label},"CMT Description"),g?r.a.createElement(D.a,{className:t.textfield,fullWidth:!0,multiline:!0,rowsMin:3,rowsMax:4,value:J,onChange:function(e){return K(Hd(e))},id:"standard-basic",placeholder:"Enter cmt description",InputProps:{classes:{input:t.input},disableUnderline:!0}}):null,g?null:r.a.createElement(y.a,{align:"left",className:t.details},F&&F.cmt_desc)),r.a.createElement(R.a,{padding:1},r.a.createElement(y.a,{align:"left",className:t.label},"Section"),g?r.a.createElement(ca.a,{id:"pmrReviewSearch",variant:"standard",disableUnderline:!0,required:!0,MenuProps:{anchorOrigin:{vertical:"bottom",horizontal:"left"},transformOrigin:{vertical:"top",horizontal:"left"},getContentAnchorEl:null},open:pe,onClose:function(){return ge(!1)},onOpen:function(){return ge(!0)},value:Ee,onChange:function(e){return be(Hd(e))},className:t.dropdownContainer,inputProps:{classes:{icon:t.icon}}},se&&se.map((function(e){return r.a.createElement(la.a,{value:e},e)})),r.a.createElement(la.a,{value:""},"''")):null,g?null:r.a.createElement(y.a,{align:"left",className:t.details},F&&F.section)),r.a.createElement(R.a,{padding:1,display:"flex",flexDirection:"column"},r.a.createElement(y.a,{align:"left",className:t.label},"Status"),g?r.a.createElement(ca.a,{id:"selectStatus",variant:"standard",disableUnderline:!0,required:!0,MenuProps:{anchorOrigin:{vertical:"bottom",horizontal:"left"},transformOrigin:{vertical:"top",horizontal:"left"},getContentAnchorEl:null},open:O,onClose:function(){return x(!1)},onOpen:function(){return x(!0)},value:Se,onChange:function(e){return ye(Hd(e))},className:t.dropdownContainer,inputProps:{classes:{icon:t.icon}}},r.a.createElement(la.a,{value:"Qced",className:t.dropdownText},"Qced"),r.a.createElement(la.a,{value:"No Document",className:t.dropdownText},"No Document"),r.a.createElement(la.a,{value:"Escalate",className:t.dropdownText},"Escalate"),r.a.createElement(la.a,{value:"Delete",className:t.dropdownText},"Delete"),r.a.createElement(la.a,{value:"",className:t.dropdownText})):null,g?null:r.a.createElement(y.a,{align:"left",className:t.details},F&&F.status)),g?r.a.createElement(R.a,{padding:1,display:"flex",flexDirection:"row"},r.a.createElement(_.a,{className:t.button,onClick:function(){return h(!1)},variant:"contained"},"Cancel"),r.a.createElement(_.a,{type:"submit",className:t.button,disabled:!(!o.userStub||"Admin"===o.userStub["custom:role"]||!F||"Qced"!==F.status),onClick:Ve,variant:"contained"},"Submit")):null):null),r.a.createElement(C.a,{item:!0,xs:12,lg:6},Me&&Me?r.a.createElement(R.a,{display:"flex",className:t.pdfContainer},r.a.createElement("iframe",{title:"pdf",src:Me&&Me,className:t.pdf})):r.a.createElement(R.a,{display:"flex",justifyContent:"center",alignItems:"center",className:t.pdfContainer},r.a.createElement(y.a,{className:t.notAvailable},"No pdf is available"))))))},tm=function(){Object(u.f)();var e=Object(n.useState)(!1),t=Object(d.a)(e,2),a=(t[0],t[1]),i=Object(n.useState)(!1),o=Object(d.a)(i,2),l=(o[0],o[1]),g=r.a.useState(),h=Object(d.a)(g,2),f=h[0],A=h[1],E=r.a.useState(),b=Object(d.a)(E,2),N=b[0],C=b[1];Object(n.useEffect)((function(){try{Object(Uo.b)((function(e,t){console.log(t),A(e),C(t)}))}catch(e){console.log(e)}}),[]);var S=function(){var e=Object(s.a)(c.a.mark((function e(){return c.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:if(!N){e.next=7;break}return e.next=3,T.a.signOut();case 3:a(!1),l(!1),C(!1),window.location.href="/";case 7:case"end":return e.stop()}}),e)})));return function(){return e.apply(this,arguments)}}();return r.a.createElement("div",{className:"App"},r.a.createElement(p.a,{theme:Yi},r.a.createElement(jo,null,r.a.createElement(kt,null,r.a.createElement(Ud,null),r.a.createElement(ra.a,{position:"top-right",autoClose:4e3,hideProgressBar:!1,newestOnTop:!1,closeOnClick:!0,rtl:!1,pauseOnFocusLoss:!0,draggable:!0,pauseOnHover:!0}),f===Uo.a.SignedIn&&N?r.a.createElement(m.a,null,window.location.pathname.indexOf("admin")>-1?r.a.createElement(Si,null):r.a.createElement(r.a.Fragment,null,"/help"===window.location.pathname||"/status"===window.location.pathname?null:r.a.createElement(yi,{logOutMethod:S})),r.a.createElement(u.c,null,r.a.createElement(u.a,{key:1,exact:!0,path:"/",component:na}),r.a.createElement(u.a,{key:2,path:"/search/:searchType/:module/:category/:search/:source",component:zl}),r.a.createElement(u.a,{key:3,path:"/search/:searchType/:module",component:zl}),r.a.createElement(u.a,{key:4,exact:!0,path:"/biologics",component:Vl}),r.a.createElement(u.a,{key:5,path:"/clinicalTrials/:module/:category/:search",component:rc}),r.a.createElement(u.a,{key:6,path:"/pmr/impact",exact:!0,component:ss}),r.a.createElement(u.a,{key:6,path:"/pmr/surveillance",exact:!0,component:ss}),r.a.createElement(u.a,{key:7,path:"/table/generics/:type/:number",component:Ys}),r.a.createElement(u.a,{key:8,path:"/regulatory360/:module/:type/:number",component:bd}),r.a.createElement(u.a,{key:9,path:"/admin/status",component:_d}),r.a.createElement(u.a,{key:10,path:"/505b2",component:Ld}),r.a.createElement(u.a,{key:"help",path:"/help",exact:!0,component:Do},r.a.createElement(Do,{logOutMethod:S})),r.a.createElement(u.a,{key:"login",path:"/registration",exact:!0,component:ua},r.a.createElement(ua,{logOutMethod:S})),r.a.createElement(u.a,{exact:!0,path:"/forgotpassword",render:function(e){return r.a.createElement(xo,e)}}),r.a.createElement(u.a,{key:11,path:"/admin",exact:!0,component:Md}),r.a.createElement(u.a,{key:12,path:"/admin/reviews",exact:!0,component:Vd}),r.a.createElement(u.a,{key:13,path:"/admin/:app/:subtype/:subno/:doctype",exact:!0,component:Qd}),r.a.createElement(u.a,{key:14,path:"/admin/dashboard",exact:!0,component:Kd}),r.a.createElement(u.a,{key:15,path:"/admin/pmr/review",exact:!0,component:Xd}),r.a.createElement(u.a,{key:15,path:"/admin/pmr/review/:key",exact:!0,component:em}))):r.a.createElement("div",{className:"Login"},r.a.createElement("div",{style:{position:"fixed",left:"35%",top:"10%",bottom:"15%",right:"35%",height:"100%"}},r.a.createElement("div",null,r.a.createElement("div",{className:"LoginHeader"},r.a.createElement("img",{src:si.a,alt:"logo",width:250,height:125})),r.a.createElement(Bo.a,null,r.a.createElement(Bo.b,{slot:"sign-in",hideSignUp:"true"})))))))))},am=a(225),nm=a(645);Boolean("localhost"===window.location.hostname||"[::1]"===window.location.hostname||window.location.hostname.match(/^127(?:\.(?:25[0-5]|2[0-4][0-9]|[01]?[0-9][0-9]?)){3}$/));am.default.configure({Auth:{manatorySignId:!0,region:nm.cognito.REGION,userPoolId:nm.cognito.USER_POOL_ID,userPoolWebClientId:nm.cognito.APP_CLIENT_ID}}),o.a.render(r.a.createElement(tm,null),document.getElementById("root")),"serviceWorker"in navigator&&navigator.serviceWorker.ready.then((function(e){e.unregister()})).catch((function(e){console.error(e.message)}))},215:function(e,t,a){e.exports=a.p+"static/media/brightness-and-contrast.90c55e12.svg"},255:function(e,t,a){e.exports=a.p+"static/media/centerBallNext.95a5ab75.svg"},296:function(e){e.exports=JSON.parse('{"2003-07-15/ORIG-1":{"Administrative_Summary":{"Study_Summary_Pie_Chart_1":[{"name":"Phase1","value":3},{"name":"Phase2","value":0},{"name":"Phase3","value":0}],"Table_1":[{"CDER_Division":"Division of Neuropharmacological Drug Products; Office of Drug Evaluation I"},{"Orphan_status":"Yes"},{"Breakthrough_designation":"No"},{"Fast_track":"No"},{"Accelerated_Approval":"No"},{"Review_Priority":"STANDARD"},{"CR_Letter":"Yes"},{"Number_of_resubmissions_numerical":"1"},{"Reason_for_CR_letter":"Medication dispensing errors, Labeling, Clinical, CMC"},{"Number_of_Indication":"1"},{"Study_Indications":"Effectiveness in Partial Onset Seizures"},{"Number_of_Studies":"3"},{"Pivotal_Evidence":"Bioequivalence"},{"New_Efficacy_data":"No"},{"New_Safety_data":"Yes"},{"Number_of_Literature_Studies":"0"}],"Time_of_Approval_No_of_days_Time_Chart_1":"390"},"AppDate":"2003-07-15","AppNo":"NDA021505","Clinical":{"No_of_Patients_Bar_Graph_1":[{"title":"Study 1","value":"293"},{"title":"Study 2","value":"322"},{"title":"Study 3","value":"284"}],"Safety_Dta_Table_3":[{"Safety_Database":"3339"}],"Study_Details_Table_2":{"Blinding":[],"Control":[],"Primary_Endpoint":[{"Study_1":"Percent Reduction in Weekly Partial Seizure Frequency"},{"Study_2":"Percent Reduction in Weekly Partial Seizure Frequency"},{"Study_3":"Percent Reduction in Weekly Partial Seizure Frequency"}],"Secondary_Endpoint_1":[{"Study_1":"Responder rate (incidence of patients with >=50% reduction from baseline in partial onset seizure frequency"},{"Study_2":"Responder rate (incidence of patients with >=50% reduction from baseline in partial onset seizure frequency"},{"Study_3":"Responder rate (incidence of patients with >=50% reduction from baseline in partial onset seizure frequency"}],"Secondary_Endpoint_2":[{"Study_1":"NA"},{"Study_2":"NA"},{"Study_3":"NA"}],"Site":[],"Study_Type":[{"Study_1":"Double-Blind"},{"Study_2":"Double-Blind"},{"Study_3":"Double-Blind"}]},"Study_Duration_Bar_Graph_2":[{"title":"Study 1","value":"18"},{"title":"Study 2","value":"12"},{"title":"Study 3","value":"16"}]},"Drug":"KEPPRA"}}')},308:function(e,t,a){e.exports=a.p+"static/media/Group705.08990a98.svg"},310:function(e,t,a){e.exports=a.p+"static/media/download-button.c2f68e64.svg"},340:function(e,t,a){e.exports=a.p+"static/media/NotLike.22534425.svg"},341:function(e,t,a){e.exports=a.p+"static/media/NotDislike.45226c54.svg"},385:function(e,t,a){e.exports=a.p+"static/media/Like.72c56310.svg"},386:function(e,t,a){e.exports=a.p+"static/media/Dislike.d91130af.svg"},411:function(e,t,a){e.exports=a.p+"static/media/plusWhite.55b170ab.svg"},412:function(e,t,a){e.exports=a.p+"static/media/centerBall.27510cdc.svg"},425:function(e,t,a){e.exports=a.p+"static/media/next.73fa00e3.svg"},475:function(e,t,a){e.exports=a.p+"static/media/Viv321.d22629cd.png"},492:function(e,t,a){e.exports=a.p+"static/media/CR.f9cb79f6.svg"},553:function(e,t,a){e.exports=a.p+"static/media/downloadDark.9274b791.svg"},620:function(e,t,a){e.exports=a.p+"static/media/searchPMR.f5f025a1.svg"},621:function(e,t,a){e.exports=a.p+"static/media/downloadPMR.74ab2d20.svg"},622:function(e,t,a){e.exports=a.p+"static/media/AAF.1e4c0083.svg"},623:function(e,t,a){e.exports=a.p+"static/media/AAT.258dc5e3.svg"},624:function(e,t,a){e.exports=a.p+"static/media/BTT.da66a638.svg"},625:function(e,t,a){e.exports=a.p+"static/media/BTF.cea69081.svg"},626:function(e,t,a){e.exports=a.p+"static/media/FTT.ff142687.svg"},627:function(e,t,a){e.exports=a.p+"static/media/FTF.7bf59832.svg"},628:function(e,t,a){e.exports=a.p+"static/media/ORT.04159a82.svg"},629:function(e,t,a){e.exports=a.p+"static/media/ORF.82f8e447.svg"},630:function(e,t,a){e.exports=a.p+"static/media/clock.5bdfde56.svg"},644:function(e,t,a){e.exports=a.p+"static/media/pmrSum.d3cf7e9d.svg"},645:function(e){e.exports=JSON.parse('{"cognito":{"REGION":"us-east-1","USER_POOL_ID":"us-east-1_6tPAOFpI0","APP_CLIENT_ID":"4ss9dca3p63u0f0n01u7o104uu"}}')},750:function(e,t,a){e.exports=a.p+"static/media/BotIntroLogo.81f4f039.svg"},754:function(e,t,a){e.exports=a.p+"static/media/downloadButton.abc2288a.svg"},812:function(e,t,a){e.exports=a.p+"static/media/RLD.ea0bd015.png"},813:function(e,t,a){e.exports=a.p+"static/media/RS.40989277.png"},814:function(e,t,a){e.exports=a.p+"static/media/TE.7ad2028a.png"},815:function(e,t,a){e.exports=a.p+"static/media/aa.cc62e825.svg"},816:function(e,t,a){e.exports=a.p+"static/media/bt.3d03ea8f.svg"},817:function(e,t,a){e.exports=a.p+"static/media/ft.696e7c17.svg"},818:function(e,t,a){e.exports=a.p+"static/media/or.7ff76f3b.svg"},823:function(e){e.exports=JSON.parse('{"pmc_commitments":[{"CMT_DOC_TYPE":"Original Biologics License Application","NDA_NUMBER":761115,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Trodelvy (sacituzumab govitecan)","NDA_BLA_APPROVAL_DATE":"4/22/20","CMT_DESC":"Submit the final study report and datasets for progression-free survival and overall survival from trial IMMU-132-05 titled \u201cPhase III Study of Sacituzumab Govitecan (IMMU-132) in Refractory/Relapsed Triple-Negative Breast Cancer\u201d, to confirm clinical benefit of sacituzumab that may inform product labeling.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Accelerated Approval","NCT1":"NCT02574455","LastCTUpdate1":"12/8/20","N1":529,"APPLICANT":"Immunomedics, Inc.","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"NA","FINAL_REPORT_DUE_DATE":"10/31/20"},{"CMT_DOC_TYPE":"Original Biologics License Application","NDA_NUMBER":761115,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Trodelvy (sacituzumab govitecan)","NDA_BLA_APPROVAL_DATE":"4/22/20","CMT_DESC":"Submit the clinical study report and related datasets to further characterize the risk of adverse events and UGT1A1 status in the IMMU-132-05 trial to support sacituzumab govitecan dosing recommendation for patients homozygous for UGT1A1*28 allele that may inform labeling. The study should be conducted for sufficient duration with a sufficient number of patients to evaluate safety following multiple dose administration.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"FDAAA Section 505(o)(3)","NCT1":"NCT02574455","LastCTUpdate1":"12/8/20","N1":529,"APPLICANT":"Immunomedics, Inc.","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"NA","FINAL_REPORT_DUE_DATE":"10/31/20"},{"CMT_DOC_TYPE":"Original Biologics License Application","NDA_NUMBER":761115,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Trodelvy (sacituzumab govitecan)","NDA_BLA_APPROVAL_DATE":"4/22/20","CMT_DESC":"Conduct an open-label, non-randomized, dose-escalation trial to determine an appropriate starting dose of sacituzumab govitecan in patients with moderate hepatic impairment, according to the National Cancer Institute Organ Dysfunction Working Group criteria in the target patient population. Safety and pharmacokinetic information of IMMU-132 and SN-38 will be collected to determine the appropriate starting dose of sacituzumab govitecan for this population. Submit the datasets with the final report.","CMT_STATUS":"Pending","SUBPART_FLAG":"FDAAA Section 505(o)(3)","NCT1":"NCT04617522","LastCTUpdate1":"1/8/21","N1":24,"APPLICANT":"Immunomedics, Inc.","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"NA","FINAL_REPORT_DUE_DATE":"9/30/21"},{"CMT_DOC_TYPE":"Original Biologics License Application","NDA_NUMBER":761115,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Trodelvy (sacituzumab govitecan)","NDA_BLA_APPROVAL_DATE":"4/22/20","CMT_DESC":"Submit the final QTc prolongation evaluation report in a sub-study of the ongoing clinical trial IMMU-132-05 titled \u201cPhase III Study of Sacituzumab Govitecan (IMMU-132) in Refractory/Relapsed Triple-Negative Breast Cancer\u201d that may further inform labelling about the QT effect of SN-38 at the recommended dose of sacituzumab govitecan.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"FDAAA Section 505(o)(3)","NCT1":"NCT02574455","LastCTUpdate1":"12/8/20","N1":529,"APPLICANT":"Immunomedics, Inc.","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"NA","FINAL_REPORT_DUE_DATE":"12/31/20"},{"CMT_DOC_TYPE":"Original Biologics License Application","NDA_NUMBER":761119,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Vyepti (eptinezumab)","NDA_BLA_APPROVAL_DATE":"2/21/20","CMT_DESC":"A single-arm, single-dose, pediatric pharmacokinetic study to evaluate eptinezumab in pediatric migraine patients ages 6 through 11 years. The primary objective will be to characterize the pharmacokinetic profile of eptinezumab compared to adult migraine patients, with additional secondary pharmacokinetic and safety endpoints. Immunogenicity will also be assessed through development of specific anti-eptinezumab antibodies.","CMT_STATUS":"Pending","SUBPART_FLAG":"Pediatric Research Equity Act","NCT1":"NCT04537429","LastCTUpdate1":"1/6/21","N1":32,"APPLICANT":"Lundbeck Seattle BioPharmaceuticals, Inc.","CMT_STATUS_DESC":"The study has not been initiated, but it does not meet the criterion for delayed.","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"NA","FINAL_REPORT_DUE_DATE":"4/30/25"},{"CMT_DOC_TYPE":"Original Biologics License Application","NDA_NUMBER":761136,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Luspatercept (ACE-536)","NDA_BLA_APPROVAL_DATE":"11/8/19","CMT_DESC":"Complete Trial ACE-536-B-THAL-001: Phase 3, Randomized, Placebocontrolled, Multicenter Study to Determine the Efficacy and Safety of Luspatercept (ACE-536) in Adults who Require Regular Blood Transfusions. Evaluate safety and efficacy data for the patients who enrolled in the open-label treatment for up to five years. Include summary analysis and updated safety summary to include safety data on thrombosis, all malignancies (including AML), hepatic toxicity, and renal toxicity. Include updated assessments of ferritin levels, liver iron concentrations and use of chelators and any cardiac iron evaluations in the reports. Include updated safety and efficacy analysis and submit datasets at the time of final clinical study report submission.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"FDAAA Section 505(o)(3)","NCT1":"NCT02604433","LastCTUpdate1":"1/27/20","N1":336,"APPLICANT":"Celgene Corporation","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"NA","FINAL_REPORT_DUE_DATE":"12/31/20"},{"CMT_DOC_TYPE":"Original Biologics License Application","NDA_NUMBER":761156,"CMT_DOC_TYPE_NO":1,"PRODUCT":"NNC0195-0092","NDA_BLA_APPROVAL_DATE":"8/28/20","CMT_DESC":"Complete ongoing study c, a 1-year phase 2, randomized, open-label, active-control, dose-finding trial, to investigate efficacy and safety of once-weekly somapacitan versus daily Norditropin (somatropin) in pre-pubertal children with Growth Hormone Deficiency (GHD) (boys = 2.5 and = 10 years of age, and girls = 2.5 and = 9 years of age) followed by a 2-year single-arm period to evaluate safety in this cohort, and a 4\xadyear single-arm period that also enrolls cohorts of younger children with GHD (boys and girls < 2.5 years of age) and older children with GHD (boys > 10 and = 17 years of age, and girls > 9 and = 17 years of age) to evaluate safety in all three cohorts.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Pediatric Research Equity Act","NCT1":"NCT02616562","LastCTUpdate1":"9/29/20","N1":74,"APPLICANT":"Novo Nordisk Inc.","CMT_STATUS_DESC":"The study was ongoing at the time of the approval.","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"NA","FINAL_REPORT_DUE_DATE":"3/31/25"},{"CMT_DOC_TYPE":"Original Biologics License Application","NDA_NUMBER":761156,"CMT_DOC_TYPE_NO":1,"PRODUCT":"NNC0195-0092","NDA_BLA_APPROVAL_DATE":"8/28/20","CMT_DESC":"Complete ongoing study NN8640-4263, a 1-year phase 3 randomized, parallel group, open-label trial, to evaluate the efficacy and safety of once weekly somapacitan versus daily Norditropin (somatropin) in pre-pubertal pediatric patients (boys = 2.5 and = 10 years of age, and girls = 2.5 and = 9 years of age) with GHD, followed by a 3-year single-arm extension period to evaluate long-term safety.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Pediatric Research Equity Act","NCT1":"NCT03811535","LastCTUpdate1":"12/30/20","N1":192,"APPLICANT":"Novo Nordisk Inc.","CMT_STATUS_DESC":"The study was ongoing at the time of the approval.","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"NA","FINAL_REPORT_DUE_DATE":"5/31/25"},{"CMT_DOC_TYPE":"Original Biologics License Application","NDA_NUMBER":761158,"CMT_DOC_TYPE_NO":1,"PRODUCT":"GSK2857916 (belantamab mafodotin)","NDA_BLA_APPROVAL_DATE":"8/5/20","CMT_DESC":"Conduct a pharmacokinetic trial to determine the appropriate dose of belantamab mafodotin in patients with moderate and severe hepatic impairment compared to patients with normal hepatic function that may inform labeling. This trial should be designed and conducted in accordance with the FDA Guidance for Industry titled, \u201cPharmacokinetics in Patients with Impaired Hepatic Function: Study Design, Data Analysis, and Impact on Dosing and Labeling\u201d","CMT_STATUS":"Ongoing","SUBPART_FLAG":"FDAAA Section 505(o)(3)","NCT1":"NCT04398680","LastCTUpdate1":"11/23/20","N1":24,"APPLICANT":"GlaxoSmithKline Intellectual Property Development Ltd. England","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"NA","FINAL_REPORT_DUE_DATE":"7/31/25"},{"CMT_DOC_TYPE":"Original Biologics License Application","NDA_NUMBER":761158,"CMT_DOC_TYPE_NO":1,"PRODUCT":"GSK2857916 (belantamab mafodotin)","NDA_BLA_APPROVAL_DATE":"8/5/20","CMT_DESC":"Conduct a pharmacokinetic trial to determine the appropriate dose of belantamab mafodotin in patients with severe renal impairment and end-stage renal disease (ESRD) with or without dialysis compared to patients with normal renal function that may inform product labeling. This trial should be designed and conducted in accordance with the FDA Guidance for Industry titled, \u201cPharmacokinetics in Patients with Impaired Renal Function \u2014 Study Design, Data Analysis, and Impact on Dosing and Labeling\u201d","CMT_STATUS":"Ongoing","SUBPART_FLAG":"FDAAA Section 505(o)(3)","NCT1":"NCT04398745","LastCTUpdate1":"12/21/20","N1":36,"APPLICANT":"GlaxoSmithKline Intellectual Property Development Ltd. England","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"NA","FINAL_REPORT_DUE_DATE":"5/31/26"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":21232,"CMT_DOC_TYPE_NO":20,"PRODUCT":"Orfadin (Nitisinone)","NDA_BLA_APPROVAL_DATE":"1/18/02","CMT_DESC":"Long-term assessment of pharmacodynamic response and pharmacokinetics of ORFADIN given under a once-daily dosage regimen in treatment-na\xefve and  treatment-experienced patients with hereditary tyrosinemia type 1 (HT-1) based on data from the ongoing Sobi.NTBC-005-study.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Post Marketing Commitment","NCT1":"NCT02320084","LastCTUpdate1":"1/14/20","N1":315,"APPLICANT":"SWEDISH ORPHAN BIOVITRUM AB PUBL","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"3/15/19","FINAL_REPORT_DUE_DATE":"9/30/20"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":21323,"CMT_DOC_TYPE_NO":3,"PRODUCT":"Lexapro (Escitalopram Oxalate)","NDA_BLA_APPROVAL_DATE":"8/14/02","CMT_DESC":"Deferred pediatric study under PREA to assess the safety and effectiveness of escitalopram oxalate as a treatment of Generalized Anxiety Disorder in pediatric patients ages 7 to 17 (children and adolescents). Both children (ages 7 to 11) and  adolescents (ages 12 to 17) should be equally represented in the samples, and there should be a reasonable distribution of both sexes in these age strata.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Pediatric Research Equity Act","NCT1":"NCT03924323","LastCTUpdate1":"10/14/20","N1":300,"APPLICANT":"ALLERGAN SALES LLC","CMT_STATUS_DESC":"Final protocol was submitted to IND 058380 on November 30,2018 (Sequence No. 0460). Protocol Amendment 1 was\\nsubmitted on March 25, 2019 (Sequence No. 0466), reflecting the addition of PK to the study to fulfill FDA\u2019s request, which resulted in a delayed study start. First Patient First Visit occurred on May 31, 2019. Although study start was delayed, enrollment is beginning to increase with mitigation efforts in effect. Actual versus planned activated sites is 23 versus 40, respectively, and actual versus planned randomized patients is 11 versus 14, respectively. Data is current as of September 20, 2019. Enrollment is being carefully monitored.","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"10/4/19","FINAL_REPORT_DUE_DATE":"1/30/22"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":21365,"CMT_DOC_TYPE_NO":4,"PRODUCT":"Lexapro (Escitalopram Oxalate)","NDA_BLA_APPROVAL_DATE":"11/27/02","CMT_DESC":"Deferred pediatric study under PREA to assess the safety and effectiveness of escitalopram oxalate as a treatment of Generalized Anxiety Disorder in pediatric patients ages 7 to 17 (children and adolescents). Both children (ages 7 to 11) and  adolescents (ages 12 to 17) should be equally represented in the samples, and there should be a reasonable distribution of both sexes in these age strata.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Pediatric Research Equity Act","NCT1":"NCT03924323","LastCTUpdate1":"10/14/20","N1":300,"APPLICANT":"ALLERGAN SALES LLC","CMT_STATUS_DESC":"Final protocol was submitted to IND 058380 on November 30,2018 (Sequence No. 0460). Protocol Amendment 1 was\\nsubmitted on March 25, 2019 (Sequence No. 0466), reflecting the addition of PK to the study to fulfill FDA\u2019s request, which resulted in a delayed study start. First Patient First Visit occurred on May 31, 2019. Although study start was delayed, enrollment is beginning to increase with mitigation efforts in effect. Actual versus planned activated sites is 23 versus 40, respectively, and actual versus planned randomized patients is 11 versus 14, respectively. Data is current as of September 20, 2019. Enrollment is being carefully monitored.","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"1/24/20","FINAL_REPORT_DUE_DATE":"1/30/22"},{"CMT_DOC_TYPE":"Original New Drug Application (NDA)","NDA_NUMBER":21610,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Opana ER (Oxymorphone Hydrochloride)","NDA_BLA_APPROVAL_DATE":"6/22/06","CMT_DESC":"Deferred pediatric study of safety and pharmacokinetics (single- and multipledose) under PREA for the relief of moderate to severe pain in patients requiring a continuous, around-the-clock opioid treatment for an extended period of time in pediatric patients ages 7 to 17 years.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Pediatric Research Equity Act","NCT1":"NCT04681027","LastCTUpdate1":"12/23/20","N1":15,"APPLICANT":"ENDO PHARMACEUTICALS INC","CMT_STATUS_DESC":"Original Final Report Due Date: 12/31/2014; Per FDA letter dated 06/24/2013, final report due date extended to 04/30/2020. Second Deferral Extension Granted per FDA letter dated 06/25/2020.","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"7/10/19","FINAL_REPORT_DUE_DATE":"12/31/20"},{"CMT_DOC_TYPE":"Original New Drug Application (NDA)","NDA_NUMBER":211371,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Zulresso","NDA_BLA_APPROVAL_DATE":"3/19/19","CMT_DESC":"Conduct an open-label study evaluating safety, tolerability, and pharmacokinetics of brexanolone in adolescent females, 15 years to less than 18 years of age, diagnosed with postpartum depression.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Pediatric Research Equity Act","NCT1":"NCT03665038","LastCTUpdate1":"4/2/20","N1":20,"APPLICANT":"SAGE THERAPEUTICS INC","CMT_STATUS_DESC":"The study was ongoing at the time of the approval.","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"5/7/20","FINAL_REPORT_DUE_DATE":"3/31/22"},{"CMT_DOC_TYPE":"Original New Drug Application (NDA)","NDA_NUMBER":212801,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Isturisa (osilodrostat)","NDA_BLA_APPROVAL_DATE":"3/6/20","CMT_DESC":"Complete Clinical Trial C2302, a Phase 3, multi-center, randomized, double-blind, 48-week study with an initial 12-week placebo-controlled period to evaluate the safety and efficacy of osilodrostat in patients with Cushing\u2019s disease. Safety evaluations include but are not limited to the occurrence of hypocortisolism and adrenal insufficiency.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"FDAAA Section 505(o)(3)","NCT1":"NCT02697734","LastCTUpdate1":"1/26/21","N1":73,"APPLICANT":"RECORDATI RARE DISEASES INC","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"NA","FINAL_REPORT_DUE_DATE":"10/31/20"},{"CMT_DOC_TYPE":"Original New Drug Application (NDA)","NDA_NUMBER":211723,"CMT_DOC_TYPE_NO":1,"PRODUCT":"tazemetostat","NDA_BLA_APPROVAL_DATE":"1/23/20","CMT_DESC":"Submit the final results and datasets for overall response rate and duration of response from clinical trial E7438-G000-101 in patients with relapsed or refractory follicular lymphoma to further characterize the clinical benefit of tazemetostat.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Post Marketing Commitment","NCT1":"NCT01897571","LastCTUpdate1":"1/7/21","N1":420,"APPLICANT":"EPIZYME INC","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"NA","FINAL_REPORT_DUE_DATE":"6/30/21"},{"CMT_DOC_TYPE":"Original New Drug Application (NDA)","NDA_NUMBER":211728,"CMT_DOC_TYPE_NO":1,"PRODUCT":"JELMYTO (mitomycin)","NDA_BLA_APPROVAL_DATE":"4/15/20","CMT_DESC":"Provide annual updates for the duration of response (median and range) for all patients with ongoing complete responses enrolled in clinical trial OLYMPUS. These updates should include information regarding incidence of recurrence of low-grade upper tract urothelial carcinoma (UTUC), incidence of/progression to high-grade UTUC, and incidence of nephroureterectomy. Annual updates should continue for five years or until all patients have either experienced recurrence, death, or been lost to follow up.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Post Marketing Commitment","NCT1":"NCT02793128","LastCTUpdate1":"12/22/20","N1":71,"APPLICANT":"UROGEN PHARMA LTD","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"NA","FINAL_REPORT_DUE_DATE":"4/30/25"},{"CMT_DOC_TYPE":"Original New Drug Application (NDA)","NDA_NUMBER":205053,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Noxafil (Posaconazole)","NDA_BLA_APPROVAL_DATE":"11/25/13","CMT_DESC":"Conduct a trial in patients, ages 2 to < 18 years, to evaluate the pharmacokinetic (PK), safety, and tolerability of two new formulations of posaconazole (IV solution and/or new ageappropriate oral formulation) in mmunocompromised pediatric patients with known or expected  neutropenia.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Pediatric Research Equity Act","NCT1":"NCT01716234","LastCTUpdate1":"8/27/18","N1":142,"APPLICANT":"MERCK SHARP AND DOHME CORP","CMT_STATUS_DESC":"Study has completed enrollment with 115 subjects treated, and completion of enrollment of a 3rd dosing cohort.","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"12/18/19","FINAL_REPORT_DUE_DATE":"7/31/20"},{"CMT_DOC_TYPE":"Original New Drug Application (NDA)","NDA_NUMBER":205422,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Rexulti (Brexpiprazole)","NDA_BLA_APPROVAL_DATE":"7/10/15","CMT_DESC":"Deferred pediatric study under PREA for the treatment of schizophrenia in adolescents aged 13 to17 years. Conduct a Phase 3, Safety: open-label, multicenter, long-term (1 year) study with at least 100 patients exposed for at least 6 months to obtain data on the safety of brexpiprazole in the relevant pediatric population.","CMT_STATUS":"Pending","SUBPART_FLAG":"Pediatric Research Equity Act","NCT1":"NCT03238326","LastCTUpdate1":"7/1/20","N1":350,"APPLICANT":"OTSUKA PHARMACEUTICAL CO LTD","CMT_STATUS_DESC":"The study has not been initiated, but does not meet the criterion for delayed.","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"8/25/20","FINAL_REPORT_DUE_DATE":"9/30/21"},{"CMT_DOC_TYPE":"Original New Drug Application (NDA)","NDA_NUMBER":207648,"CMT_DOC_TYPE_NO":1,"PRODUCT":"SMOFlipid (Fish Oil, Medium Chain Triglycerides, Olive Oil, and Soybean Oil)","NDA_BLA_APPROVAL_DATE":"7/13/16","CMT_DESC":"Randomized controlled trial to evaluate the safety and efficacy of SMOFLIPID (lipid injectable emulsion) administered for at least 90 days in pediatric patients,  compared to standard of care soybean oil based lipid emulsion administered for the same duration. Continue treatment for all patients who remain on parenteral  nutrition (PN) for up to 1 year. The study should enroll an adequate number of patients 3 month of age and older. The study\u2019s efficacy assessments should include anthropomorphic measures and evaluation of the risk of developing  essential fatty acid deficiency (EFAD). Full essential fatty acid profiles should be evaluated according to standards set by major national reference laboratories. Genetic polymorphisms in the fatty acid desaturase genes (FADS) FADS1 and FADS2 should be determined in at least a subset of patients. The cut-off values for EFAD (e.g., suspected, mild and severe) should be established prior to the study. The study\u2019s safety assessments should include evaluation of the risk of developing parenteral nutritional associated liver disease (PNALD) and parenteral nutrition associated cholestasis (PNAC). Plasma phytosterol levels should be  assessed in patients using validated analytical assay methods developed under PMR 3002-5.","CMT_STATUS":"Pending","SUBPART_FLAG":"Pediatric Research Equity Act","NCT1":"NCT03563222","LastCTUpdate1":"1/29/20","N1":144,"APPLICANT":"FRESENIUS KABI USA LLC","CMT_STATUS_DESC":"The study has not begun but does not meet the criterion for delayed.","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"9/1/20","FINAL_REPORT_DUE_DATE":"11/30/21"},{"CMT_DOC_TYPE":"Original New Drug Application (NDA)","NDA_NUMBER":21773,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Byetta (Exenatide)","NDA_BLA_APPROVAL_DATE":"4/28/05","CMT_DESC":"Deferred pediatric study under PREA for the treatment of type 2 diabetes mellitus in pediatric patients ages 10 to 16 years (inclusive).","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Pediatric Research Equity Act","NCT1":"NCT00658021","LastCTUpdate1":"12/1/20","N1":122,"APPLICANT":"ASTRAZENECA AB","CMT_STATUS_DESC":"Original Final Report Due Date: 12/31/2010. Per FDA letter dated 3/19/2013, final report due date extended to 12/31/2018. Second Deferral Extension Granted per FDA letter dated 09/08/2014, Final report submission deferral extended to 07/31/2020. Third Deferral Extension Granted per FDA letter dated 06/15/2020, Final Report due date extended to 01/31/2021.","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"11/21/19","FINAL_REPORT_DUE_DATE":"1/31/21"},{"CMT_DOC_TYPE":"Original New Drug Application (NDA)","NDA_NUMBER":21883,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Dalvance (Dalbavancin)","NDA_BLA_APPROVAL_DATE":"5/23/14","CMT_DESC":"Conduct a single dose PK study in neonates/infants from 0 to less than 3 months of age.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Pediatric Research Equity Act","NCT1":"NCT02814916","LastCTUpdate1":"1/31/20","N1":212,"APPLICANT":"ALLERGAN SALES LLC","CMT_STATUS_DESC":"Final report due 4-2020","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"7/16/20","FINAL_REPORT_DUE_DATE":"4/30/20"},{"CMT_DOC_TYPE":"Original New Drug Application (NDA)","NDA_NUMBER":21883,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Dalvance (Dalbavancin)","NDA_BLA_APPROVAL_DATE":"5/23/14","CMT_DESC":"Conduct a Phase 3, randomized, comparator-controlled study of dalbavancin in children from birth to 18 years of age with ABSSSI.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Pediatric Research Equity Act","NCT1":"NCT02814916","LastCTUpdate1":"1/31/20","N1":212,"APPLICANT":"ALLERGAN SALES LLC","CMT_STATUS_DESC":"Original Final Report Due Date: 12/31/2019. Per FDA letter dated 05/01/2019, final report due date extended to 06/30/2020. Second Deferral Extension Granted per FDA letter dated 05/14/2020.","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"7/16/20","FINAL_REPORT_DUE_DATE":"9/30/20"},{"CMT_DOC_TYPE":"Original New Drug Application (NDA)","NDA_NUMBER":21919,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Byetta (Exenatide)","NDA_BLA_APPROVAL_DATE":"10/30/09","CMT_DESC":"Deferred pediatric study under PREA for the treatment of type 2 diabetes mellitus in pediatric patients ages 10 to 16 years (inclusive).","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Pediatric Research Equity Act","NCT1":"NCT00658021","LastCTUpdate1":"12/1/20","N1":122,"APPLICANT":"ASTRAZENECA AB","CMT_STATUS_DESC":"Original Final Report Due Date: 12/31/2010. Per FDA letter dated 3/19/2013, final report due date extended to 12/31/2018. Second Deferral Extension Granted per FDA letter dated 09/08/2014, Final report submission deferral extended to 07/31/2020. Third Deferral Extension Granted per FDA letter dated 06/15/2020, Final Report due date extended to 01/31/2021.","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"NA","FINAL_REPORT_DUE_DATE":"1/31/21"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":21038,"CMT_DOC_TYPE_NO":10,"PRODUCT":"Precedex (Dexmedetomidine Hydrochloride)","NDA_BLA_APPROVAL_DATE":"12/17/99","CMT_DESC":"Deferred pediatric study under PREA for the treatment of sedation of non-intubated patients prior to and/or during surgical and other procedures in pediatric patients 0 to 16 years of age.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Pediatric Research Equity Act","NCT1":"NCT04040439","LastCTUpdate1":"6/30/20","N1":110,"APPLICANT":"HOSPIRA INC","CMT_STATUS_DESC":"Sponsor has a final protocol, study ongoing","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"2/4/19","FINAL_REPORT_DUE_DATE":"2/28/21"},{"CMT_DOC_TYPE":"Original New Drug Application (NDA)","NDA_NUMBER":22225,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Bridion (Sugammadex)","NDA_BLA_APPROVAL_DATE":"12/15/15","CMT_DESC":"A randomized, controlled trial evaluating the efficacy, safety, and pharmacokinetics of BRIDION injection when used to reverse neuromuscular blockade induced by either rocuronium or vecuronium must be conducted in pediatric patients ages 2 to less than 17 years old.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Pediatric Research Equity Act","NCT1":"NCT03909165","LastCTUpdate1":"11/27/20","N1":126,"APPLICANT":"ORGANON USA INC A SUB OF MERCK AND CO INC","CMT_STATUS_DESC":"The trial is ongoing.","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"2/11/20","FINAL_REPORT_DUE_DATE":"1/31/21"},{"CMT_DOC_TYPE":"Original New Drug Application (NDA)","NDA_NUMBER":211155,"CMT_DOC_TYPE_NO":1,"PRODUCT":"COPIKTRA (Duvelisib)","NDA_BLA_APPROVAL_DATE":"9/24/18","CMT_DESC":"Submit reports and datasets for overall survival from trial IPI-145-07 with 5 years of follow-up, with an interim report after 3 years of follow-up, measured from the last patient\u2019s randomization date. Include causes of death and narratives for death in the absence of treated disease progression.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"FDAAA Section 505(o)(3)","NCT1":"NCT02004522","LastCTUpdate1":"12/19/20","N1":319,"APPLICANT":"VERASTEM INC","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"11/22/19","FINAL_REPORT_DUE_DATE":"6/30/21"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":22254,"CMT_DOC_TYPE_NO":20,"PRODUCT":"Vimpat (Lacosamide)","NDA_BLA_APPROVAL_DATE":"10/28/08","CMT_DESC":"A safety study of replacement of oral dosing with intravenous dosing administered over 30 to 60 minutes in pediatric patients > or equal to 1 month to < 17 years of age with partial-onset seizures. If safety is acceptable, a replacement study at a faster rate of infusion (15 minutes) must be conducted in this population. Sparse PK samples must be collected to evaluate the pharmacokinetics of lacosamide and its metabolite using PPK approach in this population.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Pediatric Research Equity Act","NCT1":"NCT01969851","LastCTUpdate1":"5/7/19","N1":55,"APPLICANT":"UCB INC","CMT_STATUS_DESC":"The study has been initiated.","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"6/18/20","FINAL_REPORT_DUE_DATE":"9/30/21"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":22254,"CMT_DOC_TYPE_NO":30,"PRODUCT":"Vimpat (Lacosamide)","NDA_BLA_APPROVAL_DATE":"10/28/08","CMT_DESC":"Deferred pediatric studies under PREA for the treatment of partial onset seizures in pediatric patients ages 1 month to < 4 years.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Pediatric Research Equity Act","NCT1":"NCT02477839","LastCTUpdate1":"11/30/20","N1":255,"APPLICANT":"UCB INC","CMT_STATUS_DESC":"The study has been initiated","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"6/18/20","FINAL_REPORT_DUE_DATE":"9/30/21"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":22254,"CMT_DOC_TYPE_NO":30,"PRODUCT":"Vimpat (Lacosamide)","NDA_BLA_APPROVAL_DATE":"10/28/08","CMT_DESC":"Deferred pediatric studies under PREA for the treatment of partial onset seizures in pediatric patients ages 4 years to < 17 years.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Pediatric Research Equity Act","NCT1":"NCT01921205","LastCTUpdate1":"7/18/18","N1":404,"APPLICANT":"UCB INC","CMT_STATUS_DESC":"The study has been initiated","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"6/18/20","FINAL_REPORT_DUE_DATE":"9/30/21"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":22255,"CMT_DOC_TYPE_NO":12,"PRODUCT":"Vimpat (Lacosamide)","NDA_BLA_APPROVAL_DATE":"4/20/10","CMT_DESC":"A safety study of replacement of oral dosing with intravenous dosing administered over 30 to 60 minutes in pediatric patients > or equal to 1 month to < 17 years of age with partial-onset seizures. If safety is acceptable, a replacement study at a faster rate of infusion (15 minutes) must be conducted in this population. Sparse PK samples must be collected to evaluate the pharmacokinetics of lacosamide and its metabolite using PPK approach in this population.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Pediatric Research Equity Act","NCT1":"NCT01969851","LastCTUpdate1":"5/7/19","N1":55,"APPLICANT":"UCB INC","CMT_STATUS_DESC":"The study has been initiated.","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"6/18/19","FINAL_REPORT_DUE_DATE":"9/30/21"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":22255,"CMT_DOC_TYPE_NO":13,"PRODUCT":"Vimpat (Lacosamide)","NDA_BLA_APPROVAL_DATE":"4/20/10","CMT_DESC":"A safety study of replacement of oral dosing with intravenous dosing administered over 30 to 60 minutes in pediatric patients > or equal to 1 month to < 17 years of age with partial-onset seizures. If safety is acceptable, a replacement study at a faster rate of infusion (15 minutes) must be conducted in this population. Sparse PK samples must be collected to evaluate the pharmacokinetics of lacosamide and its metabolite using PPK approach in this population.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Pediatric Research Equity Act","NCT1":"NCT01969851","LastCTUpdate1":"5/7/19","N1":55,"APPLICANT":"UCB INC","CMT_STATUS_DESC":"The study has been initiated.","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"6/18/19","FINAL_REPORT_DUE_DATE":"9/30/21"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":22334,"CMT_DOC_TYPE_NO":36,"PRODUCT":"Afinitor (Everolimus)","NDA_BLA_APPROVAL_DATE":"3/30/09","CMT_DESC":"To submit the clinical study report and datasets for the final analysis of overall survival (OS) for Trial CRAD001T2302, entitled \u201cA randomized, double-blind,  multicenter, phase III study of everolimus (RAD001) plus best supportive care versus placebo plus best supportive care in the treatment of patients with  advanced NET of GI or lung origin - RADIANT-4,\u201d and to include the final OS data in the product label.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Post Marketing Commitment","NCT1":"NCT01524783","LastCTUpdate1":"9/23/20","N1":302,"APPLICANT":"NOVARTIS PHARMACEUTICALS CORP","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"5/24/19","FINAL_REPORT_DUE_DATE":"12/31/22"},{"CMT_DOC_TYPE":"Original Biologics License Application","NDA_NUMBER":22472,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Afrezza (Human Insulin)","NDA_BLA_APPROVAL_DATE":"6/27/14","CMT_DESC":"An open-label pharmacokinetic (PK), and multiple-dose safety and tolerability dose-titration trial of Afrezza in pediatric patients ages 4 to 17 years (inclusive) with type 1 diabetes (Part 1), followed by a prospective, multicenter, open-label, randomized, controlled trial comparing the efficacy and safety of prandial Afrezza to prandial subcutaneous insulin aspart used in combination with subcutaneous basal insulin in pediatric patients 4 to 17 years old (inclusive) with type 1 or type 2 diabetes (Part 2). Part 2 of the trial should include a 4-week run-in phase and a 52-week randomized intervention phase.","CMT_STATUS":"Delayed","SUBPART_FLAG":"Pediatric Research Equity Act","NCT1":"NCT02527265","LastCTUpdate1":"9/17/20","N1":30,"APPLICANT":"MannKind Corporation","CMT_STATUS_DESC":"The Study Completion due date was missed and FDA issued a missed milestone letter on 08/14/2020.","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"8/12/20","FINAL_REPORT_DUE_DATE":"1/31/21"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":125320,"CMT_DOC_TYPE_NO":186,"PRODUCT":"Prolia (Denosumab)","NDA_BLA_APPROVAL_DATE":"6/1/10","CMT_DESC":"\u201cA Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Safety and Efficacy of Denosumab in Pediatric Subjects With Glucocorticoid-induced Osteoporosis\u201d (Study 20140444)","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Pediatric Research Equity Act","NCT1":"NCT03164928","LastCTUpdate1":"12/17/20","N1":150,"APPLICANT":"Amgen, Inc.","CMT_STATUS_DESC":"The study has been initiated","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"7/28/20","FINAL_REPORT_DUE_DATE":"9/30/23"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":125388,"CMT_DOC_TYPE_NO":97,"PRODUCT":"Adcetris (Brentuximab Vedotin)","NDA_BLA_APPROVAL_DATE":"8/19/11","CMT_DESC":"Submit long-term safety follow-up for the ECHELON-1 clinical trial including the following events: (a) secondary malignancies, (b) treatmentrelated serious adverse events, (c) treatment-emergent neuropathy adverse events until resolution or study closure, and (d) deaths and cause of deaths. Submit an interim report and datasets with 60 months of safety follow-up. Submit the final report and datasets after minimum of 120 months of safety follow-up.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"FDAAA Section 505(o)(3)","NCT1":"NCT01712490","LastCTUpdate1":"12/23/20","N1":1334,"APPLICANT":"Seattle Genetics, Inc.","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"10/17/19","FINAL_REPORT_DUE_DATE":"8/31/26"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":125409,"CMT_DOC_TYPE_NO":113,"PRODUCT":"Perjeta (Pertuzumab)","NDA_BLA_APPROVAL_DATE":"6/8/12","CMT_DESC":"Submit the overall survival (OS) data and analysis with a final report from the clinical trial APHINITY BIG 4 11/BO25126/TOC4939g clinical trial entitled \u201cA randomized  multicenter, double-blind, placebo-controlled comparison of chemotherapy plus trastuzumab plus placebo versus chemotherapy plus trastuzumab plus pertuzumab as adjuvant therapy in patients with operable HER2-positive primary breast cancer.\u201d","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Post Marketing Commitment","NCT1":"NCT01358877","LastCTUpdate1":"12/3/20","N1":4804,"APPLICANT":"Genentech, Inc.","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"8/1/19","FINAL_REPORT_DUE_DATE":"6/30/24"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":125409,"CMT_DOC_TYPE_NO":118,"PRODUCT":"Perjeta (Pertuzumab)","NDA_BLA_APPROVAL_DATE":"6/8/12","CMT_DESC":"Submit the overall survival (OS) data and analysis with a final report from the clinical trial APHINITY BIG 4 11/BO25126/TOC4939g clinical trial entitled \u201cA randomized  multicenter, double-blind, placebo-controlled comparison of chemotherapy plus trastuzumab plus placebo versus chemotherapy plus trastuzumab plus pertuzumab as adjuvant therapy in patients with operable HER2-positive primary breast cancer.\u201d","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Post Marketing Commitment","NCT1":"NCT01358877","LastCTUpdate1":"12/3/20","N1":4804,"APPLICANT":"Genentech, Inc.","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"8/1/19","FINAL_REPORT_DUE_DATE":"6/30/24"},{"CMT_DOC_TYPE":"Original Biologics License Application","NDA_NUMBER":125476,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Entyvio (vedolizumab)","NDA_BLA_APPROVAL_DATE":"5/20/14","CMT_DESC":"A randomized, controlled, multicenter study to evaluate the efficacy and safety of vedolizumab in pediatric patients 2 to 17 years of age with moderately to severely active Crohn\u2019s disease.","CMT_STATUS":"Pending","SUBPART_FLAG":"Pediatric Research Equity Act","NCT1":"NCT03196427","LastCTUpdate1":"1/8/21","N1":80,"APPLICANT":"Takeda Pharmaceuticals U.S.A., Inc.","CMT_STATUS_DESC":"The study has not been initiated, but it does not meet the criterion for delayed.","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"7/17/19","FINAL_REPORT_DUE_DATE":"7/31/25"},{"CMT_DOC_TYPE":"Original Biologics License Application","NDA_NUMBER":125476,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Entyvio (vedolizumab)","NDA_BLA_APPROVAL_DATE":"5/20/14","CMT_DESC":"A randomized, controlled, multicenter study to evaluate the efficacy and safety of vedolizumab in pediatric patients 2 to 17 years of age with moderately to severely active ulcerative colitis.","CMT_STATUS":"Pending","SUBPART_FLAG":"Pediatric Research Equity Act","NCT1":"NCT03196427","LastCTUpdate1":"1/8/21","N1":80,"APPLICANT":"Takeda Pharmaceuticals U.S.A., Inc.","CMT_STATUS_DESC":"The study has not been initiated, but it does not meet the criterion for delayed.","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"7/17/19","FINAL_REPORT_DUE_DATE":"7/31/25"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":125476,"CMT_DOC_TYPE_NO":21,"PRODUCT":"Entyvio (vedolizumab)","NDA_BLA_APPROVAL_DATE":"5/20/14","CMT_DESC":"Conduct a dose-ranging study to determine the pharmacokinetics/pharmacodynamics, safety, and tolerability of Entyvio (vedolizumab) in pediatric patients 2 to 17 years of age with moderately to severely active ulcerative colitis or Crohn\u2019s disease who have failed conventional therapy.","CMT_STATUS":"Delayed","SUBPART_FLAG":"Pediatric Research Equity Act","NCT1":"NCT03138655","LastCTUpdate1":"12/20/20","N1":89,"APPLICANT":"Takeda Pharmaceuticals U.S.A., Inc.","CMT_STATUS_DESC":"Original Final Report Due Date: 07/31/2019. Per FDA letter dated 08/31/2020, final report due date extended to 08/31/2020. Second Deferral Extension Granted per FDA letter dated 07/21/2020.","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"7/17/19","FINAL_REPORT_DUE_DATE":"1/31/21"},{"CMT_DOC_TYPE":"Original Biologics License Application","NDA_NUMBER":125499,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Plegridy (Pegylated Interferon Beta-1a)","NDA_BLA_APPROVAL_DATE":"8/15/14","CMT_DESC":"A randomized, controlled, parallel group superiority trial in pediatric patients ages 10 through 17 years to evaluate the safety and efficacy of Plegridy (peginterferon  beta-1a) compared to an appropriate control for the treatment of relapsing forms  of multiple sclerosis.","CMT_STATUS":"Delayed","SUBPART_FLAG":"Pediatric Research Equity Act","NCT1":"NCT03958877","LastCTUpdate1":"11/19/20","N1":142,"APPLICANT":"Biogen Inc.","CMT_STATUS_DESC":"The status is delayed because the Final Protocol and Study Completion due dates have been missed. Original Final Report Due Date: 11/30/2019; Deferral Extension granted per FDA letter dated 11/23/2019.","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"10/7/19","FINAL_REPORT_DUE_DATE":"11/30/21"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":125514,"CMT_DOC_TYPE_NO":15,"PRODUCT":"Keytruda (pembrolizumab)","NDA_BLA_APPROVAL_DATE":"9/4/14","CMT_DESC":"Complete the trial and submit the final report and data to verify and describe the clinical benefit of pembrolizumab, including efficacy and safety, from Trial KN204, a Phase 3 randomized, open-label, active-controlled trial comparing pembrolizumab to brentuximab vedotin for the treatment of patients with relapsed or refractory classical Hodgkin lymphoma. Enroll approximately 300 patients. The primary endpoint should include progression-free survival.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Accelerated Approval","NCT1":"NCT02684292","LastCTUpdate1":"8/4/20","N1":304,"APPLICANT":"Merck Sharp & Dohme Corp.","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"10/31/19","FINAL_REPORT_DUE_DATE":"4/30/21"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":125514,"CMT_DOC_TYPE_NO":15,"PRODUCT":"Keytruda (pembrolizumab)","NDA_BLA_APPROVAL_DATE":"9/4/14","CMT_DESC":"Characterize the safety of long-term use in patients with classical Hodgkin lymphoma treated with pembrolizumab 200 mg every 3 weeks. Submit a final report and datasets with safety and efficacy outcomes of trial KN087 with at least 3 years of follow-up data.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"FDAAA Section 505(o)(3)","NCT1":"NCT02453594","LastCTUpdate1":"1/20/21","N1":211,"APPLICANT":"Merck Sharp & Dohme Corp.","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"10/31/19","FINAL_REPORT_DUE_DATE":"8/31/21"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":125514,"CMT_DOC_TYPE_NO":17,"PRODUCT":"Keytruda (pembrolizumab)","NDA_BLA_APPROVAL_DATE":"9/4/14","CMT_DESC":"Conduct clinical trial KEYNOTE-361 entitled \u201cA Phase III Randomized, Controlled Clinical Trial of Pembrolizumab With or Without Platinum-Based Combination Chemotherapy Versus Chemotherapy in Subjects With Advanced or Metastatic Urothelial Carcinoma\u201d. Submit the datasets with the final report.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Accelerated Approval","NCT1":"NCT02853305","LastCTUpdate1":"1/22/21","N1":1010,"APPLICANT":"Merck Sharp & Dohme Corp.","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"10/31/19","FINAL_REPORT_DUE_DATE":"11/30/21"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":125514,"CMT_DOC_TYPE_NO":30,"PRODUCT":"Keytruda (pembrolizumab)","NDA_BLA_APPROVAL_DATE":"9/4/14","CMT_DESC":"Complete the trial and submit the final report and data to verify and describe the clinical benefit of pembrolizumab, including efficacy and safety, from Trial KN204, a Phase 3 randomized, open-label, active-controlled trial comparing pembrolizumab to brentuximab vedotin for the treatment of patients with relapsed or refractory classical Hodgkin lymphoma. Enroll approximately 300 patients. The primary endpoint should include progression-free survival.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Accelerated Approval","NCT1":"NCT02684292","LastCTUpdate1":"8/4/20","N1":304,"APPLICANT":"Merck Sharp & Dohme Corp.","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"10/31/19","FINAL_REPORT_DUE_DATE":"4/30/21"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":125514,"CMT_DOC_TYPE_NO":30,"PRODUCT":"Keytruda (pembrolizumab)","NDA_BLA_APPROVAL_DATE":"9/4/14","CMT_DESC":"Characterize the safety of long-term use in patients with primary mediastinal large B-cell lymphoma. Submit a final report and data sets with safety and efficacy outcomes of trial KEYNOTE-170 with at least 3 years of follow-up data.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"FDAAA Section 505(o)(3)","NCT1":"NCT02576990","LastCTUpdate1":"11/20/20","N1":80,"APPLICANT":"Merck Sharp & Dohme Corp.","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"10/31/19","FINAL_REPORT_DUE_DATE":"11/30/20"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":125514,"CMT_DOC_TYPE_NO":34,"PRODUCT":"Keytruda (pembrolizumab)","NDA_BLA_APPROVAL_DATE":"9/4/14","CMT_DESC":"Conduct clinical trial KEYNOTE-826 (KN-826) in cervical cancer for Progression Free Survival (PFS)-Overall Survival (OS), entitled \u201cA Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Pembrolizumab Plus Chemotherapy vs. Chemotherapy Plus Placebo for the First-line Treatment of Persistent, Recurrent, or Metastatic Cervical Cancer\u201d. Submit analyses and datasets with final report for PFS and OS.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Accelerated Approval","NCT1":"NCT03635567","LastCTUpdate1":"12/13/20","N1":600,"APPLICANT":"Merck Sharp & Dohme Corp.","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"10/31/19","FINAL_REPORT_DUE_DATE":"5/31/23"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":125514,"CMT_DOC_TYPE_NO":34,"PRODUCT":"Keytruda (pembrolizumab)","NDA_BLA_APPROVAL_DATE":"9/4/14","CMT_DESC":"Submit the median Duration of Response (DOR) analyses and datasets with the final report of clinical trial Keynote 158 (Cohort E), entitled; \u201cA Clinical Trial of Pembrolizumab (MK-3475) Evaluating Predictive Biomarkers in Subjects with Advanced Solid Tumors\u201d","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Post Marketing Commitment","NCT1":"NCT02628067","LastCTUpdate1":"12/17/20","N1":1595,"APPLICANT":"Merck Sharp & Dohme Corp.","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"10/31/19","FINAL_REPORT_DUE_DATE":"2/28/20"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":125514,"CMT_DOC_TYPE_NO":35,"PRODUCT":"Keytruda (pembrolizumab)","NDA_BLA_APPROVAL_DATE":"9/4/14","CMT_DESC":"Submit the clinical trial report and datasets for the updated survival results for KEYNOTE-189, entitled \u201cA Randomized, Double-Blind, Phase III Study of Platinum plus Pemetrexed Chemotherapy with or without Pembrolizumab (MK3475) in First Line Metastatic Non-squamous Non-small Cell Lung Cancer Subjects,\u201d in order to inform the label with mature overall survival data in accordance with the pre-specified final analysis of KEYNOTE-189.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Post Marketing Commitment","NCT1":"NCT02578680","LastCTUpdate1":"10/23/20","N1":616,"APPLICANT":"Merck Sharp & Dohme Corp.","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"10/31/19","FINAL_REPORT_DUE_DATE":"6/30/21"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":125514,"CMT_DOC_TYPE_NO":40,"PRODUCT":"Keytruda (pembrolizumab)","NDA_BLA_APPROVAL_DATE":"9/4/14","CMT_DESC":"Submit the final clinical report and datasets at the time of the final analysis for overall survival (OS) of Trial KEYNOTE-054, entitled \u201cAdjuvant Immunotherapy with Anti-PD-1 Monoclonal Antibody Pembrolizumab (MK-3475) versus Placebo After Complete Resection of High-Risk Stage III Melanoma: A Randomized, Double-Blind Phase 3 study of the EORTC Melanoma Group\u201d, to revise the product label with updated relapse-free survival data and mature OS data.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Post Marketing Commitment","NCT1":"NCT02362594","LastCTUpdate1":"10/20/20","N1":1019,"APPLICANT":"Merck Sharp & Dohme Corp.","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"10/31/19","FINAL_REPORT_DUE_DATE":"12/31/23"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":125514,"CMT_DOC_TYPE_NO":41,"PRODUCT":"Keytruda (pembrolizumab)","NDA_BLA_APPROVAL_DATE":"9/4/14","CMT_DESC":"Submit the results of the final analysis of progression-free survival and overall survival data from KEYNOTE-407, entitled \u201cA Phase 3 Study of Carboplatin-Paclitaxel/Nab-paclitaxel Chemotherapy with or without Pembrolizumab in First Line Metastatic Squamous Non-Small Cell Lung Cancer,\u201d to further characterize the efficacy and benefit:risk assessment of pembrolizumab, administered in combination with carboplatin and paclitaxel or nanoparticle albumin bound paclitaxel (nab-paclitaxel), and for inclusion in product labeling.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Post Marketing Commitment","NCT1":"NCT02775435","LastCTUpdate1":"9/30/20","N1":559,"APPLICANT":"Merck Sharp & Dohme Corp.","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"10/31/19","FINAL_REPORT_DUE_DATE":"9/30/21"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":125514,"CMT_DOC_TYPE_NO":42,"PRODUCT":"Keytruda (pembrolizumab)","NDA_BLA_APPROVAL_DATE":"9/4/14","CMT_DESC":"Submit the final report, including datasets, of Study KEYNOTE-224, \u201cA Phase II Study of Pembrolizumab (MK-3475) as Monotherapy in Subjects With Previously Systemically Treated Advanced Hepatocellular Carcinoma,\u201d in which all responding patients have been followed for a minimum of 24 months and duration of response is assessed by independent central review, to more accurately characterize the durability of the response observed with pembrolizumab in this study.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Post Marketing Commitment","NCT1":"NCT02702414","LastCTUpdate1":"1/20/21","N1":150,"APPLICANT":"Merck Sharp & Dohme Corp.","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"10/31/19","FINAL_REPORT_DUE_DATE":"4/30/20"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":125514,"CMT_DOC_TYPE_NO":53,"PRODUCT":"Keytruda (pembrolizumab)","NDA_BLA_APPROVAL_DATE":"9/4/14","CMT_DESC":"Submit the final report, including datasets, for KEYNOTE-158 (Cohort G) and KEYNOTE-028 (Cohort C), in which all 16 of the 83 responding patients identified in the interim study report submitted to BLA 125514/S53, have been followed for a minimum of 24 months, to update the label with information which will more accurately characterize the blinded independent review committee-assessed durability of the response observed with pembrolizumab, as a single agent, for the third-line treatment of small cell lung cancer.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Post Marketing Commitment","NCT1":"NCT02628067","LastCTUpdate1":"12/17/20","N1":1595,"APPLICANT":"Merck Sharp & Dohme Corp.","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"10/31/19","FINAL_REPORT_DUE_DATE":"12/31/20"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":125514,"CMT_DOC_TYPE_NO":54,"PRODUCT":"Keytruda (pembrolizumab)","NDA_BLA_APPROVAL_DATE":"9/4/14","CMT_DESC":"Provide a report, datasets, and labeling for the second interim analysis of overall survival (OS) for the ongoing clinical trial KEYNOTE-426, entitled, \u201cA Phase III Randomized, Open-label Study to Evaluate Efficacy and Safety of Pembrolizumab (MK-3475) in Combination with Axitinib Versus Sunitinib Monotherapy as a First-line Treatment for Locally Advanced or Metastatic Renal Cell Carcinoma (mRCC).\u201d","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Post Marketing Commitment","NCT1":"NCT02853331","LastCTUpdate1":"4/3/20","N1":861,"APPLICANT":"Merck Sharp & Dohme Corp.","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"10/31/19","FINAL_REPORT_DUE_DATE":"8/31/20"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":125514,"CMT_DOC_TYPE_NO":54,"PRODUCT":"Keytruda (pembrolizumab)","NDA_BLA_APPROVAL_DATE":"9/4/14","CMT_DESC":"Provide a report, datasets, and labeling for the final analysis of overall survival (OS) for the ongoing clinical trial KEYNOTE-426, entitled, \u201cA Phase III Randomized, Open-label Study to Evaluate Efficacy and Safety of Pembrolizumab (MK-3475) in Combination with Axitinib Versus Sunitinib Monotherapy as a First-line Treatment for Locally Advanced or Metastatic Renal Cell Carcinoma (mRCC).\u201d","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Post Marketing Commitment","NCT1":"NCT02853331","LastCTUpdate1":"4/3/20","N1":861,"APPLICANT":"Merck Sharp & Dohme Corp.","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"10/31/19","FINAL_REPORT_DUE_DATE":"9/30/21"},{"CMT_DOC_TYPE":"Original Biologics License Application","NDA_NUMBER":125261,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Stelara (Ustekinumab)","NDA_BLA_APPROVAL_DATE":"9/25/09","CMT_DESC":"Provide data analyses from the Pregnancy Research Initiative (study C0168T71).","CMT_STATUS":"Ongoing","SUBPART_FLAG":"FDAAA Section 505(o)(3)","NCT1":"NCT00658827","LastCTUpdate1":"9/6/17","N1":370,"APPLICANT":"Janssen Biotech, Inc.","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"11/21/19","FINAL_REPORT_DUE_DATE":"12/15/21"},{"CMT_DOC_TYPE":"Original Biologics License Application","NDA_NUMBER":761108,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Ultomiris (ravulizumab-cwvz) injection","NDA_BLA_APPROVAL_DATE":"12/21/18","CMT_DESC":"Submit the final clinical study report and dataset for the randomized controlled trial of ULTOMIRIS in patients with paroxysmal nocturnal hemoglobinuria (ALXN1210-PNH-301) to include the extension period of up to 2 years of follow-up.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Post Marketing Commitment","NCT1":"NCT02946463","LastCTUpdate1":"5/15/20","N1":246,"APPLICANT":"Alexion Pharmaceuticals, Inc.","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"2/13/20","FINAL_REPORT_DUE_DATE":"10/31/23"},{"CMT_DOC_TYPE":"Original Biologics License Application","NDA_NUMBER":761108,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Ultomiris (ravulizumab-cwvz) injection","NDA_BLA_APPROVAL_DATE":"12/21/18","CMT_DESC":"Submit the final clinical study report and dataset for the randomized controlled trial of ULTOMIRIS in patients with paroxysmal nocturnal hemoglobinuria (ALXN1210-PNH-302) to include the extension period of up to 2 years of follow-up.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Post Marketing Commitment","NCT1":"NCT03056040","LastCTUpdate1":"8/12/20","N1":195,"APPLICANT":"Alexion Pharmaceuticals, Inc.","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"2/13/20","FINAL_REPORT_DUE_DATE":"9/30/21"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":205552,"CMT_DOC_TYPE_NO":17,"PRODUCT":"Imbruvica (Ibrutinib)","NDA_BLA_APPROVAL_DATE":"11/13/13","CMT_DESC":"Conduct an analysis of safety in patients with chronic graft-versus-host-disease treated with ibrutinib. Submit the complete primary study report and datasets from Study PCYC-1140-IM: A Randomized, Double-Blind Phase 3 Study of Ibrutinib in Combination with Corticosteroids versus Placebo in Combination with Corticosteroids in Subjects with New Onset Chronic Graft-Versus-Host Disease (cGVHD). Include safety analyses that evaluate impact of concomitant medications (for example, corticosteroids and additional immunosuppressants) on  the safety profile for ibrutinib.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"FDAAA Section 505(o)(3)","NCT1":"NCT02959944","LastCTUpdate1":"7/14/20","N1":193,"APPLICANT":"PHARMACYCLICS LLC","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"1/10/20","FINAL_REPORT_DUE_DATE":"12/31/22"},{"CMT_DOC_TYPE":"Original New Drug Application (NDA)","NDA_NUMBER":208700,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Lutathera (177 Lu-DOTA0-Tyr3-Octreotate)","NDA_BLA_APPROVAL_DATE":"1/26/18","CMT_DESC":"Submit the final clinical report and datasets at the time of the final analysis for overall survival (OS) for Trial NETTER-1, entitled \u201cA Multicentre, stratified, open, randomized, comparator-controlled, parallel-group phase III study comparing treatment with 177 Lu-DOTA0-Tyr3-Octreotate to Octreotide LAR in Patients with Inoperable, Progressive, Somatostin Receptor Positive, Midgut Carcinoid Tumors\u201d, to revise product labeling with mature OS data.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Post Marketing Commitment","NCT1":"NCT01578239","LastCTUpdate1":"1/20/20","N1":231,"APPLICANT":"ADVANCED ACCELERATOR APPLICATIONS USA INC","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"3/25/20","FINAL_REPORT_DUE_DATE":"5/31/21"},{"CMT_DOC_TYPE":"Original New Drug Application (NDA)","NDA_NUMBER":208716,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Verzenio (abemaciclib)","NDA_BLA_APPROVAL_DATE":"9/28/17","CMT_DESC":"Submit the overall survival (OS) data and analysis with final report from clinical trial MONARCH 3 entitled; \u201cA Randomized, Double-Blind, Placebo-Controlled,  Phase 3 Study of Nonsteroidal Aromatase Inhibitors (Anastrazole or Letrozole) plus LY2835219, a CDK 4/6 Inhibitor, or Placebo in Postmenopausal Women  with Hormone Receptor-Positive, HER2-Negative Locoregionally Recurrent or Metastatic Breast Cancer with No Prior Systemic Therapy in this Disease Setting.\u201d","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Post Marketing Commitment","NCT1":"NCT02246621","LastCTUpdate1":"12/17/20","N1":493,"APPLICANT":"ELI LILLY AND CO","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"11/25/19","FINAL_REPORT_DUE_DATE":"12/31/26"},{"CMT_DOC_TYPE":"Original New Drug Application (NDA)","NDA_NUMBER":208855,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Verzenio (abemaciclib)","NDA_BLA_APPROVAL_DATE":"2/26/18","CMT_DESC":"Submit the overall survival (OS) data and analysis with final report from clinical trial MONARCH 3 entitled; \u201cA Randomized, Double-Blind, Placebo-Controlled,  Phase 3 Study of Nonsteroidal Aromatase Inhibitors (Anastrazole or Letrozole) plus LY2835219, a CDK 4/6 Inhibitor, or Placebo in Postmenopausal Women  with Hormone Receptor-Positive, HER2-Negative Locoregionally Recurrent or Metastatic Breast Cancer with No Prior Systemic Therapy in this Disease Setting.\u201d","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Post Marketing Commitment","NCT1":"NCT02246621","LastCTUpdate1":"12/17/20","N1":493,"APPLICANT":"ELI LILLY AND CO","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"NA","FINAL_REPORT_DUE_DATE":"12/31/26"},{"CMT_DOC_TYPE":"Original New Drug Application (NDA)","NDA_NUMBER":209092,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Kisqali (Ribociclib)","NDA_BLA_APPROVAL_DATE":"3/13/17","CMT_DESC":"Submit the third overall survival (OS) interim data and analysis, and the final overall survival (OS) data and analysis from clinical trial entitled \u201cMONALEESA-2\u201d CLEE011A2301.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Post Marketing Commitment","NCT1":"NCT01958021","LastCTUpdate1":"10/19/20","N1":668,"APPLICANT":"NOVARTIS PHARMACEUTICALS CORP","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"5/6/20","FINAL_REPORT_DUE_DATE":"6/30/22"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":209115,"CMT_DOC_TYPE_NO":3,"PRODUCT":"Rubraca (Rucaparib)","NDA_BLA_APPROVAL_DATE":"12/19/16","CMT_DESC":"Submit to FDA the overall survival (OS) analyses with datasets from clinical trial CO-338-014 entitled, \u201cPhase 3 Study of Rucaparib as Switch Maintenance After Platinum in Relapsed High Grade Serous and Endometrioid Ovarian Cancer\u201d (ARIEL3).","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Post Marketing Commitment","NCT1":"NCT01968213","LastCTUpdate1":"2/20/20","N1":564,"APPLICANT":"CLOVIS ONCOLOGY INC","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"2/14/20","FINAL_REPORT_DUE_DATE":"3/31/21"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":209115,"CMT_DOC_TYPE_NO":4,"PRODUCT":"Rubraca (Rucaparib)","NDA_BLA_APPROVAL_DATE":"12/19/16","CMT_DESC":"Submit the final report of analytical and clinical validation studies that use cell-free/circulating tumor DNA (cf/ctDNA) isolated from plasma specimens from the TRITON2 clinical trial that is adequate to support labeling of an in vitro diagnostic device that demonstrates the device is essential to the safe and effective use of rucaparib for prostate cancer patients with BRCA1 and BRCA2 gene alterations. The analytical validation should consist of precision, limit of detection, and accuracy studies using samples, consistent with the clinical trial patient population, to support prostate cancer indication. The clinical validation should be supported by a clinical bridging study comparing intended CDx test(s) and the clinical trial enrollment assays.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Post Marketing Commitment","NCT1":"NCT02952534","LastCTUpdate1":"11/27/20","N1":360,"APPLICANT":"CLOVIS ONCOLOGY INC","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"2/14/20","FINAL_REPORT_DUE_DATE":"12/31/21"},{"CMT_DOC_TYPE":"Original New Drug Application (NDA)","NDA_NUMBER":209478,"CMT_DOC_TYPE_NO":1,"PRODUCT":"CaroSpir (Spironolactone)","NDA_BLA_APPROVAL_DATE":"8/4/17","CMT_DESC":"Conduct a clinical drug-drug interaction trial to evaluate a potential interaction between digoxin and spironolactone using a validated analytical method to  quantify plasma digoxin levels.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"FDAAA Section 505(o)(3)","NCT1":"NCT03909529","LastCTUpdate1":"7/24/19","N1":28,"APPLICANT":"CMP DEVELOPMENT LLC","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"9/9/19","FINAL_REPORT_DUE_DATE":"3/31/19"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":125057,"CMT_DOC_TYPE_NO":114,"PRODUCT":"Humira (Adalimumab)","NDA_BLA_APPROVAL_DATE":"12/31/02","CMT_DESC":"Conduct Study Protocol P10-262, an 800-patient observational study, with inclusion of a reference group, of pediatric patients 4 to 17 years of age with moderately to severely active polyarticular juvenile idiopathic arthritis (JIA).","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Pediatric Research Equity Act","NCT1":"NCT00783510","LastCTUpdate1":"11/6/20","N1":833,"APPLICANT":"AbbVie Inc.","CMT_STATUS_DESC":"Final report due 12/2024.","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"2/26/20","FINAL_REPORT_DUE_DATE":"12/31/21"},{"CMT_DOC_TYPE":"Original New Drug Application (NDA)","NDA_NUMBER":210806,"CMT_DOC_TYPE_NO":1,"PRODUCT":"PIFELTRO (doravirine)","NDA_BLA_APPROVAL_DATE":"8/30/18","CMT_DESC":"Conduct a study to evaluate the pharmacokinetics, safety and antiviral activity (efficacy) of doravirine in HIV-1 infected pediatric subjects less than 18 years of age and weighing at least 35 kg. The safety and antiviral activity of doravirine in pediatric subjects must be evaluated for a minimum of 24 weeks.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Pediatric Research Equity Act","NCT1":"NCT04295772","LastCTUpdate1":"11/22/21","N1":45,"APPLICANT":"MERCK SHARP AND DOHME CORP A SUB OF MERCK AND CO INC","CMT_STATUS_DESC":"Reports that 10 participants have been enrolled in Cohort 1 of the trial as of 08/30/19.","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"10/25/19","FINAL_REPORT_DUE_DATE":"1/31/22"},{"CMT_DOC_TYPE":"Original New Drug Application (NDA)","NDA_NUMBER":213973,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Qinlock (ripretinib)","NDA_BLA_APPROVAL_DATE":"5/15/20","CMT_DESC":"Conduct a clinical pharmacokinetic trial to evaluate the effect of repeat doses of ripretinib on the single dose pharmacokinetics of a sensitive CYP2C8 substrate. This trial should be designed and conducted in accordance with the FDA Guidance for Industry titled, \u201cClinical Drug Interaction Studies \u2013 Study Design, Data Analysis, and Clinical Implications.\u201d The results from this trial should determine the magnitude of increase in the exposure of the CYP2C8 substrate and an appropriate dosing recommendation of CYP2C8 substrates when they are administered concomitantly with ripretinib and may inform labeling.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"FDAAA Section 505(o)(3)","NCT1":"NCT04530981","LastCTUpdate1":"8/28/20","N1":30,"APPLICANT":"DECIPHERA PHARMACEUTICALS LLC","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"NA","FINAL_REPORT_DUE_DATE":"3/31/22"},{"CMT_DOC_TYPE":"Original New Drug Application (NDA)","NDA_NUMBER":210807,"CMT_DOC_TYPE_NO":1,"PRODUCT":"DELSTRIGO (doravirine, lamivudine, and tenofovir disoproxil fumarate)","NDA_BLA_APPROVAL_DATE":"8/30/18","CMT_DESC":"Conduct a study to evaluate the pharmacokinetics, safety, and antiviral activity (efficacy) of doravirine/lamivudine/tenofovir disoproxil fumarate fixed dose combination (FDC) product in HIV-1 infected pediatric subjects less than 18 years of age and weighing at least 35 kg. Subjects must be followed for a minimum of 24 weeks to assess the safety and antiviral activity of doravirine/lamivudine/tenofovir disoproxil fumarate FDC product. A clinical trial in pediatric subjects weighing at least 35 kg may not be required if dosing recommendation for the FDC tablets can be supported by pediatric trials already conducted with the individual drug products.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Pediatric Research Equity Act","NCT1":"NCT03332095","LastCTUpdate1":"8/25/20","N1":55,"APPLICANT":"MERCK SHARP AND DOHME CORP A SUB OF MERCK AND CO INC","CMT_STATUS_DESC":"Reports the 10 patients have been enrolled in Cohort 1 of the study.","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"10/25/19","FINAL_REPORT_DUE_DATE":"1/31/22"},{"CMT_DOC_TYPE":"Original New Drug Application (NDA)","NDA_NUMBER":210854,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Xofluza (baloxavir marboxil)","NDA_BLA_APPROVAL_DATE":"10/24/18","CMT_DESC":"Conduct a single-arm, open-label clinical trial to evaluate pharmacokinetics, safety, and antiviral activity of baloxavir marboxil in pediatric subjects from birth to less than 12 months of age with acute uncomplicated influenza. Include characterization of baloxavir-resistant substitutions in viral isolates from subjects with prolonged viral shedding.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Pediatric Research Equity Act","NCT1":"NCT03653364","LastCTUpdate1":"1/21/21","N1":30,"APPLICANT":"GENENTECH INC","CMT_STATUS_DESC":"Reporting 33 patients have been enrolled as of 11/12/19.","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"12/19/19","FINAL_REPORT_DUE_DATE":"12/31/21"},{"CMT_DOC_TYPE":"Original New Drug Application (NDA)","NDA_NUMBER":210854,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Xofluza (baloxavir marboxil)","NDA_BLA_APPROVAL_DATE":"10/24/18","CMT_DESC":"Conduct a randomized, double-blind, controlled clinical trial evaluating efficacy and safety of baloxavir marboxil in subjects hospitalized with severe influenza.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Post Marketing Commitment","NCT1":"NCT03684044","LastCTUpdate1":"1/6/21","N1":363,"APPLICANT":"GENENTECH INC","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"12/19/19","FINAL_REPORT_DUE_DATE":"11/30/22"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":761108,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Ultomiris (ravulizumab-cwvz) injection","NDA_BLA_APPROVAL_DATE":"12/21/18","CMT_DESC":"Provide safety, efficacy, PK, and PD data in pediatric patients with aHUS (Study ALXN 1210-aHUS-312) and a weight of greater than or equal to 5 kg to less than 10 kg treated with the recommended dosing regimen of ravulizumab (600 mg loading dose followed two weeks later by 300 mg maintenance doses every 4 weeks).","CMT_STATUS":"Ongoing","SUBPART_FLAG":"FDAAA Section 505(o)(3)","NCT1":"NCT03131219","LastCTUpdate1":"9/16/20","N1":31,"APPLICANT":"Alexion Pharmaceuticals, Inc.","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"2/13/20","FINAL_REPORT_DUE_DATE":"6/30/25"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":761108,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Ultomiris (ravulizumab-cwvz) injection","NDA_BLA_APPROVAL_DATE":"12/21/18","CMT_DESC":"Submit the final clinical study report and datasets for the single arm trial of ULTOMIRIS in pediatric patients with aHUS (ALXN1210- aHUS-312) to include the extension period of up to 4.5 years of follow-up on safety and efficacy.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Post Marketing Commitment","NCT1":"NCT03131219","LastCTUpdate1":"9/16/20","N1":31,"APPLICANT":"Alexion Pharmaceuticals, Inc.","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"2/13/20","FINAL_REPORT_DUE_DATE":"6/30/25"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":761108,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Ultomiris (ravulizumab-cwvz) injection","NDA_BLA_APPROVAL_DATE":"12/21/18","CMT_DESC":"Provide safety, efficacy, PK, and PD data in pediatric patients with aHUS (Study ALXN1210-aHUS-312) who switch from treatmentwith eculizumab to treatment with ravulizumab.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Post Marketing Commitment","NCT1":"NCT03131219","LastCTUpdate1":"9/16/20","N1":31,"APPLICANT":"Alexion Pharmaceuticals, Inc.","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"2/13/20","FINAL_REPORT_DUE_DATE":"6/30/25"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":761108,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Ultomiris (ravulizumab-cwvz) injection","NDA_BLA_APPROVAL_DATE":"12/21/18","CMT_DESC":"Submit the final clinical study report and datasets for the single arm trial of ULTOMIRIS in adult patients with aHUS (Study ALXN1210- aHUS-311) to include the extension period of up to 4.5 years of follow-up on safety and efficacy.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Post Marketing Commitment","NCT1":"NCT02949128","LastCTUpdate1":"5/5/20","N1":58,"APPLICANT":"Alexion Pharmaceuticals, Inc.","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"2/13/20","FINAL_REPORT_DUE_DATE":"12/31/23"},{"CMT_DOC_TYPE":"Original Biologics License Application","NDA_NUMBER":761047,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Mepsevii (vestronidase alfa-vjbk)","NDA_BLA_APPROVAL_DATE":"11/15/17","CMT_DESC":"A prospective, longitudinal study (Study UX003-CL401) to assess the long-term risk of immunogenicity and the risk of serious hypersensitivity reactions, including anaphylaxis, in patients with mucopolysaccharidosis type VII (MPS VII) followed for three years on Mepsevii (vestronidase alfa-vjbk). The following information will be collected and analyzed: (1) incidence rates for serious hypersensitivity reactions, (2) incidence rates for the appearance of anti-drug antibodies (ADA) and neutralizing antibodies (Nab) against Mepsevii (vestronidase alfa-vjbk), (3) temporal associations between ADA or Nab formation and serious hypersensitivity reactions, (4) associations between betaglucuronidase (GUSB) genotype and serious hypersensitivity reaction risk, (5)  associations between intrinsic GUSB enzymatic activity and serious hypersensitivity reaction risk, and (6) assessments of the risk of immunogenicity on clinical safety outcomes. To complete these analyses, protocol UX003-CL401 will require collection of molecular genotype and intrinsic GUSB enzymatic activity (apart from any concurrent enzyme replacement). Submit annual study reports that contain results from analyses of interim data. The final study report will be based on a study population that contains at least 12 new patients (including at least six patients less than one year old) treated with Mepsevii (vestronidase alfa-vjbk) and enrolled in Study UX003-CL401.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"FDAAA Section 505(o)(3)","NCT1":"NCT03604835","LastCTUpdate1":"1/22/21","N1":35,"APPLICANT":"Ultragenyx Pharmaceutical Inc.","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"7/29/20","FINAL_REPORT_DUE_DATE":"5/31/26"},{"CMT_DOC_TYPE":"Original Biologics License Application","NDA_NUMBER":761047,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Mepsevii (vestronidase alfa-vjbk)","NDA_BLA_APPROVAL_DATE":"11/15/17","CMT_DESC":"In MPS VII patients enrolled in the prospective, longitudinal Study UX003-CL401 (PMR-1), to collect and analyze: (1) beta glucuronidase (GUSB) genotype, (2) in patients without a history of Mepsevii (vestronidase alfa-vjbk) treatment, baseline intrinsic GUSB enzymatic activity apart from any concurrent enzyme replacement treatment, (3) a complete record of treatments with Mepsevii (vestronidase alfa-vjbk) pre- and post-UX003-CL401 enrollment, and (4) results from baseline and periodic tests for MPS VII clinical outcomes to include liver and spleen size measurement, pulmonary function, motor function, and neurocognitive function.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Post Marketing Commitment","NCT1":"NCT03604835","LastCTUpdate1":"1/22/21","N1":35,"APPLICANT":"Ultragenyx Pharmaceutical Inc.","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"7/29/20","FINAL_REPORT_DUE_DATE":"5/31/33"},{"CMT_DOC_TYPE":"Original Biologics License Application","NDA_NUMBER":761049,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Bavencio (Avelumab)","NDA_BLA_APPROVAL_DATE":"3/23/17","CMT_DESC":"Submit the final report and data for safety and efficacy of the ongoing clinical trial EMR100070-005 entitled \u201cA Phase 3, Open-Label, Multicenter Trial of Avelumab (MSB0010718C) Versus Platinum-Based Doublet as a First-Line  Treatment of Recurrent or Stage IV PD-L1+ Non-Small Cell Lung Cancer\u201d, including results of the exposure-response analysis.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Post Marketing Commitment","NCT1":"NCT02576574","LastCTUpdate1":"12/17/20","N1":1224,"APPLICANT":"EMD Serono, Inc.","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"5/17/19","FINAL_REPORT_DUE_DATE":"10/31/20"},{"CMT_DOC_TYPE":"Original New Drug Application (NDA)","NDA_NUMBER":211651,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Talzenna (talazoparib)","NDA_BLA_APPROVAL_DATE":"10/16/18","CMT_DESC":"Determine the appropriate dosing recommendations in patients with moderate and severe hepatic impairment by using the results from clinical trial C3441002 entitled, \u201cA Phase 1 Open-Label Pharmacokinetics and Safety Study of Talazoparib (MDV3800) in Patients With Advanced Solid Tumors and Normal or Varying Degrees of Hepatic Impairment\u201d. Submit datasets with the final report.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"FDAAA Section 505(o)(3)","NCT1":"NCT02997176","LastCTUpdate1":"10/30/20","N1":38,"APPLICANT":"PFIZER INC","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"12/12/19","FINAL_REPORT_DUE_DATE":"11/30/20"},{"CMT_DOC_TYPE":"Original New Drug Application (NDA)","NDA_NUMBER":213464,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Lampit (Nifurtimox)","NDA_BLA_APPROVAL_DATE":"8/6/20","CMT_DESC":"Complete the CHICO SECURE part of Study 16027 to determine the seroconversion rate in subjects treated with nifurtimox at the 4-year timepoint. Obtain antibody titers by serial dilution for all available serum samples measured by the F29-ELISA, Recombinant-ELISA and Lysate-ELISA in addition to IHA.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Accelerated Approval","NCT1":"NCT02625974","LastCTUpdate1":"12/29/20","N1":330,"APPLICANT":"BAYER HEALTHCARE PHARMACEUTICALS INC","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"NA","FINAL_REPORT_DUE_DATE":"2/28/22"}],"Sheet1":[{"NCT005":"NCT006"},{"NCT005":"NCT007"},{"NCT005":"NCT008"},{"NCT005":"NCT009"},{"NCT005":"NCT010"},{"NCT005":"NCT011"},{"NCT005":"NCT012"},{"NCT005":"NCT013"},{"NCT005":"NCT014"},{"NCT005":"NCT015"},{"NCT005":"NCT016"},{"NCT005":"NCT017"},{"NCT005":"NCT018"},{"NCT005":"NCT019"},{"NCT005":"NCT020"},{"NCT005":"NCT021"},{"NCT005":"NCT022"},{"NCT005":"NCT023"},{"NCT005":"NCT024"},{"NCT005":"NCT025"},{"NCT005":"NCT026"},{"NCT005":"NCT027"},{"NCT005":"NCT028"},{"NCT005":"NCT029"},{"NCT005":"NCT030"},{"NCT005":"NCT031"},{"NCT005":"NCT032"},{"NCT005":"NCT033"},{"NCT005":"NCT034"},{"NCT005":"NCT035"},{"NCT005":"NCT036"},{"NCT005":"NCT037"},{"NCT005":"NCT038"},{"NCT005":"NCT039"},{"NCT005":"NCT040"},{"NCT005":"NCT041"},{"NCT005":"NCT042"},{"NCT005":"NCT043"},{"NCT005":"NCT044"},{"NCT005":"NCT045"},{"NCT005":"NCT046"},{"NCT005":"NCT047"},{"NCT005":"NCT048"},{"NCT005":"NCT049"},{"NCT005":"NCT050"},{"NCT005":"NCT051"},{"NCT005":"NCT052"},{"NCT005":"NCT053"},{"NCT005":"NCT054"},{"NCT005":"NCT055"},{"NCT005":"NCT056"},{"NCT005":"NCT057"},{"NCT005":"NCT058"},{"NCT005":"NCT059"},{"NCT005":"NCT060"},{"NCT005":"NCT061"},{"NCT005":"NCT062"},{"NCT005":"NCT063"},{"NCT005":"NCT064"},{"NCT005":"NCT065"},{"NCT005":"NCT066"},{"NCT005":"NCT067"},{"NCT005":"NCT068"},{"NCT005":"NCT069"},{"NCT005":"NCT070"},{"NCT005":"NCT071"},{"NCT005":"NCT072"},{"NCT005":"NCT073"},{"NCT005":"NCT074"},{"NCT005":"NCT075"},{"NCT005":"NCT076"},{"NCT005":"NCT077"},{"NCT005":"NCT078"},{"NCT005":"NCT079"},{"NCT005":"NCT080"},{"NCT005":"NCT081"},{"NCT005":"NCT082"},{"NCT005":"NCT083"},{"NCT005":"NCT084"},{"NCT005":"NCT085"},{"NCT005":"NCT086"},{"NCT005":"NCT087"},{"NCT005":"NCT088"},{"NCT005":"NCT089"},{"NCT005":"NCT090"},{"NCT005":"NCT091"},{"NCT005":"NCT092"},{"NCT005":"NCT093"},{"NCT005":"NCT094"},{"NCT005":"NCT095"},{"NCT005":"NCT096"},{"NCT005":"NCT097"},{"NCT005":"NCT098"},{"NCT005":"NCT099"},{"NCT005":"NCT100"},{"NCT005":"NCT101"},{"NCT005":"NCT102"},{"NCT005":"NCT103"},{"NCT005":"NCT104"},{"NCT005":"NCT105"},{"NCT005":"NCT106"},{"NCT005":"NCT107"},{"NCT005":"NCT108"},{"NCT005":"NCT109"},{"NCT005":"NCT110"},{"NCT005":"NCT111"},{"NCT005":"NCT112"},{"NCT005":"NCT113"},{"NCT005":"NCT114"},{"NCT005":"NCT115"},{"NCT005":"NCT116"},{"NCT005":"NCT117"},{"NCT005":"NCT118"},{"NCT005":"NCT119"},{"NCT005":"NCT120"},{"NCT005":"NCT121"},{"NCT005":"NCT122"},{"NCT005":"NCT123"},{"NCT005":"NCT124"},{"NCT005":"NCT125"},{"NCT005":"NCT126"},{"NCT005":"NCT127"},{"NCT005":"NCT128"},{"NCT005":"NCT129"},{"NCT005":"NCT130"},{"NCT005":"NCT131"},{"NCT005":"NCT132"},{"NCT005":"NCT133"},{"NCT005":"NCT134"},{"NCT005":"NCT135"},{"NCT005":"NCT136"},{"NCT005":"NCT137"},{"NCT005":"NCT138"},{"NCT005":"NCT139"},{"NCT005":"NCT140"},{"NCT005":"NCT141"},{"NCT005":"NCT142"},{"NCT005":"NCT143"},{"NCT005":"NCT144"},{"NCT005":"NCT145"},{"NCT005":"NCT146"},{"NCT005":"NCT147"},{"NCT005":"NCT148"},{"NCT005":"NCT149"},{"NCT005":"NCT150"},{"NCT005":"NCT151"},{"NCT005":"NCT152"},{"NCT005":"NCT153"},{"NCT005":"NCT154"},{"NCT005":"NCT155"},{"NCT005":"NCT156"},{"NCT005":"NCT157"},{"NCT005":"NCT158"},{"NCT005":"NCT159"},{"NCT005":"NCT160"},{"NCT005":"NCT161"},{"NCT005":"NCT162"},{"NCT005":"NCT163"},{"NCT005":"NCT164"},{"NCT005":"NCT165"},{"NCT005":"NCT166"},{"NCT005":"NCT167"},{"NCT005":"NCT168"},{"NCT005":"NCT169"},{"NCT005":"NCT170"},{"NCT005":"NCT171"},{"NCT005":"NCT172"},{"NCT005":"NCT173"},{"NCT005":"NCT174"},{"NCT005":"NCT175"},{"NCT005":"NCT176"},{"NCT005":"NCT177"},{"NCT005":"NCT178"},{"NCT005":"NCT179"},{"NCT005":"NCT180"},{"NCT005":"NCT181"},{"NCT005":"NCT182"},{"NCT005":"NCT183"},{"NCT005":"NCT184"},{"NCT005":"NCT185"},{"NCT005":"NCT186"},{"NCT005":"NCT187"},{"NCT005":"NCT188"},{"NCT005":"NCT189"},{"NCT005":"NCT190"},{"NCT005":"NCT191"},{"NCT005":"NCT192"},{"NCT005":"NCT193"},{"NCT005":"NCT194"},{"NCT005":"NCT195"},{"NCT005":"NCT196"},{"NCT005":"NCT197"},{"NCT005":"NCT198"},{"NCT005":"NCT199"},{"NCT005":"NCT200"},{"NCT005":"NCT201"},{"NCT005":"NCT202"},{"NCT005":"NCT203"},{"NCT005":"NCT204"},{"NCT005":"NCT205"},{"NCT005":"NCT206"},{"NCT005":"NCT207"},{"NCT005":"NCT208"},{"NCT005":"NCT209"},{"NCT005":"NCT210"},{"NCT005":"NCT211"},{"NCT005":"NCT212"},{"NCT005":"NCT213"},{"NCT005":"NCT214"},{"NCT005":"NCT215"},{"NCT005":"NCT216"},{"NCT005":"NCT217"},{"NCT005":"NCT218"},{"NCT005":"NCT219"},{"NCT005":"NCT220"},{"NCT005":"NCT221"},{"NCT005":"NCT222"},{"NCT005":"NCT223"},{"NCT005":"NCT224"},{"NCT005":"NCT225"},{"NCT005":"NCT226"},{"NCT005":"NCT227"},{"NCT005":"NCT228"},{"NCT005":"NCT229"},{"NCT005":"NCT230"},{"NCT005":"NCT231"},{"NCT005":"NCT232"},{"NCT005":"NCT233"},{"NCT005":"NCT234"},{"NCT005":"NCT235"},{"NCT005":"NCT236"},{"NCT005":"NCT237"},{"NCT005":"NCT238"},{"NCT005":"NCT239"},{"NCT005":"NCT240"},{"NCT005":"NCT241"},{"NCT005":"NCT242"},{"NCT005":"NCT243"},{"NCT005":"NCT244"},{"NCT005":"NCT245"},{"NCT005":"NCT246"},{"NCT005":"NCT247"},{"NCT005":"NCT248"},{"NCT005":"NCT249"},{"NCT005":"NCT250"},{"NCT005":"NCT251"},{"NCT005":"NCT252"},{"NCT005":"NCT253"},{"NCT005":"NCT254"},{"NCT005":"NCT255"},{"NCT005":"NCT256"},{"NCT005":"NCT257"},{"NCT005":"NCT258"},{"NCT005":"NCT259"},{"NCT005":"NCT260"},{"NCT005":"NCT261"},{"NCT005":"NCT262"},{"NCT005":"NCT263"},{"NCT005":"NCT264"},{"NCT005":"NCT265"},{"NCT005":"NCT266"},{"NCT005":"NCT267"},{"NCT005":"NCT268"},{"NCT005":"NCT269"},{"NCT005":"NCT270"},{"NCT005":"NCT271"},{"NCT005":"NCT272"},{"NCT005":"NCT273"},{"NCT005":"NCT274"},{"NCT005":"NCT275"},{"NCT005":"NCT276"},{"NCT005":"NCT277"},{"NCT005":"NCT278"},{"NCT005":"NCT279"},{"NCT005":"NCT280"},{"NCT005":"NCT281"}],"ColNames":{"CMT_ID":"Commitment ID","CMT_NUMBER":"Commitment Number","CMT_DOC_TYPE":"Application Type","CMT_DOC_TYPE_NO":"Submission Number","CMT_DESC":"Commitment Description","CMT_STATUS":"Commitment Status","CMT_STATUS_DESC":"Commitment Status Description","STUDY_TYPE":"Study type","STUDY_START_DATE":"Study start date","PROTOCOL_SUBMISSION_DATE":"Protocol Submission Date","FINAL_RPT_RECV_DATE":"Final Report Received Data","ANNUAL_RPT_DUE_DATE":"Annual report due date","ANNUAL_RPT_RECV_DATE":"Annual report rececived date","NDA_BLA_APPROVAL_DATE":"Approval Date","FINAL_REPORT_DUE_DATE":"Final report due date","CURRENT_PROJ_COMPL_DATE":"Current Project Completion Date","NDA_NUMBER":"Application Number","APPLICANT":"Applicant","PRODUCT":"Product","PUBLIC_FLAG":"Public Flag","CDER_OR_CBER":"Center","SUBPART_FLAG":"Subpart Flag","Scope":"Scope","NCT1":"NCT ID","LastCTUpdate1":"Last Update Date","N1":"Sample Size","NCT2":"NCT ID","LastCTUpdate2":"Last Update Date","N2":"Sample Size","Include":"Include"},"KeyDescriptions":{"CMT_DOC_TYPE":{"B":"Original Biologics License Application","N":"Original New Drug Application (NDA)","O":"Other","S":"Supplemental NDA or BLA ","NA":"N/A"},"CMT_STATUS":{"D":"Delayed","F":"Fulfilled","O":"Ongoing","P":"Pending","R":"Released","S":"Submitted","T":"Terminated","NA":"N/A"},"CDER_OR_CBER":{"CD":"Center for Drug Evaluation and Research","CB":"Center for Biologics Evaluation and Research","NA":"N/A"},"SUBPART_FLAG":{"CD":"Center for Drug Evaluation and Research","CB":"Center for Biologics Evaluation and Research","H":"Accelerated Approval","F":"FDAAA Section 505(o)(3)","E":"Animal Efficacy Rule","P":"Pediatric Research Equity Act","":"N/A","NA":"N/A"}},"DataSchema":[{"Source":"FDA_PMRPMC","Field":"CMT_ID","ColumnName":"Commitment ID"},{"Source":"FDA_PMRPMC","Field":"CMT_NUMBER","ColumnName":"PMR/PMC Number"},{"Source":"FDA_PMRPMC","Field":"CMT_DOC_TYPE","ColumnName":"Application Type","KeyDescription":{"B":"Original Biologics License Application","N":"Original New Drug Application (NDA)","O":"Other","S":"Supplemental NDA or BLA "}},{"Source":"FDA_PMRPMC","Field":"CMT_DOC_TYPE_NO","ColumnName":"Submission Number"},{"Source":"FDA_PMRPMC","Field":"CMT_DESC","ColumnName":"Commitment Description"},{"Source":"FDA_PMRPMC","Field":"CMT_STATUS","ColumnName":"Commitment Status","KeyDescription":{"D":"Delayed","F":"Fulfilled","O":"Ongoing","P":"Pending","R":"Released","S":"Submitted","T":"Terminated"}},{"Source":"FDA_PMRPMC","Field":"CMT_STATUS_DESC","ColumnName":"Commitment Status Description"},{"Source":"FDA_PMRPMC","Field":"STUDY_TYPE","ColumnName":"Study type"},{"Source":"FDA_PMRPMC","Field":"STUDY_START_DATE","ColumnName":"Study start date"},{"Source":"FDA_PMRPMC","Field":"PROTOCOL_SUBMISSION_DATE","ColumnName":"Protocol Submission Date"},{"Source":"FDA_PMRPMC","Field":"FINAL_RPT_RECV_DATE","ColumnName":"Final Report Received Data"},{"Source":"FDA_PMRPMC","Field":"ANNUAL_RPT_DUE_DATE","ColumnName":"Annual report due date"},{"Source":"FDA_PMRPMC","Field":"ANNUAL_RPT_RECV_DATE","ColumnName":"Annual report rececived date"},{"Source":"FDA_PMRPMC","Field":"NDA_BLA_APPROVAL_DATE","ColumnName":"Approval Date"},{"Source":"FDA_PMRPMC","Field":"FINAL_REPORT_DUE_DATE","ColumnName":"Final report due date"},{"Source":"FDA_PMRPMC","Field":"CURRENT_PROJ_COMPL_DATE","ColumnName":"Current Project Completion Date"},{"Source":"FDA_PMRPMC","Field":"NDA_NUMBER","ColumnName":"Application Number"},{"Source":"FDA_PMRPMC","Field":"APPLICANT","ColumnName":"Applicant"},{"Source":"FDA_PMRPMC","Field":"PRODUCT","ColumnName":"Product"},{"Source":"FDA_PMRPMC","Field":"PUBLIC_FLAG","ColumnName":"Public Flag"},{"Source":"FDA_PMRPMC","Field":"CDER_OR_CBER","ColumnName":"Center","KeyDescription":{"CD":"Center for Drug Evaluation and Research","CB":"Center for Biologics Evaluation and Research"}},{"Source":"FDA_PMRPMC","Field":"SUBPART_FLAG","ColumnName":"Subpart Flag","KeyDescription":{"CD":"Center for Drug Evaluation and Research","CB":"Center for Biologics Evaluation and Research","H":"Accelerated Approval","F":"FDAAA Section 505(o)(3)","E":"Animal Efficacy Rule","P":"Pediatric Research Equity Act","":"N/A"}},{"Source":"ClinicalTrialsGov:Studies:nct_id","Field":"NCT1","ColumnName":"NCT ID"},{"Source":"ClinicalTrialsGov:Studies:last_update_posted_date","Field":"LastCTUpdate1","ColumnName":"Last Update Date"},{"Source":"ClinicalTrialsGov:Studies:enrollment","Field":"N1","ColumnName":"Sample Size"},{"Source":"ClinicalTrialsGov:Studies:nct_id","Field":"NCT2","ColumnName":"NCT ID"},{"Source":"ClinicalTrialsGov:Studies:last_update_posted_date","Field":"LastCTUpdate2","ColumnName":"Last Update Date"},{"Source":"ClinicalTrialsGov:Studies:enrollment","Field":"N2","ColumnName":"Sample Size"}],"ColNames2":{"pmr_issued_label":"Tools / Resources","appl_type":"Application/Submission Details","trade_name":"Product Name","approval_date":"Approval Date","cmt_number":"PMR/PMC Number","cmt_desc":"PMR/PMC Description","time_to_fulfillment":"Time(days) to fulfillment","subpart_description":"Subpart","sponsor":"Applicant Name","STUDY_START_DATE":"Study start date","category":"PMR/PMC Category","pmr_status":"Status","aa_status":"Approval Tracks"},"ColNames4":{"pmr_issued_label":"Tools / Resources","appl_type":"Application/Submission Details","product":"Product Name","approval_date":"Approval Date","cmt_number":"PMR/PMC Number","cmt_desc":"PMR/PMC Description","time_to_fulfillment":"Time(days) to fulfillment","subpart_description":"Subpart","sponsor":"Applicant Name","STUDY_START_DATE":"Study start date","category":"PMR/PMC Category","pmr_status":"Status","aa_status":"Approval Tracks"},"ColNames3":{"appl_type":"Application/Submission Details","product":"Product Name","approval_date":"Approval Date","cmt_description":"PMR/PMC Description","cmt_no":"PMR/PMC Number","subpart_approval_description":"Subpart Flag","Sponsor":"Applicant Name","category":"Cateory","aa_status":"Approval Tracks"}}')},824:function(e){e.exports=JSON.parse('{"pmc_commitments":[{"CMT_DOC_TYPE":"Original Biologics License Application","NDA_NUMBER":761115,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Trodelvy (sacituzumab govitecan)","NDA_BLA_APPROVAL_DATE":"4/22/20","CMT_DESC":"Submit the final study report and datasets for progression-free survival and overall survival from trial IMMU-132-05 titled \u201cPhase III Study of Sacituzumab Govitecan (IMMU-132) in Refractory/Relapsed Triple-Negative Breast Cancer\u201d, to confirm clinical benefit of sacituzumab that may inform product labeling.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Accelerated Approval","NCT1":"NCT02574455","LastCTUpdate1":"12/8/20","N1":529,"APPLICANT":"Immunomedics, Inc.","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"NA","FINAL_REPORT_DUE_DATE":"10/31/20"},{"CMT_DOC_TYPE":"Original Biologics License Application","NDA_NUMBER":761115,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Trodelvy (sacituzumab govitecan)","NDA_BLA_APPROVAL_DATE":"4/22/20","CMT_DESC":"Submit the clinical study report and related datasets to further characterize the risk of adverse events and UGT1A1 status in the IMMU-132-05 trial to support sacituzumab govitecan dosing recommendation for patients homozygous for UGT1A1*28 allele that may inform labeling. The study should be conducted for sufficient duration with a sufficient number of patients to evaluate safety following multiple dose administration.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"FDAAA Section 505(o)(3)","NCT1":"NCT02574455","LastCTUpdate1":"12/8/20","N1":529,"APPLICANT":"Immunomedics, Inc.","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"NA","FINAL_REPORT_DUE_DATE":"10/31/20"},{"CMT_DOC_TYPE":"Original Biologics License Application","NDA_NUMBER":761115,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Trodelvy (sacituzumab govitecan)","NDA_BLA_APPROVAL_DATE":"4/22/20","CMT_DESC":"Conduct an open-label, non-randomized, dose-escalation trial to determine an appropriate starting dose of sacituzumab govitecan in patients with moderate hepatic impairment, according to the National Cancer Institute Organ Dysfunction Working Group criteria in the target patient population. Safety and pharmacokinetic information of IMMU-132 and SN-38 will be collected to determine the appropriate starting dose of sacituzumab govitecan for this population. Submit the datasets with the final report.","CMT_STATUS":"Pending","SUBPART_FLAG":"FDAAA Section 505(o)(3)","NCT1":"NCT04617522","LastCTUpdate1":"1/8/21","N1":24,"APPLICANT":"Immunomedics, Inc.","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"NA","FINAL_REPORT_DUE_DATE":"9/30/21"},{"CMT_DOC_TYPE":"Original Biologics License Application","NDA_NUMBER":761115,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Trodelvy (sacituzumab govitecan)","NDA_BLA_APPROVAL_DATE":"4/22/20","CMT_DESC":"Submit the final QTc prolongation evaluation report in a sub-study of the ongoing clinical trial IMMU-132-05 titled \u201cPhase III Study of Sacituzumab Govitecan (IMMU-132) in Refractory/Relapsed Triple-Negative Breast Cancer\u201d that may further inform labelling about the QT effect of SN-38 at the recommended dose of sacituzumab govitecan.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"FDAAA Section 505(o)(3)","NCT1":"NCT02574455","LastCTUpdate1":"12/8/20","N1":529,"APPLICANT":"Immunomedics, Inc.","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"NA","FINAL_REPORT_DUE_DATE":"12/31/20"},{"CMT_DOC_TYPE":"Original Biologics License Application","NDA_NUMBER":761119,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Vyepti (eptinezumab)","NDA_BLA_APPROVAL_DATE":"2/21/20","CMT_DESC":"A single-arm, single-dose, pediatric pharmacokinetic study to evaluate eptinezumab in pediatric migraine patients ages 6 through 11 years. The primary objective will be to characterize the pharmacokinetic profile of eptinezumab compared to adult migraine patients, with additional secondary pharmacokinetic and safety endpoints. Immunogenicity will also be assessed through development of specific anti-eptinezumab antibodies.","CMT_STATUS":"Pending","SUBPART_FLAG":"Pediatric Research Equity Act","NCT1":"NCT04537429","LastCTUpdate1":"1/6/21","N1":32,"APPLICANT":"Lundbeck Seattle BioPharmaceuticals, Inc.","CMT_STATUS_DESC":"The study has not been initiated, but it does not meet the criterion for delayed.","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"NA","FINAL_REPORT_DUE_DATE":"4/30/25"},{"CMT_DOC_TYPE":"Original Biologics License Application","NDA_NUMBER":761136,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Luspatercept (ACE-536)","NDA_BLA_APPROVAL_DATE":"11/8/19","CMT_DESC":"Complete Trial ACE-536-B-THAL-001: Phase 3, Randomized, Placebocontrolled, Multicenter Study to Determine the Efficacy and Safety of Luspatercept (ACE-536) in Adults who Require Regular Blood Transfusions. Evaluate safety and efficacy data for the patients who enrolled in the open-label treatment for up to five years. Include summary analysis and updated safety summary to include safety data on thrombosis, all malignancies (including AML), hepatic toxicity, and renal toxicity. Include updated assessments of ferritin levels, liver iron concentrations and use of chelators and any cardiac iron evaluations in the reports. Include updated safety and efficacy analysis and submit datasets at the time of final clinical study report submission.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"FDAAA Section 505(o)(3)","NCT1":"NCT02604433","LastCTUpdate1":"1/27/20","N1":336,"APPLICANT":"Celgene Corporation","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"NA","FINAL_REPORT_DUE_DATE":"12/31/20"},{"CMT_DOC_TYPE":"Original Biologics License Application","NDA_NUMBER":761156,"CMT_DOC_TYPE_NO":1,"PRODUCT":"NNC0195-0092","NDA_BLA_APPROVAL_DATE":"8/28/20","CMT_DESC":"Complete ongoing study c, a 1-year phase 2, randomized, open-label, active-control, dose-finding trial, to investigate efficacy and safety of once-weekly somapacitan versus daily Norditropin (somatropin) in pre-pubertal children with Growth Hormone Deficiency (GHD) (boys = 2.5 and = 10 years of age, and girls = 2.5 and = 9 years of age) followed by a 2-year single-arm period to evaluate safety in this cohort, and a 4\xadyear single-arm period that also enrolls cohorts of younger children with GHD (boys and girls < 2.5 years of age) and older children with GHD (boys > 10 and = 17 years of age, and girls > 9 and = 17 years of age) to evaluate safety in all three cohorts.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Pediatric Research Equity Act","NCT1":"NCT02616562","LastCTUpdate1":"9/29/20","N1":74,"APPLICANT":"Novo Nordisk Inc.","CMT_STATUS_DESC":"The study was ongoing at the time of the approval.","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"NA","FINAL_REPORT_DUE_DATE":"3/31/25"},{"CMT_DOC_TYPE":"Original Biologics License Application","NDA_NUMBER":761156,"CMT_DOC_TYPE_NO":1,"PRODUCT":"NNC0195-0092","NDA_BLA_APPROVAL_DATE":"8/28/20","CMT_DESC":"Complete ongoing study NN8640-4263, a 1-year phase 3 randomized, parallel group, open-label trial, to evaluate the efficacy and safety of once weekly somapacitan versus daily Norditropin (somatropin) in pre-pubertal pediatric patients (boys = 2.5 and = 10 years of age, and girls = 2.5 and = 9 years of age) with GHD, followed by a 3-year single-arm extension period to evaluate long-term safety.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Pediatric Research Equity Act","NCT1":"NCT03811535","LastCTUpdate1":"12/30/20","N1":192,"APPLICANT":"Novo Nordisk Inc.","CMT_STATUS_DESC":"The study was ongoing at the time of the approval.","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"NA","FINAL_REPORT_DUE_DATE":"5/31/25"},{"CMT_DOC_TYPE":"Original Biologics License Application","NDA_NUMBER":761158,"CMT_DOC_TYPE_NO":1,"PRODUCT":"GSK2857916 (belantamab mafodotin)","NDA_BLA_APPROVAL_DATE":"8/5/20","CMT_DESC":"Conduct a pharmacokinetic trial to determine the appropriate dose of belantamab mafodotin in patients with moderate and severe hepatic impairment compared to patients with normal hepatic function that may inform labeling. This trial should be designed and conducted in accordance with the FDA Guidance for Industry titled, \u201cPharmacokinetics in Patients with Impaired Hepatic Function: Study Design, Data Analysis, and Impact on Dosing and Labeling\u201d","CMT_STATUS":"Ongoing","SUBPART_FLAG":"FDAAA Section 505(o)(3)","NCT1":"NCT04398680","LastCTUpdate1":"11/23/20","N1":24,"APPLICANT":"GlaxoSmithKline Intellectual Property Development Ltd. England","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"NA","FINAL_REPORT_DUE_DATE":"7/31/25"},{"CMT_DOC_TYPE":"Original Biologics License Application","NDA_NUMBER":761158,"CMT_DOC_TYPE_NO":1,"PRODUCT":"GSK2857916 (belantamab mafodotin)","NDA_BLA_APPROVAL_DATE":"8/5/20","CMT_DESC":"Conduct a pharmacokinetic trial to determine the appropriate dose of belantamab mafodotin in patients with severe renal impairment and end-stage renal disease (ESRD) with or without dialysis compared to patients with normal renal function that may inform product labeling. This trial should be designed and conducted in accordance with the FDA Guidance for Industry titled, \u201cPharmacokinetics in Patients with Impaired Renal Function \u2014 Study Design, Data Analysis, and Impact on Dosing and Labeling\u201d","CMT_STATUS":"Ongoing","SUBPART_FLAG":"FDAAA Section 505(o)(3)","NCT1":"NCT04398745","LastCTUpdate1":"12/21/20","N1":36,"APPLICANT":"GlaxoSmithKline Intellectual Property Development Ltd. England","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"NA","FINAL_REPORT_DUE_DATE":"5/31/26"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":21232,"CMT_DOC_TYPE_NO":20,"PRODUCT":"Orfadin (Nitisinone)","NDA_BLA_APPROVAL_DATE":"1/18/02","CMT_DESC":"Long-term assessment of pharmacodynamic response and pharmacokinetics of ORFADIN given under a once-daily dosage regimen in treatment-na\xefve and  treatment-experienced patients with hereditary tyrosinemia type 1 (HT-1) based on data from the ongoing Sobi.NTBC-005-study.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Post Marketing Commitment","NCT1":"NCT02320084","LastCTUpdate1":"1/14/20","N1":315,"APPLICANT":"SWEDISH ORPHAN BIOVITRUM AB PUBL","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"3/15/19","FINAL_REPORT_DUE_DATE":"9/30/20"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":21323,"CMT_DOC_TYPE_NO":3,"PRODUCT":"Lexapro (Escitalopram Oxalate)","NDA_BLA_APPROVAL_DATE":"8/14/02","CMT_DESC":"Deferred pediatric study under PREA to assess the safety and effectiveness of escitalopram oxalate as a treatment of Generalized Anxiety Disorder in pediatric patients ages 7 to 17 (children and adolescents). Both children (ages 7 to 11) and  adolescents (ages 12 to 17) should be equally represented in the samples, and there should be a reasonable distribution of both sexes in these age strata.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Pediatric Research Equity Act","NCT1":"NCT03924323","LastCTUpdate1":"10/14/20","N1":300,"APPLICANT":"ALLERGAN SALES LLC","CMT_STATUS_DESC":"Final protocol was submitted to IND 058380 on November 30,2018 (Sequence No. 0460). Protocol Amendment 1 was\\nsubmitted on March 25, 2019 (Sequence No. 0466), reflecting the addition of PK to the study to fulfill FDA\u2019s request, which resulted in a delayed study start. First Patient First Visit occurred on May 31, 2019. Although study start was delayed, enrollment is beginning to increase with mitigation efforts in effect. Actual versus planned activated sites is 23 versus 40, respectively, and actual versus planned randomized patients is 11 versus 14, respectively. Data is current as of September 20, 2019. Enrollment is being carefully monitored.","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"10/4/19","FINAL_REPORT_DUE_DATE":"1/30/22"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":21365,"CMT_DOC_TYPE_NO":4,"PRODUCT":"Lexapro (Escitalopram Oxalate)","NDA_BLA_APPROVAL_DATE":"11/27/02","CMT_DESC":"Deferred pediatric study under PREA to assess the safety and effectiveness of escitalopram oxalate as a treatment of Generalized Anxiety Disorder in pediatric patients ages 7 to 17 (children and adolescents). Both children (ages 7 to 11) and  adolescents (ages 12 to 17) should be equally represented in the samples, and there should be a reasonable distribution of both sexes in these age strata.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Pediatric Research Equity Act","NCT1":"NCT03924323","LastCTUpdate1":"10/14/20","N1":300,"APPLICANT":"ALLERGAN SALES LLC","CMT_STATUS_DESC":"Final protocol was submitted to IND 058380 on November 30,2018 (Sequence No. 0460). Protocol Amendment 1 was\\nsubmitted on March 25, 2019 (Sequence No. 0466), reflecting the addition of PK to the study to fulfill FDA\u2019s request, which resulted in a delayed study start. First Patient First Visit occurred on May 31, 2019. Although study start was delayed, enrollment is beginning to increase with mitigation efforts in effect. Actual versus planned activated sites is 23 versus 40, respectively, and actual versus planned randomized patients is 11 versus 14, respectively. Data is current as of September 20, 2019. Enrollment is being carefully monitored.","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"1/24/20","FINAL_REPORT_DUE_DATE":"1/30/22"},{"CMT_DOC_TYPE":"Original New Drug Application (NDA)","NDA_NUMBER":21610,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Opana ER (Oxymorphone Hydrochloride)","NDA_BLA_APPROVAL_DATE":"6/22/06","CMT_DESC":"Deferred pediatric study of safety and pharmacokinetics (single- and multipledose) under PREA for the relief of moderate to severe pain in patients requiring a continuous, around-the-clock opioid treatment for an extended period of time in pediatric patients ages 7 to 17 years.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Pediatric Research Equity Act","NCT1":"NCT04681027","LastCTUpdate1":"12/23/20","N1":15,"APPLICANT":"ENDO PHARMACEUTICALS INC","CMT_STATUS_DESC":"Original Final Report Due Date: 12/31/2014; Per FDA letter dated 06/24/2013, final report due date extended to 04/30/2020. Second Deferral Extension Granted per FDA letter dated 06/25/2020.","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"7/10/19","FINAL_REPORT_DUE_DATE":"12/31/20"},{"CMT_DOC_TYPE":"Original New Drug Application (NDA)","NDA_NUMBER":211371,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Zulresso","NDA_BLA_APPROVAL_DATE":"3/19/19","CMT_DESC":"Conduct an open-label study evaluating safety, tolerability, and pharmacokinetics of brexanolone in adolescent females, 15 years to less than 18 years of age, diagnosed with postpartum depression.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Pediatric Research Equity Act","NCT1":"NCT03665038","LastCTUpdate1":"4/2/20","N1":20,"APPLICANT":"SAGE THERAPEUTICS INC","CMT_STATUS_DESC":"The study was ongoing at the time of the approval.","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"5/7/20","FINAL_REPORT_DUE_DATE":"3/31/22"},{"CMT_DOC_TYPE":"Original New Drug Application (NDA)","NDA_NUMBER":212801,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Isturisa (osilodrostat)","NDA_BLA_APPROVAL_DATE":"3/6/20","CMT_DESC":"Complete Clinical Trial C2302, a Phase 3, multi-center, randomized, double-blind, 48-week study with an initial 12-week placebo-controlled period to evaluate the safety and efficacy of osilodrostat in patients with Cushing\u2019s disease. Safety evaluations include but are not limited to the occurrence of hypocortisolism and adrenal insufficiency.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"FDAAA Section 505(o)(3)","NCT1":"NCT02697734","LastCTUpdate1":"1/26/21","N1":73,"APPLICANT":"RECORDATI RARE DISEASES INC","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"NA","FINAL_REPORT_DUE_DATE":"10/31/20"},{"CMT_DOC_TYPE":"Original New Drug Application (NDA)","NDA_NUMBER":211723,"CMT_DOC_TYPE_NO":1,"PRODUCT":"tazemetostat","NDA_BLA_APPROVAL_DATE":"1/23/20","CMT_DESC":"Submit the final results and datasets for overall response rate and duration of response from clinical trial E7438-G000-101 in patients with relapsed or refractory follicular lymphoma to further characterize the clinical benefit of tazemetostat.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Post Marketing Commitment","NCT1":"NCT01897571","LastCTUpdate1":"1/7/21","N1":420,"APPLICANT":"EPIZYME INC","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"NA","FINAL_REPORT_DUE_DATE":"6/30/21"},{"CMT_DOC_TYPE":"Original New Drug Application (NDA)","NDA_NUMBER":211728,"CMT_DOC_TYPE_NO":1,"PRODUCT":"JELMYTO (mitomycin)","NDA_BLA_APPROVAL_DATE":"4/15/20","CMT_DESC":"Provide annual updates for the duration of response (median and range) for all patients with ongoing complete responses enrolled in clinical trial OLYMPUS. These updates should include information regarding incidence of recurrence of low-grade upper tract urothelial carcinoma (UTUC), incidence of/progression to high-grade UTUC, and incidence of nephroureterectomy. Annual updates should continue for five years or until all patients have either experienced recurrence, death, or been lost to follow up.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Post Marketing Commitment","NCT1":"NCT02793128","LastCTUpdate1":"12/22/20","N1":71,"APPLICANT":"UROGEN PHARMA LTD","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"NA","FINAL_REPORT_DUE_DATE":"4/30/25"},{"CMT_DOC_TYPE":"Original New Drug Application (NDA)","NDA_NUMBER":205053,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Noxafil (Posaconazole)","NDA_BLA_APPROVAL_DATE":"11/25/13","CMT_DESC":"Conduct a trial in patients, ages 2 to < 18 years, to evaluate the pharmacokinetic (PK), safety, and tolerability of two new formulations of posaconazole (IV solution and/or new ageappropriate oral formulation) in mmunocompromised pediatric patients with known or expected  neutropenia.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Pediatric Research Equity Act","NCT1":"NCT01716234","LastCTUpdate1":"8/27/18","N1":142,"APPLICANT":"MERCK SHARP AND DOHME CORP","CMT_STATUS_DESC":"Study has completed enrollment with 115 subjects treated, and completion of enrollment of a 3rd dosing cohort.","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"12/18/19","FINAL_REPORT_DUE_DATE":"7/31/20"},{"CMT_DOC_TYPE":"Original New Drug Application (NDA)","NDA_NUMBER":205422,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Rexulti (Brexpiprazole)","NDA_BLA_APPROVAL_DATE":"7/10/15","CMT_DESC":"Deferred pediatric study under PREA for the treatment of schizophrenia in adolescents aged 13 to17 years. Conduct a Phase 3, Safety: open-label, multicenter, long-term (1 year) study with at least 100 patients exposed for at least 6 months to obtain data on the safety of brexpiprazole in the relevant pediatric population.","CMT_STATUS":"Pending","SUBPART_FLAG":"Pediatric Research Equity Act","NCT1":"NCT03238326","LastCTUpdate1":"7/1/20","N1":350,"APPLICANT":"OTSUKA PHARMACEUTICAL CO LTD","CMT_STATUS_DESC":"The study has not been initiated, but does not meet the criterion for delayed.","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"8/25/20","FINAL_REPORT_DUE_DATE":"9/30/21"},{"CMT_DOC_TYPE":"Original New Drug Application (NDA)","NDA_NUMBER":207648,"CMT_DOC_TYPE_NO":1,"PRODUCT":"SMOFlipid (Fish Oil, Medium Chain Triglycerides, Olive Oil, and Soybean Oil)","NDA_BLA_APPROVAL_DATE":"7/13/16","CMT_DESC":"Randomized controlled trial to evaluate the safety and efficacy of SMOFLIPID (lipid injectable emulsion) administered for at least 90 days in pediatric patients,  compared to standard of care soybean oil based lipid emulsion administered for the same duration. Continue treatment for all patients who remain on parenteral  nutrition (PN) for up to 1 year. The study should enroll an adequate number of patients 3 month of age and older. The study\u2019s efficacy assessments should include anthropomorphic measures and evaluation of the risk of developing  essential fatty acid deficiency (EFAD). Full essential fatty acid profiles should be evaluated according to standards set by major national reference laboratories. Genetic polymorphisms in the fatty acid desaturase genes (FADS) FADS1 and FADS2 should be determined in at least a subset of patients. The cut-off values for EFAD (e.g., suspected, mild and severe) should be established prior to the study. The study\u2019s safety assessments should include evaluation of the risk of developing parenteral nutritional associated liver disease (PNALD) and parenteral nutrition associated cholestasis (PNAC). Plasma phytosterol levels should be  assessed in patients using validated analytical assay methods developed under PMR 3002-5.","CMT_STATUS":"Pending","SUBPART_FLAG":"Pediatric Research Equity Act","NCT1":"NCT03563222","LastCTUpdate1":"1/29/20","N1":144,"APPLICANT":"FRESENIUS KABI USA LLC","CMT_STATUS_DESC":"The study has not begun but does not meet the criterion for delayed.","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"9/1/20","FINAL_REPORT_DUE_DATE":"11/30/21"},{"CMT_DOC_TYPE":"Original New Drug Application (NDA)","NDA_NUMBER":21773,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Byetta (Exenatide)","NDA_BLA_APPROVAL_DATE":"4/28/05","CMT_DESC":"Deferred pediatric study under PREA for the treatment of type 2 diabetes mellitus in pediatric patients ages 10 to 16 years (inclusive).","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Pediatric Research Equity Act","NCT1":"NCT00658021","LastCTUpdate1":"12/1/20","N1":122,"APPLICANT":"ASTRAZENECA AB","CMT_STATUS_DESC":"Original Final Report Due Date: 12/31/2010. Per FDA letter dated 3/19/2013, final report due date extended to 12/31/2018. Second Deferral Extension Granted per FDA letter dated 09/08/2014, Final report submission deferral extended to 07/31/2020. Third Deferral Extension Granted per FDA letter dated 06/15/2020, Final Report due date extended to 01/31/2021.","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"11/21/19","FINAL_REPORT_DUE_DATE":"1/31/21"},{"CMT_DOC_TYPE":"Original New Drug Application (NDA)","NDA_NUMBER":21883,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Dalvance (Dalbavancin)","NDA_BLA_APPROVAL_DATE":"5/23/14","CMT_DESC":"Conduct a single dose PK study in neonates/infants from 0 to less than 3 months of age.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Pediatric Research Equity Act","NCT1":"NCT02814916","LastCTUpdate1":"1/31/20","N1":212,"APPLICANT":"ALLERGAN SALES LLC","CMT_STATUS_DESC":"Final report due 4-2020","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"7/16/20","FINAL_REPORT_DUE_DATE":"4/30/20"},{"CMT_DOC_TYPE":"Original New Drug Application (NDA)","NDA_NUMBER":21883,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Dalvance (Dalbavancin)","NDA_BLA_APPROVAL_DATE":"5/23/14","CMT_DESC":"Conduct a Phase 3, randomized, comparator-controlled study of dalbavancin in children from birth to 18 years of age with ABSSSI.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Pediatric Research Equity Act","NCT1":"NCT02814916","LastCTUpdate1":"1/31/20","N1":212,"APPLICANT":"ALLERGAN SALES LLC","CMT_STATUS_DESC":"Original Final Report Due Date: 12/31/2019. Per FDA letter dated 05/01/2019, final report due date extended to 06/30/2020. Second Deferral Extension Granted per FDA letter dated 05/14/2020.","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"7/16/20","FINAL_REPORT_DUE_DATE":"9/30/20"},{"CMT_DOC_TYPE":"Original New Drug Application (NDA)","NDA_NUMBER":21919,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Byetta (Exenatide)","NDA_BLA_APPROVAL_DATE":"10/30/09","CMT_DESC":"Deferred pediatric study under PREA for the treatment of type 2 diabetes mellitus in pediatric patients ages 10 to 16 years (inclusive).","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Pediatric Research Equity Act","NCT1":"NCT00658021","LastCTUpdate1":"12/1/20","N1":122,"APPLICANT":"ASTRAZENECA AB","CMT_STATUS_DESC":"Original Final Report Due Date: 12/31/2010. Per FDA letter dated 3/19/2013, final report due date extended to 12/31/2018. Second Deferral Extension Granted per FDA letter dated 09/08/2014, Final report submission deferral extended to 07/31/2020. Third Deferral Extension Granted per FDA letter dated 06/15/2020, Final Report due date extended to 01/31/2021.","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"NA","FINAL_REPORT_DUE_DATE":"1/31/21"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":21038,"CMT_DOC_TYPE_NO":10,"PRODUCT":"Precedex (Dexmedetomidine Hydrochloride)","NDA_BLA_APPROVAL_DATE":"12/17/99","CMT_DESC":"Deferred pediatric study under PREA for the treatment of sedation of non-intubated patients prior to and/or during surgical and other procedures in pediatric patients 0 to 16 years of age.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Pediatric Research Equity Act","NCT1":"NCT04040439","LastCTUpdate1":"6/30/20","N1":110,"APPLICANT":"HOSPIRA INC","CMT_STATUS_DESC":"Sponsor has a final protocol, study ongoing","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"2/4/19","FINAL_REPORT_DUE_DATE":"2/28/21"},{"CMT_DOC_TYPE":"Original New Drug Application (NDA)","NDA_NUMBER":22225,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Bridion (Sugammadex)","NDA_BLA_APPROVAL_DATE":"12/15/15","CMT_DESC":"A randomized, controlled trial evaluating the efficacy, safety, and pharmacokinetics of BRIDION injection when used to reverse neuromuscular blockade induced by either rocuronium or vecuronium must be conducted in pediatric patients ages 2 to less than 17 years old.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Pediatric Research Equity Act","NCT1":"NCT03909165","LastCTUpdate1":"11/27/20","N1":126,"APPLICANT":"ORGANON USA INC A SUB OF MERCK AND CO INC","CMT_STATUS_DESC":"The trial is ongoing.","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"2/11/20","FINAL_REPORT_DUE_DATE":"1/31/21"},{"CMT_DOC_TYPE":"Original New Drug Application (NDA)","NDA_NUMBER":211155,"CMT_DOC_TYPE_NO":1,"PRODUCT":"COPIKTRA (Duvelisib)","NDA_BLA_APPROVAL_DATE":"9/24/18","CMT_DESC":"Submit reports and datasets for overall survival from trial IPI-145-07 with 5 years of follow-up, with an interim report after 3 years of follow-up, measured from the last patient\u2019s randomization date. Include causes of death and narratives for death in the absence of treated disease progression.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"FDAAA Section 505(o)(3)","NCT1":"NCT02004522","LastCTUpdate1":"12/19/20","N1":319,"APPLICANT":"VERASTEM INC","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"11/22/19","FINAL_REPORT_DUE_DATE":"6/30/21"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":22254,"CMT_DOC_TYPE_NO":20,"PRODUCT":"Vimpat (Lacosamide)","NDA_BLA_APPROVAL_DATE":"10/28/08","CMT_DESC":"A safety study of replacement of oral dosing with intravenous dosing administered over 30 to 60 minutes in pediatric patients > or equal to 1 month to < 17 years of age with partial-onset seizures. If safety is acceptable, a replacement study at a faster rate of infusion (15 minutes) must be conducted in this population. Sparse PK samples must be collected to evaluate the pharmacokinetics of lacosamide and its metabolite using PPK approach in this population.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Pediatric Research Equity Act","NCT1":"NCT01969851","LastCTUpdate1":"5/7/19","N1":55,"APPLICANT":"UCB INC","CMT_STATUS_DESC":"The study has been initiated.","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"6/18/20","FINAL_REPORT_DUE_DATE":"9/30/21"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":22254,"CMT_DOC_TYPE_NO":30,"PRODUCT":"Vimpat (Lacosamide)","NDA_BLA_APPROVAL_DATE":"10/28/08","CMT_DESC":"Deferred pediatric studies under PREA for the treatment of partial onset seizures in pediatric patients ages 1 month to < 4 years.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Pediatric Research Equity Act","NCT1":"NCT02477839","LastCTUpdate1":"11/30/20","N1":255,"APPLICANT":"UCB INC","CMT_STATUS_DESC":"The study has been initiated","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"6/18/20","FINAL_REPORT_DUE_DATE":"9/30/21"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":22254,"CMT_DOC_TYPE_NO":30,"PRODUCT":"Vimpat (Lacosamide)","NDA_BLA_APPROVAL_DATE":"10/28/08","CMT_DESC":"Deferred pediatric studies under PREA for the treatment of partial onset seizures in pediatric patients ages 4 years to < 17 years.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Pediatric Research Equity Act","NCT1":"NCT01921205","LastCTUpdate1":"7/18/18","N1":404,"APPLICANT":"UCB INC","CMT_STATUS_DESC":"The study has been initiated","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"6/18/20","FINAL_REPORT_DUE_DATE":"9/30/21"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":22255,"CMT_DOC_TYPE_NO":12,"PRODUCT":"Vimpat (Lacosamide)","NDA_BLA_APPROVAL_DATE":"4/20/10","CMT_DESC":"A safety study of replacement of oral dosing with intravenous dosing administered over 30 to 60 minutes in pediatric patients > or equal to 1 month to < 17 years of age with partial-onset seizures. If safety is acceptable, a replacement study at a faster rate of infusion (15 minutes) must be conducted in this population. Sparse PK samples must be collected to evaluate the pharmacokinetics of lacosamide and its metabolite using PPK approach in this population.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Pediatric Research Equity Act","NCT1":"NCT01969851","LastCTUpdate1":"5/7/19","N1":55,"APPLICANT":"UCB INC","CMT_STATUS_DESC":"The study has been initiated.","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"6/18/19","FINAL_REPORT_DUE_DATE":"9/30/21"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":22255,"CMT_DOC_TYPE_NO":13,"PRODUCT":"Vimpat (Lacosamide)","NDA_BLA_APPROVAL_DATE":"4/20/10","CMT_DESC":"A safety study of replacement of oral dosing with intravenous dosing administered over 30 to 60 minutes in pediatric patients > or equal to 1 month to < 17 years of age with partial-onset seizures. If safety is acceptable, a replacement study at a faster rate of infusion (15 minutes) must be conducted in this population. Sparse PK samples must be collected to evaluate the pharmacokinetics of lacosamide and its metabolite using PPK approach in this population.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Pediatric Research Equity Act","NCT1":"NCT01969851","LastCTUpdate1":"5/7/19","N1":55,"APPLICANT":"UCB INC","CMT_STATUS_DESC":"The study has been initiated.","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"6/18/19","FINAL_REPORT_DUE_DATE":"9/30/21"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":22334,"CMT_DOC_TYPE_NO":36,"PRODUCT":"Afinitor (Everolimus)","NDA_BLA_APPROVAL_DATE":"3/30/09","CMT_DESC":"To submit the clinical study report and datasets for the final analysis of overall survival (OS) for Trial CRAD001T2302, entitled \u201cA randomized, double-blind,  multicenter, phase III study of everolimus (RAD001) plus best supportive care versus placebo plus best supportive care in the treatment of patients with  advanced NET of GI or lung origin - RADIANT-4,\u201d and to include the final OS data in the product label.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Post Marketing Commitment","NCT1":"NCT01524783","LastCTUpdate1":"9/23/20","N1":302,"APPLICANT":"NOVARTIS PHARMACEUTICALS CORP","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"5/24/19","FINAL_REPORT_DUE_DATE":"12/31/22"},{"CMT_DOC_TYPE":"Original Biologics License Application","NDA_NUMBER":22472,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Afrezza (Human Insulin)","NDA_BLA_APPROVAL_DATE":"6/27/14","CMT_DESC":"An open-label pharmacokinetic (PK), and multiple-dose safety and tolerability dose-titration trial of Afrezza in pediatric patients ages 4 to 17 years (inclusive) with type 1 diabetes (Part 1), followed by a prospective, multicenter, open-label, randomized, controlled trial comparing the efficacy and safety of prandial Afrezza to prandial subcutaneous insulin aspart used in combination with subcutaneous basal insulin in pediatric patients 4 to 17 years old (inclusive) with type 1 or type 2 diabetes (Part 2). Part 2 of the trial should include a 4-week run-in phase and a 52-week randomized intervention phase.","CMT_STATUS":"Delayed","SUBPART_FLAG":"Pediatric Research Equity Act","NCT1":"NCT02527265","LastCTUpdate1":"9/17/20","N1":30,"APPLICANT":"MannKind Corporation","CMT_STATUS_DESC":"The Study Completion due date was missed and FDA issued a missed milestone letter on 08/14/2020.","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"8/12/20","FINAL_REPORT_DUE_DATE":"1/31/21"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":125320,"CMT_DOC_TYPE_NO":186,"PRODUCT":"Prolia (Denosumab)","NDA_BLA_APPROVAL_DATE":"6/1/10","CMT_DESC":"\u201cA Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Safety and Efficacy of Denosumab in Pediatric Subjects With Glucocorticoid-induced Osteoporosis\u201d (Study 20140444)","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Pediatric Research Equity Act","NCT1":"NCT03164928","LastCTUpdate1":"12/17/20","N1":150,"APPLICANT":"Amgen, Inc.","CMT_STATUS_DESC":"The study has been initiated","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"7/28/20","FINAL_REPORT_DUE_DATE":"9/30/23"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":125388,"CMT_DOC_TYPE_NO":97,"PRODUCT":"Adcetris (Brentuximab Vedotin)","NDA_BLA_APPROVAL_DATE":"8/19/11","CMT_DESC":"Submit long-term safety follow-up for the ECHELON-1 clinical trial including the following events: (a) secondary malignancies, (b) treatmentrelated serious adverse events, (c) treatment-emergent neuropathy adverse events until resolution or study closure, and (d) deaths and cause of deaths. Submit an interim report and datasets with 60 months of safety follow-up. Submit the final report and datasets after minimum of 120 months of safety follow-up.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"FDAAA Section 505(o)(3)","NCT1":"NCT01712490","LastCTUpdate1":"12/23/20","N1":1334,"APPLICANT":"Seattle Genetics, Inc.","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"10/17/19","FINAL_REPORT_DUE_DATE":"8/31/26"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":125409,"CMT_DOC_TYPE_NO":113,"PRODUCT":"Perjeta (Pertuzumab)","NDA_BLA_APPROVAL_DATE":"6/8/12","CMT_DESC":"Submit the overall survival (OS) data and analysis with a final report from the clinical trial APHINITY BIG 4 11/BO25126/TOC4939g clinical trial entitled \u201cA randomized  multicenter, double-blind, placebo-controlled comparison of chemotherapy plus trastuzumab plus placebo versus chemotherapy plus trastuzumab plus pertuzumab as adjuvant therapy in patients with operable HER2-positive primary breast cancer.\u201d","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Post Marketing Commitment","NCT1":"NCT01358877","LastCTUpdate1":"12/3/20","N1":4804,"APPLICANT":"Genentech, Inc.","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"8/1/19","FINAL_REPORT_DUE_DATE":"6/30/24"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":125409,"CMT_DOC_TYPE_NO":118,"PRODUCT":"Perjeta (Pertuzumab)","NDA_BLA_APPROVAL_DATE":"6/8/12","CMT_DESC":"Submit the overall survival (OS) data and analysis with a final report from the clinical trial APHINITY BIG 4 11/BO25126/TOC4939g clinical trial entitled \u201cA randomized  multicenter, double-blind, placebo-controlled comparison of chemotherapy plus trastuzumab plus placebo versus chemotherapy plus trastuzumab plus pertuzumab as adjuvant therapy in patients with operable HER2-positive primary breast cancer.\u201d","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Post Marketing Commitment","NCT1":"NCT01358877","LastCTUpdate1":"12/3/20","N1":4804,"APPLICANT":"Genentech, Inc.","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"8/1/19","FINAL_REPORT_DUE_DATE":"6/30/24"},{"CMT_DOC_TYPE":"Original Biologics License Application","NDA_NUMBER":125476,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Entyvio (vedolizumab)","NDA_BLA_APPROVAL_DATE":"5/20/14","CMT_DESC":"A randomized, controlled, multicenter study to evaluate the efficacy and safety of vedolizumab in pediatric patients 2 to 17 years of age with moderately to severely active Crohn\u2019s disease.","CMT_STATUS":"Pending","SUBPART_FLAG":"Pediatric Research Equity Act","NCT1":"NCT03196427","LastCTUpdate1":"1/8/21","N1":80,"APPLICANT":"Takeda Pharmaceuticals U.S.A., Inc.","CMT_STATUS_DESC":"The study has not been initiated, but it does not meet the criterion for delayed.","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"7/17/19","FINAL_REPORT_DUE_DATE":"7/31/25"},{"CMT_DOC_TYPE":"Original Biologics License Application","NDA_NUMBER":125476,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Entyvio (vedolizumab)","NDA_BLA_APPROVAL_DATE":"5/20/14","CMT_DESC":"A randomized, controlled, multicenter study to evaluate the efficacy and safety of vedolizumab in pediatric patients 2 to 17 years of age with moderately to severely active ulcerative colitis.","CMT_STATUS":"Pending","SUBPART_FLAG":"Pediatric Research Equity Act","NCT1":"NCT03196427","LastCTUpdate1":"1/8/21","N1":80,"APPLICANT":"Takeda Pharmaceuticals U.S.A., Inc.","CMT_STATUS_DESC":"The study has not been initiated, but it does not meet the criterion for delayed.","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"7/17/19","FINAL_REPORT_DUE_DATE":"7/31/25"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":125476,"CMT_DOC_TYPE_NO":21,"PRODUCT":"Entyvio (vedolizumab)","NDA_BLA_APPROVAL_DATE":"5/20/14","CMT_DESC":"Conduct a dose-ranging study to determine the pharmacokinetics/pharmacodynamics, safety, and tolerability of Entyvio (vedolizumab) in pediatric patients 2 to 17 years of age with moderately to severely active ulcerative colitis or Crohn\u2019s disease who have failed conventional therapy.","CMT_STATUS":"Delayed","SUBPART_FLAG":"Pediatric Research Equity Act","NCT1":"NCT03138655","LastCTUpdate1":"12/20/20","N1":89,"APPLICANT":"Takeda Pharmaceuticals U.S.A., Inc.","CMT_STATUS_DESC":"Original Final Report Due Date: 07/31/2019. Per FDA letter dated 08/31/2020, final report due date extended to 08/31/2020. Second Deferral Extension Granted per FDA letter dated 07/21/2020.","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"7/17/19","FINAL_REPORT_DUE_DATE":"1/31/21"},{"CMT_DOC_TYPE":"Original Biologics License Application","NDA_NUMBER":125499,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Plegridy (Pegylated Interferon Beta-1a)","NDA_BLA_APPROVAL_DATE":"8/15/14","CMT_DESC":"A randomized, controlled, parallel group superiority trial in pediatric patients ages 10 through 17 years to evaluate the safety and efficacy of Plegridy (peginterferon  beta-1a) compared to an appropriate control for the treatment of relapsing forms  of multiple sclerosis.","CMT_STATUS":"Delayed","SUBPART_FLAG":"Pediatric Research Equity Act","NCT1":"NCT03958877","LastCTUpdate1":"11/19/20","N1":142,"APPLICANT":"Biogen Inc.","CMT_STATUS_DESC":"The status is delayed because the Final Protocol and Study Completion due dates have been missed. Original Final Report Due Date: 11/30/2019; Deferral Extension granted per FDA letter dated 11/23/2019.","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"10/7/19","FINAL_REPORT_DUE_DATE":"11/30/21"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":125514,"CMT_DOC_TYPE_NO":15,"PRODUCT":"Keytruda (pembrolizumab)","NDA_BLA_APPROVAL_DATE":"9/4/14","CMT_DESC":"Complete the trial and submit the final report and data to verify and describe the clinical benefit of pembrolizumab, including efficacy and safety, from Trial KN204, a Phase 3 randomized, open-label, active-controlled trial comparing pembrolizumab to brentuximab vedotin for the treatment of patients with relapsed or refractory classical Hodgkin lymphoma. Enroll approximately 300 patients. The primary endpoint should include progression-free survival.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Accelerated Approval","NCT1":"NCT02684292","LastCTUpdate1":"8/4/20","N1":304,"APPLICANT":"Merck Sharp & Dohme Corp.","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"10/31/19","FINAL_REPORT_DUE_DATE":"4/30/21"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":125514,"CMT_DOC_TYPE_NO":15,"PRODUCT":"Keytruda (pembrolizumab)","NDA_BLA_APPROVAL_DATE":"9/4/14","CMT_DESC":"Characterize the safety of long-term use in patients with classical Hodgkin lymphoma treated with pembrolizumab 200 mg every 3 weeks. Submit a final report and datasets with safety and efficacy outcomes of trial KN087 with at least 3 years of follow-up data.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"FDAAA Section 505(o)(3)","NCT1":"NCT02453594","LastCTUpdate1":"1/20/21","N1":211,"APPLICANT":"Merck Sharp & Dohme Corp.","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"10/31/19","FINAL_REPORT_DUE_DATE":"8/31/21"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":125514,"CMT_DOC_TYPE_NO":17,"PRODUCT":"Keytruda (pembrolizumab)","NDA_BLA_APPROVAL_DATE":"9/4/14","CMT_DESC":"Conduct clinical trial KEYNOTE-361 entitled \u201cA Phase III Randomized, Controlled Clinical Trial of Pembrolizumab With or Without Platinum-Based Combination Chemotherapy Versus Chemotherapy in Subjects With Advanced or Metastatic Urothelial Carcinoma\u201d. Submit the datasets with the final report.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Accelerated Approval","NCT1":"NCT02853305","LastCTUpdate1":"1/22/21","N1":1010,"APPLICANT":"Merck Sharp & Dohme Corp.","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"10/31/19","FINAL_REPORT_DUE_DATE":"11/30/21"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":125514,"CMT_DOC_TYPE_NO":30,"PRODUCT":"Keytruda (pembrolizumab)","NDA_BLA_APPROVAL_DATE":"9/4/14","CMT_DESC":"Complete the trial and submit the final report and data to verify and describe the clinical benefit of pembrolizumab, including efficacy and safety, from Trial KN204, a Phase 3 randomized, open-label, active-controlled trial comparing pembrolizumab to brentuximab vedotin for the treatment of patients with relapsed or refractory classical Hodgkin lymphoma. Enroll approximately 300 patients. The primary endpoint should include progression-free survival.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Accelerated Approval","NCT1":"NCT02684292","LastCTUpdate1":"8/4/20","N1":304,"APPLICANT":"Merck Sharp & Dohme Corp.","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"10/31/19","FINAL_REPORT_DUE_DATE":"4/30/21"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":125514,"CMT_DOC_TYPE_NO":30,"PRODUCT":"Keytruda (pembrolizumab)","NDA_BLA_APPROVAL_DATE":"9/4/14","CMT_DESC":"Characterize the safety of long-term use in patients with primary mediastinal large B-cell lymphoma. Submit a final report and data sets with safety and efficacy outcomes of trial KEYNOTE-170 with at least 3 years of follow-up data.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"FDAAA Section 505(o)(3)","NCT1":"NCT02576990","LastCTUpdate1":"11/20/20","N1":80,"APPLICANT":"Merck Sharp & Dohme Corp.","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"10/31/19","FINAL_REPORT_DUE_DATE":"11/30/20"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":125514,"CMT_DOC_TYPE_NO":34,"PRODUCT":"Keytruda (pembrolizumab)","NDA_BLA_APPROVAL_DATE":"9/4/14","CMT_DESC":"Conduct clinical trial KEYNOTE-826 (KN-826) in cervical cancer for Progression Free Survival (PFS)-Overall Survival (OS), entitled \u201cA Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Pembrolizumab Plus Chemotherapy vs. Chemotherapy Plus Placebo for the First-line Treatment of Persistent, Recurrent, or Metastatic Cervical Cancer\u201d. Submit analyses and datasets with final report for PFS and OS.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Accelerated Approval","NCT1":"NCT03635567","LastCTUpdate1":"12/13/20","N1":600,"APPLICANT":"Merck Sharp & Dohme Corp.","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"10/31/19","FINAL_REPORT_DUE_DATE":"5/31/23"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":125514,"CMT_DOC_TYPE_NO":34,"PRODUCT":"Keytruda (pembrolizumab)","NDA_BLA_APPROVAL_DATE":"9/4/14","CMT_DESC":"Submit the median Duration of Response (DOR) analyses and datasets with the final report of clinical trial Keynote 158 (Cohort E), entitled; \u201cA Clinical Trial of Pembrolizumab (MK-3475) Evaluating Predictive Biomarkers in Subjects with Advanced Solid Tumors\u201d","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Post Marketing Commitment","NCT1":"NCT02628067","LastCTUpdate1":"12/17/20","N1":1595,"APPLICANT":"Merck Sharp & Dohme Corp.","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"10/31/19","FINAL_REPORT_DUE_DATE":"2/28/20"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":125514,"CMT_DOC_TYPE_NO":35,"PRODUCT":"Keytruda (pembrolizumab)","NDA_BLA_APPROVAL_DATE":"9/4/14","CMT_DESC":"Submit the clinical trial report and datasets for the updated survival results for KEYNOTE-189, entitled \u201cA Randomized, Double-Blind, Phase III Study of Platinum plus Pemetrexed Chemotherapy with or without Pembrolizumab (MK3475) in First Line Metastatic Non-squamous Non-small Cell Lung Cancer Subjects,\u201d in order to inform the label with mature overall survival data in accordance with the pre-specified final analysis of KEYNOTE-189.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Post Marketing Commitment","NCT1":"NCT02578680","LastCTUpdate1":"10/23/20","N1":616,"APPLICANT":"Merck Sharp & Dohme Corp.","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"10/31/19","FINAL_REPORT_DUE_DATE":"6/30/21"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":125514,"CMT_DOC_TYPE_NO":40,"PRODUCT":"Keytruda (pembrolizumab)","NDA_BLA_APPROVAL_DATE":"9/4/14","CMT_DESC":"Submit the final clinical report and datasets at the time of the final analysis for overall survival (OS) of Trial KEYNOTE-054, entitled \u201cAdjuvant Immunotherapy with Anti-PD-1 Monoclonal Antibody Pembrolizumab (MK-3475) versus Placebo After Complete Resection of High-Risk Stage III Melanoma: A Randomized, Double-Blind Phase 3 study of the EORTC Melanoma Group\u201d, to revise the product label with updated relapse-free survival data and mature OS data.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Post Marketing Commitment","NCT1":"NCT02362594","LastCTUpdate1":"10/20/20","N1":1019,"APPLICANT":"Merck Sharp & Dohme Corp.","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"10/31/19","FINAL_REPORT_DUE_DATE":"12/31/23"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":125514,"CMT_DOC_TYPE_NO":41,"PRODUCT":"Keytruda (pembrolizumab)","NDA_BLA_APPROVAL_DATE":"9/4/14","CMT_DESC":"Submit the results of the final analysis of progression-free survival and overall survival data from KEYNOTE-407, entitled \u201cA Phase 3 Study of Carboplatin-Paclitaxel/Nab-paclitaxel Chemotherapy with or without Pembrolizumab in First Line Metastatic Squamous Non-Small Cell Lung Cancer,\u201d to further characterize the efficacy and benefit:risk assessment of pembrolizumab, administered in combination with carboplatin and paclitaxel or nanoparticle albumin bound paclitaxel (nab-paclitaxel), and for inclusion in product labeling.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Post Marketing Commitment","NCT1":"NCT02775435","LastCTUpdate1":"9/30/20","N1":559,"APPLICANT":"Merck Sharp & Dohme Corp.","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"10/31/19","FINAL_REPORT_DUE_DATE":"9/30/21"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":125514,"CMT_DOC_TYPE_NO":42,"PRODUCT":"Keytruda (pembrolizumab)","NDA_BLA_APPROVAL_DATE":"9/4/14","CMT_DESC":"Submit the final report, including datasets, of Study KEYNOTE-224, \u201cA Phase II Study of Pembrolizumab (MK-3475) as Monotherapy in Subjects With Previously Systemically Treated Advanced Hepatocellular Carcinoma,\u201d in which all responding patients have been followed for a minimum of 24 months and duration of response is assessed by independent central review, to more accurately characterize the durability of the response observed with pembrolizumab in this study.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Post Marketing Commitment","NCT1":"NCT02702414","LastCTUpdate1":"1/20/21","N1":150,"APPLICANT":"Merck Sharp & Dohme Corp.","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"10/31/19","FINAL_REPORT_DUE_DATE":"4/30/20"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":125514,"CMT_DOC_TYPE_NO":53,"PRODUCT":"Keytruda (pembrolizumab)","NDA_BLA_APPROVAL_DATE":"9/4/14","CMT_DESC":"Submit the final report, including datasets, for KEYNOTE-158 (Cohort G) and KEYNOTE-028 (Cohort C), in which all 16 of the 83 responding patients identified in the interim study report submitted to BLA 125514/S53, have been followed for a minimum of 24 months, to update the label with information which will more accurately characterize the blinded independent review committee-assessed durability of the response observed with pembrolizumab, as a single agent, for the third-line treatment of small cell lung cancer.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Post Marketing Commitment","NCT1":"NCT02628067","LastCTUpdate1":"12/17/20","N1":1595,"APPLICANT":"Merck Sharp & Dohme Corp.","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"10/31/19","FINAL_REPORT_DUE_DATE":"12/31/20"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":125514,"CMT_DOC_TYPE_NO":54,"PRODUCT":"Keytruda (pembrolizumab)","NDA_BLA_APPROVAL_DATE":"9/4/14","CMT_DESC":"Provide a report, datasets, and labeling for the second interim analysis of overall survival (OS) for the ongoing clinical trial KEYNOTE-426, entitled, \u201cA Phase III Randomized, Open-label Study to Evaluate Efficacy and Safety of Pembrolizumab (MK-3475) in Combination with Axitinib Versus Sunitinib Monotherapy as a First-line Treatment for Locally Advanced or Metastatic Renal Cell Carcinoma (mRCC).\u201d","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Post Marketing Commitment","NCT1":"NCT02853331","LastCTUpdate1":"4/3/20","N1":861,"APPLICANT":"Merck Sharp & Dohme Corp.","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"10/31/19","FINAL_REPORT_DUE_DATE":"8/31/20"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":125514,"CMT_DOC_TYPE_NO":54,"PRODUCT":"Keytruda (pembrolizumab)","NDA_BLA_APPROVAL_DATE":"9/4/14","CMT_DESC":"Provide a report, datasets, and labeling for the final analysis of overall survival (OS) for the ongoing clinical trial KEYNOTE-426, entitled, \u201cA Phase III Randomized, Open-label Study to Evaluate Efficacy and Safety of Pembrolizumab (MK-3475) in Combination with Axitinib Versus Sunitinib Monotherapy as a First-line Treatment for Locally Advanced or Metastatic Renal Cell Carcinoma (mRCC).\u201d","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Post Marketing Commitment","NCT1":"NCT02853331","LastCTUpdate1":"4/3/20","N1":861,"APPLICANT":"Merck Sharp & Dohme Corp.","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"10/31/19","FINAL_REPORT_DUE_DATE":"9/30/21"},{"CMT_DOC_TYPE":"Original Biologics License Application","NDA_NUMBER":125261,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Stelara (Ustekinumab)","NDA_BLA_APPROVAL_DATE":"9/25/09","CMT_DESC":"Provide data analyses from the Pregnancy Research Initiative (study C0168T71).","CMT_STATUS":"Ongoing","SUBPART_FLAG":"FDAAA Section 505(o)(3)","NCT1":"NCT00658827","LastCTUpdate1":"9/6/17","N1":370,"APPLICANT":"Janssen Biotech, Inc.","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"11/21/19","FINAL_REPORT_DUE_DATE":"12/15/21"},{"CMT_DOC_TYPE":"Original Biologics License Application","NDA_NUMBER":761108,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Ultomiris (ravulizumab-cwvz) injection","NDA_BLA_APPROVAL_DATE":"12/21/18","CMT_DESC":"Submit the final clinical study report and dataset for the randomized controlled trial of ULTOMIRIS in patients with paroxysmal nocturnal hemoglobinuria (ALXN1210-PNH-301) to include the extension period of up to 2 years of follow-up.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Post Marketing Commitment","NCT1":"NCT02946463","LastCTUpdate1":"5/15/20","N1":246,"APPLICANT":"Alexion Pharmaceuticals, Inc.","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"2/13/20","FINAL_REPORT_DUE_DATE":"10/31/23"},{"CMT_DOC_TYPE":"Original Biologics License Application","NDA_NUMBER":761108,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Ultomiris (ravulizumab-cwvz) injection","NDA_BLA_APPROVAL_DATE":"12/21/18","CMT_DESC":"Submit the final clinical study report and dataset for the randomized controlled trial of ULTOMIRIS in patients with paroxysmal nocturnal hemoglobinuria (ALXN1210-PNH-302) to include the extension period of up to 2 years of follow-up.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Post Marketing Commitment","NCT1":"NCT03056040","LastCTUpdate1":"8/12/20","N1":195,"APPLICANT":"Alexion Pharmaceuticals, Inc.","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"2/13/20","FINAL_REPORT_DUE_DATE":"9/30/21"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":205552,"CMT_DOC_TYPE_NO":17,"PRODUCT":"Imbruvica (Ibrutinib)","NDA_BLA_APPROVAL_DATE":"11/13/13","CMT_DESC":"Conduct an analysis of safety in patients with chronic graft-versus-host-disease treated with ibrutinib. Submit the complete primary study report and datasets from Study PCYC-1140-IM: A Randomized, Double-Blind Phase 3 Study of Ibrutinib in Combination with Corticosteroids versus Placebo in Combination with Corticosteroids in Subjects with New Onset Chronic Graft-Versus-Host Disease (cGVHD). Include safety analyses that evaluate impact of concomitant medications (for example, corticosteroids and additional immunosuppressants) on  the safety profile for ibrutinib.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"FDAAA Section 505(o)(3)","NCT1":"NCT02959944","LastCTUpdate1":"7/14/20","N1":193,"APPLICANT":"PHARMACYCLICS LLC","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"1/10/20","FINAL_REPORT_DUE_DATE":"12/31/22"},{"CMT_DOC_TYPE":"Original New Drug Application (NDA)","NDA_NUMBER":208700,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Lutathera (177 Lu-DOTA0-Tyr3-Octreotate)","NDA_BLA_APPROVAL_DATE":"1/26/18","CMT_DESC":"Submit the final clinical report and datasets at the time of the final analysis for overall survival (OS) for Trial NETTER-1, entitled \u201cA Multicentre, stratified, open, randomized, comparator-controlled, parallel-group phase III study comparing treatment with 177 Lu-DOTA0-Tyr3-Octreotate to Octreotide LAR in Patients with Inoperable, Progressive, Somatostin Receptor Positive, Midgut Carcinoid Tumors\u201d, to revise product labeling with mature OS data.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Post Marketing Commitment","NCT1":"NCT01578239","LastCTUpdate1":"1/20/20","N1":231,"APPLICANT":"ADVANCED ACCELERATOR APPLICATIONS USA INC","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"3/25/20","FINAL_REPORT_DUE_DATE":"5/31/21"},{"CMT_DOC_TYPE":"Original New Drug Application (NDA)","NDA_NUMBER":208716,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Verzenio (abemaciclib)","NDA_BLA_APPROVAL_DATE":"9/28/17","CMT_DESC":"Submit the overall survival (OS) data and analysis with final report from clinical trial MONARCH 3 entitled; \u201cA Randomized, Double-Blind, Placebo-Controlled,  Phase 3 Study of Nonsteroidal Aromatase Inhibitors (Anastrazole or Letrozole) plus LY2835219, a CDK 4/6 Inhibitor, or Placebo in Postmenopausal Women  with Hormone Receptor-Positive, HER2-Negative Locoregionally Recurrent or Metastatic Breast Cancer with No Prior Systemic Therapy in this Disease Setting.\u201d","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Post Marketing Commitment","NCT1":"NCT02246621","LastCTUpdate1":"12/17/20","N1":493,"APPLICANT":"ELI LILLY AND CO","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"11/25/19","FINAL_REPORT_DUE_DATE":"12/31/26"},{"CMT_DOC_TYPE":"Original New Drug Application (NDA)","NDA_NUMBER":208855,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Verzenio (abemaciclib)","NDA_BLA_APPROVAL_DATE":"2/26/18","CMT_DESC":"Submit the overall survival (OS) data and analysis with final report from clinical trial MONARCH 3 entitled; \u201cA Randomized, Double-Blind, Placebo-Controlled,  Phase 3 Study of Nonsteroidal Aromatase Inhibitors (Anastrazole or Letrozole) plus LY2835219, a CDK 4/6 Inhibitor, or Placebo in Postmenopausal Women  with Hormone Receptor-Positive, HER2-Negative Locoregionally Recurrent or Metastatic Breast Cancer with No Prior Systemic Therapy in this Disease Setting.\u201d","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Post Marketing Commitment","NCT1":"NCT02246621","LastCTUpdate1":"12/17/20","N1":493,"APPLICANT":"ELI LILLY AND CO","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"NA","FINAL_REPORT_DUE_DATE":"12/31/26"},{"CMT_DOC_TYPE":"Original New Drug Application (NDA)","NDA_NUMBER":209092,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Kisqali (Ribociclib)","NDA_BLA_APPROVAL_DATE":"3/13/17","CMT_DESC":"Submit the third overall survival (OS) interim data and analysis, and the final overall survival (OS) data and analysis from clinical trial entitled \u201cMONALEESA-2\u201d CLEE011A2301.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Post Marketing Commitment","NCT1":"NCT01958021","LastCTUpdate1":"10/19/20","N1":668,"APPLICANT":"NOVARTIS PHARMACEUTICALS CORP","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"5/6/20","FINAL_REPORT_DUE_DATE":"6/30/22"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":209115,"CMT_DOC_TYPE_NO":3,"PRODUCT":"Rubraca (Rucaparib)","NDA_BLA_APPROVAL_DATE":"12/19/16","CMT_DESC":"Submit to FDA the overall survival (OS) analyses with datasets from clinical trial CO-338-014 entitled, \u201cPhase 3 Study of Rucaparib as Switch Maintenance After Platinum in Relapsed High Grade Serous and Endometrioid Ovarian Cancer\u201d (ARIEL3).","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Post Marketing Commitment","NCT1":"NCT01968213","LastCTUpdate1":"2/20/20","N1":564,"APPLICANT":"CLOVIS ONCOLOGY INC","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"2/14/20","FINAL_REPORT_DUE_DATE":"3/31/21"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":209115,"CMT_DOC_TYPE_NO":4,"PRODUCT":"Rubraca (Rucaparib)","NDA_BLA_APPROVAL_DATE":"12/19/16","CMT_DESC":"Submit the final report of analytical and clinical validation studies that use cell-free/circulating tumor DNA (cf/ctDNA) isolated from plasma specimens from the TRITON2 clinical trial that is adequate to support labeling of an in vitro diagnostic device that demonstrates the device is essential to the safe and effective use of rucaparib for prostate cancer patients with BRCA1 and BRCA2 gene alterations. The analytical validation should consist of precision, limit of detection, and accuracy studies using samples, consistent with the clinical trial patient population, to support prostate cancer indication. The clinical validation should be supported by a clinical bridging study comparing intended CDx test(s) and the clinical trial enrollment assays.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Post Marketing Commitment","NCT1":"NCT02952534","LastCTUpdate1":"11/27/20","N1":360,"APPLICANT":"CLOVIS ONCOLOGY INC","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"2/14/20","FINAL_REPORT_DUE_DATE":"12/31/21"},{"CMT_DOC_TYPE":"Original New Drug Application (NDA)","NDA_NUMBER":209478,"CMT_DOC_TYPE_NO":1,"PRODUCT":"CaroSpir (Spironolactone)","NDA_BLA_APPROVAL_DATE":"8/4/17","CMT_DESC":"Conduct a clinical drug-drug interaction trial to evaluate a potential interaction between digoxin and spironolactone using a validated analytical method to  quantify plasma digoxin levels.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"FDAAA Section 505(o)(3)","NCT1":"NCT03909529","LastCTUpdate1":"7/24/19","N1":28,"APPLICANT":"CMP DEVELOPMENT LLC","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"9/9/19","FINAL_REPORT_DUE_DATE":"3/31/19"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":125057,"CMT_DOC_TYPE_NO":114,"PRODUCT":"Humira (Adalimumab)","NDA_BLA_APPROVAL_DATE":"12/31/02","CMT_DESC":"Conduct Study Protocol P10-262, an 800-patient observational study, with inclusion of a reference group, of pediatric patients 4 to 17 years of age with moderately to severely active polyarticular juvenile idiopathic arthritis (JIA).","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Pediatric Research Equity Act","NCT1":"NCT00783510","LastCTUpdate1":"11/6/20","N1":833,"APPLICANT":"AbbVie Inc.","CMT_STATUS_DESC":"Final report due 12/2024.","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"2/26/20","FINAL_REPORT_DUE_DATE":"12/31/21"},{"CMT_DOC_TYPE":"Original New Drug Application (NDA)","NDA_NUMBER":210806,"CMT_DOC_TYPE_NO":1,"PRODUCT":"PIFELTRO (doravirine)","NDA_BLA_APPROVAL_DATE":"8/30/18","CMT_DESC":"Conduct a study to evaluate the pharmacokinetics, safety and antiviral activity (efficacy) of doravirine in HIV-1 infected pediatric subjects less than 18 years of age and weighing at least 35 kg. The safety and antiviral activity of doravirine in pediatric subjects must be evaluated for a minimum of 24 weeks.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Pediatric Research Equity Act","NCT1":"NCT04295772","LastCTUpdate1":"11/22/21","N1":45,"APPLICANT":"MERCK SHARP AND DOHME CORP A SUB OF MERCK AND CO INC","CMT_STATUS_DESC":"Reports that 10 participants have been enrolled in Cohort 1 of the trial as of 08/30/19.","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"10/25/19","FINAL_REPORT_DUE_DATE":"1/31/22"},{"CMT_DOC_TYPE":"Original New Drug Application (NDA)","NDA_NUMBER":213973,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Qinlock (ripretinib)","NDA_BLA_APPROVAL_DATE":"5/15/20","CMT_DESC":"Conduct a clinical pharmacokinetic trial to evaluate the effect of repeat doses of ripretinib on the single dose pharmacokinetics of a sensitive CYP2C8 substrate. This trial should be designed and conducted in accordance with the FDA Guidance for Industry titled, \u201cClinical Drug Interaction Studies \u2013 Study Design, Data Analysis, and Clinical Implications.\u201d The results from this trial should determine the magnitude of increase in the exposure of the CYP2C8 substrate and an appropriate dosing recommendation of CYP2C8 substrates when they are administered concomitantly with ripretinib and may inform labeling.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"FDAAA Section 505(o)(3)","NCT1":"NCT04530981","LastCTUpdate1":"8/28/20","N1":30,"APPLICANT":"DECIPHERA PHARMACEUTICALS LLC","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"NA","FINAL_REPORT_DUE_DATE":"3/31/22"},{"CMT_DOC_TYPE":"Original New Drug Application (NDA)","NDA_NUMBER":210807,"CMT_DOC_TYPE_NO":1,"PRODUCT":"DELSTRIGO (doravirine, lamivudine, and tenofovir disoproxil fumarate)","NDA_BLA_APPROVAL_DATE":"8/30/18","CMT_DESC":"Conduct a study to evaluate the pharmacokinetics, safety, and antiviral activity (efficacy) of doravirine/lamivudine/tenofovir disoproxil fumarate fixed dose combination (FDC) product in HIV-1 infected pediatric subjects less than 18 years of age and weighing at least 35 kg. Subjects must be followed for a minimum of 24 weeks to assess the safety and antiviral activity of doravirine/lamivudine/tenofovir disoproxil fumarate FDC product. A clinical trial in pediatric subjects weighing at least 35 kg may not be required if dosing recommendation for the FDC tablets can be supported by pediatric trials already conducted with the individual drug products.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Pediatric Research Equity Act","NCT1":"NCT03332095","LastCTUpdate1":"8/25/20","N1":55,"APPLICANT":"MERCK SHARP AND DOHME CORP A SUB OF MERCK AND CO INC","CMT_STATUS_DESC":"Reports the 10 patients have been enrolled in Cohort 1 of the study.","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"10/25/19","FINAL_REPORT_DUE_DATE":"1/31/22"},{"CMT_DOC_TYPE":"Original New Drug Application (NDA)","NDA_NUMBER":210854,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Xofluza (baloxavir marboxil)","NDA_BLA_APPROVAL_DATE":"10/24/18","CMT_DESC":"Conduct a single-arm, open-label clinical trial to evaluate pharmacokinetics, safety, and antiviral activity of baloxavir marboxil in pediatric subjects from birth to less than 12 months of age with acute uncomplicated influenza. Include characterization of baloxavir-resistant substitutions in viral isolates from subjects with prolonged viral shedding.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Pediatric Research Equity Act","NCT1":"NCT03653364","LastCTUpdate1":"1/21/21","N1":30,"APPLICANT":"GENENTECH INC","CMT_STATUS_DESC":"Reporting 33 patients have been enrolled as of 11/12/19.","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"12/19/19","FINAL_REPORT_DUE_DATE":"12/31/21"},{"CMT_DOC_TYPE":"Original New Drug Application (NDA)","NDA_NUMBER":210854,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Xofluza (baloxavir marboxil)","NDA_BLA_APPROVAL_DATE":"10/24/18","CMT_DESC":"Conduct a randomized, double-blind, controlled clinical trial evaluating efficacy and safety of baloxavir marboxil in subjects hospitalized with severe influenza.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Post Marketing Commitment","NCT1":"NCT03684044","LastCTUpdate1":"1/6/21","N1":363,"APPLICANT":"GENENTECH INC","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"12/19/19","FINAL_REPORT_DUE_DATE":"11/30/22"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":761108,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Ultomiris (ravulizumab-cwvz) injection","NDA_BLA_APPROVAL_DATE":"12/21/18","CMT_DESC":"Provide safety, efficacy, PK, and PD data in pediatric patients with aHUS (Study ALXN 1210-aHUS-312) and a weight of greater than or equal to 5 kg to less than 10 kg treated with the recommended dosing regimen of ravulizumab (600 mg loading dose followed two weeks later by 300 mg maintenance doses every 4 weeks).","CMT_STATUS":"Ongoing","SUBPART_FLAG":"FDAAA Section 505(o)(3)","NCT1":"NCT03131219","LastCTUpdate1":"9/16/20","N1":31,"APPLICANT":"Alexion Pharmaceuticals, Inc.","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"2/13/20","FINAL_REPORT_DUE_DATE":"6/30/25"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":761108,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Ultomiris (ravulizumab-cwvz) injection","NDA_BLA_APPROVAL_DATE":"12/21/18","CMT_DESC":"Submit the final clinical study report and datasets for the single arm trial of ULTOMIRIS in pediatric patients with aHUS (ALXN1210- aHUS-312) to include the extension period of up to 4.5 years of follow-up on safety and efficacy.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Post Marketing Commitment","NCT1":"NCT03131219","LastCTUpdate1":"9/16/20","N1":31,"APPLICANT":"Alexion Pharmaceuticals, Inc.","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"2/13/20","FINAL_REPORT_DUE_DATE":"6/30/25"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":761108,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Ultomiris (ravulizumab-cwvz) injection","NDA_BLA_APPROVAL_DATE":"12/21/18","CMT_DESC":"Provide safety, efficacy, PK, and PD data in pediatric patients with aHUS (Study ALXN1210-aHUS-312) who switch from treatmentwith eculizumab to treatment with ravulizumab.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Post Marketing Commitment","NCT1":"NCT03131219","LastCTUpdate1":"9/16/20","N1":31,"APPLICANT":"Alexion Pharmaceuticals, Inc.","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"2/13/20","FINAL_REPORT_DUE_DATE":"6/30/25"},{"CMT_DOC_TYPE":"Supplemental NDA or BLA","NDA_NUMBER":761108,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Ultomiris (ravulizumab-cwvz) injection","NDA_BLA_APPROVAL_DATE":"12/21/18","CMT_DESC":"Submit the final clinical study report and datasets for the single arm trial of ULTOMIRIS in adult patients with aHUS (Study ALXN1210- aHUS-311) to include the extension period of up to 4.5 years of follow-up on safety and efficacy.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Post Marketing Commitment","NCT1":"NCT02949128","LastCTUpdate1":"5/5/20","N1":58,"APPLICANT":"Alexion Pharmaceuticals, Inc.","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"2/13/20","FINAL_REPORT_DUE_DATE":"12/31/23"},{"CMT_DOC_TYPE":"Original Biologics License Application","NDA_NUMBER":761047,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Mepsevii (vestronidase alfa-vjbk)","NDA_BLA_APPROVAL_DATE":"11/15/17","CMT_DESC":"A prospective, longitudinal study (Study UX003-CL401) to assess the long-term risk of immunogenicity and the risk of serious hypersensitivity reactions, including anaphylaxis, in patients with mucopolysaccharidosis type VII (MPS VII) followed for three years on Mepsevii (vestronidase alfa-vjbk). The following information will be collected and analyzed: (1) incidence rates for serious hypersensitivity reactions, (2) incidence rates for the appearance of anti-drug antibodies (ADA) and neutralizing antibodies (Nab) against Mepsevii (vestronidase alfa-vjbk), (3) temporal associations between ADA or Nab formation and serious hypersensitivity reactions, (4) associations between betaglucuronidase (GUSB) genotype and serious hypersensitivity reaction risk, (5)  associations between intrinsic GUSB enzymatic activity and serious hypersensitivity reaction risk, and (6) assessments of the risk of immunogenicity on clinical safety outcomes. To complete these analyses, protocol UX003-CL401 will require collection of molecular genotype and intrinsic GUSB enzymatic activity (apart from any concurrent enzyme replacement). Submit annual study reports that contain results from analyses of interim data. The final study report will be based on a study population that contains at least 12 new patients (including at least six patients less than one year old) treated with Mepsevii (vestronidase alfa-vjbk) and enrolled in Study UX003-CL401.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"FDAAA Section 505(o)(3)","NCT1":"NCT03604835","LastCTUpdate1":"1/22/21","N1":35,"APPLICANT":"Ultragenyx Pharmaceutical Inc.","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"7/29/20","FINAL_REPORT_DUE_DATE":"5/31/26"},{"CMT_DOC_TYPE":"Original Biologics License Application","NDA_NUMBER":761047,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Mepsevii (vestronidase alfa-vjbk)","NDA_BLA_APPROVAL_DATE":"11/15/17","CMT_DESC":"In MPS VII patients enrolled in the prospective, longitudinal Study UX003-CL401 (PMR-1), to collect and analyze: (1) beta glucuronidase (GUSB) genotype, (2) in patients without a history of Mepsevii (vestronidase alfa-vjbk) treatment, baseline intrinsic GUSB enzymatic activity apart from any concurrent enzyme replacement treatment, (3) a complete record of treatments with Mepsevii (vestronidase alfa-vjbk) pre- and post-UX003-CL401 enrollment, and (4) results from baseline and periodic tests for MPS VII clinical outcomes to include liver and spleen size measurement, pulmonary function, motor function, and neurocognitive function.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Post Marketing Commitment","NCT1":"NCT03604835","LastCTUpdate1":"1/22/21","N1":35,"APPLICANT":"Ultragenyx Pharmaceutical Inc.","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"7/29/20","FINAL_REPORT_DUE_DATE":"5/31/33"},{"CMT_DOC_TYPE":"Original Biologics License Application","NDA_NUMBER":761049,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Bavencio (Avelumab)","NDA_BLA_APPROVAL_DATE":"3/23/17","CMT_DESC":"Submit the final report and data for safety and efficacy of the ongoing clinical trial EMR100070-005 entitled \u201cA Phase 3, Open-Label, Multicenter Trial of Avelumab (MSB0010718C) Versus Platinum-Based Doublet as a First-Line  Treatment of Recurrent or Stage IV PD-L1+ Non-Small Cell Lung Cancer\u201d, including results of the exposure-response analysis.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Post Marketing Commitment","NCT1":"NCT02576574","LastCTUpdate1":"12/17/20","N1":1224,"APPLICANT":"EMD Serono, Inc.","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"5/17/19","FINAL_REPORT_DUE_DATE":"10/31/20"},{"CMT_DOC_TYPE":"Original New Drug Application (NDA)","NDA_NUMBER":211651,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Talzenna (talazoparib)","NDA_BLA_APPROVAL_DATE":"10/16/18","CMT_DESC":"Determine the appropriate dosing recommendations in patients with moderate and severe hepatic impairment by using the results from clinical trial C3441002 entitled, \u201cA Phase 1 Open-Label Pharmacokinetics and Safety Study of Talazoparib (MDV3800) in Patients With Advanced Solid Tumors and Normal or Varying Degrees of Hepatic Impairment\u201d. Submit datasets with the final report.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"FDAAA Section 505(o)(3)","NCT1":"NCT02997176","LastCTUpdate1":"10/30/20","N1":38,"APPLICANT":"PFIZER INC","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"12/12/19","FINAL_REPORT_DUE_DATE":"11/30/20"},{"CMT_DOC_TYPE":"Original New Drug Application (NDA)","NDA_NUMBER":213464,"CMT_DOC_TYPE_NO":1,"PRODUCT":"Lampit (Nifurtimox)","NDA_BLA_APPROVAL_DATE":"8/6/20","CMT_DESC":"Complete the CHICO SECURE part of Study 16027 to determine the seroconversion rate in subjects treated with nifurtimox at the 4-year timepoint. Obtain antibody titers by serial dilution for all available serum samples measured by the F29-ELISA, Recombinant-ELISA and Lysate-ELISA in addition to IHA.","CMT_STATUS":"Ongoing","SUBPART_FLAG":"Accelerated Approval","NCT1":"NCT02625974","LastCTUpdate1":"12/29/20","N1":330,"APPLICANT":"BAYER HEALTHCARE PHARMACEUTICALS INC","CMT_STATUS_DESC":"NA","STUDY_TYPE":"NA","STUDY_START_DATE":"NA","PROTOCOL_SUBMISSION_DATE":"NA","FINAL_RPT_RECV_DATE":"NA","ANNUAL_RPT_DUE_DATE":"NA","ANNUAL_RPT_RECV_DATE":"NA","FINAL_REPORT_DUE_DATE":"2/28/22"}],"Sheet1":[{"NCT005":"NCT006"},{"NCT005":"NCT007"},{"NCT005":"NCT008"},{"NCT005":"NCT009"},{"NCT005":"NCT010"},{"NCT005":"NCT011"},{"NCT005":"NCT012"},{"NCT005":"NCT013"},{"NCT005":"NCT014"},{"NCT005":"NCT015"},{"NCT005":"NCT016"},{"NCT005":"NCT017"},{"NCT005":"NCT018"},{"NCT005":"NCT019"},{"NCT005":"NCT020"},{"NCT005":"NCT021"},{"NCT005":"NCT022"},{"NCT005":"NCT023"},{"NCT005":"NCT024"},{"NCT005":"NCT025"},{"NCT005":"NCT026"},{"NCT005":"NCT027"},{"NCT005":"NCT028"},{"NCT005":"NCT029"},{"NCT005":"NCT030"},{"NCT005":"NCT031"},{"NCT005":"NCT032"},{"NCT005":"NCT033"},{"NCT005":"NCT034"},{"NCT005":"NCT035"},{"NCT005":"NCT036"},{"NCT005":"NCT037"},{"NCT005":"NCT038"},{"NCT005":"NCT039"},{"NCT005":"NCT040"},{"NCT005":"NCT041"},{"NCT005":"NCT042"},{"NCT005":"NCT043"},{"NCT005":"NCT044"},{"NCT005":"NCT045"},{"NCT005":"NCT046"},{"NCT005":"NCT047"},{"NCT005":"NCT048"},{"NCT005":"NCT049"},{"NCT005":"NCT050"},{"NCT005":"NCT051"},{"NCT005":"NCT052"},{"NCT005":"NCT053"},{"NCT005":"NCT054"},{"NCT005":"NCT055"},{"NCT005":"NCT056"},{"NCT005":"NCT057"},{"NCT005":"NCT058"},{"NCT005":"NCT059"},{"NCT005":"NCT060"},{"NCT005":"NCT061"},{"NCT005":"NCT062"},{"NCT005":"NCT063"},{"NCT005":"NCT064"},{"NCT005":"NCT065"},{"NCT005":"NCT066"},{"NCT005":"NCT067"},{"NCT005":"NCT068"},{"NCT005":"NCT069"},{"NCT005":"NCT070"},{"NCT005":"NCT071"},{"NCT005":"NCT072"},{"NCT005":"NCT073"},{"NCT005":"NCT074"},{"NCT005":"NCT075"},{"NCT005":"NCT076"},{"NCT005":"NCT077"},{"NCT005":"NCT078"},{"NCT005":"NCT079"},{"NCT005":"NCT080"},{"NCT005":"NCT081"},{"NCT005":"NCT082"},{"NCT005":"NCT083"},{"NCT005":"NCT084"},{"NCT005":"NCT085"},{"NCT005":"NCT086"},{"NCT005":"NCT087"},{"NCT005":"NCT088"},{"NCT005":"NCT089"},{"NCT005":"NCT090"},{"NCT005":"NCT091"},{"NCT005":"NCT092"},{"NCT005":"NCT093"},{"NCT005":"NCT094"},{"NCT005":"NCT095"},{"NCT005":"NCT096"},{"NCT005":"NCT097"},{"NCT005":"NCT098"},{"NCT005":"NCT099"},{"NCT005":"NCT100"},{"NCT005":"NCT101"},{"NCT005":"NCT102"},{"NCT005":"NCT103"},{"NCT005":"NCT104"},{"NCT005":"NCT105"},{"NCT005":"NCT106"},{"NCT005":"NCT107"},{"NCT005":"NCT108"},{"NCT005":"NCT109"},{"NCT005":"NCT110"},{"NCT005":"NCT111"},{"NCT005":"NCT112"},{"NCT005":"NCT113"},{"NCT005":"NCT114"},{"NCT005":"NCT115"},{"NCT005":"NCT116"},{"NCT005":"NCT117"},{"NCT005":"NCT118"},{"NCT005":"NCT119"},{"NCT005":"NCT120"},{"NCT005":"NCT121"},{"NCT005":"NCT122"},{"NCT005":"NCT123"},{"NCT005":"NCT124"},{"NCT005":"NCT125"},{"NCT005":"NCT126"},{"NCT005":"NCT127"},{"NCT005":"NCT128"},{"NCT005":"NCT129"},{"NCT005":"NCT130"},{"NCT005":"NCT131"},{"NCT005":"NCT132"},{"NCT005":"NCT133"},{"NCT005":"NCT134"},{"NCT005":"NCT135"},{"NCT005":"NCT136"},{"NCT005":"NCT137"},{"NCT005":"NCT138"},{"NCT005":"NCT139"},{"NCT005":"NCT140"},{"NCT005":"NCT141"},{"NCT005":"NCT142"},{"NCT005":"NCT143"},{"NCT005":"NCT144"},{"NCT005":"NCT145"},{"NCT005":"NCT146"},{"NCT005":"NCT147"},{"NCT005":"NCT148"},{"NCT005":"NCT149"},{"NCT005":"NCT150"},{"NCT005":"NCT151"},{"NCT005":"NCT152"},{"NCT005":"NCT153"},{"NCT005":"NCT154"},{"NCT005":"NCT155"},{"NCT005":"NCT156"},{"NCT005":"NCT157"},{"NCT005":"NCT158"},{"NCT005":"NCT159"},{"NCT005":"NCT160"},{"NCT005":"NCT161"},{"NCT005":"NCT162"},{"NCT005":"NCT163"},{"NCT005":"NCT164"},{"NCT005":"NCT165"},{"NCT005":"NCT166"},{"NCT005":"NCT167"},{"NCT005":"NCT168"},{"NCT005":"NCT169"},{"NCT005":"NCT170"},{"NCT005":"NCT171"},{"NCT005":"NCT172"},{"NCT005":"NCT173"},{"NCT005":"NCT174"},{"NCT005":"NCT175"},{"NCT005":"NCT176"},{"NCT005":"NCT177"},{"NCT005":"NCT178"},{"NCT005":"NCT179"},{"NCT005":"NCT180"},{"NCT005":"NCT181"},{"NCT005":"NCT182"},{"NCT005":"NCT183"},{"NCT005":"NCT184"},{"NCT005":"NCT185"},{"NCT005":"NCT186"},{"NCT005":"NCT187"},{"NCT005":"NCT188"},{"NCT005":"NCT189"},{"NCT005":"NCT190"},{"NCT005":"NCT191"},{"NCT005":"NCT192"},{"NCT005":"NCT193"},{"NCT005":"NCT194"},{"NCT005":"NCT195"},{"NCT005":"NCT196"},{"NCT005":"NCT197"},{"NCT005":"NCT198"},{"NCT005":"NCT199"},{"NCT005":"NCT200"},{"NCT005":"NCT201"},{"NCT005":"NCT202"},{"NCT005":"NCT203"},{"NCT005":"NCT204"},{"NCT005":"NCT205"},{"NCT005":"NCT206"},{"NCT005":"NCT207"},{"NCT005":"NCT208"},{"NCT005":"NCT209"},{"NCT005":"NCT210"},{"NCT005":"NCT211"},{"NCT005":"NCT212"},{"NCT005":"NCT213"},{"NCT005":"NCT214"},{"NCT005":"NCT215"},{"NCT005":"NCT216"},{"NCT005":"NCT217"},{"NCT005":"NCT218"},{"NCT005":"NCT219"},{"NCT005":"NCT220"},{"NCT005":"NCT221"},{"NCT005":"NCT222"},{"NCT005":"NCT223"},{"NCT005":"NCT224"},{"NCT005":"NCT225"},{"NCT005":"NCT226"},{"NCT005":"NCT227"},{"NCT005":"NCT228"},{"NCT005":"NCT229"},{"NCT005":"NCT230"},{"NCT005":"NCT231"},{"NCT005":"NCT232"},{"NCT005":"NCT233"},{"NCT005":"NCT234"},{"NCT005":"NCT235"},{"NCT005":"NCT236"},{"NCT005":"NCT237"},{"NCT005":"NCT238"},{"NCT005":"NCT239"},{"NCT005":"NCT240"},{"NCT005":"NCT241"},{"NCT005":"NCT242"},{"NCT005":"NCT243"},{"NCT005":"NCT244"},{"NCT005":"NCT245"},{"NCT005":"NCT246"},{"NCT005":"NCT247"},{"NCT005":"NCT248"},{"NCT005":"NCT249"},{"NCT005":"NCT250"},{"NCT005":"NCT251"},{"NCT005":"NCT252"},{"NCT005":"NCT253"},{"NCT005":"NCT254"},{"NCT005":"NCT255"},{"NCT005":"NCT256"},{"NCT005":"NCT257"},{"NCT005":"NCT258"},{"NCT005":"NCT259"},{"NCT005":"NCT260"},{"NCT005":"NCT261"},{"NCT005":"NCT262"},{"NCT005":"NCT263"},{"NCT005":"NCT264"},{"NCT005":"NCT265"},{"NCT005":"NCT266"},{"NCT005":"NCT267"},{"NCT005":"NCT268"},{"NCT005":"NCT269"},{"NCT005":"NCT270"},{"NCT005":"NCT271"},{"NCT005":"NCT272"},{"NCT005":"NCT273"},{"NCT005":"NCT274"},{"NCT005":"NCT275"},{"NCT005":"NCT276"},{"NCT005":"NCT277"},{"NCT005":"NCT278"},{"NCT005":"NCT279"},{"NCT005":"NCT280"},{"NCT005":"NCT281"}],"ColNames":{"CMT_ID":"Commitment ID","CMT_NUMBER":"Commitment Number","CMT_DOC_TYPE":"Application Type","CMT_DOC_TYPE_NO":"Submission Number","CMT_DESC":"Commitment Description","CMT_STATUS":"Commitment Status","CMT_STATUS_DESC":"Commitment Status Description","STUDY_TYPE":"Study type","STUDY_START_DATE":"Study start date","PROTOCOL_SUBMISSION_DATE":"Protocol Submission Date","FINAL_RPT_RECV_DATE":"Final Report Received Data","ANNUAL_RPT_DUE_DATE":"Annual report due date","ANNUAL_RPT_RECV_DATE":"Annual report rececived date","NDA_BLA_APPROVAL_DATE":"Approval Date","FINAL_REPORT_DUE_DATE":"Final report due date","CURRENT_PROJ_COMPL_DATE":"Current Project Completion Date","NDA_NUMBER":"Application Number","APPLICANT":"Applicant","PRODUCT":"Product","PUBLIC_FLAG":"Public Flag","CDER_OR_CBER":"Center","SUBPART_FLAG":"Subpart Flag","Scope":"Scope","NCT1":"NCT ID","LastCTUpdate1":"Last Update Date","N1":"Sample Size","NCT2":"NCT ID","LastCTUpdate2":"Last Update Date","N2":"Sample Size","Include":"Include"},"KeyDescriptions":{"CMT_DOC_TYPE":{"B":"Original Biologics License Application","N":"Original New Drug Application (NDA)","O":"Other","S":"Supplemental NDA or BLA ","NA":"N/A"},"CMT_STATUS":{"D":"Delayed","F":"Fulfilled","O":"Ongoing","P":"Pending","R":"Released","S":"Submitted","T":"Terminated","NA":"N/A"},"CDER_OR_CBER":{"CD":"Center for Drug Evaluation and Research","CB":"Center for Biologics Evaluation and Research","NA":"N/A"},"SUBPART_FLAG":{"CD":"Center for Drug Evaluation and Research","CB":"Center for Biologics Evaluation and Research","H":"Accelerated Approval","F":"FDAAA Section 505(o)(3)","E":"Animal Efficacy Rule","P":"Pediatric Research Equity Act","":"N/A","NA":"N/A"}},"DataSchema":[{"Source":"FDA_PMRPMC","Field":"CMT_ID","ColumnName":"Commitment ID"},{"Source":"FDA_PMRPMC","Field":"CMT_NUMBER","ColumnName":"Commitment Number"},{"Source":"FDA_PMRPMC","Field":"CMT_DOC_TYPE","ColumnName":"Application Type","KeyDescription":{"B":"Original Biologics License Application","N":"Original New Drug Application (NDA)","O":"Other","S":"Supplemental NDA or BLA "}},{"Source":"FDA_PMRPMC","Field":"CMT_DOC_TYPE_NO","ColumnName":"Submission Number"},{"Source":"FDA_PMRPMC","Field":"CMT_DESC","ColumnName":"Commitment Description"},{"Source":"FDA_PMRPMC","Field":"CMT_STATUS","ColumnName":"Commitment Status","KeyDescription":{"D":"Delayed","F":"Fulfilled","O":"Ongoing","P":"Pending","R":"Released","S":"Submitted","T":"Terminated"}},{"Source":"FDA_PMRPMC","Field":"CMT_STATUS_DESC","ColumnName":"Commitment Status Description"},{"Source":"FDA_PMRPMC","Field":"STUDY_TYPE","ColumnName":"Study type"},{"Source":"FDA_PMRPMC","Field":"STUDY_START_DATE","ColumnName":"Study start date"},{"Source":"FDA_PMRPMC","Field":"PROTOCOL_SUBMISSION_DATE","ColumnName":"Protocol Submission Date"},{"Source":"FDA_PMRPMC","Field":"FINAL_RPT_RECV_DATE","ColumnName":"Final Report Received Data"},{"Source":"FDA_PMRPMC","Field":"ANNUAL_RPT_DUE_DATE","ColumnName":"Annual report due date"},{"Source":"FDA_PMRPMC","Field":"ANNUAL_RPT_RECV_DATE","ColumnName":"Annual report rececived date"},{"Source":"FDA_PMRPMC","Field":"NDA_BLA_APPROVAL_DATE","ColumnName":"Approval Date"},{"Source":"FDA_PMRPMC","Field":"FINAL_REPORT_DUE_DATE","ColumnName":"Final report due date"},{"Source":"FDA_PMRPMC","Field":"CURRENT_PROJ_COMPL_DATE","ColumnName":"Current Project Completion Date"},{"Source":"FDA_PMRPMC","Field":"NDA_NUMBER","ColumnName":"Application Number"},{"Source":"FDA_PMRPMC","Field":"APPLICANT","ColumnName":"Applicant"},{"Source":"FDA_PMRPMC","Field":"PRODUCT","ColumnName":"Product"},{"Source":"FDA_PMRPMC","Field":"PUBLIC_FLAG","ColumnName":"Public Flag"},{"Source":"FDA_PMRPMC","Field":"CDER_OR_CBER","ColumnName":"Center","KeyDescription":{"CD":"Center for Drug Evaluation and Research","CB":"Center for Biologics Evaluation and Research"}},{"Source":"FDA_PMRPMC","Field":"SUBPART_FLAG","ColumnName":"Subpart Flag","KeyDescription":{"CD":"Center for Drug Evaluation and Research","CB":"Center for Biologics Evaluation and Research","H":"Accelerated Approval","F":"FDAAA Section 505(o)(3)","E":"Animal Efficacy Rule","P":"Pediatric Research Equity Act","":"N/A"}},{"Source":"ClinicalTrialsGov:Studies:nct_id","Field":"NCT1","ColumnName":"NCT ID"},{"Source":"ClinicalTrialsGov:Studies:last_update_posted_date","Field":"LastCTUpdate1","ColumnName":"Last Update Date"},{"Source":"ClinicalTrialsGov:Studies:enrollment","Field":"N1","ColumnName":"Sample Size"},{"Source":"ClinicalTrialsGov:Studies:nct_id","Field":"NCT2","ColumnName":"NCT ID"},{"Source":"ClinicalTrialsGov:Studies:last_update_posted_date","Field":"LastCTUpdate2","ColumnName":"Last Update Date"},{"Source":"ClinicalTrialsGov:Studies:enrollment","Field":"N2","ColumnName":"Sample Size"}]}')},825:function(e,t){e.exports="data:image/png;base64,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"},826:function(e,t){e.exports="data:image/png;base64,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"},827:function(e,t){e.exports="data:image/png;base64,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"},828:function(e,t){e.exports="data:image/png;base64,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"},829:function(e,t){e.exports="data:image/png;base64,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"},96:function(e){e.exports=JSON.parse('[{"appl_type":"NDA","appl_num":202429,"supplement_type":"ORIG","supplement_num":1,"approval_date":"8/17/11","pmr_issued_label":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/202429s000lbl.pdf","trade_name":"Zelboraf","active_ingredient":"Vemurafenib","product":"Zelboraf (Vemurafenib)","Sponsor":"Hoffman La Roche","cmt_no":"1803-6","cmt_description":"Conduct a drug interaction trial to evaluate the effect of a strong CYP3A4\\ninhibitor (e.g., ketoconazole) on the pharmacokinetics of vemurafenib. ","subpart_approval":"F","subpart_approval_description":"FDAA Section 505(o)(3)","status_CMT":"Ongoing","supplement_type_fufilled":"SUPPL","supplement_num_fufilled":19,"supplement_date_fufilled":"5/18/20","fulfilled_label_link":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/202429s019lbl.pdf","time_to_fulfillment":3197,"supplement_type_proximal":"SUPPL","supplement_num_proximal":16,"proximal_label_link":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/202429s016lbl.pdf","aa_status":"No","bt_status":"No","ft_status":"No","or_status":"Yes","category":["Efficacy","Pharmacokinetics"],"issued_year":"2011","fulfilled_year":"2020","STUDY_TYPE":"nan","STUDY_START_DATE":"nan","PROTOCOL_SUBMISSION_DATE":"nan","FINAL_RPT_RECV_DATE":"nan","ANNUAL_RPT_DUE_DATE":"nan","ANNUAL_RPT_RECV_DATE":"6/25/20","NDA_BLA_APPROVAL_DATE":"4/27/17","FINAL_REPORT_DUE_DATE":"12/31/2023","CURRENT_PROJ_COMPL_DATE":"nan","issued_in_last_two_months":"yes","expected_completion_in_twelve_months":"yes"},{"appl_type":"NDA","appl_num":202429,"supplement_type":"ORIG","supplement_num":1,"approval_date":"8/17/11","pmr_issued_label":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/202429s000lbl.pdf","trade_name":"Zelboraf","active_ingredient":"Vemurafenib","product":"Zelboraf (Vemurafenib)","Sponsor":"Hoffman La Roche","cmt_no":"1803-8","cmt_description":"Submit updated overall survival results from the ongoing trial (Protocol NO25026:BRIM3) with a minimum follow-up of 24 months after the last patient\\nwas enrolled into the trial. ","subpart_approval":"B","subpart_approval_description":"PMC under 506B","status_CMT":"delayed","supplement_type_fufilled":"SUPPL","supplement_num_fufilled":4,"supplement_date_fufilled":"3/19/14","fulfilled_label_link":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/202429s004lbl.pdf","time_to_fulfillment":945,"supplement_type_proximal":"SUPPL","supplement_num_proximal":5,"proximal_label_link":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/202429s005lbl.pdf","aa_status":"No","bt_status":"No","ft_status":"No","or_status":"Yes","category":["Efficacy","QT"],"issued_year":"2011","fulfilled_year":"2014","STUDY_TYPE":"nan","STUDY_START_DATE":"nan","PROTOCOL_SUBMISSION_DATE":"nan","FINAL_RPT_RECV_DATE":"nan","ANNUAL_RPT_DUE_DATE":"nan","ANNUAL_RPT_RECV_DATE":"6/25/20","NDA_BLA_APPROVAL_DATE":"4/27/17","FINAL_REPORT_DUE_DATE":"12/31/2023","CURRENT_PROJ_COMPL_DATE":"nan","issued_in_last_two_months":"yes","expected_completion_in_twelve_months":"no"}]')}},[[1232,2,3]]]);
//# sourceMappingURL=main.36ef7c81.chunk.js.map